Citrus Sinensis ID: 014960
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 415 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | yes | no | 0.963 | 0.699 | 0.696 | 1e-169 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.754 | 0.438 | 0.753 | 1e-143 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.698 | 0.574 | 0.534 | 5e-88 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.698 | 0.565 | 0.532 | 6e-88 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.698 | 0.558 | 0.535 | 7e-88 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.698 | 0.565 | 0.521 | 1e-85 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.802 | 0.223 | 0.421 | 1e-74 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.703 | 0.235 | 0.452 | 2e-73 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.703 | 0.196 | 0.452 | 2e-73 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | yes | no | 0.703 | 0.196 | 0.452 | 2e-73 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 596 bits (1537), Expect = e-169, Method: Compositional matrix adjust.
Identities = 280/402 (69%), Positives = 333/402 (82%), Gaps = 2/402 (0%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSNNEQ 60
MGCVF RE + ++ S + V + + +K++ +N ++
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNGVIADDVEKKKNEEANGDK 60
Query: 61 ETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTF 120
E + + G++RRS+KPNPRLSNP KH GEQVAAGWPSWLS GEA++GW PR+ADTF
Sbjct: 61 ERKSSK--GDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTF 118
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
EK+DKIGQGTYSNVYKA+D LTG+IVALKKVRFDNLEPESV+FMAREIL+LRRLDHPNVV
Sbjct: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVV 178
Query: 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
KLEGLVTSRMSCSLYLVF+YM+HDLAGLA+SP +KF++++VKC M QL+SGLEHCH++ V
Sbjct: 179 KLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGV 238
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
LHRDIKGSNLLID+ G+L IADFGLA+ FDPNHK+PMTSRVVTLWYR PELLLGATDYGV
Sbjct: 239 LHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGV 298
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360
G+DLWSAGCILAELLA +PIMPGRTEVEQLHKI+KLCGSPSE+YWKK K H I+KP++
Sbjct: 299 GIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPRE 358
Query: 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
YKR I ETFKDFPPSSLPLI+ LL+I+P +RQTA+AAL+SE
Sbjct: 359 PYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSE 400
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 507 bits (1306), Expect = e-143, Method: Compositional matrix adjust.
Identities = 236/313 (75%), Positives = 274/313 (87%)
Query: 90 GEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK 149
G QV AGWPSWL++VAGEAI+GW PR+AD+FEKL+KIGQGTYS+VYKARD T Q+VALK
Sbjct: 133 GAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALK 192
Query: 150 KVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA 209
KVRF N++P+SVRFMAREI+ILRRLDHPNV+KLEGL+TSR+S S+YL+F+YMEHDLAGLA
Sbjct: 193 KVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLA 252
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269
++P I F++AQ+KCYM QLL GLEHCH++ VLHRDIKGSNLL+D+ L I DFGLA+F+
Sbjct: 253 STPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFY 312
Query: 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329
+ KQP+TSRVVTLWYRPPELLLG+TDYGV VDLWS GCILAEL KPIMPGRTEVEQ
Sbjct: 313 QGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQ 372
Query: 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
LHKIFKLCGSPSEEYWK SKLPHATIFKPQQ YKRC+AETFK P S+L L+E LLA++P
Sbjct: 373 LHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEP 432
Query: 390 AERQTATAALRSE 402
R T +AL SE
Sbjct: 433 DARGTTASALESE 445
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 164/307 (53%), Positives = 211/307 (68%), Gaps = 17/307 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D FEKL++IG+GTY VY A++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 171 LRRLDHPNVVKLEGLVTS--------------RMSCSLYLVFKYMEHDLAGLAASPTIKF 216
L++L H NV++L+ +VTS + +Y+VF+YM+HDL GLA P ++F
Sbjct: 77 LKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276
T Q+KCYM QLL+GL +CH VLHRDIKGSNLLIDNEG L +ADFGLA + +H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
+T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL KPI+PG+ E EQL+KIF+L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFEL 256
Query: 337 CGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
CGSP E+ W SK+P FKP + KR + E F+ F +L L+E +L +DPA+R +A
Sbjct: 257 CGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISA 316
Query: 396 TAALRSE 402
AL +E
Sbjct: 317 KDALDAE 323
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 164/308 (53%), Positives = 211/308 (68%), Gaps = 18/308 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D FEKL++IG+GTY VY A++T T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 171 LRRLDHPNVVKLEGLVTS---------------RMSCSLYLVFKYMEHDLAGLAASPTIK 215
L++L H NV++L+ +VTS + S+Y+VF+YM+HDL GLA P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
FT Q+KCYM QLL+GL +CH VLHRDIKGSNLLIDNEG L +ADFGLA F +H
Sbjct: 136 FTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNG 195
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
+T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL KPI+ G+ E EQL KIF+
Sbjct: 196 NLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFE 255
Query: 336 LCGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
LCG+P E W +K+P FKPQ+ KR + E+FK F +L L+E +L +DP++R +
Sbjct: 256 LCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRIS 315
Query: 395 ATAALRSE 402
A AL +E
Sbjct: 316 AKDALDAE 323
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 7e-88, Method: Compositional matrix adjust.
Identities = 165/308 (53%), Positives = 209/308 (67%), Gaps = 18/308 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D FEKL++IG+GTY VY AR+T T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 171 LRRLDHPNVVKLEGLVTS---------------RMSCSLYLVFKYMEHDLAGLAASPTIK 215
L++L H NV++L+ +VTS + S+Y+VF+YM+HDL GLA P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
FT Q+KCYM QLL+GL +CH VLHRDIKGSNLLIDNEG L +ADFGLA F +H
Sbjct: 136 FTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNG 195
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
+T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL KPI+PG+ E EQL KIF
Sbjct: 196 NLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFD 255
Query: 336 LCGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
+CG+P E W +K+P FKP + KR + E FK F +L L+E +L +DPA+R +
Sbjct: 256 VCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRIS 315
Query: 395 ATAALRSE 402
A AL +E
Sbjct: 316 AQDALDAE 323
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 317 bits (811), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 160/307 (52%), Positives = 207/307 (67%), Gaps = 17/307 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D FEKL++IG+GTY VY A++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 171 LRRLDHPNVVKLEGLVTS--------------RMSCSLYLVFKYMEHDLAGLAASPTIKF 216
L++L H NV+ L+ +VTS + +Y+VF+YM+HDL GLA P ++F
Sbjct: 77 LKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276
T Q+KCYM QLL+GL +CH VLHRDIKGSNLLIDNEG L +ADFGLA + +H
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
+T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL KPI+PG+TE EQL+KI++L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYEL 256
Query: 337 CGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
CGSP E W SK+P K + KR + E ++ F +L L+E +L +DP++R A
Sbjct: 257 CGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICA 316
Query: 396 TAALRSE 402
AL +E
Sbjct: 317 KDALDAE 323
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 280 bits (717), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 146/346 (42%), Positives = 208/346 (60%), Gaps = 13/346 (3%)
Query: 67 PRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKI 126
P G+ P P+ PP+ + ++ P + E S W R D F+ + I
Sbjct: 676 PGGDLSPPDSPEPKAITPPQQPYKKRPKICCPRYGERRQTE--SDWGKRCVDKFDIIGII 733
Query: 127 GQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPNVVKLEGL 185
G+GTY VYKA+D TG++VALKKVR DN E E A REI ILR+L H +VV ++ +
Sbjct: 734 GEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLIHRSVVNMKEI 792
Query: 186 VTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
VT + + YLVF+YM+HDL GL S + F++ +K +M QL+ GLE+CH
Sbjct: 793 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLEYCHK 852
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++ LHRDIK SN+L++N G + +ADFGLA ++ +P T++V+TLWYRPPELLLG
Sbjct: 853 KNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEER 912
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHATIF 356
Y +D+WS GCIL EL +KPI E+ QL I +LCGSP W KLP+
Sbjct: 913 YTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTM 972
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
KP++ Y+R + E F P ++L L++ +L +DP++R TA L+S+
Sbjct: 973 KPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSD 1018
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 137/303 (45%), Positives = 192/303 (63%), Gaps = 11/303 (3%)
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REI 168
+ W R D F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 700 TDWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREI 758
Query: 169 LILRRLDHPNVVKLEGLVTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQ 220
ILR+L H +VV ++ +VT + + YLVF+YM+HDL GL S ++F++
Sbjct: 759 KILRQLIHKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDH 818
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
+K +M QL+ GLE+CH ++ LHRDIK SN+L++N G + +ADFGLA + +P T++
Sbjct: 819 IKSFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNK 878
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
V+TLWYRPPELLLG Y +D+WS GCIL EL +KPI E+ QL I +LCGSP
Sbjct: 879 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 938
Query: 341 SEEYWKKS-KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
W KLP+ KP++ Y+R + E F P +L L++ +L +DP++R TA L
Sbjct: 939 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTL 998
Query: 400 RSE 402
+S+
Sbjct: 999 QSD 1001
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 137/303 (45%), Positives = 193/303 (63%), Gaps = 11/303 (3%)
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REI 168
S W R D F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 713 SDWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREI 771
Query: 169 LILRRLDHPNVVKLEGLVTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQ 220
ILR+L H +VV ++ +VT + + YLVF+YM+HDL GL S + F++
Sbjct: 772 KILRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH 831
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
+K +M QL+ GL++CH ++ LHRDIK SN+L++N G + +ADFGLA ++ +P T++
Sbjct: 832 IKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNK 891
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
V+TLWYRPPELLLG Y +D+WS GCIL EL +KPI E+ QL I +LCGSP
Sbjct: 892 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSP 951
Query: 341 SEEYWKKS-KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
W KLP+ KP++ Y+R + E F P ++L L++ +L +DP++R TA L
Sbjct: 952 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTL 1011
Query: 400 RSE 402
+S+
Sbjct: 1012 QSD 1014
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 137/303 (45%), Positives = 193/303 (63%), Gaps = 11/303 (3%)
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REI 168
S W R D F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 713 SDWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREI 771
Query: 169 LILRRLDHPNVVKLEGLVTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQ 220
ILR+L H +VV ++ +VT + + YLVF+YM+HDL GL S + F++
Sbjct: 772 KILRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH 831
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
+K +M QL+ GL++CH ++ LHRDIK SN+L++N G + +ADFGLA ++ +P T++
Sbjct: 832 IKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNK 891
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
V+TLWYRPPELLLG Y +D+WS GCIL EL +KPI E+ QL I +LCGSP
Sbjct: 892 VITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSP 951
Query: 341 SEEYWKKS-KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
W KLP+ KP++ Y+R + E F P ++L L++ +L +DP++R TA L
Sbjct: 952 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTL 1011
Query: 400 RSE 402
+S+
Sbjct: 1012 QSD 1014
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 415 | ||||||
| 224102621 | 490 | predicted protein [Populus trichocarpa] | 0.812 | 0.687 | 0.934 | 0.0 | |
| 225432386 | 575 | PREDICTED: probable serine/threonine-pro | 0.937 | 0.676 | 0.812 | 0.0 | |
| 297736913 | 563 | unnamed protein product [Vitis vinifera] | 0.937 | 0.690 | 0.812 | 0.0 | |
| 356519994 | 548 | PREDICTED: probable serine/threonine-pro | 0.906 | 0.686 | 0.803 | 0.0 | |
| 356564577 | 546 | PREDICTED: probable serine/threonine-pro | 0.906 | 0.688 | 0.797 | 0.0 | |
| 357447451 | 540 | hypothetical protein MTR_2g020210 [Medic | 0.922 | 0.709 | 0.791 | 0.0 | |
| 255542430 | 571 | Serine/threonine-protein kinase cdk9, pu | 0.942 | 0.684 | 0.767 | 0.0 | |
| 356549060 | 540 | PREDICTED: probable serine/threonine-pro | 0.792 | 0.609 | 0.908 | 1e-179 | |
| 449432797 | 571 | PREDICTED: probable serine/threonine-pro | 0.939 | 0.683 | 0.788 | 1e-179 | |
| 356555563 | 541 | PREDICTED: probable serine/threonine-pro | 0.792 | 0.608 | 0.902 | 1e-179 |
| >gi|224102621|ref|XP_002312751.1| predicted protein [Populus trichocarpa] gi|222852571|gb|EEE90118.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/337 (93%), Positives = 326/337 (96%)
Query: 66 RPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDK 125
R R ++ RSSKPNPRL N PKH+HGEQVAAGWPSWLSAVAGEAI+GWTPRRADTFEKLDK
Sbjct: 1 RRREKRNRSSKPNPRLGNAPKHIHGEQVAAGWPSWLSAVAGEAINGWTPRRADTFEKLDK 60
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
IGQGTYSNVYKARDTLTG+IVALKKVRFDNLEPESV+FMAREILILRRLDHPNVVKLEGL
Sbjct: 61 IGQGTYSNVYKARDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVVKLEGL 120
Query: 186 VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI 245
VTSRMSCSLYLVF+YMEHDLAGLAASP IKFT+ QVKCYMHQLLSGLEHCHN+ VLHRDI
Sbjct: 121 VTSRMSCSLYLVFEYMEHDLAGLAASPNIKFTEPQVKCYMHQLLSGLEHCHNRCVLHRDI 180
Query: 246 KGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLW 305
KGSNLLI N+G+L IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLW
Sbjct: 181 KGSNLLIGNDGVLKIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLW 240
Query: 306 SAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRC 365
SAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRC
Sbjct: 241 SAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRC 300
Query: 366 IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE
Sbjct: 301 IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432386|ref|XP_002276606.1| PREDICTED: probable serine/threonine-protein kinase At1g54610 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/405 (81%), Positives = 346/405 (85%), Gaps = 16/405 (3%)
Query: 1 MGCVFAREFSGKAVERRREE---GSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSN 57
MGCVF RE S K V RRE+ + A E E+RNG KE S +
Sbjct: 1 MGCVFGREVSAKRVVERREDRDVAAAEAAAATVAVVRVEKEEVRNGGDRKEEEKEGSVRS 60
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRA 117
+ S +PNPRLSNPPK+VHGEQVAAGWPSWLSA AGEAI+GWTPRRA
Sbjct: 61 RRR-------------SGRPNPRLSNPPKNVHGEQVAAGWPSWLSAAAGEAINGWTPRRA 107
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
DTFEKLDKIGQGTYSNVYKARDTLTG+IVALKKVRFDNLEPESV+FMAREI ILRRLDHP
Sbjct: 108 DTFEKLDKIGQGTYSNVYKARDTLTGKIVALKKVRFDNLEPESVKFMAREIHILRRLDHP 167
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVKLEGLVTSRMSCSLYLVF+YMEHDLAGLAASP IKFT+ QVKCYMHQLLSGLEHCHN
Sbjct: 168 NVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPGIKFTEPQVKCYMHQLLSGLEHCHN 227
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++VLHRDIKGSNLL+DN G+L IADFGLAS FDPNHKQPMTSRVVTLWYRPPELLLGAT+
Sbjct: 228 RNVLHRDIKGSNLLLDNGGVLKIADFGLASTFDPNHKQPMTSRVVTLWYRPPELLLGATE 287
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK
Sbjct: 288 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 347
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
PQQSYKRCIAETFKDFP SSLPLIETLLAIDPAERQTATAALRSE
Sbjct: 348 PQQSYKRCIAETFKDFPASSLPLIETLLAIDPAERQTATAALRSE 392
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736913|emb|CBI26114.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1703), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/405 (81%), Positives = 346/405 (85%), Gaps = 16/405 (3%)
Query: 1 MGCVFAREFSGKAVERRREE---GSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSN 57
MGCVF RE S K V RRE+ + A E E+RNG KE S +
Sbjct: 1 MGCVFGREVSAKRVVERREDRDVAAAEAAAATVAVVRVEKEEVRNGGDRKEEEKEGSVRS 60
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRA 117
+ S +PNPRLSNPPK+VHGEQVAAGWPSWLSA AGEAI+GWTPRRA
Sbjct: 61 RRR-------------SGRPNPRLSNPPKNVHGEQVAAGWPSWLSAAAGEAINGWTPRRA 107
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
DTFEKLDKIGQGTYSNVYKARDTLTG+IVALKKVRFDNLEPESV+FMAREI ILRRLDHP
Sbjct: 108 DTFEKLDKIGQGTYSNVYKARDTLTGKIVALKKVRFDNLEPESVKFMAREIHILRRLDHP 167
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVKLEGLVTSRMSCSLYLVF+YMEHDLAGLAASP IKFT+ QVKCYMHQLLSGLEHCHN
Sbjct: 168 NVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPGIKFTEPQVKCYMHQLLSGLEHCHN 227
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++VLHRDIKGSNLL+DN G+L IADFGLAS FDPNHKQPMTSRVVTLWYRPPELLLGAT+
Sbjct: 228 RNVLHRDIKGSNLLLDNGGVLKIADFGLASTFDPNHKQPMTSRVVTLWYRPPELLLGATE 287
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK
Sbjct: 288 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 347
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
PQQSYKRCIAETFKDFP SSLPLIETLLAIDPAERQTATAALRSE
Sbjct: 348 PQQSYKRCIAETFKDFPASSLPLIETLLAIDPAERQTATAALRSE 392
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519994|ref|XP_003528653.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/407 (80%), Positives = 349/407 (85%), Gaps = 31/407 (7%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGN---GGPNHRKESSNSN 57
MGCVF GK +R+EE V A A E V GN GG
Sbjct: 1 MGCVF-----GKEASKRKEE--------VEFARAEEGVVQNGGNVKEGG----------- 36
Query: 58 NEQETTTVRPRGEKRRSSK--PNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPR 115
+E + RP+GE+RRSSK PNPRLSNPP HVHGEQVAAGWPSWLS VAGEAI+G PR
Sbjct: 37 --EEEKSKRPKGERRRSSKLKPNPRLSNPPNHVHGEQVAAGWPSWLSKVAGEAINGLVPR 94
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
RADTFEKL+K+GQGTYSNVYKA+DTLTG+IVALKKVRFDNLEPESV+FMAREILILR LD
Sbjct: 95 RADTFEKLNKVGQGTYSNVYKAKDTLTGKIVALKKVRFDNLEPESVKFMAREILILRHLD 154
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HPNVVKLEGLVTSRMSCSLYLVF+YM+HDLAGLA SPTIKFT++QVKCYMHQLLSGLEHC
Sbjct: 155 HPNVVKLEGLVTSRMSCSLYLVFEYMDHDLAGLATSPTIKFTESQVKCYMHQLLSGLEHC 214
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
HN+HVLHRDIKGSNLLID+EGIL IADFGLASFFDPNHK+PMTSRVVTLWYRPPELLLGA
Sbjct: 215 HNRHVLHRDIKGSNLLIDSEGILRIADFGLASFFDPNHKRPMTSRVVTLWYRPPELLLGA 274
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
TDYGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPS+EYWKKSKLPHATI
Sbjct: 275 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSDEYWKKSKLPHATI 334
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
FKP+ SYKRCIAETFK+FP SSLPLIETLLAIDPAERQTA AAL SE
Sbjct: 335 FKPRLSYKRCIAETFKNFPASSLPLIETLLAIDPAERQTAAAALHSE 381
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564577|ref|XP_003550528.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/405 (79%), Positives = 347/405 (85%), Gaps = 29/405 (7%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGN---GGPNHRKESSNSN 57
MGCVF GK +++EE V A A + V +GN GG
Sbjct: 1 MGCVF-----GKEASKKKEE--------VEVARAEDGVAQNSGNVKVGG----------- 36
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRA 117
+E + RP+GE+RRSSKPNPRLSNPP HVHGEQVAAGWPSWLS VAGEAI+G PRRA
Sbjct: 37 --EEEKSKRPKGERRRSSKPNPRLSNPPNHVHGEQVAAGWPSWLSKVAGEAINGLVPRRA 94
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
DTFEKL+K+GQGTYSNVYKA+DTLTG+IVALKKVRFDNLEPESV+FMAREILILR LDHP
Sbjct: 95 DTFEKLNKVGQGTYSNVYKAKDTLTGKIVALKKVRFDNLEPESVKFMAREILILRHLDHP 154
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVKLEGLVTSRMSCSLYLVF+YM+HDLAGLA SPTIKFT++QVKCYMHQLLSGLEHCHN
Sbjct: 155 NVVKLEGLVTSRMSCSLYLVFEYMDHDLAGLATSPTIKFTESQVKCYMHQLLSGLEHCHN 214
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+HVLHRDIKGSNLLID+EGIL IADFGLASFFDPNHK PMTSRVVTLWYRPPELLLGATD
Sbjct: 215 RHVLHRDIKGSNLLIDSEGILRIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 274
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPS+EYWKK KLPHATIFK
Sbjct: 275 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSDEYWKKLKLPHATIFK 334
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
P+ SYKRCIAETFK+FP SSLPLIE LLAIDPAERQTAT AL SE
Sbjct: 335 PRISYKRCIAETFKNFPASSLPLIEILLAIDPAERQTATDALHSE 379
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447451|ref|XP_003594001.1| hypothetical protein MTR_2g020210 [Medicago truncatula] gi|355483049|gb|AES64252.1| hypothetical protein MTR_2g020210 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/403 (79%), Positives = 339/403 (84%), Gaps = 20/403 (4%)
Query: 1 MGCVFAREFSGKAVERRREEGSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSNNEQ 60
MGCVF ++ S + E V V GG +E N
Sbjct: 1 MGCVFGKQSSVEERREEVREVKVDV-------------------GGGGSGREVENVKEGG 41
Query: 61 ETTTVRPRGEKRR-SSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADT 119
E VRP GE+RR SSK NPRLSNPP +VHGEQVAAGWPSWLS VAGEAI+G PRRADT
Sbjct: 42 EEKRVRPSGERRRRSSKANPRLSNPPNNVHGEQVAAGWPSWLSKVAGEAINGLVPRRADT 101
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
FEKLDKIGQGTYSNVYKARDTLTG++VALKKVRFDNLEPESV+FMAREILILRRLDHPNV
Sbjct: 102 FEKLDKIGQGTYSNVYKARDTLTGKVVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 161
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
VKLEGLVTSRMSCSLYLVF+YM HDLAGLA +P IKFT+ QVKCYMHQL SGLEHCHN+H
Sbjct: 162 VKLEGLVTSRMSCSLYLVFEYMAHDLAGLATNPAIKFTEPQVKCYMHQLFSGLEHCHNRH 221
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
VLHRDIKGSNLLIDN+G+L IADFGLASFFDP+HK PMTSRVVTLWYRPPELLLGAT+YG
Sbjct: 222 VLHRDIKGSNLLIDNDGVLKIADFGLASFFDPDHKHPMTSRVVTLWYRPPELLLGATEYG 281
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359
VGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSPSE+YWKKSKLPHATIFKPQ
Sbjct: 282 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWKKSKLPHATIFKPQ 341
Query: 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
QSYKRCIAETFK+FPPSSLPLIETLLAIDP ER TATAAL SE
Sbjct: 342 QSYKRCIAETFKNFPPSSLPLIETLLAIDPDERLTATAALHSE 384
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542430|ref|XP_002512278.1| Serine/threonine-protein kinase cdk9, putative [Ricinus communis] gi|223548239|gb|EEF49730.1| Serine/threonine-protein kinase cdk9, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/409 (76%), Positives = 343/409 (83%), Gaps = 18/409 (4%)
Query: 1 MGCVFAREFSGKAVERRRE--EGSVRVDRKVSAAAAAEA-----VEIRNGNGGPNHRKES 53
MGCV RE S V RE SV R + +A + VEI+N
Sbjct: 1 MGCVLGREVSSGIVSESREVKHPSVESSRTLDNDSATKTDTSSFVEIQN----------- 49
Query: 54 SNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWT 113
S E ++ + +RR S+PNPRLSNPPKH+ GEQVAAGWP WLSAV GEA++GW
Sbjct: 50 EESQKEDKSEGDKKSKAERRRSRPNPRLSNPPKHLRGEQVAAGWPPWLSAVCGEALNGWI 109
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PRRADTFEK+DK+G GTYSNVYKARD L+G+IVALKKVRFDNLEPESV+FMAREILILRR
Sbjct: 110 PRRADTFEKIDKVGSGTYSNVYKARDLLSGKIVALKKVRFDNLEPESVKFMAREILILRR 169
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
LDH NVVKLEGLVTSRMSCSLYLVF+YMEHDLAGLA SP +KFT++QVKCYMHQLLSGLE
Sbjct: 170 LDHLNVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAVSPGVKFTESQVKCYMHQLLSGLE 229
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
HCHN+ VLHRDIKGSNLLIDNEGIL IADFGLASFFDPNHK PMTSRVVTLWYRPPELLL
Sbjct: 230 HCHNRGVLHRDIKGSNLLIDNEGILRIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 289
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
GATDYGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKI+KLCGSPS+EYWKKSKLPHA
Sbjct: 290 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIYKLCGSPSDEYWKKSKLPHA 349
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
T+F+P++ YKRCI ETFKDFPPSSLPLIETLLAIDPAERQTATAAL+SE
Sbjct: 350 TLFRPREPYKRCIRETFKDFPPSSLPLIETLLAIDPAERQTATAALKSE 398
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549060|ref|XP_003542916.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1636), Expect = e-179, Method: Compositional matrix adjust.
Identities = 299/329 (90%), Positives = 313/329 (95%)
Query: 74 SSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSN 133
SSKPNPRLSNPP HVHGEQVAAGWPSWLS VAGEAI+G TPRRADTFEK+DKIGQGTYSN
Sbjct: 56 SSKPNPRLSNPPNHVHGEQVAAGWPSWLSKVAGEAINGLTPRRADTFEKIDKIGQGTYSN 115
Query: 134 VYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193
VYKARDTLTG+IVALKKVRFDNLEPESV+FMAREILILRRLDHPNV+KLEGLVTSRMSCS
Sbjct: 116 VYKARDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 175
Query: 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID 253
LYLVF+YM HDLAGLA +P IKFT++QVKCYMHQL SGLEHCHN+HVLHRDIKGSNLLID
Sbjct: 176 LYLVFEYMVHDLAGLATNPAIKFTESQVKCYMHQLFSGLEHCHNRHVLHRDIKGSNLLID 235
Query: 254 NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
N+GIL I DFGLASFFDPNHK PMTSRVVTLWYRPPELLLGAT+Y VGVDLWSAGCILAE
Sbjct: 236 NDGILKIGDFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATEYSVGVDLWSAGCILAE 295
Query: 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373
LLA KPIMPGRTEVEQLHKIFKLCGSPS+EYWKKSKLPHATIFKPQ SYKRCIAETFKDF
Sbjct: 296 LLAGKPIMPGRTEVEQLHKIFKLCGSPSDEYWKKSKLPHATIFKPQHSYKRCIAETFKDF 355
Query: 374 PPSSLPLIETLLAIDPAERQTATAALRSE 402
PPSSLPLI+TLLAIDP ER TATAAL SE
Sbjct: 356 PPSSLPLIDTLLAIDPDERLTATAALHSE 384
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432797|ref|XP_004134185.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1634), Expect = e-179, Method: Compositional matrix adjust.
Identities = 321/407 (78%), Positives = 346/407 (85%), Gaps = 17/407 (4%)
Query: 1 MGCVFAREFSGKAVER----RREEGSVRVDRKVSAAAAAEAVEIRNG-NGGPNHRKESSN 55
MGCVF RE S V++ RR+ G + +VS V++ N NGG RKE +
Sbjct: 1 MGCVFGREVSENPVQKEEEDRRQNGEEEI--RVSVKPEVVQVQVNNARNGG--SRKEVED 56
Query: 56 SNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPR 115
++ + R R R S+ P KHVHGEQVAAGWPSWLSAVAGEAI+GW PR
Sbjct: 57 DRGSRQRSERRRRPNPRSSNPP--------KHVHGEQVAAGWPSWLSAVAGEAINGWIPR 108
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
RAD+FEKLDKIGQGTYSNVYKARD+LTG+IVALKKVRFDNLEPESVRFMAREILILRRLD
Sbjct: 109 RADSFEKLDKIGQGTYSNVYKARDSLTGKIVALKKVRFDNLEPESVRFMAREILILRRLD 168
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HPNVVKLEGLVTSRMSCSLYLVF+YMEHDLAGLAASPTIKFT+ QVKCYM+QLLSGLEHC
Sbjct: 169 HPNVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPTIKFTEPQVKCYMNQLLSGLEHC 228
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
HN++VLHRDIKGSNLLI N+GIL IADFGLAS FDPNHKQPMTSRVVTLWYRPPELLLGA
Sbjct: 229 HNRYVLHRDIKGSNLLIGNDGILKIADFGLASVFDPNHKQPMTSRVVTLWYRPPELLLGA 288
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
TDYGVGVDLWSAGCILAELLA KPIMPGRTEVEQLHKIFKLCGSP++EYWKKS+LPHATI
Sbjct: 289 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPTDEYWKKSRLPHATI 348
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
FKPQ SYKRCI ETFKDFPPSSLPLIETLLAIDPAER TATAAL SE
Sbjct: 349 FKPQHSYKRCITETFKDFPPSSLPLIETLLAIDPAERLTATAALNSE 395
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555563|ref|XP_003546100.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 297/329 (90%), Positives = 314/329 (95%)
Query: 74 SSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSN 133
SSKPNPRLSNPP HVHGEQVAAGWPSWLS VAGEAI+G TPRRADTFEK+DKIGQGTYSN
Sbjct: 57 SSKPNPRLSNPPNHVHGEQVAAGWPSWLSKVAGEAINGLTPRRADTFEKIDKIGQGTYSN 116
Query: 134 VYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193
VYKARDTLTG+IVALKKVRFDNLEPESV+FMAREILILRRLDHPNV+KLEGLVTSRMSCS
Sbjct: 117 VYKARDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 176
Query: 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID 253
LYLVF+YM HDLAGLA +P IKFT++QVKCYMHQL SGLEHCHN+HVLHRDIKGSNLLID
Sbjct: 177 LYLVFEYMVHDLAGLATNPAIKFTESQVKCYMHQLFSGLEHCHNRHVLHRDIKGSNLLID 236
Query: 254 NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
N+GIL I DFGLASFFDPNHK PMTSRVVTLWYRPPELLLGAT+Y VGVDLWSAGCILAE
Sbjct: 237 NDGILKIGDFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATEYSVGVDLWSAGCILAE 296
Query: 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373
LLA KPIMPGRTEVEQLHKIFKLCGSPS+EYWKKSKLPHATIFKPQQSYKRCIAET+KDF
Sbjct: 297 LLAGKPIMPGRTEVEQLHKIFKLCGSPSDEYWKKSKLPHATIFKPQQSYKRCIAETYKDF 356
Query: 374 PPSSLPLIETLLAIDPAERQTATAALRSE 402
PPSSLPL++TLLAI+P ER TATAAL SE
Sbjct: 357 PPSSLPLMDTLLAINPDERLTATAALHSE 385
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 415 | ||||||
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.963 | 0.698 | 0.694 | 8.2e-154 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.833 | 0.498 | 0.727 | 8.3e-138 | |
| TAIR|locus:2096199 | 593 | AT3G05050 [Arabidopsis thalian | 0.869 | 0.608 | 0.701 | 7.7e-135 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.754 | 0.438 | 0.753 | 1.3e-130 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.739 | 0.529 | 0.768 | 5.7e-130 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.797 | 0.473 | 0.699 | 3e-129 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.795 | 0.465 | 0.690 | 3e-127 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.838 | 0.566 | 0.636 | 4e-122 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.766 | 0.429 | 0.694 | 7.4e-122 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.826 | 0.532 | 0.647 | 9.8e-119 |
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1500 (533.1 bits), Expect = 8.2e-154, P = 8.2e-154
Identities = 279/402 (69%), Positives = 328/402 (81%)
Query: 1 MGCVFAREFSGKAXXXXXXXXXXXXXXKVSXXXXXXXVEIRNGNGGPNHRKESSNSNNEQ 60
MGCVF RE + V + +K++ +N ++
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNGVIADDVEKKKNEEANGDK 60
Query: 61 ETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTF 120
E + +G++RRS+KPNPRLSNP KH GEQVAAGWPSWLS GEA++GW PR+ADTF
Sbjct: 61 ERKS--SKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTF 118
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
EK+DKIGQGTYSNVYKA+D LTG+IVALKKVRFDNLEPESV+FMAREIL+LRRLDHPNVV
Sbjct: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVV 178
Query: 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
KLEGLVTSRMSCSLYLVF+YM+HDLAGLA+SP +KF++++VKC M QL+SGLEHCH++ V
Sbjct: 179 KLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGV 238
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
LHRDIKGSNLLID+ G+L IADFGLA+ FDPNHK+PMTSRVVTLWYR PELLLGATDYGV
Sbjct: 239 LHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGV 298
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360
G+DLWSAGCILAELLA +PIMPGRTEVEQLHKI+KLCGSPSE+YWKK K H I+KP++
Sbjct: 299 GIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPRE 358
Query: 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
YKR I ETFKDFPPSSLPLI+ LL+I+P +RQTA+AAL+SE
Sbjct: 359 PYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSE 400
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 8.3e-138, P = 8.3e-138
Identities = 259/356 (72%), Positives = 296/356 (83%)
Query: 57 NNEQETTTVRPRGEK--RRSSK-PNPRLSNP-------PKHVHGEQVAAGWPSWLSAVAG 106
+N+Q ++ RGE RR + N ++P K GE VAAGWP WL++VAG
Sbjct: 61 SNKQSNVSLHLRGENLSRREKRIENVAATSPLAMSITIAKATEGEYVAAGWPPWLASVAG 120
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
EAI GW PRRAD+FEKLDKIGQGTYSNVY+ARD +IVALKKVRFDNLEPESVRFMAR
Sbjct: 121 EAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 180
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
EI ILRRLDHPN++KLEGLVTSRMSCSLYLVF+YMEHDLAGLA+ P IKF+++QVKCY+
Sbjct: 181 EIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIKFSESQVKCYLQ 240
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
QLL GL+HCH++ VLHRDIKGSNLLIDN G+L IADFGLASFFDP QP+TSRVVTLWY
Sbjct: 241 QLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTSRVVTLWY 300
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
RPPELLLGAT YG VDLWSAGCILAEL A KPIMPGRTEVEQLHKIFKLCGSP+E+YW
Sbjct: 301 RPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPTEDYWV 360
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
KS+LPHATIFKP Q YKR + ETFK+FP +L L+ETLL+++P +R TATAAL+SE
Sbjct: 361 KSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTATAALKSE 416
|
|
| TAIR|locus:2096199 AT3G05050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1321 (470.1 bits), Expect = 7.7e-135, P = 7.7e-135
Identities = 258/368 (70%), Positives = 298/368 (80%)
Query: 39 EIRNGNGGPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWP 98
E+RN + +KE N E + +GE++RS P+PR SNPPK++ GEQVAAGWP
Sbjct: 59 EVRNHEDVVDQKKE--NGFVVTEAKERKSKGERKRSKPPDPRRSNPPKNLLGEQVAAGWP 116
Query: 99 SWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP 158
SWLS V GEA+SGW PR+AD+FEK+DKIG GTYSNVYKA+D+LTG IVALKKVR D E
Sbjct: 117 SWLSEVCGEALSGWLPRKADSFEKIDKIGSGTYSNVYKAKDSLTGNIVALKKVRCDVNER 176
Query: 159 ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ 218
ES++FMAREILILRRLDHPNV+KLEGLVTSRMS SLYLVF+YM+HDLAGLAASP IKFT+
Sbjct: 177 ESLKFMAREILILRRLDHPNVIKLEGLVTSRMSSSLYLVFRYMDHDLAGLAASPEIKFTE 236
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
QVKCYM QLLSGLEHCHN+ VLHRDIKGSNLLID+ G+L I DFGLA+FFD + +Q MT
Sbjct: 237 QQVKCYMKQLLSGLEHCHNRGVLHRDIKGSNLLIDDGGVLRIGDFGLATFFDASKRQEMT 296
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
+RVVTLWYR PELL G +Y VGVDLWSAGCILAELLA + IMPGR EVEQLH+I+KLCG
Sbjct: 297 NRVVTLWYRSPELLHGVVEYSVGVDLWSAGCILAELLAGRAIMPGRNEVEQLHRIYKLCG 356
Query: 339 SPSEEYWKKSKLP----HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
SPSEEYWKK +LP HA KP YKR I E +KDF P +L L++TLLA+DPAERQT
Sbjct: 357 SPSEEYWKKIRLPSTHKHAH-HKPLPQYKRRIREVYKDFSPEALSLLDTLLALDPAERQT 415
Query: 395 ATAALRSE 402
AT L S+
Sbjct: 416 ATDVLMSD 423
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
Identities = 236/313 (75%), Positives = 274/313 (87%)
Query: 90 GEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK 149
G QV AGWPSWL++VAGEAI+GW PR+AD+FEKL+KIGQGTYS+VYKARD T Q+VALK
Sbjct: 133 GAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALK 192
Query: 150 KVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA 209
KVRF N++P+SVRFMAREI+ILRRLDHPNV+KLEGL+TSR+S S+YL+F+YMEHDLAGLA
Sbjct: 193 KVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLA 252
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269
++P I F++AQ+KCYM QLL GLEHCH++ VLHRDIKGSNLL+D+ L I DFGLA+F+
Sbjct: 253 STPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFY 312
Query: 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329
+ KQP+TSRVVTLWYRPPELLLG+TDYGV VDLWS GCILAEL KPIMPGRTEVEQ
Sbjct: 313 QGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQ 372
Query: 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
LHKIFKLCGSPSEEYWK SKLPHATIFKPQQ YKRC+AETFK P S+L L+E LLA++P
Sbjct: 373 LHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEP 432
Query: 390 AERQTATAALRSE 402
R T +AL SE
Sbjct: 433 DARGTTASALESE 445
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
Identities = 236/307 (76%), Positives = 271/307 (88%)
Query: 96 GWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN 155
GWP WL A G++I TPRRA T+EKL+KIGQGTYSNVYKA+D L+G+IVALKKVRFDN
Sbjct: 90 GWPPWLIAACGDSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFDN 149
Query: 156 LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK 215
LE ESV+FMAREIL+LRRL+HPNV+KL+GLVTSR+SCSLYLVF+YMEHDL+GLAA+ +K
Sbjct: 150 LEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLK 209
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
F QVKC+M QLLSGLEHCH++ VLHRDIKGSNLLIDN+GIL IADFGLA+F+DP KQ
Sbjct: 210 FDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQ 269
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
MTSRVVTLWYRPPELLLGAT YG GVDLWSAGCI+AELLA KP+MPGRTEVEQLHKIFK
Sbjct: 270 TMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFK 329
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
LCGSPS+ YWKK +LP+AT+FKPQ YKRC+AE F F PSS+ L+ETLL IDPA+R T+
Sbjct: 330 LCGSPSDSYWKKYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTS 389
Query: 396 TAALRSE 402
T+AL SE
Sbjct: 390 TSALNSE 396
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1252 (445.8 bits), Expect = 3.0e-129, Sum P(2) = 3.0e-129
Identities = 233/333 (69%), Positives = 280/333 (84%)
Query: 72 RRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTY 131
R S + RL N +++ EQVAAGWP+WLS VAGEAI GW P R+D FEKL+KIGQGTY
Sbjct: 73 RASDSLSFRLGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFEKLEKIGQGTY 132
Query: 132 SNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191
SNV++A +T TG+IVALKKVRFDN EPESV+FMAREILILRRL+HPN++KLEGL+TS++S
Sbjct: 133 SNVFRAVETETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSKLS 192
Query: 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLL 251
C++ LVF+YMEHDL GL +SP IKFT Q+KCYM QLLSGL+HCH++ V+HRDIKGSNLL
Sbjct: 193 CNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVMHRDIKGSNLL 252
Query: 252 IDNEGILTIADFGLASFFDPN-HKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGC 309
+ NEGIL +ADFGLA+F + + HK+ P+TSRVVTLWYRPPELLLGATDYG VDLWS GC
Sbjct: 253 LSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSVGC 312
Query: 310 ILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAET 369
+ AELL KPI+ GRTEVEQLHKIFKLCGSP E+YWKKSKLPHA +FKPQQ+Y C+ ET
Sbjct: 313 VFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQTYDSCLRET 372
Query: 370 FKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
KD + + LIETLL+IDP +R TA++AL S+
Sbjct: 373 LKDLSETEINLIETLLSIDPHKRGTASSALVSQ 405
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1230 (438.0 bits), Expect = 3.0e-127, Sum P(2) = 3.0e-127
Identities = 230/333 (69%), Positives = 277/333 (83%)
Query: 73 RSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYS 132
RS + RL N K++ EQVAAGWP+WLS VAGEAI GW P R+D FEKL+KIGQGTYS
Sbjct: 84 RSESVSFRLGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYS 143
Query: 133 NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192
+V++AR+T TG+IVALKKVRFDN EPESVRFMAREILILR+L+HPN++KLEG+VTS++SC
Sbjct: 144 SVFRARETETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSC 203
Query: 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252
S++LVF+YMEHDL GL +SP I FT Q+KCYM QLLSGL+HCH + V+HRDIKGSNLL+
Sbjct: 204 SIHLVFEYMEHDLTGLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLV 263
Query: 253 DNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 311
+NEGIL +ADFGLA+F + + +KQP+TSRVVTLWYRPPELLLGAT+YG VDLWS GC+
Sbjct: 264 NNEGILKVADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVF 323
Query: 312 AELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFK 371
AELL KP++ GRTEVEQLHKIFKLCGSP E+YWKKSKLPHA +FKPQQ Y C+ ET K
Sbjct: 324 AELLIGKPVLQGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLK 383
Query: 372 --DFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ + LIETLL+I P +R TA+ AL S+
Sbjct: 384 LKGLSDADINLIETLLSIQPHKRGTASTALVSQ 416
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
Identities = 226/355 (63%), Positives = 284/355 (80%)
Query: 55 NSNNEQETTTV-RP-RGEKRRSSKPNPR-----LSNPPKHVHGEQVAAGWPSWLSAVAGE 107
+ +++ +T V RP R ++ R N + +SN P+ E +AAGWP WL++VAGE
Sbjct: 69 DDSHDGKTVIVERPSRSQRGRRVSDNGKGGGLIISNVPRSAEAELIAAGWPYWLTSVAGE 128
Query: 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMARE 167
AI GW PRRAD+FEKLDKIGQGTYS VYKARD TG+IVA+KKVRF N++PESVRFMARE
Sbjct: 129 AIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLETGKIVAMKKVRFANMDPESVRFMARE 188
Query: 168 ILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
I ILR+LDHPNV+KL+ LVTS++S SL+LVF+YMEHDL+GLA P +KFT+ Q+KC+M Q
Sbjct: 189 INILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQIKCFMKQ 248
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
LL GLEHCH++ +LHRDIKGSNLL++N+G+L I DFGLASF+ P+ QP+TSRVVTLWYR
Sbjct: 249 LLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVTLWYR 308
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PELLLG+T+YG +DLWS GCILAEL KPIMPGRTEVEQ+HKIFKLCGSPSEE+W
Sbjct: 309 APELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEEFWNT 368
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+K P AT +KPQ YKR + ETFK+ SSL L++ LL+++P +R +A++ L SE
Sbjct: 369 TKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSE 423
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1182 (421.1 bits), Expect = 7.4e-122, Sum P(2) = 7.4e-122
Identities = 221/318 (69%), Positives = 264/318 (83%)
Query: 85 PKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQ 144
PK +QVAAGWPSWL +VAGE++ W PRRA+TFEKL+KIGQGTYS+VY+ARD L +
Sbjct: 178 PKDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLHNK 237
Query: 145 IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204
IVALKKVRFD + ESV+FMAREI+++RRLDHPNV+KLEGL+T+ +S SLYLVF+YM+HD
Sbjct: 238 IVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHD 297
Query: 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
L GL++ P +KFT+ QVKCYM QLLSGLEHCH++ VLHRDIKGSNLLID++G+L IADFG
Sbjct: 298 LLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFG 357
Query: 265 LASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR 324
LA+FFDP +TS VVTLWYRPPELLLGA+ YGVGVDLWS GCIL EL A KPI+PG+
Sbjct: 358 LATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGK 417
Query: 325 TEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETL 384
TEVEQLHKIFKLCGSP+E YW+K KLP + FK Y+R ++E FKDFP S L L+ETL
Sbjct: 418 TEVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETL 477
Query: 385 LAIDPAERQTATAALRSE 402
L+IDP R +A AL SE
Sbjct: 478 LSIDPDHRSSADRALESE 495
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1169 (416.6 bits), Expect = 9.8e-119, P = 9.8e-119
Identities = 224/346 (64%), Positives = 273/346 (78%)
Query: 58 NEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGE-QVAAGWPSWLSAVAGEAISGWTPRR 116
+E E P E +R +P+ + P+ V E ++AAGWP+WL +VAGEA+ WTPRR
Sbjct: 76 DEDEDDDHHPPEELKR--EPSVVIPPSPETVSKEAELAAGWPAWLVSVAGEALVNWTPRR 133
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A TFEKL+KIGQGTYS+VYKARD +IVALK+VRFD + ESV+FMAREI+++RRLDH
Sbjct: 134 ASTFEKLEKIGQGTYSSVYKARDLTNNKIVALKRVRFDLSDLESVKFMAREIIVMRRLDH 193
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PNV+KLEGL+T+ +S SLYLVF+YM+HDL GLA+ P IKF++ QVKCYM QLLSGL HCH
Sbjct: 194 PNVLKLEGLITASVSSSLYLVFEYMDHDLVGLASIPGIKFSEPQVKCYMQQLLSGLHHCH 253
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ VLHRDIKGSNLLID+ G+L IADFGLA+FFDP + P+TSRVVTLWYRPPELLLGA
Sbjct: 254 SRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVTLWYRPPELLLGAC 313
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
YGVGVDLWS GCIL EL + KPI+ G+TEVEQLHKIFKLCGSP+E+YW+K KLP + F
Sbjct: 314 HYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLHKIFKLCGSPTEDYWRKLKLPPSAAF 373
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+P Y R +AE FKD P + L L+E LL+IDP R +A AL SE
Sbjct: 374 RPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSAARALESE 419
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ZVM9 | Y1461_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6965 | 0.9638 | 0.6993 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.VIII.1954.1 | hypothetical protein (490 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 415 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-156 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-119 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-107 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-107 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-105 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-104 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-103 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-98 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-94 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-90 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-88 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-84 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-81 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-81 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-81 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-80 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-79 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-77 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-77 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-76 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-76 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-75 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-74 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-71 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-70 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-70 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-70 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-65 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-64 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-63 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-63 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-62 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-61 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-60 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-59 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-58 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-58 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-57 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-55 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-55 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-55 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-55 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-53 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-51 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-50 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-48 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-46 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-46 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-46 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-46 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-45 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-45 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-45 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-39 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-35 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-34 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-33 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-25 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-20 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-14 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 442 bits (1139), Expect = e-156
Identities = 155/285 (54%), Positives = 209/285 (73%), Gaps = 2/285 (0%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+EK+ +IG+GTY VYKAR+ TG++VALKK+R +N + REI +L++L HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
V+L+ +VTS+ S+Y+VF+YM+HDL GL SP +KFT++Q+KCYM QLL GL++ H+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
+LHRDIKGSN+LI+N+G+L +ADFGLA + + T+RV+TLWYRPPELLLGAT YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATIFKP 358
VD+WS GCILAEL KPI G TE+EQL KIF+LCGSP++E W SKLP KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 359 QQSYKRCIAETFKDF-PPSSLPLIETLLAIDPAERQTATAALRSE 402
++ YKR + E FK PS+L L++ LL +DP +R +A AL+ E
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 348 bits (896), Expect = e-119
Identities = 123/285 (43%), Positives = 175/285 (61%), Gaps = 13/285 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----PESVRFMAREILILRRLD 175
+EKL+K+G+GTY VYKARD TG+IVALKK+R DN E ++R EI +L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HPN+VKL ++ + LYLVF+Y + DL + +K M+QLL GL +C
Sbjct: 57 HPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H+ +LHRD+K N+LI+ +G+L +ADFGLA F + T VVTLWYR PE+LLG+
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGS 173
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
Y VD+WS GCI AE++ KP+ PG +E++QL KIF++ G+P+EE W +KLP
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
P+ K + + P + L+ +L +PA+R +A AL
Sbjct: 234 PTFPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 319 bits (819), Expect = e-107
Identities = 128/288 (44%), Positives = 180/288 (62%), Gaps = 11/288 (3%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMA-REILILRRLDH 176
+EK K+G+GTY+ VYKARD TG+IVA+KK++ + + + F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PN++ L + + + + LVF++ME DL + +I T A +K YM L GLE+ H
Sbjct: 62 PNIIGLLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGA 295
+ +LHRD+K +NLLI ++G+L +ADFGLA F PN K MT +VVT WYR PELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGA 177
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
YGVGVD+WS GCI AELL P +PG ++++QL KIF+ G+P+EE W + LP
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
FKP + + F +L L++ LL ++P +R TA AL
Sbjct: 238 EFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 318 bits (817), Expect = e-107
Identities = 141/300 (47%), Positives = 193/300 (64%), Gaps = 11/300 (3%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
W R D F+ + +IG+GTY VYKARD TG++VALKKVR DN E E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 171 LRRLDHPNVVKLEGLVTSRMSC--------SLYLVFKYMEHDLAGLAASPTIKFTQAQVK 222
LR+L+H N+V L+ +VT + + YLVF+YM+HDL GL S + F++ +K
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
+M QLL GL +CH ++ LHRDIK SN+L++N+G + +ADFGLA ++ +P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
TLWYRPPELLLG YG +D+WS GCIL EL +KPI E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 343 EYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
W KLP+ KP++ Y+R + E F P +L L++ +L +DP++R TA AL S
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 313 bits (804), Expect = e-105
Identities = 137/298 (45%), Positives = 186/298 (62%), Gaps = 19/298 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
+E L K+G+GT+ VYKAR TG++VALKK+ N E + A REI IL++L HPN
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKHPN 68
Query: 179 VVKLEGLV------TSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
VV L + + R S+Y+V YM+HDL+GL +P++K T++Q+KCYM QLL G+
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM----------TSRVV 282
+ H H+LHRDIK +N+LIDN+GIL IADFGLA +D P T+ VV
Sbjct: 129 NYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
T WYRPPELLLG Y VD+W GC+ AE+ +PI+ G+++++QLH IFKLCG+P+E
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248
Query: 343 EYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
E W LP +Y R + E F P L L+ LL++DP +R TA+ AL
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 310 bits (796), Expect = e-104
Identities = 141/297 (47%), Positives = 189/297 (63%), Gaps = 16/297 (5%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRR 173
R D +EKL++I +GTY VY+ARD TG+IVALKK++ + E E + REI IL +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLK 60
Query: 174 LDHPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
L HPN+V + E +V S + +Y+V +Y+EHDL L + F Q++VKC M QLLSG+
Sbjct: 61 LQHPNIVTVKEVVVGSNLD-KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPEL 291
H H+ +LHRD+K SNLL++N GIL I DFGLA + P +P T VVTLWYR PEL
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP--LKPYTQLVVTLWYRAPEL 177
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKL 350
LLGA +Y +D+WS GCI AELL +KP+ PG++E++QL+KIFKL G+P+E+ W S+L
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLP-----LIETLLAIDPAERQTATAALRSE 402
P A Y K FP SL L+ LL DPA+R +A AL+
Sbjct: 238 PGAKKKTF-TKYPYNQLR--KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 306 bits (787), Expect = e-103
Identities = 140/291 (48%), Positives = 189/291 (64%), Gaps = 6/291 (2%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRR 173
R FEKL++IG+GTY VY+ARDT +G+IVALKKVR DN E + + + REI +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLN 62
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
L HPN+V+L+ +V + S++LV +Y E DLA L + F+++QVKC M QLL GL+
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H ++HRD+K SNLL+ ++G L IADFGLA + +PMT +VVTLWYR PELLL
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLL 181
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPH 352
G T Y +D+W+ GCILAELLA KP++PG++E+EQL I +L G+P+E W S LP
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 353 ATIFK-PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
F P+Q Y + F + L L+ LL DP +R TA AL S
Sbjct: 242 VGKFTLPKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 295 bits (756), Expect = 4e-98
Identities = 141/295 (47%), Positives = 181/295 (61%), Gaps = 14/295 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+EKL KIGQGT+ V+KAR T QIVALKKV +N E E A REI IL+ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKH 70
Query: 177 PNVVKL------EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLS 230
NVV L + +R S YLVF++ EHDLAGL ++ +KFT +++K M LL+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQP--MTSRVVTLWYR 287
GL + H +LHRD+K +N+LI +GIL +ADFGLA +F + +P T+RVVTLWYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PPELLLG DYG +D+W AGCI+AE+ PIM G TE QL I +LCGS + E W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 348 -SKLPHATIFKPQQSYKRCIAETFKDF--PPSSLPLIETLLAIDPAERQTATAAL 399
KL + Q KR + E K + P +L LI+ LL +DPA+R A AL
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 284 bits (728), Expect = 3e-94
Identities = 123/281 (43%), Positives = 172/281 (61%), Gaps = 4/281 (1%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++KL KIG+GTY VYKARD LTG+IVA+KK++ + REI +L+ L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
+KL + + LYLVF++M+ DL L ++ +K Y++QLL GL CH+
Sbjct: 61 IKLLDVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
+LHRD+K NLLI+ EG+L +ADFGLA F + P T VVT WYR PELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYS 177
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATIFKP 358
VD+WS GCI AELL+ +P+ PG++E++QL KIF+ G+P E W K + L F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+ + + F + P +L L+ +L DP +R TA AL
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 273 bits (701), Expect = 4e-90
Identities = 128/288 (44%), Positives = 184/288 (63%), Gaps = 18/288 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
++K++KIG+GTY VYKARD LTG+IVALKK+R + E E V A REI +L+ L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+V+L +V S LYLVF++++ DL + +SP +K Y++QLL G+ +CH+
Sbjct: 60 IVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM---TSRVVTLWYRPPELLLG 294
VLHRD+K NLLID EG L +ADFGLA F P+ T VVTLWYR PE+LLG
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFG----VPVRTYTHEVVTLWYRAPEILLG 173
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353
+ Y VD+WS GCI AE++ +P+ PG +E++QL +IF+ G+P E+ W + LP
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD- 232
Query: 354 TIFKPQ--QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+KP + ++ +++ + L L+ +L DPA+R +A AAL
Sbjct: 233 --YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 2e-88
Identities = 119/290 (41%), Positives = 158/290 (54%), Gaps = 15/290 (5%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLD 175
++ L +IG+G + V+KA+D TG+ VALKKV LE P REI L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA---LREIKALQACQ 57
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HP VVKL L LV +YM DL+ + +AQVK YM LL G+ +
Sbjct: 58 HPYVVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H ++HRD+K +NLLI +G+L IADFGLA F + + +V T WYR PELL GA
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
Y GVDLW+ GCI AELL P+ PG ++EQL +F+ G+P+EE W + LP
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 355 --IFKPQQSYKRCIAET-FKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
F K E F D P +L L++ LL DP++R +A ALR
Sbjct: 236 KITFPES---KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 259 bits (664), Expect = 2e-84
Identities = 118/294 (40%), Positives = 172/294 (58%), Gaps = 24/294 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLD- 175
+E+L +IG+G Y VYKARD TG+ VALKKVR E P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 176 --HPNVVKL----EGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQL 228
HPN+V+L G T R L LVF++++ DLA L+ P +K M QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
L G++ H+ ++HRD+K N+L+ ++G + IADFGLA + +TS VVTLWYR
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVVTLWYRA 174
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW-KK 347
PE+LL ++ Y VD+WS GCI AEL +P+ G +E +QL KIF + G PSEE W +
Sbjct: 175 PEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 348 SKLPHATI-FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
LP ++ +S+K + E ++ L L++ +L +P +R +A AL+
Sbjct: 234 VSLPRSSFPSYTPRSFKSFVPEICEE----GLDLLKKMLTFNPHKRISAFEALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 252 bits (644), Expect = 1e-81
Identities = 127/290 (43%), Positives = 175/290 (60%), Gaps = 22/290 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
F+K++KIG+GTY VYKAR+ LTG++VALKK+R D E E V A REI +L+ L+HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHPN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+VKL ++ + LYLVF+++ DL + ASP +K Y+ QLL GL CH+
Sbjct: 61 IVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM---TSRVVTLWYRPPELLLG 294
VLHRD+K NLLI+ EG + +ADFGLA F P+ T VVTLWYR PE+LLG
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAPEILLG 174
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353
Y VD+WS GCI AE++ + + PG +E++QL +IF+ G+P E W + LP
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD- 233
Query: 354 TIFKPQQSYKRCIAETFKDFPP----SSLPLIETLLAIDPAERQTATAAL 399
+KP S+ + + F P L+ +L DP +R +A AAL
Sbjct: 234 --YKP--SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 249 bits (639), Expect = 3e-81
Identities = 105/287 (36%), Positives = 154/287 (53%), Gaps = 43/287 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E L+K+G+G++ VY ARD TG++VA+K ++ ++ + R + REI IL++L HPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 180 VKLEG-LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK----FTQAQVKCYMHQLLSGLE 233
V+L LYLV +Y E DL L +K ++ + + Y+ Q+LS LE
Sbjct: 60 VRLYDVFEDED---KLYLVMEYCEGGDLFDL-----LKKRGRLSEDEARFYLRQILSALE 111
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H++ ++HRD+K N+L+D +G + +ADFGLA DP K +T+ V T Y PE+LL
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLL 169
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
G YG VD+WS G IL ELL KP PG +QL ++FK G P +
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEWD--- 222
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
I+ KD I LL DP +R TA AL+
Sbjct: 223 ------------ISPEAKDL-------IRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 6e-81
Identities = 121/284 (42%), Positives = 169/284 (59%), Gaps = 8/284 (2%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + E V A REI +L+ L H N
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
+V+L ++ S L LVF+Y + DL S VK +M QLL GL CH+
Sbjct: 61 IVRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
+VLHRD+K NLLI+ G L +ADFGLA F + ++ VVTLWYRPP++L GA Y
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLY 177
Query: 299 GVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATIF 356
+D+WSAGCI AEL A +P+ PG +QL +IF+L G+P+EE W SKLP +
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + K + L++ LL +P +R +A AL+
Sbjct: 238 PMYPATTSLVNVVPKLN-STGRDLLQNLLVCNPVQRISAEEALQ 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 2e-80
Identities = 107/284 (37%), Positives = 163/284 (57%), Gaps = 12/284 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHPNVVKLE 183
IG G Y V A D TG+ VA+KK+ FD+L + + REI +LR L H N++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHENIIGLL 65
Query: 184 GLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
++ +Y+V + ME DL + SP T ++ +++Q+L GL++ H+ +V
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANV 124
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTSRVVTLWYRPPELLLGATDY 298
+HRD+K SN+L+++ L I DFGLA DP+ + +T VVT WYR PELLL ++ Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT--IF 356
+D+WS GCI AELL KP+ PGR ++QL+ I ++ G+PSEE K A +
Sbjct: 185 TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLK 244
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ K+ +++ F P ++ L+E +L DP +R TA AL
Sbjct: 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 5e-79
Identities = 116/310 (37%), Positives = 175/310 (56%), Gaps = 32/310 (10%)
Query: 120 FEKLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-----------VRFMA-R 166
+ + +G+GTY V KA DTLTG+IVA+KKV+ + + + F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
E+ I+ + H N++ L + + LV M DL + I+ T++QVKC +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVDR-KIRLTESQVKCILL 126
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS------FFDPNHKQP---- 276
Q+L+GL H + +HRD+ +N+ I+++GI IADFGLA + D K
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 277 ---MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
MTS+VVTLWYR PELL+GA Y VD+WS GCI AELL KP+ PG E++QL +I
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 334 FKLCGSPSEEYW-KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
F+L G+P+E+ W + KLP T F P++ + + F + ++ L+++LL ++P ER
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRK--PKDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 393 QTATAALRSE 402
+A AL+ E
Sbjct: 305 ISAKEALKHE 314
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 1e-77
Identities = 122/288 (42%), Positives = 180/288 (62%), Gaps = 15/288 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
+ K++KIG+GTY VYK R+ TGQIVA+KK+R ++ E E V A REI +L+ L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQ-VKCYMHQLLSGLEHCH 236
+V L+ ++ LYL+F+++ DL L + P ++ A+ VK Y++Q+L G+ CH
Sbjct: 61 IVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM---TSRVVTLWYRPPELLL 293
++ VLHRD+K NLLIDN+G++ +ADFGLA F P+ T VVTLWYR PE+LL
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG----IPVRVYTHEVVTLWYRAPEVLL 174
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPH 352
G+ Y VD+WS G I AE+ +KP+ G +E++QL +IF++ G+P+E+ W + LP
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P+ K + K+ L L+E +L DPA+R +A AL
Sbjct: 235 YKNTFPKWK-KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 240 bits (613), Expect = 9e-77
Identities = 128/296 (43%), Positives = 175/296 (59%), Gaps = 21/296 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
D +EKL+KIG+GTY VYKARD TG++VALKK R + ++ E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 177 -PNVVKL---EGLVTSRMSCSLYLVFKYMEHDLA----GLAASPTIKFTQAQVKCYMHQL 228
+V+L E + SLYLVF+Y++ DL P +K +M+QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
L G+ HCH V+HRD+K NLL+D + G+L IAD GL F K T +VTLWYR
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYR 178
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PE+LLG+T Y VD+WS GCI AE+ ++P+ PG +E++QL IFKL G+P+E+ W
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 348 -SKLPHATIF---KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
SKL F KPQ ++ D P L L++ +L DPA+R +A AAL
Sbjct: 239 VSKLRDWHEFPQWKPQD-----LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 1e-76
Identities = 100/285 (35%), Positives = 143/285 (50%), Gaps = 29/285 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E L K+G G++ VYKA+ TG+IVA+K ++ + + + + REI ILRRL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
V+L LYLV +Y E DL + ++ + K Q+L GLE+ H+
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSN 117
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
++HRD+K N+L+D G++ IADFGLA +T+ V T WY PE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK-LCGSPSEEYWKKSKLPHATIFK 357
G VD+WS G IL ELL KP G ++QL I + L + K S
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS--------- 227
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+E KD I+ L DP++R TA L+
Sbjct: 228 -------SGSEEAKDL-------IKKCLNKDPSKRPTAEEILQHP 258
|
Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 1e-76
Identities = 126/297 (42%), Positives = 182/297 (61%), Gaps = 25/297 (8%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
D +EK++KIG+GTY VYKARD +T + +ALKK+R + E E V A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHC 235
N+V+L+ +V S LYLVF+Y++ DL + +SP +K Y++Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 236 HNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFD-PNHKQPMTSRVVTLWYRPPELLL 293
H+ VLHRD+K NLLID L +ADFGLA F P + T VVTLWYR PE+LL
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILL 176
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK------- 346
G+ Y VD+WS GCI AE++ +KP+ PG +E+++L KIF++ G+P+EE W
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236
Query: 347 -KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
KS P + P+ +A P+ + L+ +L +DP++R TA AAL E
Sbjct: 237 YKSAFPK---WPPKD-----LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285
|
Length = 294 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 3e-75
Identities = 111/287 (38%), Positives = 171/287 (59%), Gaps = 14/287 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMAREILILRRLDHP 177
F++L+K+G+GTY+ VYK R+ TG+IVALK++ D E P + REI +++ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHE 58
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK--FTQAQVKCYMHQLLSGLEHC 235
N+V+L ++ + L LVF+YM+ DL + ++ VK + +QLL G+ C
Sbjct: 59 NIVRLHDVIHTE--NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H VLHRD+K NLLI+ G L +ADFGLA +F P + ++ VVTLWYR P++LLG
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLG 174
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353
+ Y +D+WS GCI+AE++ +P+ PG +QL KIF++ G+P+E W S+LP
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P+ + + + F P + L+ LL ++P R +A AL+
Sbjct: 235 KPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 7e-74
Identities = 117/298 (39%), Positives = 171/298 (57%), Gaps = 22/298 (7%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRL 174
+ +T++KLDK+G+G+Y+ VYK R LTGQ+VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
H N+V L ++ ++ + L LVF+Y++ DL + V+ ++ QLL GL +
Sbjct: 61 KHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLA---SFFDPNHKQPMTSRVVTLWYRPPEL 291
CH + VLHRD+K NLLI G L +ADFGLA S P+ ++ VVTLWYRPP++
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--PSKT--YSNEVVTLWYRPPDV 174
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKK-SK 349
LLG+T+Y +D+W GCI E+ +P+ PG T+V +QLHKIF++ G+P+EE W S
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234
Query: 350 LPHATIFKPQQS--YKR---CIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
P FKP Y D P L L +P +R +A A++
Sbjct: 235 NPE---FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 3e-71
Identities = 110/313 (35%), Positives = 157/313 (50%), Gaps = 32/313 (10%)
Query: 119 TFEKLDKIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLD 175
+E IG+GTY VYKA+ + G+ A+KK + D + + A REI +LR L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL----AASPTIKFTQAQVKCYMHQLLSG 231
H NVV L + S+YL+F Y EHDL + + + + VK + Q+L+G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 232 LEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMTSR--VVTLW 285
+ + H+ VLHRD+K +N+L+ G++ I D GLA F+ K VVT+W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKL 336
YR PELLLGA Y +D+W+ GCI AELL +PI GR +QL +IF++
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 337 CGSPSEEYWKK-SKLPH----ATIFKPQQSYKRC----IAETFKDFPPSSLPLIETLLAI 387
G+P+E+ W K+P FK ++Y E K L+ LL
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKT-KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 388 DPAERQTATAALR 400
DP +R TA AL
Sbjct: 300 DPTKRITAEEALE 312
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 2e-70
Identities = 107/286 (37%), Positives = 173/286 (60%), Gaps = 12/286 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKV--RFDNLEPESVRFMAREILILRRL-DH 176
++ + ++G GT+ +VY AR+ TG++VA+KK+ +F + E E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK-FTQAQVKCYMHQLLSGLEHC 235
PN+VKL+ + R + LY VF+YME +L L K F+++ ++ ++Q+L GL H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H HRD+K NLL+ ++ IADFGLA + + P T V T WYR PE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHAT 354
T Y VD+W+ GCI+AEL +P+ PG +E++QL+KI + G+P+++ W + KL
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
F+ Q + + + P ++ LI+ +L DP +R TA+ AL+
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 3e-70
Identities = 103/284 (36%), Positives = 151/284 (53%), Gaps = 7/284 (2%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E L +G+G Y V K R+ TG+IVA+KK + + + + RE+ +LR+L H N+
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
V L R LYLVF+Y+E L L ASP V+ Y+ QLL + +CH+
Sbjct: 63 VNL--KEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
+++HRDIK N+L+ G+L + DFG A P+T V T WYR PELL+G T+Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS-PSEEYWKKSKLPHATIFK 357
G VD+W+ GCI+AELL +P+ PG ++++QL+ I K G P S P
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239
Query: 358 -PQQSYKRCIAETF-KDFPPSSLPLIETLLAIDPAERQTATAAL 399
P+ S + + +L ++ L +DP ER T L
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 3e-70
Identities = 116/297 (39%), Positives = 169/297 (56%), Gaps = 27/297 (9%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD---NLEPESVRFMAREILILRRL-D 175
+E L K+G+G Y V+KA D T ++VALKK+ FD N F REI+ L+ L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDL-----AGLAASPTIKFTQAQVKCY-MHQLL 229
HPN+VKL ++ + +YLVF+YME DL A + + K Y M+QLL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI--------LEDVHKRYIMYQLL 117
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA---SFFDPNHKQP-MTSRVVTLW 285
L++ H+ +V+HRD+K SN+L++++ + +ADFGLA S + N + P +T V T W
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
YR PE+LLG+T Y GVD+WS GCIL E+L KP+ PG + + QL KI ++ G PS E
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 346 K--KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ KS + ++ + E +L L++ LL +P +R TA AL
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 4e-65
Identities = 116/292 (39%), Positives = 173/292 (59%), Gaps = 17/292 (5%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ +T+ KLDK+G+GTY+ V+K R LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 176 HPNVVKLEGLV-TSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
H N+V L ++ T R L LVF+Y++ DL + + VK +M QLL GL +
Sbjct: 62 HANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
CH + +LHRD+K NLLI+ +G L +ADFGLA K ++ VVTLWYRPP++LLG
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLG 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
+T+Y +D+W GCIL E+ +P+ PG T E+LH IF+L G+P+EE W P T
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-----PGIT 232
Query: 355 IFKPQQSY--KRCIAETFKDFPP----SSLPLIETLLAIDPAERQTATAALR 400
+ +SY + A+ + P + L+ +LL + R +A AALR
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 3e-64
Identities = 109/282 (38%), Positives = 153/282 (54%), Gaps = 11/282 (3%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALK--KVRFDNLEPESVRFMAREILILRRL-DHPNV 179
L KIG+GT+S V KA+ TG+ A+K K F +LE + REI LRRL HPN+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
++L ++ R + L LVF+ M+ +L L + +VK YM+QLL L+H H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
+ HRDIK N+LI ++ IL +ADFG S K P T + T WYR PE LL YG
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG--SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY-WKKSKLPHATIFKP 358
+D+W+ GC+ E+L+ P+ PG E++Q+ KI + G+P E K K H P
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + + + L L++ LLA DP ER TA ALR
Sbjct: 238 SKK-GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 5e-63
Identities = 100/295 (33%), Positives = 153/295 (51%), Gaps = 21/295 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +EKL KIG+G+Y V+K R+ TGQIVA+KK +P + REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V L + R L+LVF+Y +H L L +P + +K + Q L + CH
Sbjct: 61 NLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH 117
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +HRD+K N+LI +G + + DFG A T V T WYR PELL+G T
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDT 176
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS---------PSEEYWKK 347
YG VD+W+ GC+ AELL +P+ PG+++V+QL+ I K G + +++K
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+P +P + F + +L ++ L +DP ER + L
Sbjct: 237 LSIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 204 bits (519), Expect = 9e-63
Identities = 101/230 (43%), Positives = 144/230 (62%), Gaps = 4/230 (1%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ +T+ KLDK+G+GTY+ VYK R LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
H N+V L ++ + S L LVF+Y++ DL VK ++ QLL GL +C
Sbjct: 63 HANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H + VLHRD+K NLLI+ G L +ADFGLA K ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YSNEVVTLWYRPPDILLGS 179
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
TDY +D+W GCI E+ +P+ PG T EQLH IF++ G+P+EE W
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 1e-62
Identities = 102/292 (34%), Positives = 154/292 (52%), Gaps = 12/292 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV--RFDNLEPESVRFMAREILILRRLD 175
++ ++ IG G Y V A DT +G+ VA+KK+ FD P + RE+ ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFK 62
Query: 176 HPNVVKLEGLVTSRMS--CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
H N++ + ++ + +Y+V ME DL + S T+ ++ +++QLL GL+
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLK 121
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN---HKQPMTSRVVTLWYRPPE 290
+ H+ +V+HRD+K SNLL++ + L I DFG+A + HK MT V T WYR PE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--S 348
LLL +Y +D+WS GCI AE+L + + PG+ V QL I + GSPSEE + S
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
I + ++ F P +L L+ +L DP ER T AL+
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 4e-61
Identities = 118/293 (40%), Positives = 169/293 (57%), Gaps = 20/293 (6%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLD 175
A ++ L+K+G+G+Y+ VYK + GQ+VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
H N+V L ++ ++ + L VF+YM DLA V+ +M QLL GL +
Sbjct: 62 HANIVLLHDIIHTKET--LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H QH+LHRD+K NLLI G L +ADFGLA + P+ Q +S VVTLWYRPP++LLG
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLG 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKK-SKLPH 352
ATDY +D+W AGCI E+L +P PG ++V EQL KI+ + G P+E+ W SKLP+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237
Query: 353 ATIFKPQQSYKRCIAETFKDF------PPSSLPLIETLLAIDPAERQTATAAL 399
+KP+ + C + + PP + L +L + P +R +A AL
Sbjct: 238 ---YKPEW-FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 2e-60
Identities = 112/291 (38%), Positives = 165/291 (56%), Gaps = 31/291 (10%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHPNVVKLE 183
IG+G Y V A+++ T + VA+KK+ FDN ++ R + REI +LR LDH NV+ ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTL-REIKLLRHLDHENVIAIK 70
Query: 184 GLV--TSRMSCS-LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
++ R + + +Y+V++ M+ DL + S + + +++QLL GL++ H+ +V
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
LHRD+K SNLL++ L I DFGLA MT VVT WYR PELLL ++Y
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTT 188
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE------------YWKKS 348
+D+WS GCI AELL KP+ PG+ V QL I +L GSPSEE Y +
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIR-- 246
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
LP+ P+QS+ A F P ++ L+E +L DP++R T AL
Sbjct: 247 SLPYT----PRQSF----ARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 4e-59
Identities = 96/230 (41%), Positives = 147/230 (63%), Gaps = 4/230 (1%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ +T+ KL+K+G+GTY+ V+K R LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
H N+V L +V + S L LVF+Y++ DL + VK +++Q+L GL +C
Sbjct: 63 HANIVTLHDIVHTDKS--LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H + VLHRD+K NLLI+ G L +ADFGLA K ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLGS 179
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
++Y +D+W GCI E+ + +P+ PG T ++LH IF+L G+P+EE W
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 1e-58
Identities = 110/288 (38%), Positives = 156/288 (54%), Gaps = 14/288 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL---DH 176
+E + +IG G Y VYKARD +G VALK VR E RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 177 PNVVKLEGL-VTSRM--SCSLYLVFKYMEHDL-AGLAASPTIKFTQAQVKCYMHQLLSGL 232
PN+V+L + TSR + LVF++++ DL L P +K M Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ H ++HRD+K N+L+ + G + +ADFGLA + + + +T VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVL 179
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLP 351
L +T Y VD+WS GCI AE+ KP+ G +E +QL KIF L G P E+ W + LP
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
F P+ R + + S L+ +L +P +R +A AL
Sbjct: 239 RGA-FSPRG--PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 2e-58
Identities = 104/305 (34%), Positives = 156/305 (51%), Gaps = 40/305 (13%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILR 172
++ L IG+G Y V A TG VA+KK+ P + REI ILR
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILR 58
Query: 173 RLDHPNVVKLEGLVTSRMSCSL---YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
R H N++ + ++ S Y+V + ME DL L T + ++ +++Q+L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQIL 116
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTSRVVTLWYR 287
GL++ H+ +VLHRD+K SNLL++ L I DFGLA DP H +T V T WYR
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE--YW 345
PE++L + Y +D+WS GCILAE+L+ +P+ PG+ + QL+ I + G+PS+E
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 346 KKSK--------LPHATIFKPQQSYKRCIAETFKDFP---PSSLPLIETLLAIDPAERQT 394
S LP FKP+ + + FP P +L L++ +L +P +R T
Sbjct: 237 IISLRARNYIKSLP----FKPKVPWNKL-------FPNADPKALDLLDKMLTFNPHKRIT 285
Query: 395 ATAAL 399
AL
Sbjct: 286 VEEAL 290
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 2e-58
Identities = 71/191 (37%), Positives = 109/191 (57%), Gaps = 6/191 (3%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
+G+G + VY ARD TG+ VA+K ++ ++ + REI IL++L+HPN+VKL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 186 VTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244
LYLV +Y E L L K ++ ++ + Q+L GLE+ H+ ++HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 245 IKGSNLLIDN-EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
+K N+L+D+ G + +ADFGL+ + K + + V T Y PE+LLG Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 304 LWSAGCILAEL 314
+WS G IL EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 3e-57
Identities = 101/289 (34%), Positives = 165/289 (57%), Gaps = 13/289 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPN 178
+E L +G+G+Y V K + TGQIVA+KK ++ + + V+ +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+V L + R LYLVF++++H L L P +++V+ Y+ Q+L G+E CH+
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHS 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-PNHKQPMTSRVVTLWYRPPELLLGAT 296
+++HRDIK N+L+ G++ + DFG A P + T V T WYR PELL+G T
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDT 176
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE---EYWKKSKLPHA 353
YG VD+W+ GC++ E+L +P+ PG ++++QL+ I K G+ E ++K+ L A
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-FA 235
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ P+ + + F L L + L IDP +R +++ L E
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 1e-55
Identities = 103/292 (35%), Positives = 153/292 (52%), Gaps = 18/292 (6%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLD 175
D ++ L +G G Y V A DT TG+ VA+KK+ F + + RE+ +L+ +D
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72
Query: 176 HPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
H NV+ L + T S +YLV M DL + K + ++ ++Q+L G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRG 130
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L++ H+ ++HRD+K SN+ ++ + L I DFGLA D MT V T WYR PE+
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 186
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+L Y VD+WS GCI+AELL K + PG ++QL +I L G+P EE +K
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 352 HATIF---KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
A + PQ K+ E F P ++ L+E +L +DP +R TA AL
Sbjct: 247 SARNYIQSLPQMP-KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 101/285 (35%), Positives = 151/285 (52%), Gaps = 9/285 (3%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ L +G G + V ARD LTGQ VA+KK+ P + RE+ +L+ L H N+
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
+ L + S + +Y V + + DL L S ++ Q +++Q+L GL++ H+
Sbjct: 72 ISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRPLEKQFIQY--FLYQILRGLKYVHSAG 128
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
V+HRD+K SN+LI+ L I DFGLA DP MT V T +YR PE++L Y
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYD 184
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLPHATIFK 357
V VD+WSAGCI AE+L KP+ PG+ V Q I L G+P ++ S+ +
Sbjct: 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ +E FK+ PS++ L+E +L DP +R +A AL
Sbjct: 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 4e-55
Identities = 113/296 (38%), Positives = 169/296 (57%), Gaps = 18/296 (6%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRL 174
+AD++EKL+K+G+G+Y+ VYK + + G++VALK +R E E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
H N+V L ++ ++ + L LVF+Y+ DL VK ++ QLL GL +
Sbjct: 61 KHANIVLLHDIIHTKET--LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-PNHKQPMTSRVVTLWYRPPELLL 293
H +++LHRD+K NLLI + G L +ADFGLA P+H ++ VVTLWYRPP++LL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT--YSNEVVTLWYRPPDVLL 176
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKK-SKLP 351
G+T+Y +D+W GCI E++ PG +++ QL +IF + G+P+E+ W LP
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236
Query: 352 HATIFKPQQ----SYKRCIAETFK-DFPPSSLPLIETLLAIDPAERQTATAALRSE 402
H FKP++ S K K + + L LL P R +A AAL E
Sbjct: 237 H---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 6e-55
Identities = 106/298 (35%), Positives = 155/298 (52%), Gaps = 27/298 (9%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLT--GQIVALKKVR--FDNLEPESVRFMAREILILRRL- 174
+E + ++GQG Y V AR+ T + VA+KK+ F + RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFR 59
Query: 175 DHPNVVKLEGL--VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
H N+ L + V LYL + ME DL + S T A + +++Q+L GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGL 118
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP---MTSRVVTLWYRPP 289
++ H+ +VLHRD+K NLL++ + L I DFGLA F N + MT V T WYR P
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++L Y +D+WS GCILAELL KP+ G+ V+QL++I ++ G+P EE +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 350 LPHATIFKPQQSY--------KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
P A Q+Y K+ F + P +L L+E LLA DP +R + AL
Sbjct: 239 SPKA------QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 7e-53
Identities = 102/299 (34%), Positives = 163/299 (54%), Gaps = 22/299 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ L +G G+ V+ A D+ + VA+KK+ +P+SV+ REI I+RRLDH N+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNI 64
Query: 180 VKLEGLVTSRMS------------CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
VK+ ++ S S+Y+V +YME DLA + + ++ + +M+Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLFMYQ 122
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPN--HKQPMTSRVVTL 284
LL GL++ H+ +VLHRD+K +N+ I+ E +L I DFGLA DP+ HK ++ +VT
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
WYR P LLL +Y +D+W+AGCI AE+L KP+ G E+EQ+ I + EE
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 345 WKK--SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
+ + +P + + +R + + P +L +E +L +P +R TA AL
Sbjct: 243 RNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 2e-52
Identities = 111/292 (38%), Positives = 162/292 (55%), Gaps = 21/292 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNLEPESVRFMAREILILRRLD--- 175
+E + +IG+G Y V+KARD G + VALK+VR E RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 176 HPNVVKLEGLVT-SRM--SCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
HPNVV+L + T SR L LVF++++ DL L P +K M QLL G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L+ H+ V+HRD+K N+L+ + G + +ADFGLA + + + +TS VVTLWYR PE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEV 180
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P EE W +
Sbjct: 181 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD--- 236
Query: 352 HATIFKPQQSYKRCIAETFKDFPPS----SLPLIETLLAIDPAERQTATAAL 399
+ P+Q++ A+ + F L+ L +PA+R +A +AL
Sbjct: 237 ---VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
+ + + +G+G++ +VY A D TG+++A+K V E + + REI IL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+V+ G +L + ++E+ L+ L K + ++ Y Q+L GL +
Sbjct: 61 IVRYYGSERDEEKNTLNI---FLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAY 116
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLL 293
H+ ++HRDIKG+N+L+D++G++ +ADFG A T V T ++ PE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKLPH 352
G +YG D+WS GC + E+ KP L+KI P +P
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE--------IP- 226
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
++E KDF + L DP +R TA
Sbjct: 227 -----------EHLSEEAKDF-------LRKCLRRDPKKRPTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 107/295 (36%), Positives = 164/295 (55%), Gaps = 23/295 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
++ + IG+G+Y V A DT TG+ VA+KK+ F+++ ++ R + REI +LR L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHP 59
Query: 178 NVVKLEGLV---TSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLS 230
++V+++ ++ + R +Y+VF+ ME DL IK T + +++QLL
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEHHQFFLYQLLR 114
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA--SFFDPNHKQPMTSRVVTLWYRP 288
L++ H +V HRD+K N+L + + L I DFGLA +F D T V T WYR
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 289 PELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PEL G+ + Y +D+WS GCI AE+L KP+ PG+ V QL I L G+PS E
Sbjct: 175 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 347 KSKLPHATIFKPQQSYKRCI--AETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+ + A + K+ + ++ F + P +L L+E LLA DP +R TA AL
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-48
Identities = 110/310 (35%), Positives = 165/310 (53%), Gaps = 38/310 (12%)
Query: 125 KIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
K+G+GTY +VYKA+ D + ALK++ + + REI +LR L HPNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 183 EGLVTSRMSCSLYLVFKYMEHDL--------AGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ + S ++L+F Y EHDL A A ++ + VK ++Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 235 CHNQHVLHRDIKGSNLLIDNEGI----LTIADFGLASFFDPNHK--QPMTSRVVTLWYRP 288
H VLHRD+K +N+L+ EG + IAD G A F+ K + VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLCGS 339
PELLLGA Y +D+W+ GCI AELL +PI R E +QL +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 340 PSEEYWKK-SKLP-HATIFKP--QQSYKRC----IAETFKDFPPS-SLPLIETLLAIDPA 390
P+++ W+ K+P H+T+ K + +Y C E K P S + L++ LL +DP
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 303
Query: 391 ERQTATAALR 400
+R T+ A++
Sbjct: 304 KRITSEQAMQ 313
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-47
Identities = 101/281 (35%), Positives = 151/281 (53%), Gaps = 12/281 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+ FE L +G+G Y V K R T +IVA+KK + D+ E E V+ RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V+L+ R LYLVF+Y+E ++ L +V+ Y++QL+ + CH
Sbjct: 60 ENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++HRDIK NLLI + +L + DFG A T V T WYR PELLLGA
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS-PSEE---YWKKSKLPH 352
YG VD+WS GCIL EL +P+ PG +E++QL I K+ G P+E+ ++ + H
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF-H 235
Query: 353 ATIFKPQQSYKRCIAETFKDFPPS-SLPLIETLLAIDPAER 392
F P ++ + + + L L++ LL ++P +R
Sbjct: 236 GLRF-PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-46
Identities = 81/282 (28%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
FE L+KIG+G + VYKAR TG+ VA+K ++ + E + EI IL++ HPN+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
VK G + L++V ++ L L S T++Q+ +LL GLE+ H+
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
++HRDIK +N+L+ ++G + + DFGL++ + + + V T ++ PE++ G Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVING-KPY 174
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358
D+WS G EL KP ++ L KI + + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------------ATNGPPGLRNP 220
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ ++ FKDF ++ L +P +R TA L+
Sbjct: 221 EKW-----SDEFKDF-------LKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 6e-46
Identities = 99/291 (34%), Positives = 155/291 (53%), Gaps = 21/291 (7%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILRRL 174
+ L ++G G Y +V A D TG+ VA+KK+ P A RE+ +L+ +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHM 71
Query: 175 DHPNVVKLEGLVTSRMSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLS 230
H NV+ L + TS +S YLV YM+ DL + P ++ +V+ ++Q+L
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLC 128
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
GL++ H+ ++HRD+K NL ++ + L I DFGLA D MT VVT WYR PE
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPE 184
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--S 348
++L Y VD+WS GCI+AE+L K + G+ ++QL +I K+ G P E+ +K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
K + I + ++ + F P ++ L+E +L +D +R TAT AL
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 6e-46
Identities = 95/284 (33%), Positives = 150/284 (52%), Gaps = 13/284 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHPNVVK-L 182
IG G + V+ D G+ VALKK+ F NL S + + RE+ +L H NV+ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 183 EGLVTSRMSC--SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
+ L + +Y+V + M+ DL + SP + VK +++Q+L GL++ H+ +
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
LHRDIK NLL+++ +L I DFGLA +P+ + MT VVT +YR PE+L+G+ Y
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSKLPHATIFKPQ 359
VD+WS GCI AELL + + ++ ++QL I L G+PS E + A I +
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP 244
Query: 360 QSYKRCIAETFKDFPPSS---LPLIETLLAIDPAERQTATAALR 400
+ + ++ + L+ +L DP +R +A AL
Sbjct: 245 HKPP-SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 7e-46
Identities = 103/296 (34%), Positives = 153/296 (51%), Gaps = 23/296 (7%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
P R ++ L +G G Y +V A DT Q VA+KK+ R RE+ +L+
Sbjct: 14 PER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70
Query: 174 LDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
+ H NV+ L + T S +YLV M DL + K + V+ ++QLL
Sbjct: 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLL 128
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
GL++ H+ ++HRD+K SN+ ++ + L I DFGLA D MT V T WYR P
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAP 184
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++L Y VD+WS GCI+AELL K + PG ++QL +I ++ G+PS E KK
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244
Query: 350 LPHATIF------KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
HA + PQQ K + F+ P ++ L+E +L +D +R +A+ AL
Sbjct: 245 SEHARKYIQSLPHMPQQDLK----KIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 9e-46
Identities = 108/312 (34%), Positives = 162/312 (51%), Gaps = 42/312 (13%)
Query: 125 KIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
K+G+GTY +VYKA+ D + ALK++ + + REI +LR L HPNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 183 EGLVTSRMSCSLYLVFKYMEHDL--------AGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ + S ++L+F Y EHDL A A ++ ++ VK ++Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 235 CHNQHVLHRDIKGSNLLIDNEGI----LTIADFGLASFFDPNHK--QPMTSRVVTLWYRP 288
H VLHRD+K +N+L+ EG + IAD G A F+ K + VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLCGS 339
PELLLGA Y +D+W+ GCI AELL +PI R E +QL +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 340 PSEEYWKK-SKLPHATIFKPQQSYKRCI---------AETFKDFPPSSL-PLIETLLAID 388
P+++ W+ K+P Q+ ++R E K P S + L++ LL +D
Sbjct: 244 PADKDWEDIRKMPEYPTL--QKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301
Query: 389 PAERQTATAALR 400
P +R T+ AL+
Sbjct: 302 PTKRITSEQALQ 313
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 69/199 (34%), Positives = 117/199 (58%), Gaps = 10/199 (5%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
D IG+G + VYK + TG VA+K++ + ++ E+++ + +EI +L+ L HPN+VK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 184 GLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G + + S SLY++ +Y E+ L + F ++ V Y++Q+L GL + H Q V+H
Sbjct: 66 GSIET--SDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL--GATDYGV 300
RDIK +N+L +G++ +ADFG+A+ + K + V T ++ PE++ GA+
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSGAS---T 178
Query: 301 GVDLWSAGCILAELLAEKP 319
D+WS GC + ELL P
Sbjct: 179 ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 3e-45
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E + +IG+G++ VY R G++ LK++ N+ + E+ IL++L+HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 180 VKL-EGLVTSRMSCSLYLVFKYMEH----DLAGL---AASPTIKFTQAQVKCYMHQLLSG 231
+K E L +V ME+ DL+ F + Q+ + QL
Sbjct: 62 IKYYESFEE---KGKLCIV---MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPE 290
L++ H++ +LHRDIK N+ + + G++ + DFG++ + + VV T +Y PE
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYYLSPE 173
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKP 319
L Y D+WS GC+L EL K
Sbjct: 174 LCQNKP-YNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 4e-45
Identities = 101/288 (35%), Positives = 147/288 (51%), Gaps = 12/288 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++ L +G G Y +V A DT TG VA+KK+ + RE+ +L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T S +YLV M DL + K T V+ ++Q+L GL+
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 134
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H+ ++HRD+K SNL ++ + L I DFGLA D MT V T WYR PE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIML 190
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLP 351
Y VD+WS GCI+AELL + + PG ++QL I +L G+P E KK S+
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
I Q K A F P ++ L+E +L +D +R TA AL
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 9e-45
Identities = 98/292 (33%), Positives = 152/292 (52%), Gaps = 20/292 (6%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILRR 173
D + L ++G G Y V A D TG VA+KK+ P A RE+ +L+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKH 70
Query: 174 LDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
+ H NV+ L + T +S YLV +M DL L K ++ +++ ++Q+L
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQML 128
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
GL++ H ++HRD+K NL ++ + L I DFGLA D MT VVT WYR P
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAP 184
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++L Y VD+WS GCI+AE+L KP+ G ++QL +I K+ G+PS+E+ +K +
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244
Query: 350 LPHAT--IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
A + K + K+ + P ++ ++E +L +D R TA AL
Sbjct: 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 9e-44
Identities = 85/300 (28%), Positives = 133/300 (44%), Gaps = 40/300 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESVRFMAREILILRRLDHP- 177
+ L K+G+G++ VY ARD ++VALK + + + V REI IL L+HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEH 234
N+VKL SLYLV +Y++ L L ++++ + Q+LS LE+
Sbjct: 59 NIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 235 CHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPN-----HKQPMTSRVVTLWYRP 288
H++ ++HRDIK N+L+D + ++ + DFGLA ++ V T Y
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 289 PELLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSEE 343
PE+LLG + D+WS G L ELL P G Q KI +PS
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403
P ++ L++ LLA DP R ++++ L ++
Sbjct: 237 SPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 87/302 (28%), Positives = 133/302 (44%), Gaps = 65/302 (21%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV--RFDNLEPESVRFMAREILILRRLD 175
D F+ IG+G++S V A++ T + A+K + R E + V+++ E +L RL+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLN 59
Query: 176 -HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK----FTQAQVKCYMHQLL 229
HP ++KL T + +LY V +Y + +L I+ + + Y ++L
Sbjct: 60 GHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQY-----IRKYGSLDEKCTRFYAAEIL 112
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--------------- 274
LE+ H++ ++HRD+K N+L+D + + I DFG A DPN
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 275 QPMTSR----VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330
+ R V T Y PELL G DLW+ GCI+ ++L KP G E
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390
KI KL EY P +FPP + LIE LL +DP
Sbjct: 232 QKILKL------EY----SFPP-------------------NFPPDAKDLIEKLLVLDPQ 262
Query: 391 ER 392
+R
Sbjct: 263 DR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 89/288 (30%), Positives = 131/288 (45%), Gaps = 38/288 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
E++ +GQG+ VYK R TG+I ALKK+ D + E + + RE+ LR + P V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYV 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
VK G + +V +YM+ LA L K + + Q+L GL++ H +
Sbjct: 62 VKCYGAFYK--EGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 239 -HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
H++HRDIK SNLLI+++G + IADFG++ + Q T V T+ Y PE + G +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGES- 176
Query: 298 YGVGVDLWSAGCILAEL-LAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
Y D+WS G L E L + P +P E + I C P LP
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPPPS------LPA-- 225
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ F+DF I L DP +R +A L+
Sbjct: 226 ---------EEFSPEFRDF-------ISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 94/306 (30%), Positives = 157/306 (51%), Gaps = 38/306 (12%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
++ L IG G V A DT+TGQ VA+KK+ F N + RE+++++ ++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHK 75
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ L + T + S +YLV + M+ +L + + ++ ++Q+L G++
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQMLCGIK 132
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-----SFFDPNHKQPMTSRVVTLWYRP 288
H H+ ++HRD+K SN+++ ++ L I DFGLA SF MT VVT +YR
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-------MTPYVVTRYYRA 185
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
PE++LG Y VD+WS GCI+ E++ + PG ++Q +KI + G+PS+E+ +
Sbjct: 186 PEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 349 KLPHATIFKPQQSYK-RCIAETFKD--FPPSS-----------LPLIETLLAIDPAERQT 394
+ + + Y E F D FPP S L+ +L IDP +R +
Sbjct: 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 395 ATAALR 400
AL+
Sbjct: 305 VDDALQ 310
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 48/275 (17%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
+G+G++ V R TG++ A+K ++ ++ + V E IL R++HP +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 185 LVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+ LYLV +Y +L S +F++ + + Y +++ LE+ H+
Sbjct: 59 ------HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+++RD+K N+L+D +G + + DFGLA + + T Y PE+LLG
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGK-G 169
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
YG VD WS G +L E+L KP E KI K L
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI------------LKDPL------- 210
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ ++ +D LI LL DP +R
Sbjct: 211 ---RFPEFLSPEARD-------LISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 40/290 (13%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ ++ L+KIG+G VYKA D TG+ VA+KK+R E + EILI++
Sbjct: 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCK 73
Query: 176 HPNVVKLEG--LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
HPN+V LV L++V +YM+ L + ++ + Q+ ++L GL
Sbjct: 74 HPNIVDYYDSYLV---GDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
E+ H+Q+V+HRDIK N+L+ +G + +ADFG A+ + S V T ++ PE++
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAPEVI 188
Query: 293 LGATDYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
DYG VD+WS G + E+ E P + L +F + +K
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYL----REPPLRALFLI----------TTKGI 233
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
P + FKDF + L DP +R +A L+
Sbjct: 234 ------PPLKNPEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-36
Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 54/288 (18%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN---LEPESVRFMAREILILRRLDHPNVVKL 182
+G G++ +VY+ + G A+K+V + E+V+ + +EI +L +L HPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHCHNQH 239
G T R +LY+ ++E G A K F + ++ Y Q+L GLE+ H+++
Sbjct: 68 LG--TEREEDNLYI---FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLA---SFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+HRDIKG+N+L+D G++ +ADFG+A F S + ++ PE++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYWMAPEVIAQQG 177
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
YG+ D+WS GC + E+ KP +++E + +FK+ S LP
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKE--------LPP---- 222
Query: 357 KPQQSYKRCIAETF----KDFPPSSLPLIETLLAIDPAERQTATAALR 400
I + KDF I L DP+ R TA L
Sbjct: 223 ---------IPDHLSDEAKDF-------ILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 67/209 (32%), Positives = 114/209 (54%), Gaps = 17/209 (8%)
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
++ +KIG GT+ VY A + TG+++A+K++R + +P++++ +A E+ +L L HPN+V
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
K G+ R V+ +ME+ L L I + ++ Y QLL GL + H
Sbjct: 63 KYYGVEVHREK-----VYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLEGLAYLH 116
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYRPPELL 292
+ ++HRDIK +N+ +D+ G++ + DFG A N+ M V +L Y PE++
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 293 LGATDYGVG--VDLWSAGCILAELLAEKP 319
G G G D+WS GC++ E+ K
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-35
Identities = 90/301 (29%), Positives = 155/301 (51%), Gaps = 29/301 (9%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++ L IG G V A D + + VA+KK+ + RE+++++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 180 VKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + T + S +YLV + M+ A L ++ ++ ++Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H+ ++HRD+K SN+++ ++ L I DFGLA + MT VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG- 192
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ KK + T+
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ---PTV 249
Query: 356 FKPQQSYKRCIAETF-KDFPPSSLP---------------LIETLLAIDPAERQTATAAL 399
++ + TF K FP S P L+ +L IDPA+R + AL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309
Query: 400 R 400
+
Sbjct: 310 Q 310
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-34
Identities = 95/289 (32%), Positives = 147/289 (50%), Gaps = 28/289 (9%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
IG G++ VY+A T + VA+KKV D P+ + RE+LI++ L+H N++ L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQ---YKNRELLIMKNLNHINIIFLKDY 127
Query: 186 VTS----RMSCSLYL----------VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+ + +++L V KYM+H A P VK Y +QL
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-----LVKLYSYQLCRA 182
Query: 232 LEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
L + H++ + HRD+K NLLID N L + DFG A + S + + +YR PE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPE 240
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L+LGAT+Y +DLWS GCI+AE++ PI G++ V+QL +I ++ G+P+E+ K+
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+A I P K K P ++ I L +P +R AL
Sbjct: 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 92/299 (30%), Positives = 151/299 (50%), Gaps = 25/299 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+++L IG G V A DT+ G VA+KK+ + RE+++L+ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 180 VKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + T + S +YLV + M+ A L ++ ++ ++Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIHMELDHERMSYLLYQMLCGIKHL 139
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H+ ++HRD+K SN+++ ++ L I DFGLA N MT VVT +YR PE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPEVILG- 196
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLPHA 353
Y VD+WS GCI+ EL+ I G ++Q +K+ + G+PS E+ + + +
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 354 TIFKPQQSYKRCIAETFKD--FPPSS----------LPLIETLLAIDPAERQTATAALR 400
+PQ E F D FP S L+ +L IDP +R + ALR
Sbjct: 257 VENRPQY-PGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 70/223 (31%), Positives = 111/223 (49%), Gaps = 11/223 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E L+ IG+G++ V K R G+I+ K++ + N+ + + + E+ ILR L HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLLSGLEHC 235
V+ + R + +LY+V +Y E DLA L + + + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 236 HN-----QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
HN VLHRD+K +N+ +D + + DFGLA + + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
L + Y D+WS GC++ EL A P R +++ KI
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 74/212 (34%), Positives = 113/212 (53%), Gaps = 25/212 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
F+ KIG+G +S VYKA L G++VALKKV+ F+ ++ ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 177 PNVVK-LEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKC--------YMH 226
PNV+K L + + L +V + + DL S IK + Q + Y
Sbjct: 62 PNVIKYLASFIENNE---LNIVLELADAGDL-----SRMIKHFKKQKRLIPERTIWKYFV 113
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT--SRVVTL 284
QL S LEH H++ ++HRDIK +N+ I G++ + D GL FF + S V T
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTP 170
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+Y PE + Y D+WS GC+L E+ A
Sbjct: 171 YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 86/303 (28%), Positives = 151/303 (49%), Gaps = 33/303 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++ L IG G V A D + + VA+KK+ + RE+++++ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 180 VKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + T + S +Y+V + M+ A L ++ ++ ++Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLA-----SFFDPNHKQPMTSRVVTLWYRPPE 290
H+ ++HRD+K SN+++ ++ L I DFGLA SF MT VVT +YR PE
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-------MTPYVVTRYYRAPE 195
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
++LG Y VD+WS GCI+ E++ + PG ++Q +K+ + G+P E+ KK +
Sbjct: 196 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 351 PHATIFKPQQSYK-RCIAETFKD--FPPSS----------LPLIETLLAIDPAERQTATA 397
T + + Y + F D FP S L+ +L ID ++R +
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314
Query: 398 ALR 400
AL+
Sbjct: 315 ALQ 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 72/221 (32%), Positives = 120/221 (54%), Gaps = 15/221 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKV--------RFDNLEPESVRFMAREILILRRLDHP 177
IG+GTY VY A + TG+++A+K+V R D+ + + V+ + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+V+ G T+ S++L +Y+ G +F + V+ + Q+L GL + H+
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP--NHKQPMTSRVVTLWYRPPELLLGA 295
+ +LHRD+K NLL+D +GI I+DFG++ D ++ Q M+ + W P + +
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
Y VD+WS GC++ E+ A + P E E + +FKL
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKL 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 78/266 (29%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKK-VRFDNLEPESVRFMAREILILRRLDHPN 178
FE L IG+G + V + T ++ A+K + +E SVR + E IL+ L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG---LAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+V L + + ++YLV + L G S +KF++ QVK ++ +++ LE+
Sbjct: 62 LVNLW--YSFQDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H++ ++HRDIK N+L+D +G + I DF +A+ P+ TS T Y PE+L
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQ 174
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPG--RTEVEQLHKIFKLCGSPSEEYWKK---SKL 350
Y V VD WS G E L K G RT +Q+ + W +
Sbjct: 175 -GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 351 PHATIFKPQQSYKR--CIAETFKDFP 374
PQ KR + K+ P
Sbjct: 234 NKLLERDPQ---KRLGDNLKDLKNHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 73/239 (30%), Positives = 122/239 (51%), Gaps = 38/239 (15%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRF----DNLEPESVRFMAREILILRRLDHPNVVK 181
+G G +S+ Y+ARD TG ++A+K+V + + + E V + +EI ++ RL+HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLSGLEHCHN 237
+ G +L++ + +AG + S + F +A + Y QLL GL + H
Sbjct: 68 MLGATCEDSHFNLFVEW------MAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 238 QHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQPMTSRVV-----------TLW 285
++HRD+KG+NLLID+ G L IADFG A+ + ++ T+
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAA--------RLAAKGTGAGEFQGQLLGTIA 173
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC---GSPS 341
+ PE+L G YG D+WS GC++ E+ KP L IFK+ +PS
Sbjct: 174 FMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 78/258 (30%), Positives = 124/258 (48%), Gaps = 24/258 (9%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDHPNVVKL 182
+GQG + VY D TG+ +A+K+V FD PE+ V + EI +L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLSGLEHCHNQ 238
G + + S++ ME+ + G + +K T+ + Y Q+L G+E+ H+
Sbjct: 70 YGCLRDDETLSIF-----MEY-MPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGAT 296
++HRDIKG+N+L D+ G + + DFG + + V T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
YG D+WS GC + E+L EKP E E + IFK+ P+ P A F
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 357 KPQQSYKRCIAETFKDFP 374
+R E K P
Sbjct: 240 -----LRRTFVENAKKRP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 75/287 (26%), Positives = 124/287 (43%), Gaps = 45/287 (15%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
F L+ IG+G++ VYKA D T Q+VA+K + + E E + + +EI L + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHCH 236
K G L+++ ME+ G + +K + + + ++L GLE+ H
Sbjct: 62 TKYYGSFLKG--SKLWII---MEY-CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR---VVTLWYRPPELLL 293
+ +HRDIK +N+L+ EG + +ADFG++ M+ R V T ++ PE++
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSG----QLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
+ Y D+WS G EL +P + + L I K
Sbjct: 172 Q-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN----------------- 213
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P ++ FKDF + L DP ER +A L+
Sbjct: 214 ---NPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 83/285 (29%), Positives = 140/285 (49%), Gaps = 45/285 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F+ L+K+G+G+Y +VYKA TGQ+VA+K V + E ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 178 NVVKLEGLVTSRMSCS-LYLVFKYMEHDLAG----LAASPTIKFTQAQVKCYMHQLLSGL 232
+VK G S + L++V ME+ AG + T+ ++ ++Q L GL
Sbjct: 59 YIVKYYG---SYFKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGL 112
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS-FFDPNHKQPMTSRVVTLWYRPPEL 291
E+ H+ +HRDIK N+L++ EG +ADFG++ D K+ + + T ++ PE+
Sbjct: 113 EYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR--NTVIGTPFWMAPEV 170
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+ Y D+WS G I A +AE P +++ + IF + P
Sbjct: 171 IQE-IGYNNKADIWSLG-ITAIEMAEG--KPPYSDIHPMRAIFMIPNKPPP--------- 217
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
T+ P++ + F DF ++ L DP ER +A
Sbjct: 218 --TLSDPEK-----WSPEFNDF-------VKKCLVKDPEERPSAI 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 72/240 (30%), Positives = 110/240 (45%), Gaps = 27/240 (11%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR---FMAREILILRRLDHPNVVKL 182
I +G Y V+ A+ TG I A+K ++ ++ ++ R+IL + P VVKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKL 58
Query: 183 -EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
+ +LYLV +Y+ DLA L + + + Y+ +++ LE+ H+ +
Sbjct: 59 YYSFQGKK---NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGI 114
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-------TSRVV-TLWYRPPELL 292
+HRD+K N+LID+ G L + DFGL S +Q R+V T Y PE++
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGL-SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI------FKLCGSPSEEYWK 346
LG + VD WS GCIL E L P G T E I + S+E
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAID 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-29
Identities = 79/297 (26%), Positives = 130/297 (43%), Gaps = 56/297 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +E + +IG GTY +VYKARD TG++VA+K ++ + + + +EI +L+ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 178 NVVKLEGLVTSR------MSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
N+V G R M SL +++ L ++ Q+ +
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL-----------SELQIAYVCRE 109
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
L GL + H +HRDIKG+N+L+ +G + +ADFG+++ S + T ++
Sbjct: 110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPYWM 168
Query: 288 PPELLL--GATDYGVGVDLWSAG--CI-LAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
PE+ Y D+W+ G I LAEL P ++ + +F + S+
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQ------PPMFDLHPMRALFLI----SK 218
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+ KL + P F DF I+ L DP +R TAT L
Sbjct: 219 SNFPPPKLKDKEKWSPV----------FHDF-------IKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 19/227 (8%)
Query: 120 FEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
E K+G+G + VYK T VA+K ++ E E F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
HPN+V+L G+ T LY+V +YM DL K T + Q+ G+E+
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYRPPE 290
+++ +HRD+ N L+ ++ I+DFGL+ D R W PE
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 291 LLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFK 335
L + D+WS G +L E+ L E+P PG + E L +
Sbjct: 175 SLKDGK-FTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 69/234 (29%), Positives = 124/234 (52%), Gaps = 26/234 (11%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-------VRFMAREILILRRLDHPN 178
IG G++ +VY + +G+++A+K+V ++ S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHC 235
+V+ G S + + +L ++E+ G A+ F + V+ ++ Q+L GL +
Sbjct: 68 IVQYLG---SSLD-ADHLNI-FLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN------HKQPMTSRVVTLWYRPP 289
HN+ ++HRDIKG+N+L+DN+G + I+DFG++ + N + + + W P
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343
++ T Y D+WS GC++ E+L K P + QL IFK+ + S E
Sbjct: 183 --VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 29/236 (12%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-D 175
FE ++ IG+GTY VYKAR TGQ+VA+K + E E ++ E ILR+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSN 61
Query: 176 HPNVVKLEGLVTSRMSCS----LYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQ 227
HPN+ G + L+LV + DL + + + + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-PNHKQPMTSRVVTLWY 286
L GL + H V+HRDIKG N+L+ + + DFG+++ D ++ + + T ++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGTPYW 179
Query: 287 RPPELLLG----ATDYGVGVDLWSAGCILAELLAE-KP----IMPGRTEVEQLHKI 333
PE++ Y D+WS G I A LA+ KP + P R L KI
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLG-ITAIELADGKPPLCDMHPMRA----LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 121 EKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
K+G+G + VYK + VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
PNVVKL G+ T LY+V +YME DL K + + + + Q+ G+E+
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL-WYRPPELLLG 294
+++ +HRD+ N L+ ++ I+DFGL+ + + + W PE L
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKE 177
Query: 295 ATDYGVGVDLWSAGCILAEL--LAEKP 319
+ D+WS G +L E+ L E+P
Sbjct: 178 GK-FTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 121 EKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
K+G+G + VYK VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSGLEH 234
PN+VKL G+ T L +V +YM DL L + + + + + + Q+ G+E+
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL-WYRPPELLL 293
+++ +HRD+ N L+ ++ I+DFGL+ + + + + W PE L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK 177
Query: 294 GATDYGVGVDLWSAGCILAEL--LAEKP 319
+ D+WS G +L E+ L E+P
Sbjct: 178 EGK-FTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 94/315 (29%), Positives = 130/315 (41%), Gaps = 80/315 (25%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
D FE + IG+G + V+ RD TGQ+ A+K +R D ++ + + E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 177 PNVVKLEGLVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIK---FTQAQVKCYMH 226
P +VKL S LYLV +YM DL L I+ F + + Y+
Sbjct: 61 PWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNL----LIRKDVFPEETARFYIA 108
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD---------------- 270
+L+ L+ H +HRDIK N+LID +G + +ADFGL +
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 271 ---------PNHKQPMT---SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK 318
+HKQ S V T Y PE+L G T YG+ D WS G IL E+L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGF 227
Query: 319 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPHATIFKPQQSYKRCIAETFKDFPPSS 377
P T E +KI WK+S + P P +
Sbjct: 228 PPFYSDTLQETYNKIIN---------WKESLRFPPD-----------------PPVSPEA 261
Query: 378 LPLIETLLAIDPAER 392
+ LI LL DP +R
Sbjct: 262 IDLICRLLC-DPEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 9/221 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDHPNVVKL 182
+GQG + VY D TG+ +A K+V+FD PE+ V + EI +L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G + R +L + +YM T++ + Y Q+L G+ + H+ ++H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDP--NHKQPMTSRVVTLWYRPPELLLGATDYGV 300
RDIKG+N+L D+ G + + DFG + + S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGR 188
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
D+WS GC + E+L EKP E E + IFK+ P+
Sbjct: 189 KADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 75/297 (25%), Positives = 123/297 (41%), Gaps = 48/297 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMAREILILRRLD 175
D +E ++ IG G + VY A + VA+K++ +LE SV + +E+ + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
HPNVVK L+LV Y+ D+ ++ P +A + + ++L G
Sbjct: 58 HPNVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL-ASFFDPNHKQPMTSRVV--TLWYRP 288
LE+ H+ +HRDIK N+L+ +G + IADFG+ AS D + + T +
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 347
PE++ Y D+WS G EL P K P +
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAA--PY-------SKYP-----PMKVLMLTL 220
Query: 348 ----SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
L YK+ +++F+ I L DP++R TA L+
Sbjct: 221 QNDPPSLETGA------DYKKY-SKSFRKM-------ISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 76/226 (33%), Positives = 112/226 (49%), Gaps = 18/226 (7%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPNVVKLE 183
KIG+G +S VY+A L G VALKKV+ FD ++ ++ +EI +L++L+HPNV+K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC--------YMHQLLSGLEHC 235
++ L D L S IK + Q + Y QL S LEH
Sbjct: 69 ASFIEDNELNIVLELA----DAGDL--SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H++ V+HRDIK +N+ I G++ + D GL FF + S V T +Y PE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHE 180
Query: 296 TDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSP 340
Y D+WS GC+L E+ A + P + + L K + C P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 124 DKIGQGTYSNVYKAR---DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
K+G+G + VYK + VA+K ++ D E E F+ +E ++++L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPNVV 59
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH-DL-------AGLAASPTIK-FTQAQVKCYMHQLLSG 231
+L G+ T LYLV +YME DL + SP + + + Q+ G
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVTL-WYRPP 289
+E+ ++ +HRD+ N L+ + ++ I+DFGL+ +D ++ + T + + W P
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-AP 176
Query: 290 ELLLGATDYGVGVDLWSAGCILAEL--LAEKP 319
E L + D+WS G +L E+ L P
Sbjct: 177 ESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 88/298 (29%), Positives = 126/298 (42%), Gaps = 68/298 (22%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
+G+GTY VY ARD T +A+K++ + V+ + EI + L H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 186 VTSRMSCSLYLVFK-YMEH----DLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQ 238
S S FK +ME L+ L S +K + + Y Q+L GL++ H+
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 239 HVLHRDIKGSNLLIDN-EGILTIADFG----LASFFDPNHKQPMTSRVV-TLWYRPPELL 292
++HRDIKG N+L++ G++ I+DFG LA P T TL Y PE++
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI------NPCTETFTGTLQYMAPEVI 181
Query: 293 -LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
G YG D+WS GC + E+ KP P F G P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP--P-----------FIELGE-----------P 217
Query: 352 HATIFKPQQSYKRCIAETFKDFP--PSSLPL-----IETLLAIDPAERQTATAALRSE 402
A +FK FK P P SL I DP +R +A L+
Sbjct: 218 QAAMFK---------VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 9/221 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDHPNVVKL 182
+GQG + VY D TG+ +A+K+V+FD PE+ V + EI +L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G + M +L + ++M T+ + Y Q+L G+ + H+ ++H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPN--HKQPMTSRVVTLWYRPPELLLGATDYGV 300
RDIKG+N+L D+ G + + DFG + M S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGR 188
Query: 301 GVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
D+WS GC + E+L EKP E E + IFK+ P+
Sbjct: 189 KADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
F L +IG G++ VY ARD T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
++ +G + +LV +Y + + + ++ H L GL + H+
Sbjct: 77 TIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD- 297
+HRDIK N+L+ G + +ADFG AS P + S V T ++ PE++L A D
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVIL-AMDE 188
Query: 298 --YGVGVDLWSAGCILAELLAEKP 319
Y VD+WS G EL KP
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 77/254 (30%), Positives = 124/254 (48%), Gaps = 43/254 (16%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPN 178
F+ KIG+G +S VY+A L + VALKKV+ F+ ++ ++ + +EI +L++L+HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 179 VVK-LEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKC--------YMHQL 228
V+K L+ + L +V + + DL S IK+ + Q + Y QL
Sbjct: 64 VIKYLDSFIEDN---ELNIVLELADAGDL-----SQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
S +EH H++ V+HRDIK +N+ I G++ + D GL FF + S V T +Y
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLA----------------------EKPIMPGRTE 326
PE + Y D+WS GC+L E+ A + P +P
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHY 233
Query: 327 VEQLHKIFKLCGSP 340
E+L ++ +C P
Sbjct: 234 SEKLRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 12/219 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
F+ L K+G+G+Y +VYK + Q ALK+V ++ + EI IL ++HPN+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHC 235
+ + L +V +Y DL+ + K + ++ QLL GL+
Sbjct: 62 ISYKE--AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLG 294
H Q +LHRD+K +N+L+ ++ I D G++ K+ M + T Y PE+ G
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKG 175
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y D+WS GC+L E+ P R+ + +K+
Sbjct: 176 -RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 85/252 (33%), Positives = 117/252 (46%), Gaps = 50/252 (19%)
Query: 98 PSWLSAVAGEAISGWTPRRADTFEKLDK---IGQGTYSNVYKARDTLTGQIVALKKVRFD 154
S S+ + + SG P A + +L++ IG G VYK TG++ ALK V +
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYG 109
Query: 155 NLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM------------E 202
N E R + REI ILR ++HPNVVK + + + ++ ++M E
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFMDGGSLEGTHIADE 167
Query: 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIAD 262
LA +A Q+LSG+ + H +H++HRDIK SNLLI++ + IAD
Sbjct: 168 QFLADVA----------------RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIAD 211
Query: 263 FG----LASFFDPNHKQPMTSRVVTLWYRPPE-----LLLGATDYGVGVDLWSAG-CILA 312
FG LA D P S V T+ Y PE L GA D G D+WS G IL
Sbjct: 212 FGVSRILAQTMD-----PCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILE 265
Query: 313 ELLAEKPIMPGR 324
L P GR
Sbjct: 266 FYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 122 KLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++G+G + V R TG+ VA+K + E + REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHE 66
Query: 178 NVVKLEGLVTSRMSCSLYLVFKY-----MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
N+VK +G+ SL L+ +Y + L + ++ + Q+ G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGM 122
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-----KQPMTSRVVTLWYR 287
++ +Q +HRD+ N+L+++E ++ I+DFGLA + K+P S + WY
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY- 179
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELL 315
PE L + D+WS G L EL
Sbjct: 180 APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 73/264 (27%), Positives = 122/264 (46%), Gaps = 36/264 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMAREILILRRLDHPN 178
+ + +KIGQG VY A D TGQ VA+K++ NL+ + + + EIL++R HPN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPN 77
Query: 179 VVKLEGLVTSRMSC-SLYLVFKYMEHDLAGLAASPTIKFTQ---AQVKCYMHQLLSGLEH 234
+V + S + L++V +Y LAG + + + T Q+ + L LE
Sbjct: 78 IVNY---LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 130
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H+ V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVT- 188
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
YG VD+WS G + E++ +P + L+ I AT
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------AT 229
Query: 355 IFKPQQSYKRCIAETFKDFPPSSL 378
P+ ++ F+DF L
Sbjct: 230 NGTPELQNPEKLSAIFRDFLNRCL 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 10/217 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
F L +IG G++ VY ARD T ++VA+KK+ + + E + + +E+ L+R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
++ +G + +LV +Y + L + ++ H L GL + H+
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD- 297
+++HRDIK N+L+ G + +ADFG AS P S V T ++ PE++L +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVILAMDEG 199
Query: 298 -YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y VD+WS G EL KP + + L+ I
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 2e-23
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
F L +IG G++ VY ARD ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
++ G + +LV +Y + L + ++ H L GL + H+
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD- 297
+++HRD+K N+L+ G++ + DFG AS P V T ++ PE++L +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDEG 189
Query: 298 -YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y VD+WS G EL KP + + L+ I
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
D FE + +G G++ V R +G+ ALK + ++ + V + E IL+ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYME-------HDLAGLAASPTIKFTQAQVKCYMHQLL 229
P +V L G + + +LYLV +Y+ +G P +F AQV +
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV-------V 111
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW---- 285
LE+ H+ +++RD+K NLL+D++G + I DFG A R TL
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--------RTYTLCGTPE 163
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLA 316
Y PE++L YG VD W+ G ++ E+LA
Sbjct: 164 YLAPEIILS-KGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-22
Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 10/221 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+E + KIG+G++ +Y A+ + +K++ + + +E+++L ++ HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
V + + + L++V +Y + DL + + F++ Q+ + Q+ GL+H H+
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 238 QHVLHRDIKGSNLLIDNEGILT-IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +LHRDIK N+ + G++ + DFG+A + + + T V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC 337
Y D+WS GC+L EL K G + QL + K+C
Sbjct: 179 -YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQ-IVALKKVRFDNLE--------PESVRFMAREIL 169
+ L+ +G G + VYK R GQ ++ALK++ N +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 170 ILR-RLDHPNVVK-----LEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIK---FTQA 219
I++ +L HPN+V+ LE LY+V +E L S K FT+
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN-------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113
Query: 220 QVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
++ Q++ L + H + ++HRD+ +N+++ + +TI DFGLA P K +T
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LT 171
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319
S V T+ Y PE++ YG D+W+ GCIL ++ +P
Sbjct: 172 SVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 19/232 (8%)
Query: 114 PRRADTFEK---------LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRF 163
P AD F K L +IG G++ VY A ++ T ++VA+KK+ + + E +
Sbjct: 8 PEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD 67
Query: 164 MAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC 223
+ +E+ L++L HPN ++ +G + +LV +Y + L + ++
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAA 125
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT 283
H L GL + H+ +++HRDIK N+L+ G + +ADFG AS P S V T
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGT 180
Query: 284 LWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
++ PE++L + Y VD+WS G EL KP + + L+ I
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 67/245 (27%), Positives = 99/245 (40%), Gaps = 58/245 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D E L ++G G V K TG+I+A+K +R + + + + RE+ IL + + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 178 NVVKLEG---------LVTSRMSC-SLYLVFKYM-----EHDLAGLAASPTIKFTQAQVK 222
+V G + M SL + K + E L +A
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIA------------- 106
Query: 223 CYMHQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFG--------LASFFDPNH 273
+L GL + H +H ++HRD+K SN+L+++ G + + DFG LA F
Sbjct: 107 ---VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---- 159
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL-LAEKPI----MPGRTEVE 328
V T Y PE + G DY V D+WS G L EL P P E
Sbjct: 160 -------VGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 329 QLHKI 333
L I
Sbjct: 212 LLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 6e-22
Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 10/204 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F KL++IG+G++ V+K D T Q+VA+K + + E E + + +EI +L + D P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME--HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
V K G + L+++ +Y+ L L A P F + Q+ + ++L GL++
Sbjct: 63 YVTKYYG--SYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYL 117
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H++ +HRDIK +N+L+ +G + +ADFG+A + T W P ++
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--VIQQ 175
Query: 296 TDYGVGVDLWSAGCILAELLAEKP 319
+ Y D+WS G EL +P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 6/201 (2%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ K+ KIG+G++ + G+ +K++ + P+ +E+ +L + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DL-AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
V+ + + + +LY+V Y E DL + A + F + Q+ + Q+ L+H H+
Sbjct: 62 VQYQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+ +LHRDIK N+ + +G + + DFG+A + + T + T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRP- 177
Query: 298 YGVGVDLWSAGCILAELLAEK 318
Y D+W+ GC+L E+ K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 7e-22
Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 49/279 (17%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRRLDHPN 178
L I +G + +VY A+ TG A+K ++ ++ + +V+ R I++++ + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQG-ESPY 58
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK----FTQAQVKCYMHQLLSGLE 233
V KL S+ LYLV +Y+ D A L IK + K Y+ +++ G+E
Sbjct: 59 VAKLYYSFQSKDY--LYLVMEYLNGGDCASL-----IKTLGGLPEDWAKQYIAEVVLGVE 111
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H + ++HRDIK NLLID G L + DFGL+ N K V T Y PE +L
Sbjct: 112 DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETIL 166
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
G D + D WS GC++ E L P E +F +
Sbjct: 167 GVGDDKMS-DWWSLGCVIFEFLFGYPPF----HAETPDAVFD-------------NILSR 208
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
I P E + P ++ LI LL +DPA+R
Sbjct: 209 RINWP--------EEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 8e-22
Identities = 63/204 (30%), Positives = 109/204 (53%), Gaps = 15/204 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMAREILILRRLDHPN 178
+ + +KIGQG V+ A D TGQ VA+K++ NL+ + + + EIL+++ L +PN
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPN 77
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHC 235
+V L + + L++V +Y LAG + + + T +AQ+ + L LE
Sbjct: 78 IVNF--LDSFLVGDELFVVMEY----LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFL 131
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 190
Query: 296 TDYGVGVDLWSAGCILAELLAEKP 319
YG VD+WS G + E++ +P
Sbjct: 191 A-YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 73/287 (25%), Positives = 114/287 (39%), Gaps = 42/287 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
FE L+KIG+G++ V+K ++ A+K++ + E +L +LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 180 VK-LEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
++ E + L +V +Y E H L L + QV + Q+L GL H
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H++ +LHRDIK NL +D + I D G+A N T V T +Y PE L
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE-LCE 174
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
Y D+W+ G +L E K + + KI +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR------------------G 216
Query: 355 IFKP-QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+F P Q Y + +A+ LI+ L D +R LR
Sbjct: 217 VFPPVSQMYSQQLAQ-----------LIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 47/277 (16%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHPNVVKLEG 184
+G+G + V + TG++ A KK+ L+ MA E IL ++ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 185 LVTSRMSCSLYLV--------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
++ L + + G F +A+ Y Q++ GLEH H
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIFYAAQIICGLEHLH 112
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +++RD+K N+L+D+ G + I+D GLA + + R T Y PE+L G
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y VD ++ GC L E++A GR+ Q K E +K +L T+
Sbjct: 171 -YDFSVDWFALGCTLYEMIA------GRSPFRQ-RK----------EKVEKEELKRRTLE 212
Query: 357 KPQQSYKRCIAETFKD-FPPSSLPLIETLLAIDPAER 392
+ D F P + L E LL DP +R
Sbjct: 213 MA---------VEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDHPNVVKL 182
+G+G + VY D TG+ +A+K+V FD E+ V + EI +L+ L H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLSGLEHCHNQ 238
G + L + +YM G + +K T+ + Y Q+L G+ + H+
Sbjct: 70 YGCLRDPEEKKLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGAT 296
++HRDIKG+N+L D+ G + + DFG + + V T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-E 184
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
YG D+WS C + E+L EKP E E + IFK+ P++
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 44/293 (15%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
D +E + ++G G + VYKA+ TG A K ++ ++ E E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKH 61
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK-----FTQAQVKCYMHQLLSG 231
PN+V L + + F G A + T+ Q++ Q+L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEF------CDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L H+ V+HRD+K N+L+ +G + +ADFG+ S + + Q + + T ++ PE+
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRDTFIGTPYWMAPEV 174
Query: 292 LLGATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
+ T Y D+WS G L E LA+ + P E+ + + K+ S
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIE-LAQ--MEPPHHELNPMRVLLKILKSEP------ 225
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P + +F DF S L DP +R TA L+
Sbjct: 226 ----------PTLDQPSKWSSSFNDFLKSC-------LVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 3e-21
Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + +KIGQG VY A D TGQ VA++++ +P+ + EIL++R +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKK-ELIINEILVMRENKNPNI 79
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCH 236
V L + + L++V +Y LAG + + + T + Q+ + L LE H
Sbjct: 80 VNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKA 192
Query: 297 DYGVGVDLWSAGCILAELLAEKP 319
YG VD+WS G + E++ +P
Sbjct: 193 -YGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 69/286 (24%), Positives = 111/286 (38%), Gaps = 42/286 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + +G+G + R T +V K+V L + R EI+IL L HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ + + ME+ G + F + V Y+ Q++S + +
Sbjct: 62 IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLL 293
H +LHRDIK N+ + G++ + DFG++ + M VV T +Y PEL
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQ 174
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
G Y D+W+ GC+L ELL L + F +P K + +
Sbjct: 175 GV-KYNFKSDIWALGCVLYELLT-------------LKRTFD-ATNPLNLVVKIVQGNYT 219
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+ S L+ +LL DP +R TA L
Sbjct: 220 PVVSVYSSELI--------------SLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-----MAREILILR 172
D E++ +G GT+ V+ RD ++ ALK + PE +R + E +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIRLKQEQHVHNEKRVLK 56
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKCYMH 226
+ HP +++L T LY++ +Y + G L S +F+ + Y
Sbjct: 57 EVSHPFIIRLF--WTEHDQRFLYMLMEY----VPGGELFSYLRNSG--RFSNSTGLFYAS 108
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW- 285
+++ LE+ H++ +++RD+K N+L+D EG + + DFG A + + R TL
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCG 160
Query: 286 ---YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y PE ++ + + VD W+ G ++ E+L P KI
Sbjct: 161 TPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 5e-21
Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + +KIGQG VY A D TGQ VA+K++ +P+ + EIL++R +PN+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKNPNI 78
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCH 236
V L + + L++V +Y LAG + + + T + Q+ + L L+ H
Sbjct: 79 VNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKA 191
Query: 297 DYGVGVDLWSAGCILAELLAEKP 319
YG VD+WS G + E++ +P
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
F KL++IG+G++ VYK D T ++VA+K + + E E + + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHCH 236
+ G + L+++ +Y L G +A +K + + + ++L GL++ H
Sbjct: 65 TRYYG--SYLKGTKLWIIMEY----LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ +HRDIK +N+L+ +G + +ADFG+A + T W P + A
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 297 DYGVGVDLWSAGCILAELLAEKP 319
D+ D+WS G EL +P
Sbjct: 179 DF--KADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 9/207 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDH 176
+ FE + +IG GTY +VYKAR+ TG++ A+K ++ LEP E + +EI++++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKH 65
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V G R L++ ++ T +++Q+ + L GL + H
Sbjct: 66 SNIVAYFGSYLRRDK--LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL--LLG 294
++ +HRDIKG+N+L+ + G + +ADFG+++ + S + T ++ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVAAVER 182
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIM 321
Y D+W+ G EL +P M
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 49/292 (16%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--- 176
+++L+ IG+G Y VY+ + TG++VALK + D + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 177 PNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLL 229
PN+ K G L R L+++ ME+ G + A P I V + ++L
Sbjct: 62 PNITKYYGSYLKGPR----LWII---MEYAEGGSVRTLMKAGP-IAEKYISV--IIREVL 111
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
L++ H V+HRDIK +N+L+ N G + + DFG+A+ + N + T V T ++ P
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAP 170
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++ Y D+WS G + E+ P + L
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMML------------- 213
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
+P + KP + ++ ++F + L +P ER +A L+S
Sbjct: 214 IPKS---KPPRLEDNGYSKLLREF-------VAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 9/223 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
F+ +G+G + V R+ TG I A+K ++ L E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P + +L + +LYLV +Y DL L +F + + Y+ +L+ +
Sbjct: 61 PWIPQL--QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL-- 293
H +HRDIK N+LID G + +ADFG A+ N V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 294 ---GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
G YGV D WS G I E++ + T + + I
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 75/263 (28%), Positives = 110/263 (41%), Gaps = 59/263 (22%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
D FE + IG+G + V + TG I A+KK+R + LE E V + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 177 PNVVKLEGLVTSRMSCS------LYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQ 227
P VVK + S LYL+ ME+ G + +K FT+ + + Y+ +
Sbjct: 61 PWVVK--------LYYSFQDENYLYLI---MEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-------------- 273
+ ++ H +HRDIK NLL+D +G + ++DFGL + +H
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 274 ------KQPMTS-RVVTLW----------------YRPPELLLGATDYGVGVDLWSAGCI 310
+PM+S R W Y PE+ L T Y D WS G I
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVI 228
Query: 311 LAELLAEKPIMPGRTEVEQLHKI 333
+ E+L P E KI
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 73/234 (31%), Positives = 102/234 (43%), Gaps = 27/234 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
F+ L ++GQG Y V+ A+ TG+IVALK+++ L VR + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLE 233
+VKL L + LYL ME+ G L + A + YM ++ ++
Sbjct: 63 LVKL--LYAFQDDEYLYLA---MEYVPGGDFRTLLNNLGVLSEDHA--RFYMAEMFEAVD 115
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H +HRD+K N LID G + + DFGL+ S V + Y PE+L
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLR 171
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
G Y VD WS GC+L E L P G T E + YWK+
Sbjct: 172 G-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 120 FEKLDKIGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+K+ +G+G + V Y + TG++VA+K ++ + ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEH 234
H N+VK +G + + L L+ +Y+ L L P K AQ+ + Q+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR---VVTLWYRPPEL 291
H+QH +HRD+ N+L+DN+ ++ I DFGLA H+ WY
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE-- 180
Query: 292 LLGATDYGVGVDLWSAGCILAELL 315
L + D+WS G L ELL
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 28/214 (13%)
Query: 118 DTFEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMAREILILRR 173
D LD KIG+G+ V A D TG+ VA+KK+ +L + R + E++I+R
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRD 72
Query: 174 LDHPNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTI---KFTQAQVKCYMHQL 228
HPN+V++ LV L++V +++E G A + + + + Q+ +
Sbjct: 73 YQHPNIVEMYSSYLVGDE----LWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLAV 124
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD---PNHKQPMTSRVVTLW 285
L L H Q V+HRDIK ++L+ ++G + ++DFG + P K S V T +
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPY 180
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319
+ PE ++ YG VD+WS G ++ E++ +P
Sbjct: 181 WMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F KL+KIG+G++ V+K D T ++VA+K + + E E + + +EI +L + D P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
V K G + L+++ +Y+ A P + Q+ + ++L GL++ H+
Sbjct: 63 YVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHS 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +HRDIK +N+L+ G + +ADFG+A D K+ + V T ++ PE ++ +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQS 176
Query: 297 DYGVGVDLWSAGCILAELLAEKP 319
Y D+WS G EL +P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 21/240 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILR 172
P +DT+E ++ IG+GTY V+K + G A+K + +++ E + E IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 173 RL-DHPNVVKLEGLVTSRMSCS---LYLVFKYME----HDLAGLAASPTIKFTQAQVKCY 224
L DHPNVVK G+ + + L+LV + DL + + +
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
+H+ L GL+H H +HRD+KG+N+L+ EG + + DFG+++ + TS
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 285 WYRPP----ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
W P E L +T Y D+WS G EL P + ++ + +FK+ +P
Sbjct: 190 WMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +L ++G+G +V K R TG I ALK + D P+ + + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL-------LS 230
+VK G S S+ + +Y E G S K + + L L
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCE---GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
GL + H++ ++HRDIK SN+L+ +G + + DFG++ + T T +Y PE
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTF-TGTSFYMAPE 173
Query: 291 LLLGATDYGVGVDLWSAGCILAEL 314
+ G Y + D+WS G L E+
Sbjct: 174 RIQGKP-YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 123 LDKIGQGTYSNVYKAR-DTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
+ ++G+G + +V R D L TG++VA+KK++ E +R REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+VK +G+ S +L LV +Y+ + L + ++ Y Q+ G+E+ +
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-----KQPMTSRVVTLWYRPPELL 292
+ +HRD+ N+L+++E + I DFGL + ++P S + WY P
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWYAPES-- 182
Query: 293 LGATDYGVGVDLWSAGCILAEL 314
L + + V D+WS G +L EL
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 52/295 (17%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREIL---- 169
DT+E ++ IG+GTY VYK + G + A+K L+P + + EI
Sbjct: 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDP--ISDVDEEIEAEYN 70
Query: 170 ILRRL-DHPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIK--------FT 217
IL+ L +HPNVVK G+ L+LV + G + + +K
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN----GGSVTELVKGLLICGQRLD 126
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277
+A + ++ L GL+H HN ++HRD+KG+N+L+ EG + + DFG+++ +
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 278 TSRVVTLWYRPPELLLGATDYGVG----VDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
TS V T ++ PE++ Y D+WS G EL P + V+ L KI
Sbjct: 187 TS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
Query: 334 FKLCGSPSEEYWKKSKLPHATIFKPQQ---SYKRCIAETF-KDFP--PSSLPLIE 382
+ P T+ P++ S+ I++ KDF PS L+E
Sbjct: 246 --------------PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 30/253 (11%)
Query: 167 EILILRRLDHPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYM 225
E ++L+ ++HP+V+++ + LV+ ++C +V + DL + Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TL 284
Q+L GL + H Q ++HRD+K N+ I++ + I D G A F P + T+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTV 220
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLA----------EKPIMPGRTEVEQLHKIF 334
PE+L Y D+WSAG +L E+LA P ++ L KI
Sbjct: 221 ETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS---LP-----LIETLLA 386
EE+ + P + + + Y + + +P LP L+ +L
Sbjct: 280 STLKVHPEEF---PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLT 336
Query: 387 IDPAERQTATAAL 399
D A R +A L
Sbjct: 337 FDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR----FDNLEPESVRFMAREILILRRLDHPNVVK 181
+G G + V + + ALK V+ + + E + E IL +HP +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 182 LEGLVTSRMSCSLYLVFKYME--------HDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
L T + +Y++ +Y D GL T +F A V + E
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACV-------VLAFE 107
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ HN+ +++RD+K NLL+D+ G + + DFG A Q + T Y PE++L
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--GQKTWTFCGTPEYVAPEIIL 165
Query: 294 GATDYGVGVDLWSAGCILAELLAEKP 319
Y VD WS G +L ELL +P
Sbjct: 166 N-KGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 9/205 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLDHPN 178
+E + ++G GTY +VYKAR+ TG++ A+K ++ LEP + + +EI +++ H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCN 67
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
+V G SR L++ +Y T ++ Q+ + L GL + H++
Sbjct: 68 IVAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
+HRDIKG+N+L+ + G + +ADFG+A+ + S + T ++ PE+ +
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-RKSFIGTPYWMAPEVAAVEKNG 184
Query: 299 GVG--VDLWSAGCILAELLAEKPIM 321
G D+W+ G EL +P M
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 16/236 (6%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHP 177
TF +G+G + V + TG++ A KK+ ++ MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 178 NVVKLEGLVTSRMSCSLYLV------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
VV L ++ + L L K+ +++ F + + Y ++ G
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFYAAEITCG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LE H + +++RD+K N+L+D+ G + I+D GLA + + RV T+ Y PE
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYMAPE- 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
++ Y D W GC++ E++ K R E + ++ + EEY +K
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES---VRFMAREILILRRLDH 176
+ L +G+G++ + + Q A+K++R P+S V +E ++L ++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK-FTQAQVKCYMHQLLSGLEH 234
PN+V + + LY+V +Y + DL K F + + + Q+ G++H
Sbjct: 58 PNIVAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT---SRVVTLWYRPPEL 291
H + VLHRDIK N+ + G + + DFG A P + V T +Y PPE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPGAYACTYVGTPYYVPPEI 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLC 337
Y D+WS GCIL EL K P + + I K+C
Sbjct: 172 WENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWK----NLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-18
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV----RFMAREILILRRLDHPNVVK 181
+G+G Y VY T GQ++A+K+V D + + E+ +L+ L H N+V+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK----FTQAQVKCYMHQLLSGLEHCHN 237
G + S+++ F + G + S + + Y Q+L G+ + HN
Sbjct: 67 YLGTCLDDNTISIFMEF------VPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFF-----DPNHKQPMTSRVVTLWYRPPELL 292
V+HRDIKG+N+++ GI+ + DFG A H + S T ++ PE +
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-V 179
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKP 319
+ + YG D+WS GC + E+ KP
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRR---LDHPNVVK 181
IG+GT+ VY+ R T +I A+K + + + + + V E IL R + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
L+ + + LYLV YM +F++ + K Y+ +L+ LEH H ++
Sbjct: 61 LK--FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGATDYG 299
+RD+K N+L+D G + + DFGL+ N T+ T Y PE+LL Y
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 300 VGVDLWSAGCILAEL 314
VD WS G ++ E+
Sbjct: 176 KHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 120 FEKLDKIGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPES----VRFMAREILIL 171
+++ +G+G + V Y TG+ VA+K +L+PES + + +EI IL
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEIL 60
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLS 230
R L H N+VK +G+ T + L+ +++ L K Q Y Q+
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-----KQPMTSRVVTLW 285
G+++ ++ +HRD+ N+L+++E + I DFGL + + K + S V W
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FW 178
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELL 315
Y PE L+ + Y + D+WS G L ELL
Sbjct: 179 Y-APECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 64/233 (27%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +E + ++G G + VYKA++ TG + A K + + E E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHP 69
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTI-----KFTQAQVKCYMHQLLSGL 232
+VKL G + + F G A + T+ Q++ Q+L L
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEF------CPGGAVDAIMLELDRGLTEPQIQVICRQMLEAL 123
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--QPMTSRVVTLWYRPPE 290
++ H+ ++HRD+K N+L+ +G + +ADFG+++ N K Q S + T ++ PE
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPE 180
Query: 291 LLLGAT----DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
+++ T Y D+WS G L E+ I P E+ + + K+ S
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKS 230
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +E + ++G G + VYKA++ TG + A K + D E + EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 62
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTI-----KFTQAQVKCYMHQLLSGL 232
N+VKL L +L+++ ++ AG A + T+ Q++ Q L L
Sbjct: 63 NIVKL--LDAFYYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ H ++HRD+K N+L +G + +ADFG+++ + Q S + T ++ PE++
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 293 LGATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
+ T Y D+WS G L E+ I P E+ + + K+ S
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKS 223
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 11/195 (5%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRL-DHPNVVK 181
IG+G + VY R TG++ A+K K R + E++ R +L L D P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 182 LE-GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
+ T C + M S F++ +++ Y +++ GLEH HN+ V
Sbjct: 62 MTYAFHTPDKLC---FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
++RD+K +N+L+D G + I+D GLA F + K+P S V T Y PE+L T Y
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS-VGTHGYMAPEVLQKGTAYDS 175
Query: 301 GVDLWSAGCILAELL 315
D +S GC+L +LL
Sbjct: 176 SADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VRFMAREILILRRLDHPNVVKLEG 184
IG+G++ V + R T +I ALK +R ++ S V E +L +++ P +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244
S LYLV ++ +F ++ + Y +LL LE+ H +V++RD
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 245 IKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGATDYGVGV 302
+K N+L+D +G + + DFGL N K + T Y PELLLG Y V
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAV 174
Query: 303 DLWSAGCILAELLAEKP 319
D W+ G +L E+L P
Sbjct: 175 DWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A FE ++ +G GTY VYK R TGQ+ A+K + E E ++ +EI +L++ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 177 -PNVVKLEGLVTSR----MSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQ 227
N+ G + M L+LV ++ DL T+K C +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC--RE 119
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+L GL H H V+HRDIKG N+L+ + + DFG+++ D + T + T ++
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 178
Query: 288 PPELLLGATD------YGVGVDLWSAGCILAELLAEKP 319
PE++ A D Y DLWS G E+ P
Sbjct: 179 APEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 45/294 (15%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHP 177
TF + +G+G + V + TG++ A KK+ ++ MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 178 NVVKLEGLVTSRMSCSLYLV--------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
VV L ++ + L L F AG F + + Y ++
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--------FEEGRAVFYAAEIC 112
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
GLE H + +++RD+K N+L+D+ G + I+D GLA Q + RV T+ Y P
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAP 170
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++ Y D W+ GC+L E++A + R + + ++ +L EEY +K
Sbjct: 171 EVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK-- 227
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403
F P + L + LL DP ER EV
Sbjct: 228 -----------------------FSPDARSLCKMLLCKDPKERLGCQGGGAREV 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 104 VAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVR 162
S W + FE + +G G++ V A+ TG+ A+K ++ L+ + V+
Sbjct: 7 FTKPDTSSW---KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ 63
Query: 163 FMAREILILRRLDHPNVVKLEGLVTSRMSCS------LYLVFKYMEHDLAGLAASPTIKF 216
+A+E IL L HP +V M CS +Y + +++ +F
Sbjct: 64 HVAQEKSILMELSHPFIVN--------MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF 115
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276
K Y +L+ E+ H++ +++RD+K NLL+DN+G + + DFG A +
Sbjct: 116 PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KK 167
Query: 277 MTSRVVTLW----YRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319
+ R TL Y PE ++ + +G VD W+ G +L E +A P
Sbjct: 168 VPDRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 62/194 (31%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRL-DHPNVVK 181
IG+G + VY R TG++ A+K K R + E++ R +L L D P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
+ L + M S F++A+++ Y +++ GLEH HN+ V+
Sbjct: 62 MS--YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
+RD+K +N+L+D G + I+D GLA D + K+P S V T Y PE+L Y
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSS 176
Query: 302 VDLWSAGCILAELL 315
D +S GC+L +LL
Sbjct: 177 ADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 126 IGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
IG G + V + R L G VA+K ++ E + F++ E I+ + DHPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQFDHPNIIHL 70
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
EG+VT S + ++ ++ME+ L +FT Q+ + + +G+++ + +
Sbjct: 71 EGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFF-----DPNHKQPMTSRVVTLWYRPPELLLGAT 296
HRD+ N+L+++ + ++DFGL+ F DP + + ++ W P +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--R 186
Query: 297 DYGVGVDLWSAGCILAELLA--EKP 319
+ D+WS G ++ E+++ E+P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D E LD++G+G Y +VYK TG +A+K++R + L+ + E+ IL + P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSP 59
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH---DLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+V G + ++Y+ +YM+ D T + ++ + ++ GL+
Sbjct: 60 YIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 235 CHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL- 292
+H ++HRD+K +N+L++ G + + DFG++ + + Y PE +
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPERIK 174
Query: 293 -LGATD---YGVGVDLWSAGCILAEL 314
G Y V D+WS G + E+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 43/282 (15%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
+G+G+Y V R G+ +KK+ N + +E +L +L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV----- 62
Query: 186 VTSRMS-----CSLYLVFKYMEH-DL-AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
R S LY+V + E DL L + QV + Q+ L++ H +
Sbjct: 63 -AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
H+LHRD+K N+ + I+ + D G+A + N ++ + T +Y PE L Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE-LFSNKPY 179
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358
D+W+ GC + E+ K + +++I + KLP
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------------EGKLPPMP---- 223
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
KD+ P LI T+L+ P +R + + LR
Sbjct: 224 ------------KDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL-----EPESVRFMAREILIL 171
FE L +G G Y V+ R TG++ A+K ++ L E R R +L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-TERNVLEH 60
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
R P +V L + L+L+ Y+ F++ +V+ Y +++
Sbjct: 61 VR-QSPFLVTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA 117
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LEH H +++RDIK N+L+D+EG + + DFGL+ F K+ S T+ Y PE+
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 292 LLGATDYGVGVDLWSAGCILAELL 315
+ G +G VD WS G ++ ELL
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
PR + E+ K+G G + V+ T G VA+K ++ + PE+ +E I++
Sbjct: 4 PRESLKLER--KLGAGQFGEVWMG--TWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMK 56
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMH-QLLS 230
+L H +V+L + + +Y+V +YM L S K + M Q+
Sbjct: 57 KLRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
G+ + +++ +HRD+ N+L+ + IADFGLA + + + + PE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 291 LLLGATDYG---VGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKI 333
A +YG + D+WS G +L E++ + PG T E L ++
Sbjct: 175 ----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 123 LDKIGQGTYSNVY---KARDTLTGQIVALKKVRFDNLE-PESVRF-MAREILILRRLDHP 177
L +GQG++ V+ K GQ+ A+K ++ L+ + VR M R+IL ++HP
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA--EVNHP 58
Query: 178 NVVKL------EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+VKL EG LYL+ ++ S + FT+ VK Y+ +L
Sbjct: 59 FIVKLHYAFQTEG--------KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 110
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L+H H+ +++RD+K N+L+D EG + + DFGL S +H++ S T+ Y PE
Sbjct: 111 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYMAPE- 168
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
++ + D WS G ++ E+L G+ E + I K
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-16
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+EK+ +G+G + V+ R ++V +K++ + + + E +L+ L HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK-----FTQAQVKCYMHQLLSGLEH 234
+ E +L +V +Y G A K + + + Q+L L H
Sbjct: 62 I--EYYENFLEDKALMIVMEYAP---GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 235 CHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H + +LHRD+K N+L+D ++ ++ I DFG++ + K + V T Y PEL
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCE 174
Query: 294 GATDYGVGVDLWSAGCILAELLAEK 318
G Y D+W+ GC+L EL + K
Sbjct: 175 GKP-YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL 171
W R D K K+G G Y VY+ VA+K ++ D +E E F+ +E ++
Sbjct: 1 WEMERTDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVM 56
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM-HQLL 229
+ + HPN+V+L G+ T Y++ ++M + +L + A V YM Q+
Sbjct: 57 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRP 288
S +E+ ++ +HRD+ N L+ ++ +ADFGL+ + ++ W P
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174
Query: 289 PELLLGATDYGVGVDLWSAGCILAEL 314
L + + D+W+ G +L E+
Sbjct: 175 ES--LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 51/202 (25%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
IG G + V + R L G+ VA+K ++ + + + + F+ E I+ + DHPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNIIRL 70
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
EG+VT + ++ +YME+ L KFT Q+ + + SG+++ + +
Sbjct: 71 EGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPELLLGATDYG 299
HRD+ N+L+++ + ++DFGL+ + + T ++ W P + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--FT 186
Query: 300 VGVDLWSAGCILAELLA--EKP 319
D+WS G ++ E+++ E+P
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 116 RADTFEKLDKIGQGTYSNVYKA--RDTLTGQ---IVALKKVRFDNLEPESVRFMAREILI 170
+ DT ++G+G + V+ +VA+K ++ + ++ + RE +
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAEL 61
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH------------DLAGLAA--SPTIKF 216
L H N+VK G+ T +VF+YMEH D A L + SP +
Sbjct: 62 LTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQ 275
T +Q+ Q+ SG+ + +QH +HRD+ N L+ + ++ I DFG++ + ++ +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 314
++ + + PPE ++ + D+WS G +L E+
Sbjct: 180 VGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A FE ++ +G GTY VYK R TGQ+ A+K + E E ++ EI +L++ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 177 -PNVVKLEGLVTSRMSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQ------VKCYM 225
N+ G + L+LV ME AG + + +K T+ +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLV---MEFCGAG-SVTDLVKNTKGNALKEDWIAYIC 127
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
++L GL H H V+HRDIKG N+L+ + + DFG+++ D + T + T +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 186
Query: 286 YRPPELLLGATD------YGVGVDLWSAGCILAELLAEKP 319
+ PE++ A D Y D+WS G E+ P
Sbjct: 187 WMAPEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 125 KIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK 181
++G+G++ VY +D ++ LK++ L P +E +L +LDHP +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 182 LEGLVTSRMSCSLY--------LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
R + + L K E G ++ QV + QLL G+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK------TLSENQVCEWFIQLLLGVH 120
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H + +LHRD+K N+ + N +L I DFG++ T+ T +Y PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE-AL 177
Query: 294 GATDYGVGVDLWSAGCILAEL 314
Y D+WS GCIL E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRL 174
+A+ F+ + IG+G + V R + Q+ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 175 DHPNVVKLEGLVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
+ +V+L + LY+V +YM DL L ++ I A+ Y +
Sbjct: 101 NSEWIVQLH--------YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF--YTAE 150
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++ L+ H+ +HRD+K N+L+D G L +ADFG D N + V T Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210
Query: 288 PPELLL---GATDYGVGVDLWSAGCILAELL 315
PE+L G YG D WS G L E+L
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 35/102 (34%), Positives = 61/102 (59%), Gaps = 1/102 (0%)
Query: 215 KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274
FT+++V+ Y+ +++ L+H H +++RDIK N+L+D+EG + + DFGL+ F +
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 275 QPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELL 315
+ S T+ Y PE++ G + + VD WS G + ELL
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREI---LILRRL-----DHP 177
+G+G++ V+ A T Q A+K ++ D V M ++ ++ +R+ +HP
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+ L T + +L+ V +Y+ KF + Y +++ GL+ H+
Sbjct: 57 FLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW------YRPPEL 291
+ +++RD+K N+L+D +G + IADFG+ K+ M T Y PE+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMC-------KENMLGDAKTCTFCGTPDYIAPEI 167
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
LLG Y VD WS G +L E+L + G E E I
Sbjct: 168 LLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 20/231 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
PR ++ + + K+G G + V+ T G VA+K ++ + PES E I++
Sbjct: 4 PR--ESLQLIKKLGNGQFGEVW--MGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMK 56
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLS 230
+L H +V+L +V+ +Y+V +YM L L + Q+ +
Sbjct: 57 KLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPP 289
G+ + + +HRD++ +N+L+ + + IADFGLA + N + ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEK----PIMPGRTEVEQLHKIFKL 336
L G + + D+WS G +L EL+ + P M R +EQ+ + +++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 42/228 (18%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMARE--ILILRRLDHPNVVKL 182
+G+G++ V A T ++ A+K ++ D L+ + V E +L L HP + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 183 EGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
SC L+ V +Y M H + +F + + + Y +++ G
Sbjct: 62 -------HSCFQTKDRLFFVMEYVNGGDLMFHIQR------SGRFDEPRARFYAAEIVLG 108
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW------ 285
L+ H + +++RD+K N+L+D+EG + IADFG+ K+ + V T
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGTPD 161
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y PE+L YG VD W+ G +L E+LA + G E E I
Sbjct: 162 YIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
KIG+G+ V A + TG+ VA+KK+ + + F E++I+R H NVV +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVDMYN 86
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCHNQHVL 241
+ + L++V +++E G A + + T + Q+ +L L + HNQ V+
Sbjct: 87 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFD---PNHKQPMTSRVVTLWYRPPELLLGATDY 298
HRDIK ++L+ ++G + ++DFG + P K S V T ++ PE ++ Y
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK----SLVGTPYWMAPE-VISRLPY 195
Query: 299 GVGVDLWSAGCILAELLAEKP 319
G VD+WS G ++ E++ +P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 71/283 (25%), Positives = 133/283 (46%), Gaps = 39/283 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
E KIG+G+ V AR+ +G+ VA+K + + + F E++I+R H NV
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
V++ + + L+++ ++++ S + + Q+ +L L + H+Q
Sbjct: 81 VEM--YKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFD---PNHKQPMTSRVVTLWYRPPELLLGAT 296
V+HRDIK ++L+ +G + ++DFG + P K S V T ++ PE ++ T
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMAPE-VISRT 192
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
YG VD+WS G ++ E++ +P + V+ + ++ + S P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPPP----- 235
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
K + ++K I+ +DF +E +L +P ER TA L
Sbjct: 236 KLKNAHK--ISPVLRDF-------LERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 18/225 (8%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDHP 177
F L +G+G++ V A T ++ A+K ++ D ++ + V E +L D P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 178 NVVKLEGLVTSRMSC-----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+T SC LY V +Y+ KF + Q Y ++ GL
Sbjct: 61 P------FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGL 114
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPE 290
H + +++RD+K N+++D+EG + IADFG+ + +T+R T Y PE
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE 171
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
++ YG VD W+ G +L E+LA +P G E E I +
Sbjct: 172 -IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLE- 183
+G+GT+ V R+ TG+ A+K +R + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
T C V +Y S FT+ + + Y +++S LE+ H++ V++R
Sbjct: 63 AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
DIK NL++D +G + I DFGL + M + T Y PE +L DYG VD
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 304 LWSAGCILAELL 315
W G ++ E++
Sbjct: 178 WWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 55/190 (28%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 163 FMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQA--- 219
+ EIL L RL+H N++K+E ++ R + Y++ + + DL +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 220 -QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
Q + M QLL +E+ H++ ++HRDIK N+ ++ +G + + DFG A F+ +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP----GRTEVEQLHKIF 334
V T+ PE+L G Y D+WS G IL ++L+ P G +QL KI
Sbjct: 327 GWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKII 384
Query: 335 KLCGSPSEEY 344
EE+
Sbjct: 385 DSLSVCDEEF 394
|
Length = 501 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 58/249 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH- 176
D E ++++G+G Y V K R TG I+A+K++R + + + + ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDC 59
Query: 177 PNVVKLEGLVTSR---------MSCSLYLVFKYM--------EHDLAGLAASPTIKFTQA 219
P V G + M SL +K + E L +A S
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-------- 111
Query: 220 QVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFG--------LASFFD 270
++ LE+ H++ V+HRD+K SN+LI+ G + + DFG +A D
Sbjct: 112 --------IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATD---YGVGVDLWSAGCILAELLAEK-PIMPGRTE 326
K Y PE + + Y V D+WS G + EL + P +T
Sbjct: 164 AGCKP----------YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP 213
Query: 327 VEQLHKIFK 335
+QL ++ +
Sbjct: 214 FQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR----FDNLEPESVRFMAREILILRRLD 175
F L +G+G + V A TG++ A+K ++ E ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
HP +V L + + V +Y M H + F++ + Y ++
Sbjct: 61 HPFLVNLFACFQT--EDHVCFVMEYAAGGDLMMHIHTDV-------FSEPRAVFYAACVV 111
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM--TSRVVTLWYR 287
GL++ H +++RD+K NLL+D EG + IADFGL K+ M R T
Sbjct: 112 LGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGT 164
Query: 288 P----PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE 328
P PE+L T Y VD W G ++ E+L + PG E E
Sbjct: 165 PEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 17/225 (7%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
K+GQG + V+ T + VA+K ++ + PE+ +E ++++L H +V+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYA 68
Query: 185 LVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
+V+ +Y+V +YM L L Q+ Q+ SG+ + + +H
Sbjct: 69 VVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVG 301
RD++ +N+L+ + +ADFGLA + N + ++ W P L G + +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183
Query: 302 VDLWSAGCILAELLAEK----PIMPGRTEVEQLHKIFKLCGSPSE 342
D+WS G +L EL + P M R ++Q+ + +++ P E
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE 227
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 58/236 (24%), Positives = 107/236 (45%), Gaps = 16/236 (6%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHP 177
TF + +G+G + V + TG++ A K++ ++ MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 178 NVVKLEGLVTSRMSCSLYLV------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
VV L ++ + L L K+ +++ F + + Y ++L G
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FEEERALFYAAEILCG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LE H ++ ++RD+K N+L+D+ G + I+D GLA + + RV T+ Y PE
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPE- 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
+L Y + D W GC++ E++ + GR E + ++ + E Y K
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL--EPESVRFMAREILILRRL 174
FE L +G G Y V+ R +G++ A+K ++ + + ++ E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 175 DH-PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
P +V L + L+L+ Y+ S +F + +V+ Y +++ LE
Sbjct: 62 RQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H H +++RDIK N+L+D+ G + + DFGL+ F + + S T+ Y P+++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 294 GA-TDYGVGVDLWSAGCILAELL 315
G + VD WS G ++ ELL
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 59/189 (31%), Positives = 95/189 (50%), Gaps = 18/189 (9%)
Query: 165 AREILILRRLDHPNVVKLEGLVT-SRMSCSLYLVFKYMEHDL-AGLAASPTIKFTQAQVK 222
A E ILR ++HP++++L+G T ++ +C L+ + DL LAA I +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKRNIAI--CDIL 185
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
+L +++ H ++HRDIK N+ I++ G + + DFG A F +
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 283 TLWYRPPELLLGATD-YGVGVDLWSAGCILAEL------LAEKPIMPGRTEVE-QLHKIF 334
T+ PELL A D YG VD+WSAG +L E+ L EK + G + + Q+ I
Sbjct: 246 TIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303
Query: 335 KLCGS-PSE 342
+ G+ P+E
Sbjct: 304 RRSGTHPNE 312
|
Length = 391 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
KIG+G+ V A +G++VA+KK+ + + F E++I+R H NVV++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCHNQHVL 241
+ + L++V +++E G A + + T + Q+ +L L H Q V+
Sbjct: 85 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
HRDIK ++L+ ++G + ++DFG + S V T ++ PE L+ YG
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPE-LISRLPYGPE 196
Query: 302 VDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361
VD+WS G ++ E++ +P ++ + I + LP P+
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP------PKLK 237
Query: 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ + K F ++ LL DPA+R TA L+
Sbjct: 238 NLHKVSPSLKGF-------LDRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 27/225 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
PR +T + + K+G G + V Y VA+K ++ ++ PE+ F+A E
Sbjct: 4 PR--ETLKLVKKLGAGQFGEVWMGYYNGH-----TKVAIKSLKQGSMSPEA--FLA-EAN 53
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQ 227
++++L HP +V+L +VT +Y++ +YME+ + L IK T ++ Q
Sbjct: 54 LMKQLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+ G+ ++ +HRD++ +N+L+ IADFGLA + N + +
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT 170
Query: 288 PPELLLGATDYG---VGVDLWSAGCILAELLAEKPI-MPGRTEVE 328
PE A +YG + D+WS G +L E++ I PG T E
Sbjct: 171 APE----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 31/202 (15%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+ +G G VYKA LT +I+A+K + D + E + + E+ IL + D P ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 183 EG--LVTSRMS-CSLYL------VFKYM-EHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
G V +R+S C+ ++ V++ + EH L +A + ++ GL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA----------------VVKGL 108
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ + +LHRD+K SN+L++ G + + DFG+++ + V T Y PE +
Sbjct: 109 TYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERI 165
Query: 293 LGATDYGVGVDLWSAGCILAEL 314
G YG+ D+WS G EL
Sbjct: 166 SG-EQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 68/222 (30%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRR 173
+ FE + I G Y VY R T Q A+KK+ NL + + V F+ R+IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA- 58
Query: 174 LDHPNVVKLEG-LVTSRMSCSLYLVFKYMEH-DLAGL----AASPTIKFTQAQVKCYMHQ 227
++P VV + T R C +V +Y+E D A L A P + Y +
Sbjct: 59 -ENPFVVSMFCSFETKRHLC---MVMEYVEGGDCATLLKNIGALPV-----DMARMYFAE 109
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS-------------FFDPNHK 274
+ LE+ HN ++HRD+K NLLI + G + + DFGL+ + + +
Sbjct: 110 TVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 275 QPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ + +V T Y PE++L YG VD W+ G IL E L
Sbjct: 170 EFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 122 KLDK-IGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
K++K IG G + V R L G+ VA+K ++ E + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N++ LEG+VT S + +V +YME+ L +FT Q+ + + SG+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTLWYRPPELLLG 294
+ +HRD+ N+L+++ + ++DFGL+ DP + + + PE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 182
Query: 295 ATDYGVGVDLWSAGCILAELLA--EKP 319
+ D+WS G ++ E+++ E+P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDH 176
F+K+ +G+G V+ R TG++ ALK + + + ++ V+ + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDL-AGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
P + L + + L LV Y +L L P ++ + Y ++L LE+
Sbjct: 61 PFLPTLYA--SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLA----------------SFFDPNHKQPMT 278
H +++RD+K N+L+ G + ++DF L+ + +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 279 SRVV------------TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
T Y PE++ G +G VD W+ G +L E+L
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 69/252 (27%), Positives = 105/252 (41%), Gaps = 40/252 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
D FE L IG+G + V + TG I A+K +R D LE E V + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
VVK+ + + +LYL+ +++ D+ L ++ + Y+ + + ++
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI 117
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGL------------------------------ 265
H +HRDIK NLL+D +G + ++DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 266 ----ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIM 321
A + N +Q S V T Y PE+ + T Y D WS G I+ E+L P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 322 PGRTEVEQLHKI 333
T E K+
Sbjct: 237 CSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 71/258 (27%), Positives = 100/258 (38%), Gaps = 48/258 (18%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPN 178
F K+ IG G + V R T + A+K +R D L + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
VVKL + + +LY V Y+ D+ L I F + + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH------------------------ 273
+HRDIK N+LID +G + + DFGL + F H
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 274 --KQPMT----------------SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ + S V T Y PE+LL T Y D WS G IL E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 316 AEKPIMPGRTEVEQLHKI 333
+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRL 174
+A+ ++ + IG+G + V R + ++ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ P VV+L + LY+V +YM DL L ++ + + K Y +++ L+
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP--EKWAKFYTAEVVLALD 156
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H+ ++HRD+K N+L+D G L +ADFG D + V T Y PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 294 ---GATDYGVGVDLWSAGCILAELL 315
G YG D WS G L E+L
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
+ IG+G + V + TGQ VA+K ++ D + + E ++ +L H N+V+L
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 184 GLVTSRMSCSLYLVFKYMEHD-------LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
G++ + LY+V + M G A I+ Q + + G+E+
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ-----FSLDVAEGMEYLE 117
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ ++HRD+ N+L+ +G+ ++DFGLA S++ W P L
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKHK-- 172
Query: 297 DYGVGVDLWSAGCILAELL----AEKPIMPGRTEVEQLHKIFKLCGSPSEE 343
+ D+WS G +L E+ A P M + E + K +++ P E
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPEG 221
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 124 DKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+KIG+G + +VYK L G VA+K R L P+ R +E IL++ DHPN+VKL
Sbjct: 1 EKIGKGNFGDVYKGV--LKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
G+ + +Y+V + + L + T ++ +G+E+ +++ +
Sbjct: 58 IGVCVQKQP--IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPN--HKQPMTSRVVTLWYRPPELLLGATDYG 299
HRD+ N L+ +L I+DFG++ + ++ W P L G Y
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR--YT 173
Query: 300 VGVDLWSAGCILAE 313
D+WS G +L E
Sbjct: 174 SESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 72/264 (27%), Positives = 105/264 (39%), Gaps = 52/264 (19%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRF-DNLEPESVRFMAREILILRRLDHPN 178
F K+ +G G + V AR T + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
VV+L + + +LY V Y+ D+ L I F + + Y+ +L +E H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK----------------------- 274
+HRDIK N+LID +G + + DFGL + F H
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 275 ----------QPMTSR-------------VVTLWYRPPELLLGATDYGVGVDLWSAGCIL 311
+P+ R V T Y PE+LL T Y D WS G IL
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 312 AELLAEKPIMPGRTEVEQLHKIFK 335
E+L +P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 6/149 (4%)
Query: 167 EILILRRLDHPNVVKLEGL-VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYM 225
E +LRRL HP V+ L + V ++C LV DL + AQV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TL 284
QLLS +++ H + ++HRDIK N+L++ + + DFG A F + P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAE 313
PE+L G Y VD+WSAG ++ E
Sbjct: 327 DTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRL 174
+A+ +E + IG+G + V R T ++ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ P VV+L + LY+V +YM DL L ++ + A+ Y +++ L+
Sbjct: 101 NSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLALD 156
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H+ +HRD+K N+L+D G L +ADFG + + V T Y PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 294 ---GATDYGVGVDLWSAGCILAELL 315
G YG D WS G L E+L
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 10/195 (5%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
+IG G + V+ L + VA+K +R + E E ++ +L HP +V+L G
Sbjct: 11 EIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFI---EEAQVMMKLSHPKLVQLYG 66
Query: 185 LVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ T R + LVF++MEH L+ + KF+Q + + G+ + + +V+HR
Sbjct: 67 VCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 244 DIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGV 302
D+ N L+ ++ ++DFG+ F D + ++ W P Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS--KYSSKS 182
Query: 303 DLWSAGCILAELLAE 317
D+WS G ++ E+ +E
Sbjct: 183 DVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 58/218 (26%), Positives = 112/218 (51%), Gaps = 34/218 (15%)
Query: 123 LDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
L+++G+G + VYK + L+ VA+K ++ +N EP+ + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 178 NVVKLEGLVT-SRMSCSLYLVFKYMEH-DL----------AGLAASPTIKFTQAQVKC-- 223
N+V L G+ T + +C L F+Y+ H DL + + A + ++ + C
Sbjct: 69 NIVCLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 224 YMH---QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTS 279
++H Q+ +G+E+ + H +HRD+ N L+ + I+DFGL+ + ++ + +
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 280 RVVTLWYRPPELLLGATDYG---VGVDLWSAGCILAEL 314
++ + + PPE +L YG D+WS G +L E+
Sbjct: 186 SLLPVRWMPPEAIL----YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
+ IG+G + +V GQ VA+K ++ D+ ++ F+A E ++ L HPN+V
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+L G+V LY+V +YM D L + T AQ + + G+E+
Sbjct: 64 QLLGVVLQ--GNPLYIVTEYMAKGSLVDY--LRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ +HRD+ N+L+ + + ++DFGLA + + Q + ++ W P L
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQD-SGKLPVKWTAPEALREK-- 174
Query: 297 DYGVGVDLWSAGCILAELLA 316
+ D+WS G +L E+ +
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 23/197 (11%)
Query: 133 NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192
V+ A+ T +VA+KK+ D+ E ++ + +EI+ R+L HPN++ VTS +
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YVTSFIVD 71
Query: 193 S-LYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247
S LY+V M + DL L + + + +L+ L++ H++ +HR +K
Sbjct: 72 SELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKA 129
Query: 248 SNLLIDNEGILTIADFGLA-SFFDPNHKQ-----PMTSRVVTLWYRPPELL----LGATD 297
S++L+ +G + ++ + S +Q S V L + PE+L G
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG--- 186
Query: 298 YGVGVDLWSAGCILAEL 314
Y D++S G EL
Sbjct: 187 YNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 10/217 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
F K+G G + V++ VA+K ++ D+L + +E+ L+RL H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHL 64
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMH-QLLSGLEHCHN 237
+ L + + +Y++ + ME L SP + M Q+ G+ +
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
Q+ +HRD+ N+L+ + + +ADFGLA + ++ W P G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-- 180
Query: 298 YGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKI 333
+ D+WS G +L E+ + PG E +I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 68/252 (26%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDH 176
+ FE L IG+G + V + TG + A+K +R D LE E V + E IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
VVK+ +++ LYL+ +++ D+ L T+ + + Y+ + + ++
Sbjct: 61 LWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI 117
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-----------------QPMT 278
H +HRDIK NLL+D++G + ++DFGL + H+ Q M
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 279 S-RVVTLWYR----------------PPELLLGATDYGVGVDLWSAGCILAELLAEKPIM 321
S R W R PE+ + T Y D WS G I+ E+L P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 322 PGRTEVEQLHKI 333
T E K+
Sbjct: 237 CSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 54/226 (23%), Positives = 106/226 (46%), Gaps = 24/226 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + L K+G G + V++ T VA+K ++ ++P+ F+ E I+++L HP
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIMKKLRHP 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ--AQVKCYMHQLL------ 229
+++L + T + +Y+V + M++ +++ Q A + QL+
Sbjct: 62 KLIQLYAVCT--LEEPIYIVTELMKY-------GSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 230 -SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
SG+ + Q+ +HRD+ N+L+ I +ADFGLA + + + +
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKI 333
PE L + + D+WS G +L E++ + PG T E L ++
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 78/318 (24%), Positives = 132/318 (41%), Gaps = 60/318 (18%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV--RFMAREILILRRLDHP 177
++ + IG+G VY A D + + VALKK+R D E + RF+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAAS-------PTIKFTQAQVKCYM---H 226
+V + + + +Y Y+E + L L S + V ++ H
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA----------SFFDPNHKQP 276
++ + +E+ H++ VLHRD+K N+L+ G + I D+G A D + +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 277 MTSR-------VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329
S V T Y PE LLG D+++ G IL ++L P R
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLS--FPYR----- 232
Query: 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
+ +K I P + +A +++ PP + LA+DP
Sbjct: 233 ------------RKKGRKISYRD-VILSPIE-----VA-PYREIPPFLSQIAMKALAVDP 273
Query: 390 AERQTATAALRSEVSLYM 407
AER ++ L+ ++ ++
Sbjct: 274 AERYSSVQELKQDLEPHL 291
|
Length = 932 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 7/192 (3%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLE- 183
+G+GT+ V R+ TG+ A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
T C V +Y S F++ + + Y +++S L + H+ V++R
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
D+K NL++D +G + I DFGL + M + T Y PE +L DYG VD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 304 LWSAGCILAELL 315
W G ++ E++
Sbjct: 178 WWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 48/192 (25%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
++IG+G + V+ R VA+K R + L P+ +E IL++ HPN+V+L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 184 GLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G+ T + +Y+V + ++ D + + ++ + +G+E+ ++H +H
Sbjct: 60 GVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 243 RDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
RD+ N L+ + +L I+DFG++ D + + + + + PE L Y
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYGRYSSE 176
Query: 302 VDLWSAGCILAE 313
D+WS G +L E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 126 IGQGTYSNVYKARDTL---TGQIVA---LKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+G+G Y V++ R TG+I A LKK + ++ A E IL + HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 180 VKLEGLVTSRMSCSLYLVFKY-------MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
V L + + LYL+ +Y M + G+ T F Y+ ++ L
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-------YLSEISLAL 113
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPEL 291
EH H Q +++RD+K N+L+D +G + + DFGL + H+ +T T+ Y PE+
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
L+ + +G VD WS G ++ ++L P + + KI K
Sbjct: 172 LM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 72/235 (30%), Positives = 102/235 (43%), Gaps = 37/235 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKK-VRFDNLEPESVRFMAREILILRRLDH 176
+ E L +IG GT VYK R TG ++A+K+ R N E M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 177 PNVVKLEGLVTSR---------MSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKC 223
P +VK G + MS L + K ++ D+ G K T A VK
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-------KMTVAIVKA 126
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVV 282
L L+ H V+HRD+K SN+L+D G + + DFG++ D K T
Sbjct: 127 -----LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAG 176
Query: 283 TLWYRPPELLLGAT---DYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKI 333
Y PE + Y + D+WS G L EL + P +TE E L KI
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 35/300 (11%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ D FEK+ ++G G V+K +G I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P +V G S S+ + ++M+ + + + ++ GL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 236 HNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+H ++HRD+K SN+L+++ G + + DFG++ + S V T Y PE L G
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQG 176
Query: 295 ATDYGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIF--KLCGSPSEEYWKKSKLP 351
T Y V D+WS G L E+ + PI P + ++L +F + G P+E P
Sbjct: 177 -THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAESETSPRPRP 233
Query: 352 HATIFKPQQSY---KRCIAETFK--DF----PPSSLP----------LIETLLAIDPAER 392
+P SY R F+ D+ PP LP + L +PAER
Sbjct: 234 PG---RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAER 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A+ + L +IG+G + V K +G I+A+K++R E E R + +++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 177 PNVVKLEGLVTSR---------MSCSLYLVFKYM-EHDLAGLAASPTIKFTQAQVKCYMH 226
P +VK G + M SL +KY+ E + + K A VK
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK---- 118
Query: 227 QLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
L + + ++HRD+K SN+L+D G + + DFG++ ++
Sbjct: 119 ----ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-----QLVDSIAKTRDAG 169
Query: 286 YRP---PELLL--GATDYGVGVDLWSAGCILAEL 314
RP PE + Y V D+WS G L E+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 14/218 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
+G+G + V+K TL + VA+K + D + ++F++ E IL++ DHPN+VKL G
Sbjct: 3 LGKGNFGEVFKG--TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIG 59
Query: 185 LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ T R +Y+V + + D + Q+ + +G+ + +++ +HR
Sbjct: 60 VCTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVGV 302
D+ N L+ +L I+DFG++ D + ++ W P L G Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR--YSSES 175
Query: 303 DLWSAGCILAELLA----EKPIMPGRTEVEQLHKIFKL 336
D+WS G +L E + P M + EQ+ K +++
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 41/177 (23%), Positives = 82/177 (46%), Gaps = 12/177 (6%)
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCY 224
E ++ +L HPN+V+L G+ T + +++V +YM + L L K +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDM 105
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVT 283
+ +E+ + +HRD+ N L+ + ++ ++DFGLA + D + ++
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165
Query: 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTE---VEQLHKIFKL 336
W PPE+ + + D+WS G ++ E+ +E K + VE + ++L
Sbjct: 166 KW-APPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 14/224 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLE 183
IG+G++ V A+ G A+K ++ + + E MA ++L+ L HP +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ + + LY V Y+ F + + + Y ++ S + + H+ ++++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGATDYGVGV 302
D+K N+L+D++G + + DFGL + + TS T Y PE +L Y V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTV 177
Query: 303 DLWSAGCILAELLAEKPIMPGRTEVEQ-----LHKIFKLCGSPS 341
D W G +L E+L P R +V Q LHK +L G +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 49/191 (25%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEG 184
+G+GT+ V R+ +G+ A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244
+ + L V +Y+ S F++ + + Y +++S L++ H+ +++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 245 IKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDL 304
+K NL++D +G + I DFGL M + T Y PE +L DYG VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 305 WSAGCILAELL 315
W G ++ E++
Sbjct: 179 WGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV- 282
Y Q++SGLEH H + +++RD+K N+L+DN+G + I+D GLA + Q T
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAG 159
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
T + PELL G +Y VD ++ G L E++A + P R E++
Sbjct: 160 TPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARG--PFRARGEKV------------ 204
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ +L + + F P+S E LLA DP +R
Sbjct: 205 ---ENKELKQRILNDSVTYPDK--------FSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVR--FMAREILILRRLDHPNVVKL 182
+G+G++ V A T + A+K ++ D LE + V + R +L L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
T + L+ V +Y+ + +F +A+ + Y +++ GL+ H + +++
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV------TLWYRPPELLLGAT 296
RD+K N+L+D +G + IADFG+ K+ M T Y PE+L G
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC-------KENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Y VD WS G +L E+L + G E E I
Sbjct: 173 -YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 37/235 (15%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
R + +E + KIG G + V+ + T + K + + L+ + E+ ++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH-------QL 228
H N+V+ ++ + LY++ ++ + AG + K + K H QL
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCD---AGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 229 LSGLEHCHN-------QHVLHRDIKGSNLL-----------------IDNEGILTIADFG 264
L L +CHN + VLHRD+K N+ ++ I I DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 265 LASFFDPNHKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEK 318
L+ + + S V T +Y PELLL T Y D+W+ GCI+ EL + K
Sbjct: 188 LSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 18/222 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDHPN 178
F L +G+G++ V A T ++ A+K ++ D ++ + V E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 179 VVKLEGLVTSRMSC-----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+T SC LY V +Y+ KF + Y ++ GL
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPEL 291
H++ +++RD+K N+++D EG + IADFG+ N T+R T Y PE+
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIAPEI 172
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
+ YG VD W+ G +L E+LA +P G E E I
Sbjct: 173 IA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-------FMAREILILRRLDHPN 178
IG+G++ V A+ G+ A+K L+ +++ MA ++L+ + HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV-----LQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
+V L + + + LY V Y+ F + + + Y ++ S L + H+
Sbjct: 58 LVGLH--YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
++++RD+K N+L+D++G + + DFGL H + ++ T Y PE+L Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-KQPY 173
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
VD W G +L E+L P R E I
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR-EILILRRLDHPNVVKLEG 184
+G+G + V + TG++ A KK+ L+ +S MA E IL +++ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 185 LVTSRMSCSLYLVF------KYMEHDLA--GLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
S+ L + KY +++ GL I ++ AQ+ C G+ H H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYS-AQITC-------GILHLH 112
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +++RD+K N+L+D++G ++D GLA + + +T R T Y PE+L
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332
Y VD ++ GC + E++A + P + E++ K
Sbjct: 171 -YSYPVDWFAMGCSIYEMVAGR--TPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEG 184
K+GQG + V+ T + VA+K ++ + PE+ +E I+++L H +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYA 68
Query: 185 LVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
+V+ +Y+V ++M L L Q+ Q+ G+ + + +H
Sbjct: 69 VVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPN-HKQPMTSRVVTLWYRPPELLLGATDYGVG 301
RD++ +N+L+ + + IADFGLA + N + ++ W P L G + +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183
Query: 302 VDLWSAGCILAELLAEK----PIMPGRTEVEQLHKIFKL 336
D+WS G +L EL+ + P M R +EQ+ + +++
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 19/225 (8%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ D FE++ ++G G V K + +G I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL----LSG 231
P +V G S S+ MEH + G + +K + + + ++ L G
Sbjct: 62 SPYIVGFYGAFYSDGEISIC-----MEH-MDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115
Query: 232 LEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
L + +H ++HRD+K SN+L+++ G + + DFG++ + S V T Y PE
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPE 172
Query: 291 LLLGATDYGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIF 334
L G T Y V D+WS G L EL + PI P + ++L IF
Sbjct: 173 RLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 51/194 (26%), Positives = 95/194 (48%), Gaps = 8/194 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLE 183
IG+G+Y+ V R T +I A+K V+ + + + E + ++ E + + +HP +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ L+ V +Y+ K + + Y ++ L + H + +++R
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGATDYGVGV 302
D+K N+L+D+EG + + D+G+ + TS T Y PE+L G DYG V
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSV 177
Query: 303 DLWSAGCILAELLA 316
D W+ G ++ E++A
Sbjct: 178 DWWALGVLMFEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 126 IGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK 181
+G G + +V Y + + VA+K ++ + RE ++ +LDHP +V+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE-VAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ-------AQVKCYMHQLLSGLEH 234
L G+ LV ME LA L P +K+ + + +K HQ+ G+ +
Sbjct: 61 LIGVCKGEPLM---LV---ME--LAPLG--PLLKYLKKRREIPVSDLKELAHQVAMGMAY 110
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGL--ASFFDPNHKQPMTS-RVVTLWYRPPEL 291
++H +HRD+ N+L+ N I+DFG+ A ++ + T+ R WY P +
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 292 LLGATDYGVGVDLWSAGCILAELLA--EKPI--MPGRTEVEQLHKIFKLCGSPSE 342
G D+WS G L E + KP M G + L +L P E
Sbjct: 171 NYGKFSS--KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-PRPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 73/317 (23%), Positives = 133/317 (41%), Gaps = 57/317 (17%)
Query: 125 KIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+IG+G ++VY AR T TG +V ++ +N E ++ + E+++ HPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK------FTQAQVKCYMHQLLSGLEHCH 236
+ T+ L+++ +M + +A+ +K ++A + + L GL + H
Sbjct: 65 WTVFTT--GSWLWVISPFMAYG----SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-PNHKQ--------PMTSRVVTLWYR 287
+HR+IK S++LI +G+++++ GL+ + + Q P S V W
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK----IFKLCGSPSEE 343
P L Y V D++S G EL GR + + + + KL G P
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELAT------GRVPFQDMLRTQMLLQKLKGPPYSP 230
Query: 344 YWKKSKLPHA-TIFKPQQS--------------------YKRCIAETFKDFPPSSLPLIE 382
+ P + K QS +R + K F P+ L+E
Sbjct: 231 -LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE 289
Query: 383 TLLAIDPAERQTATAAL 399
L DP +R +A++ L
Sbjct: 290 LCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 122 KLDKI-GQGTYSNVYKAR---DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
KL KI G+G + +V + + D + VA+K ++ D + E ++ DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 178 NVVKLEGLVTSRMSC-----SLYLVFKYMEH-DL------AGLAASPTIKFTQAQVKCYM 225
NV+KL G V S ++ +M+H DL + L P Q +K +M
Sbjct: 62 NVMKLIG-VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-FM 119
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ G+E+ N++ +HRD+ N ++ + + +ADFGL+
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 14/228 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK----KVRFDNLEPESVRFMAREILILRRLDHPNVVK 181
IG+G++ V A+ L G+ A+K K+ + E + + MA ++L+ + HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
L + + + LY V ++ F + + + Y ++ S L + H+ +++
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
+RD+K N+L+D++G + + DFGL T+ T Y PE++ Y
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNT 176
Query: 302 VDLWSAGCILAELLAEKPIMPGRTEVEQ----LHKIFKLCGSPSEEYW 345
VD W G +L E+L P R E LHK L S W
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVR--FMAREILILRRLDHPNVVKL 182
+G+G++ V A T ++ A+K ++ D L+ + V + IL L HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHP----- 56
Query: 183 EGLVTSRMSC-----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+T+ C L+ V +Y+ + KF + + + Y ++ L H
Sbjct: 57 --FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW------YRPPEL 291
V++RD+K N+L+D EG +ADFG+ K+ + + V T Y PE
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMC-------KEGILNGVTTTTFCGTPDYIAPE- 166
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKP 319
+L +YG VD W+ G ++ E++A +P
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 36/232 (15%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR--DTLTGQ---IVALKKVRFDNLEPESVRFMAREI 168
PR + E + IGQG + V++AR L + +VA+K ++ + F RE
Sbjct: 3 PR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 59
Query: 169 LILRRLDHPNVVKLEGL-VTSRMSCSLYLVFKYMEH-DL--------------------- 205
++ DHPN+VKL G+ + C L+F+YM + DL
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 206 AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL 265
A + + + C Q+ +G+ + + +HRD+ N L+ ++ IADFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 266 A-SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ + + ++ + + + + + PPE + Y D+W+ G +L E+ +
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 46/202 (22%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 126 IGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
IG G + V++ + G+ VA+K ++ E + F++ E I+ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 183 EGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
EG+VT ++ +YME+ L +F+ Q+ + + +G+++ + + +
Sbjct: 72 EGVVTKFKP--AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
HRD+ N+L+++ ++DFGL+ DP + + + + PE + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFT 188
Query: 300 VGVDLWSAGCILAELLA--EKP 319
D+WS G ++ E+++ E+P
Sbjct: 189 SASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 119 TFEKLDKIGQGTYSNVYKAR--DTLTG---QIVALKKVRFDNLEPESVRFMAREILILRR 173
T ++++G+ + VYK T G Q VA+K ++ D E E ++ R
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSR 64
Query: 174 LDHPNVVKLEGLVTSRMSCSL------------YLVFKYMEHDLAGLAASPTIKFTQAQV 221
L HPN+V L G+VT S+ +LV + D+ T+K T
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 222 KCYMH---QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL-ASFFDPNHKQPM 277
++H Q+ +G+E + HV+H+D+ N+L+ ++ + I+D GL + ++ + M
Sbjct: 125 D-FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 278 TSRVVTL-WYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ ++ + W P ++ G + + D+WS G +L E+ +
Sbjct: 184 GNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 57/236 (24%), Positives = 104/236 (44%), Gaps = 16/236 (6%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDHP 177
TF +G+G + V + TG++ A KK+ ++ MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 178 NVVKLEGLVTSRMSCSLYLV------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
VV L ++ + L L K+ +++ F + + Y +L G
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FDEQRAIFYAAELCCG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LE + +++RD+K N+L+D+ G + I+D GLA + + RV T+ Y PE+
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV--QIPEGETVRGRVGTVGYMAPEV 172
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
+ Y D W GC++ E++ + R E + ++ + EEY +K
Sbjct: 173 INNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMARE--ILILRRLDHPNVVKL 182
+G+G++ V AR +G++ A+K ++ D L+ + V E IL L R +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
+ L+ V +++ + +F +A+ + Y ++ S L H++ +++
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGATDYGVG 301
RD+K N+L+D+EG +ADFG+ + TS T Y PE +L YG
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPS 176
Query: 302 VDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
VD W+ G +L E+L E + I
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 6/211 (2%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLE 183
IG+G++ V AR + A+K ++ + + E M+ ++L+ + HP +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHR 243
+ + + LY V Y+ F + + + Y ++ S L + H+ ++++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
D+K N+L+D++G + + DFGL + H ++ T Y PE +L Y VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVD 178
Query: 304 LWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
W G +L E+L P R E I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 38/150 (25%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYM 225
E ++ +L H +V+L G+ T + +Y+V +YM + L +F +Q+
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVTL 284
+ G+ + ++ +HRD+ N L+D++G + ++DFGL+ + D + + S+
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAEL 314
W PPE+LL + + D+W+ G ++ E+
Sbjct: 167 W-SPPEVLL-YSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 12/224 (5%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDH 176
D FE + IG+G + V + T +I A+K + +++ L+ E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + LYLV Y + DL L + + + + Y+ +++ +
Sbjct: 61 QWITTLH--YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLL 293
H H +HRDIK N+L+D G + +ADFG S N + S V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 294 GATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
D YG D WS G + E+L + + VE KI
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 6e-11
Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 125 KIGQGTYSNVYKA--------RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
++G+G + V+ A +D + + LK DN + RE +L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKD----FHREAELLTNLQH 66
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DL----------AGLAA--SPTIKFTQAQVKC 223
++VK G+ L +VF+YM+H DL A L A + + TQ+Q+
Sbjct: 67 EHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVV 282
Q+ +G+ + +QH +HRD+ N L+ ++ I DFG++ + ++ + ++
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ + PPE ++ + D+WS G +L E+
Sbjct: 185 PIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLDH 176
EK+ +G G + VYK G+ V + KV + P++ + + E ++ +DH
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P+VV+L G+ +S + L+ + M L + + + Q+ G+ +
Sbjct: 69 PHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPELLL 293
+ ++HRD+ N+L+ + I DFGLA D + K+ +V W +L
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 294 GATDYGVGVDLWSAGCILAELL 315
Y D+WS G + EL+
Sbjct: 186 R--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 43/284 (15%)
Query: 124 DKIGQGTYSNVY------------KARDTLTGQ--IVALKKVRFDNLEPESVRFMAREIL 169
+K+G+G + V+ + GQ +VA+K +R D + F+ +EI
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-KEIK 69
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTI--KFTQAQ-VKC-- 223
I+ RL +PN+++L G+ S L ++ +YME+ DL + I FT A +
Sbjct: 70 IMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 224 -----YMH-QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277
YM Q+ SG+++ + + +HRD+ N L+ N + IADFG++ +
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 278 TSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAE---LLAEKP--IMPGRTEVEQL 330
R V W +LLG + D+W+ G L E L E+P ++ +E
Sbjct: 188 QGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFP 374
+ F+ G + Y ++ L + +FK RC + KD P
Sbjct: 246 GEFFRNQG--RQIYLSQTPLCPSPVFKLMM---RCWSRDIKDRP 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 51/206 (24%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 126 IGQGTYSNVYKAR---DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+G+G + +V +A+ + + Q VA+K ++ D + RE ++ DHPNV+KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 183 EGL-VTSRMSCSL---YLVFKYMEH-DL------AGLAASPTIKFTQAQVKCYMHQLLSG 231
G+ + SR L ++ +M+H DL + + P Q V+ +M + SG
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR-FMIDIASG 125
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRVVTLWYRPP 289
+E+ +++ +HRD+ N +++ + +ADFGL+ + ++Q S++ W
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185
Query: 290 ELLLGATDYGVGVDLWSAGCILAELL 315
L Y D+W+ G + E++
Sbjct: 186 S--LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 124 DKIGQGTYSNVYKAR-DTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
K+G G++ V + T G++ VA+K ++ D L F+ +E I+ LDH N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 181 KLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKC-YMHQLLSGLEHCHNQ 238
+L G+V ++ L +V + L + C Y Q+ +G+ + ++
Sbjct: 60 RLYGVV---LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPELLLGAT 296
+HRD+ N+L+ ++ + I DFGL N + V + PE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 297 DYGVGVDLWSAGCILAELLA--EKPIMPGRTEVEQLHKI 333
+ D+W G L E+ E+P G + + L KI
Sbjct: 177 -FSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PR + EK K+G G + V+ A + VA+K ++ ++ SV E +++
Sbjct: 4 PRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMKT 57
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSG 231
L H +VKL +VT +Y++ ++M L L + K ++ + Q+ G
Sbjct: 58 LQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
+ ++ +HRD++ +N+L+ + IADFGLA + N + + PE
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE- 173
Query: 292 LLGATDYG---VGVDLWSAGCILAELLAEKPI-MPGRTEVE 328
A ++G + D+WS G +L E++ I PG + E
Sbjct: 174 ---AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 119 TFEKLDKIGQGTYSNVY--KARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
TF K ++G G + V+ K R + VA+K + + E F+ E ++ +L H
Sbjct: 7 TFMK--ELGSGQFGVVHLGKWRAQIK---VAIKAINEGAMSEED--FI-EEAKVMMKLSH 58
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P +V+L G+ T + LY+V ++ME+ L K ++ + + G+E+
Sbjct: 59 PKLVQLYGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASF-FDPNHKQPMTSRVVTLWYRPPELLLG 294
+HRD+ N L+ + G++ ++DFG+ + D + ++ W PPE+
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPEVFN- 174
Query: 295 ATDYGVGVDLWSAGCILAELLAE 317
+ Y D+WS G ++ E+ E
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 142 TGQIVALKKVRFDNLEPESVRF-MAREILILRRLDHPNVVKL--EGLVTSRMSCSLYLVF 198
TG VA+K +R D E E R RE + RL HPN+V L G + L+ VF
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAVF 58
Query: 199 KYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257
+Y+ L + A+ + M Q+L L HNQ ++HRD+K N+++ G+
Sbjct: 59 EYVPGRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 258 LTIA---DFGLASFFDPNHKQ-----PMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAG 308
A DFG+ + T+ V+ T Y PE L G DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWG 176
Query: 309 CILAELLAEKPIMPGRTEVEQLHK 332
I E L + ++ G + E L++
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 72/302 (23%), Positives = 115/302 (38%), Gaps = 68/302 (22%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
R + E + +G G +V K + TG ++A KKV + + + RE+ I+
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 176 HPNVVKLEG---------LVTSRMSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQVK 222
P +V G + M C +Y + ++ G A ++
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVE------- 114
Query: 223 CYMHQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLA-----SFFDPNHKQP 276
GL + +N H ++HRDIK SN+L+++ G + + DFG++ S D
Sbjct: 115 --------GLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD------ 160
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL-LAEKPI-MPGRTEVEQLHK-- 332
+ V T Y PE + G Y V D+WS G + EL L + P + Q
Sbjct: 161 --TFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217
Query: 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
I L +E +LP + DFP ++ L DP ER
Sbjct: 218 ILDLLQQIVQE--PPPRLPSS------------------DFPEDLRDFVDACLLKDPTER 257
Query: 393 QT 394
T
Sbjct: 258 PT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D FEKL ++G G V K +G I+A K + + ++P + RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSP 59
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH------DL----AGLAASPTI-KFTQAQVKCYMH 226
+V G S S+ MEH D AG + K + A ++
Sbjct: 60 YIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPENILGKISIAVLR---- 110
Query: 227 QLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
GL + +H ++HRD+K SN+L+++ G + + DFG++ S V T
Sbjct: 111 ----GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRS 163
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PI-MPGRTEVEQLH 331
Y PE L G T Y V D+WS G L E+ + PI P E+E +
Sbjct: 164 YMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 18/224 (8%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDHPN 178
F L +G+G++ V A T ++ A+K ++ D ++ + V E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 179 VVKLEGLVTSRMSC-----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+T SC LY V +Y+ +F + Y ++ GL
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPEL 291
H++ +++RD+K N+++D+EG + IADFG+ N +T++ T Y PE
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPE- 171
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
++ YG VD W+ G +L E+LA + G E E I +
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 64/266 (24%), Positives = 102/266 (38%), Gaps = 56/266 (21%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
+ F + IG+G + V + TG+I A+K + + + + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLE 233
P VV L + + + LYL+ ME G + IK F++ + YM + + +E
Sbjct: 61 PWVVSL--YYSFQDAQYLYLI---MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE 115
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-----KQPMTSRVVT----- 283
H +HRDIK N+LID G + ++DFGL++ F H ++ + +
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 284 --------------------LW----------------YRPPELLLGATDYGVGVDLWSA 307
W Y PE+ L YG D WS
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSL 234
Query: 308 GCILAELLAEKPIMPGRTEVEQLHKI 333
G I+ E L P E KI
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 48/218 (22%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 123 LDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
++++G+ + +YK L G Q+VA+K ++ D P+ +E ++ L HPN
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPN 68
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC--------------- 223
+V L G+VT + ++F+Y+ L ++ + V C
Sbjct: 69 IVCLLGVVTQEQP--VCMLFEYLNQ--GDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 224 -YMH---QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMT 278
++H Q+ +G+E+ + +H+D+ N+LI + + I+D GL+ + ++ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
++ + + PPE ++ + D+WS G +L E+ +
Sbjct: 185 KSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 8/223 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDH 176
+ FE L IG+G + V + ++ A+K + +++ L+ E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + +LYLV Y + DL L + + + + Y+ +++ ++
Sbjct: 61 QWITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H H +HRDIK N+L+D G + +ADFG + + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 296 TD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
D YG D WS G + E+L + + VE KI
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 68/259 (26%), Positives = 100/259 (38%), Gaps = 54/259 (20%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRF-DNLEPESVRFMAREILILRRLDHPN 178
F K+ +G G + V A T + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
VVKL + + LY V Y+ D+ L + F + + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFF----------DPNHKQPMTSRVVTLW-- 285
+HRDIK N+LID +G + + DFGL + F +H + + LW
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 286 ----------------------------------YRPPELLLGATDYGVGVDLWSAGCIL 311
Y PE+LL Y D WS G IL
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238
Query: 312 AELLAEKP--IMPGRTEVE 328
E+L +P + P TE +
Sbjct: 239 FEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 49/179 (27%), Positives = 77/179 (43%), Gaps = 35/179 (19%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA--SFFDPNHKQPMTSRV 281
Y +++ GL+ H++ +++RD+K N+++D +G + IADFG+ + F N ++
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFC 157
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
T Y PE+L G Y VD WS G +L E+L + G E E I
Sbjct: 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-------- 208
Query: 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ PH Y R I + KD ++E L DP R +R
Sbjct: 209 -----RVDTPH---------YPRWITKESKD-------ILEKLFERDPTRRLGVVGNIR 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 30/195 (15%)
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPN 272
+ F + +V +Q++ L+ H++ ++HRD+K +N+ + GI+ + DFG + + D
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332
+S T +Y PE L Y D+WS G IL ELL LH+
Sbjct: 224 SLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLT-------------LHR 269
Query: 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
FK PS+ ++ ++ + ++ K L++ LL+ +PA R
Sbjct: 270 PFK---GPSQR-----EIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALR 314
Query: 393 QTATAALRSEVSLYM 407
T L +E Y+
Sbjct: 315 PTTQQLLHTEFLKYV 329
|
Length = 478 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 126 IGQGTYSNVYKARDTLTGQI---VALKKV-RFDNLEPESVRFMAREILILRRLDHPNVVK 181
IG+G + VY + A+K + R +LE V +E +I++ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVLS 60
Query: 182 LEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
L G+ L +V YM+H DL S T T + + Q+ G+E+ ++
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELL----LGA 295
+HRD+ N ++D + +ADFGLA +D + L P + + L
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL---PVKWMALESLQT 176
Query: 296 TDYGVGVDLWSAGCILAELL 315
+ D+WS G +L EL+
Sbjct: 177 QKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 50/192 (26%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEG 184
+G+GT+ V ++ TG+ A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHR 243
+ + L V +Y S F++ + + Y +++S L++ H++ +V++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 244 DIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
D+K NL++D +G + I DFGL M + T Y PE +L DYG VD
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 178
Query: 304 LWSAGCILAELL 315
W G ++ E++
Sbjct: 179 WWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP--ESVRFMAREILILRRLD 175
++ + + K+G G + V+ G KV L+P SV+ E +++ L
Sbjct: 6 ESIKLVKKLGAGQFGEVW------MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ 59
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
H +V+L +VT +Y++ +YM L L + K ++ + Q+ G+
Sbjct: 60 HDKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ ++ +HRD++ +N+L+ + IADFGLA + N + + PE
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--- 174
Query: 294 GATDYG---VGVDLWSAGCILAELLAEKPI-MPGRTEVE 328
A ++G + D+WS G +L E++ I PG + +
Sbjct: 175 -AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLE 183
IG+G+Y+ V R QI A+K V+ + + + E + ++ E + + +P +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 184 GL--VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
TSR L+LV +Y+ K + + Y ++ L H + ++
Sbjct: 63 SCFQTTSR----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 242 HRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV 300
+RD+K N+L+D +G + + D+G+ P ++ T Y PE+L G +YG
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRG-EEYGF 175
Query: 301 GVDLWSAGCILAELLA 316
VD W+ G ++ E++A
Sbjct: 176 SVDWWALGVLMFEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 10/223 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPESVRFMAREILILRRLDH 176
D FE L IG+G + V + TGQ+ A+K + +++ L+ E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ L + LYLV Y + DL L + + + + Y+ +++ ++
Sbjct: 61 RWITNLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H +HRDIK N+L+D G + +ADFG + V T Y PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 296 TD----YGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKI 333
D YG D WS G + E+L E P VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 125 KIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++G+G + V+ A T +VA+K ++ L + RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGL--AASPTIKF------TQAQVKCYMHQLL- 229
VK G+ L +VF+YM+H DL A P QA+ + + Q+L
Sbjct: 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 230 ------SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVV 282
SG+ + +QH +HRD+ N L+ ++ I DFG++ + ++ + ++
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ + PPE ++ + D+WS G IL E+
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 39/238 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNV----------YKARDTLTGQI------VALKKVRFDNLE 157
PR+ TF+ +K+G+G + V + +D VA+K +R D +
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 158 PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME----------HDLAG 207
F+ +EI I+ RL PN+++L L S L ++ +YME H+
Sbjct: 61 NARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 208 LAASPTIKFTQAQVKCYMH-QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
A + +M Q+ SG+++ + + +HRD+ N L+ + IADFG++
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 267 SFFDPNHKQPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA---EKP 319
+ R V W +LLG + D+W+ G L E+L E+P
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLE 183
IG+G+Y+ V T +I A+K ++ + + + E + ++ E + +HP +V L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 184 GL--VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
SR L+ V +++ K + + Y ++ L H + ++
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGATDYGV 300
+RD+K N+L+D EG + + D+G+ + TS T Y PE+L G DYG
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175
Query: 301 GVDLWSAGCILAELLA 316
VD W+ G ++ E++A
Sbjct: 176 SVDWWALGVLMFEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 38/157 (24%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 125 KIGQGTYSNVYKARDTLTGQI-----VALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
IG+G + +VY+ VA+K + +F+ E I+R+ DHP++
Sbjct: 13 CIGEGQFGDVYQG--VYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHI 69
Query: 180 VKLEGLVTSRMS------CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
VKL G++T L + Y++ + L + I + Y QL + L
Sbjct: 70 VKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTALA 121
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270
+ ++ +HRDI N+L+ + + + DFGL+ + +
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 52/231 (22%), Positives = 102/231 (44%), Gaps = 33/231 (14%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYK--ARDTLTGQI---VALKKVRFDNLEPESVRFMAR 166
W R + + ++GQG++ VY+ A+ + G+ VA+K V + E + F+
Sbjct: 1 WELPR-EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN- 58
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLA--------------GLAAS 211
E +++ + +VV+L G+V+ +V + M DL GL
Sbjct: 59 EASVMKEFNCHHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 212 PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFD 270
KF Q ++ G+ + + +HRD+ N ++ + + I DFG+ ++
Sbjct: 117 TLQKFIQ-----MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKP 319
++ + ++ + + PE L + D+WS G +L E+ LAE+P
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 126 IGQGTYSNVYK--ARDTL---TGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+G G + VY+ A D L +G I VA+K +R + E F+ E ++ +HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQVKCYMHQLLSGL 232
VKL G+ ++ Y++ + ME DL A + T ++ + G
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEG-----ILTIADFGLA-SFFDPNHKQPMTSRVVTLWY 286
+ H +HRD+ N L+ +G ++ I DFGLA + ++ + ++ + +
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELL--AEKPIMPGRTEVEQLHKI 333
PE LL + D+WS G ++ E+L ++P P E L +
Sbjct: 180 MAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 124 DKIGQGTYSNVYKARDTLTG--QIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVV 180
D IG+G + V KAR G A+K+++ + + R A E+ +L +L HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH---------------DLA-GLAASPTIKFTQAQVKCY 224
L G R LYL +Y H D A +A S + Q+ +
Sbjct: 72 NLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
+ G+++ + +HRD+ N+L+ + IADFGL+ + K+ M R+
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVR 188
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
W L + Y D+WS G +L E+++
Sbjct: 189 WMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 166 REILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDL-AGLAASPTIKFTQAQVKCY 224
REI IL+ + H ++ L + R ++ +V + DL + S + QA
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT--I 190
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT-SRVVT 283
+LL L + H + ++HRD+K N+ +D + DFG A D + P T
Sbjct: 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 284 LWYRPPELLLGATD-YGVGVDLWSAGCILAELLAEKPIMPGR---TEVEQLHKIFK 335
L PELL A D Y D+WSAG +L E+ + + G+ + QL I +
Sbjct: 251 LETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 116 RADTFEKLDKIGQGTYSNV----YKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL 171
+ + F + +G G++ V YK D I +K + ++ + V + E IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKIL 85
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC-YMHQLLS 230
++HP V L G + + LYLV +++ +F V C Y Q++
Sbjct: 86 NYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVL 142
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP-- 288
E+ + ++++RD+K NLL+D +G + + DFG A D +R TL P
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--------TRTYTLCGTPEY 194
Query: 289 --PELLLGATDYGVGVDLWSAGCILAELLAEKP 319
PE+LL +G D W+ G + E+L P
Sbjct: 195 IAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 125 KIGQGTYSNVYKA--------RDTLTGQIVALKKVRFDNLEPESVRF-MAREILILRRLD 175
++G+G + V+ A +D + + ALK+ ES R RE +L L
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS------ESARQDFQREAELLTVLQ 65
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHD---------------LAGLAASPTIKFTQAQ 220
H ++V+ G+ T L +VF+YM H LAG + T Q
Sbjct: 66 HQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTS 279
+ Q+ SG+ + + H +HRD+ N L+ ++ I DFG++ + ++ +
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
++ + + PPE +L + D+WS G +L E+
Sbjct: 184 TMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 61/232 (26%), Positives = 110/232 (47%), Gaps = 29/232 (12%)
Query: 125 KIGQGTYSNVYKA--RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
++G G + V K + + + VA+K ++ DN +P + RE ++++LD+P +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKF-------TQAQVKCYMHQLLSGLEHC 235
G+ + S LV ME LA L P KF T+ + +HQ+ G+++
Sbjct: 62 IGICEAE---SWMLV---ME--LAELG--PLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTL-WYRPPELL 292
+ +HRD+ N+L+ + I+DFGL+ D N+ + T + WY P
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169
Query: 293 LGATDYGVGVDLWSAGCILAELLA--EKPI--MPGRTEVEQLHKIFKLCGSP 340
+ + D+WS G ++ E + +KP M G EV Q+ + + P
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGERMECP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 30/200 (15%)
Query: 134 VYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192
VYK R QI VA+K ++ +N E M RE I+ +LD+P +V++ G+ +
Sbjct: 15 VYKMRKK---QIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE--- 67
Query: 193 SLYLVFKYMEHDLAGLAASPTIKF--------TQAQVKCYMHQLLSGLEHCHNQHVLHRD 244
+L LV ME G P KF T + V MHQ+ G+++ ++ +HRD
Sbjct: 68 ALMLV---MEMASGG----PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 245 IKGSNLLIDNEGILTIADFGLASFF---DPNHKQPMTSRVVTLWYRPPELLLGATDYGVG 301
+ N+L+ N+ I+DFGL+ D +K + WY P + +
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF--RKFSSR 178
Query: 302 VDLWSAGCILAELLA--EKP 319
D+WS G + E + +KP
Sbjct: 179 SDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 126 IGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
+G+G + +V + + I VA+K ++ + E + ++ DHPNV++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 184 GLVTSRMSCSLY----LVFKYMEH-DL------AGLAASPTIKFTQAQVKCYMHQLLSGL 232
G+ + Y ++ +M+H DL + L P TQ VK +M + SG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRVVTLWYRPPE 290
E+ ++ +HRD+ N +++ + +ADFGL+ + ++Q +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 291 LLLGATDYGVGVDLWSAGCILAEL 314
L Y D+WS G + E+
Sbjct: 186 --LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 34/276 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-----ESVRFMAREI 168
PR +F K +G G + V +A + A+ KV L+P E M+ E+
Sbjct: 33 PRNNLSFGKT--LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-EL 89
Query: 169 LILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKF-TQAQVKCYM 225
I+ L +H N+V L G T + + ++ +Y + DL F T + +
Sbjct: 90 KIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRVVT 283
+Q+ G+ +++ +HRD+ N+L+ + I+ I DFGLA D N+ +R+
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 284 LWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFKLCGSPS 341
W P + Y D+WS G +L E+ L P PG + +K+ K
Sbjct: 208 KWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNP-YPGMPVDSKFYKLIK------ 258
Query: 342 EEYWKKSKLPHATIFKPQQSY---KRCIAETFKDFP 374
E ++ ++ HA P + Y K C P
Sbjct: 259 -EGYRMAQPEHA----PAEIYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 126 IGQGTYSNVYKAR-----DTLTGQIV---ALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+G+G + V+ A+ + +V AL+K + +NL+ E RE+ + R+L H
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE----FRRELDMFRKLSHK 68
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME-HDL-----AGLAASPTIK---FTQAQVKCYMHQL 228
NVV+L GL R + Y++ +Y + DL A + +K + Q Q+
Sbjct: 69 NVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ--PMTSRVVTLWY 286
G++H N +HRD+ N L+ ++ + ++ L+ D + + + + ++ L +
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRW 184
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAEL 314
PE + D+ D+WS G ++ E+
Sbjct: 185 LAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 146 VALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKY---- 200
VA+K ++ D+ + + + E+ +++ + H N++ L G T LY++ +Y
Sbjct: 50 VAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKG 106
Query: 201 -------------MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247
ME+ +A P + T + +Q+ G+E+ +Q +HRD+
Sbjct: 107 NLREYLRARRPPGMEYSY-DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165
Query: 248 SNLLIDNEGILTIADFGLASFFDPN----HKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
N+L+ ++ IADFGLA D N +K+ R+ W P L Y D
Sbjct: 166 RNVLVTENNVMKIADFGLAR--DVNNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSD 221
Query: 304 LWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFK 335
+WS G ++ E+ L P PG VE+L K+ K
Sbjct: 222 VWSFGVLMWEIFTLGGSP-YPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 123 LDK-IGQGTYSNVYKARDT-LTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDH 176
L K +G+G + V KA L G+ VA+K ++ +N +R + E +L++++H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNH 62
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH------------------------DLAGLAASP 212
P+V+KL G + L L+ +Y ++ + + L
Sbjct: 63 PHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFD 270
T + + Q+ G+++ ++HRD+ N+L+ + I+DFGL+ + +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
++ + R+ W L Y D+WS G +L E++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 20/193 (10%)
Query: 129 GTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS 188
G V DT T Q LK +R + R +I + PN+V L + S
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRE-----RLTIIPHCV--PNMVCLHKYIVS 56
Query: 189 RMSCSLYLVFKYMEHDLAGLAASPTIKFT---QAQVKCYMHQLLSGLEHCHNQHVLHRDI 245
S VF ++H G S KF + VK + +++ L+ H + ++ RD+
Sbjct: 57 EDS-----VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL 111
Query: 246 KGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLW 305
+N+L+D+ G + + F S + + + Y PE + G ++ D W
Sbjct: 112 NPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE-VGGISEETEACDWW 166
Query: 306 SAGCILAELLAEK 318
S G IL ELL K
Sbjct: 167 SLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 14/130 (10%)
Query: 146 VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-D 204
VA+K +R D + F+ +E+ IL RL PN+ +L G+ T L ++ +YME+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGD 105
Query: 205 L---------AGLAASPTIKFTQAQVKCYMH-QLLSGLEHCHNQHVLHRDIKGSNLLIDN 254
L + K YM Q+ SG+ + + + +HRD+ N L+
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 255 EGILTIADFG 264
+ IADFG
Sbjct: 166 NYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNH 273
T + CY Q+ G+E ++ +HRD+ N+L+ ++ I DFGLA + DP++
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ +R+ W P + Y + D+WS G +L E+ +
Sbjct: 236 VRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 9/161 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPES-VRFMAREILILRRLD 175
+++ +G G + VYK G+ V + K+ + P++ V FM E LI+ +D
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMASMD 67
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
HP++V+L G+ +S ++ LV + M H L + + Q+ G+ +
Sbjct: 68 HPHLVRLLGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
+ ++HRD+ N+L+ + + I DFGLA + + K+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 40/232 (17%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL-EG 184
+G G V A+ G+ A+K V + + E+ L D ++VK E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 185 LVTS-----RMSCSLYLVFKY-----MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ LV Y + ++ A + F + + Q+L + H
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNR-TFREHEAGLLFIQVLLAVHH 158
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--------------DPNHKQPMTSR 280
H++H++HRDIK +N+L+ + G++ + DFG + + P + P
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP---- 214
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332
+W R P Y D++S G +L ELL K G E +HK
Sbjct: 215 --EIWRRKP--------YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 35/117 (29%), Positives = 55/117 (47%), Gaps = 5/117 (4%)
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD--PNHKQPMT 278
V C +Q+ G+E+ +Q +HRD+ N+L+ + ++ IADFGLA +K+
Sbjct: 137 VSC-AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
R+ W P L Y D+WS G +L E+ VE+L K+ K
Sbjct: 196 GRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 45/242 (18%)
Query: 126 IGQGTYSNVYKARDTLTG-------QIVALKKVRFDNLEPESVRFMAREILILRRL-DHP 177
+G+G + V KA G VA+K ++ D E + ++ E+ +++ + H
Sbjct: 20 LGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHK 76
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------AGLAASPTI------KFTQAQV 221
N++ L G+ T LY+V +Y H +L G ASP TQ +
Sbjct: 77 NIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH----KQPM 277
+ +Q+ G+E ++ +HRD+ N+L+ + ++ IADFGLA D +H ++
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTT 192
Query: 278 TSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
R+ W P L D Y D+WS G +L E+ L P PG VE+L K+
Sbjct: 193 NGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKL 246
Query: 334 FK 335
K
Sbjct: 247 LK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNH 273
T + CY Q+ G+E ++ +HRD+ N+L+ ++ I DFGLA + DP++
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ ++R+ W P + Y D+WS G +L E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 51/224 (22%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL 185
IG+G + +V G VA+K ++ D + F+A E ++ +L H N+V+L G+
Sbjct: 14 IGKGEFGDVMLG--DYRGNKVAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 186 VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVK------CYMH---QLLSGLEHCH 236
+ LY+V +YM A + + +++ + C + + +E+
Sbjct: 68 IVEEKG-GLYIVTEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +HRD+ N+L+ + + ++DFGL + + Q T ++ W P L
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD-TGKLPVKWTAPEALR--EK 174
Query: 297 DYGVGVDLWSAGCILAELLA----EKPIMPGRTEVEQLHKIFKL 336
+ D+WS G +L E+ + P +P + V ++ K +K+
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 40/121 (33%), Positives = 61/121 (50%), Gaps = 13/121 (10%)
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH----KQP 276
V C +Q+ G+E+ ++ +HRD+ N+L+ + ++ IADFGLA D +H K+
Sbjct: 143 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKT 199
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIF 334
R+ W P L Y D+WS G +L E+ L P PG VE+L K+
Sbjct: 200 TNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG-VPVEELFKLL 255
Query: 335 K 335
K
Sbjct: 256 K 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 44/201 (21%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 146 VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD- 204
VA+ +R + + F+A E L L + DH N+V+LEG++T ++ +V +YM +
Sbjct: 36 VAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNGA 92
Query: 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
L + Q+ + L SG+++ +H+ + +L++++ + I+ F
Sbjct: 93 LDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 265 LASFFDPNHK-----QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--E 317
K M+ + LW P + + D+WS G ++ E+++ E
Sbjct: 153 RL----QEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGE 206
Query: 318 KPI--MPGRTEVEQLHKIFKL 336
+P M G+ ++ + F+L
Sbjct: 207 RPYWDMSGQDVIKAVEDGFRL 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLD 175
F+K+ +G G + VYK G+ VA+K++R + P++ + + E ++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 67
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+P+V +L G+ ++ ++ L+ + M L + + Q+ G+ +
Sbjct: 68 NPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--QPMTSRVVTLWYRPPELL 292
+ ++HRD+ N+L+ + I DFGLA + K +V W +L
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 293 LGATDYGVGVDLWSAGCILAELL 315
Y D+WS G + EL+
Sbjct: 185 --HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 35/237 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKA-----RDTLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
D+ L +G G + VY+ VA+K + E + F+ E LI+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMS 64
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAGL-------AASPTIKFTQAQVKCY 224
+ +H N+V+L G+ R+ +++ + M DL P+ + + C
Sbjct: 65 KFNHQNIVRLIGVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLA------SFFDPNHKQ 275
+ G ++ H +HRDI N L+ +G + IADFG+A S++ +
Sbjct: 123 R-DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQL 330
+ + + PPE L + D+WS G +L E+ L P PGRT E +
Sbjct: 182 MLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMP-YPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 41/224 (18%)
Query: 119 TFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
FE D IG+G + V +A + I LK+ +N R A E+ +L +
Sbjct: 5 KFE--DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN----DHRDFAGELEVLCK 58
Query: 174 L-DHPNVVKLEGLVTSRMSCSLYLVFKY---------------MEHDLA-----GLAASP 212
L HPN++ L G +R LY+ +Y +E D A G A++
Sbjct: 59 LGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST- 115
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272
T Q+ + + +G+++ + +HRD+ N+L+ IADFGL+ +
Sbjct: 116 ---LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY 172
Query: 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
K+ M R+ W L + Y D+WS G +L E+++
Sbjct: 173 VKKTM-GRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 11/207 (5%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILR 172
+ KL +G G + V+K G + + K D ++ + + +L +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
LDH +V+L G+ SL LV + L ++ + Q+ G
Sbjct: 65 SLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT--LWYRPP 289
+ + ++HR++ N+L+ ++ I+ IADFG+A P+ K+ S T W
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLA 316
+L G Y D+WS G + E+++
Sbjct: 182 SILFGR--YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 82/359 (22%), Positives = 135/359 (37%), Gaps = 69/359 (19%)
Query: 18 REEGSVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSNNEQETTTVR--PRGEKRRSS 75
+ R S A +G + ++ TT V P +K++ +
Sbjct: 44 TSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVT 103
Query: 76 KPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVY 135
P S H + V GE I T R F+ L +G+GT+ V
Sbjct: 104 YALPNQSREEGHFY-------------VVLGEDIDVSTQR----FKILSLLGEGTFGKVV 146
Query: 136 KARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL------DHPNVVKLEGLVTSR 189
+A D + A+K VR N+ P+ R EI + ++ D ++K++ +
Sbjct: 147 EAWDRKRKEYCAVKIVR--NV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203
Query: 190 MSCSLYLVFKY--------MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HV 240
++ KY M+H F+ + + Q L++ H + H+
Sbjct: 204 TGHMCIVMPKYGPCLLDWIMKHG----------PFSHRHLAQIIFQTGVALDYFHTELHL 253
Query: 241 LHRDIKGSNLLIDNEGI----------------LTIADFGLASFFDPNHKQPMTSRVVTL 284
+H D+K N+L++ + I D G D H + T+ V T
Sbjct: 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC--DERHSR--TAIVSTR 309
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK-LCGSPSE 342
YR PE++LG + D+WS GCI+ EL K + +E LH + K L PSE
Sbjct: 310 HYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 51/213 (23%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 146 VALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYM--- 201
VA+K ++ DN + + + E+ +++ + H N++ L G+ T LY++ +Y
Sbjct: 47 VAVKMLK-DNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKG 103
Query: 202 ---EHDLAGLAASPTIKFT-----------QAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247
E A P F + V C +Q+ G+E+ ++ +HRD+
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC-AYQVARGMEYLESRRCIHRDLAA 162
Query: 248 SNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWS 306
N+L+ + ++ IADFGLA D ++ + ++ + + + PE L Y D+WS
Sbjct: 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWS 221
Query: 307 AGCILAELL----AEKPIMPGRTEVEQLHKIFK 335
G ++ E+ + P +P VE+L K+ +
Sbjct: 222 FGILMWEIFTLGGSPYPGIP----VEELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 32/148 (21%)
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSR 280
Y Q+ G+E ++ +HRD+ N+L+ ++ I DFGLA + DP++ + +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340
+ W P + Y D+WS G +L E IF L SP
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWE-------------------IFSLGASP 275
Query: 341 ------SEEYWKKSKLPHAT-IFKPQQS 361
EE+ +L T + P+ +
Sbjct: 276 YPGVQIDEEFC--RRLKEGTRMRAPEYA 301
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKA--RDTLTG--QIVALKKVRFDNLEPESVRFMAREILILRR 173
D D + +GT+ ++ D G + V +K V+ D+ V + +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYG 64
Query: 174 LDHPNVVKLEGLVTSR----MSCSLYLVF----KYMEHDLAGLAASPTIKFTQAQVKCYM 225
L H N++ + + Y+ + +++ G A +P + Q+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ-ALSTQQLVHMA 123
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP--------NHKQPM 277
Q+ G+ + H + V+H+DI N +ID E + I D L+ P N +P+
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIM 321
W L+ +Y D+WS G +L EL L + P +
Sbjct: 184 K------WMALESLV--NKEYSSASDVWSFGVLLWELMTLGQTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 30/204 (14%)
Query: 133 NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192
NV K R L VA+K +R D + F+ +E+ IL RL PN+++L G+
Sbjct: 40 NVRKGRPLL----VAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--ED 92
Query: 193 SLYLVFKYMEH-------------DLAGLAASPTIKFTQAQVKCY---MH---QLLSGLE 233
L ++ +YME+ D Y +H Q+ SG++
Sbjct: 93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPEL 291
+ + + +HRD+ N L+ + IADFG++ + R V W +
Sbjct: 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 292 LLGATDYGVGVDLWSAGCILAELL 315
L+G + D+W+ G L E+L
Sbjct: 213 LMG--KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 21/213 (9%)
Query: 124 DKIGQGTYSNVYKA---RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
D+IG G + V R ++V +K++R E + F+ +E+ R L+HPNV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFL-QEVQPYRELNHPNVL 58
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM----HQLLSGLEHC 235
+ G S LV ++ DL S Q K + ++ SGL
Sbjct: 59 QCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELL-- 292
H +H D+ N + + + I D+GLA + ++ V L + PEL+
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 293 ----LGATDYGVGVDLWSAGCILAEL--LAEKP 319
L D ++WS G + EL A++P
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 121 EKLDKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
E L IG+G V AR TG+ V ++++ + E V F+ E+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG--LAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+V + L++V +M + A + ++ + + +L L++ H
Sbjct: 61 IVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP-NHKQ--------PMTSRVVTLWYR 287
+ +HR +K S++LI +G + ++ GL S NH Q P S V W
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 288 PPELLLGATDYGVGVDLWSAGCILAEL 314
P L Y D++S G EL
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFM--AREILILRRLDHPNVVKL 182
I +G + VY R ++ A+K V+ D + V + R+ L L + P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHL 69
Query: 183 EGLVTSRMSCS-LYLVFKYM-EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
S S + +YLV +Y+ D+ L F + Y+ ++ L++ H +
Sbjct: 70 ---YYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGI 125
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLA 266
+HRD+K N+LI NEG + + DFGL+
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 124 DKIGQGTYSNVYKA---RDTL--TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHP 177
D IG+G + V KA +D L I +K+ + R A E+ +L +L HP
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----DHRDFAGELEVLCKLGHHP 56
Query: 178 NVVKLEGLVTSRMSCSLYLVFKY---------------MEHDLAGLAASPTIK-FTQAQV 221
N++ L G R LYL +Y +E D A A+ T + Q+
Sbjct: 57 NIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281
+ + G+++ + +HRD+ N+L+ + IADFGL+ + K+ M R+
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRL 173
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
W L + Y D+WS G +L E+++
Sbjct: 174 PVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 44/202 (21%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 120 FEKLDKIGQGTYSNVYK---ARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+K+ +G G + VYK D +I KV +N P++ + + E ++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P V +L G+ ++ ++ LV + M + L + + + Q+ G+ +
Sbjct: 69 PYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPELLL 293
++HRD+ N+L+ + + I DFGLA D + + +V W +L
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL- 184
Query: 294 GATDYGVGVDLWSAGCILAELL 315
+ D+WS G + EL+
Sbjct: 185 -HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 49/217 (22%)
Query: 122 KLDK-IGQGTYSNVY----KARDTLTGQIVALKKVRFDNLEPESVRFMAREILI------ 170
K+DK IG G + VY + + Q VA + +NLE E+ + E L+
Sbjct: 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVA----KIENLENET---IVMETLVYNNIYD 67
Query: 171 ---------LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQV 221
+ +DH + K G S C +Y F +E L + F + +
Sbjct: 68 IDKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEK----LVENTKEIFKR--I 120
Query: 222 KCY--------MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273
KC M +L+ LE+ H + H DIK N+++D I D+G+AS F +
Sbjct: 121 KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 310
K S+ +R T Y G+D + C+
Sbjct: 181 KHIEYSKEQKDLHR-------GTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRV 281
+ +Q+ +G+E +++ +HRD+ N+LI ++ I DFGLA D N+ ++ +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFKLCGS 339
W P + Y D+WS G +L E+ L P P EQ + +
Sbjct: 304 PLKWMAPESIF--NNLYTTLSDVWSFGILLWEIFTLGGTP-YPELPMNEQFY-------N 353
Query: 340 PSEEYWKKSKLPHAT--IFKPQQSYKRCIAETFKDFPPSS 377
+ ++ +K HA+ I++ Q +C E F+ P S
Sbjct: 354 AIKRGYRMAKPAHASDEIYEIMQ---KCWEEKFEIRPDFS 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 21/46 (45%), Positives = 29/46 (63%)
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+K M Q+L+GL H ++HRDIK NLL+ +G + I DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 27/131 (20%)
Query: 215 KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNH 273
K ++A+VK + QL+ L H +++H DIK N+L D + + + D+GL
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-------- 156
Query: 274 KQPMTSRVV--------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PIMPGR 324
+++ TL Y PE + G +Y V D W+ G + ELL K P
Sbjct: 157 -----CKIIGTPSCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 325 TE---VEQLHK 332
E +E L K
Sbjct: 211 DEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 54/219 (24%), Positives = 106/219 (48%), Gaps = 30/219 (13%)
Query: 123 LDKIGQGTYSNVYK--ARDTLTGQI---VALKKVRFDNLEPESVRFMAREILILRRLDHP 177
L ++GQG++ VY+ ARD + G+ VA+K V E + F+ E +++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCH 69
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAAS-------------PTIKFTQAQVKC 223
+VV+L G+V S+ +L +V + M H DL S PT++ ++
Sbjct: 70 HVVRLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ----EMIQ 123
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVV 282
++ G+ + + + +HRD+ N ++ ++ + I DFG+ ++ ++ + ++
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKP 319
+ + PE L + D+WS G +L E+ LAE+P
Sbjct: 184 PVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRV 281
+ Q+ G++ +++ +HRD+ N+L+ + + I DFGLA D N+ +R+
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
W P + Y V D+WS G +L E+ +
Sbjct: 277 PVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS--FFDPNHKQPMTSRV 281
+ +Q+ G+E +++ +HRD+ N+L+ I+ I DFGLA D N+ ++ +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
W P + Y D+WS G +L E+ +
Sbjct: 302 PVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 32/116 (27%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRV 281
+ +Q+ G+ +++ +HRD+ N+L+ + I I DFGLA D N+ +R+
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKIFK 335
W P + Y D+WS G +L E+ L P PG + +K+ K
Sbjct: 279 PVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSP-YPGMPVDSKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 42/180 (23%), Positives = 78/180 (43%), Gaps = 22/180 (12%)
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMH---Q 227
R L HPN+++ G + LVF+Y E DL + +Q+ +
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWY 286
+ +G+ H H + LH D+ N + ++ + + D+G+ S + ++ + + V L +
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 287 RPPEL-------LLGA--TDYGVGVDLWSAGCILAELL--AEKPIMPGRTEVEQLHKIFK 335
PEL L+ A T ++W+ G L EL A +P ++ E L+ + K
Sbjct: 168 LAPELVGEFHGGLITAEQTKPS---NVWALGVTLWELFENAAQP-YSHLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 46/216 (21%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 125 KIGQGTYSNVYK--ARDTLTGQI---VALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++GQG++ VY+ A+ + + VA+K V E + F+ E +++ + +V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 180 VKLEGLVT------------SRMSCSLYL-VFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
V+L G+V+ +R YL + + A K Q
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA-----G 126
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLW 285
++ G+ + + +HRD+ N ++ + + I DFG+ ++ ++ + ++ +
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKP 319
+ PE L + D+WS G +L E+ LAE+P
Sbjct: 187 WMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 46/232 (19%), Positives = 85/232 (36%), Gaps = 41/232 (17%)
Query: 126 IGQGTYSNVYKAR------DTLTGQIVALKKVRFDNLEPESVRFMA--REILILRRLDHP 177
+GQGT++N+YK + G + V L + +A ++ +L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDHRDSLAFFETASLMSQLSHK 61
Query: 178 NVVKLEGLVTSRMSCSLY-LVFKYMEHDLAGLAASPTIKFTQAQVKC--------YMHQL 228
++VKL G+ +V +Y++ P F + QL
Sbjct: 62 HLVKLYGV----CVRDENIMVEEYVKF-------GPLDVFLHREKNNVSLHWKLDVAKQL 110
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF---DPNHKQPMTSRVVTL- 284
S L + ++ ++H ++ G N+L+ G+ + G F DP + SR +
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGL----NEGYVPFIKLSDPGIPITVLSREERVE 166
Query: 285 ---WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHK 332
W P + G + D WS G L E+ + + + E+
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 415 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.58 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.46 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.32 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.24 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.95 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.79 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.77 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.58 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.56 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.44 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.38 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.29 | |
| PLN02236 | 344 | choline kinase | 97.2 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.1 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.04 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.94 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.56 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.5 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.44 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.34 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.18 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.09 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.91 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.12 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.72 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-73 Score=535.15 Aligned_cols=328 Identities=68% Similarity=1.134 Sum_probs=313.1
Q ss_pred CCCCCCCCCCcccccCCCccchhcccccccCCCCCCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHH
Q 014960 81 LSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES 160 (415)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~ 160 (415)
..+.++.....+..++|+.|....+++++.+|.++..+.|+.+++||+|.||.||+|++..+|+.||+|.++.+....+.
T Consensus 80 ~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~ 159 (560)
T KOG0600|consen 80 PSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF 159 (560)
T ss_pred CCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc
Confidence 33445555567789999999999999999999999999999999999999999999999999999999999998878888
Q ss_pred HHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 014960 161 VRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240 (415)
Q Consensus 161 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 240 (415)
.....|||.||++|+||||++|.+.+..+..+.+|||||||+++|..++......|++.++..|++||+.||+|||++||
T Consensus 160 ~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gv 239 (560)
T KOG0600|consen 160 PITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGV 239 (560)
T ss_pred hHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCe
Confidence 88999999999999999999999999887778999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCC
Q 014960 241 LHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI 320 (415)
Q Consensus 241 vHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~p 320 (415)
+|||||.+|||||.+|.+||+|||+|+++.......+++.+.|.||.|||+++|...|+.+.|+||.||||.||+.|+|.
T Consensus 240 lHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI 319 (560)
T KOG0600|consen 240 LHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI 319 (560)
T ss_pred eeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC
Confidence 99999999999999999999999999999988878899999999999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 321 MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 321 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
|.|.++.+++.+|++.||.|...+|+...++....+++..++.+.+.+.++.++....+|+..||+.||.+|.||.++|+
T Consensus 320 ~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 320 LQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 014960 401 SEVSLYMX 408 (415)
Q Consensus 401 h~~f~~~~ 408 (415)
|+||..-.
T Consensus 400 seyF~t~p 407 (560)
T KOG0600|consen 400 SEYFTTEP 407 (560)
T ss_pred CcccccCC
Confidence 99995433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-61 Score=441.19 Aligned_cols=266 Identities=28% Similarity=0.389 Sum_probs=231.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-----hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.... ......+++|++||++|+|||||+++++|+. .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--P 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--C
Confidence 46788899999999999999999999999999999876442 2233456799999999999999999999998 4
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC---CcEEEEeeccccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASF 268 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DfG~a~~ 268 (415)
.+.||||||++||.+....-.++.+.|..-..+++||+.|+.|||++||+||||||+|||+..+ -.+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 5689999999999888888778889999999999999999999999999999999999999776 5799999999998
Q ss_pred cCCCCCCCcccccccCccCCcccccCC--cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHH
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 345 (415)
.... ..+.+.+|||.|.|||++.+. ..+..++|+|||||+||.+|+|.+||.+..... ..++|.+....+....|
T Consensus 329 ~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 329 SGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred cccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 8643 557889999999999999652 344568999999999999999999999876665 77888777666655556
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
. .+++++++||+.||..||+.|||++++|+||||+....-+
T Consensus 407 ~-------------------------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 407 D-------------------------RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred h-------------------------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 4 4889999999999999999999999999999999776433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-59 Score=410.14 Aligned_cols=291 Identities=41% Similarity=0.716 Sum_probs=255.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.+|..+++||+|.||.||+|++..+|+.||||+++.............|||+.|+.++|+||+.++++|.+ ...+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEE
Confidence 46889999999999999999999999999999999876544444566789999999999999999999988 4559999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
+||++.++...+......++..++..|+.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.+.... .
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-Q 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-c
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998765543 3
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
...+.|.||+|||++.|...|+..+||||.|||+.||+-|.|.|.|.++.+++..|++.+|+|..+.|+....-++...-
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 44488999999999999999999999999999999999999999999999999999999999999999986654443211
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
...+ .......+...+.++.||+.+||.+||.+|+|+.|+|.|+||+.....++
T Consensus 239 ~~~P-~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 239 QQFP-KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred hcCC-CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 1111 11122356677888999999999999999999999999999998766554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-59 Score=419.80 Aligned_cols=295 Identities=42% Similarity=0.724 Sum_probs=258.1
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
+..+.|+.+.+|++|.||.||+|+|+.+++.||+|.++.+.-....--.-.|||.+|.+++|||||.+.+++....-..+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 34578999999999999999999999999999999998664322222234579999999999999999999887666779
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|||||||++++...+.....+|.+.++..++.|++.||+|||.+.|+|||||++|+|++..|.+||+|||+|+.++...
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~- 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL- 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence 9999999999999988888899999999999999999999999999999999999999999999999999999987653
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
..++..+.|.||+|||++++...|+.+.|+||+|||+.|||+++|.|.|..+.+++.+|++.+|.|....|+.....+..
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 45788899999999999999999999999999999999999999999999999999999999999999999997665543
Q ss_pred --cCCCcchhhhhhhhhcCC--CCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 355 --IFKPQQSYKRCIAETFKD--FPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 355 --~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
......++.. +...+.. +++...+|++.+|.+||.+|.||+|+|.|.||.+.....
T Consensus 312 k~~~f~~~pyn~-lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 312 KKMTFSEHPYNN-LRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred hccccCCCCchh-hhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 2333333333 3333443 559999999999999999999999999999999976544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-59 Score=416.34 Aligned_cols=289 Identities=33% Similarity=0.550 Sum_probs=248.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.|+.+.++|+|+||.||+|+++.+|+.||||++.-..-++...+-..|||.+|++|+|+|+|.++++|.. ...+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 46889999999999999999999999999999987555456666677899999999999999999999987 4569999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||||++..+..+...-..++...+..|+.|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+.. ....+
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999998888777666789999999999999999999999999999999999999999999999999998763 33567
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh--CCCCCCCc
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLPHATI 355 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--~~~~~~~~ 355 (415)
+..+.|.||+|||.+.|...|+..+|||++||++.||++|.|.|.|.++-+++..|.+.+|.....-... ..-....+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 8889999999999999989999999999999999999999999999999999999999999876543221 01111111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
--+...-+..+...++.++.-++||+++||..||.+|++.+|+|.|+||+.+-+
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 122222334466677788888999999999999999999999999999976543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-60 Score=441.63 Aligned_cols=290 Identities=35% Similarity=0.627 Sum_probs=263.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|.++++||.|.||.||+|+.+.+|..||||.+++....-++...+ ||++.|++|+ ||||++|.+++.+.. ..+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nL-REvksL~kln~hpniikL~Evi~d~~-~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNPHPNIIKLKEVIRDND-RILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHH-HHHHHHHhcCCCCcchhhHHHhhccC-ceEe
Confidence 468999999999999999999999999999999998765544444444 6999999998 999999999998864 3899
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+|||||+..+..++..++..|++..++.|+.||+.||+|+|.+|++||||||||||+.....|||+|||+|+..... .
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--p 164 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--P 164 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC--C
Confidence 99999999999999988999999999999999999999999999999999999999999999999999999987643 5
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh-CCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~ 354 (415)
+++..+.|.||+|||+++....|+.+.|||++|||++|+.+-+|.|.|.++.+++.+|.+.+|+|..+.|.. ..+....
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 678889999999999999989999999999999999999999999999999999999999999999999988 6666677
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.+..++.-...+.......+.++.+||.+||.+||.+||||.|+|+||||++-...
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 77777766666777777889999999999999999999999999999999976544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-58 Score=443.76 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=232.3
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+|...+.||+|||+.||++++..+|+.||+|++.+... .....+.+.+||+|.+.|+|||||+++++|++ ..++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 679999999999999999999999999999999987654 56677889999999999999999999999999 668999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|+|+|..+.+..+..+++.++|.+|+.+++||+.||.|||+++|+|||||..|||++++.+|||+|||+|..+..+.. .
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-r 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-R 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-c
Confidence 999999988888888888999999999999999999999999999999999999999999999999999999875543 3
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
..+.+|||.|+|||++.. ...+..+||||+|||||.||+|+|||...+-.+++..|...--..
T Consensus 175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~---------------- 237 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM---------------- 237 (592)
T ss_pred cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc----------------
Confidence 356799999999999985 679999999999999999999999999999999999986632111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...++.++++||.+||+.||.+|||++++|.|+||
T Consensus 238 -------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 238 -------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 13688999999999999999999999999999999
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-58 Score=422.90 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=234.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+++.+++++.||+|++++... .....+....|..||.+++||.||+++-.|++ ...+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeEE
Confidence 5789999999999999999999999999999999988765 44567889999999999999999999988887 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+|+||+.||.+..++++.+.|+|..++.|+.+|+.||.|||++|||||||||||||||.+|+|+|+|||+|+...... .
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~ 180 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-D 180 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-C
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998654433 3
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
...+.+||+.|||||++.+ ..|+.++|+||||+++||||+|.+||.+.+.....++|.+.....
T Consensus 181 ~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~--------------- 244 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL--------------- 244 (357)
T ss_pred ccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC---------------
Confidence 3456799999999999997 689999999999999999999999999999999999998754111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ----TATAALRSEVSLYMXX 409 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~~~L~h~~f~~~~~ 409 (415)
...-++.+.++||+++|..||++|. .++++-+||||+.++-
T Consensus 245 -------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 245 -------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred -------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 1123788899999999999999996 6899999999998863
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-56 Score=408.39 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=227.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+.+.++.||+|..|+||+|+++.+++.||+|++.. ..+....+++.+|+++++.++||+||++||.|..... .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 3567888999999999999999999999999999953 3567778899999999999999999999999998543 6999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+++.+..+....++++|.....++.+++.||.|||+ ++||||||||+||||+..|+|||||||.+..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999999888887899999999999999999999995 99999999999999999999999999999887654
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR--TEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
...+.+||..|||||.+.+ ..|+.++||||||+.++|+++|+.||... +....+..+...+..++..
T Consensus 233 ~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~---------- 301 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR---------- 301 (364)
T ss_pred hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC----------
Confidence 4577899999999999997 67999999999999999999999999874 2233333333333333221
Q ss_pred CcCCCcchhhhhhhhhcC-CCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFK-DFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
... .+++++.++|..||++||.+|+++.|+|+|||++...+..
T Consensus 302 ---------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 302 ---------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred ---------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 112 3888999999999999999999999999999999776543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-55 Score=417.08 Aligned_cols=264 Identities=31% Similarity=0.456 Sum_probs=234.9
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCC
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 192 (415)
+...+|..++.||.|+|++||+|+++.+++.||||++.+... ....+..+.+|-.+|.+| .||.|++|+-.|.+ ..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EE 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--cc
Confidence 345799999999999999999999999999999999987655 344566778899999999 89999999888887 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+|+||+.+|.+..++.+.+.|.+..++.|+.+|++||+|||++|||||||||||||||.|+++||+|||.|+.+.+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 79999999999888788888889999999999999999999999999999999999999999999999999999887543
Q ss_pred CCC------------CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 014960 273 HKQ------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340 (415)
Q Consensus 273 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 340 (415)
... ...+.+||..|++||++.. ...+..+|+|+||||||.||.|.|||.+.++.-++++|+...-.+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF 306 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence 221 1145899999999998875 778999999999999999999999999999999999998865433
Q ss_pred CHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 341 SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
+ +.+++.+.|||+++|..||.+|+|++++.+||||..++-.
T Consensus 307 p-----------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 307 P-----------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred C-----------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 2 4688999999999999999999999999999999988643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-55 Score=398.54 Aligned_cols=296 Identities=38% Similarity=0.666 Sum_probs=254.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeeeeeEeecC----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRM----S 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~----~ 191 (415)
...|+.+++||+|.||+||+|+++.+|+.||+|+++.+......-....+|+.+|+.|+|+| ||.+++++.... .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35688899999999999999999999999999999876543223345678999999999999 999999987632 2
Q ss_pred CeEEEEEEecccChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASPT---IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
..+++||||+..++...+.... ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3799999999999888777655 4678899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
+.-.. ..++..++|.+|+|||++++...|+...||||+|||++||+++++.|.+..+.+++..|++.+|+|..+.|+..
T Consensus 170 ~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 65322 34677889999999999999889999999999999999999999999999999999999999999999999985
Q ss_pred CCCCCCcCCCcchh-hhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSY-KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXX 413 (415)
Q Consensus 349 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~ 413 (415)
..-........... ...+....+....+..+++.+||+++|.+|.|++.+|.||||..+.....+
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~ 314 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ 314 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence 54444332222222 444566666777899999999999999999999999999999999776553
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-55 Score=389.78 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=234.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||.|+||.|.+++.+.+|..||+|++.+... ...+.+...+|..+|+.+.||+++++++.+.+ ...+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEE
Confidence 5789999999999999999999999999999999987765 56677788899999999999999999988877 67899
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||||++|+.++.++.+.++|++..++.|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
..+.+|||.|+|||++.. .+|+.++|+|+|||++|||+.|.+||...+...+.++|++..-.++
T Consensus 198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP-------------- 261 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP-------------- 261 (355)
T ss_pred -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC--------------
Confidence 467899999999999986 7899999999999999999999999999999999999988654443
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
..++.++++||.++|+.|-.+|. ...++..||||+.+.
T Consensus 262 ---------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 262 ---------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred ---------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 35788999999999999999994 467999999999765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-55 Score=414.65 Aligned_cols=264 Identities=32% Similarity=0.444 Sum_probs=230.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|+++..||+|+||.||+|+.+.||..||+|++++... ..++++.+..|..+|...+.+.||+|+..|.+ ..++|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~LY 217 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYLY 217 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCeeE
Confidence 5899999999999999999999999999999999998765 67778889999999999999999999988888 67899
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC---
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--- 272 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~--- 272 (415)
|||||++||....++.....|++..++.|+.+++.|++.||+.|+|||||||+|+|||..|++||+|||++.-+...
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999988888888889999999999999999999999999999999999999999999999999998543210
Q ss_pred -------------------C-C-----------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHH
Q 014960 273 -------------------H-K-----------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGC 309 (415)
Q Consensus 273 -------------------~-~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~ 309 (415)
. . ......+|||.|+|||++.+ .+|+..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHH
Confidence 0 0 01123589999999999998 66999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCC
Q 014960 310 ILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389 (415)
Q Consensus 310 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 389 (415)
||||||.|.|||.+.+..++..+|++.... ..++ ....++++++|||.+||+ ||
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------l~fP-----------------~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRET--------LKFP-----------------EEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------ccCC-----------------CcCcccHHHHHHHHHHhc-CH
Confidence 999999999999999999999999873211 1111 113567899999999999 99
Q ss_pred CCCCC---HHHHhcCCCCCCCCC
Q 014960 390 AERQT---ATAALRSEVSLYMXX 409 (415)
Q Consensus 390 ~~R~t---~~~~L~h~~f~~~~~ 409 (415)
.+|+- ++|+-.||||+.++=
T Consensus 431 ~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHhcCcccHHHHhcCCccccCCc
Confidence 99996 899999999998863
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=387.97 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=232.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|++.+.||+|.|+.||+|.+..+|+.+|+|++..........+.+.+|+.|-+.|+|||||++.+.+.. ..+.||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEE
Confidence 468999999999999999999999999999999998777766678899999999999999999999998876 678999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC---CcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DfG~a~~~~~~~ 273 (415)
|||+|.|+.+..-+-.+..++|..+-.+++||+++|.|+|.+||||||+||+|+|+-.. ..+||+|||+|.... .
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~ 165 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D 165 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence 99999997655444444578999999999999999999999999999999999999543 359999999998877 3
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......+|||.|||||++.. ..|+..+|||+.|||||.||.|.+||++++...++++|.+..-..+..+|
T Consensus 166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w-------- 236 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW-------- 236 (355)
T ss_pred ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc--------
Confidence 355677899999999999986 67999999999999999999999999999999999999887666655555
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
+.++++.++||++||..||.+|+|+.++|+|||+.+
T Consensus 237 -----------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 237 -----------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -----------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 458999999999999999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=396.70 Aligned_cols=294 Identities=36% Similarity=0.578 Sum_probs=249.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEee---cCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS---RMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~~~ 194 (415)
..|..++.||+|+||.|..|.++.+|+.||||++...-...-..++..||+.+|+.++|+||+.+.+++.. ..-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45666899999999999999999999999999997433345566788899999999999999999998865 234679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC-
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH- 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~- 273 (415)
|+|+|+|+.++...+.. +..+++..+..++.||+.||.|+|+.+|+||||||.|+|++.+..+||+|||+|+..++..
T Consensus 102 YiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 99999998777765544 4469999999999999999999999999999999999999999999999999999876431
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....+..+.|.||.|||++.....|+.+.||||+||||.|||+|++.|.|.+...++..|++.+|.|+.+.+........
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 23457778899999999998888999999999999999999999999999999999999999999999887766442211
Q ss_pred --CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 354 --TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 354 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
.+...++.-+..+...++..++.+++|+.+||.+||.+|+|++|+|+||||..+-+.+.
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 11112222223356677788999999999999999999999999999999998877654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=391.43 Aligned_cols=262 Identities=29% Similarity=0.438 Sum_probs=230.0
Q ss_pred CCCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 114 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
....++|.+.+.||+|+||+||+|+++.++..||||.+.+.......++.+..|+.+|+.++|||||++++++.. +.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~ 83 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDF 83 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCe
Confidence 345678999999999999999999999999999999999887778888999999999999999999999999988 568
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC------CcEEEEeecccc
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE------GILTIADFGLAS 267 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~------~~vkl~DfG~a~ 267 (415)
+|+|||||.|+.+..++...+.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999888899999999999999999999999999999999999999775 359999999999
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
.+.++. ...+.+|+|.|||||++.. ..|+.++|+||+|+|||+|++|++||...+..+.+..+.+.....+
T Consensus 164 ~L~~~~--~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~------ 234 (429)
T KOG0595|consen 164 FLQPGS--MAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP------ 234 (429)
T ss_pred hCCchh--HHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC------
Confidence 987543 3466799999999999974 7899999999999999999999999999999988876554321111
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.....++....+|+...|..+|.+|.+..+-+.|+++..
T Consensus 235 --------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 235 --------------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred --------------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 111235666778999999999999999999999988654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=389.52 Aligned_cols=284 Identities=36% Similarity=0.592 Sum_probs=241.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC---eEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC---SLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~---~~~ 195 (415)
.|.-.+++|+|+||.||+|....+++.||||.+..+..- -.+|+++|+.++|||||+++-+|....+. ++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 578889999999999999999999999999998765432 22699999999999999999888665444 677
Q ss_pred EEEEecccChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-CcEEEEeeccccccCC
Q 014960 196 LVFKYMEHDLAGLAAS---PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDP 271 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DfG~a~~~~~ 271 (415)
+|||||+..+...+.. .+..++...++-|+.||+.||.|||+.||+||||||.|||||.+ |.+||||||.|+.+.+
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999887766542 45688999999999999999999999999999999999999986 8999999999999877
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
+... .+...|..|+|||.+.|...|+.+.||||.||++.||+-|++.|.|++..+++..|.+..|.|+.+.-..+...
T Consensus 179 ~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 GEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 6433 55667999999999999999999999999999999999999999999999999999999999998876654432
Q ss_pred CCCcCCCcchhhhhhhh-hcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAE-TFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.. .+..++.-...+.+ .....++++.+|+.++|.++|.+|.++.|+|.||||+.+++..
T Consensus 257 y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 257 YT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred cc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 11 12222222222223 4567899999999999999999999999999999999999873
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-52 Score=406.20 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=231.9
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCC
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~ 192 (415)
...++|.++++||+|+||+|+++..+.+++.||||+++++.. ..+.++....|..|+...+ ||.+++++..|.. ..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~ 442 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KE 442 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CC
Confidence 346899999999999999999999999999999999999876 6778888999999999885 9999999999988 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
++|+||||+.|+. ..++.....|++..++.|+..|+.||.|||++||||||||.+|||||.+|.+||+|||+++.--..
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 8999999999988 445556668999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
....++.+|||.|||||++.+ ..|+.++|+|+|||+|||||.|.+||.|.+++++++.|+..-..
T Consensus 522 -g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~------------- 586 (694)
T KOG0694|consen 522 -GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR------------- 586 (694)
T ss_pred -CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 234577899999999999987 78999999999999999999999999999999999999764211
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~L~h~~f~~~~ 408 (415)
+...++.++.++++++|..||++|+-+ +++..||||+.++
T Consensus 587 ----------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 587 ----------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred ----------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 123578899999999999999999986 7888999999886
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=380.82 Aligned_cols=250 Identities=29% Similarity=0.491 Sum_probs=219.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+|+++++||+|+||.||++.+..+|..+|.|.+..+..+....+....|+.+|++|+|||||++++.-.......++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45799999999999999999999999999999999988788888889999999999999999999998433333456999
Q ss_pred EEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 197 VFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHN--QH--VLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 197 v~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~--ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
|||+|.++.+..++ .....++|..+|.++.|+|.||.+||+ .. |+||||||.||+|+.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999988776655 346679999999999999999999998 55 99999999999999999999999999999
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
+.... ....+.+|||+||+||++.+ .+|+.+|||||+||++|||+.-.+||.|.+-.+...+|.+.-..|-..
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~----- 250 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD----- 250 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-----
Confidence 87643 44567899999999999986 789999999999999999999999999998888888887753222110
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 395 (415)
..++.++..||..|++.||+.||+.
T Consensus 251 ----------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ----------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2478889999999999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-53 Score=409.18 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=235.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecC-CCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.+-|++++.||.|+.|.|-+|++..||+.+|||++.+. .........+.+||.||+-+.||||+++|++|+. ..++|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~ly 88 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLY 88 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEE
Confidence 45699999999999999999999999999999999876 3445556678899999999999999999999998 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+|.||+.+|.++.++-..+++++.+++.+++||+.|+.|||..+|+||||||+|+||+..++|||+|||+|..-.++ .
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--k 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--K 166 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--c
Confidence 99999999988888888889999999999999999999999999999999999999999999999999999876554 3
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
...+.+|+|.|.|||+++|..+.+.++||||+|||||.||+|+.||.+.+-...+.++.+....
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~---------------- 230 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE---------------- 230 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc----------------
Confidence 4566799999999999999888899999999999999999999999998888888888775432
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
....++.++.+||.+||..||.+|+|.+|++.|||+..-...
T Consensus 231 -------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 231 -------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 224689999999999999999999999999999998765543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=393.70 Aligned_cols=265 Identities=30% Similarity=0.431 Sum_probs=228.5
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC------------hHHHHHHHHHHHHHHhCCCCceeeee
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE------------PESVRFMAREILILRRLDHPNVVKLE 183 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~l~ 183 (415)
..++|++++.||+|.||.|-+|++..+++.||||++.+.... ....+.+.+||.||++|.|+|||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 468999999999999999999999999999999999764321 11245888999999999999999999
Q ss_pred eeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
++..++....+|||+|||..+-....-.....+++.+++.|+++++.||+|||.+|||||||||+|+||+.+|+|||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99999989999999999998776655554544999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC----CCCcccccccCccCCcccccC---CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014960 264 GLASFFDPNH----KQPMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336 (415)
Q Consensus 264 G~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 336 (415)
|.+..+..+. .......+|||.|+|||...+ ....+.+.||||+||+||-|+.|+.||.+....+.+.+|.+.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998763221 122334689999999999876 234678999999999999999999999999999999999876
Q ss_pred cCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
...++. .+++.++++|||++||++||.+|++..++..|||...-
T Consensus 335 pL~fP~---------------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 335 PLEFPE---------------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccCCC---------------------------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 443322 23577889999999999999999999999999998765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=400.71 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=224.2
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCC
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLD-HPNVVKLEGLVTSRMS 191 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~ 191 (415)
..+.|.+.+.||+|+||.|+.|++..++..||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 356899999999999999999999999999999988765221 234567779999999998 99999999999884
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-CcEEEEeeccccccC
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFD 270 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DfG~a~~~~ 270 (415)
..+|+||||+.++.+...+...+++.|.+++.+|+||+.|++|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 4599999999986555555557899999999999999999999999999999999999999999 999999999998874
Q ss_pred CCCCCCcccccccCccCCcccccCCc-CCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.......+.+||+.|+|||++.+.. ..+.++||||+||+||.|++|..||...+......+|.+.....
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~--------- 242 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI--------- 242 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC---------
Confidence 3334567889999999999998855 45689999999999999999999999988888887765532221
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCC-CCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDF-PPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
...+ +.++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 243 --------------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 243 --------------------PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1234 888999999999999999999999999999996
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=380.54 Aligned_cols=263 Identities=26% Similarity=0.330 Sum_probs=229.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||.|.-|+||+|+...++..+|+|++.++.. ..+...+.+.|.+||+.++||.+++||..|+. +.+.|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeE
Confidence 4789999999999999999999999999999999998765 35667788889999999999999999999988 67899
Q ss_pred EEEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC--
Q 014960 196 LVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP-- 271 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~-- 271 (415)
++||||.|+.+..+.+ ....|++..++.|+.+++.||+|||..|||+||||||||||.++|+|.|+||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999987776654 466899999999999999999999999999999999999999999999999998754310
Q ss_pred -------------------------------CCC----------------------CCcccccccCccCCcccccCCcCC
Q 014960 272 -------------------------------NHK----------------------QPMTSRVVTLWYRPPELLLGATDY 298 (415)
Q Consensus 272 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 298 (415)
... ......+||-+|+|||++.| .+.
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GH 312 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGH 312 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCC
Confidence 000 01124689999999999998 568
Q ss_pred CchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChH
Q 014960 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSL 378 (415)
Q Consensus 299 ~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (415)
+.++|||+|||+|||||.|..||.|.+..+.+.+|+.....++.. +.++.+++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~---------------------------~~vs~~ak 365 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE---------------------------PEVSSAAK 365 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC---------------------------CcchhHHH
Confidence 999999999999999999999999999999999997654333221 25678899
Q ss_pred HHHHHhcccCCCCCCC----HHHHhcCCCCCCCCC
Q 014960 379 PLIETLLAIDPAERQT----ATAALRSEVSLYMXX 409 (415)
Q Consensus 379 ~li~~~L~~dP~~R~t----~~~~L~h~~f~~~~~ 409 (415)
|||+++|.+||.+|+. |+|+-+||||+.++=
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 9999999999999999 999999999999873
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=386.55 Aligned_cols=283 Identities=38% Similarity=0.685 Sum_probs=234.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||.|+||.||+|++..++..||+|++..... ......+.+|+.++++++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 4679999999999999999999999999999999975432 2223456789999999999999999999876 457999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 99999988777665555568999999999999999999999999999999999999999999999999997654322 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC--C
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA--T 354 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~ 354 (415)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.|+....... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 34457799999999987666789999999999999999999999999999999999999999999998876432211 0
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...+. ............++.++++||.+||.+||.+|||++|+|+||||
T Consensus 240 ~~~~~-~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQ-YRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCc-cCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 01111 00111223345678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=381.11 Aligned_cols=284 Identities=33% Similarity=0.558 Sum_probs=232.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||+|++..+++.||+|++..........+.+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 36999999999999999999999999999999998665444456678889999999999999999999877 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++++..+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999998887766566799999999999999999999999999999999999999999999999999987654333333
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC---C
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA---T 354 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~ 354 (415)
....|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+..+...+........ .
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 44578999999999876 5689999999999999999999999999888888888877777666555443111100 0
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
..................++.++.+||++||+.||++|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000111122234578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-51 Score=392.20 Aligned_cols=264 Identities=32% Similarity=0.475 Sum_probs=234.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~ 194 (415)
...|++.+.||+|.||.||+|+++.+|+.||+|.+.+.... ......+.+|+.+|+++. |||||+++++|++. ..+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeE
Confidence 46799999999999999999999999999999999877653 335678899999999998 99999999999984 579
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC----CcEEEEeeccccccC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE----GILTIADFGLASFFD 270 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DfG~a~~~~ 270 (415)
|+|||++.|+.+...+... .++|..+..+++||+.++.|||+.||+||||||+|||+... +.+|++|||++....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999988777666554 49999999999999999999999999999999999999643 479999999999887
Q ss_pred CCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
. .......+||++|+|||++.. ..|+..+||||+|+++|.|++|.+||++.+..+...+|.+....+..++|
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w----- 262 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW----- 262 (382)
T ss_pred C--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc-----
Confidence 6 345677899999999999975 67999999999999999999999999999999999999887766666665
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
+.+++.++++|++||..||.+|+|+.++|+|||++......
T Consensus 263 --------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 263 --------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred --------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 45889999999999999999999999999999988875443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=382.12 Aligned_cols=289 Identities=34% Similarity=0.593 Sum_probs=231.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999998754322 223456689999999999999999999987 457999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 99999998888777666679999999999999999999999999999999999999999999999999987543222 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+. +..+.+..+....+.+....|+.........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 344578999999999876667899999999999999999999999874 4456777777777777777776533211100
Q ss_pred -CCCcchhhhhhhhhc--CCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 356 -FKPQQSYKRCIAETF--KDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 356 -~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
..........+.... ..++.++.+||.+||+.||++|||++|+|+||||+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 000000000111111 135678899999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-52 Score=394.46 Aligned_cols=256 Identities=32% Similarity=0.469 Sum_probs=228.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+..........+.+|++|++.|+|||||.+++.|+. ..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 57899999999999999999999999999999999988878888899999999999999999999999998 6679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
+||+.|++. .++.....++|+.++.++.+++.||.|||+++|+|||+||.|||++..|.+|+||||+|+....+. ...
T Consensus 80 te~a~g~L~-~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vl 157 (808)
T KOG0597|consen 80 TEYAVGDLF-TILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVL 157 (808)
T ss_pred ehhhhhhHH-HHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-eee
Confidence 999999554 555666689999999999999999999999999999999999999999999999999999876543 445
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
+..-|||.|||||++.+ ..|+..+|+||||||+|||.+|+|||......+....|......++
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p---------------- 220 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP---------------- 220 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----------------
Confidence 66789999999999986 7899999999999999999999999998777777777765432222
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
..++.+++++++.+|.+||.+|+|..+++.|||++.-
T Consensus 221 -------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 221 -------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred -------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 2477889999999999999999999999999998754
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-52 Score=363.34 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=232.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL------EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
..|.-.+.||+|..+.|.+|.++.+|+.+|+|++..... ..+-.+...+|+.||+++ .||+|+++.++|+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 356667889999999999999999999999999975432 123345566799999998 69999999999988
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
+..+|+|+|+|..+.+++++...-.++|...+.|++||++|++|||.++||||||||+|||++++.++||+|||++..+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 67899999999999999988888899999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCcccccccCccCCccccc-----CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLL-----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
++. .....+|||+|+|||.+. +..+|+..+|+|++|||||.||.|.|||+.....-.+..|++....+.+..|
T Consensus 175 ~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred Cch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 764 357789999999999884 3457899999999999999999999999999999999999998877777666
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.+++++++|||.+||..||.+|+|++++|+||||..
T Consensus 253 -------------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 253 -------------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred -------------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 468999999999999999999999999999999943
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=380.60 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=214.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.+|...+.||+|+||.||++.+..+|..+|+|.+...... ..+.+.+|+.+|++++|||||+++|.........+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 4688889999999999999999999999999999876322 26778999999999999999999997544322379999
Q ss_pred EEecccChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEeeccccccCC--CC
Q 014960 198 FKYMEHDLAGLAASPTI-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDP--NH 273 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~--~~ 273 (415)
|||+.++.+..++...+ .++|..++.+.+||++||+|||++|||||||||+||||+. ++.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999988877776654 7999999999999999999999999999999999999999 79999999999987763 22
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
........||+.|||||++........++|||||||++.||+||++||... .+....++.......
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~------------ 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDS------------ 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCC------------
Confidence 222345789999999999985223335999999999999999999999873 222223333221110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.......++++++++|.+||..||.+||||+++|+|||.+.-..
T Consensus 241 ------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 241 ------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 11222458889999999999999999999999999999976443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-51 Score=336.65 Aligned_cols=289 Identities=38% Similarity=0.657 Sum_probs=252.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
..|...++||+|.||+||+|++..+++.||+|.++.+.-+...-....+||-+|+.++|.|||+++++... +..+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 35778899999999999999999999999999999877655555566789999999999999999998765 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
+|||..++...+..-++.+..+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+++-++-.- ..+
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 9999999999999889999999999999999999999999999999999999999999999999999998876433 234
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
+..+.|.+|.+|+++.|..-|+...|+||.|||+.|+.. |+|.|.|.+..+++..|++.+|.|..+.|+......+...
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 566789999999999998999999999999999999985 9999999999999999999999999999998554444332
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.+--+..-.++...+.+.....||++++|..+|.+|++++.+|+||||.+..+
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP 291 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence 22222223356667778888999999999999999999999999999987643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=391.84 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=227.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
...|....+||+|+.|.||.|+...+++.||||++.+.... ..+.+.+|+.+|+.++|+|||.+++.|... ..+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEE
Confidence 45788889999999999999999999999999999876543 345688999999999999999999988763 56999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||++|+.+.+..... .++|.+++.|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+..... .
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999999888877665 599999999999999999999999999999999999999999999999999998876543 5
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
..+.+|||+|||||++.. ..|+++.||||||++++||+-|.|||-.++....+..|.. .|.|...
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk------------- 490 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK------------- 490 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC-------------
Confidence 677899999999999985 7899999999999999999999999998887777666654 2333222
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
....++..+++++.+||+.|+.+|++|.++|+||||+-..
T Consensus 491 ------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 491 ------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred ------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 2246889999999999999999999999999999995443
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=396.81 Aligned_cols=286 Identities=30% Similarity=0.476 Sum_probs=228.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec------C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------M 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~ 190 (415)
..+|.+++.||+|+||.||+|++..+++.||||++.... ....+|+.+|+.++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 467999999999999999999999999999999886432 2344799999999999999999876432 1
Q ss_pred CCeEEEEEEecccChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLA 266 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a 266 (415)
...+++||||+++++...+. .....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23578999999987655432 3456799999999999999999999999999999999999999765 7999999999
Q ss_pred cccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
..+..... .....||+.|+|||++.+...++.++|||||||+||||++|.+||.+.+..+.+..+.+..+.+..+.+.
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 87654322 2345789999999998776679999999999999999999999999999999999999999888877665
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
........+..+......+........++++++||.+||.+||.+|+|+.|+|+||||+.+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 4321111110011001111111223567889999999999999999999999999999987653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=370.47 Aligned_cols=272 Identities=24% Similarity=0.364 Sum_probs=225.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||.|..++||+|+...++..||||++..+....+ ...+++|+..|+.++||||++++..|.. +..+|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeEE
Confidence 5789999999999999999999999999999999998876544 7889999999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||.||.++....++.. ...+.|..++.|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+-....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999998766655543 23489999999999999999999999999999999999999999999999998765433221
Q ss_pred C---CcccccccCccCCcccc-cCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 275 Q---PMTSRVVTLWYRPPELL-LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 275 ~---~~~~~~gt~~y~aPE~~-~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
. .+...+||++|||||++ ....+|+.++|||||||+..||.+|..||..-.....+...++ +.|+.-. ..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~--t~-- 255 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLL--TS-- 255 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCcc--cc--
Confidence 1 11556899999999994 4456799999999999999999999999998777666544433 3332110 00
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
..-.+..+.++.+++++|..||.+||++|||++++|.|+||+.....
T Consensus 256 -------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 256 -------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred -------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 01223345678899999999999999999999999999999987653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=382.20 Aligned_cols=292 Identities=34% Similarity=0.516 Sum_probs=231.1
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC---CCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~~~ 195 (415)
+|++.+.||+|+||.||+|++..++..||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 489999999999999999999999999999998754333344456788999999999999999999875432 23589
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~- 274 (415)
+||||+++++...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999887665544 445799999999999999999999999999999999999999999999999999976432211
Q ss_pred -CCcccccccCccCCcccccC-CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 -QPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.+....+..+....+.+....+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 12234578999999998754 2468899999999999999999999999998888888888888887766554422110
Q ss_pred CCcC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.... .-............+.++.++.++|.+||+.||++|||++++|+||||+.+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~ 300 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence 0000 0000000112333456788899999999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=376.73 Aligned_cols=289 Identities=35% Similarity=0.643 Sum_probs=238.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.++||+|+||.||+|++..+++.||+|.+...... .....+.+|+.++++++|+||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEE
Confidence 46899999999999999999999999999999999765432 223456689999999999999999999887 457999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 99999998887776666678999999999999999999999999999999999999999999999999987654322 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc-
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI- 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 355 (415)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....|+.........
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 2345678999999998766678999999999999999999999999999999999999999999888887643221110
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
...............+.++.++++||.+||..||.+|||++|+|+||||+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 000000011122334567889999999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=388.98 Aligned_cols=279 Identities=29% Similarity=0.493 Sum_probs=227.9
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-C-----CceeeeeeeEeecCCC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-H-----PNVVKLEGLVTSRMSC 192 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~l~~~~~~~~~~ 192 (415)
+|.+++.||+|+||.|.+|++..+++.||||+++.. ......-..|+.+|..|+ | -|+|+++++|.. ..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cc
Confidence 689999999999999999999999999999999844 444556667999999996 3 489999999998 46
Q ss_pred eEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC--cEEEEeecccccc
Q 014960 193 SLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG--ILTIADFGLASFF 269 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~--~vkl~DfG~a~~~ 269 (415)
++|||+|++...|..++... ...|+...++.++.||+.||.+||+.+|||+|||||||||.+-+ .|||+|||++...
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 79999999999888877654 34699999999999999999999999999999999999997644 6999999999876
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
...- ...+-+..|+|||+++| ..|+.+.||||||||+.||++|.|+|.|.++.+++..|++.+|.|+...+....
T Consensus 342 ~q~v----ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQRV----YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCcc----eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5322 25566889999999998 789999999999999999999999999999999999999999999987766543
Q ss_pred CCCCCcCCCcchhhh-----------------------hhhhhcC------------CCCCChHHHHHHhcccCCCCCCC
Q 014960 350 LPHATIFKPQQSYKR-----------------------CIAETFK------------DFPPSSLPLIETLLAIDPAERQT 394 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~-----------------------~~~~~~~------------~~~~~~~~li~~~L~~dP~~R~t 394 (415)
-... ++.....+.+ ......+ .-...++|+|++||.+||.+|+|
T Consensus 417 ~~~k-ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 417 KAHK-FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred ccce-ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 3211 1111000000 0000011 11134799999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 014960 395 ATAALRSEVSLYMX 408 (415)
Q Consensus 395 ~~~~L~h~~f~~~~ 408 (415)
+.++|+||||....
T Consensus 496 p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 496 PAQALNHPFLTGTS 509 (586)
T ss_pred HHHHhcCccccccc
Confidence 99999999998443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=370.41 Aligned_cols=282 Identities=38% Similarity=0.622 Sum_probs=225.7
Q ss_pred CCceeeeeeccCCceEEEEEEECC-CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeeeeeEee---cC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTS---RM 190 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~---~~ 190 (415)
++|++.+.||+|+||.||+|++.. ++..||+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999854 568899999876544333334555677777766 69999999998753 22
Q ss_pred CCeEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
...+++||||+.+++...+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4568999999998776665432 345899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+.++....+.+....|+...
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 433 22344568999999999875 568999999999999999999999999999999999999988887777776532
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
......+... -...+....++++..+.+||.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1111111100 0111333445688899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=370.26 Aligned_cols=290 Identities=37% Similarity=0.664 Sum_probs=239.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||.|+||.||+|++..++..||+|.+..... ......+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEE
Confidence 5789999999999999999999999999999999875532 2223456789999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 160 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 160 (301)
T ss_pred EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cc
Confidence 99999988877776666678999999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC-Cc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA-TI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~ 355 (415)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+....|+....... ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 23446689999999987656788999999999999999999999999998888989998888888877765321111 01
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
...+.....+.......++.++.+||.+||+.||.+|||++++|+||||+.+.+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 1111112223334445778899999999999999999999999999999998843
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=385.18 Aligned_cols=289 Identities=31% Similarity=0.467 Sum_probs=232.4
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC---CCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~~~ 195 (415)
+|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++.... ....|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999999999999999998754334445567889999999999999999999987632 12689
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.+++...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999999877765544 447999999999999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC-C
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA-T 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~ 354 (415)
......+++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+.+..+.+..+.+..+.+........ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 344557899999999998766689999999999999999999999999999999999999988887665433110000 0
Q ss_pred cC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 355 IF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
+. ....+............++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00 0000000011122345678899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=373.53 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=218.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 368999999999999999999999999999999975432 23345678899999999999999999998876 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999998777666666668999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------- 216 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE----------------- 216 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC-----------------
Confidence 234568999999999876 56899999999999999999999999998887777776543211
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMXX 409 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~~ 409 (415)
....++..+++||++||..||.+|++ ++++++|+||+.++.
T Consensus 217 ------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 217 ------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred ------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 11245677899999999999999995 999999999987653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=387.56 Aligned_cols=283 Identities=23% Similarity=0.296 Sum_probs=218.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC------CceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH------PNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~l~~~~~~~~ 190 (415)
.++|+++++||+|+||.||+|++..+++.||||+++... .....+..|+.+++.+.| .+++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 478999999999999999999999999999999996432 223345667888777754 4588999888764
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCC-------------
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEG------------- 256 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~------------- 256 (415)
..++|+|||++++.++..+... ..+++..++.|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 4579999999988777665543 479999999999999999999997 5999999999999998765
Q ss_pred ---cEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014960 257 ---ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333 (415)
Q Consensus 257 ---~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i 333 (415)
.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..+
T Consensus 283 ~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCcc----ccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998754321 2345678999999999986 67999999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHhhCCCCCCC-------c---CCCcchhhhhhhhh-cC--CCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 334 FKLCGSPSEEYWKKSKLPHAT-------I---FKPQQSYKRCIAET-FK--DFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~-------~---~~~~~~~~~~~~~~-~~--~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.+..+.++..++......... . ......+....... .. .....+.|||.+||.+||.+|||++|+|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 998888876654332111100 0 00000000000000 00 01345789999999999999999999999
Q ss_pred CCCCCCCCC
Q 014960 401 SEVSLYMXX 409 (415)
Q Consensus 401 h~~f~~~~~ 409 (415)
||||.....
T Consensus 438 Hp~~~~~~~ 446 (467)
T PTZ00284 438 HPYVLKYYP 446 (467)
T ss_pred CccccccCC
Confidence 999987543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=378.36 Aligned_cols=256 Identities=24% Similarity=0.326 Sum_probs=218.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|.+.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEE
Confidence 5789999999999999999999999999999999976432 23345678899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 999999987776666666689999999999999999999999999999999999999999999999999998764322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 173 --~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---------------- 233 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK---------------- 233 (329)
T ss_pred --ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC----------------
Confidence 24578999999999876 56899999999999999999999999988877776666442110
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
....++..+++||.+||+.||.+|++ ++++++||||+..+
T Consensus 234 -------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 234 -------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred -------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 01235677899999999999999997 79999999998753
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=376.35 Aligned_cols=287 Identities=30% Similarity=0.502 Sum_probs=227.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~ 192 (415)
.++|++.+.||+|+||.||+|++..+|..||+|++............+.+|+.+++.++|+||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999999999999999997654444556677889999999999999999998865321 3
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+||||+++++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 589999999998776543 25789999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC--
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-- 350 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 350 (415)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+..+.+..+.+.....
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 22344578999999999976 5789999999999999999999999999988888888888887776654433110
Q ss_pred -------CCCCcCCCcchhhhh----hhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 351 -------PHATIFKPQQSYKRC----IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 351 -------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
+..........+..+ ........+.++++||.+||..||++|||++|+|+||||+.+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 000000000000000 01111234677899999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=382.37 Aligned_cols=284 Identities=24% Similarity=0.330 Sum_probs=218.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
...|++++.||+|+||.||+|++..+++.||+|.... ..+.+|+.++++++||||+++++++.. ....++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence 4679999999999999999999999999999996532 245689999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||++.+++...+.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 161 v~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999998877665544 3478999999999999999999999999999999999999999999999999997543322223
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT-------EVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ....+..+.+..+.++.+++....
T Consensus 240 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 345678999999999876 578999999999999999999998776432 344566666666655433211000
Q ss_pred CCCCCcC------CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 350 LPHATIF------KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 350 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
......+ .......+........++.++.+||.+||+.||.+|||++|+|+||||+.+.+.-+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 387 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP 387 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCC
Confidence 0000000 00000000001112245778999999999999999999999999999999876644
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-49 Score=376.97 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=213.0
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.++++++|+||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999986432 23445667789999999999999999999887 567999999999
Q ss_pred cChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccc
Q 014960 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (415)
Q Consensus 203 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~g 282 (415)
++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccceec
Confidence 98777766666789999999999999999999999999999999999999999999999999987543221 22344578
Q ss_pred cCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchh
Q 014960 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (415)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (415)
|+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+......
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------------- 213 (323)
T cd05571 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----------------------- 213 (323)
T ss_pred CccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------
Confidence 999999999876 67899999999999999999999999988776666655432110
Q ss_pred hhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 014960 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYM 407 (415)
Q Consensus 363 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~ 407 (415)
....++.++.+||.+||..||++|| ++.++++|+||..+
T Consensus 214 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 214 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 1134678899999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=344.64 Aligned_cols=256 Identities=31% Similarity=0.437 Sum_probs=227.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|-||.||+|+.+.++-.||+|++.+... .......+.+|++|...|+||||+++|++|-+ ....|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeE
Confidence 5789999999999999999999999999999999987654 33445678999999999999999999999988 56799
Q ss_pred EEEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 196 LVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+++||..++.+...+. ...++++..++.|+.|++.||.|||.++|+||||||+|+|++.++.+||+|||.+.....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-- 176 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 176 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence 9999999876555544 667899999999999999999999999999999999999999999999999999976542
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....+.+||..|.+||...+ ..++..+|+|++|++.||+|.|.+||...+..+.++.|.+.....+
T Consensus 177 -~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p------------ 242 (281)
T KOG0580|consen 177 -NKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP------------ 242 (281)
T ss_pred -CCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC------------
Confidence 34577899999999999887 6789999999999999999999999999998899998887543222
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
..++.++.|||.+||.++|.+|.+..|++.|||...+
T Consensus 243 -----------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 243 -----------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred -----------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 3588999999999999999999999999999998654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=379.84 Aligned_cols=262 Identities=25% Similarity=0.322 Sum_probs=216.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||+|++..+++.||||++.+... .......+.+|+.++..++|+||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 479999999999999999999999999999999976432 23445678889999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-- 274 (415)
||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999887777766667899999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCC
Q 014960 275 --------------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP 322 (415)
Q Consensus 275 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~ 322 (415)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123579999999999876 578999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCC---CCCCHHHHh
Q 014960 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA---ERQTATAAL 399 (415)
Q Consensus 323 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~R~t~~~~L 399 (415)
+.+..+...++.+....... .....+++++++||.+|+. +|. .||++++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~-------------------------p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETLIF-------------------------PPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCcccC-------------------------CCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 98888887777652211100 0012467789999999876 454 458999999
Q ss_pred cCCCCCCCC
Q 014960 400 RSEVSLYMX 408 (415)
Q Consensus 400 ~h~~f~~~~ 408 (415)
+||||+.++
T Consensus 292 ~hp~f~~~~ 300 (363)
T cd05628 292 TNPFFEGVD 300 (363)
T ss_pred CCCCCCCCC
Confidence 999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=365.66 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=214.2
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++|+||+++++++.. ....++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 378899999999999999999999999999998765432 2334467789999999999999999998877 4579999
Q ss_pred EEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+.++.+..... ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999876654432 23468999999999999999999999999999999999999999999999999998754322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 2244578999999999986 5789999999999999999999999988665443333332221111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMXX 409 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~~ 409 (415)
......++.++.+||++||+.||.+|++ ++++++||||+.++.
T Consensus 222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 1122357888999999999999999997 899999999998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=363.07 Aligned_cols=281 Identities=36% Similarity=0.636 Sum_probs=225.3
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeeeeeEeec---CCC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTSR---MSC 192 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~---~~~ 192 (415)
+|++.+.||+|+||.||+|++..+++.||+|.+............+.+|+.+++.+ +|+||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48899999999999999999999999999999876433222223455677777665 799999999987542 234
Q ss_pred eEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..+++|||+.+++...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999998776655432 34589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+.++....+.+....|+.....
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 QM--ALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cc--cCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 22 2234567999999999876 56899999999999999999999999999888889999888887777777642211
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
....+.. ..........+.+++++.+||.+||+.||++|||+.++|.||||
T Consensus 238 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSP--RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCC--CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1111111 11122344445678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=362.11 Aligned_cols=283 Identities=40% Similarity=0.694 Sum_probs=230.4
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|++|.||+|++..++..||+|.+............+.+|+.+++.++|+||+++++++.+ +..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4889999999999999999999999999999987654434445667889999999999999999999987 56799999
Q ss_pred EecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 199 KYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 199 e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||+.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 9999876655433 23578999999999999999999999999999999999999999999999999997654332 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+.+..+.+....|+..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23346688999999987656678999999999999999999999999888888888888777777777764332211111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
................++.+++++|.+||+.||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 111111122333445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=375.90 Aligned_cols=289 Identities=27% Similarity=0.483 Sum_probs=230.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
.++|.+.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999999999999999999765444455567788999999999999999999875421 24
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+||||+.+++...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 589999999998776553 25789999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...++.+..+.+..+.+.......
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 F--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred C--cccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2 2244578999999999876 678999999999999999999999999999999999998888887766554422110
Q ss_pred CCc---------CCCcchh----hhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 353 ATI---------FKPQQSY----KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 353 ~~~---------~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
... +.....+ ...........+.++++||.+||..||.+|||+.++|+||||..+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 328 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 328 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence 000 0000000 0001111122355789999999999999999999999999998755543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=362.73 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=230.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
..+|++.+.||+|.||.|-+|++...|+.||||.|+++.. +....-.+.+||+||..|+||||+++|++|+.+ ..+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk--dKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK--DKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC--ceEE
Confidence 3689999999999999999999999999999999998876 456677899999999999999999999999984 4699
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||||..++.+.+++...+.++|.+++.+|+||..|+.|||.++++|||||.+|||+|.++++||+|||++..+... .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--K 207 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999887643 4
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
..++++|+|-|.+||++.|..+-++.+|.|||||+||.|+.|..||.|.+......+|.+..-.
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---------------- 271 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---------------- 271 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc----------------
Confidence 5678899999999999999877789999999999999999999999999988888888653211
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
-+.-|.+..-||+.||..||++|.|++++-.|=|+.
T Consensus 272 --------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 --------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 133566778899999999999999999999997764
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=362.55 Aligned_cols=283 Identities=40% Similarity=0.656 Sum_probs=230.4
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|+||.||+|++..+|+.||+|.+............+.+|+.+++.++|+||+++++++.+ ...+|+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4889999999999999999999999999999997654433334567789999999999999999999887 55799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
||++++++..+......+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 999998887776656679999999999999999999999999999999999999999999999999998664332 2223
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....|............
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456788999999987756678999999999999999998766 5666777788888888888777777653321111111
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
........+....+.+++++.+||.+||..||.+|||++++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11111111234445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=379.26 Aligned_cols=262 Identities=28% Similarity=0.395 Sum_probs=218.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++|+||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 369999999999999999999999999999999986432 23445678889999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ- 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~- 275 (415)
||||+.++.+...+.....+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999998877776666668999999999999999999999999999999999999999999999999998754321100
Q ss_pred ------------------------------------CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCC
Q 014960 276 ------------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319 (415)
Q Consensus 276 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~ 319 (415)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 0112468999999999875 678999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC---HH
Q 014960 320 IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---AT 396 (415)
Q Consensus 320 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ 396 (415)
||.+.+..+....+.+...... ......+++++++||.+||. ||.+|++ ++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQ-------------------------FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccC-------------------------CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9998887777666643211100 00012467789999999997 9999998 99
Q ss_pred HHhcCCCCCCCC
Q 014960 397 AALRSEVSLYMX 408 (415)
Q Consensus 397 ~~L~h~~f~~~~ 408 (415)
++|+||||+.++
T Consensus 292 ~ll~h~~~~~~~ 303 (364)
T cd05599 292 EIKSHPFFKGVD 303 (364)
T ss_pred HHhcCCCcCCCC
Confidence 999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=365.98 Aligned_cols=278 Identities=35% Similarity=0.605 Sum_probs=215.8
Q ss_pred eeeeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 123 LDKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
.++||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.++++++||||+++++++....+..+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 368999999999999865 4678999999875432 2346689999999999999999999876656789999999
Q ss_pred cccChhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE----cCCCcEEEEeeccccc
Q 014960 201 MEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASF 268 (415)
Q Consensus 201 ~~~~l~~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DfG~a~~ 268 (415)
+++++...... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99877655432 12358999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCCCC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 014960 269 FDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLC 337 (415)
Q Consensus 269 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~ 337 (415)
...... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... ...+..+++..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 654321 1223457899999999998756789999999999999999999999976442 35677888888
Q ss_pred CCCCHHHHhhCCCCCCC-c--------CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 338 GSPSEEYWKKSKLPHAT-I--------FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 338 ~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
+.+....|......... . ..........+.......+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 88887777663221110 0 0000011111122222345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=373.68 Aligned_cols=263 Identities=26% Similarity=0.355 Sum_probs=221.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||+|++..+++.||||++.+... .......+.+|+.++..++|+||+++++++.. ....|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 369999999999999999999999999999999986532 23345678889999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999999887777776667899999999999999999999999999999999999999999999999999976543 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+...........
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------ 221 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV------------ 221 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC------------
Confidence 345678999999999886 5789999999999999999999999999888777766654321110000
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.......+++++++||.+||..+|.+|++++++++||||+.+.
T Consensus 222 ---------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 222 ---------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred ---------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 0000135688899999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=375.32 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=218.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC-ceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.+... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 106 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYL 106 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCEE
Confidence 468999999999999999999866554 6899999875432 23445678889999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999988777777766678999999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.+....
T Consensus 185 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 246 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--------------- 246 (340)
T ss_pred --cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 234578999999999876 56899999999999999999999999988877777666542211
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
....++.++.++|++||+.||.+|+ +++++++||||++++
T Consensus 247 --------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 247 --------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred --------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 1134667789999999999999996 899999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=363.16 Aligned_cols=294 Identities=45% Similarity=0.723 Sum_probs=239.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.++++++|+||+++++++.......+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 56899999999999999999999999999999999765433333334567999999999999999999987654467899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+++...+......+++.++..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++....... ..
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 99999987777666555679999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC-Cc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA-TI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~ 355 (415)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|+....... ..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 23345588899999987656789999999999999999999999999999999999999888888777765322111 11
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
+.........+......+++++.+||.+||..||++|||++++|+||||+......
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 11111111122333445688899999999999999999999999999999776654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=378.39 Aligned_cols=262 Identities=27% Similarity=0.343 Sum_probs=214.2
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++|+||+++++++.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 58999999999999999999999999999999986543 34456678899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC---
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--- 274 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~--- 274 (415)
|||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999877766666666899999999999999999999999999999999999999999999999999754311000
Q ss_pred -------------------------------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHH
Q 014960 275 -------------------------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 311 (415)
Q Consensus 275 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il 311 (415)
......+||+.|+|||++.+ ..++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHH
Confidence 00123478999999999876 5689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhccc--CC
Q 014960 312 AELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAI--DP 389 (415)
Q Consensus 312 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP 389 (415)
|||++|.+||...+..+....+........ ......++.++++||.+|+.. ++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH-------------------------IPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccC-------------------------CCCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999998877666655543211110 001124678899999996654 55
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 014960 390 AERQTATAALRSEVSLYMX 408 (415)
Q Consensus 390 ~~R~t~~~~L~h~~f~~~~ 408 (415)
.+|++++++++||||+.+.
T Consensus 294 ~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 294 LGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred cCCCCHHHHhcCcccCCCC
Confidence 5599999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.66 Aligned_cols=287 Identities=29% Similarity=0.485 Sum_probs=228.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
.++|++.+.||+|+||.||+|++..+++.||+|.+............+.+|+.+++.++|+||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999999999999999999765444555667788999999999999999999886532 23
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|+||||+.+++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 5799999999887665532 5789999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+..+.+..+.+.......
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 22344578999999999876 568999999999999999999999999999888888888888777766554422110
Q ss_pred CCcCCC---------cch----hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 353 ATIFKP---------QQS----YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 353 ~~~~~~---------~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
...... ... ............+.++++||.+||..||++|||+.|+|+||||....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 000000 000 000011112234567899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=350.49 Aligned_cols=293 Identities=36% Similarity=0.582 Sum_probs=235.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
...|+++..||+|.||.||+|....++ +.||||.+.-+...........+|+.+++.++|+||+.+..+|... +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 467999999999999999999755544 3799999976532222233456899999999999999999988764 66
Q ss_pred eEEEEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC----CcEEEEeec
Q 014960 193 SLYLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE----GILTIADFG 264 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DfG 264 (415)
.+++++||.+++++..+.. ....++...+..|+.||++|+.|||++=|+||||||.||||..+ |.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 7999999999998876542 23468999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCCCCC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q 014960 265 LASFFDPNHKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---------EVEQLHKI 333 (415)
Q Consensus 265 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~---------~~~~~~~i 333 (415)
+++.+...-.. .....+.|.+|.|||+++|...|+.+.|||++|||+.|||+-.|.|.+.. ..+++..|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99988654332 22345779999999999999999999999999999999999999998754 33789999
Q ss_pred HHhcCCCCHHHHhhCCCCCCC-----cCCCcchhh---hhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 334 FKLCGSPSEEYWKKSKLPHAT-----IFKPQQSYK---RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
++.+|.|....|+..+--+.. .+....... ...-...+.-++...+|+.+||++||.+|+|++++|+|+||+
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 999999999999875432221 111111000 112223344566799999999999999999999999999998
Q ss_pred CCCCC
Q 014960 406 YMXXX 410 (415)
Q Consensus 406 ~~~~~ 410 (415)
.....
T Consensus 342 ~d~lp 346 (438)
T KOG0666|consen 342 EDPLP 346 (438)
T ss_pred cCCCC
Confidence 76443
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=369.85 Aligned_cols=289 Identities=33% Similarity=0.535 Sum_probs=229.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 36799999999999999999999999999999998765433344556778999999999999999999875421 24
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|++++++++++..... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 579999999776655443 346999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.+.......
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 2345789999999998775678999999999999999999999999988888888888877777665544322111
Q ss_pred CCcC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.... ..+..............++.+.+||.+||..||.+|||+.++|.||||....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 0000 0000000112222334566789999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=379.75 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=214.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|.+++.||+|+||.||+|++..+++.||||++.+... .......+.+|+.+++.++|+||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 369999999999999999999999999999999875432 33455678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ- 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~- 275 (415)
||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999988777666666668999999999999999999999999999999999999999999999999998643210000
Q ss_pred ---------------------------------------------CcccccccCccCCcccccCCcCCCchhcHHHHHHH
Q 014960 276 ---------------------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 310 (415)
Q Consensus 276 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~i 310 (415)
.....+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 0012468999999999876 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCC
Q 014960 311 LAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390 (415)
Q Consensus 311 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 390 (415)
+|||++|.+||.+.+..+.+..+........ + .....++.++.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~----------------------p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLY---F----------------------PDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccC---C----------------------CCCCCCCHHHHHHHHHHhc-CHh
Confidence 9999999999998887777766654211100 0 0012467789999999997 777
Q ss_pred CC---CCHHHHhcCCCCCCCC
Q 014960 391 ER---QTATAALRSEVSLYMX 408 (415)
Q Consensus 391 ~R---~t~~~~L~h~~f~~~~ 408 (415)
+| +++.++++||||+.++
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCCC
Confidence 75 5999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=367.04 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=211.7
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccC
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
||+|+||.||+|++..+++.||+|++..... .......+.+|+.++++++||||+++++++.. ....|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975432 33445677889999999999999999998876 56799999999988
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccC
Q 014960 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284 (415)
Q Consensus 205 l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~ 284 (415)
.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 777666666789999999999999999999999999999999999999999999999999987543222 2233457899
Q ss_pred ccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhh
Q 014960 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKR 364 (415)
Q Consensus 285 ~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (415)
.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+....
T Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~------------------------- 211 (312)
T cd05585 158 EYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR------------------------- 211 (312)
T ss_pred ccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC-------------------------
Confidence 9999999886 67899999999999999999999999988877766665432111
Q ss_pred hhhhhcCCCCCChHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q 014960 365 CIAETFKDFPPSSLPLIETLLAIDPAERQ---TATAALRSEVSLYMX 408 (415)
Q Consensus 365 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~~~L~h~~f~~~~ 408 (415)
....++.++.+||.+||..||.+|| ++.++|.||||+..+
T Consensus 212 ----~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 212 ----FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ----CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 1134678899999999999999997 589999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=378.13 Aligned_cols=261 Identities=28% Similarity=0.367 Sum_probs=214.9
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.|++++.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++|+||+++++.+.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 58999999999999999999999999999999975432 34456678899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC----
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---- 273 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~---- 273 (415)
|||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999987666666555678999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHH
Q 014960 274 ------------------------------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 311 (415)
Q Consensus 274 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il 311 (415)
.......+||+.|+|||++.+ ..++.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHH
Confidence 000123468999999999876 5789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC
Q 014960 312 AELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE 391 (415)
Q Consensus 312 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 391 (415)
|||++|.+||.+.+..+...++........ ......+++++.++|.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLH-------------------------IPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcC-------------------------CCCcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999998887766666543211110 0011357888999999976 59999
Q ss_pred CCC---HHHHhcCCCCCCCC
Q 014960 392 RQT---ATAALRSEVSLYMX 408 (415)
Q Consensus 392 R~t---~~~~L~h~~f~~~~ 408 (415)
|++ ++++++||||+.+.
T Consensus 293 R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred cCCCCCHHHHhcCCCcCCcC
Confidence 998 99999999998864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=374.62 Aligned_cols=263 Identities=31% Similarity=0.428 Sum_probs=220.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|.+.+.||+|+||.||+|++..+++.||||++.+... .......+.+|+.++..++|+||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 369999999999999999999999999999999986533 22455678899999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC---
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH--- 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~--- 273 (415)
||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999887666666555789999999999999999999999999999999999999999999999999997665432
Q ss_pred -------------------------CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH
Q 014960 274 -------------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE 328 (415)
Q Consensus 274 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~ 328 (415)
........||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112234578999999999886 578999999999999999999999999988777
Q ss_pred HHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-HHHHhcCCCCCCC
Q 014960 329 QLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-ATAALRSEVSLYM 407 (415)
Q Consensus 329 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~~~L~h~~f~~~ 407 (415)
....+........ ......+++++.+||.+||. ||.+|++ ++++|+||||+.+
T Consensus 238 ~~~~i~~~~~~~~-------------------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLR-------------------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCccc-------------------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7766654211110 00112368889999999997 9999999 9999999999986
Q ss_pred CC
Q 014960 408 XX 409 (415)
Q Consensus 408 ~~ 409 (415)
..
T Consensus 292 ~~ 293 (350)
T cd05573 292 DW 293 (350)
T ss_pred CH
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=367.32 Aligned_cols=252 Identities=26% Similarity=0.380 Sum_probs=213.0
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
+.||+|+||.||++++..+|..||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 369999999999999999999999999986432 23445667789999999999999999999887 467999999999
Q ss_pred cChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccc
Q 014960 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (415)
Q Consensus 203 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~g 282 (415)
++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccC
Confidence 98777666666689999999999999999999999999999999999999999999999999987532221 22234578
Q ss_pred cCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchh
Q 014960 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (415)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (415)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~----------------------- 213 (323)
T cd05595 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR----------------------- 213 (323)
T ss_pred CcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------------------
Confidence 999999999876 57899999999999999999999999988777666665432110
Q ss_pred hhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 363 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
....+++++.+||.+||+.||.+|+ ++.++++|+||..+.
T Consensus 214 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 214 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 1134678899999999999999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=368.89 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=211.8
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 368999999999999999999999999986532 33455677889999999999999999998887 567999999999
Q ss_pred cChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccc
Q 014960 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (415)
Q Consensus 203 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~g 282 (415)
++.+...+.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccC
Confidence 88777766666689999999999999999999999999999999999999999999999999987543221 22334578
Q ss_pred cCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchh
Q 014960 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (415)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (415)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (328)
T cd05593 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI------------------------ 212 (328)
T ss_pred CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc------------------------
Confidence 999999999876 5689999999999999999999999988777666555432110
Q ss_pred hhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 014960 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYM 407 (415)
Q Consensus 363 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~ 407 (415)
.....++.++.+||.+||..||.+|+ +++++++|+||...
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 213 -----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 01134678899999999999999997 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=374.34 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=219.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++|+||+++++++.+ ...+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~~ 119 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYLY 119 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEEE
Confidence 5789999999999999999999999999999999975432 23344567889999999999999999998887 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 999999887666655443 6899999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccCCcccccCC---cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
......||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+....+.++........ +
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---~------- 268 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---F------- 268 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---C-------
Confidence 33456789999999998642 2478999999999999999999999999888777777654321110 0
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEVSLYM 407 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~~L~h~~f~~~ 407 (415)
.....++.++.+||.+||..+|.+ |+|++++++||||+..
T Consensus 269 ---------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 269 ---------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ---------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 011246888999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=370.21 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=210.7
Q ss_pred CceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 192 (415)
+|++++.||+|+||.||+|++. .+++.||+|++.+... .....+.+..|+.+++.+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4889999999999999999863 5789999999975432 233455678899999999 59999999998876 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+||||+.++.+...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 79999999998777666666668999999999999999999999999999999999999999999999999999865443
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.........||+.|+|||++.+...++.++|||||||++|||++|..||...........+.+.....
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------ 226 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC------------ 226 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC------------
Confidence 33333456789999999998765568899999999999999999999997543221111111110000
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
.......++..+.+||.+||..||++|| +++++++||||+.+.
T Consensus 227 -------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 227 -------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0011134677889999999999999999 889999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=370.21 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=222.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
..|..+++||+|+||.||+|.+..+++.||||++..+.. .+..+.+++|+.+|..++++||.++|+.+.. +..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHH
Confidence 468888999999999999999999999999999998754 4567889999999999999999999999887 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||||+|+....++.....+.|.++..++++++.||.|||..+.+|||||+.||||..+|.|||+|||.+......... .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-R 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc-c
Confidence 999999988888888877899999999999999999999999999999999999999999999999999887654433 3
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
.+.+|||.|||||++.+ ..|+.++||||||++++||++|.||+......-.+..|-+ .++.
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---~~PP--------------- 229 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SAPP--------------- 229 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---CCCC---------------
Confidence 77899999999999985 7899999999999999999999999987666333322211 1100
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
....+++..++++|..||++||+.||+|.++|.|+|++.
T Consensus 230 ----------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 230 ----------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ----------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 011268888999999999999999999999999999887
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=377.64 Aligned_cols=261 Identities=27% Similarity=0.337 Sum_probs=214.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+|++++.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+|+.++|+||+++++.+.+ ...+|+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 69999999999999999999999999999999875432 22345678899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC----
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---- 273 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~---- 273 (415)
|||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 9999987777666666689999999999999999999999999999999999999999999999999975331000
Q ss_pred --------------------------------------CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHH
Q 014960 274 --------------------------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315 (415)
Q Consensus 274 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell 315 (415)
.......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehh
Confidence 000123478999999999876 66899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC--
Q 014960 316 AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-- 393 (415)
Q Consensus 316 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-- 393 (415)
+|++||.+.+..+....+........ ......++.++.++|.+|+ .+|.+|+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLH-------------------------IPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCcccc-------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999998887666655533211100 0011346778899999976 5999999
Q ss_pred -CHHHHhcCCCCCCCC
Q 014960 394 -TATAALRSEVSLYMX 408 (415)
Q Consensus 394 -t~~~~L~h~~f~~~~ 408 (415)
++.++++||||+.+.
T Consensus 293 ~t~~ell~h~~~~~~~ 308 (376)
T cd05598 293 NGADEIKAHPFFKGID 308 (376)
T ss_pred CCHHHHhCCCCcCCCC
Confidence 999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=363.85 Aligned_cols=252 Identities=29% Similarity=0.401 Sum_probs=212.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCce-EEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
....+.+.||+|+||+||++.. .|.. ||+|++..........+.|.+|+.+|.+++|||||+++|++.... ..+.|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEE
Confidence 3455566799999999999965 4555 999999876665555789999999999999999999999998743 26899
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCEEEcCCC-cEEEEeeccccccCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPN 272 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~ 272 (415)
||||+.++.+..++.. ...++...+..|+.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999988887765 678999999999999999999999999 99999999999999998 9999999999876543
Q ss_pred CCCCcccccccCccCCcccccC-CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. ...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||.+....+....+......|..
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~--------- 267 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI--------- 267 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC---------
Confidence 2 33445789999999999985 257999999999999999999999999998886666666544333321
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+..+.+||..||..||.+||+..+++.
T Consensus 268 ------------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 268 ------------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ------------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 1237788999999999999999999988863
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=370.53 Aligned_cols=263 Identities=26% Similarity=0.343 Sum_probs=218.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|.+.+.||+|+||.||+|++..+|+.||+|++..... ..+....+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 369999999999999999999999999999999986533 33456678899999999999999999998877 567999
Q ss_pred EEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999987666555544 367999999999999999999999999999999999999999999999999999876544332
Q ss_pred CcccccccCccCCcccccC-----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
......||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+.++........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 229 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK--------- 229 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---------
Confidence 2234578999999999863 34678899999999999999999999998887777766654311000
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
......++.++.+||..||. ||.+|||+++++.||||+.++
T Consensus 230 ----------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 230 ----------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 00113467889999999998 999999999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=352.08 Aligned_cols=284 Identities=40% Similarity=0.668 Sum_probs=234.8
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|+||.||+|++..+|..||+|++............+.+|+.++++++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4889999999999999999999999999999998765444556678899999999999999999999887 56799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
||+++++...+......+++.+++.++.||+.+|+|||+.|++|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99955665555454567999999999999999999999999999999999999999999999999999876544332344
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC--cC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT--IF 356 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~ 356 (415)
...++..|+|||++.+...++.++|||||||++|+|++|.++|.+.++.+....+....+.+....|+........ ..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 5578999999999876566789999999999999999999999999888888899888888887777663322110 00
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
.... ....+....+..+.++.+||.+||..||.+|||++++|+||||.
T Consensus 239 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPES-KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCC-CcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 01112334456778899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=345.81 Aligned_cols=290 Identities=44% Similarity=0.725 Sum_probs=239.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec------C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------M 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~ 190 (415)
...|..+.+||+|.||.||+|+.+.+|+.||+|++..+......-....+|+.+|+.|+|+|++.+++.+... .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4568888999999999999999999999999998765433222233455799999999999999999887442 2
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
...+|+||.+|++++...+-....+|+..++..++++++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 34599999999999999988888899999999999999999999999999999999999999999999999999997664
Q ss_pred CCC---CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 271 PNH---KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 271 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
... ...++.++.|.+|++||.++|...|++..|||..||||.||+++.|.|.+.+++.++..|...||....+.|+.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 332 23356778899999999999999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCC--Cc--CCCcchhhhhhhhhcCCC--CCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 348 SKLPHA--TI--FKPQQSYKRCIAETFKDF--PPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 348 ~~~~~~--~~--~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
..--+- .+ ..-++--.+.+....+.+ +++..||+..||..||.+|+++.++|+|.||..
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 321110 01 000000111122222222 467899999999999999999999999999954
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=363.72 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=212.9
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHH---HhCCCCceeeeeeeEeecCCCeEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILIL---RRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
|++++.||+|+||.||+|.+..+++.||||++.+... .....+.+.+|+.++ +.++|+||+++++++.. ....|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 6789999999999999999999999999999986432 233445666776665 45689999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+...... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999998877665543 479999999999999999999999999999999999999999999999999987543222 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~---------------- 219 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR---------------- 219 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 2344678999999999876 57899999999999999999999999998887777766542111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
....++.++.++|.+||..||.+|| ++.++++|+||++++
T Consensus 220 -------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 220 -------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 1134678889999999999999999 799999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=362.36 Aligned_cols=259 Identities=28% Similarity=0.387 Sum_probs=207.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|+++++||+|+||.||+|++..+++.||||++.... .......+.+|+++++.++|+||+++++++.. ...+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 467899999999999999999999999999999986543 34455678899999999999999999999877 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+.. .....+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 150 v~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred EEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 999999876543 2245788889999999999999999999999999999999999999999999998764322 12
Q ss_pred cccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 277 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
....+||..|+|||++.. ....+.++|||||||++|||++|+.||......+....+.......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------------ 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------------
Confidence 244578999999998743 1334578999999999999999999997543322222221111000
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.......++.++++||.+||..||++|||+.|+|+||||..-.
T Consensus 293 -------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 -------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0011235677899999999999999999999999999998754
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=363.38 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=215.2
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCC-ceeeeeeeEeecCCCeEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHP-NVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~~~l 196 (415)
+|++++.||+|+||.||+|++..+++.||+|++.+... .....+.+..|+.++..+.|+ +|+++++++.. ...+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 48899999999999999999999999999999986432 234456677899999999765 58888888876 457999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999987777666666689999999999999999999999999999999999999999999999999986532221 12
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.+....
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~----------------- 219 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS----------------- 219 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 234578999999999886 56899999999999999999999999988887777766542111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEVSLYMX 408 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~L~h~~f~~~~ 408 (415)
....++.++.++|.+||..||.+|++. +++++||||+.++
T Consensus 220 ------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 220 ------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred ------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 112467788999999999999999986 8999999998764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=364.90 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=212.3
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++.+... .......+..|+.++..+ +|+||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999976432 233455667788888876 69999999999887 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccccc
Confidence 988777766666789999999999999999999999999999999999999999999999999987543222 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---------------------- 214 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----------------------
Confidence 8999999999876 56899999999999999999999999998888777776542111
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA------TAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~~~L~h~~f~~~~ 408 (415)
....++.++.+||.+||+.||.+|+++ +++++||||+.+.
T Consensus 215 -------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 215 -------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred -------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 112367788999999999999999998 9999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=360.92 Aligned_cols=265 Identities=26% Similarity=0.453 Sum_probs=236.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+-|.+.+.||+|.|..|-+|++..+|..||+|++.+...+.-....+.+|+..|+.++|||||+||++... ...+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEE
Confidence 467999999999999999999999999999999999988877777788899999999999999999999887 456999
Q ss_pred EEEeccc-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc-CCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+|+-.+ ++..+++.....+.|..+..||+||+.|+.|||+..+|||||||+|+.+. .-|-|||.|||++..+.++..
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 9999887 55555666677899999999999999999999999999999999998765 568999999999999988754
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
..+.+|+..|-|||+++|..+.-+++||||||||||-|+||++||...++.+.+..|+...-.-+
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP------------- 239 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP------------- 239 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc-------------
Confidence 57789999999999999988778999999999999999999999999999999999987543322
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXXX 414 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~~ 414 (415)
..++.+.++||..||..||++|.+.+++..|+|++.+.....++
T Consensus 240 ----------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~ 283 (864)
T KOG4717|consen 240 ----------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA 283 (864)
T ss_pred ----------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence 35788899999999999999999999999999999988766554
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=371.43 Aligned_cols=263 Identities=24% Similarity=0.301 Sum_probs=217.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+ +..+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999999975322 23345567889999999999999999999887 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999987666655443 6899999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccCCcccccCC---cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
......||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.++........ +
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~------- 268 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---F------- 268 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---C-------
Confidence 23456799999999998652 2378899999999999999999999999888777777765322111 0
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEVSLYM 407 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~~L~h~~f~~~ 407 (415)
.....++..++++|..||..++.+ |++++++++||||+..
T Consensus 269 ---------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 269 ---------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ---------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 011246778899999999866544 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=370.53 Aligned_cols=262 Identities=26% Similarity=0.345 Sum_probs=216.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||+|++..+++.||+|++..... ..+....+.+|+.++..++|+||+++++.+.+ ...+|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 469999999999999999999999999999999975432 34455678889999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-- 274 (415)
||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999887777666666899999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCC
Q 014960 275 --------------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP 322 (415)
Q Consensus 275 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~ 322 (415)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 00123578999999999876 678999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC---HHHHh
Q 014960 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAAL 399 (415)
Q Consensus 323 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~L 399 (415)
+.+..+...++........ + .....+++++++||.+|+ .||.+|++ +++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~---~----------------------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETLV---F----------------------PPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCcee---c----------------------CCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 9888777776654211100 0 001236778899999977 59999994 89999
Q ss_pred cCCCCCCCC
Q 014960 400 RSEVSLYMX 408 (415)
Q Consensus 400 ~h~~f~~~~ 408 (415)
+||||+.++
T Consensus 292 ~hp~f~~~~ 300 (360)
T cd05627 292 SHPFFEGVD 300 (360)
T ss_pred cCCCCCCCC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=365.46 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=211.4
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++|+||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999986432 23445667789999999999999999998887 567999999999
Q ss_pred cChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 203 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
++.+...+.....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccccc
Confidence 98777777666689999999999999999999997 799999999999999999999999999987543221 2233457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (325)
T cd05594 158 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR---------------------- 214 (325)
T ss_pred CCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC----------------------
Confidence 8999999999876 57899999999999999999999999988776666555332110
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYM 407 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~ 407 (415)
....++.++.+||.+||+.||++|+ ++.++|+|+||+.+
T Consensus 215 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 215 -------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 1124677889999999999999997 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=355.76 Aligned_cols=277 Identities=35% Similarity=0.608 Sum_probs=213.2
Q ss_pred eeeccCCceEEEEEEECC--CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTL--TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
.+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+.+++.++|+||+++++++........|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999998653 568899999875432 23467899999999999999999998765567899999999
Q ss_pred ccChhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE----cCCCcEEEEeecccccc
Q 014960 202 EHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFF 269 (415)
Q Consensus 202 ~~~l~~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DfG~a~~~ 269 (415)
++++...+.. ....+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9887665431 12358999999999999999999999999999999999999 45678999999999876
Q ss_pred CCCCC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcC
Q 014960 270 DPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLHKIFKLCG 338 (415)
Q Consensus 270 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~~ 338 (415)
..... .......+|+.|+|||++.+...++.++|||||||++|||++|.+||....+ ...+..+....+
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 54322 1223457899999999987656689999999999999999999999976442 345667777778
Q ss_pred CCCHHHHhhCCCCCCC---------cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 339 SPSEEYWKKSKLPHAT---------IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 339 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.+....|......... ...................+..+.+||.+||..||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7777777653321110 00000111111111122345568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=344.34 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=231.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|..+++||+|.||.|-+|+.+.+++.||||+++++-. ..+.+.....|-.+|+..+||.+..+.-.|.. ...++
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlC 244 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLC 244 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEE
Confidence 5789999999999999999999999999999999988765 56667777789999999999999998777776 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||..|+.+..++++...|+|..++.|..+|+.||.|||+++||+||||.+|+|+|.||++||+|||+++.--... .
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-~ 323 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-D 323 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc-c
Confidence 999999999999999988899999999999999999999999999999999999999999999999999997643322 3
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
...+.+|||+|+|||++.. ..|++++|+|.+||+||||+||+.||...+....+..|+-.-..+
T Consensus 324 t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF--------------- 387 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF--------------- 387 (516)
T ss_pred eeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC---------------
Confidence 4577899999999999875 789999999999999999999999999999888888876543222
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
...++++++.|+..+|.+||.+|.. +.++.+|+||..++
T Consensus 388 --------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 388 --------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred --------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 2468899999999999999999985 78999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=359.94 Aligned_cols=286 Identities=23% Similarity=0.315 Sum_probs=219.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||++++..++..||+|.+.... .....+.+.+|++++++++|+||+++++++.. ....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999987642 34456678899999999999999999999887 557999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999987777776666799999999999999999999986 6999999999999999999999999998765432
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC-CCC--
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPH-- 352 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~-- 352 (415)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.+.........+.... ...
T Consensus 158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2234568999999999876 568999999999999999999999998776655433322111111111110000 000
Q ss_pred ----C---CcCCCcch---hhh-hhhhh-----cCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 353 ----A---TIFKPQQS---YKR-CIAET-----FKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 353 ----~---~~~~~~~~---~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
. ........ ... ..... ...++.++++||.+||..||++|||+.++|+||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 0 00000000 000 01111 1135678999999999999999999999999999987544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=362.01 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=215.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||++++..+++.||+|++.+... .....+.+.+|+.++..++|+||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 479999999999999999999999999999999975322 23345668889999999999999999999887 567999
Q ss_pred EEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999998766655543 3557999999999999999999999999999999999999999999999999998766543322
Q ss_pred CcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 2233568999999999863 24578899999999999999999999998877777666643221110
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEVSLYMX 408 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~~L~h~~f~~~~ 408 (415)
+......+++++.+||++||+.++.+ |++++++|+||||..++
T Consensus 229 --------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 229 --------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred --------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 11112347888999999999765544 88999999999998753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=351.80 Aligned_cols=287 Identities=44% Similarity=0.750 Sum_probs=234.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.++++++|+||+++++++........|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 45799999999999999999999999999999999865444333445678999999999999999999987754478999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+.+...+......+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+|||++....... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999987666655555579999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC-CCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH-ATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~ 355 (415)
.....+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+...++....+.+....|+...... ...
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 2344678899999998765567899999999999999999999999999999999999988888888787543211 111
Q ss_pred CCCcchhhhhhhhhcCC--CCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 356 FKPQQSYKRCIAETFKD--FPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
..........+....+. +++.+.+||++||+.||++|||++|+|.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111111112233333 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=360.63 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=215.4
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~l 196 (415)
+|.+.+.||+|+||.||+|++..+++.||+|++.+... .......+..|+.++..+ .|++|+++++++.. ...+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 48899999999999999999999999999999986532 233345566788888877 58999999998877 457999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999987776666666689999999999999999999999999999999999999999999999999987543222 12
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----------------- 219 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----------------- 219 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 334578999999999876 67899999999999999999999999998887777776543211
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
....++.++.+||.+||+.||.+|++ ..++++|+||+.++
T Consensus 220 ------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 220 ------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred ------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 11246778899999999999999998 48999999998765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=362.30 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=211.5
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++.+... ..+....+..|+.++..+ +|+||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 369999999999999999999999999986432 234455677789998866 79999999999987 45799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccc
Confidence 987776666666689999999999999999999999999999999999999999999999999987543222 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~--------------------- 215 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY--------------------- 215 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence 8999999999875 578999999999999999999999999988888777765421110
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-------CHHHHhcCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-------TATAALRSEVSLYM 407 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-------t~~~~L~h~~f~~~ 407 (415)
...++.++.+||.+||+.||++|+ +++++++||||..+
T Consensus 216 --------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 216 --------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred --------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 123567889999999999999999 99999999999775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=351.47 Aligned_cols=283 Identities=40% Similarity=0.710 Sum_probs=227.5
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.|++.+.||.|++|.||+|++..+++.||||.+............+.+|++++++++|+||+++++++.+ ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4888999999999999999999999999999987654444444578889999999999999999999876 56799999
Q ss_pred EecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 199 KYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 199 e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||+.+++...+.. ....+++..++.++.||+.||+|||+++++||||+|+||+++.++.+||+|||++....... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 9998776655443 34578999999999999999999999999999999999999999999999999987664332 222
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+...++.+..+.+....|+...........
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 33456889999998876555788999999999999999999999998888888888888887776666532211000000
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.............+.++.+++++|.+||+.||.+|||++++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00011111223334577889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=351.13 Aligned_cols=290 Identities=40% Similarity=0.702 Sum_probs=232.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|++|.||+|.+..+|+.||+|.+............+.+|++++++++|+||+++++++.. ....|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 57999999999999999999999999999999987654333444567889999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+++++....... ...+++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 999988776665443 234688999999999999999999999999999999999985 4579999999997654322 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+...++++..+.+....|..........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22344678899999998765568899999999999999999999999988888888888888888877776422111110
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
...............+.+++++.++|.+||+.||++||++.++|+||||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~ 293 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence 0000001111223345678899999999999999999999999999999998764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=363.82 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=231.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|..++.+|+|+||.+++++++..++.|++|.+...............|+.+++++.|||||.+++.|... +.+++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 4689999999999999999999999999999999998877666666788899999999999999999999874 566999
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||+||+|+.+...+.. +..|+|+.+..|+.||+.|+.|||++.|+|||||+.|||++.++.|||.|||+|+...+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999877765543 3579999999999999999999999999999999999999999999999999999987654
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
....+.+|||.|++||++.+ .+|+.++|||||||++|||++-+++|.+.+-.+...+|.+....|-.
T Consensus 161 ~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------ 227 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------ 227 (426)
T ss_pred hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence 24567899999999998886 78999999999999999999999999999999999999887644422
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
..++.+++.||+.||..+|..||++.++|.+|.+.
T Consensus 228 ----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 ----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 35788899999999999999999999999998765
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=358.90 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=207.9
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++..... .......+..|..++..+ +|+||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986432 223344455677777654 89999999999877 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 988777666666689999999999999999999999999999999999999999999999999997643322 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---------------------- 214 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH---------------------- 214 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8999999999876 56899999999999999999999999998877776665432100
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-TAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~~~L~h~~f~~~~ 408 (415)
....++.++.+||.+||..||.+|+++ .+++.|+||+.+.
T Consensus 215 -------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 215 -------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred -------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 112467778999999999999999986 5888999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=360.24 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=210.2
Q ss_pred eeeccCCceEEEEEEEC---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 124 DKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+.||+|+||.||+|++. .+++.||+|++..... .......+.+|+.+|+.++||||+++++++.. +..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 67999999999999863 5788999999975432 22334567789999999999999999999887 56799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
||+.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTH 158 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cccc
Confidence 999998777777667788999999999999999999999999999999999999999999999999987543222 1223
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
...||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.+....
T Consensus 159 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~------------------- 218 (323)
T cd05584 159 TFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN------------------- 218 (323)
T ss_pred ccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 4578999999999876 56889999999999999999999999988877766666542110
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYM 407 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~ 407 (415)
....++.++.+||.+||..||++|+ +++++++||||+..
T Consensus 219 ----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 219 ----------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 1134677889999999999999999 89999999999865
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=345.17 Aligned_cols=283 Identities=33% Similarity=0.591 Sum_probs=225.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|++|.||+|++..+++.||+|++..........+.+.+|+.+++.++|+||+++++++.. ....++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 46899999999999999999999999999999987554333344567889999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||++++++..+......+++..+..++.||+.+|+|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999998888776666799999999999999999999999999999999999999999999999999987654332 22
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH---HhhCCCCCCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY---WKKSKLPHAT 354 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~ 354 (415)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+.+..+...... |.........
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 3345788899999987656688999999999999999999999999887777777666554432211 1110000000
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
..... ....-.......++..+.+||.+||+.||++|||+.++|.||||
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEP-ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCc-ccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00000 00011223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=345.41 Aligned_cols=281 Identities=37% Similarity=0.582 Sum_probs=225.3
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
|++.+.||+|+||.||+|.+..++..||+|++.......... ...+|+.++.++. |+||+++++++.+.....+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678899999999999999999999999999987643333322 3346888999885 99999999999875446799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
||+.++++..+......+++..++.++.||+.||+|||+.|++||||||+||+++. +.+||+|||++....... ...
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcC
Confidence 99999888777665567999999999999999999999999999999999999999 999999999997664322 223
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+...............+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 34578899999987654567899999999999999999999999999888888888888777665432221111111111
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
+......+......++.++.+||.+||..||.+|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111112233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=348.77 Aligned_cols=290 Identities=41% Similarity=0.684 Sum_probs=233.3
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+..|+++++.++|+||+++++++.+ ....|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488899999999999999999989999999999865433 2334566789999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.+++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 9999995555544433333799999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.+..+.+.++.+..+.+....|..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334568889999998765678899999999999999999999999988888888888888888777776532211110
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
.................+.++.++|.+||..||++|||+.++|+|+||++....++
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 -EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred -cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 00000111123334556788999999999999999999999999999999776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=358.01 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=207.9
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+|+.||+|++..... .......+..|+.++..+ +|+||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 469999999999999999999999999986432 123345566788888754 89999999999987 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccC
Confidence 987776666666689999999999999999999999999999999999999999999999999986532221 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~----------------------- 213 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP----------------------- 213 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------------
Confidence 8999999999886 5789999999999999999999999998887766665533210
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-TAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~~~L~h~~f~~~~ 408 (415)
.....++.++.+||.+||..||++|+++ +++++||||+.+.
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 214 ------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 0112366788999999999999999998 5788999998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=345.69 Aligned_cols=282 Identities=37% Similarity=0.680 Sum_probs=230.8
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.++||.|++|.||+|++..+|..||+|++..... ......+.+|+.++++++|+||+++++++.+ ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 48899999999999999999999999999999986543 2234556789999999999999999999987 45789999
Q ss_pred EecccChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 199 KYMEHDLAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 199 e~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||+.+++...+.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........ .
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 999987776654432 4689999999999999999999999999999999999999999999999999976543221 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|++||++.+...++.++|||||||++|+|++|.+||.+.+..+....+.+....+....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23456788999999987656678999999999999999999999999999999999998888888887765442221111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
..............+.++..+.++|.+||+.||.+||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111111111233334568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=360.25 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=208.3
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHH-HHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREIL-ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+|+.||+|++.+... .......+..|.. +++.++||||+++++.+.. ....|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 369999999999999999999999999975432 1222334444544 5678999999999999877 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccccc
Confidence 998777666666789999999999999999999999999999999999999999999999999987532221 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (323)
T cd05575 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL----------------------- 213 (323)
T ss_pred CChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 8999999999876 6789999999999999999999999998887777766654211
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~~L~h~~f~~~~ 408 (415)
.....++.++.++|.+||+.||.+||++ .+++.||||..++
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 214 ------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 1123467889999999999999999998 6999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.25 Aligned_cols=289 Identities=46% Similarity=0.835 Sum_probs=236.3
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC-----
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----- 190 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----- 190 (415)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+++++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 357899999999999999999999999999999999865443344456778999999999999999999886532
Q ss_pred ---CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 191 ---SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 191 ---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
...+|+|+||+++++...+......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 23799999999998877776665679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
..............++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+.+.++.+....|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 76544332333345678899999887655678999999999999999999999999888888999999888887776654
Q ss_pred CCCCCC-CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 348 SKLPHA-TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 348 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...... ..........+.+......++..+.++|.+||..||.+|||++++|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 322111 001111112223344455678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=365.42 Aligned_cols=264 Identities=24% Similarity=0.303 Sum_probs=216.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999999875322 23345567889999999999999999999877 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 999999887666655443 6899999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccCCcccccCC---cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
......||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+......++.+...... +
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~------- 268 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---F------- 268 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---C-------
Confidence 23456789999999998642 2378999999999999999999999999888777777654321111 0
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~~L~h~~f~~~~ 408 (415)
.....++..+++||..||..++.+ |++++++++|+||++..
T Consensus 269 ---------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 269 ---------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ---------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 011357888999999999844433 78999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=350.16 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=205.6
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccC
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
||+|+||.||+|.+..+++.||+|++...... ....+.+..|+.+++.++|+||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 69999999999999999999999998765332 2334567789999999999999999998877 45699999999987
Q ss_pred hhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccc
Q 014960 205 LAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (415)
Q Consensus 205 l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~ 280 (415)
.+...+ .....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 665433 2345689999999999999999999999999999999999999999999999999976644322 22345
Q ss_pred cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcc
Q 014960 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (415)
Q Consensus 281 ~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (415)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 217 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS------------------- 217 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-------------------
Confidence 78999999999986 5788999999999999999999999987543322222222111100
Q ss_pred hhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 014960 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMXX 409 (415)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~~ 409 (415)
......++.++.+++.+||+.||++|+ +++++++||||+.++.
T Consensus 218 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 218 ------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred ------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 011235778899999999999999999 8899999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=351.17 Aligned_cols=288 Identities=46% Similarity=0.805 Sum_probs=233.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 190 (415)
.++|.+.++||+|+||.||+|++..+++.||+|++............+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999999999999998765433323345678999999999999999999875432
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
...+|+||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23589999999998887777666689999999999999999999999999999999999999999999999999997654
Q ss_pred CCCC----------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 014960 271 PNHK----------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340 (415)
Q Consensus 271 ~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 340 (415)
.... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3221 112234568889999998765668899999999999999999999999999988889998888877
Q ss_pred CHHHHhhCCCCCCCcC-CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 341 SEEYWKKSKLPHATIF-KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 341 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
....|+.......... ................+..++.++|.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 7666655332221110 111112222334455677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=359.29 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=204.8
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 368999999999999999999999999986533 234456688899999998 79999999999887 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccccc
Confidence 987776666666689999999999999999999999999999999999999999999999999987532211 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh--------HH-HHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--------VE-QLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~--------~~-~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+ ..+.+...
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------------- 220 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK---------------- 220 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------------
Confidence 8999999999886 6689999999999999999999999963211 11 11111110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT------ATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~~~L~h~~f~~~~ 408 (415)
.......++.++.+||++||+.||.+|++ ++++++||||+.+.
T Consensus 221 -------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 221 -------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 00112346777899999999999999997 78999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=359.76 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=215.3
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..++|++|+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 469999999999999999999999999999999875322 23344567889999999999999999999887 467999
Q ss_pred EEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999987666555543 457899999999999999999999999999999999999999999999999998765433322
Q ss_pred CcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
......||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+...++........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---------- 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc----------
Confidence 2234578999999999852 34678999999999999999999999998887777776654221110
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEVSLYMX 408 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~~L~h~~f~~~~ 408 (415)
.......++.++++||.+||+.++.+ |++++++++||||..++
T Consensus 229 --------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 229 --------------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred --------------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 11112357888999999999765554 78999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=346.24 Aligned_cols=284 Identities=38% Similarity=0.666 Sum_probs=226.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|++.+.||+|++|.||+|++..+++.||||.+...... .....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 46899999999999999999999989999999998754322 222345679999999999999999999886 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+++...+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 999999877766655555789999999999999999999999999999999999999999999999999875432221 1
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+..+.+..+.+....|..........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2233568889999998765668899999999999999999999998765 566777788888888777776543221111
Q ss_pred CCC-cchhhhhhhhhcCCCC--CChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 356 FKP-QQSYKRCIAETFKDFP--PSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 356 ~~~-~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
... .......+......++ .++.++|.+||+.||++|||+.++|+|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0000111223333444 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=357.17 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=211.5
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||||++.+... .......+.+|+.++..+ +|+||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986432 234455677899999888 69999999999887 45799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+.........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 988777766666689999999999999999999999999999999999999999999999999986532221 1223456
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~---------------------- 214 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR---------------------- 214 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8999999999876 67899999999999999999999999988776666655432110
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~L~h~~f~~~~ 408 (415)
....++.++.+||.+||..||.+||++ .+++.||||+.++
T Consensus 215 -------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 215 -------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred -------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 112467788999999999999999999 9999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=345.47 Aligned_cols=285 Identities=53% Similarity=0.927 Sum_probs=236.5
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++|+|++++++++........|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999999999999999999876433444566778999999999999999999988743368999999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~ 279 (415)
|+.+++...+......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99987777766655689999999999999999999999999999999999999999999999999998775543323344
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC-CCCcCCC
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP-HATIFKP 358 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~ 358 (415)
..++..|+|||.+.+...++.++||||||+++|+|++|.+||...+....+..+.+..+.+....|+..... .......
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 567888999998876566889999999999999999999999999988889999998888887777653221 1122222
Q ss_pred cchhhhhhhhhcCCC-CCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 359 QQSYKRCIAETFKDF-PPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......+....... +.++.++|.+||..||.+||++++++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 222333334444444 8889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=348.98 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=212.5
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.|++.+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++.+.. ...+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 488999999999999999999999999999999764332 2233556789999999999999999998877 4579999
Q ss_pred EEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+.++.+...+. ....+++..+..++.||+.||.|||+++|+||||||+||++++++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 99998876654432 23468999999999999999999999999999999999999999999999999997754322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence 2234578999999999876 5689999999999999999999999998766544444433211100
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
......++..+.+||.+||..||.+|| +++++++|+||...+
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 222 -----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred -----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 011234677889999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=354.80 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=214.6
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~l 196 (415)
+|+..+.||+|+||.||+|++..+|+.||+|++.+... .....+.+..|+.++..+. |++|+++++++.. ...+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 47888999999999999999999999999999986432 2334456778899998886 5778889888877 457999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+...+.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999987777776666689999999999999999999999999999999999999999999999999987543222 12
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~----------------- 219 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS----------------- 219 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 234568999999999876 56899999999999999999999999998887777766542211
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
....++.++.+++.+||..||.+|++ .+++++||||+.++
T Consensus 220 ------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 220 ------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred ------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 11346778899999999999999998 47999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=334.74 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=215.0
Q ss_pred CCCceee-eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeec--CCC
Q 014960 117 ADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSR--MSC 192 (415)
Q Consensus 117 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~--~~~ 192 (415)
.++|.+- ++||-|-.|.|..|.++.+++.+|+|++.-. ...++|+++.-.. .|+|||.++++|+.. .-.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4677775 5799999999999999999999999987522 3445788876665 699999999998653 234
Q ss_pred eEEEEEEecccChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC---CcEEEEeecccc
Q 014960 193 SLYLVFKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLAS 267 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DfG~a~ 267 (415)
.+.+|||+|+|+.++..++..+ .|+|.++..|++||+.|+.|||+.+|.||||||||+|.... ..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 6889999999988877776544 49999999999999999999999999999999999999654 469999999998
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCHH
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE----VEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~ 343 (415)
..... ....+.+-||+|.|||++.. ..|+..+|+||+||+||.||||.|||..... ...-.+|......++.+
T Consensus 213 ~t~~~--~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQEP--GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCCC--ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 76542 33456677999999998764 6799999999999999999999999986543 34556666666777777
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.|.. ++++.+|+|+.+|..+|.+|+|+++++.|||+..-+-
T Consensus 290 EWs~-------------------------VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 290 EWSC-------------------------VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred hHhH-------------------------HHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 7765 7788889999999999999999999999999876543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=357.47 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=204.4
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++.++ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986533 334456677899988877 89999999999887 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccccc
Confidence 988777666666689999999999999999999999999999999999999999999999999987543221 1223457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT--------EVE-QLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~--------~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ... ....+...
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------------- 220 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------------- 220 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------------
Confidence 8999999999886 678999999999999999999999995311 011 11111110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT------ATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~~~L~h~~f~~~~ 408 (415)
.......++.++.+||++||+.||++|++ ++++++||||+.++
T Consensus 221 -------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 221 -------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 00112346677899999999999999998 58999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=360.02 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=210.8
Q ss_pred eeeccCCceEEEEEEE---CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 124 DKIGQGTYSNVYKARD---TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
+.||+|+||.||++++ ..+|+.||+|++............+.+|+.++++++|+||+++++++.. ....|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 5799999999999976 3578999999998654333344567789999999999999999999887 5679999999
Q ss_pred cccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccc
Q 014960 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (415)
Q Consensus 201 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~ 280 (415)
+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceecc
Confidence 9987766666666679999999999999999999999999999999999999999999999999987654332 122345
Q ss_pred cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcc
Q 014960 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (415)
Q Consensus 281 ~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (415)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+....
T Consensus 159 ~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~--------------------- 216 (318)
T cd05582 159 CGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--------------------- 216 (318)
T ss_pred cCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC---------------------
Confidence 78999999999876 56889999999999999999999999988877777666542211
Q ss_pred hhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 014960 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYM 407 (415)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~ 407 (415)
....++.++.+||.+||+.||.+||+ +++++.|+||+.+
T Consensus 217 --------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 217 --------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 11246778899999999999999999 7889999999875
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=338.47 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=223.0
Q ss_pred Cceee-eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEE
Q 014960 119 TFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 119 ~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~l 196 (415)
-|++. +.||+|+|+.|-.|....+|..||+|++.+.. .....++.+|++++.++ .|+||++++++|++ +...|+
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYL 153 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYL 153 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEE
Confidence 35543 67999999999999999999999999998763 56667888999999999 59999999999998 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---cEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DfG~a~~~~~~~ 273 (415)
|||-|.|+-+-..+.....|+|.++..+.++|+.||.|||.+||.||||||+|||-.... -||||||.++.-+..+.
T Consensus 154 VfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred EEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999987777777788999999999999999999999999999999999999997655 49999999876543221
Q ss_pred ------CCCcccccccCccCCccccc----CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC---------------hHH
Q 014960 274 ------KQPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGRT---------------EVE 328 (415)
Q Consensus 274 ------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~---------------~~~ 328 (415)
.....+.+|+.+|||||+.. ....|+.++|.||||+|||.||+|.+||.|.- .+.
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 12234568899999999862 23568999999999999999999999998642 335
Q ss_pred HHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 329 QLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 329 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.++.|++....+++..|. +++.+.+|||..+|..|+.+|.++.++|+|||++...
T Consensus 314 LFesIQEGkYeFPdkdWa-------------------------hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWA-------------------------HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHhccCCcCChhhhH-------------------------HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 677788877777777774 5888899999999999999999999999999998765
Q ss_pred C
Q 014960 409 X 409 (415)
Q Consensus 409 ~ 409 (415)
.
T Consensus 369 ~ 369 (463)
T KOG0607|consen 369 P 369 (463)
T ss_pred h
Confidence 4
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=357.83 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=215.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|.+.+.||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..++|+||+++++++.. ....|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999875322 23344567889999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999988766655543 557899999999999999999999999999999999999999999999999999776543322
Q ss_pred CcccccccCccCCcccccCC----cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~----~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
......||+.|+|||++.+. ..++.++|||||||+||+|++|+.||...+..+...++........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---------- 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc----------
Confidence 22335689999999988642 3578899999999999999999999998887777666654211110
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEVSLYMX 408 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~~L~h~~f~~~~ 408 (415)
......++++++++||.+||+.++++ |++++++++|+||+.+.
T Consensus 229 --------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 229 --------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred --------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 01112356788999999999976655 57899999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=354.16 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=207.7
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHh-CCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRR-LDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++..... .......+..|..++.. ++||||+++++++.+ ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986432 12334456668888876 489999999999887 45799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 987776666666679999999999999999999999999999999999999999999999999987543221 1223457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.... +.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~-------------------- 214 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PC-------------------- 214 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC--------------------
Confidence 8999999999876 568999999999999999999999999888776666553211 00
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT-AALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-~~L~h~~f~~~~ 408 (415)
....++.++.+||.+||..||.+|+++. ++++||||+.+.
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 215 -------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 0123567789999999999999999996 899999998875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=358.53 Aligned_cols=276 Identities=23% Similarity=0.311 Sum_probs=208.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
..|.+++.||+|+||.||+|++..++..||+|+..... ...|+.++++++|+||+++++++.. ....++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEEE
Confidence 57999999999999999999999999999999754321 2358999999999999999999987 4578999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||++.+++...+......+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||++...... ...
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 999999888877766678999999999999999999999999999999999999999999999999998753322 122
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHhcCCCCHHHHhh
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PIMPGRTE---------VEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~ 347 (415)
....||+.|+|||++.+ ..++.++|||||||++|||+++. ++|..... ...+..+....+..+.. +..
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~ 291 (357)
T PHA03209 214 LGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE-FPR 291 (357)
T ss_pred ccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh-cCC
Confidence 34568999999999876 56899999999999999999854 44443211 12233333333322221 110
Q ss_pred CCCCCC------CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 348 SKLPHA------TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 348 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
...... .......+...........++.++.+||.+||+.||.+|||++|+|+||||+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000000 000000000011111223567889999999999999999999999999999875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=345.95 Aligned_cols=286 Identities=42% Similarity=0.690 Sum_probs=227.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecC---CCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRM---SCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~---~~~ 193 (415)
++|++.+.||+|+||.||+|++..+++.||+|.+............+.+|+.+++.+. |+||+++++++.... ...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3689999999999999999999999999999998765433334456778999999995 699999999886532 124
Q ss_pred EEEEEEecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEeeccccc
Q 014960 194 LYLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASF 268 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~ 268 (415)
.|+||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999998776665432 245899999999999999999999999999999999999998 88999999999876
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
+..... ......+++.|+|||++.+...++.++||||||+++|+|++|.+||.+.+..+....+++..+.+....|...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543221 1233456888999998876566889999999999999999999999999888888888888877777766542
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
......... .......+....+.++.++.++|.+||..||.+||+++++|.||||+
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEF-PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhc-CcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 211110000 00011113334456889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=343.84 Aligned_cols=282 Identities=42% Similarity=0.744 Sum_probs=227.6
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+++++.++|+||+++++++.+ ....|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 677889999999999999999999999999998664433444567789999999999999999999876 567999999
Q ss_pred ecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 200 YMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 200 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
|+++.+...+.... ..+++..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||++........ ...
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccC
Confidence 99876665544332 3689999999999999999999999999999999999999999999999999976543321 223
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
...+++.|+|||++.+...++.++||||||+++|+|++|.+||...+....+.++.+..+.+....|.............
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999988765567899999999999999999999999988888888888888888877775532221110000
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
..............++.++.++|.+||+.||.+|||+++++.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011111233345678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=342.13 Aligned_cols=285 Identities=34% Similarity=0.613 Sum_probs=231.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+++++.++|+||+++++++.. ....+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36999999999999999999999999999999987654444556778899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||++++++..+......+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999998887776666799999999999999999999999999999999999999999999999999987765443234
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC--Cc
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA--TI 355 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~ 355 (415)
....++..|+|||++.+...++.++||||||+++|+|++|.+||.+.+..+.+..+....+......+........ ..
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 4567789999999998754789999999999999999999999998888777777777666655443332111000 00
Q ss_pred CCCcchhhhhhhhhc-CCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 356 FKPQQSYKRCIAETF-KDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...+........... ..++.++++||++||..||++|||+++++.|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000000011112222 2358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=359.97 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=206.7
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC---CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL---DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
||+|+||.||+|++..+++.||+|++.+... .......+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999975432 222334455677777665 69999999999887 46799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 987776666666789999999999999999999999999999999999999999999999999987543222 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 217 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-------------------- 217 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence 899999999987655689999999999999999999999998887776665543211000
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQ----TATAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~~~L~h~~f~~~~ 408 (415)
...+++++.+||++||+.||.+|| +++++++||||+...
T Consensus 218 --------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 218 --------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred --------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 023677889999999999999998 799999999998753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=346.12 Aligned_cols=288 Identities=47% Similarity=0.733 Sum_probs=226.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 190 (415)
.++|++.++||+|+||.||+|.+..+++.||||.+............+.+|+.++++++|+||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46799999999999999999999999999999998765433333345567999999999999999999876532
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
....|+||||+.+++...+......+++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 24579999999998877776666679999999999999999999999999999999999999999999999999997664
Q ss_pred CCCCC---CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 271 PNHKQ---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 271 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
..... ......++..|+|||++.+...++.++||||||+++|+|++|.+||.+.+.......+.+..+..+.+.|+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 33221 123345688899999887655678999999999999999999999999888888888888887777666554
Q ss_pred CCCCCC-CcCCCcchhhhhhhhhcC--CCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 348 SKLPHA-TIFKPQQSYKRCIAETFK--DFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 348 ~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...... .................. ..+..+.+||.+||..||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 321110 000000011011111111 134567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=356.10 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=207.5
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHH-HHHHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMARE-ILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E-~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++..... .......+..| ..+++.++|+||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 369999999999999999999999999975432 11222233334 445778999999999999877 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccccc
Confidence 998777777666789999999999999999999999999999999999999999999999999987543221 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05602 158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----------------------- 213 (325)
T ss_pred CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-----------------------
Confidence 8999999999876 6789999999999999999999999999888777766654211
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH----HHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT----AALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----~~L~h~~f~~~~ 408 (415)
.....++.++.++|.+||+.||.+|+++. ++++|+||..++
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 11235788899999999999999999976 899999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=357.74 Aligned_cols=279 Identities=22% Similarity=0.277 Sum_probs=213.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..+|.+++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.++|+||+++++++.. ...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW--KSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee--CCEE
Confidence 457999999999999999999753 45678999987643 234579999999999999999999876 4579
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+|||++.+++...+ .....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 162 ~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999999998877766 4455799999999999999999999999999999999999999999999999999976654322
Q ss_pred C-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 275 Q-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. ....+..+.+..+..+.++......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 1 1224578999999999876 568999999999999999999999998754 3455666666555433221110000
Q ss_pred C-------CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 351 P-------HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 351 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
. .......+......+ ....++.++.++|.+||..||++|||+.++|.||||+...
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVI--RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hHHHHHHhhcccccCCccccchh--hccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 0 000000000000001 1124567889999999999999999999999999998643
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=371.08 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=219.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC-----
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----- 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----- 191 (415)
.++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.++..++|+||+++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 468999999999999999999999999999999998776666677788899999999999999999887654221
Q ss_pred -CeEEEEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 192 -CSLYLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 192 -~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
..+++||||+.++.+...+. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 24789999999866554432 2346899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 267 SFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 267 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
+.+..... .......||+.|+|||++.+ ..++.++|||||||+||||++|..||.+.+..+.+..+......
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~------ 263 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD------ 263 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC------
Confidence 87643221 22234578999999999876 56899999999999999999999999988877766665432111
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....+++++.+||.+||+.||.+||++.++|+|||++.+
T Consensus 264 ----------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 264 ----------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 1123567889999999999999999999999999998754
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=354.84 Aligned_cols=287 Identities=29% Similarity=0.502 Sum_probs=227.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
.++|++.+.||+|+||.||+|++..+++.||||.+............+.+|+.+++.++|+||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999999999999999998755444455566778999999999999999999886432 23
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|+||||+.+.+...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999999877665543 2899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....+.+..+.+.......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 F--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred C--CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 2 1234467889999999876 678999999999999999999999999988888888888888887766544322110
Q ss_pred CCcCC-----Ccchhhh---------hhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 353 ATIFK-----PQQSYKR---------CIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 353 ~~~~~-----~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
..... ....+.. .........++.+.++|.+||..||++|||+.++|.||||+.+-+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 00000 0000000 001112234567899999999999999999999999999975444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=341.31 Aligned_cols=284 Identities=38% Similarity=0.609 Sum_probs=221.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
...|.+.+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 36799999999999999999999999999999998755322 223356689999999999999999999876 557999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++++..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 99999988887766655678899999999999999999999999999999999999999999999999987643322 12
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+.++....+.+....|..........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2334578999999998765568889999999999999999999998654 446666676666766666554432111100
Q ss_pred CCC-cchhhhhhhhhcC--CCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 356 FKP-QQSYKRCIAETFK--DFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 356 ~~~-~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
... ............. ..+.++.++|.+||..||.+|||++|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0000001111111 235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=352.29 Aligned_cols=285 Identities=23% Similarity=0.318 Sum_probs=215.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++|+||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEE
Confidence 468999999999999999999999999999999987652 34455678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 999999877776666666789999999999999999999975 79999999999999999999999999987653321
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCCHHHHhhCCCCC--
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL-CGSPSEEYWKKSKLPH-- 352 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~-- 352 (415)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+... .+.+............
T Consensus 159 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 233468999999999876 56899999999999999999999999876554332221100 0011000000000000
Q ss_pred -----CCcCCCcchh----hhhhhhhc-----CCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 353 -----ATIFKPQQSY----KRCIAETF-----KDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 353 -----~~~~~~~~~~----~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.....+.... ........ ..++.++++||.+||..||++|||++++|.|+||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000000000 00011111 12456789999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=342.75 Aligned_cols=284 Identities=32% Similarity=0.590 Sum_probs=225.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+++++.++|+||+++++++.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 36899999999999999999998899999999987654433445678889999999999999999999976 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++.+..+......+++..+..++.||+.+|.|||+.+|+|+||+|+||+++.++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999998887776655568999999999999999999999999999999999999999999999999998764433 223
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC--CCc
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH--ATI 355 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~ 355 (415)
....++..|+|||++.+...++.++||||||+++|+|++|.+||......+....+................... ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345678899999998765667899999999999999999999999888777777776655543321111000000 000
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...............+.++..+.+||.+||..||.+||++.++|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000001111223345778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=360.11 Aligned_cols=277 Identities=23% Similarity=0.279 Sum_probs=207.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
...|.+.+.||+|+||.||+|++..+++.||||.... ..+.+|+.+|++|+|+|||++++++.. ....++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 4579999999999999999999999999999996432 234579999999999999999999877 567899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ- 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~- 275 (415)
|||++.+++...+......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++.........
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999998888777665567999999999999999999999999999999999999999999999999999765432221
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC-CC------hHHHHHHHHHhcCCCCHHH----
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RT------EVEQLHKIFKLCGSPSEEY---- 344 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~-~~------~~~~~~~i~~~~~~~~~~~---- 344 (415)
......||+.|+|||++.+ ..++.++|||||||+||||++|..++.. .. ....+.++++.......+.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1223568999999999976 5689999999999999999998755432 21 1233333333322211110
Q ss_pred ----HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 345 ----WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 345 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.................. ..+ .....++.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTR-PAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCC-cch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000000000000000 000 111245678999999999999999999999999999974
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=356.22 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=207.1
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHH-HHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREIL-ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+|+.||+|++.+... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 369999999999999999999999999975422 2223334445554 5677999999999998877 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccccc
Confidence 998777666666789999999999999999999999999999999999999999999999999987543221 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~----------------------- 213 (325)
T cd05604 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL----------------------- 213 (325)
T ss_pred CChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-----------------------
Confidence 8999999999876 6689999999999999999999999998887776666544210
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~~L~h~~f~~~~ 408 (415)
...+.++.++.++|.+||..||.+||++ .+++.||||+.+.
T Consensus 214 ------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 214 ------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred ------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 0113466778899999999999999987 5999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=350.62 Aligned_cols=293 Identities=33% Similarity=0.537 Sum_probs=231.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC---CCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~ 193 (415)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.++++++|+||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4689999999999999999999999999999999864322 234456778999999999999999998875431 245
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.|+++||+.+++...... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999999877655533 378999999999999999999999999999999999999999999999999997654322
Q ss_pred C--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 274 K--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 274 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. .......|++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 11223467899999998766567899999999999999999999999998888888888888887776665432211
Q ss_pred CCCcCC--CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 352 HATIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 352 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
....+. .+...........+.++.++.++|.+||+.||.+|||+.++++||||+...+.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 110000 0000011122233456888999999999999999999999999999998877644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=354.58 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=205.5
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHH-HHHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREI-LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++.+... .......+..|+ .+++.++|+||+++++++.+ ....|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999975432 122233444454 46788999999999998877 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+...+.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccccc
Confidence 988776666666689999999999999999999999999999999999999999999999999987532221 2234457
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (321)
T cd05603 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL----------------------- 213 (321)
T ss_pred CCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 8999999999876 5689999999999999999999999998877666655543210
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~~L~h~~f~~~~ 408 (415)
......+.++.++|.+||+.||.+|+++ .++++|+||..++
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 214 ------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 0112456678999999999999999976 5999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=384.92 Aligned_cols=262 Identities=26% Similarity=0.312 Sum_probs=229.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|.+++.||+|+||.|.+++++.+++.||+|++.+... .......|..|-.||..-+.+=|++++-.|.+ ..++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceE
Confidence 5789999999999999999999999999999999987432 34556789999999999999999999888887 67899
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.||.+-.++....++++..++.|+..|+.||+.||+.|+|||||||+|||||..|+|||+|||.|...+.++.-
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999998766666666558999999999999999999999999999999999999999999999999999988876665
Q ss_pred CcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc--CCCCHHHHhhCC
Q 014960 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC--GSPSEEYWKKSK 349 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 349 (415)
.....+|||.|++||++.. .+.|++.+|+||+||++||||+|..||...+-.+.+.+|+... ..++.+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~------ 305 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE------ 305 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc------
Confidence 6667899999999999842 2579999999999999999999999999999999999998862 222211
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEVSLYMX 408 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~L~h~~f~~~~ 408 (415)
.++|++.++||+++| .+|+.|.. ++++-.||||.++.
T Consensus 306 ---------------------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 306 ---------------------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred ---------------------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCC
Confidence 248899999999866 57889999 99999999999875
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=343.12 Aligned_cols=260 Identities=29% Similarity=0.428 Sum_probs=211.9
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
|++.+.||+|+||.||++++..+++.||+|++..............+|+.++++++|+||+++++++.. ....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 788999999999999999999999999999999775444444445669999999999999999999988 567999999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~ 279 (415)
++.++.+..++.....+++..+..++.||+.||++||+++|+|+||||+||+++.++.++|+|||.+.... ........
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNP 157 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99996555555455678999999999999999999999999999999999999999999999999997642 22233455
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCc
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (415)
..++..|+|||++.....++.++||||||+++|+|++|..||...........+.+.........+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 223 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-------------- 223 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--------------
Confidence 678999999999873467899999999999999999999999987544444444333221111110
Q ss_pred chhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
......+..+.++|.+||+.||++||++.++++||||
T Consensus 224 --------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 --------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001123678999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=351.66 Aligned_cols=294 Identities=34% Similarity=0.559 Sum_probs=232.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC---CCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~~ 194 (415)
++|.+.+.||+|+||.||+|++..+++.||||.+............+.+|+.+++.++|+||+++++++.... ...+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999999999999999998764333344456778999999999999999999876532 2458
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+|+||+.+++...+. ....+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 85 YIVYELMDTDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEeCCCCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 9999999987665544 44579999999999999999999999999999999999999999999999999997664332
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+.+..+.|.........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22234567889999998875456889999999999999999999999998888888888887777766555321111000
Q ss_pred cCC--CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 014960 355 IFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXX 413 (415)
Q Consensus 355 ~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~ 413 (415)
... .............+.++.++.+||.+||+.||.+|||++++|+||||..+++.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 000 00000001122345688899999999999999999999999999999998877643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=366.81 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=215.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||++++++.. ...+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEE
Confidence 34599999999999999999998777 7889999875442 3445677889999999999999999999987 56799
Q ss_pred EEEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 196 LVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 196 lv~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
+||||+.++.+...+ .....+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999886665432 2345789999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 272 NHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 272 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---------- 290 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---------- 290 (478)
T ss_pred ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence 322 12334568999999999876 678999999999999999999999999888777776665422111
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
....++.++.+||.+||..||++||+++++|.|+|++.+
T Consensus 291 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 291 ------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 112467789999999999999999999999999998754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=352.24 Aligned_cols=294 Identities=33% Similarity=0.557 Sum_probs=234.4
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec--CCCeEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSLY 195 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~~~ 195 (415)
++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 679999999999999999999999999999999876543334456677899999999999999999987542 245789
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.+++...+ .....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 85 lv~e~~~~~l~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 99999987665554 34456999999999999999999999999999999999999999999999999999765433221
Q ss_pred ---CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 276 ---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 276 ---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.++...+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 11234678999999998665568899999999999999999999999988888888888888887766554322110
Q ss_pred CC--cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 353 AT--IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 353 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
.. ...........+....+.+++++.++|++||+.||.+|||++++|.||||+...+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 00 0000000001122334567889999999999999999999999999999998877654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=341.32 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=202.2
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccC
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
||+|+||.||++++..+|+.||+|.+...... ......+..|++++++++|+||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 69999999999999999999999998754332 2223345569999999999999999998876 56799999999887
Q ss_pred hhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccc
Q 014960 205 LAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (415)
Q Consensus 205 l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~g 282 (415)
.+..... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCC
Confidence 6654432 33458899999999999999999999999999999999999999999999999997764332 2234568
Q ss_pred cCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchh
Q 014960 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (415)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (415)
++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.+......
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 214 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--------------------- 214 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc---------------------
Confidence 999999999876 4589999999999999999999999976543222222222110000
Q ss_pred hhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCC
Q 014960 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEVSLYMXX 409 (415)
Q Consensus 363 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~~L~h~~f~~~~~ 409 (415)
+......++.++.+||.+||+.||.+||++ +++++|+||+.++.
T Consensus 215 ---~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 215 ---VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ---cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 001113578889999999999999999999 77889999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=351.08 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=205.6
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++.++ +|+||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986543 234556788899999888 69999999999887 46799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceeccc
Confidence 988776666666689999999999999999999999999999999999999999999999999987532221 2234467
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE------VEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
||+.|+|||++.+ ..++.++|||||||+||+|++|.+||..... .+...++.... +
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~--------------- 219 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--P--------------- 219 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--C---------------
Confidence 8999999999876 6789999999999999999999999964221 11111111100 0
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT------ATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~~~L~h~~f~~~~ 408 (415)
......++..+.++|.+||..||.+|++ .++++.||||+.++
T Consensus 220 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 220 -----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 0112246777899999999999999998 57999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=335.81 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=212.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
+.|++.+.||+|++|.||.|.+..+++.||+|.+...... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 4688999999999999999999999999999998754332 2234578889999999999999999999987 4589
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+|+||+.++.+...+.....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999877666665556789999999999999999999999999999999999999999999999999976543222
Q ss_pred CCc--ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 QPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
... ....++..|+|||++.+ ..++.++||||||+++|+|++|++||...+..+...++......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN------------- 225 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-------------
Confidence 111 23457889999999886 55899999999999999999999999876555444333221110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
......++.++.++|.+||..||.+|||+.++|+|+||
T Consensus 226 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 --------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01123567788999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=350.50 Aligned_cols=294 Identities=35% Similarity=0.576 Sum_probs=238.2
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC---CCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~~~ 195 (415)
+|++.+.||+|++|.||+|++..+++.||||.+..........+.+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 488999999999999999999888999999998765433455677889999999999999999999887642 23689
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~- 274 (415)
++|||+++++...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 999999976655544 444899999999999999999999999999999999999999999999999999987654421
Q ss_pred -CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 -QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 -~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......+++.|+|||++.+...++.++|+||||+++|+|++|.+||.+.+..+.+..+....+.+..+.|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1234456789999999998754789999999999999999999999999999999999999888887776653221111
Q ss_pred CcC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 014960 354 TIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXX 413 (415)
Q Consensus 354 ~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~ 413 (415)
..+ .........+....+.++.++.++|.+||+.||.+|||++++|+||||+.+.+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 100 000011111233345578889999999999999999999999999999998886543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=378.47 Aligned_cols=265 Identities=26% Similarity=0.404 Sum_probs=216.2
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
..++|.+++.||+|+||.||+|++..++..||+|++............+..|+.+|+.|+|||||+++++|.......+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 35789999999999999999999999999999999987666566667888999999999999999999998765567899
Q ss_pred EEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCeeccCCCCCEEEcCC---------
Q 014960 196 LVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQ-------HVLHRDIKGSNLLIDNE--------- 255 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~-------~ivHrDlkp~NILl~~~--------- 255 (415)
|||||+.++.+..++. ....+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999865554443 235799999999999999999999984 49999999999999642
Q ss_pred --------CcEEEEeeccccccCCCCCCCcccccccCccCCcccccC-CcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh
Q 014960 256 --------GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGRTE 326 (415)
Q Consensus 256 --------~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~ 326 (415)
+.+||+|||++....... ......||+.|+|||++.+ ...++.++||||||||||+|++|.+||...+.
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 349999999997664322 2244578999999999864 24588999999999999999999999987665
Q ss_pred HHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 327 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
...+...+..... .....++.++.+||..||..+|.+||++.|+|.|+||+.
T Consensus 249 ~~qli~~lk~~p~----------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 FSQLISELKRGPD----------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHHhcCCC----------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 5444333221100 001235678999999999999999999999999999987
Q ss_pred CCCC
Q 014960 407 MXXX 410 (415)
Q Consensus 407 ~~~~ 410 (415)
+...
T Consensus 301 i~~p 304 (1021)
T PTZ00266 301 VGPP 304 (1021)
T ss_pred cCCC
Confidence 7543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.29 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=207.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.+++++.||+|.||.||+|+...+ ..||+|.++..... .+.|.+|+++|++|+|++||++++++... ..+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecC--CceEEE
Confidence 4577788999999999999986433 36899999854332 24566999999999999999999999873 369999
Q ss_pred EEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||..+.+..++. .+..+...+...++.|||+|++||+++++|||||.+.||||+++..+||+|||+|+....+...
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999875555554 3667999999999999999999999999999999999999999999999999999965544433
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.....--...|.|||.+.- ..++.+||||||||+|+||.| |+.|+.+.++.+.++.+.+...-|.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~------------- 425 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR------------- 425 (468)
T ss_pred ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-------------
Confidence 3333333667999999975 679999999999999999998 9999999999999999987654332
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHh
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L 399 (415)
....|+++.+|++.||..+|++|||++.+.
T Consensus 426 ---------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 ---------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 246899999999999999999999998654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=340.68 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=209.3
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|++|+.+++.+.+ ....|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 378889999999999999999999999999998765432 2334556789999999999999999998877 4579999
Q ss_pred EEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+.++.+...+. ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99998866654432 23468999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...................
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~--------------- 220 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------------- 220 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---------------
Confidence 2234578999999999876 568999999999999999999999998754322111111110000
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMXX 409 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~~ 409 (415)
.......++.++.+||.+||+.||.+|+| ++++++||||+.++.
T Consensus 221 ----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 221 ----------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred ----------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 00112356778899999999999999999 999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=360.85 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=223.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|.++..||.|+||.||+|.++.++-..|.|+|... ..+..+++.-||+||..++||+||+|++.|.. .+.++|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwi 106 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWI 106 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEE
Confidence 36799999999999999999999999999999998743 46778889999999999999999999997766 456999
Q ss_pred EEEecccChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+.|||+||-...+ +.-...+.+.++..+++|+|+||.|||+++|||||||+.|||++.+|.|+|+|||.+...... ..
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 9999999765543 344568999999999999999999999999999999999999999999999999988654322 23
Q ss_pred CcccccccCccCCccccc----CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 PMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
...++.|||+|||||+++ ...+|+.++|||||||+|.||..+.||-...+..-++-+|.+.- |+.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PPT--------- 254 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPT--------- 254 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CCc---------
Confidence 446789999999999974 34689999999999999999999999999988888888887642 111
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
......++.++.|++++||.+||.-||+++++|+||||.++.-.
T Consensus 255 ---------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 255 ---------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred ---------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 01123467788999999999999999999999999999987543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=342.61 Aligned_cols=286 Identities=37% Similarity=0.603 Sum_probs=221.2
Q ss_pred CceeeeeeccCCceEEEEEEECC--CCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTL--TGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.|.+.++||+|+||.||+|.+.. ++..||+|.+..... .......+.+|+.+++.++||||+++++++.+.....+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999888 889999999986431 122335567899999999999999999999886457899
Q ss_pred EEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC----CCcEEEEeecccc
Q 014960 196 LVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN----EGILTIADFGLAS 267 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~----~~~vkl~DfG~a~ 267 (415)
+||||+++++...+.. ....+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999877665432 1236899999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCCC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHh
Q 014960 268 FFDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV---------EQLHKIFKL 336 (415)
Q Consensus 268 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~~~ 336 (415)
....... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643322 11223467889999999877567899999999999999999999999875533 356666777
Q ss_pred cCCCCHHHHhhCCCCCCCcC----CCcchhh----hhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 337 CGSPSEEYWKKSKLPHATIF----KPQQSYK----RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
++.+....|........... .....+. ....+.....+.++.++|.+||..||++|||+.+++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 77666665543221111000 0000000 01112223677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=338.97 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=213.9
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.|+..+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++|+||+.+++++.. +...+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 377889999999999999999999999999999765432 2334567789999999999999999998877 4579999
Q ss_pred EEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+.++.+..... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999876654432 23469999999999999999999999999999999999999999999999999987654321
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.........+.........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE------------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-------------
Confidence 2234578999999999876 56899999999999999999999999887665554444332211110
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMXX 409 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~~ 409 (415)
.....++.++.+|+..||..||++||+ +.+++.|+||+.++.
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 223 ------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 112346778899999999999999999 899999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.04 Aligned_cols=287 Identities=18% Similarity=0.246 Sum_probs=210.0
Q ss_pred eeeeeccC--CceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 122 KLDKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 122 ~~~~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
++++||+| +|++||+++++.+|+.||+|.+............+.+|+.+++.++||||+++++++.. +...|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 45789999 78999999999999999999998765555666788899999999999999999999987 467999999
Q ss_pred ecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC--
Q 014960 200 YMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-- 275 (415)
Q Consensus 200 ~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~-- 275 (415)
|+.++.+..+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++++||+.+.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9998766655532 345899999999999999999999999999999999999999999999999875433211100
Q ss_pred ----CcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-------CCHH
Q 014960 276 ----PMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS-------PSEE 343 (415)
Q Consensus 276 ----~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------~~~~ 343 (415)
......++..|+|||++.+. ..++.++|||||||++|+|++|..||.................. ...+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 01123457789999998653 35889999999999999999999999875544433333221100 0000
Q ss_pred HHhhCC--C-CCCCcC-------CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 344 YWKKSK--L-PHATIF-------KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 344 ~~~~~~--~-~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.+.... . ...... ................++.++.+||.+||+.||++|||++++|+||||+.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~ 316 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 316 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence 000000 0 000000 000000001111223456789999999999999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=330.20 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=211.8
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.|++.+.||.|++|.||++.+..+++.||+|.+............+.+|++++++++|+|++++++.+... ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999999999999999987655555566788999999999999999999887643 45689999
Q ss_pred EecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 199 KYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 199 e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||+.++.+...... ...+++.+++.++.||+.+|+|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 99987655544432 3468999999999999999999999999999999999999999999999999998764332 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------------- 220 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP----------------- 220 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----------------
Confidence 334567899999999876 56889999999999999999999999877765554444332110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....+++++.++|.+||+.||.+|||+.++++||||
T Consensus 221 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 -----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1113467789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=345.99 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=211.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
....|+++++||+||.+.||++.. .+.+.||+|.+.....+.....-+.+|+..|.+| .|.+||+|++|-.. ++++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence 357899999999999999999974 4456788888877777788888999999999999 49999999998766 7899
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||||-+.+|-..+......++.-.++.|..|++.++.++|+.||||.||||.|+|+-. |.+||+|||.|..+.++..
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 999999998888877776666666689999999999999999999999999999998865 8899999999988876554
Q ss_pred CC-cccccccCccCCcccccCC----------cCCCchhcHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCH
Q 014960 275 QP-MTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAELLAEKPIMPGRT-EVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 275 ~~-~~~~~gt~~y~aPE~~~~~----------~~~~~~sDvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~ 342 (415)
.. ....+||+.||+||.+... ...+++|||||||||||+|+.|++||..-. ....+..| ..|..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI----~~P~~ 590 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI----TDPNH 590 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh----cCCCc
Confidence 33 2346899999999998531 135689999999999999999999996532 22222222 22221
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCC--ChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPP--SSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
...++++++ +++++++.||..||++|||+.++|+|||++-+
T Consensus 591 ------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 591 ------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred ------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 112233332 38999999999999999999999999998764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=347.72 Aligned_cols=292 Identities=37% Similarity=0.605 Sum_probs=231.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++++ +|+||+++++++........|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4689999999999999999999988999999999865433334455677899999999 999999999998765456789
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~- 274 (415)
+||||+.+++....... .+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 86 lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999998665554433 788999999999999999999999999999999999999999999999999986644322
Q ss_pred ---CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 275 ---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 275 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.......++..|+|||++.+...++.++||||||+++|+|++|++||.+....+....+....+.+....|......
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12233567899999998876566889999999999999999999999998888888888887777665554432111
Q ss_pred CCCcC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 352 HATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 352 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
..... ..............+.++.++.++|.+||+.||.+|||+.++|+|+||+.+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 00000 000000111223344578889999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=353.08 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=228.7
Q ss_pred ceee--eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 120 FEKL--DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 120 y~~~--~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
|++. +.||+|.||+||-|+++.+|+.||||+|.+..+.......+++|+.||+++.||+||.+.-.|+. ...+|+|
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVV 641 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVV 641 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEE
Confidence 5554 78999999999999999999999999999988877777899999999999999999999888887 4569999
Q ss_pred EEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---cEEEEeeccccccCCCC
Q 014960 198 FKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNH 273 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DfG~a~~~~~~~ 273 (415)
||-+.|+.+.+++.. .+++++.....++.||+.||.|||.++|||+||||||||+.... ++||||||+|+.+...
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 999999999988754 66899999999999999999999999999999999999997643 7999999999998643
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....+.+|||.|+|||++.. +.|++.-|+||.|||+|.-|+|..||.. ++++.++|++.....+...|.
T Consensus 721 -sFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~------- 789 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWS------- 789 (888)
T ss_pred -hhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchh-------
Confidence 45577899999999999986 7899999999999999999999999954 556778888877766666664
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.++.+++|||+.+|+..=.+|.+.+..|.|+|+++-
T Consensus 790 ------------------eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 790 ------------------EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ------------------hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 488999999999999999999999999999998764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=345.98 Aligned_cols=288 Identities=33% Similarity=0.542 Sum_probs=228.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~ 193 (415)
++|.+.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++|+||+++++++.... ...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5799999999999999999999999999999998764333333456778999999999999999999886532 135
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+|+||+...+.... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 95 FYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred EEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 7999999987554432 236899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+........
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 23446788999999987645688999999999999999999999999888888888888777666655544322111
Q ss_pred CcCC--CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 354 TIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 354 ~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
..+. ........+....+.++.++.+||.+||+.||.+||+++++|.||||+.+++..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 1000 0000011122233456788999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.25 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=222.1
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..+.|...+.||+|+||.||-|+-+.||+.||+|.+.+.... ........+|-.||++++.+.||.+--.|+.+ ..+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--d~L 260 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK--DAL 260 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--Cce
Confidence 357899999999999999999999999999999998765542 22233455799999999999999997778774 469
Q ss_pred EEEEEecccChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
++||..|+|+.+..++...+ .|+|..++.|+.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|+|+|..+..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999998888776655 7999999999999999999999999999999999999999999999999999988654
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
......+||.+|||||++.+ ..|+...|+|||||+||||+.|+.||...-+....+.+-+-....+
T Consensus 341 --~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~----------- 406 (591)
T KOG0986|consen 341 --KPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP----------- 406 (591)
T ss_pred --CccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-----------
Confidence 34566799999999999987 4599999999999999999999999987655444433333221111
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMXX 409 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~~ 409 (415)
.+....+++++++|.+.+|++||.+|+. ++++-+||||++++-
T Consensus 407 --------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 407 --------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred --------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 1223568999999999999999999985 579999999999874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=335.44 Aligned_cols=282 Identities=42% Similarity=0.733 Sum_probs=232.1
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
|++.+.||+|++|.||+|++..+++.||+|++............+..|+.+++.++|+||+++++++.. ....++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 567789999999999999999999999999998764334445667789999999999999999999887 467999999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~ 279 (415)
|+++++...+......+++..+..++.||+.+|.|||++||+||||+|+||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 999876666555445799999999999999999999999999999999999999999999999999977644322 2233
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCc
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (415)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.++.+..+.+....|.............+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 45578899999987655789999999999999999999999999999999999999998888888876433221111111
Q ss_pred chhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...........+.++.++.++|++||..||++||++++++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111122334445668889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=335.34 Aligned_cols=259 Identities=21% Similarity=0.325 Sum_probs=209.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||+|++..+++.||+|.+..+. .......+.+|+.++++++|+||+++++++.. ....++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEE
Confidence 36888999999999999999999999999999987653 34455678899999999999999999999987 4578999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++.+... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence 999999876543 257899999999999999999999999999999999999999999999999997664332 2
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE---QLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.+.......
T Consensus 151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------ 217 (279)
T cd06619 151 KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------ 217 (279)
T ss_pred cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC------------
Confidence 34578999999999876 568999999999999999999999997532111 00111111100000
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.......++.++.++|.+||..||.+||+++++++||||+..+..
T Consensus 218 -----------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~ 262 (279)
T cd06619 218 -----------PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG 262 (279)
T ss_pred -----------CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence 000112356778999999999999999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=337.01 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=216.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|++++++++|+||+++++++.. +...|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 368999999999999999999999999999999875432 23445678899999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+...+.....+++..+..++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999977666666666668999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV------------------ 215 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc------------------
Confidence 234467899999998875 5678999999999999999999999988776555555542110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
.....++..+.++|.+||..||.+|+ +++++++||||+.+.
T Consensus 216 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 216 -----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 01124577889999999999999999 999999999998875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=334.09 Aligned_cols=284 Identities=25% Similarity=0.416 Sum_probs=221.2
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--C----ceeeeeeeEee
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--P----NVVKLEGLVTS 188 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----~iv~l~~~~~~ 188 (415)
....+|.++.++|+|.||.|-+|+|..++..||||+++.-. ...+.-.-|+++|+++.+ | -+|++.++|+.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34678999999999999999999999999999999987432 222334458999999942 1 36778888877
Q ss_pred cCCCeEEEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-------------
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN------------- 254 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~------------- 254 (415)
.++.+||+|.++-++...+.. ...+|+...++.+++||+.+++|||+++++|-||||||||+.+
T Consensus 163 --rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 163 --RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred --cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 567999999999777666554 4568999999999999999999999999999999999999842
Q ss_pred -------CCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH
Q 014960 255 -------EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV 327 (415)
Q Consensus 255 -------~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~ 327 (415)
+..|+|+|||.|....... +..+.|..|.|||++++ -+++.++||||+||||+|+.+|...|.+.++.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2248999999998765432 56678999999999998 67999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCHHHHhhC---------CCCCCCc---------CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCC
Q 014960 328 EQLHKIFKLCGSPSEEYWKKS---------KLPHATI---------FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389 (415)
Q Consensus 328 ~~~~~i~~~~~~~~~~~~~~~---------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 389 (415)
+.+..+.+.+|.++....... ++.+.-. +.+..+....+.. ...--..+.|||++||.+||
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~-~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ-DDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc-CcHHHhHHHHHHHHHHccCc
Confidence 999999999997775543322 2221110 1111111111000 00011348999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCC
Q 014960 390 AERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 390 ~~R~t~~~~L~h~~f~~~~~ 409 (415)
.+|+|+.|+|.||||+.+..
T Consensus 395 ~~RiTl~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 395 ARRITLREALSHPFFARLTP 414 (415)
T ss_pred cccccHHHHhcCHHhhcCCC
Confidence 99999999999999987653
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.31 Aligned_cols=288 Identities=38% Similarity=0.645 Sum_probs=229.1
Q ss_pred CCcee-eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHH------------HHHHHHHHHHHHhCCCCceeeeee
Q 014960 118 DTFEK-LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES------------VRFMAREILILRRLDHPNVVKLEG 184 (415)
Q Consensus 118 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~l~~ 184 (415)
++|.. .+.||+|+||.||+|++..+++.||+|++......... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46664 56799999999999999999999999998754322100 124668999999999999999999
Q ss_pred eEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 185 LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 185 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
++.. ....++||||+.+++...+. ....+++..+..++.||+.||+|||++||+||||+|+|||++.++.++|+|||
T Consensus 88 ~~~~--~~~~~lv~e~~~~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEec--CCcEEEEEeccccCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9876 56799999999987665553 44578999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-------------CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014960 265 LASFFDPNH-------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLH 331 (415)
Q Consensus 265 ~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~ 331 (415)
++....... ........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 997654110 1112234568889999998765567899999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 332 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.+....+.+....|+........ ..................+.++.++|.+||+.||++|||++++|.|+||+....
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 99998888887767653211110 000111112233344567888999999999999999999999999999986643
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.49 Aligned_cols=283 Identities=23% Similarity=0.297 Sum_probs=214.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|++++++++|+||+++++++.. +..+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 36999999999999999999999999999999987542 34455678889999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++.+..++.....+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999987777776666789999999999999999999997 599999999999999999999999999987653321
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC-Cc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA-TI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~ 355 (415)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+ ....... .+........ ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF-GRPVSEG--EAKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh-cCccccc--cccCCcccccCCC
Confidence 234577899999998875 56889999999999999999999999876643332222 1111000 0000000000 00
Q ss_pred CCCcc------hhhhhhhhhc-----CCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 356 FKPQQ------SYKRCIAETF-----KDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 356 ~~~~~------~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
..... .......... ..++.++.+||.+||..||++|||++++++||||......
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 00000 0000011111 1256679999999999999999999999999999886443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=346.12 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=198.6
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|.+ ..++..||+|++... ........+.+|+.++..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 36899999999999999999974 244578999998743 2334456788999999999 899999999988753
Q ss_pred CCeEEEEEEecccChhhhhcCC----------------------------------------------------------
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (415)
...++++|||+.++.+..++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4568999999998766544321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-CcccccccCccC
Q 014960 213 ----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYR 287 (415)
Q Consensus 213 ----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~ 287 (415)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 124788899999999999999999999999999999999999999999999999765332211 112334567899
Q ss_pred CcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhh
Q 014960 288 PPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCI 366 (415)
Q Consensus 288 aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (415)
|||++.+ ..++.++|||||||+||||++ |.+||.+....+.+.........+
T Consensus 244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------------- 296 (338)
T cd05102 244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-------------------------- 296 (338)
T ss_pred CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--------------------------
Confidence 9999876 568999999999999999997 999998765443333322211000
Q ss_pred hhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 367 AETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 367 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......++++.+||.+||..||.+|||+.++++
T Consensus 297 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 011245677899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=334.92 Aligned_cols=282 Identities=43% Similarity=0.753 Sum_probs=230.8
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|+||+++++++.. ....|+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 567789999999999999998899999999987665444456678889999999999999999999877 467999999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~ 279 (415)
|+.+++...+......+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99998777766655689999999999999999999999999999999999999999999999999998775543 22334
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC-CCCcCCC
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP-HATIFKP 358 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~ 358 (415)
..++..|+|||.+.+...++.++|+||||+++|+|++|++||...+..+....+.+..+.+....|...... .......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 567888999999876547899999999999999999999999999888888888888877776666553220 0000000
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
............+.++.++.++|.+||..||.+||++.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0000001122334578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.24 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=214.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|.+.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4788899999999999999999999999999998765556667788899999999999999999999887 46799999
Q ss_pred EecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 199 KYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 199 e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||+.++.+..++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence 99987665554432 45789999999999999999999999999999999999999999999999999887654322 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||++.+ ..++.++|+|||||++++|++|..||...+..+....+.+....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP---------------- 220 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 234467889999999876 568899999999999999999999998887666555554321110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
....++.++.++|.+||+.+|++||++.++++|||+
T Consensus 221 ------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 ------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 112467789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.60 Aligned_cols=262 Identities=26% Similarity=0.316 Sum_probs=216.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+..|+++++.++|+||+++++++.. ....|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 3699999999999999999999999999999999876543 2455678899999999999999999999877 567999
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..+... ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999988666555443 35789999999999999999999999999999999999999999999999999876533211
Q ss_pred C----------------------------CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh
Q 014960 275 Q----------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE 326 (415)
Q Consensus 275 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~ 326 (415)
. .....+|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 1123467889999999876 5689999999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC----HHHHhcCC
Q 014960 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT----ATAALRSE 402 (415)
Q Consensus 327 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~L~h~ 402 (415)
...+..+....... .....++.++.++|.+||..||++||| ++++|.||
T Consensus 238 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVTF---------------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCccC---------------------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 66665554211100 001126788999999999999999999 99999999
Q ss_pred CCCCCCC
Q 014960 403 VSLYMXX 409 (415)
Q Consensus 403 ~f~~~~~ 409 (415)
||+..+.
T Consensus 291 ~~~~~~~ 297 (316)
T cd05574 291 FFRGVNW 297 (316)
T ss_pred hhhcCCh
Confidence 9998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.38 Aligned_cols=290 Identities=33% Similarity=0.541 Sum_probs=229.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~ 192 (415)
.++|++.+.||+|+||.||++.+..++..||+|++............+.+|+.+++.++|+||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 467999999999999999999999999999999986543334445567889999999999999999998865322 2
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+++||||+++++..... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 468999999766554443 246899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+.......+.+..+.+....+.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2334568899999998764568899999999999999999999999988888888888777666655444322211
Q ss_pred CCcCC--CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 353 ATIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 353 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
...+. .............+.++.++.++|.+||+.||.+|||+.+++.||||+.+++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 10000 0000001122233567788999999999999999999999999999999877643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=345.43 Aligned_cols=290 Identities=35% Similarity=0.572 Sum_probs=232.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~ 192 (415)
.++|++.+.||+|++|.||+|++..+++.||+|++............+.+|+.++++++|+||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 467999999999999999999999999999999987543334445667789999999999999999987755321 3
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|+|+||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999998766555443 36899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 2344678899999998654568899999999999999999999999988888888888888877776665433211
Q ss_pred CCcCCCc--chhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 353 ATIFKPQ--QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 353 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
...+... .............++.++.++|.+||+.||.+|||+.++|+||||+...+..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 1100000 00000112223456888999999999999999999999999999999887754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=334.83 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=215.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|+++++||+|+||.||+|++..++..|++|.+... .......+.+|+.+++.++|+||+++++.+.. +...|+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 86 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWI 86 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEE
Confidence 36799999999999999999999999999999998754 34556778889999999999999999999876 457999
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..+. .....+++..+..++.||+.+|+|||+++|+||||||+||+++.++.+||+|||++....... .
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 99999987765543 334578999999999999999999999999999999999999999999999999987543221 1
Q ss_pred CcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+......++.+... +
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~----------- 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-P----------- 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-c-----------
Confidence 2234467889999998852 24568899999999999999999999987665554444432110 0
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
.......++.++.++|.+||..||++||+++++|+||||..++...+
T Consensus 234 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 234 --------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred --------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchh
Confidence 00011245667899999999999999999999999999998776543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.34 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=223.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..|.-++.||.|+||.||-|++..+.+.||||.+...+. ..+..+++..|+.+|++++|||++.+.|+|.. ....|+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHH
Confidence 457788999999999999999999999999999988765 45667788999999999999999999999987 456899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||||-|+-...+.-..+++.+.++..|..+.+.||.|||+.+.||||||..|||+.+.|.|||+|||.|....+
T Consensus 104 VMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred HHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 999999976666655666899999999999999999999999999999999999999999999999999988765
Q ss_pred cccccccCccCCccccc--CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 277 MTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
..+++|||+|||||+++ ..+.|+-++|||||||+..||.-.+||+.+-+....+..|.+.-. |..
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-PtL------------ 245 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PTL------------ 245 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-CCC------------
Confidence 36789999999999984 346799999999999999999999999998888777777765321 110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.-.++++.+..+|..||.+-|.+|||.+++|+|+|+..-+
T Consensus 246 --------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 246 --------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred --------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 0124566788899999999999999999999999976543
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=335.18 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=216.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||.|+||.||++.+..++..||+|.+... .....+.+.+|+.++++++|+||+++++++.. ....|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 35799999999999999999999889999999998754 34455678889999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..+... ...+++..++.++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999766665543 45799999999999999999999999999999999999999999999999999876543221
Q ss_pred CcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
......+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+....+.++.+... +.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~---------- 227 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-PT---------- 227 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-CC----------
Confidence 2234567899999998742 24577899999999999999999999988776665555533210 00
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
......++.++.++|.+||..||.+||+++++|+|+||+...+.
T Consensus 228 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (280)
T cd06611 228 ---------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271 (280)
T ss_pred ---------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence 00113467788999999999999999999999999999887543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.38 Aligned_cols=263 Identities=26% Similarity=0.432 Sum_probs=231.9
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.....|.+.++||+|.|+.|.++++..++..||||.+++........+.+.+|+++|+.|+|||||+++.+... ...+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--ccee
Confidence 34578999999999999999999999999999999999988877777779999999999999999999999987 4569
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++...+++.+..++.++.|++.+++|||+++|||||||++||||+.+.++||+|||++.+++.+
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--
Confidence 999999999988888888889999999999999999999999999999999999999999999999999999998855
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
....+.+|++.|.|||++.+....++++|+||+|++||.|++|..||.+.+-.+.....+.....
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--------------- 273 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--------------- 273 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec---------------
Confidence 34577899999999999999888899999999999999999999999987765555444332111
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
..--++.+..+||++||..+|.+|+++++++.|.|.....+.
T Consensus 274 --------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 274 --------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred --------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 111357788899999999999999999999999997665443
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.06 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=208.3
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
+|+..+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++|+||+++++++.......++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68889999999999999999999999999999875432 234456788999999999999999999988765456789
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~- 274 (415)
+++||+.++.+...+.....+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++........
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 9999999876666655555789999999999999999999999999999999999999999999999999876533211
Q ss_pred -CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 -QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 -~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+......+
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 228 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP------------- 228 (266)
T ss_pred CCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC-------------
Confidence 11223457889999999876 568899999999999999999999998765444333322111000
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
.....+++.+.++| +||..||++||+++++++||||+
T Consensus 229 --------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 --------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00123566778888 68889999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=336.88 Aligned_cols=290 Identities=34% Similarity=0.559 Sum_probs=232.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||.|+||.||+|++..+++.||+|++.+..........+.+|+.+++.++||||+++++++... ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEE
Confidence 4679999999999999999999999999999999876544344456777899999999999999999988653 346899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
++||+++.+...+. ...+++..+..++.||+.||.|||+++|+||||+|.|||++.++.++|+|||++......
T Consensus 88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 99999876654433 236789999999999999999999999999999999999999999999999998754322
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+.+..+.++.+.+..........+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 23346788899999886545789999999999999999999999999888888888888888877665543221110000
Q ss_pred --CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 014960 357 --KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXX 413 (415)
Q Consensus 357 --~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~ 413 (415)
..............+.++.++.++|.+||+.||++|||++++|.|+||....+...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 000000111233445678899999999999999999999999999999988877554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=357.72 Aligned_cols=286 Identities=24% Similarity=0.321 Sum_probs=205.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC-ceEEEEE--------------EecC-CCChHHHHHHHHHHHHHHhCCCCcee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-QIVALKK--------------VRFD-NLEPESVRFMAREILILRRLDHPNVV 180 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vaiK~--------------~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv 180 (415)
.++|+++++||+|+||.||+|..+... ..+++|. +.+. .........+.+|+.+|++++|+|||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998754322 2222221 1110 11223455688999999999999999
Q ss_pred eeeeeEeecCCCeEEEEEEecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC
Q 014960 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (415)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 256 (415)
++++++.. ....|+|++++.++++..+... ........++.|+.||+.||+|||++|||||||||+|||++.++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999987 4568999999988877665432 22345677889999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC---CChHHHHHHH
Q 014960 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG---RTEVEQLHKI 333 (415)
Q Consensus 257 ~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~---~~~~~~~~~i 333 (415)
.+||+|||++..+...........+||+.|+|||++.+ ..++.++|||||||+||||++|..++.+ ......+.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999998775443333334678999999999886 5689999999999999999998754433 2334455555
Q ss_pred HHhcCCCCHHH-------HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 334 FKLCGSPSEEY-------WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 334 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.........+. |..... ..+......+...+. ...++.++.++|.+||++||.+|||+.|+|.||||..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~--~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDS--AEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhh--hhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 55443322211 110000 000001111111111 1246778899999999999999999999999999987
Q ss_pred CCC
Q 014960 407 MXX 409 (415)
Q Consensus 407 ~~~ 409 (415)
...
T Consensus 460 ~~~ 462 (501)
T PHA03210 460 EEE 462 (501)
T ss_pred CCc
Confidence 654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=329.50 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=214.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+++.++|+||+++++.+.. ....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 46999999999999999999988899999999987654433 56788999999999999999999998877 5679999
Q ss_pred EEecccChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 198 FKYMEHDLAGLAASP---TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||++.++.+...+.. ...+++..++.++.||+.||.|||++||+||||+|+||++++++.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999998766655533 24689999999999999999999999999999999999999999999999999977654332
Q ss_pred C---CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 275 Q---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 275 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. ......++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++.+.. +.. +.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--~~----- 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PPS--LE----- 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC--CCC--cC-----
Confidence 2 12334678999999998764478999999999999999999999998876665555543321 000 00
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++..+.++|.+||..||++|||++++++||||
T Consensus 229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 229 --------------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 001124677889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=331.17 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=209.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEE
Confidence 57999999999999999999999999999999987653 2334567889999999999999999999877 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||++++.+..+......+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 9999987777666666689999999999999999999999999999999999999999999999999987654322 222
Q ss_pred ccccccCccCCccccc--CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 278 TSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
....|++.|+|||++. ....++.++|||||||++|+|++|.+||...........+......+. .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~----------- 230 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--K----------- 230 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--c-----------
Confidence 3457899999999874 224578899999999999999999999976554433332222111100 0
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~ 403 (415)
. .....++..+.++|.+||..||++|||+++++.|||
T Consensus 231 ----------~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 231 ----------L-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ----------c-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 011245677899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=341.93 Aligned_cols=292 Identities=33% Similarity=0.550 Sum_probs=222.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC-----
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----- 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----- 191 (415)
..+|.+.+.||.|+||.||+|++..+|+.||+|.+..... ...+.+.+|+++++.++|+||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 3689999999999999999999999999999999876543 445667889999999999999999987655321
Q ss_pred -------CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEee
Q 014960 192 -------CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADF 263 (415)
Q Consensus 192 -------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~Df 263 (415)
...|+||||+.+++...+. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 3579999999976655443 236899999999999999999999999999999999999975 557899999
Q ss_pred ccccccCCCCC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 014960 264 GLASFFDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341 (415)
Q Consensus 264 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 341 (415)
|++........ .......++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99976543211 1122345788999999876556788999999999999999999999999888777777766544433
Q ss_pred HHHHhhCCC-CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 342 EEYWKKSKL-PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 342 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
...+....- ....................+.++.++.+||.+||+.||.+|||+.++|.|+||+.+....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~ 311 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFD 311 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCcc
Confidence 322221000 00000000000111122233467888999999999999999999999999999997766543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=332.93 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=214.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.|++.+.||+|+||.||++.+..++..+++|.+.... ....+.+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEE
Confidence 34788899999999999999999999999999986432 4456678889999999999999999999877 4679999
Q ss_pred EEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++.+.... .....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 9999987776544 335579999999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccccccCccCCccccc----CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 277 MTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.....+++.|+|||++. ....++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------------ 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC------------
Confidence 23456789999999874 22457789999999999999999999998877666655554321110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
......++.++.+||.+||..||.+||+++++++||||+....
T Consensus 228 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 228 --------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred --------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 0011346778999999999999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=338.80 Aligned_cols=292 Identities=35% Similarity=0.542 Sum_probs=229.7
Q ss_pred CceeeeeeccCCceEEEEEEECCC--CceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee--cCCCe
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLT--GQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS--RMSCS 193 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~--~~~~~ 193 (415)
+|.+.+.||+|+||.||++++..+ +..||+|.+............+.+|+.+++++ +|+||+++++++.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488899999999999999999887 89999999875433333455677899999999 59999999987532 12346
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+++|++++++...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 88999999887666554 44579999999999999999999999999999999999999999999999999998664332
Q ss_pred CC---CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 274 KQ---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 274 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
.. ......|++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++...+.+..+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 11 123346899999999887655689999999999999999999999999998999999999988887766554322
Q ss_pred CCCCcC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 351 PHATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 351 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
...... ..............+..+..+.++|.+||+.||.+|||+.+++.||||+.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~ 302 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPD 302 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcc
Confidence 111000 0000000012222344677899999999999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=329.04 Aligned_cols=255 Identities=28% Similarity=0.499 Sum_probs=209.7
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-------hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-------PESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
+|.+...||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 377888999999999999999889999999998754321 1234578899999999999999999999887 4
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
...+++|||+.++.+..++.....+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 57999999999877776666666789999999999999999999999999999999999999999999999999887652
Q ss_pred CCC-----CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 272 NHK-----QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 272 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--------- 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---------
Confidence 211 11122357888999999876 568899999999999999999999998766544443332211
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++..+.++|.+||+.||.+||++.++++|+||
T Consensus 229 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 -------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001123467788999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=330.24 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=215.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||.|++|.||+|++..+++.||+|.+.... .......+.+|+.+++.++|+||+++++++.+ +...|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEE
Confidence 36888999999999999999999999999999987653 23344567899999999999999999999887 4679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
+||+.++.+..+.... .+++..++.++.||+.+|.|||+++++||||+|+||+++.++.++|+|||++....... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999987666665544 78999999999999999999999999999999999999999999999999998775432 122
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.+.....
T Consensus 156 ~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----------------- 217 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS----------------- 217 (274)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCC-----------------
Confidence 34567889999999876 458999999999999999999999998766554444333211000
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
+. ...++.++.++|.+||..||++|||++++++|+||+.....
T Consensus 218 --------~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 218 --------LE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred --------Cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 00 01267889999999999999999999999999999886654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.30 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=207.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++|+||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Confidence 357999999999999999999999999999999987543 2334567889999999999999999999877 467999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+..+......+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999987776666555678999999999999999999999999999999999999999999999999998664322 11
Q ss_pred cccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 277 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.....+++.|+|||.+.. ...++.++|||||||++|+|++|.+||......+....+......+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 229 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP------------- 229 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC-------------
Confidence 233467889999998742 24577899999999999999999999976543332222211100000
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~ 403 (415)
.......++..+.+||.+||+.||++|||++++|+|.|
T Consensus 230 -----------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 -----------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00011246778999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=333.59 Aligned_cols=262 Identities=24% Similarity=0.427 Sum_probs=215.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+|++.+.||+|+||.||++++..+++.||+|.+...... ....+.+|+.+++.+.|+||+++++.+.. ....|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEE
Confidence 36899999999999999999999999999999999865432 34668889999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+..+... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 9999998766665543 3689999999999999999999999999999999999999999999999999876543321 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+.......+.... .+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~--------------- 235 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE--------------- 235 (296)
T ss_pred cCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCC---------------
Confidence 234568899999998875 567899999999999999999999998776544433322110 000
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
......++..+.+||.+||..||.+|||+.++++|+||...+..+
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~ 280 (296)
T cd06654 236 ----------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280 (296)
T ss_pred ----------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCcc
Confidence 001134667789999999999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=333.14 Aligned_cols=262 Identities=21% Similarity=0.368 Sum_probs=213.4
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++++.||+|+||.||+|++..++..||+|.+... ........+.+|+.++++++|+||+++++.+.. ....|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 3689999999999999999999989999999998754 234445678899999999999999999998877 5679999
Q ss_pred EEecccChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 198 FKYMEHDLAGLAASP---TIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|||+.++.+..+... ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999998776655543 2378999999999999999999996 599999999999999999999999999987653321
Q ss_pred CCCcccccccCccCCcccccCC-----cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGA-----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.....+++.|+|||++.+. ..++.++|+|||||++|+|++|..||...+.......+.........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 228 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------ 228 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC------
Confidence 2334678899999988542 23578999999999999999999999776555544443332211110
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.....++.++.++|.+||..||++||++++++.||||......
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 229 -------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred -------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 1123477888999999999999999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=332.45 Aligned_cols=262 Identities=25% Similarity=0.444 Sum_probs=217.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+|++.+.||.|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEE
Confidence 3579999999999999999999999999999999875432 334667889999999999999999999876 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|+||+.++.+..+.... .+++.++..++.||+.+|+|||++|++||||||+||+++.++.+||+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 99999988777666543 689999999999999999999999999999999999999999999999999876544322 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.... .+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~--------------- 234 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPE--------------- 234 (296)
T ss_pred CCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Ccc---------------
Confidence 234467889999998875 568899999999999999999999998877665554443211 110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
......++..+.++|.+||..||.+|||+.+++.||||+..++.+
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~ 279 (296)
T cd06655 235 ----------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLS 279 (296)
T ss_pred ----------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccc
Confidence 011234677889999999999999999999999999999877643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=338.23 Aligned_cols=288 Identities=34% Similarity=0.536 Sum_probs=225.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++|+||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 36899999999999999999999999999999998764333344566778999999999999999999875421 23
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|++++++++.+..... . ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~lv~~~~~~~L~~~~~-~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 96 DVYLVTHLMGADLNNIVK-C-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred cEEEEehhcccCHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 578999998766654433 2 36899999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+.+..+.+....+.......
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 174 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred ----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 2344678899999988765568899999999999999999999999888888888888777766665554322111
Q ss_pred CCcC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.... .................+.++.+||.+||..||.+|+++.++|+||||+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 0000 000000000111222457789999999999999999999999999999976554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=334.59 Aligned_cols=263 Identities=24% Similarity=0.430 Sum_probs=215.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+|++.+.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.. +...|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 3689999999999999999999999999999999976443 234567889999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+..+... ..+++.++..++.|++.+|.|||+.||+||||||+|||++.++.++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 9999998777666543 3689999999999999999999999999999999999999999999999999876544322 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+.......+... +.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~--------------- 234 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------- 234 (297)
T ss_pred cCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCC---------------
Confidence 234567889999998876 66889999999999999999999999876543332222110 1110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
......++..+.+||.+||..||++||+++++|.||||+..+....
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 235 ----------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 0011246677899999999999999999999999999998877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=325.10 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=214.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||.|+||.||+|.+..++..||+|.+..........+.+..|+++++.++|+||+++++++........|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48899999999999999999999999999999987666666677888999999999999999999988765567789999
Q ss_pred EecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 199 KYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCH-----NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 199 e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH-----~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
||+.++.+..++. ....+++..++.++.||+.||+||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9998865544432 2457899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
..... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 227 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----------- 227 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-----------
Confidence 54332 1234568999999999876 5588999999999999999999999988775554444432110
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
......++..+.+++.+||..||++|||++++|+|||+
T Consensus 228 -----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 -----------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 01112467789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=332.71 Aligned_cols=263 Identities=27% Similarity=0.326 Sum_probs=215.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 368999999999999999999999999999999876533 23345677889999999999999999999876 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-- 274 (415)
||||+.++.+..++.....+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999877776666666899999999999999999999999999999999999999999999999999864211100
Q ss_pred ------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 275 ------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 275 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 00112356888999999876 56899999999999999999999999988777666655442211100
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEVSLYMXX 409 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~L~h~~f~~~~~ 409 (415)
....++.++.++|.+||..||++||+ +.++|+||||...+-
T Consensus 238 --------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 238 --------------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred --------------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 01246778899999999999999998 799999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=324.87 Aligned_cols=254 Identities=22% Similarity=0.442 Sum_probs=212.1
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|+||.||.+++..+|+.||+|.+............+.+|+.++++++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 4889999999999999999999999999999998655445556678899999999999999999999876 56799999
Q ss_pred EecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 199 KYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 199 e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||+.++.+..... ....+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++........ .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 9998755444432 233689999999999999999999999999999999999999999999999999976644321 1
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP----------------- 219 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-----------------
Confidence 223457888999999876 56888999999999999999999999887776666555432110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....++.++.++|.+||+.||.+||++.++|+||||
T Consensus 220 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 1123467789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.39 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=215.6
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|+.++.||.|+||.||.+++..+++.+++|.+............+.+|+.++++++|+||+++++++.+ ...++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 4899999999999999999999999999999998765555666778899999999999999999999987 56799999
Q ss_pred EecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 199 KYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 199 e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||+.++.+...+.. ...+++..+..++.|++.+|.|||+.|++||||+|+||+++.++.+||+|||++........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 99988655554433 35689999999999999999999999999999999999999999999999999987644331 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......+
T Consensus 158 ~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---------------- 220 (256)
T ss_pred ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 344568999999999876 457889999999999999999999998877777666664321110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
....++.++.++|.+||..||.+||+++++|+|+|+
T Consensus 221 ------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 ------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 113467789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=325.34 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=209.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.+|++.+.||+|+||.||.+++..+++.||||.+..... .....+.+.+|+.++++++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999999865432 23456788899999999999999999998876545678
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+++|||+.++.+...+.....+++..+..++.||+.+|+|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999876666665555789999999999999999999999999999999999999999999999999876532111
Q ss_pred --CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 --QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 --~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||..........++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCC----------
Confidence 11233457889999999876 5688999999999999999999999987654444433321 1100
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
......++..+.++|.+|+. +|.+||+++++++|||++
T Consensus 228 --------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 --------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 00112456678889999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.34 Aligned_cols=280 Identities=39% Similarity=0.653 Sum_probs=221.5
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeeeeeEeecCC---Ce
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTSRMS---CS 193 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~---~~ 193 (415)
|++.+.||+|+||.||+|++..+++.||+|.+............+.+|+.+++++ +|+||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999988899999999976543333334566788777766 69999999999876321 24
Q ss_pred EEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
++++|||+.+.+...+... ...+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 8999999998766554432 236899999999999999999999999999999999999999999999999999776543
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......+....|.......
T Consensus 161 ~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 M--ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred c--ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 2 2233457888999999876 568899999999999999999999999999888888888877666655554432211
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...+.. ..........+.++..+.++|.+||+.||.+||+++++|+||||
T Consensus 238 ~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPS--YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhccc--ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 111111 11111233344667888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=325.39 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=209.5
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC----ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..... .......+.+|+++++.++|+||+++++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 478889999999999999986 5788999999875432 23344678899999999999999999999987 4689
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC-
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH- 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~- 273 (415)
+++|||+.++.+..++.....+++..+..++.||+.||+|||+.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999998777776666678999999999999999999999999999999999999999999999999987653211
Q ss_pred ----CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 274 ----KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 274 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
........++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------- 226 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence 111233467899999999876 56889999999999999999999999876654444333221111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++.++.++|.+||..||.+||++.++|.||||
T Consensus 227 ----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 ----------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=309.66 Aligned_cols=262 Identities=23% Similarity=0.351 Sum_probs=218.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++.+.+..||.|..|.|++++.+.+|...|+|.+..... .+..+++...+.++.+. ++|+||+++|+|.. +..++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~ 167 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVF 167 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHH
Confidence 3556677889999999999999999999999999987654 44556677777777666 59999999999988 45589
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+.||.|......++..-.++++|..+-.+...++.||.||.+ ++|+|||+||+|||+|..|++||||||.+-++....
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 999999877666666666789999999999999999999986 589999999999999999999999999997765432
Q ss_pred CCcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.-+...|-+.|||||.+.- ...|+.++||||||+.|+||.||..||.+ .++.+.+.++++.. |+
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--PP---------- 313 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--PP---------- 313 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--CC----------
Confidence 2244567888999999843 35689999999999999999999999998 67889999988732 21
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.......|++++.+++..||.+|+.+||...++|+|||.+....
T Consensus 314 --------------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 314 --------------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred --------------CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 11122348999999999999999999999999999999765543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=332.90 Aligned_cols=258 Identities=24% Similarity=0.424 Sum_probs=214.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.|.++++||+|+||.||+|.++.+|+.+|||.+..+ ...+.+..|+.|+++++.+++|++||.+.. ...+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEee
Confidence 5699999999999999999999999999999998754 244567789999999999999999997765 3459999
Q ss_pred EEecccChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+....+ ..+++.++|.++..+++..+.||+|||...=+|||||..|||++.+|..||+|||.|..+... ...
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 999997666554 456779999999999999999999999999999999999999999999999999999766432 234
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.++..|||.|||||++.. -.|+..+||||||+...||.-|+|||...-. +..|+-....|+...
T Consensus 186 RNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF------------ 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTF------------ 249 (502)
T ss_pred hCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCC------------
Confidence 567789999999999975 6799999999999999999999999976433 233333333332110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
......+.++-|+|+.||.++|++|-|+.++++|+|.++..-
T Consensus 250 -----------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 250 -----------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred -----------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 112245778899999999999999999999999999887653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=310.50 Aligned_cols=286 Identities=29% Similarity=0.522 Sum_probs=240.8
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~ 194 (415)
..++|++.+++|+|-|+.||.|.+..+++.++||+++ +-..+.+.+|+.||+.|. |+||+++++++.++.+...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3578999999999999999999999999999999986 445678899999999996 9999999999999888889
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~ 273 (415)
.+++||+++.....+.. .++...++.++.+|+.||.|||++||+|||+||.|++||... .++|+|+|+|.++.++.
T Consensus 111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99999999865554433 578889999999999999999999999999999999999865 69999999999998764
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCHH-HHhhCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKIFKLCGSPSEE-YWKKSKLP 351 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~ 351 (415)
..+-++.+.+|--||++.....|+..-|+|||||+|..|+..+.| |.|.++.+++-+|.+.+|+.... +...+++.
T Consensus 188 --eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 188 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred --eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 345667788999999998878899999999999999999987655 57889999999999999876533 33444433
Q ss_pred CCC------cCCCcchhhhhhhhhcCCC-CCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 352 HAT------IFKPQQSYKRCIAETFKDF-PPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 352 ~~~------~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
-.. -......+.+++....+.+ +++++||+.++|.+|..+|+||.+++.||||..+.+..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 222 1233445566666666654 58999999999999999999999999999999876654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=323.59 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=211.3
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||.|+||.||+|.+..+++.+++|++..... .....+.+|+.+++.++|+||+++++++.. ...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 579999999999999999999988999999999986532 355778899999999999999999999877 5679999
Q ss_pred EEecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||++++.+..+.... ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999987776655443 689999999999999999999999999999999999999999999999999997765432 12
Q ss_pred cccccccCccCCcccccCC--cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 277 MTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||...+.......+.+....+..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK------------ 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc------------
Confidence 2345678899999988652 26788999999999999999999999887765554443332111100
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~ 403 (415)
......++.++.++|.+||..||.+|||+.+++.|+|
T Consensus 226 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 ------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0011234567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=327.39 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=205.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM----S 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~----~ 191 (415)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 357899999999999999999999999999999997543 2234677899999998 7999999999986532 2
Q ss_pred CeEEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
...|++|||+.++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 468999999998665554443 346899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
.... .......|++.|+|||++.+ ...++.++|||||||++|+|++|..||...........+... +.
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~---- 233 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PA---- 233 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CC----
Confidence 4322 22334568899999999853 235788999999999999999999999765443333222110 00
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++.++.+||.+||..||.+|||+.+++.||||
T Consensus 234 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 --------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --------------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000112466788999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=328.14 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=204.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHH-HHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI-LRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||++++..+|+.||||++.......... .+..|+.+ ++.++|+||+++++++.. ....|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 36899999999999999999999999999999998654333333 34445554 666799999999999876 456999
Q ss_pred EEEecccChhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 197 VFKYMEHDLAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 197 v~e~~~~~l~~~~---~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
+|||+++.+...+ ......+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999998654443 23445799999999999999999999997 9999999999999999999999999998765432
Q ss_pred CCCCcccccccCccCCcccccCC---cCCCchhcHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
. ......++..|+|||++.+. ..++.++|+|||||++|+|++|..||... +..+.+..+.......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 227 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ-------- 227 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCC--------
Confidence 1 12334678899999988542 34688999999999999999999999652 2333333332211000
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.....++.++.++|.+||..||.+||++++++.|+||+..+
T Consensus 228 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 228 -------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 00123678899999999999999999999999999998865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=325.79 Aligned_cols=261 Identities=28% Similarity=0.493 Sum_probs=208.9
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC--------ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--------EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 190 (415)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 47888999999999999999988999999998864321 11224567889999999999999999999877
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
....++||||+.++.+...+.....+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 45799999999987777666665689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC-CcccccccCccCCcccccCCc-CCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 271 PNHKQ-PMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 271 ~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
..... ......++..|+|||++.... .++.++|+||||+++|+|++|..||...+..+....+......+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 232 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP------- 232 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc-------
Confidence 32111 122345788999999886533 478999999999999999999999976554443333221110000
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
........++.++.++|.+||..||.+|||++++|+||||
T Consensus 233 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 ----------------IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=328.16 Aligned_cols=244 Identities=18% Similarity=0.185 Sum_probs=203.6
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEee--cCCCeEEEEEEe
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTS--RMSCSLYLVFKY 200 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~~~lv~e~ 200 (415)
..||+|++|.||+|.. +|+.||+|.+...... ....+.+.+|+.+|++++||||+++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999975 7899999999765432 3335678899999999999999999999876 434578999999
Q ss_pred cccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 014960 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (415)
Q Consensus 201 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~ 279 (415)
+.++.+...+.....+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++....... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----cc
Confidence 9998877777777789999999999999999999998 499999999999999999999999999997654321 23
Q ss_pred ccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 280 RVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
..++..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+.+....+.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 4678999999998642 4689999999999999999999999998887777766654321111
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+.++++||.+||+.||++|||++++++
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01246778999999999999999999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=332.15 Aligned_cols=262 Identities=23% Similarity=0.391 Sum_probs=215.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+.. ....|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 45666788999999999999998899999999986532 3445678899999999999999999998876 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++.+..+... ..+++.+++.++.||+.||+|||+++|+||||||+||+++.++.++|+|||++....... ...
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999998777665543 368999999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....++..|+|||++.+ ..++.++||||||+++|||++|..||...+....+..+.......
T Consensus 176 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 237 (292)
T cd06658 176 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR----------------- 237 (292)
T ss_pred ceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------------
Confidence 34568899999998875 568899999999999999999999998877666555443321100
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
......++..+.++|.+||..||.+|||++++|+|+||+.....+.
T Consensus 238 ---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 238 ---------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred ---------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 0011245677889999999999999999999999999998877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.23 Aligned_cols=257 Identities=27% Similarity=0.459 Sum_probs=212.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..|.+.+.||+|+||.||+|.+..+++.||+|++..... ..+....+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 469999999999999999999988999999999875433 34455678899999999999999999999987 456899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+.+...+......+++..+..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999998887776655567999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 277 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
....+++.|+|||++.+ ...++.++||||||+++|+|++|.+||.+.+.......+... .++.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~------------ 233 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT------------ 233 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC------------
Confidence 23467888999998742 346888999999999999999999999887665544333211 0000
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.....++.++.++|.+||..||.+||++.+++.|+||..-.
T Consensus 234 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 234 -------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred -------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 00112566789999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=325.36 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=210.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC----hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
+|+..+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.++++++|+||+++++++.+ ....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 377889999999999999999999999999998754321 2245678899999999999999999999877 4579
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~ 273 (415)
++||||+.++.+..++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999887777666666899999999999999999999999999999999999998876 59999999997765432
Q ss_pred C---CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 274 K---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 274 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 228 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--------- 228 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---------
Confidence 1 11123467889999999875 5688999999999999999999999976544333333322110000
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
.......++.++.++|.+||..||.+|||+.++|+||||+
T Consensus 229 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 229 ---------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0011234677889999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=325.23 Aligned_cols=280 Identities=36% Similarity=0.651 Sum_probs=224.2
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
|.+.+.||+|++|.||+|++..+++.|+||.+....... ......+|+..+.+++ |+||+++++++.. +...|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 678899999999999999998899999999987543322 2234456999999998 9999999999887 56799999
Q ss_pred EecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 199 KYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 199 e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||+++.+...+.... ..+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--Cc
Confidence 999777766655443 478999999999999999999999999999999999999999999999999998664332 22
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc-C
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI-F 356 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~ 356 (415)
....++..|+|||++.+...++.++|+||||+++++|++|.+||...+..+...++....+.+....|.......... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 345678899999988665668899999999999999999999999999888898888888888777665432111110 0
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.................+.+++++|.+||..||.+|||++|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000001111223333446789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=319.87 Aligned_cols=253 Identities=23% Similarity=0.419 Sum_probs=211.6
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|+||.||+|.+..+++.+|+|.+............+.+|+.+++.++|+||+++++.+.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4889999999999999999999999999999998766555667788999999999999999999998876 56799999
Q ss_pred EecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCCCC
Q 014960 199 KYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 199 e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~~~ 275 (415)
||+.++.+..++.. ...+++..+..++.|++.+|+|||++||+|+||||+||+++.++ .+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 99988665555433 34589999999999999999999999999999999999998654 68999999998765432
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 219 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---------------- 219 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----------------
Confidence 2233567889999999876 56889999999999999999999999887766655554332111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....++.++.++|.+||..||.+|||+.++|+||||
T Consensus 220 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0112467789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=331.34 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=227.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCe
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 193 (415)
+..+|..+.+||+|+||.|.+|..+.+.+.||||+++++-. ..+.++-...|-.+|... +-|.+++++.+|.. -..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhh
Confidence 35689999999999999999999999999999999988764 444555555676777655 57889999999987 456
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+||||+.|+.+-..+++.+.|.|..+..|+.+|+-||=|||++||++||||.+|||++.+|+|||+|||+++.--.+.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997643332
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....+.+|||.|+|||++.- .+|+..+|+||+||+|||||.|.+||.|+++.+.++.|.+....
T Consensus 505 -~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-------------- 568 (683)
T KOG0696|consen 505 -VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-------------- 568 (683)
T ss_pred -cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--------------
Confidence 33456799999999998874 78999999999999999999999999999999999999875322
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEVSLYMX 408 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~L~h~~f~~~~ 408 (415)
..+.++.++.++.+.+|.+.|.+|+.+ .++-.||||+.+.
T Consensus 569 ---------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 569 ---------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred ---------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 235788899999999999999999876 6888999999875
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=320.43 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=211.6
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|+||.||++.+..+++.|++|.+..........+.+.+|+.+++.++|+||+++++++.. ...+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 4889999999999999999998899999999998765555677889999999999999999999998776 56799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC--
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP-- 276 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~-- 276 (415)
||+.++.+..+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 999988877777666678999999999999999999999999999999999999999999999999998765433221
Q ss_pred -cccccccCccCCcccccCCc--CCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 277 -MTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 277 -~~~~~gt~~y~aPE~~~~~~--~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+++.|+|||++.+.. .++.++||||||+++|+|++|..||..................+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 226 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP------------ 226 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCC------------
Confidence 11345688999999987532 378899999999999999999999976533222221111110000
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
......++..+.++|.+||..||.+|||+.+++.|||+
T Consensus 227 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 -------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00112357778999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.15 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=209.0
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccC
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
||.|++|.||+|++..+++.||+|++.+... .....+.+.+|+.+++.++|+||+++++++.+ +...|++|||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 6999999999999998899999999986543 33455778999999999999999999999876 56799999999987
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccC
Q 014960 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284 (415)
Q Consensus 205 l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~ 284 (415)
.+...+.....+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 777776666679999999999999999999999999999999999999999999999999998765432 123346788
Q ss_pred ccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchh
Q 014960 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT--EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (415)
Q Consensus 285 ~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (415)
.|++||.+.+ ..++.++|+||||+++|+|++|..||.... ..+...++......+
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 213 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL---------------------- 213 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC----------------------
Confidence 9999998875 568899999999999999999999998766 444444443211100
Q ss_pred hhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 363 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
......++++.++|.+||..||++|++ ++|+++||||++++
T Consensus 214 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 214 -----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred -----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 011234778999999999999999999 99999999998763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=339.82 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=210.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+++.++..||+|.||+||+|++.. .||||++..+....+..+.|++|+.++++-+|.||+-+.|++..+ . +.|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p--~-~AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP--P-LAI 464 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--c-eee
Confidence 4567788999999999999997653 499999999888888999999999999999999999999999874 2 599
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC-CCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP-NHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~-~~~ 274 (415)
|+-+|+|..+..++ .....|.....+.|++||+.|+.|||.++|||||||..|||+.+++.|||+|||++..... ...
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999997666554 3456799999999999999999999999999999999999999999999999999865321 112
Q ss_pred CCcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......|...|||||+++. ..+|+..+|||||||++|||++|..||...+...++..+=+....+.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd----------- 613 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD----------- 613 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-----------
Confidence 22333456788999999864 45799999999999999999999999996666555554433332222
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......+.+.++++|+..||.+++++||+..++|.
T Consensus 614 -------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 -------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 23334466778999999999999999999999986
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=325.92 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=205.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeec----CCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSR----MSC 192 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~----~~~ 192 (415)
+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +|+||+++++++... ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 57999999999999999999999999999999987542 3345678899999998 799999999988532 245
Q ss_pred eEEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 193 SLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
.+|++|||+.++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 78999999998655544432 3458899999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
... .......|++.|+|||++.. ...++.++|||||||++|+|++|.+||...........+.+...
T Consensus 173 ~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-------- 243 (282)
T cd06636 173 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-------- 243 (282)
T ss_pred ccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--------
Confidence 322 12234568899999998752 24578899999999999999999999976554433332221100
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++.++.+||.+||..||.+|||+.++|+||||
T Consensus 244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 001123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.32 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=208.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM----S 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~----~ 191 (415)
.++|++.+.||+|++|.||+|.+..+++.|++|++.... .....+.+|+.+++++ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999998899999999987543 2345788999999999 7999999999986632 4
Q ss_pred CeEEEEEEecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
..+|+||||+.++.+..+... ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 568999999998665554432 4578999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 343 (415)
...... .......+++.|+|||++.. ...++.++|||||||+||+|++|.+||..........++.+.....
T Consensus 162 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 237 (275)
T cd06608 162 QLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT--- 237 (275)
T ss_pred ecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC---
Confidence 654322 22334568899999998753 2356788999999999999999999998765554444433211000
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
+ .....++.++.+||.+||..||++|||+.++++|||+
T Consensus 238 ----------------------~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 ----------------------L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------------------C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0012366788999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.70 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=199.2
Q ss_pred eeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHH---hCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILR---RLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~---~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
.||+|+||.||++.+..+++.||+|.+...... ......+.+|..+++ ..+|+||+.+++++.. ....|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 489999999999999999999999999765432 122223334444443 3479999999998876 4579999999
Q ss_pred cccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccc
Q 014960 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (415)
Q Consensus 201 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~ 280 (415)
+.++.+...+.....+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 9988777666666689999999999999999999999999999999999999999999999999987654322 1234
Q ss_pred cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcc
Q 014960 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (415)
Q Consensus 281 ~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (415)
.|++.|+|||.+.+...++.++|||||||++|+|++|..||........ ..+.+.....
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-------------------- 214 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTV-------------------- 214 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcC--------------------
Confidence 6899999999886445688999999999999999999999976432111 1111110000
Q ss_pred hhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014960 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMXXX 410 (415)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~~~ 410 (415)
.......++.++.++|.+||..||.+|+ +++++++||||+.++..
T Consensus 215 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 215 -----NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred -----CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 0011234678899999999999999999 69999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=323.39 Aligned_cols=251 Identities=16% Similarity=0.234 Sum_probs=203.2
Q ss_pred CCceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.+|++.+.||+|+||.||+|++. ..+..||+|.+.... .......+.+|+.++.+++||||+++++++.. ....
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCc
Confidence 57999999999999999999764 456789999987543 33445678899999999999999999999886 4579
Q ss_pred EEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
++||||+.++.+..++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999877665543 4578999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
........++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.+....+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 228 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP------------ 228 (266)
T ss_pred hhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC------------
Confidence 111112234678999998875 678999999999999999775 999999888777666553321110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++..+.+++..||..||.+||+++++++
T Consensus 229 ----------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 ----------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ----------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 11346778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=323.61 Aligned_cols=253 Identities=29% Similarity=0.396 Sum_probs=211.8
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+|++.+.||.|+||.||+|.+..++..||+|++.+... .....+.+.+|++++++++||||+++++++.. ....|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 48899999999999999999999999999999986543 23556788999999999999999999998876 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
+||+.++.+...+.....+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999998777766655689999999999999999999999999999999999999999999999999987764432 22
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.. +.+.+.... .
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A--------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c---------------
Confidence 34567888999999876 55899999999999999999999999876642 222211110 0
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA--TAALRSEVS 404 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~~~L~h~~f 404 (415)
.......++.++.++|.+||..||.+|+++ .++++||||
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 011123467889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=318.83 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=210.3
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ..+....+.+|+.+++.++|+||+++++++.. ...+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 36777899999999999999988999999999876432 24456678899999999999999999998876 46799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+++||+.+..+..++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999987776666666678999999999999999999999999999999999999999999999999987764332
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......++..|++||.+.....++.++|+|||||++|+|++|.+||......+....+.....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE----------------- 219 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----------------
Confidence 223456789999999886533488999999999999999999999977664444433322110
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++.++.++|.+||..||.+||++.++|.|||+
T Consensus 220 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 ----------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 001123467788999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=324.20 Aligned_cols=259 Identities=27% Similarity=0.392 Sum_probs=207.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC---CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM---SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~---~~ 192 (415)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +|+||+++++++.... ..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 478999999999999999999999999999999986432 2335677899999999 8999999999986532 24
Q ss_pred eEEEEEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 193 SLYLVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
..|+||||+.++.+..+. .....+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 689999999886665443 2345789999999999999999999999999999999999999999999999999886
Q ss_pred cCCCCCCCcccccccCccCCcccccCCc----CCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGAT----DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
...... ......++..|+|||++.... .++.++|||||||++|+|++|++||...+.......+.+.....
T Consensus 178 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 252 (291)
T cd06639 178 LTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT---- 252 (291)
T ss_pred cccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC----
Confidence 543321 123346788999999875422 36789999999999999999999998766555544433211000
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
+ .....++.++.+||.+||..||++||++.++++||||+
T Consensus 253 ---------------------~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 ---------------------L-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------------------C-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 00123456789999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=326.02 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=204.4
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccC
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
||+|+||.||+|.+..+|+.||+|.+...... ......+..|+++++.++|+||+++++++.. ....|+||||+.++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 68999999999999999999999998754322 2334566789999999999999999999877 45799999999987
Q ss_pred hhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccc
Q 014960 205 LAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (415)
Q Consensus 205 l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~g 282 (415)
.+...+.... .+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 6665544333 6899999999999999999999999999999999999999999999999998765432 22234567
Q ss_pred cCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchh
Q 014960 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (415)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (415)
+..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.+.....
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM---------------------- 213 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc----------------------
Confidence 889999999876 458899999999999999999999998765422222222211000
Q ss_pred hhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 014960 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMXX 409 (415)
Q Consensus 363 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~~ 409 (415)
.......+++++.++|.+||..||.+|| ++.++++||||+.++.
T Consensus 214 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 214 ---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred ---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 0111234678899999999999999999 9999999999988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.36 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=213.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
..|+..+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++|+||+++++++.+ +...|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEE
Confidence 358888999999999999999999999999999876532 3445678899999999999999999999887 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++.+..++.. ..+++.++..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccc
Confidence 999998776665544 468999999999999999999999999999999999999999999999999997764432 122
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+.... +
T Consensus 159 ~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~----------------- 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--P----------------- 218 (277)
T ss_pred ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--C-----------------
Confidence 33467889999999875 568999999999999999999999998766554443321110 0
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
......++..+.++|.+||..||++||+++++++|+||......
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 219 ---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred ---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 00112356678899999999999999999999999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=327.48 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=200.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECC----------------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCcee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL----------------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 180 (415)
.++|.+.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.+++|+||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3679999999999999999997532 34579999987543 344566788999999999999999
Q ss_pred eeeeeEeecCCCeEEEEEEecccChhhhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 014960 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP-------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241 (415)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 241 (415)
++++++.+ ....++||||+.++.+..++.. ...+++..++.++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999987 4569999999988655443321 12467888999999999999999999999
Q ss_pred eccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh--CC
Q 014960 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--EK 318 (415)
Q Consensus 242 HrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~--g~ 318 (415)
||||||+|||++.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999765433211 1123345788999999875 568999999999999999986 66
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHH
Q 014960 319 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398 (415)
Q Consensus 319 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 398 (415)
.||.+.+..+....+........... ........+..+.+||.+||..||.+|||++++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQV---------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccc---------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 78887776666655433221110000 001123467789999999999999999999999
Q ss_pred hc
Q 014960 399 LR 400 (415)
Q Consensus 399 L~ 400 (415)
.+
T Consensus 299 ~~ 300 (304)
T cd05096 299 HA 300 (304)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=320.32 Aligned_cols=253 Identities=27% Similarity=0.454 Sum_probs=208.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||+|.+..+++.|++|.+.... ....+.+|+++++.++|+||+++++++.. ....|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEE
Confidence 57999999999999999999998889999999987432 26788899999999999999999999887 4679999
Q ss_pred EEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
+||+.++.+..++. ....+++..+..++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++........ .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 99999876665553 355789999999999999999999999999999999999999999999999999987654321 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....++..|+|||++.+ ..++.++||||||+++|+|++|.+||...........+.... . .
T Consensus 156 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-~------------- 217 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP---P-P------------- 217 (256)
T ss_pred cccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC---C-C-------------
Confidence 233457889999999876 578899999999999999999999998765544332221100 0 0
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++.++.++|.+||..||.+|||+.++|.||||
T Consensus 218 ---------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 218 ---------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ---------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000112466778999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=327.51 Aligned_cols=265 Identities=20% Similarity=0.313 Sum_probs=208.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|...+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. |+||+++++++.. ....++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 4677788999999999999999999999999998765433 45567888999999996 9999999998876 456899
Q ss_pred EEEecccChhhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 197 VFKYMEHDLAGLA----ASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 197 v~e~~~~~l~~~~----~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
+|||+...+.... ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999987543322 12345799999999999999999999974 999999999999999999999999999976543
Q ss_pred CCCCCcccccccCccCCcccccCC--cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
... .....+++.|+|||++.+. ..++.++|||||||++|+|++|++||.... .....+.+.........
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~----- 231 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL----- 231 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC-----
Confidence 221 1334678899999998764 368899999999999999999999997654 22222322211110000
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.......++.++.+||.+||..||.+|||+++++.||||+.....
T Consensus 232 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 232 ----------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred ----------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 011113477889999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=319.46 Aligned_cols=257 Identities=31% Similarity=0.426 Sum_probs=214.7
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|++|.||+|.+..+++.|++|++...... .....+.+|+.++..++|+||+++++++.. ...+|+||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEE
Confidence 688999999999999999999999999999998765432 456778899999999999999999999887 46799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||+.++.+..++.....+++..+..++.||+.+|+|||+ ++++||||+|+||+++.++.++|+|||++......... .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~ 157 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-C 157 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-c
Confidence 999987777666655789999999999999999999999 99999999999999999999999999999876543322 2
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.... ..+....+....
T Consensus 158 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----------------- 219 (264)
T cd06623 158 NTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP----------------- 219 (264)
T ss_pred cceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC-----------------
Confidence 24467889999998876 578899999999999999999999998764 222232222110
Q ss_pred cCCCcchhhhhhhhhcCC-CCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKD-FPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
....... ++..+.++|..||..+|++||++.++|+||||+.++
T Consensus 220 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 220 -----------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred -----------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 0001123 678899999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=323.64 Aligned_cols=259 Identities=25% Similarity=0.450 Sum_probs=211.5
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeeeeeEeecCCCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~~ 195 (415)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. |+|++++++++.. ....|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 4788899999999999999999999999999987543 3344567888999999996 9999999999876 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..+.... .+++..++.++.||+.+|.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred EEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 999999887666665443 789999999999999999999999999999999999999999999999999987654432
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......|+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+... .++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~------------- 221 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPR------------- 221 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCC-------------
Confidence 2234468899999999876556789999999999999999999999876543332211110 0000
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
+ ....++.++.++|.+||..||++||++.++++|+||+....
T Consensus 222 ----------~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 222 ----------L--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred ----------C--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 0 00126778999999999999999999999999999988653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=325.37 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=205.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCC-----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTG-----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CC
Confidence 57999999999999999999875554 679999887442 34455678899999999999999999999876 45
Q ss_pred eEEEEEEecccChhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPT----------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 256 (415)
..|++|||+.++.+..++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 689999999876655444321 4588899999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014960 257 ILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIF 334 (415)
Q Consensus 257 ~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (415)
.+||+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999976533221 12233456888999998875 568999999999999999998 999999888777666554
Q ss_pred HhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+.... .....++.++.+|+.+||+.||.+||++.+++++
T Consensus 241 ~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32110 1123578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=322.49 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=214.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.|...+.||+|++|.||++.+..+++.+++|.+.... ....+.+.+|+.+++.++|+||+++++++.. ....++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 4666689999999999999998899999999986543 2334567889999999999999999998876 56799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
||+.++.+...... ..+++..+..++.||+.+|+|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 99988777666555 4789999999999999999999999999999999999999999999999998875543221 123
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
...|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... .+
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~------------------ 233 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PP------------------ 233 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CC------------------
Confidence 3468899999999876 568899999999999999999999998877666665544321 00
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.......++..+.++|.+||+.||++|||+.++++|+||+..++.
T Consensus 234 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 234 -------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred -------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence 001112367789999999999999999999999999999998874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=328.88 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=212.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.++++++|+||+++++++.. ....|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEE
Confidence 458888999999999999999999999999999875532 3445678899999999999999999999877 5579999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++.+...... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 999998776665544 4689999999999999999999999999999999999999999999999999976643221 12
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.... +
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~----------------- 218 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--P----------------- 218 (277)
T ss_pred hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC--C-----------------
Confidence 23457889999999876 568899999999999999999999997655443332221100 0
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
......++.++.++|.+||..+|.+||++.++|+|+||......+
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 263 (277)
T cd06642 219 ---------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKT 263 (277)
T ss_pred ---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence 001123567789999999999999999999999999998766543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=324.62 Aligned_cols=268 Identities=22% Similarity=0.306 Sum_probs=212.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+.+|+++++.++|+||+++++++.. ...+|+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEE
Confidence 468999999999999999999999999999999987543 24445678899999999999999999999987 467999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..+......+++..+..++.+++.+|.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999998777766666679999999999999999999997 689999999999999999999999999986543221
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ----LHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ...+.. ..
T Consensus 159 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~- 230 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL----QQIVQE-PP- 230 (284)
T ss_pred -cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH----HHHhhc-cC-
Confidence 123568999999999875 5788999999999999999999999986544211 00010000 000000 00
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.......++.++.+||.+||..||.+|||++++++|+||..-..++
T Consensus 231 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 231 --------------PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred --------------CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 0000012567789999999999999999999999999997654433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=318.87 Aligned_cols=254 Identities=25% Similarity=0.479 Sum_probs=209.2
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|.+.+.||+|+||.||++.+..+|..||+|.+..........+.+.+|+.+++.++|+||+++++.+.. ....|+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4888999999999999999999999999999998754444455678899999999999999999998876 56799999
Q ss_pred EecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCCCC
Q 014960 199 KYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 199 e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~~~ 275 (415)
||+.+..+...... ...+++..+..++.||+.||.|||+++++|+||||+||+++.++ .+||+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 99988665554433 23579999999999999999999999999999999999999886 47999999997765332 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......|++.|+|||++.+ ..++.++|+||||+++++|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 218 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------ 218 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------------
Confidence 2233467889999998875 568899999999999999999999998776555444333211
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....+.++.++.++|.+||..+|++|||+.++++||||
T Consensus 219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 011123567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=321.78 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=205.4
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee---cCC
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS---RMS 191 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~---~~~ 191 (415)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++.. ..+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 4578999999999999999999999999999999876432 2235677899999999 79999999998743 234
Q ss_pred CeEEEEEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 192 CSLYLVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
...|+||||++++.+..++ .....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 6799999999987665432 234568999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 343 (415)
...... .......|++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.... +.
T Consensus 173 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~-- 247 (286)
T cd06638 173 QLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP--PP-- 247 (286)
T ss_pred ecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC--CC--
Confidence 664322 12234468999999998753 2347889999999999999999999998765443332221110 00
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++..+.+||.+||..||++|||+.++|+|+||
T Consensus 248 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 ----------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ----------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000012346678999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.23 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=213.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.+.|...++||+|+||.||+|++..++..|++|++..... .......+.+|+.+++.++|+|++++++++.+ ....|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 97 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAW 97 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEE
Confidence 3457778899999999999999999999999999976543 33445678889999999999999999999987 46799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.+.++..+......+++.++..++.||+.+|.|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus 98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 9999999888777666666799999999999999999999999999999999999999999999999999864322
Q ss_pred CcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....++..|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+..... +
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 238 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-P------------- 238 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-C-------------
Confidence 234567889999999742 24578899999999999999999999988776555554432110 0
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
......++..+.+||.+||+.+|.+||++.++++||||+..+
T Consensus 239 -------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 239 -------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred -------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 001124566789999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=322.13 Aligned_cols=266 Identities=25% Similarity=0.354 Sum_probs=209.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|...+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++|+||+++++++.......+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 368899999999999999999999999999999876533 2445678899999999999999999999876556679999
Q ss_pred EEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 198 FKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 198 ~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|||+.++.+..++ .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999886554332 334568999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCCHHHHhhC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE-----VEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+... ... ....
T Consensus 160 ~---~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~- 230 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNP-ELKD- 230 (287)
T ss_pred c---ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cch-hhcc-
Confidence 1 23456888999998875 5689999999999999999999999986522 2222221110 000 0000
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.......+++++.++|.+||..||.+|||+.|+++|+||+...-.
T Consensus 231 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 231 -----------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred -----------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 000011245678899999999999999999999999999766543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.52 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=208.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+++++.++|+||+++++++.. ...++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEE
Confidence 358888999999999999999999999999999876543 3455678889999999999999999999877 4679999
Q ss_pred EEecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||+.+..+..+.... ..+++..+..++.||+.+|+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999976555555433 689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT-----EVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..+.+..+.. .....
T Consensus 157 --~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~------- 223 (265)
T cd06605 157 --KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPR------- 223 (265)
T ss_pred --hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCC-------
Confidence 12567889999999876 578999999999999999999999997642 1122222211 00000
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
+ ....++.++.++|.+||..||.+|||+.+++.||||+..
T Consensus 224 ---------------~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 224 ---------------L--PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ---------------C--ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 0 001167789999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=326.71 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=212.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
..|.....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.. +...|++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEE
Confidence 456666789999999999999988999999999875432 234567889999999999999999999877 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++.+..+... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 999998777665543 4689999999999999999999999999999999999999999999999999876543321 22
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.... .+
T Consensus 175 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~----------------- 235 (297)
T cd06659 175 KSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP----------------- 235 (297)
T ss_pred cceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CC-----------------
Confidence 34568899999999876 568999999999999999999999998877666554442211 00
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.......++.++.++|.+||+.||.+||+++++++|+||.....
T Consensus 236 --------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 236 --------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred --------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 00112346778899999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=321.54 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=199.4
Q ss_pred eeccCCceEEEEEEECCCCceEEEEEEecCCCCh-HHHHHHHHHH---HHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREI---LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~---~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
.||+|+||.||+|++..+++.||+|++....... .....+..|. ..++...|++|+.+++++.. ....|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 3899999999999999999999999998654321 1112233333 34445689999999998887 4579999999
Q ss_pred cccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccc
Q 014960 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (415)
Q Consensus 201 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~ 280 (415)
+.++.+.........+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++..+.... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 9988777766666689999999999999999999999999999999999999999999999999987654322 2334
Q ss_pred cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcc
Q 014960 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (415)
Q Consensus 281 ~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (415)
.|+..|+|||++.+...++.++||||+||++|+|++|..||.......... +.+.....
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-------------------- 214 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM-------------------- 214 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhcc--------------------
Confidence 689999999998754568899999999999999999999998753221111 10100000
Q ss_pred hhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 014960 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMXX 409 (415)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~~ 409 (415)
.......++.++.++|.+||..||.+|+ ++.++++||||+.+.-
T Consensus 215 -----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 215 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred -----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 0011124578899999999999999999 9999999999988753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=318.50 Aligned_cols=252 Identities=28% Similarity=0.365 Sum_probs=203.7
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHH-hCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILR-RLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|.+..+++.||+|.+.+.... ......+..|..++. .++|+||+++++++.. ....|+|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5699999999999999999999999998754321 222233444555444 4589999999999976 56799999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~ 281 (415)
.++.+..++.....+++..+..++.||+.||.|||+.+++||||+|+||+++.++.+||+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9887777776666899999999999999999999999999999999999999999999999999875432 12345
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+....+........
T Consensus 155 ~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 213 (260)
T cd05611 155 GTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-------------------- 213 (260)
T ss_pred CCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC--------------------
Confidence 7888999999876 4589999999999999999999999988777666555533211110
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEVSLYMX 408 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~L~h~~f~~~~ 408 (415)
......++.++.++|.+||..||++||+ ++|+|.||||+.++
T Consensus 214 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 214 -----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred -----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 0111257888999999999999999995 58999999998765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.40 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=210.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN---LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.+|.+.+.||+|+||.||+|++..+++.||+|.+.... ........+.+|+.++++++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36999999999999999999999999999999986532 123455688899999999999999999999877555678
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
++++||+.++.+.........+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999998876666555555789999999999999999999999999999999999999999999999999976543211
Q ss_pred --CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 --QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 --~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||......+...++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK---------- 227 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCC----------
Confidence 11223457889999999876 5688999999999999999999999987655554443321 1110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
......+++.+.++|.+||. +|.+||++.++++|||.
T Consensus 228 --------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 --------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01123577789999999999 57999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=322.42 Aligned_cols=255 Identities=31% Similarity=0.482 Sum_probs=213.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~ 195 (415)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++ |+||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 369999999999999999999999999999999876433 3344567888999999998 9999999998876 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~- 274 (415)
+|||++.++.+...+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999997766666665566899999999999999999999999999999999999999999999999999976643321
Q ss_pred ------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014960 275 ------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336 (415)
Q Consensus 275 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 336 (415)
.......++..|+|||++.+ ..++.++|+||||+++++|++|..||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 12233457889999998875 56889999999999999999999999987766555554421
Q ss_pred cCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q 014960 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEVS 404 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~~L~h~~f 404 (415)
.. .....+++.+.++|.+||+.||.+||++ +++|+||||
T Consensus 238 ~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EY-----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CC-----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11 1112457788999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.00 Aligned_cols=254 Identities=27% Similarity=0.464 Sum_probs=214.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|.+.+.||+|+||.||++.+..++..|++|++............+.+|+++++.++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 4889999999999999999999899999999998766555667788899999999999999999999877 46799999
Q ss_pred EecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 199 KYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 199 e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+++++.+...... ...+++..+..++.+|+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99998655544432 3679999999999999999999999999999999999999999999999999998765433
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+..+....+.+....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 221 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP--------------- 221 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC---------------
Confidence 12234567889999998875 56889999999999999999999999887765555544332100
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....++.++.++|..||..||++|||+.++|+||||
T Consensus 222 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 222 -------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 1112567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=336.88 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=198.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++... +..||+|++.... ..+....+.+|+.+++.+ +|+|||++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 45799999999999999999986443 3579999997543 234456788999999999 89999999999877
Q ss_pred CCeEEEEEEecccChhhhhcCC----------------------------------------------------------
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (415)
...+|+||||+.++.+...+..
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 4579999999987655443311
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC-ccc
Q 014960 213 ------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP-MTS 279 (415)
Q Consensus 213 ------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~-~~~ 279 (415)
...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.......... ...
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1247889999999999999999999999999999999999999999999999997654332111 112
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
..+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||........+..+.+....+.
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~----------------- 335 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS----------------- 335 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc-----------------
Confidence 234667999999875 678999999999999999997 9999987655444433332211000
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.++|.+||+.||.+|||+.++++
T Consensus 336 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 ----------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01235778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.77 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=214.9
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|++|.||++++..+++.|++|.+............+.+|++++++++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4888999999999999999999899999999998765544566789999999999999999999999877 46799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
||+.+..+..+......+++..+..++.|++.+|.|||++||+||||||+||+++.++.++|+|||++......... ..
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 99998777776666678999999999999999999999999999999999999999999999999999877644321 23
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
...++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+......++....
T Consensus 158 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 215 (254)
T cd06627 158 SVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--------------------- 215 (254)
T ss_pred ccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---------------------
Confidence 4467889999998876 458899999999999999999999998766544444332110
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++..+.++|.+||..+|++|||+.+++.|+||
T Consensus 216 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 -------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 001113467789999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=318.94 Aligned_cols=253 Identities=29% Similarity=0.418 Sum_probs=209.1
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccC
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
||.|+||.||++++..+|+.|++|.+..... .......+.+|+.++++++|+||+++++.+.. ....|++|||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999998999999999876543 23456678899999999999999999998876 56799999999886
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-------CCc
Q 014960 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-------QPM 277 (415)
Q Consensus 205 l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-------~~~ 277 (415)
.+..++.....+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 6665555545899999999999999999999999999999999999999999999999999876543311 122
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....++..|++||.+.+ ..++.++||||||+++|+|++|..||......+....+...... |+.
T Consensus 159 ~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~---------- 222 (265)
T cd05579 159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE-----WPE---------- 222 (265)
T ss_pred cCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC-----CCc----------
Confidence 33467888999999876 45889999999999999999999999888777666655431111 100
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH---HHHhcCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA---TAALRSEVSLYMX 408 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~~~L~h~~f~~~~ 408 (415)
...++..+.++|.+||+.+|++|||+ .++|+||||+.++
T Consensus 223 ------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 223 ------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred ------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 01257888999999999999999999 9999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=332.80 Aligned_cols=282 Identities=22% Similarity=0.321 Sum_probs=207.0
Q ss_pred eeeccC--CceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
..||+| +||+||++++..+|+.||+|++.......+..+.+.+|+.+++.++|+||++++++|.. ....++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 356666 99999999999999999999998765555666889999999999999999999999987 55799999999
Q ss_pred ccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC---
Q 014960 202 EHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--- 276 (415)
Q Consensus 202 ~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~--- 276 (415)
.++.+..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 98665555443 2358999999999999999999999999999999999999999999999998654332111100
Q ss_pred ---cccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 277 ---MTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 277 ---~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+....+....+....... .|.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS---PLDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC---Cccccccch
Confidence 0112345679999998653 347899999999999999999999998876655544443321110 110000000
Q ss_pred ------------------CCcCCC---cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 353 ------------------ATIFKP---QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 353 ------------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
...... ..............++..+++||.+||+.||++|||++++|+|+||+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 000000 0000000111123456678999999999999999999999999999887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=317.61 Aligned_cols=250 Identities=20% Similarity=0.341 Sum_probs=203.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+..+. .....+.+|+.+++.++|+||+++++++.. ...++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 46889999999999999999999999999999987442 334567889999999999999999999876 4568999
Q ss_pred EEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+.++.+..... ....+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99998765555443 2346899999999999999999999999999999999999999999999999999876543222
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------- 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------------- 223 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------------
Confidence 1122233567999998875 568899999999999999998 9999988776665555432110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......++.++.++|.+||+.||++|||+.++++.
T Consensus 224 ------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 224 ------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 01123567889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=371.14 Aligned_cols=264 Identities=26% Similarity=0.424 Sum_probs=225.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
-+|+...+||.|.||.||.|.+..+|...|+|.+............+.+|+.+|..++|||+|+++|+-.++ ..++|.
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IF 1312 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIF 1312 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--HHHHHH
Confidence 467778899999999999999999999999999987766666677888999999999999999999987774 358999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC---
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--- 274 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~--- 274 (415)
||||.++.+..+...+...+|.....|..|++.||.|||+.|||||||||+|||++.+|.+|++|||.|..+.+...
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999999988887888999999999999999999999999999999999999999999999999988765532
Q ss_pred CCcccccccCccCCcccccCCc--CCCchhcHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~sDvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.......||+.|||||++.+.. +...+.|||||||+.+||+||+.||.. .++..++.++.-....+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq----------- 1461 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ----------- 1461 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC-----------
Confidence 2234568999999999997743 567899999999999999999999987 45556665553321111
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
....++.+..|+|.+||..||++|+++.|+|.|.|-+.=.|..
T Consensus 1462 -----------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1462 -----------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred -----------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence 1124888999999999999999999999999999977665543
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=319.44 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=213.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+-|++.+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.++.+++|+||+++++++.. +...|+|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEE
Confidence 458888999999999999999988999999999875432 3445678899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++.+..++.. ..+++..+..++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999998776665543 368999999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+.... +
T Consensus 159 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------------- 218 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--P----------------- 218 (277)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--C-----------------
Confidence 33467889999998875 567889999999999999999999998766544444332210 0
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
......++.++.++|.+||..||.+||++.++++|+||......
T Consensus 219 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 219 ---------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred ---------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence 00113467788999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.28 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=207.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+.+|+.+++.++|+||+++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48899999999999999999999999999999875432 3455678889999999999999999999987 56899999
Q ss_pred EecccChhhhhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 199 KYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 199 e~~~~~l~~~~~-~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||+.++.+.... . ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 999875444333 2 34468999999999999999999999999999999999999999999999999997664322 12
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||...+.......+.+....+
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---------------- 219 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC----------------
Confidence 234567889999999876 568999999999999999999999998877666555543321110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~ 403 (415)
....++..+.+||.+||+.||++|||+.++|+-.+
T Consensus 220 ------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 254 (255)
T cd08219 220 ------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSRGS 254 (255)
T ss_pred ------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhccC
Confidence 01235667889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=324.65 Aligned_cols=262 Identities=26% Similarity=0.446 Sum_probs=213.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 468999999999999999999988899999999986543 2334667889999999999999999999887 457999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|+||+.++.+..+.... .+++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 99999987776655443 578999999999999999999999999999999999999999999999999876654332 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+....+... +.+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~--------------- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------- 234 (293)
T ss_pred cccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCC---------------
Confidence 233467889999999875 56889999999999999999999999876654433222110 0000
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
......++..+.++|.+||..+|.+||++.+++.|+||+..++.+
T Consensus 235 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~ 279 (293)
T cd06647 235 ----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279 (293)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccc
Confidence 001124566788999999999999999999999999999888543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=335.21 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=234.6
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
....+++++..||-|+||.|-++.-......+|+|++++... +..+.+.+..|-.||..++.+.||++|..|.+ +.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~ky 494 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKY 494 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chh
Confidence 345678888999999999999998666666799999987654 66777888999999999999999999999987 678
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+.||-|-|+.+...+..++.|.+..++.|+..+++|++|||++|||+|||||+|++++.+|-+||.|||+|+.+..+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999998888888888899999999999999999999999999999999999999999999999999999998765
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
+ ..+.+|||+|+|||+++. ...+.++|.|+||+++||||+|.|||.+.+...++..|++...
T Consensus 575 K--TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--------------- 636 (732)
T KOG0614|consen 575 K--TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--------------- 636 (732)
T ss_pred c--eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---------------
Confidence 4 478899999999999996 6789999999999999999999999999999999999998652
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
..+..+.++....+||+++-..+|.+|.. +.++-.|-||..++
T Consensus 637 ------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 637 ------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred ------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 11223568888999999999999999997 79999999999876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.46 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=214.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..|...+.||+|+||.||++++..++..||+|.+..... ..+....+.+|+.+++.++|+|++++++++.. ....|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEE
Confidence 458889999999999999999999999999999876533 33455678889999999999999999999887 456899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+.++.........+++.++..++.||+.||.|||+++|+||||+|+||+++.++.+||+|||++......
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 9999998877766655667999999999999999999999999999999999999999999999999998755432
Q ss_pred cccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 277 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+.......+.......
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 243 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-------------- 243 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------------
Confidence 33467889999998742 2457889999999999999999999998876666555554421110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....++..+.++|.+||..+|.+||++.++++|+|+.....
T Consensus 244 -------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 244 -------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 001235667899999999999999999999999999865544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.96 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=204.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|.+.+.||+|+||.||+|.+. .++..||+|.+.... ..+....+.+|+++++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec--C
Confidence 457999999999999999999864 345789999987543 33355788999999999999999999999887 4
Q ss_pred CeEEEEEEecccChhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc
Q 014960 192 CSLYLVFKYMEHDLAGLAASP--------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 257 (415)
...++||||+.++.+..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 679999999998766655432 235789999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014960 258 LTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFK 335 (415)
Q Consensus 258 vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 335 (415)
+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999876432221 11123345788999999876 568999999999999999998 9999988777766655542
Q ss_pred hcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.... .....++..+.++|.+||..||.+||++.++++
T Consensus 240 ~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLL----------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2110 111346778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=333.98 Aligned_cols=254 Identities=19% Similarity=0.274 Sum_probs=197.7
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++ ..++..||+|++..... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 35799999999999999999964 34567899999875432 33446788899999999 89999999999987
Q ss_pred CCeEEEEEEecccChhhhhcCC----------------------------------------------------------
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (415)
....|+||||+.++.+...+..
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 4569999999987655433321
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 213 -----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 213 -----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999999999999999999999999999999999766433221
Q ss_pred C-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 276 P-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 276 ~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
. .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||..........++......+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM------------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-------------
Confidence 1 112334667999999876 578999999999999999998 899998765444333332211000
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......+.++.+||..||+.||++|||+.++++.
T Consensus 337 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 --------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0012346678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=337.33 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=214.4
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
....||+|+|-+||+|.|..+|-.||--.++.... .+...++|..|+.+|+.|+|+||+++++.|.+.....+-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34679999999999999999999998665554433 4666789999999999999999999999998876778999999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeeccCCCCCEEEcC-CCcEEEEeeccccccCCCCCCC
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ--HVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
++..|.+..+..+.+.+....+..|++||++||.|||++ .|+|||||.+||||+. .|.|||+|+|+|...... .
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---H 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---c
Confidence 999999999998888999999999999999999999987 5999999999999986 589999999999987543 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
....+|||.|||||++. ..|+..+||||||++|+||+|+..||....+. ++++++.... .|.. +.
T Consensus 201 aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi-KP~s--l~--------- 266 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI-KPAA--LS--------- 266 (632)
T ss_pred cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC-CHHH--hh---------
Confidence 34579999999999886 47999999999999999999999999886554 4455443321 1111 11
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
+-=.++++++|.+||.. .++|+|+.|+|.||||..-
T Consensus 267 ---------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 ---------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ---------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11257899999999999 9999999999999999874
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=329.21 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=199.5
Q ss_pred CCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 191 (415)
++|++.+.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.++.++ +|+||+++++++... +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 57999999999999999999743 345789999987443 334456677899999999 899999999988654 4
Q ss_pred CeEEEEEEecccChhhhhcCC-----------------------------------------------------------
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------------------------------------------------------- 212 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------------------------------------------------------- 212 (415)
..++++|||+.++.+...+..
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 578999999998665544321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-CcccccccCccCCc
Q 014960 213 --TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPP 289 (415)
Q Consensus 213 --~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aP 289 (415)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 126789999999999999999999999999999999999999999999999999876433221 12233456789999
Q ss_pred ccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhh
Q 014960 290 ELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAE 368 (415)
Q Consensus 290 E~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (415)
|++.+ ..++.++|||||||+||||++ |.+||.+....+.+....+....+ .
T Consensus 245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~ 296 (337)
T cd05054 245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM---------------------------R 296 (337)
T ss_pred HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC---------------------------C
Confidence 99876 678999999999999999998 999998755444333332211000 0
Q ss_pred hcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 369 TFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 369 ~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....++.++.+++.+||+.+|++||++.++++|
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112456778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=315.74 Aligned_cols=253 Identities=18% Similarity=0.250 Sum_probs=199.8
Q ss_pred ceeeeeeccCCceEEEEEEECCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec----CCCe
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQ--IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSCS 193 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----~~~~ 193 (415)
|.+.+.||+|+||.||+|++..++. .||+|.+..........+.+.+|+.+++.++|+||+++++++... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999877765 589999876655566677888999999999999999999976431 1235
Q ss_pred EEEEEEecccChhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 194 LYLVFKYMEHDLAGLAA------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
.+++|||+.++.+.... .....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999876554332 123358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 268 FFDPNHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 268 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
......... .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+.+... +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~----- 233 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-L----- 233 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C-----
Confidence 764332111 112235678999999876 568999999999999999999 8999988776665554432110 0
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++..+.++|.+||+.||++|||+.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 ----------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113467778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=322.34 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=213.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
...|+..+.||+|+||.||+|++..++..+|+|.+..... .......+.+|+++++.++|+|++++++++.. ....|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeE
Confidence 3568888999999999999999999999999999875432 33445567789999999999999999999887 45689
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.+.+...+......+++..++.++.||+.||.|||+++++||||||+|||++.++.++|+|||++....+.
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 99999998777666555667899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+.+... +
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 232 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P------------- 232 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C-------------
Confidence 23457889999998752 24578899999999999999999999987665544444332110 0
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
......++..+.+||++||..+|.+||+++++++|+|+.....
T Consensus 233 -------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 233 -------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred -------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 0001246677899999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=319.96 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=209.4
Q ss_pred CceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 192 (415)
.|++.+.||.|+||.||+|++. .+|..||+|++..... .....+.+.+|+.+++++ +|+||+.+++++.. +.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 3788999999999999999874 4789999999875432 223345678899999999 59999999998877 46
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|+||||+.++.+...+.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 79999999998776666666667899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.........|+..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----------- 227 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----------
Confidence 33333345688999999998642 346789999999999999999999997543322222222211000
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
.....+.++..+.+++.+||..||.+|+ ++++++.||||..++
T Consensus 228 --------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 228 --------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred --------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 0001134667789999999999999997 899999999999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.75 Aligned_cols=248 Identities=20% Similarity=0.316 Sum_probs=200.3
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||++... .+..+|+|.+...... ...+.+|+.++++++|+||+++++++.. ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 46899999999999999999864 4567999988644322 3467789999999999999999999877 4569999
Q ss_pred EEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++.+...+ .....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999876555444 334568999999999999999999999999999999999999999999999999987654322221
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....++..|+|||++.+ ..++.++||||||+++|+|++ |++||...+..+....+.+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--------------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY--------------- 221 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---------------
Confidence 222234567999999875 568999999999999999999 999999888777776664421100
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+.++.++|.+||+.||++||+++++++
T Consensus 222 -------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 -------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01124567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.56 Aligned_cols=286 Identities=18% Similarity=0.221 Sum_probs=204.7
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
.+.+.+|.| |.||.+++..+++.||+|++............+.+|+.+++.++|+||+++++++.. ....|++|||
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPL 80 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEec
Confidence 344445455 445555557799999999998765556677889999999999999999999999887 4569999999
Q ss_pred cccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC----
Q 014960 201 MEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK---- 274 (415)
Q Consensus 201 ~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~---- 274 (415)
+.++.+..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 998766655543 34689999999999999999999999999999999999999999999999998865532211
Q ss_pred --CCcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--HHHHhhC-
Q 014960 275 --QPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKKS- 348 (415)
Q Consensus 275 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~- 348 (415)
.......++..|+|||++.+. ..++.++|||||||++|+|++|..||.................... ...++..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 111234567889999998653 3588999999999999999999999987655443322222111000 0000000
Q ss_pred -CCCCC-CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 349 -KLPHA-TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 349 -~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
..... ...................++.++.+||..||..||++|||++++|+||||+.++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 00000 000000000001111122345678899999999999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=319.38 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=202.3
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|.+.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--G 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 36799999999999999999975 234567999988643 24455678899999999999999999999876 5
Q ss_pred CeEEEEEEecccChhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcE
Q 014960 192 CSLYLVFKYMEHDLAGLAASP-------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGIL 258 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~-------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~v 258 (415)
..+++||||+.++.+..++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 679999999987666544432 1248999999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014960 259 TIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKL 336 (415)
Q Consensus 259 kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 336 (415)
||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999976543221 11122345778999999876 578999999999999999998 99999888777666665442
Q ss_pred cCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
... .....++.++.+|+.+||+.||.+|||+.+++.
T Consensus 239 ~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RVL----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CcC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 110 011246678999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=347.82 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=201.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeee-eEeec---C-C
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEG-LVTSR---M-S 191 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~-~~~~~---~-~ 191 (415)
.++++.+.|.+|||+.||+|.+...|..||+|++-.. +....+.+.+||++|+.|. |+|||.+++ ..... . .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4688899999999999999999888899999998765 5788899999999999996 999999999 33221 1 2
Q ss_pred CeEEEEEEeccc-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 192 CSLYLVFKYMEH-DLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 192 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
..++|.||||.+ ++...+..+ ...|+|.++..||.|+|+|+.+||... |||||||-|||||..+|+.||||||.|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 457899999995 666665532 234999999999999999999999887 9999999999999999999999999986
Q ss_pred ccCCCCCCC--c------ccccccCccCCccccc--CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014960 268 FFDPNHKQP--M------TSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC 337 (415)
Q Consensus 268 ~~~~~~~~~--~------~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 337 (415)
-.-...... . -...-|+.|+|||++. .....+.|+|||+|||+||.|+....||.+.-...++..-+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P 274 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFP 274 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCC
Confidence 432211100 0 0123489999999872 23678999999999999999999999998765444443222211
Q ss_pred CCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCC
Q 014960 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (415)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~ 402 (415)
..+.++..+++||+.||..||.+||++.|++.+-
T Consensus 275 -------------------------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 275 -------------------------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred -------------------------------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 1135778899999999999999999999998653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=314.92 Aligned_cols=253 Identities=19% Similarity=0.252 Sum_probs=201.1
Q ss_pred ceeeeeeccCCceEEEEEEECCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
|++.+.||+|+||.||+|....+ +..||+|.+..+.........+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999986543 478999999876555556678889999999999999999999875422 13
Q ss_pred eEEEEEEecccChhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 193 SLYLVFKYMEHDLAGLAA------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
..+++|||+.++.+...+ .....+++..++.++.||+.||.|||+++|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999986554443 12246899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 267 SFFDPNHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 267 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
.......... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+..... +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---- 234 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR-L---- 234 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C----
Confidence 8654332111 111234667999998865 678999999999999999999 9999988777666555533110 0
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++.++.++|.+||+.||.+|||+.+++++
T Consensus 235 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -----------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=312.03 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=196.5
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEeccc
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH 203 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~ 203 (415)
+.||+|+||.||+|.+..+++.||+|.+... ...+....+.+|+++++.++|+||+++++++.. ....|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3699999999999999999999999987643 334556778899999999999999999999877 4579999999988
Q ss_pred ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc-cccc
Q 014960 204 DLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRV 281 (415)
Q Consensus 204 ~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~-~~~~ 281 (415)
+.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 76665543 344689999999999999999999999999999999999999999999999999876543211111 1112
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcc
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (415)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------------- 215 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------------
Confidence 2456999998875 568999999999999999998 89999876665554444321100
Q ss_pred hhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++..+.+||.+||..||++|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=317.96 Aligned_cols=260 Identities=17% Similarity=0.234 Sum_probs=204.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--G 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 4689999999999999999997542 34579999886443 23334457789999999999999999999876 4
Q ss_pred CeEEEEEEecccChhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEE
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 261 (415)
...|+||||+.++.+...+.. ...++...+..++.||+.||.|||+++|+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 568999999987666555432 1235677889999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 014960 262 DFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 262 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY- 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99998765332211 1122344677999999875 568999999999999999998 7899988776665554432110
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc------CCCCCCCC
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR------SEVSLYMX 408 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~------h~~f~~~~ 408 (415)
+ ......+..+.++|.+||+.||++|||+.++++ ||||+.+.
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 240 L---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 0 011245678999999999999999999999987 99998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=315.78 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=195.8
Q ss_pred CCceeeeee--ccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKI--GQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
+.|++.+.+ |+|+||.||+++++.++..||+|.+....... .|+.+...+ +|+||+++++.+.. ...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~--~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT--LKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec--CCee
Confidence 456666665 99999999999999999999999987543221 122222222 79999999999987 4579
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~ 273 (415)
|+||||+.++.+..++.....+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999998866666655555899999999999999999999999999999999999999998 9999999998765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCCHHHHhhCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL-HKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
....++..|+|||++.+ ..++.++||||||+++|+|++|..||......... ..+.... ..
T Consensus 164 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------------ 225 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK------------ 225 (267)
T ss_pred ----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc------------
Confidence 23357889999999876 56889999999999999999999999865443321 1111111 00
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-ATAALRSEVSLY 406 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~~~L~h~~f~~ 406 (415)
.....+.++..+.++|.+||+.||.+|++ .+++|+||||++
T Consensus 226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00112357888999999999999999997 599999999974
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=308.72 Aligned_cols=259 Identities=28% Similarity=0.485 Sum_probs=212.8
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|.+.+.||+|++|.||+|.+..+++.|++|++............+.+|+.++++++|+||+++++.+.......+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999998999999999987655456678899999999999999999999998774236799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC-Cc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PM 277 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~-~~ 277 (415)
||+.++.+..+......+++..++.++.|++.+|+|||+.+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99987777666655558999999999999999999999999999999999999999999999999999877654321 12
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ...+.+... ...
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-~~~--------------- 221 (260)
T cd06606 161 GSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGS-SGE--------------- 221 (260)
T ss_pred cCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccc-cCC---------------
Confidence 34567889999998875 45889999999999999999999999876521 111111110 000
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......++..+.++|.+||..||.+||++.+++.||||
T Consensus 222 --------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 222 --------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 111123457889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=313.71 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=203.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCC-CChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||+|++..+++.||||.+.... ........+.+|+.+++.++|+||+++++++.. ....++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 57999999999999999999999999999999887533 245556678899999999999999999999887 457999
Q ss_pred EEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 197 VFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 197 v~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
++||+.++.+..+. .....+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999986555433 23345899999999999999999999999999999999999999999999999998876533
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
.. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+ .....++
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--------- 227 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPP--------- 227 (267)
T ss_pred hH-HHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCC---------
Confidence 21 1223467889999999876 5688999999999999999999999976432 2222222 2111111
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++..+.++|.+||..||++||++.++++.
T Consensus 228 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 -----------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -----------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0012356778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=313.13 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=199.0
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
+.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. +...++++|
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 85 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFME 85 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEEe
Confidence 334468999999999999999899999999887543 3445678899999999999999999999877 567999999
Q ss_pred ecccChhhhhcCC-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEeeccccccCCCCCC
Q 014960 200 YMEHDLAGLAASP-TIKF--TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 200 ~~~~~l~~~~~~~-~~~~--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|+.++.+...+.. ...+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~ 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-P 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-C
Confidence 9998666655433 3345 88889999999999999999999999999999999976 6799999999987654322 1
Q ss_pred CcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......+++.|+|||++.+. ..++.++||||||+++|+|++|.+||....... ....+. ....
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-~~~~-------------- 229 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-MFKI-------------- 229 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-hhcc--------------
Confidence 22334578899999988542 347889999999999999999999997543221 111110 0000
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.......+++++.++|.+||..+|.+|||+.+++.||||
T Consensus 230 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 230 ------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 001123466788999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=318.91 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=212.1
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
|....+||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.. ....|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 444578999999999999999999999999886432 3445678899999999999999999999887 567999999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccc
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~ 279 (415)
|+.++.+..+... ..+++..++.++.||+.+|+|||++|++||||+|+||+++.++.++|+|||++....... .....
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 9998777665543 368999999999999999999999999999999999999999999999999987654322 12233
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCc
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (415)
..+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.+....+....+......
T Consensus 176 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------------- 234 (292)
T cd06657 176 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-------------------- 234 (292)
T ss_pred cccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc--------------------
Confidence 567899999998865 56789999999999999999999999887766555444321110
Q ss_pred chhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.......++.++.++|.+||..||.+||++.++|+|+||......+
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 235 ------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred ------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 0001134567788999999999999999999999999999888644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=313.25 Aligned_cols=249 Identities=20% Similarity=0.337 Sum_probs=202.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence 468999999999999999999864 56679999876432 234678899999999999999999998876 456899
Q ss_pred EEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+|||+.++.+..++. ....+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999998765544432 245688999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22223345678999998875 568899999999999999998 99999887776666655432110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.++|.+||..||++||+++++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 --------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111346778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=316.63 Aligned_cols=253 Identities=20% Similarity=0.330 Sum_probs=202.4
Q ss_pred CCCceeeeeeccCCceEEEEEEE----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Confidence 35799999999999999999985 3456789999987543 34445678899999999999999999999877 45
Q ss_pred eEEEEEEecccChhhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC
Q 014960 193 SLYLVFKYMEHDLAGLAASP-----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~-----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 255 (415)
..|+||||+.++.+..++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 68999999987655444321 1247889999999999999999999999999999999999999
Q ss_pred CcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014960 256 GILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKI 333 (415)
Q Consensus 256 ~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 333 (415)
+.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....++...+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543321 11223345677999999875 568999999999999999998 99999887766665555
Q ss_pred HHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
...... .....++..+.++|..||+.||.+||++.+++++
T Consensus 240 ~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLL----------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcC----------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 331100 1113467788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=333.14 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=206.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
..+.|.+...+|.|+|+.|-.|.+..+++.+++|++.+.. ....+|+.++... +|+||+++.+++.+ +.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYED--GKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecC--Ccee
Confidence 4678999999999999999999999999999999998652 1233577666655 79999999999988 6779
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE-cCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI-DNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl-~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|+|||.+.++.+...+.....+. .++..|+++|+.++.|||++|||||||||+|||+ +..++++|+|||.+......
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999987776666655555 8888999999999999999999999999999999 68999999999999876543
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
....+-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... +++..|. .+..
T Consensus 470 ---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----~~~~---------- 531 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----MPKF---------- 531 (612)
T ss_pred ---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----CCcc----------
Confidence 223355888999999884 78999999999999999999999999886665 3333332 2110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...+|+.+++||..||+.||.+|+++.+++.|+||
T Consensus 532 -----------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 -----------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 03588899999999999999999999999999999
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=350.97 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=201.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.++||+|+||.||+|++..+|+.||+|++..+.. .....+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 579999999999999999999999999999999976433 23445678899999999999999999999887 567999
Q ss_pred EEEecccChhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecc
Q 014960 197 VFKYMEHDLAGLAASP-----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL 265 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~ 265 (415)
||||+.++.+..++.. ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999998766544321 12356778889999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-----------------CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH
Q 014960 266 ASFFDPNH-----------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE 328 (415)
Q Consensus 266 a~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~ 328 (415)
+....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 97652110 011123468999999999876 568999999999999999999999998755433
Q ss_pred HHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 329 QLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 329 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.... .....+. . ......++..+.+++.+||..||++|++..+.|..
T Consensus 239 i~~~--~~i~~P~-~-----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYR--DVILSPI-E-----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh--hhccChh-h-----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3221 1111100 0 00123577889999999999999999988776654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=307.12 Aligned_cols=252 Identities=30% Similarity=0.486 Sum_probs=208.8
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|.+.+.||+|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 47888999999999999999988999999999976543 355678899999999999999999999877 46799999
Q ss_pred EecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 199 KYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 199 e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||+++..+....... ..+++..+..++.||+.+|.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999976666655443 5789999999999999999999999999999999999999999999999999987755432 2
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....++..|++||.+.+ ..++.++||||||+++|+|++|..||...+.......+.... .+.
T Consensus 155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------- 216 (253)
T cd05122 155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PPG---------------- 216 (253)
T ss_pred cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-CCC----------------
Confidence 34567889999999876 458899999999999999999999998775544444332211 000
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~ 403 (415)
......++..+.++|.+||..||++|||+.++|+|||
T Consensus 217 ---------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 ---------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0001124677899999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=311.05 Aligned_cols=252 Identities=26% Similarity=0.430 Sum_probs=210.8
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+|++.++||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4889999999999999999999999999999998765545556677889999999999999999999877 46799999
Q ss_pred EecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 199 KYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 199 e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||+.+..+...... ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99988655544322 356899999999999999999999999999999999999999999999999999876544
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--------------- 219 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 2233567889999999876 56888999999999999999999999887766555444321110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....++.++.++|.+||..+|.+|||+.++|+||++
T Consensus 220 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 -------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 1112456779999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=312.60 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=200.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+.++++++||||+++++++.. ....|++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEE
Confidence 479999999999999999997643 456999998754322 3467889999999999999999999876 4568999
Q ss_pred EEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++.+..++.. ...+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||.+..........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999988655555433 3478999999999999999999999999999999999999999999999999987654332211
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.+....+
T Consensus 158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY--------------- 221 (256)
T ss_pred cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC---------------
Confidence 122234567999999875 568899999999999999998 999998877766666554322110
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....+..+++++.+||..||.+|||+.+++.+
T Consensus 222 -------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 -------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 011346778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=312.15 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=203.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCce
Confidence 5799999999999999999987644 4579999886543 34455678889999999999999999999876 4569
Q ss_pred EEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+++|||+.++.+..+. .....+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999886665554 334578999999999999999999999999999999999999999999999999998775221
Q ss_pred CCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 274 KQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 274 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
... .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+.+....+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP----------- 228 (266)
T ss_pred cceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 111 112234678999998875 568999999999999999998 999998877666665554321111
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++.+.+|+.+||+.||++||++.+++++
T Consensus 229 -----------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 -----------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 012467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=310.63 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=200.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|++|.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeee
Confidence 357999999999999999999864 457799999875432 24567889999999999999999998876 456899
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+|||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999976655554433 24689999999999999999999999999999999999999999999999999987653221
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
........+..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+.......+.+....+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP------------- 224 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 11111222457999998875 568999999999999999999 999998877766666554321100
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+.++.++|.+||+.||.+||++.++++
T Consensus 225 ---------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 ---------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 01246678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.62 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=205.3
Q ss_pred eeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccC
Q 014960 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
+||+|.||+||-|+|..+....|||.+.-.. ....+-+..||.+.+.|+|.|||+++|.+.. ++++-|.||-++|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 5999999999999999999999999986432 3455678899999999999999999999876 67889999999998
Q ss_pred hhhhhcC-CCCCC--CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEeeccccccCCCCCCCcccc
Q 014960 205 LAGLAAS-PTIKF--TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQPMTSR 280 (415)
Q Consensus 205 l~~~~~~-~~~~~--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~~~~~~~~~~ 280 (415)
.+..++. .-+++ .|..+..|.+||++||.|||++.|||||||-+|+||+. .|.+||+|||.++.+..- ....-+.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 7766554 44566 78899999999999999999999999999999999975 789999999999876422 1223456
Q ss_pred cccCccCCccccc-CCcCCCchhcHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 281 VVTLWYRPPELLL-GATDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 281 ~gt~~y~aPE~~~-~~~~~~~~sDvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
.||..|||||++. |..+|+.++|||||||++.||.||+|||... +.+..+.++ . . ++-
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV---G-m----------------yKv 796 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV---G-M----------------YKV 796 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh---c-c----------------eec
Confidence 7899999999984 4568999999999999999999999999763 333333222 1 0 011
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.. .....++.+.+.+|.+|+..||.+||+|.++|+.||++.-+-
T Consensus 797 HP-------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 797 HP-------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred CC-------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence 11 112245667788999999999999999999999999987643
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=315.29 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=200.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 4679999999999999999999876 67889999886443 23344567889999999999999999998876 3
Q ss_pred CeEEEEEEecccChhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---cEEEE
Q 014960 192 CSLYLVFKYMEHDLAGLAASPT-------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIA 261 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~ 261 (415)
...++||||+.++.+..++... ..+++..+..++.||+.||+|||+++++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 4689999999876555444322 2589999999999999999999999999999999999998765 59999
Q ss_pred eeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 014960 262 DFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 262 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
|||++......... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c
Confidence 99999866322111 1112233567999999875 568999999999999999997 999999877766655443211 0
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
. .....++..+.+++.+||+.||++||++.++|+|
T Consensus 240 ~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0113467789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=353.89 Aligned_cols=262 Identities=31% Similarity=0.470 Sum_probs=205.6
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec------
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------ 189 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------ 189 (415)
-..+|+.++.||+||||.||+|+++-+|+.||||+|.... .......+.+|+..|.+|+|||||+++..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 4578999999999999999999999999999999999776 566677888999999999999999986522110
Q ss_pred --------------------------------------------------------------------------------
Q 014960 190 -------------------------------------------------------------------------------- 189 (415)
Q Consensus 190 -------------------------------------------------------------------------------- 189 (415)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred -----------------------CC--------CeEEEEEEecccChhhhhcCCCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 014960 190 -----------------------MS--------CSLYLVFKYMEHDLAGLAASPTIKF-TQAQVKCYMHQLLSGLEHCHN 237 (415)
Q Consensus 190 -----------------------~~--------~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~i~~qi~~~L~~LH~ 237 (415)
.. ..+||-||||+..++..++..+... ....++.+|++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 00 3589999999999999998887655 578899999999999999999
Q ss_pred CCCeeccCCCCCEEEcCCCcEEEEeeccccccC-----------------CCCCCCcccccccCccCCcccccCCc--CC
Q 014960 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFD-----------------PNHKQPMTSRVVTLWYRPPELLLGAT--DY 298 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~--~~ 298 (415)
+|||||||||.||+++.++.|||+|||+|.... .......+..+||.-|+|||++.+.. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998721 01112446679999999999997755 69
Q ss_pred CchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChH
Q 014960 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSL 378 (415)
Q Consensus 299 ~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (415)
+.++|+|||||||+||+. ||.. ..+....+.+.. .+. ++... ..+..--+.-.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR-~g~--------iP~~~-------------~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLR-KGS--------IPEPA-------------DFFDPEHPEEA 848 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcc-cCC--------CCCCc-------------ccccccchHHH
Confidence 999999999999999995 4643 333333332211 111 00000 00001112345
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 379 PLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 379 ~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
.+|+.||+.||.+||||.|+|++.||-
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 689999999999999999999999987
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=318.17 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=208.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+..|+.++.++ .|+||+++++++.. ....|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEE
Confidence 57899999999999999999999888999999999765332 2334455677766666 59999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
++|||+.+.+..........+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++..+.....
T Consensus 91 ~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999999887666655545578999999999999999999997 6999999999999999999999999999876543221
Q ss_pred CCcccccccCccCCcccccCC---cCCCchhcHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAEKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
.....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .+.+..+..... +. +
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~---~----- 239 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PS---L----- 239 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-CC---C-----
Confidence 2233567889999998653 2478899999999999999999999976332 333333322110 00 0
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.....++.++.+||.+||..||.+||+++++++|+||+..+...
T Consensus 240 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 283 (296)
T cd06618 240 -----------------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283 (296)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence 00114677899999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=311.13 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=198.5
Q ss_pred eeccCCceEEEEEEE--CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 125 KIGQGTYSNVYKARD--TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
.||+|+||.||+|.+ ..++..||+|++..........+.+.+|+.+++.++|+||+++++++.. ...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 4667899999987665555566788899999999999999999998754 35789999999
Q ss_pred cChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC--Ccccc
Q 014960 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ--PMTSR 280 (415)
Q Consensus 203 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~--~~~~~ 280 (415)
++.+..++.....+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++......... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 8766666655567999999999999999999999999999999999999999999999999999766433211 11122
Q ss_pred cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCc
Q 014960 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359 (415)
Q Consensus 281 ~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (415)
.++..|+|||.+.. ..++.++|||||||++|||++ |.+||...+..+....+.+... +
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~------------------- 217 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M------------------- 217 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C-------------------
Confidence 33578999998864 568899999999999999998 9999988777666665543210 0
Q ss_pred chhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.+||..||+.||++||+++++..
T Consensus 218 --------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 --------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011246788999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=315.14 Aligned_cols=253 Identities=16% Similarity=0.230 Sum_probs=199.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 467999999999999999999764 2456799999864332 2334567889999999999999999999876 4
Q ss_pred CeEEEEEEecccChhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEE
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 261 (415)
...++||||+.++.+..++.. ...+++..+..++.|++.||+|||+++++||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 579999999998766554432 1235778899999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 014960 262 DFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 262 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
|||++......... ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998755332211 1112345778999999875 568999999999999999999 78999887776655544332100
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......+.++.++|.+||+.||++|||+.+++++
T Consensus 241 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 ----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112456778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=349.08 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=133.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|.++++||+|+||.||+|++..+++.||||++..... .......+..|+.++..++|+||+++++++.. ..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999976433 34455778899999999999999999988876 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
+||||+.++.+..++.....+++..++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999887666666555678999999999999999999999999999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=316.90 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=202.9
Q ss_pred CCceeeeeeccCCceEEEEEEECC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.+|.+.+.||.|+||.||+|.+.. .+..||+|++.... .....+.+.+|+.++..++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--Q 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--C
Confidence 468889999999999999998653 35789999987543 334456788999999999999999999998773 4
Q ss_pred eEEEEEEecccChhhhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC
Q 014960 193 SLYLVFKYMEHDLAGLAAS----------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~----------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 256 (415)
..++++||+.++.+..++. ....+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 6899999998765544432 123578899999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014960 257 ILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIF 334 (415)
Q Consensus 257 ~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (415)
.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999876543221 11223345788999999875 568999999999999999998 889998887777766664
Q ss_pred HhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+.... ....+++..+.+|+..||+.||.+||++.+++..
T Consensus 241 ~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 42211 1123577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=310.78 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=199.3
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|.+.++||+|+||.||+|.+..+ ..||+|++..... ..+.+.+|+++++.++|+||+++++++.. ...|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence 5799999999999999999987655 4599999875433 23467889999999999999999988753 458999
Q ss_pred EEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+.++.+..++.. ...+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999998655555432 345789999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------------- 223 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC--------------
Confidence 2233445678999998865 568999999999999999999 889998877766655543211000
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.+||.+||+.||++||+++++++
T Consensus 224 --------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 --------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 11246778899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=311.62 Aligned_cols=249 Identities=19% Similarity=0.281 Sum_probs=199.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.+|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 36889999999999999999875 4667999998654322 2356779999999999999999998876 4579999
Q ss_pred EEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++.+..++ .....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999876555443 334478999999999999999999999999999999999999999999999999987654322111
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....++..|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 112223457999998876 568999999999999999999 89999887776666554332110
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......+.++.+++.+||+.+|++|||+.++++.
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1112467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=332.40 Aligned_cols=268 Identities=27% Similarity=0.356 Sum_probs=221.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.-|..++.||-|+||.|.+++..++...||+|.+++... ..+.+..++.|..||..-+.+-||+||-.|.++ ..+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk--dnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC--CceEE
Confidence 348889999999999999999889999999999987654 566777888999999999999999998888874 56999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-- 274 (415)
||+|+.|+.+-.++.+.+.|.|..++.|+.++..|+++.|..|+|||||||+|||||.+|+|||.|||+|.-+.....
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999977766666777899999999999999999999999999999999999999999999999999954421000
Q ss_pred ---------------------------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHH
Q 014960 275 ---------------------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315 (415)
Q Consensus 275 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell 315 (415)
......+||+.|+|||++.. .+|+..+|+||.|||||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHh
Confidence 01134689999999999986 67999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-
Q 014960 316 AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT- 394 (415)
Q Consensus 316 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t- 394 (415)
.|++||...+..+...++.+ |... +.......++.+..+||.+ |+.++++|+.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~n---------w~~~----------------l~~~~~~~ls~e~~~li~k-Lc~sad~RLGk 919 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVIN---------WRNF----------------LHIPYQGNLSKEALDLIQK-LCCSADSRLGK 919 (1034)
T ss_pred hCCCCccCCCCCcceeeeee---------hhhc----------------cccccccccCHHHHHHHHH-HhcChhhhhcc
Confidence 99999988877666555543 2210 0111224678889999986 6778999986
Q ss_pred --HHHHhcCCCCCCCCCCCCCC
Q 014960 395 --ATAALRSEVSLYMXXXXXXX 414 (415)
Q Consensus 395 --~~~~L~h~~f~~~~~~~~~~ 414 (415)
++|+-.||||+.|...+.++
T Consensus 920 ng~d~vKaHpfFkgIDfsslRk 941 (1034)
T KOG0608|consen 920 NGADQVKAHPFFKGIDFSSLRK 941 (1034)
T ss_pred cchhhhhcCccccccchHhhhh
Confidence 67899999999998766443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=314.56 Aligned_cols=259 Identities=29% Similarity=0.488 Sum_probs=213.6
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
..+.|++.+.||+|++|.||++.+..++..|++|++..... ....+.+|+++++.++|+||+++++++.. ....|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEE
Confidence 34679999999999999999999988899999999986532 45667889999999999999999999887 46799
Q ss_pred EEEEecccChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTI-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+++||+.++.+..++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999766666555444 799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......++..|++||++.+ ..++.++|+||||+++|+|++|..||...+.......+.... .+.
T Consensus 172 -~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~------------- 235 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPP------------- 235 (286)
T ss_pred -hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC-------------
Confidence 2233457889999998875 568999999999999999999999998776655554443211 000
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
......++.++.++|.+||+.+|.+|||+.++|+|+||+..
T Consensus 236 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 236 ------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00112367789999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=318.59 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=197.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCce--EEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence 46899999999999999999998777764 466665432 2344556788899999999 89999999999877 567
Q ss_pred EEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc
Q 014960 194 LYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 257 (415)
.|+||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 9999999987655444321 235889999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014960 258 LTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKL 336 (415)
Q Consensus 258 vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 336 (415)
+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99999999864321111 111223567999998865 568899999999999999998 99999877766555443211
Q ss_pred cCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.. + .....++.++.+||.+||+.||++||+++++|.+
T Consensus 240 ~~------~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 YR------L----------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred Cc------C----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0 0112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.06 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=203.5
Q ss_pred eeeccCCceEEEEEEECCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 124 DKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 4689999999999998765 8899999987654332 46788899999999999999999999887 5679999999
Q ss_pred cccChhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 201 MEHDLAGLAASP---------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 201 ~~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
+.++.+...+.. ...+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 977655555544 36899999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+....+.+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY------------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 321 11233456888999998876 478999999999999999999 699999887766666554311
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.......++.++.++|.+||..||++|||+.+++++
T Consensus 225 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ----------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.62 Aligned_cols=259 Identities=19% Similarity=0.280 Sum_probs=204.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC----------------ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCcee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG----------------QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 180 (415)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+.++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999876543 568999987553 335567888999999999999999
Q ss_pred eeeeeEeecCCCeEEEEEEecccChhhhhcCCCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCC
Q 014960 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTI-----------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN 249 (415)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 249 (415)
++++++.. +...+++||++.++.+..++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999877 467999999998876655544333 68999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh--CCCCCCCCCh
Q 014960 250 LLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--EKPIMPGRTE 326 (415)
Q Consensus 250 ILl~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~--g~~pf~~~~~ 326 (415)
|+++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ +..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999876533221 11223455778999998875 568999999999999999998 7788887776
Q ss_pred HHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 327 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.+.+..+........... .......++.++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQI---------------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccc---------------------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 666655543211110000 00112345678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=311.25 Aligned_cols=249 Identities=20% Similarity=0.314 Sum_probs=205.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+|++.++||.|+||.||+|++.. +..+|+|++.... ......+.+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEE
Confidence 4579999999999999999999877 8889999987543 2335568889999999999999999999877 456999
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..+... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999998665555432 34689999999999999999999999999999999999999999999999999976643221
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
. .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+.+..+......+
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP------------- 224 (261)
T ss_pred c-ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-------------
Confidence 1 223345678999998875 578899999999999999998 899998888777776665321110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++++.++|.+||+.||.+|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 ---------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11356778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=322.49 Aligned_cols=259 Identities=26% Similarity=0.337 Sum_probs=192.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.|.-...||+|+||.||+|.- .+|..||||.+....... ...|.+|+.++.+++|+|+|+|+|||.+... ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEE
Confidence 5788788999999999999984 445899999877544322 3459999999999999999999999987422 59999
Q ss_pred EEecccChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 198 FKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQ---HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
+||+..+.+..++.... .++|..+..|+.+++.||+|||+. .|||||||++|||||+++++||+|||+|+.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999877766655433 899999999999999999999974 3999999999999999999999999999655431
Q ss_pred CCCCcccc-cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHH-HHhcCCCCHHHHhhC
Q 014960 273 HKQPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT--EVEQLHKI-FKLCGSPSEEYWKKS 348 (415)
Q Consensus 273 ~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~--~~~~~~~i-~~~~~~~~~~~~~~~ 348 (415)
....... .||.+|+|||++.. ...+.++|||||||+|+||++|+.+..... ....+... ...........+-+.
T Consensus 231 -~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~ 308 (361)
T KOG1187|consen 231 -DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP 308 (361)
T ss_pred -ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence 1222222 78999999999875 678999999999999999999998877532 11111111 111111111111000
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCC-----CChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFP-----PSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
++ .. ..++ ..+..+...|+..+|.+||++.|++.
T Consensus 309 ~l----------------~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 309 RL----------------KE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred Cc----------------cC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00 00 1111 11567889999999999999999753
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.32 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=199.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||+|+||.||+|.+. .+..+|+|.+...... ...+.+|+.++++++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEE
Confidence 357999999999999999999765 5667999998765433 3458889999999999999999998753 34789
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+|||+.++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999987655554432 34589999999999999999999999999999999999999999999999999977644322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+.+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-------------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22223345667999998865 568899999999999999999 89999887776666655432100
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHh
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L 399 (415)
......+.++.+||.+||..||.+|||+++++
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 223 --------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred --------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 01134677899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.69 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=197.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ--IVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
++|++.+.||+|+||.||+|++..++. .+++|.+... ......+.+.+|+.++.++ +||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 579999999999999999999877665 4688877632 2334456788899999999 79999999999876 4569
Q ss_pred EEEEEecccChhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcE
Q 014960 195 YLVFKYMEHDLAGLAASPT----------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGIL 258 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~v 258 (415)
|++|||+.++.+..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 9999999876554443221 258899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014960 259 TIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLC 337 (415)
Q Consensus 259 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 337 (415)
||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+...++.+..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999864322111 111122456999998875 568999999999999999997 999998877766655543221
Q ss_pred CCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.. .....++.++.+||.+||..||.+|||++++++.
T Consensus 236 ~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 1113467789999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=311.26 Aligned_cols=252 Identities=30% Similarity=0.451 Sum_probs=202.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|.+.+.||+|+||.||+|++..++..||+|.+..... .......+.+|+.+++.++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 468899999999999999999988999999998875432 34455678899999999999999999999887 457999
Q ss_pred EEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 197 VFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 197 v~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
+|||+.++.+..++. ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999865554432 3456899999999999999999999999999999999999999999999999998766433
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHHhhCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
.. ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.+.... +....+.... .+
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~---------- 226 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YP---------- 226 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-CC----------
Confidence 21 2234467889999999875 56889999999999999999999999764432 2222221110 00
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......++..+.++|.+||..||.+|||+.+++.
T Consensus 227 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 227 ----------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0011246778999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.15 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=202.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||++..... ...+|+|.+..... ......+.+|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 46799999999999999999987543 37899999875432 33446688899999999 89999999999876
Q ss_pred CCeEEEEEEecccChhhhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC
Q 014960 191 SCSLYLVFKYMEHDLAGLAAS----------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~----------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 254 (415)
...++++|||+.++.+..++. ....+++..++.++.||+.||.|||+++|+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 456999999998866555442 2346899999999999999999999999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014960 255 EGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (415)
Q Consensus 255 ~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 332 (415)
++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999876432211 1122234567999998865 568999999999999999997 9999988776666655
Q ss_pred HHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+...... ......+.++.+||.+||..||.+|||+.+++++
T Consensus 247 ~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYRM----------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCcC----------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4322100 0112456788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.76 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=200.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|.+.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD--G 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--C
Confidence 357999999999999999999753 345668999876432 3444678899999999999999999999876 4
Q ss_pred CeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 255 (415)
...++||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 569999999987766554432 2348999999999999999999999999999999999999999
Q ss_pred CcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014960 256 GILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKI 333 (415)
Q Consensus 256 ~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 333 (415)
+.++|+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543221 11223456788999998876 568899999999999999998 99999887766655544
Q ss_pred HHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
..... ......++..+.++|.+||..||.+|||+.++++
T Consensus 239 ~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRV----------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCC----------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 22110 0111235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.98 Aligned_cols=264 Identities=24% Similarity=0.360 Sum_probs=205.9
Q ss_pred CceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 192 (415)
+|++.+.||+|++|.||++++. .+++.||+|++..... .......+.+|+.++.++ +|+||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4888999999999999999853 4678899999875422 123345678899999999 59999999998876 55
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|+||||+.++.+.........+++..+..++.|++.+|.|||+.+++||||||.||+++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 79999999998766666555567899999999999999999999999999999999999999999999999998765443
Q ss_pred CCCCcccccccCccCCcccccCCc-CCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.........|+..|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+.+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS----------- 227 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-----------
Confidence 322223345788999999886522 36789999999999999999999996543222222221111000
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEVSLYMXX 409 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~L~h~~f~~~~~ 409 (415)
.......++.++.++|.+||+.||++||| +.++|+|+||+.+..
T Consensus 228 --------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 228 --------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred --------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 00111346778899999999999999998 567799999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=306.66 Aligned_cols=291 Identities=34% Similarity=0.519 Sum_probs=237.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC---CeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS---CSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---~~~ 194 (415)
.+.+-.+-||-|+||.||.+.|..+|+.||+|++..-...-...+.+.+|+++|..++|.|++..++......- ..+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 44555678999999999999999999999999986433334456678899999999999999998876654322 237
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+++|+|..++...+.... .++...+..++.||+.||.|||+.+|.||||||.|+||+.+-.+||||||+++..+.+..
T Consensus 133 YV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 8899999988888777765 789999999999999999999999999999999999999999999999999999988877
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC-
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA- 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 353 (415)
..++..+.|.+|.|||+++|...|+.+.||||.|||+.|||..+-.|...+.-++++.|...+|+|..+.......-..
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 7788888999999999999999999999999999999999999999999999999999999999999887654221110
Q ss_pred CcCCCc---chhhhhh-hhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 354 TIFKPQ---QSYKRCI-AETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 354 ~~~~~~---~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.+.+.. .....+. .....+-..+..+++..||.+||++|++.++++.|++....+.
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 000000 0000000 0011122345778999999999999999999999999887654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.06 Aligned_cols=244 Identities=20% Similarity=0.279 Sum_probs=196.4
Q ss_pred eeeccCCceEEEEEEECCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 124 DKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
++||+|+||.||+|+...++ ..||+|.+...... .....+.+|+.+++.++|+||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999865544 78999998765443 445678889999999999999999998764 358999999
Q ss_pred cccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccc-
Q 014960 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS- 279 (415)
Q Consensus 201 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~- 279 (415)
+.++.+...+.....+++..+..++.||+.+|+|||+++++||||||+|||++.++.+||+|||++.............
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9887666666555579999999999999999999999999999999999999999999999999998765433221111
Q ss_pred -ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 280 -RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 280 -~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------- 216 (257)
T cd05060 157 AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------------- 216 (257)
T ss_pred CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-------------------
Confidence 123467999998875 568999999999999999998 9999988776655554432110
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......++..++++|.+||..||++||++.+++.
T Consensus 217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=310.06 Aligned_cols=253 Identities=18% Similarity=0.252 Sum_probs=201.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|.+.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--G 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--C
Confidence 36899999999999999999987543 4789999986443 23344567789999999999999999999887 4
Q ss_pred CeEEEEEEecccChhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEE
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 261 (415)
...|+||||+.++.+..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 679999999987655544422 2246888999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 014960 262 DFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 262 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG-H 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC-C
Confidence 9999876543221 11233456788999998875 568999999999999999998 999998877766665543210 0
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+ .....++.++.++|.+||+.+|++|||+.+++..
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 240 L---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0112346788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=308.02 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=200.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 468999999999999999999854 5678999998754432 3467889999999999999999998753 45899
Q ss_pred EEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+|||+.++.+..+.. ....+++.++..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999998765544432 344689999999999999999999999999999999999999999999999999977653322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......++..|+|||++.+ ..++.++||||||+++|+|++ |++||.+.+..+....+.+....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------
Confidence 22223345678999998875 568899999999999999999 99999887766655554322110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.++|.+||+.||++|||++++++
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 --------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011245678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.31 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=199.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQI----VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
..+|++.+.||+|+||.||+|++..++.. ||+|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 35799999999999999999987666654 899998643 2344556788899999999999999999998752
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++++||+.++.+...+ .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 467899999876554444 4345689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
..... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+ .....++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~-------- 231 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLP-------- 231 (316)
T ss_pred CCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCC--------
Confidence 32211 112234667999999875 678999999999999999997 99999887665543322 2111100
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....+.++.++|.+||..||.+||++.+++.+
T Consensus 232 -------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 -------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012345678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=310.24 Aligned_cols=251 Identities=20% Similarity=0.268 Sum_probs=199.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.+.||+|+||.||+|++..++. .||+|++.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---C
Confidence 4689999999999999999998777766 48999887543 34455678899999999999999999998865 3
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++++||+.++.+...+ .....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 478999999876555444 3345799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||...........+... ..++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-------- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERLP-------- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCC--------
Confidence 2221 1112234678999999875 568999999999999999998 99999876655544433221 1110
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+.++.++|.+||..||.+||++.+++.
T Consensus 232 -------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 -------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01245677899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=305.34 Aligned_cols=252 Identities=30% Similarity=0.466 Sum_probs=202.3
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|++++++++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 579999999999999999999998999999999875333 34446788899999999999999999999887 467999
Q ss_pred EEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 197 VFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 197 v~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
||||+.++.+..++ .....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999986554433 23446899999999999999999999999999999999999999999999999998766433
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
.. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+......+
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 227 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP---------- 227 (267)
T ss_pred Cc-ccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC----------
Confidence 21 1233467889999998875 5688999999999999999999999965431 12222221110000
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.++|.+||..+|++|||+.++++
T Consensus 228 -----------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 -----------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001246678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=306.49 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=202.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEE
Confidence 468999999999999999999865 457799999875443 23567889999999999999999999876 456999
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+...... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999988655554433 24689999999999999999999999999999999999999999999999999877643221
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
........+..|+|||.+.+ ..++.++||||||+++|+|++ |+.||.+.+....+..+......+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------------- 224 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 11122234567999998875 568999999999999999998 999998887777776664422111
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+.++.+++.+||+.||++||+++++++
T Consensus 225 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 ---------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01235678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=326.15 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=196.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~ 190 (415)
.++|.+++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+++. ||||+++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 46899999999999999999986432 3569999987543 3344567889999999996 9999999999976
Q ss_pred CCeEEEEEEecccChhhhhcCC----------------------------------------------------------
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (415)
...+|+||||+.++.+..++..
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 4579999999987655433211
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC
Q 014960 213 --------------------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (415)
Q Consensus 213 --------------------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 254 (415)
...+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124788889999999999999999999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014960 255 EGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (415)
Q Consensus 255 ~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 332 (415)
++.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||........+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999976543221 11223356788999999876 568999999999999999997 9999977544333322
Q ss_pred HHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......+ .....++.++.++|.+||+.||++|||+.++.+
T Consensus 352 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22211000 011346778999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.00 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=201.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC--------------CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT--------------GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l 182 (415)
.++|++.+.||+|+||.||+|++..+ ...||+|.+... ........+.+|++++++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 35899999999999999999986543 235899998754 234556678899999999999999999
Q ss_pred eeeEeecCCCeEEEEEEecccChhhhhcCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCE
Q 014960 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPT------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNL 250 (415)
Q Consensus 183 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 250 (415)
++++.. ....++||||+.++.+...+... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999876 45799999999986655443221 2368889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh--CCCCCCCCChH
Q 014960 251 LIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--EKPIMPGRTEV 327 (415)
Q Consensus 251 Ll~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~--g~~pf~~~~~~ 327 (415)
|++.++.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999876533221 11122344678999998875 568999999999999999988 67889887777
Q ss_pred HHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 328 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+....+.+......... .....+.+++.+.+||.+||..||++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQI---------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccc---------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 76665544221110000 00112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=328.06 Aligned_cols=236 Identities=24% Similarity=0.357 Sum_probs=198.1
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
++-||+|+.|.||+|+ ..++.||||+++- .-..+|+.|++|+|+||+.+.|+|.. ...++||||||.
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecC--CceeEEeeeccc
Confidence 5779999999999995 5678999998751 22348999999999999999999987 567999999999
Q ss_pred cChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccc
Q 014960 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (415)
Q Consensus 203 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~g 282 (415)
.+-+..++..+..+.......|.++|+.|++|||.+.|||||||.-||||..+..|||+|||.++..... ...-.++|
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 9988888888889999999999999999999999999999999999999999999999999999876543 33456789
Q ss_pred cCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchh
Q 014960 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (415)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (415)
|..|||||++.. .+.+.++|||||||+|||||||.-||..-+...++. ..|....
T Consensus 274 TVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVGsNsL-------------------- 328 (904)
T KOG4721|consen 274 TVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVGSNSL-------------------- 328 (904)
T ss_pred hHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEE----eccCCcc--------------------
Confidence 999999999986 678999999999999999999999997654433321 1111110
Q ss_pred hhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 363 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
-.......|+.++-||+.||+..|..||++.++|.|
T Consensus 329 ---~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 329 ---HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ---cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 011123567788999999999999999999999988
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=311.11 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=200.2
Q ss_pred CCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.+|.+.++||+|+||.||++.. ..++..+|+|.+... .......+.+|+++++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--GR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CC
Confidence 5788899999999999999964 235678999987643 34556688999999999999999999998877 45
Q ss_pred eEEEEEEecccChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc
Q 014960 193 SLYLVFKYMEHDLAGLAASPT---------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 257 (415)
..+++|||+.++.+..++... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 689999999886665444322 25889999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014960 258 LTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFK 335 (415)
Q Consensus 258 vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 335 (415)
+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999875532211 11122334678999998876 568999999999999999998 9999988777666655533
Q ss_pred hcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.... .....++..+.+||.+||+.||.+||++++++.
T Consensus 240 ~~~~----------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GREL----------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2110 011246778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=306.62 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=197.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|.+.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|+|++++++++.. ...|++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence 5699999999999999999987554 4589998765432 23567789999999999999999988753 358899
Q ss_pred EEecccChhhhhc-C-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAA-S-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~-~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+.++.+..+. . ....+++..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999875444443 2 2335889999999999999999999999999999999999999999999999999766443222
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+.+....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM--------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2223345678999998875 568999999999999999999 99999987776666555332110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++..+.++|.+||..||.+||+++++++
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=307.20 Aligned_cols=251 Identities=20% Similarity=0.338 Sum_probs=203.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
++|+..+.||+|+||.||+|++..++. .+|+|.+.... .....+.+..|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCc
Confidence 478889999999999999999876554 79999886543 23445678889999999999999999999876 4568
Q ss_pred EEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|+||||+.++.+..+.. ....+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 99999999876665553 34578999999999999999999999999999999999999999999999999997664332
Q ss_pred CCCccc--ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 274 KQPMTS--RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 274 ~~~~~~--~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
...... ...+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 230 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---------- 230 (268)
T ss_pred ccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC----------
Confidence 221111 122457999998875 568999999999999999997 999998877766666654321111
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
...+.+.++.+++.+||..||.+||++.++++
T Consensus 231 ------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01246678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=315.02 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=199.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 188 (415)
.++|.+.+.||+|+||.||++++.. +...||+|.+..+. .......+.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3679999999999999999997643 23579999987543 234456678899999999 79999999999877
Q ss_pred cCCCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
....|+||||+.++.+..++.. ...+++.+++.++.||+.||+|||++|++||||||+|||+
T Consensus 96 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 --DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 4579999999988655544432 1248889999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 999999999999987654221111 111223567999998876 568999999999999999998 88999877665555
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+..... ......++.++.+||.+||..+|.+|||+.+++++
T Consensus 253 ~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 54432110 01123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=307.73 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=202.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
++|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .......+.+|+.+++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcc
Confidence 57999999999999999999876444 379999886543 34445678899999999999999999999876 4579
Q ss_pred EEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|+||||+.++.+..++ .....+++.++..++.||+.||.|||+++++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999876555444 334568999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcc--cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 274 KQPMT--SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 274 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
..... ...++..|+|||++.+ ..++.++|+|||||++|++++ |..||......+....+.+....+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 229 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP---------- 229 (267)
T ss_pred ceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC----------
Confidence 21111 1223567999999875 568999999999999999886 999998877666655554321100
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.+++.+||+.+|.+||++.++++
T Consensus 230 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 ------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 01245778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.45 Aligned_cols=285 Identities=24% Similarity=0.362 Sum_probs=220.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--------CCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD--------HPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~l~~~~~~ 188 (415)
..+|.+.++||.|.|++||+|+|..+.+.||+|+.+.. ....+....||.+|++++ ..+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 37899999999999999999999999999999998743 344455667999999983 3479999999965
Q ss_pred --cCCCeEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEc-----------
Q 014960 189 --RMSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLID----------- 253 (415)
Q Consensus 189 --~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~----------- 253 (415)
..+.+++||+|+++..|+..+... ...++...++.|++||+.||.|||. .||||-||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 456789999999999999988754 4569999999999999999999995 6999999999999984
Q ss_pred --------------------------------------------------------------------------------
Q 014960 254 -------------------------------------------------------------------------------- 253 (415)
Q Consensus 254 -------------------------------------------------------------------------------- 253 (415)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------CC----------------------------------------------------CcE
Q 014960 254 -----------------------NE----------------------------------------------------GIL 258 (415)
Q Consensus 254 -----------------------~~----------------------------------------------------~~v 258 (415)
.. -.|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 00 016
Q ss_pred EEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC------ChHHHHHH
Q 014960 259 TIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR------TEVEQLHK 332 (415)
Q Consensus 259 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~------~~~~~~~~ 332 (415)
||+|||-|..... .++.-..|..|+|||+++| ..|+..+||||++|++|||+||-.+|... .+++.+..
T Consensus 394 KIaDlGNACW~~k----hFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWVHK----HFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhhhh----hhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 7777777766542 2344566889999999998 67999999999999999999999988643 46788999
Q ss_pred HHHhcCCCCHHHHhhCCCCCCC--------cCCCcch--hhhhhhhhcCCCC----CChHHHHHHhcccCCCCCCCHHHH
Q 014960 333 IFKLCGSPSEEYWKKSKLPHAT--------IFKPQQS--YKRCIAETFKDFP----PSSLPLIETLLAIDPAERQTATAA 398 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~R~t~~~~ 398 (415)
|++.+|.-+.......+-.... .+....+ +...+.+.+ .++ .++-+++.-||+++|++|+||.++
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY-~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKY-EWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHh-CCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 9999987764433222211110 0111111 111122222 233 347899999999999999999999
Q ss_pred hcCCCCCCCCCC
Q 014960 399 LRSEVSLYMXXX 410 (415)
Q Consensus 399 L~h~~f~~~~~~ 410 (415)
|+|||+..+...
T Consensus 548 l~hPwLn~~~~~ 559 (590)
T KOG1290|consen 548 LKHPWLNPVAGP 559 (590)
T ss_pred hcCccccCCCCC
Confidence 999999987764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=303.37 Aligned_cols=246 Identities=29% Similarity=0.439 Sum_probs=205.4
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccC
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
||+|+||.||++.+..+++.||+|++..... .......+..|+.+++.++|+||+++++.+.. +...|++|||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 6999999999999988899999999886543 23456678899999999999999999998876 56799999999776
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccC
Q 014960 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284 (415)
Q Consensus 205 l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~ 284 (415)
.+...+.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 666555555578999999999999999999999999999999999999999999999999997764432 1223456788
Q ss_pred ccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhh
Q 014960 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKR 364 (415)
Q Consensus 285 ~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (415)
.|++||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.+.. +
T Consensus 158 ~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------------------ 210 (250)
T cd05123 158 EYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--L------------------------ 210 (250)
T ss_pred cccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--C------------------------
Confidence 9999999876 557889999999999999999999998777655554443311 0
Q ss_pred hhhhhcCCCCCChHHHHHHhcccCCCCCCCH---HHHhcCCCC
Q 014960 365 CIAETFKDFPPSSLPLIETLLAIDPAERQTA---TAALRSEVS 404 (415)
Q Consensus 365 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~~~L~h~~f 404 (415)
.....++..+.++|++||..||++||++ ++++.||||
T Consensus 211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0112347888999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=312.79 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=200.3
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|.+.+.||+|+||.||++.+ ..++..||+|.+.... .....+.+.+|+.+++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 46799999999999999999975 3345689999887543 234456788999999999 79999999999877
Q ss_pred CCeEEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
....|++|||+.++.+..++.. ...+++.++..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 4569999999987655554432 22389999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 269 FDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 269 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+.++......+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM------ 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC------
Confidence 5432211 1122345778999998876 568999999999999999998 999998766555444433211000
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.++|.+||..+|++|||+.++++
T Consensus 264 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 ---------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011245678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=310.48 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=197.2
Q ss_pred CceeeeeeccCCceEEEEEEECC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
+|++.+.||+|+||.||+|++.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47888999999999999998643 23568888886543 33445678899999999999999999999876 456
Q ss_pred EEEEEEecccChhhhhcCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASP------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN 249 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 249 (415)
.+++|||+.++.+..++.. ...+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 8999999997666544321 2357899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChH
Q 014960 250 LLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEV 327 (415)
Q Consensus 250 ILl~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~ 327 (415)
||+++++.+||+|||++......... ......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999765332211 1122234678999998875 568999999999999999998 99999887766
Q ss_pred HHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 328 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+....+.+.... .....++.++.++|..||+.||.+||++++++.
T Consensus 237 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYRM----------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCCC----------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 555443221100 011346778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=310.42 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=194.6
Q ss_pred eeeeeeccCCceEEEEEEEC----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 121 EKLDKIGQGTYSNVYKARDT----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.+.||.|.||.||+|... ..+..|+||.+.. ....+..+.+.+|++++++++|+||++++|++.. ....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc--cccccc
Confidence 45688999999999999876 4467899999954 3345557888999999999999999999999985 445999
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+...+.. ...+++..+..|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999997655544433 46799999999999999999999999999999999999999999999999999987632211
Q ss_pred -CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 -QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 -~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
...........|+|||.+.+ ..++.++||||||+++|||++ |..||...+..+...++.+....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~------------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL------------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET-------------
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccc-------------
Confidence 11122345778999999875 458999999999999999999 78999888887777777432211
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++..+.++|..||..||++|||+.++++
T Consensus 225 ---------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 225 ---------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 112346778899999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=306.68 Aligned_cols=252 Identities=22% Similarity=0.394 Sum_probs=202.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.+|++.+.||+|+||.||+|.+..+++ .||+|.+... ........+..|+.+++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCce
Confidence 468999999999999999999876664 5999998654 234556788999999999999999999999876 5568
Q ss_pred EEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
++||||+.++.+..+.. ....+++.+++.++.|++.||+|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999876655443 34578999999999999999999999999999999999999999999999999987654322
Q ss_pred CCC-ccccc---ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 274 KQP-MTSRV---VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 274 ~~~-~~~~~---gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
... ..... .+..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------- 231 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP-------- 231 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC--------
Confidence 111 11111 2457999999875 568999999999999999886 999998877766666553221100
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
...+++.++.+++.+||..+|.+||++.+++..
T Consensus 232 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 232 --------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred --------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012456778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=303.23 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=199.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ....+.+|+.+++.++|+||+++++++.+ ....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 35799999999999999999975 478999999875432 45678889999999999999999999876 556999
Q ss_pred EEEecccChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+........ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999766555544333 68999999999999999999999999999999999999999999999999997763221
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+..|+|||++.+ ..++.++||||||+++|+|++ |..||...+..+....+.+.. .
T Consensus 157 ---~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-------------- 217 (256)
T cd05039 157 ---DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-R-------------- 217 (256)
T ss_pred ---ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-C--------------
Confidence 12234567999998875 568899999999999999997 999998776655544443210 0
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......+++++.++|.+||..+|++|||+.+++.
T Consensus 218 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 218 -------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=319.57 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=196.5
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|+.++.++ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 35799999999999999999974 3567899999997543 234456778899999999 689999999987654
Q ss_pred CCeEEEEEEecccChhhhhcCC----------------------------------------------------------
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP---------------------------------------------------------- 212 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~---------------------------------------------------------- 212 (415)
+..++++|||+.++.+..++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4568999999998765544321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-CCcccccc
Q 014960 213 ---------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVV 282 (415)
Q Consensus 213 ---------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~g 282 (415)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999999999999999999999999999999999876532211 11122334
Q ss_pred cCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
+..|+|||++.+ ..++.++|||||||++|+|++ |..||..................+
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 301 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------- 301 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC---------------------
Confidence 677999999875 568999999999999999997 999997754333222222111000
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++.++.+++..||..||.+|||+.++++|
T Consensus 302 ------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011245678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=303.08 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=215.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|.++++||+|+|+.|.+++.+.+.+.||+|+++++-. +.+...-++.|-.+..+- +||.+|.++.+|.. ...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence 5789999999999999999999999999999999988755 344555667777777765 79999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
++|.||++|+.+-...++...++|+.++.|..+|+.||.|||++||++||||.+|+|++..|.+||.|||+++.--...
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g- 405 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG- 405 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC-
Confidence 9999999998888888888899999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC-------CChHHHHHH-HHHhcCCCCHHHHh
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-------RTEVEQLHK-IFKLCGSPSEEYWK 346 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~-------~~~~~~~~~-i~~~~~~~~~~~~~ 346 (415)
...++.+|||.|+|||++.+ ..|+..+|+|+|||+|+||+.|+.||.- .+.++.+.+ |++..
T Consensus 406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--------- 475 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--------- 475 (593)
T ss_pred cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---------
Confidence 34567899999999999987 6899999999999999999999999962 122232222 22210
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT------ATAALRSEVSLYMX 408 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t------~~~~L~h~~f~~~~ 408 (415)
....+.++.....+++..|++||.+|.. ..++-.|+||+.+.
T Consensus 476 --------------------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 476 --------------------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred --------------------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 1112345556677999999999999975 47999999999765
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=313.57 Aligned_cols=252 Identities=19% Similarity=0.302 Sum_probs=199.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-------LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 188 (415)
.++|.+.+.||+|+||.||+|++. .....||+|.+.... .......+.+|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 367999999999999999999753 234579999887542 344556788899999999 69999999999876
Q ss_pred cCCCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
...+|++|||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 4569999999988665544422 2358899999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999976543211 11112233567999999876 568999999999999999999 89999887776666
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
..+..... ......++.++++||.+||..||++|||+.+++.
T Consensus 247 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHR----------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 65533110 0111345678899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=337.31 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=209.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
..+....+.||+|+||.||+|+-. .....||||.++.. .+.....+|+||++++..|+|||||+|+|++.. +
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCRE--G 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--C
Confidence 356677789999999999999742 23467999998754 355578899999999999999999999999988 5
Q ss_pred CeEEEEEEecccChhhhhcCC----------CC----CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------TI----KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 257 (415)
..+++|||||.++.+..++.. .. +++..+...|+.||+.|++||-++.+|||||-..|+||.++..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 679999999998766654431 11 3889999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014960 258 LTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFK 335 (415)
Q Consensus 258 vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 335 (415)
|||+|||+++.+-..+. .......-...||+||.++- ..|+.+|||||+||+|||+.+ |+.||.+-+++++++.|.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 99999999986543322 22223344778999999985 789999999999999999997 9999999999999988866
Q ss_pred hcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHH
Q 014960 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398 (415)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 398 (415)
.. +.....+.|.++++|+..||+.+|++||++.|+
T Consensus 721 g~----------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 721 GQ----------------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred CC----------------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 32 223345789999999999999999999999887
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=303.07 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=202.2
Q ss_pred ceeeeeeccCCceEEEEEEECCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
+++.+.||.|+||.||+|.+...+ ..||+|.+.... .......+..|+.+++.++|+||+++++++.+ ....|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeE
Confidence 356789999999999999987766 889999986543 22256678899999999999999999999887 46799
Q ss_pred EEEEecccChhhhhcCCCCC--CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIK--FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
++|||+.++.+......... +++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999988666555543322 8999999999999999999999999999999999999999999999999997765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
........+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+.......+.+....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL------------- 223 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 211112236788999998854 678999999999999999998 88999887776666655432110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.+++.+||+.||++|||+.++++
T Consensus 224 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 ---------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 011236778999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=303.33 Aligned_cols=243 Identities=22% Similarity=0.275 Sum_probs=193.7
Q ss_pred eeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 125 KIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ...++||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999764 445679999987542 34455678899999999999999999998754 35899999998
Q ss_pred cChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC--ccc
Q 014960 203 HDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTS 279 (415)
Q Consensus 203 ~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~--~~~ 279 (415)
++.+...+. ....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... ...
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 876665543 45578999999999999999999999999999999999999999999999999997654332211 111
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
..++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.+... +
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~------------------ 217 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-L------------------ 217 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-C------------------
Confidence 223578999998875 568899999999999999996 9999988777666554433210 0
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......++++.++|.+||..||++||++.++++
T Consensus 218 ---------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 218 ---------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011245778999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=312.31 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=201.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-------LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 188 (415)
.++|.+.+.||+|+||.||+|+.. .++..||+|.+... ........+.+|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 468999999999999999999742 23457999988644 2344556788999999999 89999999999887
Q ss_pred cCCCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
....|++|||+.++.+..++.. ...++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 4578999999988655544322 2357888999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||++.......... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999998664322211 122345678999998876 568999999999999999998 88999887776666
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+...... .....++.++++||.+||..+|.+|||+.++++.
T Consensus 250 ~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 555321100 0113567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.49 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=195.2
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEeccc
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH 203 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~ 203 (415)
+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+.+++.++|+||+++++++.. ....++||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 3689999999999985 467889999886543 34444568889999999999999999999877 4569999999987
Q ss_pred Chhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccc
Q 014960 204 DLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282 (415)
Q Consensus 204 ~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~g 282 (415)
+.+.... .....+++..+..++.||+.+|.|||++|++||||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 6555444 334568999999999999999999999999999999999999999999999999987543322111122234
Q ss_pred cCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch
Q 014960 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS 361 (415)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (415)
++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+.......+......
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------- 213 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---------------------- 213 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 567999998875 568899999999999999998 99999887766555544321100
Q ss_pred hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++..+.+++.+||+.||++||++.++++.
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 214 ------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 0112467789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=307.83 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=197.4
Q ss_pred ceeeeeeccCCceEEEEEE----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 120 FEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
|++.+.||+|+||+||++. ...++..||+|.+.... .......+.+|++++++++|+||+++++++.......+|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 4889999999999998764 34577899999987543 223446677899999999999999999988765456789
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
++|||+.++.+..+.... .+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 85 lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 999999987776665443 6899999999999999999999999999999999999999999999999999876533211
Q ss_pred --CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCHHHHhhCCCCC
Q 014960 276 --PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG-SPSEEYWKKSKLPH 352 (415)
Q Consensus 276 --~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~ 352 (415)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... +..+..... ......+.......
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhhhhcC
Confidence 1112234667999998875 56889999999999999999999998654321 111111100 00000000000000
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
........++.++.+++..||..||++|||++++++
T Consensus 241 ------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 ------------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ------------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000112356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.74 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=196.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQI----VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.+.||+|+||.||+|.+..+++. +++|.+... ........+..|+.++.+++|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---C
Confidence 36799999999999999999998777764 677776432 223344567788889999999999999998753 3
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++++||+.++.+..++ .....+++..+..|+.||+.||+|||+++++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 478899999876555444 4455789999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+.+. ..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-------- 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERLA-------- 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCC--------
Confidence 3221 1223345778999999875 568999999999999999998 99999887655543333211 1100
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+.++.+++.+||..||.+|||+.+++.
T Consensus 232 -------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 -------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01124556788999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=306.03 Aligned_cols=253 Identities=19% Similarity=0.338 Sum_probs=202.2
Q ss_pred CCceeeeeeccCCceEEEEEEECC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
++|++.+.||+|+||.||+|+.+. ..+.|++|.+.... .......+.+|+.++++++|+||+++++++.+ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CC
Confidence 579999999999999999998653 34679999876432 23355678899999999999999999998876 45
Q ss_pred eEEEEEEecccChhhhhcCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 193 SLYLVFKYMEHDLAGLAASPTI---------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
..|+||||+.++.+..++.... .+++..+..++.||+.+|.|||+++|+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 6899999999776665554333 6899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
|++...............++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+.......+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~--- 237 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE--- 237 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC---
Confidence 9987543322222334456788999998875 467899999999999999998 88899776665554444221100
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
| .....++..+.++|.+||..||.+|||+.+++..
T Consensus 238 --~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 --L----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --C----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 1 0113467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.38 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=198.0
Q ss_pred eeeccCCceEEEEEEECC-CC--ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 124 DKIGQGTYSNVYKARDTL-TG--QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
+.||+|++|.||+|.+.. .+ ..||||.+...... ...+.+.+|+.++++++|+||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999998755 33 36899999866543 566788999999999999999999998876 568999999
Q ss_pred cccChhhhhcCC-C-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC--C
Q 014960 201 MEHDLAGLAASP-T-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ--P 276 (415)
Q Consensus 201 ~~~~l~~~~~~~-~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~--~ 276 (415)
+.++.+...+.. . ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 987655544433 2 46899999999999999999999999999999999999999999999999999876543211 1
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL--------------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---------------
Confidence 112345778999998875 568999999999999999998 999998877777666654311000
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++..+.+++.+||+.+|++||++.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011246778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=302.44 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=200.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.+|++.+.||+|+||.||++.+. .+..+|+|.+...... ...+.+|++++++++|+||+++++++.. ....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence 46889999999999999999875 4678999988754332 2457789999999999999999999876 4568999
Q ss_pred EEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++.+..+.. ....+++..++.++.|++.+|+|||+++++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999876665543 34568999999999999999999999999999999999999999999999999987654322211
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....++..|+|||++.+ ..++.++||||||+++|+|++ |.+||......+....+.+....
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---------------- 220 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC----------------
Confidence 222334678999998875 568899999999999999998 99999887766666555321100
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......+..+.+|+.+||+.||++|||+.++++.
T Consensus 221 ------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 ------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0012256779999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=305.20 Aligned_cols=268 Identities=22% Similarity=0.340 Sum_probs=197.4
Q ss_pred CCceeeeeeccCCceEEEEEE----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.+|++.+.||+|+||.||+|. +..++..||+|.+... .....+.+.+|+++++.++|+||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 579999999999999999997 4567889999998644 2445567889999999999999999999876544567
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
+++||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 89999999876555544 33456899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCC--cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC-HHHHhhCC
Q 014960 273 HKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSK 349 (415)
Q Consensus 273 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~ 349 (415)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|..++..... .....+........ ...... .
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~ 238 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIE-L 238 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHH-H
Confidence 2211 111223456999999875 5689999999999999999998776644321 11111100000000 000000 0
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.... . .......++.++.+||.+||..||++|||+.+++..
T Consensus 239 ~~~~------~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 239 LKNN------G-----RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HhcC------C-----cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0000 0 001123567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.13 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=200.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
++|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++|+||+++++++.+ ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCc
Confidence 5789999999999999999986544 3468999886442 24556678899999999999999999998875 347
Q ss_pred EEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|+||||+.++.+..++.. ...+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999987655555443 4468999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
........++..|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+.+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------------- 227 (270)
T ss_pred ceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-------------
Confidence 111122233567999998865 568999999999999999986 99999888776666554321100
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++.++.++|.+||..+|.+|||+.+++..
T Consensus 228 ---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 ---------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123567889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=308.78 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=199.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++++++|+||+++++++.. +
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--G 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--C
Confidence 367999999999999999999864 357889999987542 34455678899999999999999999998876 4
Q ss_pred CeEEEEEEecccChhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN 249 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 249 (415)
...+++|||+.++.+...+.. ...+++..++.++.||+.||+|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 568999999998655444321 1247889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChH
Q 014960 250 LLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEV 327 (415)
Q Consensus 250 ILl~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~ 327 (415)
||++.++.++|+|||++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999875532211 11122234667999998875 568999999999999999997 88899887766
Q ss_pred HHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 328 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+....+..... ......++.++.+||.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNV----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 65554432110 0011246778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=304.56 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=201.7
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecC---CCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD---NLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
+|.+.+.||+|+||.||++.+...+..+++|++... .........+.+|+.+++.++||||+++++++.+ ....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 488999999999999999998877777777766532 2223334456779999999999999999998876 45689
Q ss_pred EEEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 196 LVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 196 lv~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
+||||+.++.+...+ .....+++..+..++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999986655433 23457899999999999999999999999999999999999975 6799999999876643
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.... ++
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~---------- 223 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP--TP---------- 223 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--CC----------
Confidence 321 2233457889999998865 567889999999999999999999998766655554443211 00
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....++.++.++|.+||..||++||+++++++||||
T Consensus 224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ----------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0113466788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.22 Aligned_cols=244 Identities=20% Similarity=0.336 Sum_probs=196.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+|++.+.||+|+||.||++.. .|..||+|.+.... ....+.+|+.++++++|+|++++++++... ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence 35799999999999999999964 47889999886432 235678899999999999999999976543 456899
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+|||+.++.+...... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999987655544432 2348899999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------- 217 (256)
T ss_pred ---CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 22334567999998875 568899999999999999997 9999987766555554432110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......++..+.++|.+||..||++|||+.++++
T Consensus 218 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 -------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0111346778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=307.86 Aligned_cols=268 Identities=21% Similarity=0.346 Sum_probs=199.1
Q ss_pred CCceeeeeeccCCceEEEEEEE----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARD----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
..|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++|+||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4588999999999999999973 4678899999986543 3444567889999999999999999999987754567
Q ss_pred EEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.++||||+.++.+..++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8999999988766655533 346899999999999999999999999999999999999999999999999999876533
Q ss_pred CCC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH-HhhCC
Q 014960 273 HKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY-WKKSK 349 (415)
Q Consensus 273 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~ 349 (415)
... ......++..|+|||++.+ ..++.++|||||||++|+|+++..|+..... ... +..+....+. +...
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~- 235 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFL---KMIGPTHGQMTVTRL- 235 (284)
T ss_pred ccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hhh---hhcccccccccHHHH-
Confidence 221 1123445778999998876 5688999999999999999998776533211 110 1111000000 0000
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
. ..... .........++.++.+||.+||+.||.+|||++++++.
T Consensus 236 ~---~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 V---RVLEE-----GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred H---HHHHc-----CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 00000 00001123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.36 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=195.5
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEeccc
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH 203 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~ 203 (415)
++||+|+||.||+|.+.. ++.||+|.+...... .....+.+|++++++++|+||+++++++.. ....|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 369999999999999877 999999998765433 455678899999999999999999999877 4579999999987
Q ss_pred Chhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc-cccc
Q 014960 204 DLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRV 281 (415)
Q Consensus 204 ~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~-~~~~ 281 (415)
+.+..++ .....+++..+..++.+++.+|+|||+++++||||||+|||++.++.+||+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 6555444 3345689999999999999999999999999999999999999999999999999976542211111 1122
Q ss_pred ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcc
Q 014960 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (415)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (415)
.+..|+|||++.+ ..++.++|+|||||++|+|++ |..||...........+......
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 3567999998875 568999999999999999999 88999877665544443221100
Q ss_pred hhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.++|.+||..+|.+|||+.++|+
T Consensus 215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011246778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=302.79 Aligned_cols=282 Identities=30% Similarity=0.525 Sum_probs=229.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~ 193 (415)
.+|.-+..+|.|.- .|-.|.|.-.++.||+|.+..........++..+|...+..++|+||++++.+|.... -..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46888889999999 8888999999999999988765434445567788999999999999999999986532 245
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.|+|||+|...+..... ..+.-+.+..++.|++.|+.|||+.||+||||||+||++..+..+||.|||+|+..+..
T Consensus 96 ~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 89999999988776655 35677888999999999999999999999999999999999999999999999876654
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
-..+..++|..|.|||++.+.+ |...+||||+||++.||++|.-.|.|.+.-++..++.+.+|+|...+..+......
T Consensus 172 -~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred -cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 3457788999999999999854 99999999999999999999999999999999999999999999887765332211
Q ss_pred CcCCCcchhh-hhhhhhcCC------------CCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 354 TIFKPQQSYK-RCIAETFKD------------FPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 354 ~~~~~~~~~~-~~~~~~~~~------------~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
....+...+. ....+..++ =+..+.+|+.+||..||++|.+++++|+||||+.
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 1111111110 111111111 1234789999999999999999999999999983
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=291.52 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=198.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEee---cCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS---RMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~~ 193 (415)
..+|.+.+.||.|||+-||++++..+++.||+|++.... .+..+...+|++..++++||||++++++... .....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 578999999999999999999999999999999998654 5667788899999999999999999887533 13456
Q ss_pred EEEEEEecccC-hhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 194 LYLVFKYMEHD-LAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 194 ~~lv~e~~~~~-l~~~~---~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
.||+++|...+ ++..+ ...+..++|.++..|+.+|++||++||+.. +.||||||.|||+.+++.++|.|||.+.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999876 44332 233447999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCC--------CcccccccCccCCccccc--CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014960 268 FFDPNHKQ--------PMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC 337 (415)
Q Consensus 268 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 337 (415)
...-.-.. .......|..|.|||.+. .....+.++|||||||+||+|+.|..||.-. ++.-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~G 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQG 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcC
Confidence 65321110 011223488899999873 2345788999999999999999999999431 1100
Q ss_pred CCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+... -. ....+-. +.. ...+++.+.+||+.||+.||.+||++.+++.+
T Consensus 249 gSla----------LA-v~n~q~s----~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLA----------LA-VQNAQIS----IPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEE----------Ee-eeccccc----cCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0000 00 0000000 000 12388999999999999999999999999864
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.33 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=198.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 468999999999999999999754 4566999988643 2334678889999999999999999998865 45899
Q ss_pred EEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+|||+.++.+..++. ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999998755544443 234678899999999999999999999999999999999999999999999999976643322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------------- 221 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---------------
Confidence 22223345677999999875 568899999999999999998 9999988776655554432110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......++.++.+++.+||+.||++||++.+++.
T Consensus 222 -------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 -------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112356778999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.26 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=199.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCC-------CceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeec
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLT-------GQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSR 189 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 189 (415)
.+|++.+.||+|+||.||+|++... +..||+|.+... ........+.+|+.+++++ +|+||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 5799999999999999999976432 236899987643 2344556788999999999 79999999999876
Q ss_pred CCCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc
Q 014960 190 MSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID 253 (415)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 253 (415)
....|++|||+.++.+..++.. ...++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 4579999999988665554432 22478889999999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014960 254 NEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLH 331 (415)
Q Consensus 254 ~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~ 331 (415)
.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999765432211 1112233567999999876 568899999999999999998 899998877766665
Q ss_pred HHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 332 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.+..... ......++.++.+||.+||..+|.+|||+.+++.+
T Consensus 248 ~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5532110 01112456778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.43 Aligned_cols=239 Identities=19% Similarity=0.245 Sum_probs=186.2
Q ss_pred eeeccCCceEEEEEEECC------------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 124 DKIGQGTYSNVYKARDTL------------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
+.||+|+||.||+|+... ....+++|.+.... ......+.+|+.++..++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--D 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 368999999999997432 22358888875432 3445567889999999999999999999876 4
Q ss_pred CeEEEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc-------EEEEee
Q 014960 192 CSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI-------LTIADF 263 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-------vkl~Df 263 (415)
...++||||++++.+..... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++. ++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 56899999999877666554 3456899999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
|++...... ....++..|+|||.+.....++.++|||||||++|+|+ .|..||......+... +.....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~---- 226 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC---- 226 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc----
Confidence 998655322 23457888999998865567899999999999999998 5888887654333221 111000
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......+.++.+||.+||+.||.+||++.++|++
T Consensus 227 -------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 -------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0011234568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.84 Aligned_cols=238 Identities=20% Similarity=0.265 Sum_probs=186.1
Q ss_pred eeccCCceEEEEEEECC------------------------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCcee
Q 014960 125 KIGQGTYSNVYKARDTL------------------------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 180 (415)
.||+|+||.||+|.... ....|++|++.... ......+.+|+.+++.++|+||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999997422 12358888876432 33345677899999999999999
Q ss_pred eeeeeEeecCCCeEEEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---
Q 014960 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG--- 256 (415)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~--- 256 (415)
++++++.. ....|+||||+.++.+..++. ....+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999887 457899999999987766654 355789999999999999999999999999999999999997654
Q ss_pred ----cEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHH-hCCCCCCCCChHHHHH
Q 014960 257 ----ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLH 331 (415)
Q Consensus 257 ----~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell-~g~~pf~~~~~~~~~~ 331 (415)
.+|++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|.+||......+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999988644221 22356788999998876567899999999999999995 6999998765544322
Q ss_pred HHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 332 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.+.... ......+.++.++|.+||+.+|++|||++++|++
T Consensus 233 ~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FYEKKH------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHhcc------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 111100 0011234568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.59 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=197.3
Q ss_pred CCceeeeeeccCCceEEEEEEECC----------------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceee
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTL----------------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK 181 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 181 (415)
++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 469999999999999999985432 34578999987542 3445567889999999999999999
Q ss_pred eeeeEeecCCCeEEEEEEecccChhhhhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCE
Q 014960 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLAASPT-----------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNL 250 (415)
Q Consensus 182 l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 250 (415)
+++++.. ....+++|||+.++.+..++... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999877 45689999999876555443221 2477889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh--CCCCCCCCChH
Q 014960 251 LIDNEGILTIADFGLASFFDPNHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--EKPIMPGRTEV 327 (415)
Q Consensus 251 Ll~~~~~vkl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~--g~~pf~~~~~~ 327 (415)
|++.++.++|+|||++..+....... .....+++.|++||+..+ ..++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999997654332111 122334678999998775 568999999999999999998 77899877766
Q ss_pred HHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 328 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+......+.. .... ... .......++..+.+||..||..||.+||++.++++
T Consensus 241 ~~~~~~~~~~--------~~~~-~~~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFF--------RDQG-RQV------------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHH--------hhcc-ccc------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6554432211 0000 000 00111235677899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=305.11 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=201.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECC----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.++++++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 4689999999999999999998765 3578999987643 3455567788999999999999999999987653 45
Q ss_pred eEEEEEEecccChhhhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 193 SLYLVFKYMEHDLAGLAASPT--------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
..++++||+.++.+...+... ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 689999999875555443221 468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 265 LASFFDPNHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 265 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
+++.+....... .....++..|+|||++.+ ..++.++|||||||++|++++ |.+||...+..+....+.... .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-- 238 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL-- 238 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC--
Confidence 997654332111 112234667999999876 568999999999999999998 999998876655444333211 00
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+++++.++|.+||..||++|||+.++++
T Consensus 239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 -------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001235678899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=305.06 Aligned_cols=239 Identities=17% Similarity=0.225 Sum_probs=187.1
Q ss_pred eeeccCCceEEEEEEECCCCc-------eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 124 DKIGQGTYSNVYKARDTLTGQ-------IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
+.||+|+||.||+|.+...+. .||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. +...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEE
Confidence 368999999999998765443 48888875432 3344567889999999999999999999887 456899
Q ss_pred EEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc--------EEEEeecccc
Q 014960 197 VFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--------LTIADFGLAS 267 (415)
Q Consensus 197 v~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--------vkl~DfG~a~ 267 (415)
||||+.++.+..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999876665554 3446899999999999999999999999999999999999987765 6999999986
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
..... ....++..|+|||++.+...++.++|||||||++|+|++|. +||...+...... +.....
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~-------- 222 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRH-------- 222 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccc--------
Confidence 55332 23457888999999876556889999999999999999984 6666554443322 111100
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......+.++.+||.+||+.||++|||++++++.
T Consensus 223 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 ---------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0011234568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.04 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=198.3
Q ss_pred CCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMS 191 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~ 191 (415)
++|.+.++||+|+||.||+|++. ..++.||+|++..... ......+.+|+.+|.++. |+||+++++++.. .
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--~ 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK--G 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--C
Confidence 56888999999999999999853 3456899999975432 333456888999999997 9999999999877 4
Q ss_pred CeEEEEEEecccChhhhhcCC-----------------------------------------------------------
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------------------------------------------------------- 212 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------------------------------------------------------- 212 (415)
...++||||+.++.+..++..
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 569999999998655443321
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc
Q 014960 213 ---------------------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID 253 (415)
Q Consensus 213 ---------------------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 253 (415)
...+++..+..|+.||+.||+|||+++|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 12367778899999999999999999999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014960 254 NEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLH 331 (415)
Q Consensus 254 ~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~ 331 (415)
.++.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||......+...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999976532221 11223456788999999876 568999999999999999998 889998765555443
Q ss_pred HHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 332 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
........+ .....++.++.+||.+||..||.+||++.++++.
T Consensus 353 ~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRM---------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332211000 0113467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=303.15 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=189.7
Q ss_pred eeccCCceEEEEEEECCCCc--eEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 125 KIGQGTYSNVYKARDTLTGQ--IVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
.||+|+||.||+|++..++. .+++|.+... ......+.+.+|+.++.++ +|+||+++++++.. ....|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 58999999999999887775 4688877632 2345556788999999999 79999999999877 45689999999
Q ss_pred ccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecc
Q 014960 202 EHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL 265 (415)
Q Consensus 202 ~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~ 265 (415)
.++.+..++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 87655444322 12478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
+........ ......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------ 229 (270)
T cd05047 159 SRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR------ 229 (270)
T ss_pred ccccchhhh--ccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC------
Confidence 853321111 111223567999998865 668999999999999999997 9999987766555544422100
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.+....++.++.+|+.+||..||.+|||+.+++.
T Consensus 230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 230 ----------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0011235677899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.40 Aligned_cols=280 Identities=21% Similarity=0.245 Sum_probs=186.5
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCC----CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeE----e
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLT----GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLV----T 187 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~----~ 187 (415)
..++|.+.+.||+|+||.||+|++..+ +..||+|++..... .+....+ .+....+.+++.++..+ .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 457899999999999999999999888 89999998763221 1111111 12222223333222221 1
Q ss_pred ecCCCeEEEEEEecccChhhhhcCCCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014960 188 SRMSCSLYLVFKYMEHDLAGLAASPTI--------------------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (415)
Q Consensus 188 ~~~~~~~~lv~e~~~~~l~~~~~~~~~--------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 247 (415)
......+++||||++++.+..++.... ...+..+..++.||+.||+|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 123557999999999876554443211 122345678999999999999999999999999
Q ss_pred CCEEEcC-CCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCc---------------------CCCchhcHH
Q 014960 248 SNLLIDN-EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT---------------------DYGVGVDLW 305 (415)
Q Consensus 248 ~NILl~~-~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~sDvw 305 (415)
+|||++. ++.+||+|||+|...............+++.|+|||++.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 579999999999866544333345567899999999764211 234567999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhc
Q 014960 306 SAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLL 385 (415)
Q Consensus 306 SlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 385 (415)
||||+||||+++..+ ..+....+..++...+.. ...|........ . ..... ..+........+++||.+||
T Consensus 364 SlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~---~--~~~~~-~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYD-LVAWRKLVEPRA---S--PDLRR-GFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCc-HHHHHHhhcccc---c--hhhhh-hhhhccccchHHHHHHHHHc
Confidence 999999999986544 344444555555544332 233433211110 0 00000 01111223445779999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 386 AIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 386 ~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
++||++|||+.++|+||||+.....
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999999876554
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=301.91 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=188.8
Q ss_pred eeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 125 KIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
.||+|+||.||+|... .....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.. ...+|+||||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCC
Confidence 6899999999999643 234568888776432 34445667889999999999999999999876 456999999999
Q ss_pred cChhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-CC
Q 014960 203 HDLAGLAASPT-----IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-QP 276 (415)
Q Consensus 203 ~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-~~ 276 (415)
++.+..++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 86665544321 2346788899999999999999999999999999999999999999999999865432211 11
Q ss_pred cccccccCccCCcccccC------CcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 277 MTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~------~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.....+++.|+|||++.. ...++.++|||||||++|||++ |.+||....+.+.+..+.........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------- 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP------- 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC-------
Confidence 123345678999998742 2356889999999999999999 78899887777666555443211100
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......++..+.+++..|+ .||++|||++++++
T Consensus 232 ----------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 232 ----------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ----------------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00112346677788999888 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=301.77 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=200.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.++++++|+||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 4679999999999999999998776664 589998765532 4455678899999999999999999998875 4
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++||||+.++.+...+ .....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 689999999876555444 4445689999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCc-ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQPM-TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
...... ....++..|+|||.+.. ..++.++|+|||||++|||++ |.+||.+....+....+..... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--------- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-L--------- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-C---------
Confidence 322111 11223567999998864 568899999999999999998 9999988776666555532110 0
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......+.++.+++.+||..||.+||++.++++
T Consensus 231 ------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001234567889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=303.34 Aligned_cols=261 Identities=18% Similarity=0.164 Sum_probs=188.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC---CceEEEEEEecCCCChHHH---------HHHHHHHHHHHhCCCCceeeeee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESV---------RFMAREILILRRLDHPNVVKLEG 184 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~~iv~l~~ 184 (415)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+........... .....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999998777 6677888654432211000 01112334455678999999998
Q ss_pred eEeecCC--CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEe
Q 014960 185 LVTSRMS--CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIAD 262 (415)
Q Consensus 185 ~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~D 262 (415)
++..... .+.+++++++...+..... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 7654322 2457788887665544332 233468889999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCC------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014960 263 FGLASFFDPNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336 (415)
Q Consensus 263 fG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 336 (415)
||+|+.+..... .......||+.|+|||++.+ ..++.++|||||||+||||++|.+||.+......+....+.
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999987643221 11123468999999999886 66899999999999999999999999886433222221110
Q ss_pred cCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+.+..... ........+..+.++++.|+..+|++||+.+++++
T Consensus 249 ------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ------DFIKRLHE---------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------HHHHHhhh---------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00000000 00112345788999999999999999999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=297.54 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=189.5
Q ss_pred eeeccCCceEEEEEEECC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 124 DKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++.++|+||+++++++... +...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998643 3457999987532 2344566788899999999999999999976543 4458899999
Q ss_pred cccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC---CC
Q 014960 201 MEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK---QP 276 (415)
Q Consensus 201 ~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~---~~ 276 (415)
+.++.+..++. ....+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 98766555543 344567888899999999999999999999999999999999999999999999875532211 11
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--~~-------------- 221 (262)
T cd05058 159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--RL-------------- 221 (262)
T ss_pred cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--CC--------------
Confidence 112345678999998875 568999999999999999999 567787666555444432210 00
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++..+.+++.+||..||++||++.+++.
T Consensus 222 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 222 ------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001235677999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=298.02 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=201.9
Q ss_pred CceeeeeeccCCceEEEEEEECC-CCceEEEEEEecCC--------CChHHHHHHHHHHHHHHh-CCCCceeeeeeeEee
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDN--------LEPESVRFMAREILILRR-LDHPNVVKLEGLVTS 188 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~ 188 (415)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... ........+.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37888999999999999999877 67899999886432 123344567778888875 799999999999877
Q ss_pred cCCCeEEEEEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
....+++|||+.++.+..+. .....+++..++.++.|++.+|.|||+ .+++|+||+|+|||++.++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 56799999999875544332 344578999999999999999999996 78999999999999999999999999
Q ss_pred ccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 014960 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 343 (415)
|++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.......+......+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 9998765432 2344567889999999876 5689999999999999999999999987766655554443221110
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....++.++.++|.+||..||++||++.++..+
T Consensus 234 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 -------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012466789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=317.61 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=206.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCc---e-EEEEEEecCC-CChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ---I-VALKKVRFDN-LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~-vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
++..+.++||+|+||.||+|+-+..+. . ||+|...... ...+....+.+|+++|++++|+|||++||+... ..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~~ 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--EE 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CC
Confidence 455566899999999999998654422 3 8999988633 567888899999999999999999999999987 45
Q ss_pred eEEEEEEecccChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTI-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
.+|+|||+|.|+.+..++.... .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++....
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 6999999999987777776655 599999999999999999999999999999999999999999999999999876431
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh-cCCCCHHHHhhCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKL-CGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 349 (415)
- .......-....|+|||.+.. ..|+.++|||||||++||+.+ |..||.+....++..+|... ...+
T Consensus 315 ~-~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~--------- 383 (474)
T KOG0194|consen 315 Y-VMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP--------- 383 (474)
T ss_pred e-eeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC---------
Confidence 1 111111224677999999986 589999999999999999998 89999999999999888542 2111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....-|.++..++..|+..||++|+|+.++.+
T Consensus 384 -------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 -------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 11245667888999999999999999988764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=299.78 Aligned_cols=253 Identities=19% Similarity=0.269 Sum_probs=197.3
Q ss_pred ceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC----C
Q 014960 120 FEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~ 192 (415)
|.+.+.||+|+||.||+|.+. .++..||||++..+.......+.+.+|+.+++.++|+||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999854 357889999997665555566778899999999999999999998765321 1
Q ss_pred eEEEEEEecccChhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 193 SLYLVFKYMEHDLAGLAAS------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
..++++||+.++.+...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478889998765543321 1225789999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 267 SFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 267 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
......... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---- 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-L---- 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-C----
Confidence 865432211 1122334677999998875 568899999999999999999 8999987776655544432110 0
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++..+.+++.+||..+|++||++.+++.+
T Consensus 235 -----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 -----------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012466789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.98 Aligned_cols=250 Identities=18% Similarity=0.206 Sum_probs=187.4
Q ss_pred eeeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.++++++|+||+++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36899999999999754 3456799998875543 2334567889999999999999999999876 45689999999
Q ss_pred ccChhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-C
Q 014960 202 EHDLAGLAASP-----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-Q 275 (415)
Q Consensus 202 ~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-~ 275 (415)
.++.+..++.. ...+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 97666544421 23467778889999999999999999999999999999999999999999999865432211 1
Q ss_pred CcccccccCccCCcccccCC------cCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 276 PMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~------~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
......++..|+|||++.+. ..++.++||||||+++|||++ |.+||......+.............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL------- 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC-------
Confidence 11234567889999988532 135789999999999999996 9999987665554433222110000
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+ ........++.+.+++..|+ .+|++|||+++++.
T Consensus 231 --~--------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 231 --P--------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --C--------------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0 00011235667889999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=334.17 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=207.5
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCC-----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTG-----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 190 (415)
.....++.+.||+|.||.||.|.-.... ..||+|.+... .+......|.+|+.+|+.++|||||+++|++.+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-- 766 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-- 766 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--
Confidence 3456778899999999999999754332 24899988754 356667788899999999999999999999988
Q ss_pred CCeEEEEEEecccChhhhhc-CC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 191 SCSLYLVFKYMEHDLAGLAA-SP------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~-~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
....+|++|||.++.+..++ .. ...++....+.++.|||.|++||+++++|||||...|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 55699999999986554444 33 446899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcccc-cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 014960 264 GLASFFDPNHKQPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPS 341 (415)
Q Consensus 264 G~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 341 (415)
|+|+.+........... .-...|||||.+.. ..++.++|||||||+|||++| |..||.+.++.+++...++.- ..
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL- 923 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL- 923 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc-
Confidence 99994432221111111 22467999999985 789999999999999999998 999999999999998666542 11
Q ss_pred HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+.....|+.+++||..||+.+|++||++..+++
T Consensus 924 --------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 --------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 112457889999999999999999999999986
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=296.76 Aligned_cols=236 Identities=21% Similarity=0.268 Sum_probs=186.4
Q ss_pred eeeccCCceEEEEEEECCCC----------ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 124 DKIGQGTYSNVYKARDTLTG----------QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 46899999999999987766 347788765432 115678889999999999999999998876 34
Q ss_pred EEEEEEecccChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-------cEEEEeecc
Q 014960 194 LYLVFKYMEHDLAGLAASPTI-KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-------ILTIADFGL 265 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-------~vkl~DfG~ 265 (415)
.++||||+.++.+..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 789999999887776665443 789999999999999999999999999999999999999888 799999999
Q ss_pred ccccCCCCCCCcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHH
Q 014960 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 343 (415)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+....... ..
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~----- 223 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QH----- 223 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CC-----
Confidence 976543 1234567789999998764 368899999999999999999 5778866543332221110 00
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.........+.++|.+||..||.+|||+.++++
T Consensus 224 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 ------------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000011267889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=303.88 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=196.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 4678999999999999999999877776 46888876443 233344678899999999999999999988652
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++++||+.++.+.... .....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 367899999876544443 4344689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.. ...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~-------- 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERLP-------- 231 (303)
T ss_pred cccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCC--------
Confidence 32211 122344678999999875 568999999999999999997 8999987665444333221 11000
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....+.++.+++..||..||++||++++++..
T Consensus 232 -------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 -------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012345678899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=299.26 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=192.4
Q ss_pred eeccCCceEEEEEEECCCC------ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 125 KIGQGTYSNVYKARDTLTG------QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.||+|+||.||+|++.... ..||+|.+.... .......+.+|+.+++.++|+||+++++++.. ....++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEE
Confidence 6899999999999875433 689999886432 23445678889999999999999999999876 45699999
Q ss_pred EecccChhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-----cEEEEeeccc
Q 014960 199 KYMEHDLAGLAAS-------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-----ILTIADFGLA 266 (415)
Q Consensus 199 e~~~~~l~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-----~vkl~DfG~a 266 (415)
||+.++.+...+. ....+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9998765544332 223478899999999999999999999999999999999999887 8999999998
Q ss_pred cccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 267 SFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 267 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~----- 231 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-R----- 231 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-c-----
Confidence 76532211 11122345678999998875 568999999999999999998 999998877666555442211 0
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......+|..+.++|.+||..+|.+||+++++++
T Consensus 232 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 ----------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0112346778899999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=297.67 Aligned_cols=229 Identities=25% Similarity=0.296 Sum_probs=183.7
Q ss_pred CCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccChhhh
Q 014960 129 GTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL 208 (415)
Q Consensus 129 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~ 208 (415)
|.+|.||+|++..+++.||+|.+.... .+.+|...+....||||+++++++.. ....|++|||+.++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997542 22345555556679999999999887 467999999999876665
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCC
Q 014960 209 AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288 (415)
Q Consensus 209 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~a 288 (415)
.+.....+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+...... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 5555557999999999999999999999999999999999999999999999999987665432 122345677999
Q ss_pred cccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhh
Q 014960 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAE 368 (415)
Q Consensus 289 PE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (415)
||.+.+ ..++.++||||+|+++|+|++|..||...... + .. .. ...
T Consensus 151 PE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~-----~~-----------~~~ 196 (237)
T cd05576 151 PEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT-----HT-----------TLN 196 (237)
T ss_pred CcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc-----cc-----------ccC
Confidence 998865 56889999999999999999999887432110 0 00 00 001
Q ss_pred hcCCCCCChHHHHHHhcccCCCCCCCH-----HHHhcCCCC
Q 014960 369 TFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEVS 404 (415)
Q Consensus 369 ~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~L~h~~f 404 (415)
....++..++++|.+||+.||++|+++ ++++.||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 113467788999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.35 Aligned_cols=241 Identities=22% Similarity=0.371 Sum_probs=194.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEE
Confidence 579999999999999999985 578889999986432 23567889999999999999999998865 237999
Q ss_pred EEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||+.++.+..++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999987555444432 335899999999999999999999999999999999999999999999999998764322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+.+...
T Consensus 154 -~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------- 215 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---------------- 215 (254)
T ss_pred -CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC----------------
Confidence 122233567999998875 568899999999999999997 9999988776655544432110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......++.++.++|.+||+.+|.+||++++++.
T Consensus 216 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 ------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011356788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.30 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=198.6
Q ss_pred CCceeeeeeccCCceEEEEEEEC----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDT----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
++|++.+.||+|+||.||+|... .++..||+|++...... .....+.+|+++++.+.|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 57888999999999999999854 34789999999765433 35678899999999999999999999987755667
Q ss_pred EEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+++|||+.++.+..++.. ...+++..+..++.||+.||+|||++|++|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 9999999987655554433 336899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCC--cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH-----------HHHHHHhcCC
Q 014960 273 HKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-----------LHKIFKLCGS 339 (415)
Q Consensus 273 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~-----------~~~i~~~~~~ 339 (415)
.... .....++..|++||.+.+ ..++.++||||||+++|+|++|..||........ ...+.+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 2111 112234566999998875 5688999999999999999999998865432210 1111111000
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.. .......++.++.+|+.+||..||.+|||+.++++
T Consensus 242 ~~------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GE------------------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CC------------------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00001235677899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.07 Aligned_cols=281 Identities=30% Similarity=0.477 Sum_probs=226.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC------CCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD------HPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~l~~~~~~~~ 190 (415)
..+|.+....|+|-|++|..|.+...|..||||+|+.+.. -.+.=..|++||++|+ --++++|+..|.+
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence 4679999999999999999999999999999999986543 1223346999999994 3478888888877
Q ss_pred CCeEEEEEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeecccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLAS 267 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~ 267 (415)
..++|||||.+.-.|-..+.. .+..|....++.|+.|+..||..|-..||+|.||||.||||++.. .+||||||.|.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 567999999988776665543 444688899999999999999999999999999999999999865 68999999998
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
....+. .+....+..|.|||+++| ..|+...|+||.||+||||.||+-.|.|.++...+...+...|.++......
T Consensus 586 ~~~ene---itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASENE---ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccc---ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 776543 455667788999999998 6799999999999999999999999999999999999999999998877666
Q ss_pred CCCCCCCcCCCc----------------------chhhhhhhhhc--CCCCC-------ChHHHHHHhcccCCCCCCCHH
Q 014960 348 SKLPHATIFKPQ----------------------QSYKRCIAETF--KDFPP-------SSLPLIETLLAIDPAERQTAT 396 (415)
Q Consensus 348 ~~~~~~~~~~~~----------------------~~~~~~~~~~~--~~~~~-------~~~~li~~~L~~dP~~R~t~~ 396 (415)
..+.+..+...- .+...+.++.. +.+++ .+.+|+.+||..||++|+|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 555433221111 11111111111 12343 378999999999999999999
Q ss_pred HHhcCCCCCC
Q 014960 397 AALRSEVSLY 406 (415)
Q Consensus 397 ~~L~h~~f~~ 406 (415)
|+|.||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999863
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.66 Aligned_cols=203 Identities=30% Similarity=0.461 Sum_probs=175.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~ 193 (415)
..|...+.||+|+||.||+++++.+|+.||||.++... .....+..-+|+++|++|+|+|||++.++-++.. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 45777789999999999999999999999999998754 3344567788999999999999999988766544 455
Q ss_pred EEEEEEecccChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC--CC--cEEEEeeccc
Q 014960 194 LYLVFKYMEHDLAGLAASP---TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EG--ILTIADFGLA 266 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~--~vkl~DfG~a 266 (415)
-.+|||||.++.+...+.. ...++|.+.+.++.+++.||.|||++||+||||||.||++.. +| .-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 7899999998776665543 346999999999999999999999999999999999999853 34 4799999999
Q ss_pred cccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC
Q 014960 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG 323 (415)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~ 323 (415)
+..+.+. ...+.+||+.|++||++-....|+..+|.|||||++|+++||..||..
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9887654 678899999999999987557899999999999999999999999864
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=293.04 Aligned_cols=249 Identities=18% Similarity=0.254 Sum_probs=187.8
Q ss_pred eeccCCceEEEEEEECCC--CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 125 KIGQGTYSNVYKARDTLT--GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
.||+|+||.||++....+ ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.. ....|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 599999999999975333 2356677766543 23445678899999999999999999999887 456899999999
Q ss_pred cChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC-CCCc
Q 014960 203 HDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-KQPM 277 (415)
Q Consensus 203 ~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~-~~~~ 277 (415)
++.+..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 8665544432 2346777888999999999999999999999999999999999999999999986432211 1112
Q ss_pred ccccccCccCCcccccC------CcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 278 TSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~------~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
....++..|+|||++.. ...++.++|||||||++|||++ |.+||...+..+.+..+.+...... +
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~----- 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL---F----- 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc---C-----
Confidence 34567889999998743 1235788999999999999997 6788988777776666544211100 0
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......+++.+.+++..|| .+|++||+++++++
T Consensus 231 ---------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 231 ---------------KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ---------------CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00011236677889999999 78999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.81 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=216.4
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee---cC
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS---RM 190 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~---~~ 190 (415)
...+.|++.+.||.|.+|.||+++++.+++..|+|++..+. +..+.++.|..||+.+ .|||++.++|+|.- ..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 44678999999999999999999999999999999987653 3334566789999987 69999999998843 23
Q ss_pred CCeEEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
+..+|||||||+++...++... +..+.|..++.|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.+..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 4679999999999877666543 55789999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
.+... ....+.+|||.|||||++.- ...|+..+|+||||++..||.-|.||+...-. +..++....+|+..
T Consensus 173 ldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---mraLF~IpRNPPPk- 247 (953)
T KOG0587|consen 173 LDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRNPPPK- 247 (953)
T ss_pred eeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---hhhhccCCCCCCcc-
Confidence 76543 34567799999999999843 24577899999999999999999999976444 33334444444322
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
...+...++++.++|..||.+|..+||+..++|+|||.+.
T Consensus 248 ----------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 ----------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ----------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1122456778899999999999999999999999999873
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=287.99 Aligned_cols=262 Identities=22% Similarity=0.338 Sum_probs=205.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh-CCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR-LDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++.+-+..||.|+||+|++..++.+|+..|+|.|+..... ..+.++..|.+...+ -+.||||+++|.... ++..||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWi 140 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWI 140 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceee
Confidence 4455567899999999999999999999999999987653 445566677776554 479999999998766 456899
Q ss_pred EEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 197 VFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 197 v~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
.||+|.-++..++. -....++|..+-.|..-+++||+||.. ..|||||+||+|||++..|.|||||||.+..+..
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99999987655433 234578999999999999999999985 5899999999999999999999999999976543
Q ss_pred CCCCCcccccccCccCCcccccCCc-CCCchhcHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~sDvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.. ..+..+|-..|||||.+.... +|+.+|||||||++|||+.||..|+.+- +..+++.++.. +.|+.-.
T Consensus 221 Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~----- 291 (361)
T KOG1006|consen 221 SI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILL----- 291 (361)
T ss_pred HH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeec-----
Confidence 22 223346677799999995433 5999999999999999999999999763 33344443332 3332111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....-+++..+..+|..||.+|-++||...+++.++|++.-
T Consensus 292 ----------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 292 ----------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ----------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 112224578889999999999999999999999999998653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=300.46 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=209.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+...+.++||+|.||.|.+|. ...+..||+|.++.+. ..+..+.|.+||++|.+|+|||||.++|+|.. +..+++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEE-ecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHH
Confidence 3567788999999999999997 3456899999998654 34556789999999999999999999999987 456999
Q ss_pred EEEecccChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
++||++.+.+..++... ....-.....|+.||+.||+||.+.++|||||.+.|||++.++++||+|||+++.+-.+..
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999988777766554 1234455567999999999999999999999999999999999999999999986544433
Q ss_pred C-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 275 Q-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL--AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. .-...+-...|||+|.+.. ..++.+||||+||++|||++ |...||...+++++.++........+...
T Consensus 693 y~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~------- 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV------- 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce-------
Confidence 2 2233455788999999875 67999999999999999974 68899998888877776655544333221
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+.+|..+.+||.+||..|-++||+.+++-.
T Consensus 765 --------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 --------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 22233567888999999999999999999999854
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=298.16 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=212.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-----ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-----EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|-++..||+|||+.||+|+|....+.||+|+-..+.. ..+..+...+|..|.+.|+||.||++|++|.-. .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence 4789999999999999999999999999999998654322 223344566899999999999999999999764 4
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeeccCCCCCEEEcC---CCcEEEEeeccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ--HVLHRDIKGSNLLIDN---EGILTIADFGLA 266 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NILl~~---~~~vkl~DfG~a 266 (415)
..++-|+|||+|..+..++....-++|.+++.|+.||+.||.||.+. .|||-||||.|||+.. .|.+||.|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 56899999999998888888888999999999999999999999975 5999999999999954 478999999999
Q ss_pred cccCCCCCC------CcccccccCccCCcccccC---CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHH--HH
Q 014960 267 SFFDPNHKQ------PMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHK--IF 334 (415)
Q Consensus 267 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~--i~ 334 (415)
+..+.+... ..+...||.||++||.+.- ....+.++||||+|||+|..|.|+.||.....+ ++++. |+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 988654332 2234578999999998842 345788999999999999999999999765432 22221 11
Q ss_pred HhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
+.. ... |. .-+.++.+.+++|++||++.-++|....++-.||||..
T Consensus 701 kAt----EVq-----------FP-----------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 701 KAT----EVQ-----------FP-----------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cce----ecc-----------CC-----------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 110 000 00 01357788999999999999999999999999999975
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.36 Aligned_cols=248 Identities=22% Similarity=0.357 Sum_probs=202.7
Q ss_pred CceeeeeeccCCceEEEEEEECC--CC--ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTL--TG--QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~--~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
...+.++||.|.||.||+|.... .| -.||||..+.+. ..+..+.|..|+.+|+.++||||++++|++.+ ...
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cce
Confidence 34445779999999999997432 23 358999988764 44557788899999999999999999999986 359
Q ss_pred EEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|||||++.-+.+..+++ ....++.....-|+.||+.+|.|||+.++|||||...||||....-|||+|||+++.++...
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999776666554 45578999999999999999999999999999999999999999999999999999887654
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.-..+...-...|||||.+.- ..++.+||||.|||+|||++. |..||.+-.+.+++-.|.+.-.-|
T Consensus 546 yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------------ 612 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------------ 612 (974)
T ss_pred hhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------------
Confidence 333332233677999998864 679999999999999999986 999999977777666554432221
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHh
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L 399 (415)
..+..|+.+..|+.+||++||.+||...++.
T Consensus 613 ----------------~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 613 ----------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ----------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 2346888999999999999999999987764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.72 Aligned_cols=274 Identities=23% Similarity=0.280 Sum_probs=187.6
Q ss_pred CCCceeeeeeccCCceEEEEEEEC----------------CCCceEEEEEEecCCCCh------------HHHHHHHHHH
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT----------------LTGQIVALKKVRFDNLEP------------ESVRFMAREI 168 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~ 168 (415)
.++|.+.++||+|+||.||+|... ..++.||||.+....... ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 578999999999999999999642 345679999986542110 0112233477
Q ss_pred HHHHhCCCCce-----eeeeeeEeec------CCCeEEEEEEecccChhhhhcCC------------------------C
Q 014960 169 LILRRLDHPNV-----VKLEGLVTSR------MSCSLYLVFKYMEHDLAGLAASP------------------------T 213 (415)
Q Consensus 169 ~~l~~l~h~~i-----v~l~~~~~~~------~~~~~~lv~e~~~~~l~~~~~~~------------------------~ 213 (415)
.++.+++|.++ ++++++|... .....++||||+.++.+..++.. .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766654 6677776532 12458999999998665544321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCccccc
Q 014960 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293 (415)
Q Consensus 214 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 293 (415)
..+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++...............+|+.|+|||++.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 13456788999999999999999999999999999999999999999999999765433222122234488999999875
Q ss_pred CCcC-------------------CC--chhcHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 294 GATD-------------------YG--VGVDLWSAGCILAELLAEKP-IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 294 ~~~~-------------------~~--~~sDvwSlG~il~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.... |+ ...||||+||++|+|++|.. ||.+...... ..+.. ......|......
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~-~~~~~~~r~~~~~ 459 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQY-DNDLNRWRMYKGQ 459 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhc-cchHHHHHhhccc
Confidence 3210 11 24799999999999999875 6654321111 11111 1111223221110
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCC---CCCCCHHHHhcCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP---AERQTATAALRSEVSLY 406 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~R~t~~~~L~h~~f~~ 406 (415)
.. .-......++..+|||.+||..+| .+|+|++|+|+||||..
T Consensus 460 ~~------------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KY------------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CC------------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 001234567889999999999876 68999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=309.64 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=218.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
....+.+.||.|.||.|++|+.+..| ..||||.++... ...+...|..|+.||-+++||||++|.|++.. ...+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--SKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--Ccee
Confidence 45677889999999999999977666 469999997543 45566788899999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.||+|||+.+.++.++ ...+.|+.-+...+++.|+.|+.||-+.++|||||.+.||||+.+..+||+|||+++.++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999987665544 556789999999999999999999999999999999999999999999999999999887665
Q ss_pred CCCcccccc--cCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 274 KQPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 274 ~~~~~~~~g--t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
...+++.-| ...|.|||.+.- ..++.+|||||+||+|||.++ |..|||.-++++++..|.+...-|+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-------- 856 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-------- 856 (996)
T ss_pred CccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--------
Confidence 444555444 577999999874 679999999999999999886 99999999999999999887655532
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.+.|..+.+|+..||++|-.+||++.|++.+
T Consensus 857 --------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 --------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 4788899999999999999999999998753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=275.60 Aligned_cols=243 Identities=37% Similarity=0.568 Sum_probs=197.5
Q ss_pred CceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccChhhhh
Q 014960 130 TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA 209 (415)
Q Consensus 130 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~ 209 (415)
+||.||+|.+..+++.+|+|++........ ...+.+|++.+++++|+||+++++++.. ....++++|+++++.+..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999988899999999876543221 5788899999999999999999999877 4679999999999555555
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCc
Q 014960 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289 (415)
Q Consensus 210 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aP 289 (415)
......+++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 5444448999999999999999999999999999999999999999999999999998765432 23445678899999
Q ss_pred ccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhh
Q 014960 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAE 368 (415)
Q Consensus 290 E~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (415)
|.+.+ ..++.++||||||+++++|++|..||... +.......+.+...... .
T Consensus 156 E~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~ 208 (244)
T smart00220 156 EVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP--------------------------P 208 (244)
T ss_pred HHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--------------------------c
Confidence 98875 56788999999999999999999999873 33333333322111110 0
Q ss_pred hcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 369 TFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 369 ~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
....++.++.+++.+||..||++||++.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 011267789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=294.07 Aligned_cols=244 Identities=22% Similarity=0.362 Sum_probs=203.6
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
+..+..+||.|.||.||.+.++.-...||+|.++-+ .-.++.|..|+.+|+.++|||+|+|+|+|.. ...+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEE
Confidence 455668899999999999999988899999998744 3345678889999999999999999999988 45699999
Q ss_pred EecccC-hhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 199 KYMEHD-LAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 199 e~~~~~-l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||..+ ++.++... +..++.-....++.||..|++||..+++|||||...|+||.++..|||+|||++++...+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--- 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--- 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc---
Confidence 999865 55544433 3456777788899999999999999999999999999999999999999999999886543
Q ss_pred cccccc---cCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 277 MTSRVV---TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 277 ~~~~~g---t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
++...| ...|.|||-+.- ..++.++|||+|||+|||+.| |..||.|.+-.+++..+.+...
T Consensus 420 YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR-------------- 484 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR-------------- 484 (1157)
T ss_pred eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc--------------
Confidence 344444 667999998764 678999999999999999987 9999999887777776655431
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHh
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L 399 (415)
.+.....|+.+++|++.||++.|.+||+++++-
T Consensus 485 --------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 485 --------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred --------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 122346889999999999999999999998763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=298.45 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=208.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-Cc--eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-GQ--IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++.+++++||+|.||.|++|.+... |+ .||||+++.+.... ...+|.+|+.+|.+|+|+|+++|||++.++ .
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q---p 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---P 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc---h
Confidence 35677889999999999999976543 33 58999998665433 678899999999999999999999999863 4
Q ss_pred EEEEEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 194 LYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..||||++..+.+...+. ....|.......|+.||+.||.||.++++|||||-..||||.....|||+|||+.+-+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 889999999765554443 455788899999999999999999999999999999999999999999999999988765
Q ss_pred CCCCC-ccc-ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 272 NHKQP-MTS-RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 272 ~~~~~-~~~-~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
+.... +.. .-....|+|||.+.. ..++.+||||++||+||||.+ |..||.|.....++++|-+.-
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e----------- 332 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE----------- 332 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-----------
Confidence 43211 111 223566999999875 779999999999999999998 889999999999888874211
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~ 403 (415)
.....+..+++++++++.||+.+|.+|||+..+...-+
T Consensus 333 -----------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 333 -----------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -----------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 12234578899999999999999999999988754433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=249.21 Aligned_cols=215 Identities=24% Similarity=0.397 Sum_probs=179.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++...+..||+|+||.|-+.++..+|...|+|.++..- ....++++.+|+.+..+. .+|.+|.++|.... ...++
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvw 121 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVW 121 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEE
Confidence 455666788999999999999999999999999998653 345556777888887765 79999999997766 45699
Q ss_pred EEEEecccChhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 196 LVFKYMEHDLAG---LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 196 lv~e~~~~~l~~---~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
|.||.|.-++.. ..+..+..++|..+-.|+..+..||+|||++ .++|||+||+||||+.+|+||+||||.+-.+..
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999999986544 3456777899999999999999999999976 799999999999999999999999999977653
Q ss_pred CCCCCcccccccCccCCcccccC---CcCCCchhcHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHh
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKL 336 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~sDvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~ 336 (415)
.-. .+-..|-..|||||.+.. ...|+.+|||||||+.++||.+++.||.. .++.+++.++++.
T Consensus 202 SiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 321 122456677999998843 34799999999999999999999999975 7888888888764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.79 Aligned_cols=261 Identities=27% Similarity=0.395 Sum_probs=221.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|+++.++|+|.||.||+++|+.+++..|+|+++.+. .+...-+++|+-+++.++|+|||.++|-+... ..+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhh--cCcEE
Confidence 368999999999999999999999999999999999765 44566788899999999999999999988763 45999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
.||||+++.+.......+.++|.++..+.++.+.||+|||++|=+|||||-.|||+++.|.+|++|||.+..+...- ..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 99999999999888888899999999999999999999999999999999999999999999999999987765322 33
Q ss_pred cccccccCccCCcccc--cCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 277 MTSRVVTLWYRPPELL--LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~--~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
..+..||++|||||+- .....|+..+|||++|+...|+---.+|....-....+..+-+....|+..
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l----------- 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL----------- 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-----------
Confidence 4667899999999986 223579999999999999999988888876666666666555544433311
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
+.-...++.+-+|++.+|.++|++|||++.+|.|||...
T Consensus 238 -------------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 238 -------------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -------------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 111234566788999999999999999999999999753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=298.26 Aligned_cols=247 Identities=25% Similarity=0.354 Sum_probs=188.9
Q ss_pred eeeeeeccCCce-EEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEEEE
Q 014960 121 EKLDKIGQGTYS-NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 121 ~~~~~lG~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.-.+.+|.|+-| .||+|. ..|+.||||.+- .+...+.++||..|+.- +|||||++++. +.+...+||..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~--E~d~qF~YIal 582 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGV--YEGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCS--EQDRQFLYIAL 582 (903)
T ss_pred ccHHHcccCCCCcEEEEEe--eCCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEee--ccCCceEEEEe
Confidence 334678999886 689995 678899999875 44556788999999988 59999999654 44478899999
Q ss_pred EecccChhhhhcCCCCC--CCH-HHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---CC--cEEEEeeccccccC
Q 014960 199 KYMEHDLAGLAASPTIK--FTQ-AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EG--ILTIADFGLASFFD 270 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~--~~~-~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~--~vkl~DfG~a~~~~ 270 (415)
|.|...+...+...... ... ...+.++.|++.||++||+.+||||||||.||||.. ++ .++|+|||+++.+.
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999888877663111 111 445788999999999999999999999999999976 34 69999999999987
Q ss_pred CCCCCC--cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 271 PNHKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 271 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
.+.... .....||-+|+|||++... .-+.++||+||||++|+.++| ..||...- +...+|++.. ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~--~~------ 731 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGN--YT------ 731 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCc--cc------
Confidence 654322 3456789999999999863 456799999999999999985 89996533 2233333321 10
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
+......-..++.|||.+||++||..||+|.++|.||||=
T Consensus 732 ------------------L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 732 ------------------LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ------------------eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 0000011111789999999999999999999999999984
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=275.04 Aligned_cols=285 Identities=30% Similarity=0.469 Sum_probs=210.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 192 (415)
...|.+.++||.|.|++||++.+.. ..+.||+|.+.... ...++.+|+++|..+ .+.||+++.+++.. ..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd 108 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN--ND 108 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc--CC
Confidence 4578999999999999999999877 78899999987543 234688899999999 59999999999887 55
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~ 271 (415)
.+.+||||+++.....+.. .++..++..|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|...+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 6999999999976666554 4678999999999999999999999999999999999976 56789999999972210
Q ss_pred C-------------------------------------------CCCCcccccccCccCCcccccCCcCCCchhcHHHHH
Q 014960 272 N-------------------------------------------HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAG 308 (415)
Q Consensus 272 ~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG 308 (415)
. .........||++|.|||++.....-++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 000112357899999999999877888999999999
Q ss_pred HHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCC----------HHHHhhCCCCCC---C-cCCCc--chhh-----hhh
Q 014960 309 CILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPS----------EEYWKKSKLPHA---T-IFKPQ--QSYK-----RCI 366 (415)
Q Consensus 309 ~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~----------~~~~~~~~~~~~---~-~~~~~--~~~~-----~~~ 366 (415)
||++-++++..||.. .++.+.+..|....|.-. ...|.....+.. . .+... .... +..
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999988765 444444444443332211 012321111000 0 00000 0000 011
Q ss_pred hhhc-CCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 367 AETF-KDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 367 ~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.+.. .-++..+.+|+.+||..||.+|+|++++|.||||....+.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~ 390 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT 390 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence 1222 2234578999999999999999999999999999976543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.85 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=184.3
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.|...+.||+|+||.||+|++..++..||+|.+..... ....|++++++++|||||++++++.+ ....|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 45566789999999999999989999999998864321 11246889999999999999999987 45689999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH---NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||+.++.+..++. .+++..+..|+.||+.||+||| +.+|+||||||+||+++.++..++. ||.+......
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999887776664 4789999999999999999999 6799999999999999999888875 6665443221
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcC-CCCHHHHhhCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCG-SPSEEYWKKSKLPHA 353 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~-~~~~~~~~~~~~~~~ 353 (415)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......+... ......|.....
T Consensus 836 --~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 909 (968)
T PLN00113 836 --TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI--- 909 (968)
T ss_pred --CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc---
Confidence 23367899999999875 67999999999999999999999998542211 11111111110 000111100000
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.... ........++.+++.+||+.||++|||+.|+++.
T Consensus 910 ---~~~~-------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 ---RGDV-------SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ---cCCC-------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000 0000111246789999999999999999999865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=279.46 Aligned_cols=203 Identities=25% Similarity=0.401 Sum_probs=178.6
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHH------HHHHHHHHHHHHhCC---CCceeeeeeeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES------VRFMAREILILRRLD---HPNVVKLEGLV 186 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~---h~~iv~l~~~~ 186 (415)
+..+|..++.+|.|+||.|++|.++.+...|+||.|.+++...+. .-.+-.||+||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 456799999999999999999999999999999999887642221 223556999999997 99999999999
Q ss_pred eecCCCeEEEEEEecccC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecc
Q 014960 187 TSRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL 265 (415)
Q Consensus 187 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~ 265 (415)
++ +.++||+||-.+.+ .++.++.....++|.++..|++|++.|+++||+.||||||||-||+.|+.+|-+||+|||.
T Consensus 639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 ED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 98 67899999987653 4566677777899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC
Q 014960 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG 323 (415)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~ 323 (415)
|..... .++...+||..|.|||++.|..+.+...|||+||++||.++...-||.+
T Consensus 717 aa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 988765 3467789999999999999988889999999999999999998888754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=267.58 Aligned_cols=249 Identities=25% Similarity=0.335 Sum_probs=190.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC--CCCceeeeeeeEeecC--CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL--DHPNVVKLEGLVTSRM--SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~--~~ 192 (415)
....++++.||+|.||.||+| ..+++.||||++. ....+.++.|-.|.+.. +|+||+++++.-.... ..
T Consensus 209 l~pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehh--hccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 456778899999999999999 4677999999986 45567788888888864 7999999988754321 23
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN---------QHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---------~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
.++||++|.+.+.+..++..+ .+++.+...++..++.||+|||+ ..|+|||||..||||..|+++.|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 699999999988887777665 78999999999999999999995 36999999999999999999999999
Q ss_pred ccccccCCCCC-CCcccccccCccCCcccccCCcCCC-----chhcHHHHHHHHHHHHhCCCCCC-C-------------
Q 014960 264 GLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYG-----VGVDLWSAGCILAELLAEKPIMP-G------------- 323 (415)
Q Consensus 264 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~-----~~sDvwSlG~il~ell~g~~pf~-~------------- 323 (415)
|+|..+.++.. ......+||..|||||++.+...+. .+.||||+|.+||||++.-..+. +
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99998876543 2233479999999999997755444 46899999999999997543332 1
Q ss_pred ---CChHHHHHHHHHhcCCCC-HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH
Q 014960 324 ---RTEVEQLHKIFKLCGSPS-EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396 (415)
Q Consensus 324 ---~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 396 (415)
.+-.+....+++....|. ...|.. . .....+++.+..||..||+-|+|+.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~---------------------h--~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRK---------------------H--AGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhc---------------------C--ccHHHHHHHHHHHcCCchhhhhhhH
Confidence 112222233333333321 112211 0 1234578999999999999999984
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=285.61 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=197.1
Q ss_pred CceeeeeeccCCceEEEEEEEC----C---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDT----L---TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
...+.+.||+|.||.|++|.-. . ....||+|.++..... ...+.+..|+++|+.+ .|+||+.++|++..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 3466679999999999999632 1 1457999988765444 6778899999999999 59999999999987
Q ss_pred CCeEEEEEEecccChhhhhcCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTI----------------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 254 (415)
.+.+++|+||+.++.+..++.... .++......++.||+.|++||++.++|||||-+.||||..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 567999999999865554443322 4889999999999999999999999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCCCccccc--ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCC-hHHHH
Q 014960 255 EGILTIADFGLASFFDPNHKQPMTSRV--VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT-EVEQL 330 (415)
Q Consensus 255 ~~~vkl~DfG~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~-~~~~~ 330 (415)
+..+||+|||+|+.............. -...|||||.+.. ..|+.++||||+||+||||.+ |..||.+-. ..+..
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 999999999999865433222112122 2345999999986 789999999999999999998 889998744 44444
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+.+.+.. ..+.....++++.++++.||+.+|++||+..++..
T Consensus 533 ~~l~~G~----------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGN----------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4332211 11223456888999999999999999999988763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-31 Score=234.81 Aligned_cols=213 Identities=36% Similarity=0.593 Sum_probs=179.5
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccCh
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDL 205 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l 205 (415)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++|+++++++.. ....++++|++.+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999988889999999988654321 35678899999999999999999999887 367999999999655
Q ss_pred hhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEeeccccccCCCCCCCccccccc
Q 014960 206 AGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQPMTSRVVT 283 (415)
Q Consensus 206 ~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~~~~~~~~~~~gt 283 (415)
+..+.... ..+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 55554433 46899999999999999999999999999999999999999 89999999999987654321 12334568
Q ss_pred CccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhh
Q 014960 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYK 363 (415)
Q Consensus 284 ~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (415)
..|++||.+.....++.+.|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999887533788999999999999999
Q ss_pred hhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCC
Q 014960 364 RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (415)
Q Consensus 364 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~ 402 (415)
..+.+++..|++.||++||++.++++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2245689999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=271.52 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=201.9
Q ss_pred CceeeeeeccCCceEEEEEEECCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..+..++||+|+||+||+|.+-..|+ +||||++..... ......+.+|+.+|.+|+|+|+++|++++... .+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hH
Confidence 34556789999999999998765554 689998865433 34455677899999999999999999999863 38
Q ss_pred EEEEEecccC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.||++|++.+ |+..+...+..+-.+....|..||++||.|||++++|||||-..||||..-..+||.|||+++...++.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 8999999976 445555566688899999999999999999999999999999999999999999999999999887765
Q ss_pred CCCcccc-cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 274 KQPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 274 ~~~~~~~-~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.+..... ...+.|||-|.+.. ..|+.++|||||||.+||++| |..|+.+....++-..+.+...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------------- 918 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------------- 918 (1177)
T ss_pred ccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-------------
Confidence 5432221 22667999998875 679999999999999999998 9999999888777665543211
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHh
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L 399 (415)
....+..+-+++.++.+||..|+..||+++++.
T Consensus 919 ---------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 919 ---------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred ---------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 011234677899999999999999999998875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=250.49 Aligned_cols=251 Identities=26% Similarity=0.320 Sum_probs=184.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--CCCCceeeeeeeEeec--CCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR--LDHPNVVKLEGLVTSR--MSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~--~~~ 192 (415)
.++..+.+.||+|-||.||+|. ..|+.||||++.... ...+.+|.+|.+. |+|+||+.+++.-... .-.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecc--ccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4678999999999999999995 568999999987432 2345567777764 6999999998764321 224
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------QHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
.+|||++|.+.+.+.+++... .++-+....++..++.||+|||. ..|.|||||..||||..++.+-|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 699999999999888888874 78999999999999999999994 359999999999999999999999999
Q ss_pred cccccCCCCC---CCcccccccCccCCcccccCCcCC-----CchhcHHHHHHHHHHHHhC----------CCCCCCC--
Q 014960 265 LASFFDPNHK---QPMTSRVVTLWYRPPELLLGATDY-----GVGVDLWSAGCILAELLAE----------KPIMPGR-- 324 (415)
Q Consensus 265 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-----~~~sDvwSlG~il~ell~g----------~~pf~~~-- 324 (415)
+|........ ...+..+||..|||||++...... -..+||||||.++||++.. ++||.+-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9988765432 344668999999999998542221 1358999999999999742 3666542
Q ss_pred --ChHHHHHHHHH--hcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHH
Q 014960 325 --TEVEQLHKIFK--LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398 (415)
Q Consensus 325 --~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 398 (415)
...+.+.+++= .+....+..|... ..-..+..||+.||..||.-|.|+-.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~-----------------------~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSD-----------------------PALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccC-----------------------HHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 12222222210 0011111112110 000124568999999999999998655
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=237.02 Aligned_cols=213 Identities=35% Similarity=0.540 Sum_probs=176.5
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
|.+.+.||+|++|.||++.+..+++.+|+|.+...... ...+.+.+|++.++.++|+|++++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 56778999999999999999888999999998865432 256788899999999999999999998876 456999999
Q ss_pred ecccChhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 200 YMEHDLAGLAASPTIK-FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
++.+..+..+...... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||.+............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999555555544434 899999999999999999999999999999999999999999999999999877543211224
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHHHH
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEV-EQLHKIFK 335 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~-~~~~-~~~~~i~~ 335 (415)
...++..|++||.+.+...++.++|+|+||+++++|++|++||.. .++. ++.+.+..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 456788899999883346678899999999999999999999977 4444 55555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=286.85 Aligned_cols=203 Identities=16% Similarity=0.167 Sum_probs=143.7
Q ss_pred CCC-CceeeeeeeEeec-----CCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014960 174 LDH-PNVVKLEGLVTSR-----MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (415)
Q Consensus 174 l~h-~~iv~l~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 247 (415)
+.| .||+++++.|... ....++++||++++++...+......+++.+++.|+.||+.||+|||++||+||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 344 5777777766221 1235788899998887777655566799999999999999999999999999999999
Q ss_pred CCEEEcCCCc-------------------EEEEeeccccccCCCCC---------------CCcccccccCccCCccccc
Q 014960 248 SNLLIDNEGI-------------------LTIADFGLASFFDPNHK---------------QPMTSRVVTLWYRPPELLL 293 (415)
Q Consensus 248 ~NILl~~~~~-------------------vkl~DfG~a~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~ 293 (415)
+||||+..+. +||+|||+++....... ......+||++|+|||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999965444 55555555543211000 0011245799999999988
Q ss_pred CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCC
Q 014960 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373 (415)
Q Consensus 294 ~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (415)
+ ..|+.++|||||||+||||++|.+|+.... ..+..+.... .++ .. ..-
T Consensus 189 ~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~~--------------------------~~~ 237 (793)
T PLN00181 189 G-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-QI--------------------------LLN 237 (793)
T ss_pred c-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-hh--------------------------hhc
Confidence 6 568999999999999999999998875321 1222221111 000 00 001
Q ss_pred CCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 374 PPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 374 ~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....+++..||..||.+||++.++|+||||...
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 2234678999999999999999999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=233.71 Aligned_cols=244 Identities=21% Similarity=0.282 Sum_probs=183.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeee-EeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGL-VTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~-~~~~~~~~~ 194 (415)
.+.|.+.+.||+|-||.+.+|+++.++..+++|.+... ......|.+|..---.| .|.||+.-|++ |+. .+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt--~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT--SDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc--CceE
Confidence 47899999999999999999999999999999998754 34566788887665555 59999998876 444 4578
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-C-CcEEEEeeccccccCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-E-GILTIADFGLASFFDPN 272 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~-~~vkl~DfG~a~~~~~~ 272 (415)
++++||++.+.+..-.... .+-|.....++.|++.|++|||++++||||||.+||||-. | ..|||||||..+..+..
T Consensus 98 vF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999987776655553 5788889999999999999999999999999999999944 3 37999999998765421
Q ss_pred CCCCcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhh
Q 014960 273 HKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 347 (415)
.....-+-.|.+||+... .-...+.+|+|.||+|+|.+|+|.+||......+ -+...+ .|-+
T Consensus 177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~---------~w~~ 243 (378)
T KOG1345|consen 177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE---------QWLK 243 (378)
T ss_pred ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH---------HHhc
Confidence 122223566999997642 2234577999999999999999999997322111 011111 1211
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCC
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 392 (415)
... ..+...++.+++.+..+.++-|..++++|
T Consensus 244 rk~-------------~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 244 RKN-------------PALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ccC-------------ccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 110 01334456678888889999999999999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=227.70 Aligned_cols=252 Identities=20% Similarity=0.245 Sum_probs=200.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCC-----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTG-----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++++...+-+|.||.||.|.+++.. +.|-+|.++.. ..+-+...+..|.-.+..+.|+|+..+.++.... ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cC
Confidence 56888889999999999999654332 34556766533 3455667788888888889999999999987664 45
Q ss_pred eEEEEEEecccChhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 193 SLYLVFKYMEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
..++.+.+++-+.+..++. ....++..+...++.|++.|++|||+.||||.||...|++|++.-+|||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 6778888888765555443 12246778888999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccc-ccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 265 LASFFDPNHKQPMTSRV-VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 265 ~a~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
+++.+=+.+....+... -...||+||.+.. ..|+.++||||||++||||+| |+.|+...++.|....+.....
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR---- 516 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR---- 516 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce----
Confidence 99876555443333322 2566999999875 789999999999999999998 9999999998888777655321
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....-+.|+++..++.-||+.+|++||+.+|+..
T Consensus 517 ------------------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 ------------------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ------------------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1112367899999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=258.72 Aligned_cols=264 Identities=24% Similarity=0.302 Sum_probs=198.5
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEec----CCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRF----DNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
....+|.|++|.|+.+......+.++.|.++. ..........+..|..+-..+.|+|++..+..+.+... .+-+
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--~~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--ILQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--chhh
Confidence 45779999999999888777777677776542 22222222236677778888899999887776655322 3344
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC---
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--- 274 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~--- 274 (415)
||||.+ .+..+......+...++..+++||+.||.|||+.||.|||||++|+++..+|.+||+|||.+..+.....
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 999999 5555555556889999999999999999999999999999999999999999999999999988765544
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLH-KIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......+|+..|+|||++.+.....+..||||.|++++.|++|+.||......+... .... . .+.
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-~-------------~~~ 544 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-S-------------DQR 544 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-c-------------ccc
Confidence 334567889999999999875555567999999999999999999997643332221 0000 0 000
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.++.. .......++...+.+|.+||+.||.+|.|++++++.+||+.+..
T Consensus 545 ~~~~~-------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 545 NIFEG-------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ccccC-------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 00000 12223457778889999999999999999999999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=214.66 Aligned_cols=164 Identities=21% Similarity=0.276 Sum_probs=124.7
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccC
Q 014960 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284 (415)
Q Consensus 205 l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~ 284 (415)
+...+......+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||+
T Consensus 3 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~~ 68 (176)
T smart00750 3 LADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVDP 68 (176)
T ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCcc
Confidence 33344334557999999999999999999999998 999999999999999 9999876432 226789
Q ss_pred ccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhh
Q 014960 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYK 363 (415)
Q Consensus 285 ~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (415)
.|+|||++.+ ..++.++|||||||++|||++|.+||...... ..+..+..........
T Consensus 69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------- 127 (176)
T smart00750 69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR-------------------- 127 (176)
T ss_pred cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc--------------------
Confidence 9999999986 67899999999999999999999999765432 2333333221111000
Q ss_pred hhhhhhcCCCCC--ChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 364 RCIAETFKDFPP--SSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 364 ~~~~~~~~~~~~--~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
.......++. +++++|.+||..||.+||++.+++.|+|+.
T Consensus 128 --~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 --DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred --ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0000112233 689999999999999999999999999865
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-27 Score=223.30 Aligned_cols=205 Identities=25% Similarity=0.279 Sum_probs=167.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCC-ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC----CceeeeeeeEeecCCCe
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNLEPESVRFMAREILILRRLDH----PNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~l~~~~~~~~~~~ 193 (415)
.|.+.++||+|+||.||.|.+..++ ..+|+|........... .+..|+.++..+.. .+++.+++... ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999987764 67899987754322211 56778999998863 68888888874 22568
Q ss_pred EEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-----CcEEEEeecccc
Q 014960 194 LYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-----GILTIADFGLAS 267 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-----~~vkl~DfG~a~ 267 (415)
.|+||+.++.++..+.... ...|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|+|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999999988877443 4789999999999999999999999999999999999999765 369999999998
Q ss_pred --ccCCCCC----CC---cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH
Q 014960 268 --FFDPNHK----QP---MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV 327 (415)
Q Consensus 268 --~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~ 327 (415)
.+..... .. .....||..|.++..+.+ ...+++.|+||+++++.+|+.|..||.+....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 3321111 11 123459999999999987 67899999999999999999999999775543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=227.49 Aligned_cols=164 Identities=22% Similarity=0.232 Sum_probs=129.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECC-CCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceee-eeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVK-LEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~-l~~~~~~~~~ 191 (415)
.+.|.+.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+++|++++|+|++. ++++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 4679999999999999999998776 678889998753311 2334567999999999999999985 4432
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccC-CCCCEEEcCCCcEEEEeeccccccC
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI-KGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl-kp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
...|+||||+.++.+.... .. . ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~~-~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR-PH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHhC-cc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 2479999999987765321 11 1 1467899999999999999999999 9999999999999999999998775
Q ss_pred CCCCCC-------cccccccCccCCccccc
Q 014960 271 PNHKQP-------MTSRVVTLWYRPPELLL 293 (415)
Q Consensus 271 ~~~~~~-------~~~~~gt~~y~aPE~~~ 293 (415)
...... .....+++.|+|||.+.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 433211 13456788899999873
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-27 Score=202.58 Aligned_cols=215 Identities=23% Similarity=0.254 Sum_probs=175.7
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~ 194 (415)
..+.|.++++||+|+||.+|+|....+|..||||+-...... ..+..|..+.+.|+ -..|+.+..++.+ ..+-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e--~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTE--KDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccc--cccc
Confidence 357899999999999999999999999999999986654332 34557899999886 4678888777766 5678
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC---CcEEEEeeccccccCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASFFDP 271 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DfG~a~~~~~ 271 (415)
.+||++++.++..++......|+...+..++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||+|+.+..
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 9999999998888777777789999999999999999999999999999999999998643 4699999999988753
Q ss_pred CCC------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhc
Q 014960 272 NHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLC 337 (415)
Q Consensus 272 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~ 337 (415)
... ..-....||..|.+-..+.+ ..-+++.|+-|+|++|.....|..||.+... .+..++|.+..
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 321 11234578999999887776 5568899999999999999999999998543 34455555543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-25 Score=213.33 Aligned_cols=266 Identities=31% Similarity=0.462 Sum_probs=206.0
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChH-HHHHHHHHHHHHHhCCCC-ceeeeeeeEeecCCCeEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE-SVRFMAREILILRRLDHP-NVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~~~lv 197 (415)
|.+...||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 778899999999999999876 7889999887654332 577888999999999988 79999999855 4458999
Q ss_pred EEecccChhhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCC
Q 014960 198 FKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNH 273 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~ 273 (415)
++++.+..+........ .+.+..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999877765555443 789999999999999999999999999999999999999998 79999999998654433
Q ss_pred CC-----CcccccccCccCCcccccCC--cCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC-CH
Q 014960 274 KQ-----PMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSP-SE 342 (415)
Q Consensus 274 ~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~-~~ 342 (415)
.. ......|+..|++||.+.+. ..+....|+|++|++++++++|..||..... .............+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 21 23567889999999998763 4788999999999999999999999877664 23333332222211 00
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
..... . .. ......+.+++..++..+|..|.+..+...++|.......
T Consensus 237 ~~~~~--------------~---~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~ 284 (384)
T COG0515 237 SPLSP--------------S---NP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK 284 (384)
T ss_pred cccCc--------------c---cc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence 00000 0 00 1122467889999999999999999999988776654443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-28 Score=238.97 Aligned_cols=243 Identities=25% Similarity=0.361 Sum_probs=203.1
Q ss_pred eeccCCceEEEEEEE---CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEEEEEe
Q 014960 125 KIGQGTYSNVYKARD---TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
.+|+|+||.|++++. ...|..||+|+..+.............|..++..++ |+.+|++...++. ...+|+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhh
Confidence 379999999998852 456778999998765442222225566888999886 9999999988887 5569999999
Q ss_pred cccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccc
Q 014960 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280 (415)
Q Consensus 201 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~ 280 (415)
..++.+.........+.+.....+...++.+++++|+.+|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 999888888888878999999999999999999999999999999999999999999999999999876543322
Q ss_pred cccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcc
Q 014960 281 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ 360 (415)
Q Consensus 281 ~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (415)
+||..|||||++. ....++|+||+|+++++|++|..||.+ +++..|.+.....+.
T Consensus 154 cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~------------------ 208 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR------------------ 208 (612)
T ss_pred ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch------------------
Confidence 8999999999987 367899999999999999999999988 778888775433333
Q ss_pred hhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCC
Q 014960 361 SYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEVSLYMXXX 410 (415)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~L~h~~f~~~~~~ 410 (415)
.++..+.+++..|+..+|..|.-. .++++|+||..+.-.
T Consensus 209 -----------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 209 -----------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -----------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 345567789999999999999875 799999999887643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=208.15 Aligned_cols=211 Identities=21% Similarity=0.269 Sum_probs=176.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~l 196 (415)
-.|.++++||.|+||.++.|++..+++.||||.-... .....+..|....+.| ..++|+..+-|... +.+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhh
Confidence 3799999999999999999999999999999965432 2234567788888887 57899998755444 778899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-----cEEEEeeccccccCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-----ILTIADFGLASFFDP 271 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-----~vkl~DfG~a~~~~~ 271 (415)
|+|+++.+|..++.-.+..|+...++.++.|++.-++|+|++.+|+|||||+|+||..-+ .|.|+|||+|+.+..
T Consensus 102 VidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999999998888888888999999999999999999999999999999999999997544 499999999998743
Q ss_pred CCC------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHH
Q 014960 272 NHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG---RTEVEQLHKIFK 335 (415)
Q Consensus 272 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~---~~~~~~~~~i~~ 335 (415)
... ....+..||..||+=..++| ..-+++.|+-|||=+++..|.|..||.| .+..+..++|=.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred ccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 321 12245678999999999998 6679999999999999999999999998 455666666543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=228.54 Aligned_cols=226 Identities=29% Similarity=0.375 Sum_probs=171.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+|..++.|-.|+||.||.++++.+.+++|+| +.+.. .+.+- |+.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------LILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------hhhhc--cccccCCccee----------------
Confidence 468999999999999999999999999999995 44322 11111 22222233332
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-- 274 (415)
++....+ ..-+.++... +.+++|||+.||+|||+||+|.||+.-|.+|+.|||+++.......
T Consensus 136 ------gDc~tll-k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhc-ccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 2222222 2222343322 7899999999999999999999999999999999999865421110
Q ss_pred ------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 275 ------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 275 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
......+|||+|+|||++.. .+|+..+|||+||+|+||.+.|..||.+++.++.+.+++.....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~--- 276 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--- 276 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc---
Confidence 01123589999999999986 67999999999999999999999999999999999998875433
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT---ATAALRSEVSLYMXXX 410 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~L~h~~f~~~~~~ 410 (415)
|+ +....++.++.++|..+|..+|..|.- +.++.+|+||+.+...
T Consensus 277 --wp---------------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 277 --WP---------------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred --cc---------------------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 22 234568899999999999999999975 5778899999988765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-25 Score=192.63 Aligned_cols=142 Identities=21% Similarity=0.257 Sum_probs=110.0
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHH------------------------HHHHHHHHHHHHhCCCCc
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES------------------------VRFMAREILILRRLDHPN 178 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~~ 178 (415)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 367999999999999986 8999999999765321111 123345999999998877
Q ss_pred eeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeccCCCCCEEEcCCCc
Q 014960 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC-HNQHVLHRDIKGSNLLIDNEGI 257 (415)
Q Consensus 179 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~NILl~~~~~ 257 (415)
+.....+... . .+|||||++++.+.........+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~--~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK--S--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec--C--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7443322221 2 389999999865543323345789999999999999999999 799999999999999998 578
Q ss_pred EEEEeeccccccC
Q 014960 258 LTIADFGLASFFD 270 (415)
Q Consensus 258 vkl~DfG~a~~~~ 270 (415)
++|+|||+|...+
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=186.08 Aligned_cols=191 Identities=17% Similarity=0.133 Sum_probs=143.8
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC--hHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEEE
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~lv 197 (415)
.+...|++|+||+||.+. ..+..++.+.+...... .-....+.+|+++|++|. |++|++++++ ...|++
T Consensus 5 ~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 345789999999999885 36778887777655431 222336889999999995 5889999885 126999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccC-CCCCEEEcCCCcEEEEeeccccccCCCCCC-
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI-KGSNLLIDNEGILTIADFGLASFFDPNHKQ- 275 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl-kp~NILl~~~~~vkl~DfG~a~~~~~~~~~- 275 (415)
|||+.|..+...... ....++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|....+....
T Consensus 77 meyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999998776543211 12457889999999999999999999 799999999999999999999866543320
Q ss_pred ---Cc--------ccccccCccCCcccccCCcCCC-chhcHHHHHHHHHHHHhCCCCCCCCCh
Q 014960 276 ---PM--------TSRVVTLWYRPPELLLGATDYG-VGVDLWSAGCILAELLAEKPIMPGRTE 326 (415)
Q Consensus 276 ---~~--------~~~~gt~~y~aPE~~~~~~~~~-~~sDvwSlG~il~ell~g~~pf~~~~~ 326 (415)
.. .-...++.|++|+........+ .+.++++.|+-+|.++|+..++++.++
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 00 0122478899998754433334 678999999999999999988876553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=203.26 Aligned_cols=238 Identities=21% Similarity=0.296 Sum_probs=151.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCC----------CceeeeeeeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH----------PNVVKLEGLV 186 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h----------~~iv~l~~~~ 186 (415)
..+...+.||.|+++.||.++|..+|+.+|+|++..... .....+.+.+|......+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 467778899999999999999999999999999876543 23456677777655544322 1222222221
Q ss_pred ---------eecC-CC-----eEEEEEEecccChhhhhc---C-CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccC
Q 014960 187 ---------TSRM-SC-----SLYLVFKYMEHDLAGLAA---S-PT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI 245 (415)
Q Consensus 187 ---------~~~~-~~-----~~~lv~e~~~~~l~~~~~---~-~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 245 (415)
.... .. ..+++|+-+.+++..... . .. ..+.......+..|++..+++||..|+||+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1111 11 246788888777655422 1 11 11223333456689999999999999999999
Q ss_pred CCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccC-------CcCCCchhcHHHHHHHHHHHHhCC
Q 014960 246 KGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG-------ATDYGVGVDLWSAGCILAELLAEK 318 (415)
Q Consensus 246 kp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~sDvwSlG~il~ell~g~ 318 (415)
||+|+|++.+|.++|+||+.....+... .....+..|.+||.... ...++.+.|.|+||+++|.|+||.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999999887654321 11334577999997632 135788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCC
Q 014960 319 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392 (415)
Q Consensus 319 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 392 (415)
.||.......... | . + ..+.++|+.+++||..||+.||.+|
T Consensus 248 lPf~~~~~~~~~~-------------~---------------~----f-~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE-------------W---------------D----F-SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG-------------G---------------G----G-TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc-------------c---------------c----c-hhcCCcCHHHHHHHHHHccCCcccC
Confidence 9997543211100 0 1 1 1234789999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=185.58 Aligned_cols=142 Identities=21% Similarity=0.270 Sum_probs=112.1
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh------------------------HHHHHHHHHHHHHHhCCCCc
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP------------------------ESVRFMAREILILRRLDHPN 178 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~~ 178 (415)
.+.||+|++|.||+|++. +|+.||||+++...... .....+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999976 89999999998653210 01223467899999999998
Q ss_pred eeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCc
Q 014960 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGI 257 (415)
Q Consensus 179 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~ 257 (415)
+.....+... ..|+||||++++.+.........+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 8554444332 248999999986332222233467889999999999999999999 9999999999999999 899
Q ss_pred EEEEeeccccccC
Q 014960 258 LTIADFGLASFFD 270 (415)
Q Consensus 258 vkl~DfG~a~~~~ 270 (415)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-24 Score=189.47 Aligned_cols=174 Identities=12% Similarity=0.134 Sum_probs=132.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh-HHHHH------HHHHHHHHHhCCCCceeeeeeeEeec
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRF------MAREILILRRLDHPNVVKLEGLVTSR 189 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~------~~~E~~~l~~l~h~~iv~l~~~~~~~ 189 (415)
.++|.+.+.||.|+||.||++.+ ++..+|+|++....... ..... +.+|+..+.++.|++|+.+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46899999999999999999754 46689999997543322 22222 67899999999999999998886643
Q ss_pred C------CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 190 M------SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 190 ~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
. ....+++|||++|..+.... .+++ ....+|+.+|..||+.|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 24589999999997665542 2333 2466999999999999999999999999999999 999999
Q ss_pred ccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHH
Q 014960 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315 (415)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell 315 (415)
|.......... .. .+++ ...|+.++|+|+||+.+....
T Consensus 179 g~~~~~~e~~a---~d----------~~vl-er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKA---KD----------RIDL-ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhh---HH----------HHHH-HhHhcccccccceeEeehHHH
Confidence 98865532111 00 0223 245778999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=191.39 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=173.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC-----------------------------------ceEEEEEEecCCC---Ch
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-----------------------------------QIVALKKVRFDNL---EP 158 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----------------------------------~~vaiK~~~~~~~---~~ 158 (415)
.++|++++.||+|....||.|+...+| -+.|||.+..-.. ..
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 578999999999999999999753311 1346665432111 12
Q ss_pred HHHHHHHHHHHH------H--------Hh--------CCCCceeeeeeeEeec-------------------------CC
Q 014960 159 ESVRFMAREILI------L--------RR--------LDHPNVVKLEGLVTSR-------------------------MS 191 (415)
Q Consensus 159 ~~~~~~~~E~~~------l--------~~--------l~h~~iv~l~~~~~~~-------------------------~~ 191 (415)
...+.+.+|..- + +. -+|||||++.++|.+. ..
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 222333333211 1 11 1599999998877542 23
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE--cCCC--cEEEEeecccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI--DNEG--ILTIADFGLAS 267 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl--~~~~--~vkl~DfG~a~ 267 (415)
..+|+||....+.+..++..+ ..+....+.++.|+++|+.|||.+||.|||+|.+|||| ++|+ .+.|+|||.+-
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 568999999988887777655 45778888999999999999999999999999999998 4444 58999999874
Q ss_pred ccCCC-----CCCCcccccccCccCCcccccCCcCC-----CchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014960 268 FFDPN-----HKQPMTSRVVTLWYRPPELLLGATDY-----GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC 337 (415)
Q Consensus 268 ~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 337 (415)
-.+.. .....-+.-|....||||+....... -.++|.|+.|-+.||++...-||.+.-+.-.
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------- 465 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------- 465 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--------
Confidence 33221 11112234567778999987532211 1479999999999999999999977322110
Q ss_pred CCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH---HHHhc
Q 014960 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA---TAALR 400 (415)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~~~L~ 400 (415)
....+.+.+ +......++..+.+||..+|+.||++|+++ +.+|+
T Consensus 466 ---~~r~Yqe~q----------------LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 466 ---DTRTYQESQ----------------LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ---chhhhhhhh----------------CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 011122212 122234678889999999999999999995 45554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-23 Score=209.25 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=174.9
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.|...+.||++-|=+|.+|++. .| .|++|++-+..- .-....+...|++ ....++||++.+.-+... +...||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 5777889999999999999754 34 488999876542 2222222333444 455689999998766444 456888
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccccc--CCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~--~~~~~ 274 (415)
|-+|+.+.+... +..+.-+..-+.+.|+.||+.||.-+|..||+|||||.|||||+.=+.+.|+||..-+-. ..++.
T Consensus 99 vRqyvkhnLyDR-lSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDR-LSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhh-hccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 989988876654 455556788899999999999999999999999999999999999999999999865432 11111
Q ss_pred CCcccccc----cCccCCcccccCCc----------CCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 014960 275 QPMTSRVV----TLWYRPPELLLGAT----------DYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 275 ~~~~~~~g----t~~y~aPE~~~~~~----------~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
..++...- -.+|+|||.+.... ..+++-||||+||+++||++ |.|||. +.+++.....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LSQL~aYr~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LSQLLAYRSG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HHHHHhHhcc
Confidence 11221111 34699999985411 15678999999999999987 799994 2222221111
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
. .. ....+.+... +..++.||..|++.||++|.+|++.|+.
T Consensus 251 ~-~~------------------~~e~~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 N-AD------------------DPEQLLEKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred C-cc------------------CHHHHHHhCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 00 0000122222 2378899999999999999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=175.97 Aligned_cols=147 Identities=20% Similarity=0.179 Sum_probs=115.5
Q ss_pred CCCceeeeeeccCCceEEEEEE-ECCCCceEEEEEEecCCCCh----------------------HHHHHHHHHHHHHHh
Q 014960 117 ADTFEKLDKIGQGTYSNVYKAR-DTLTGQIVALKKVRFDNLEP----------------------ESVRFMAREILILRR 173 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~~~~----------------------~~~~~~~~E~~~l~~ 173 (415)
...|.+.+.||+|+||.||+|+ +..+|+.||+|+++...... .....+.+|+.++++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4468899999999999999998 66789999999997543110 012346789999999
Q ss_pred CCCCc--eeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCE
Q 014960 174 LDHPN--VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH-VLHRDIKGSNL 250 (415)
Q Consensus 174 l~h~~--iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NI 250 (415)
+.+.+ +++++++ ...++||||+++..+.........+.+..+..++.||+.+|.+||+.| |+||||||+||
T Consensus 107 L~~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 107 LYEAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred HHhcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 97533 3444432 125899999999766544434445677778899999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeeccccccC
Q 014960 251 LIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 251 Ll~~~~~vkl~DfG~a~~~~ 270 (415)
+++ ++.++|+|||.+...+
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=169.98 Aligned_cols=136 Identities=17% Similarity=0.196 Sum_probs=104.7
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-----CCCceeeeeeeEeecCC-CeEE-
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-----DHPNVVKLEGLVTSRMS-CSLY- 195 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~~~~~-~~~~- 195 (415)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||++++|++++..+ +.++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 46899999999995 6767665 6999876432 2346789999999999 67999999999988532 3434
Q ss_pred EEEEecc--cChhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCeeccCCCCCEEEcCC----CcEEEEeeccc
Q 014960 196 LVFKYME--HDLAGLAASPTIKFTQAQVKCYMHQLLSGL-EHCHNQHVLHRDIKGSNLLIDNE----GILTIADFGLA 266 (415)
Q Consensus 196 lv~e~~~--~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L-~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DfG~a 266 (415)
+|+||.+ ++.+..++... .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899954 55665555443 46666 35688888888 99999999999999999999743 37999995444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=193.63 Aligned_cols=194 Identities=22% Similarity=0.244 Sum_probs=151.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~ 193 (415)
...|.|-+.||+|+||.||+|.+.. |+.||||+-...... .|.--.+++.+|+ -+.|..+...+.- ...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~--~~~ 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVF--QNA 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHcc--CCc
Confidence 4679999999999999999999766 999999986544321 1111234445554 2334444333333 234
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-------CCcEEEEeeccc
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-------EGILTIADFGLA 266 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-------~~~vkl~DfG~a 266 (415)
.++|+||...|.+-.+....+.+++..+..+..|+|..+++||..+||||||||+|+||.. ..-++|+|||-+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 7899999998888778888889999999999999999999999999999999999999943 224999999998
Q ss_pred cccCCCC-CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCC
Q 014960 267 SFFDPNH-KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319 (415)
Q Consensus 267 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~ 319 (415)
.....-. ...+...++|-.+-.+|+..| +.++...|.|.|+-+++-||.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 6543221 235666788999999998887 789999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.4e-22 Score=201.10 Aligned_cols=263 Identities=25% Similarity=0.346 Sum_probs=205.0
Q ss_pred CCceeeeeeccCCceEEEEEEEC-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~ 195 (415)
..|.+.+.||+|+|+.|-.+... .....+|.|.+...............|..+-+.+. |.|++.+++.... ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 35777788999999999988753 33445677776655444555566667888888887 9999999998877 45689
Q ss_pred EEEEecccChhhhhc-CCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCC
Q 014960 196 LVFKYMEHDLAGLAA-SPTI-KFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDP 271 (415)
Q Consensus 196 lv~e~~~~~l~~~~~-~~~~-~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~ 271 (415)
++++|..++.+.... .... ..+...+-.++.|+..+|.|+| ..++.|+||||+|.+++..+ .+|++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998887776666 4444 6788888999999999999999 99999999999999999999 999999999988765
Q ss_pred --CCCCCcccccc-cCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 272 --NHKQPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 272 --~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
+........+| ++.|+|||.+.+........|+||+|+++..+++|..||.......... ..|...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~~ 246 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKSN 246 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------eeeccc
Confidence 33333445678 9999999999875567889999999999999999999997644332110 011110
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
+ .......+..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 247 ~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 K-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00011223467788899999999999999999999999999988
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=159.36 Aligned_cols=140 Identities=22% Similarity=0.209 Sum_probs=108.4
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh--------------------HHHHHHHHHHHHHHhCCCCc
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP--------------------ESVRFMAREILILRRLDHPN 178 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~~ 178 (415)
.|.+.+.||+|+||.||++... +|+.||||+++...... .......+|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4788899999999999999864 79999999987543110 01123567889999987774
Q ss_pred --eeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC
Q 014960 179 --VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (415)
Q Consensus 179 --iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 256 (415)
++..++ ....++||||+.+..+...... .....++.+|+.++.++|+.||+||||||+||+++.++
T Consensus 95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444433 1236899999999766543221 34567889999999999999999999999999999999
Q ss_pred cEEEEeeccccccCC
Q 014960 257 ILTIADFGLASFFDP 271 (415)
Q Consensus 257 ~vkl~DfG~a~~~~~ 271 (415)
.++|+|||++...+.
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-20 Score=180.34 Aligned_cols=177 Identities=27% Similarity=0.430 Sum_probs=132.6
Q ss_pred CeEEEEEEecccChhhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
.++||.|++|....+.+++.+.. ..+......++.||+.+++| ++.+|+|+||.||+...+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999988888875432 35677888999999999999 9999999999999999999999999999877
Q ss_pred cCCCC-----CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHhcCCCC
Q 014960 269 FDPNH-----KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI--FKLCGSPS 341 (415)
Q Consensus 269 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~~ 341 (415)
..... ....+..+||.+||+||++.+ ..|+.++|||+||+||+|++.- |.. ..+....+ .+.. ..+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~---f~T--~~er~~t~~d~r~g-~ip 478 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQ---FST--QFERIATLTDIRDG-IIP 478 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHH---hcc--HHHHHHhhhhhhcC-CCC
Confidence 65443 223455689999999999997 6799999999999999999972 211 11111111 1110 001
Q ss_pred HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
...| .++ +.-.+|+..||...|.+||++.+.-.|.|.
T Consensus 479 ~~~~-------------------------~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFL-------------------------QDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHh-------------------------hcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111 111 223579999999999999988888888775
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=158.99 Aligned_cols=136 Identities=18% Similarity=0.215 Sum_probs=109.0
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCCh------HHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP------ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.||+|++|.||+|++ .|..+++|+........ .....+.+|+.++..+.|++|+....++.. ....+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5799999999999975 67789999865433211 123457789999999999988776666554 3457899
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
|||++|..+........ . ....++.+|+.+|.+||+.+++|||++|.|||++ ++.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999876665554322 2 7889999999999999999999999999999999 78999999999865
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=160.52 Aligned_cols=244 Identities=16% Similarity=0.203 Sum_probs=183.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
..+..+..+|.....|..|++++ +|..++.|++...........+|..|.-.|+-+.||||+.+++.+..+ ..+.+
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~ 264 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVI 264 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceE
Confidence 34566677899999999999965 455667788877766666677888899899999999999999999874 56899
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEcCCCcEEEE--eeccccccC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIA--DFGLASFFD 270 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~--DfG~a~~~~ 270 (415)
+..||+.+.+...+.. .......++..++.+|+.|++|||+.. |----|....++||++.+.+|. |--++...
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe- 343 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE- 343 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-
Confidence 9999998776655543 334677889999999999999999874 3334578889999998876653 33222211
Q ss_pred CCCCCCcccccccCccCCcccccCCcC--CCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
......|.||+||.+..... .-+++|+|||+++||||.|...||..-.+.+.-.+|.-...
T Consensus 344 -------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl---------- 406 (448)
T KOG0195|consen 344 -------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL---------- 406 (448)
T ss_pred -------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc----------
Confidence 12234788999999865332 23579999999999999999999998777766555432111
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHh
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L 399 (415)
-....+.++..+..|++-|++.||.+||..+.++
T Consensus 407 -----------------rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 407 -----------------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1112345667788899999999999999987764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-19 Score=173.12 Aligned_cols=205 Identities=26% Similarity=0.377 Sum_probs=152.1
Q ss_pred HHhCCCCceeeeeeeEeecCCCeEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC-eeccCCCC
Q 014960 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHV-LHRDIKGS 248 (415)
Q Consensus 171 l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~i-vHrDlkp~ 248 (415)
|+.+.|.|+.+++|.+.+. ...++|.+||..+.+...+.. ...+..-....++++|+.||+|||+..| +|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4568899999999999884 679999999998766665544 6678888899999999999999998876 99999999
Q ss_pred CEEEcCCCcEEEEeeccccccCCCC-CCCcccccccCccCCcccccCCc------CCCchhcHHHHHHHHHHHHhCCCCC
Q 014960 249 NLLIDNEGILTIADFGLASFFDPNH-KQPMTSRVVTLWYRPPELLLGAT------DYGVGVDLWSAGCILAELLAEKPIM 321 (415)
Q Consensus 249 NILl~~~~~vkl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~------~~~~~sDvwSlG~il~ell~g~~pf 321 (415)
|++++....+||.|||+........ ........-..-|.|||.+.+.. ..+.+.||||+|++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987764210 01111112245599999987621 1456799999999999999999999
Q ss_pred CCCC----hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHH
Q 014960 322 PGRT----EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397 (415)
Q Consensus 322 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 397 (415)
.... ..++...+.+ .+..+ +...+... ..+++++..+++.||..+|.+||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~~--------------------~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSNP--------------------FRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCCC--------------------cCcchhhh-hhcchHHHHHHHHhcccChhhCccHHH
Confidence 8632 2234444333 11100 00001111 155668999999999999999999987
Q ss_pred Hh
Q 014960 398 AL 399 (415)
Q Consensus 398 ~L 399 (415)
+-
T Consensus 217 i~ 218 (484)
T KOG1023|consen 217 IR 218 (484)
T ss_pred HH
Confidence 64
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=153.35 Aligned_cols=133 Identities=17% Similarity=0.200 Sum_probs=102.2
Q ss_pred eeccCCceEEEEEEECCCCceEEEEEEecCCCCh------HHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP------ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.||+|+||.||++. .++..+++|......... .....+.+|++++..+.|+++.....++.. ....++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 38999999999997 467889999865432211 123567789999999988765544333333 33478999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
||++|..+......... .++.+|+.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99998766654433211 7899999999999999999999999999999 899999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-18 Score=150.44 Aligned_cols=138 Identities=25% Similarity=0.272 Sum_probs=98.6
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHH----------------------HHHHHHHHHhCCCCc--
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF----------------------MAREILILRRLDHPN-- 178 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~~-- 178 (415)
.+.||+|+||.||+|.+. +++.||||++............ ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 7899999998764322111111 134666666664433
Q ss_pred eeeeeeeEeecCCCeEEEEEEecccChhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCC
Q 014960 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEG 256 (415)
Q Consensus 179 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~ 256 (415)
+++.+++ ...++||||++++.... .+... .. ..++..++.+++.++.++|. .+|+||||||+||+++ ++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444432 13689999999842211 11110 11 16778899999999999999 9999999999999999 89
Q ss_pred cEEEEeeccccccC
Q 014960 257 ILTIADFGLASFFD 270 (415)
Q Consensus 257 ~vkl~DfG~a~~~~ 270 (415)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.2e-18 Score=172.40 Aligned_cols=139 Identities=15% Similarity=0.144 Sum_probs=107.4
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-C-----hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-E-----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
..|...+.||+|+||.||++... +..+++|+...... . ....+.+.+|+++++.++|++++..+.++.. .
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~ 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--P 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--C
Confidence 34566789999999999999754 33445554322111 1 1123568899999999999999887666655 3
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
...++||||+++..+...+. ....++.+|+.+|.+||+.||+||||||+|||+ .++.++|+|||++...
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 35789999999877665443 457789999999999999999999999999999 6789999999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8e-18 Score=164.94 Aligned_cols=257 Identities=21% Similarity=0.247 Sum_probs=199.3
Q ss_pred CCceeeeeecc--CCceEEEEEEE--CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCC
Q 014960 118 DTFEKLDKIGQ--GTYSNVYKARD--TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 118 ~~y~~~~~lG~--G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 192 (415)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+.....+.....=.+|+...+.+ .|+|.++.+..++. .+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 56777888999 99999999987 88899999997443322222222333567666677 49999998888887 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCeeccCCCCCEEEcCC-CcEEEEeecccc
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLS----GLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLAS 267 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~----~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DfG~a~ 267 (415)
.+|+-+|+++..++.........++...++.++.+... ||.++|+.+++|-|+||+||++..+ ...+++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 79999999999999988888878999999999999999 9999999999999999999999999 889999999998
Q ss_pred ccCCCCCCCc----ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCC
Q 014960 268 FFDPNHKQPM----TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR--TEVEQLHKIFKLCGSPS 341 (415)
Q Consensus 268 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~ 341 (415)
.+....-... ....|...|++||+..+ -++..+|+|+||.++.+..++..++... +....+.+++
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------- 342 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------- 342 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------
Confidence 8876542111 12256777999998865 5889999999999999999887766543 2222222111
Q ss_pred HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.-.+.....+.++...+..|+..+|..|++++.++.+.+.....
T Consensus 343 -----------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 343 -----------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred -----------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence 01122334455555689999999999999999999999987543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=7e-17 Score=147.69 Aligned_cols=138 Identities=15% Similarity=0.175 Sum_probs=102.8
Q ss_pred eeec-cCCceEEEEEEECCCCceEEEEEEecCCC-----------ChHHHHHHHHHHHHHHhCCCCce--eeeeeeEeec
Q 014960 124 DKIG-QGTYSNVYKARDTLTGQIVALKKVRFDNL-----------EPESVRFMAREILILRRLDHPNV--VKLEGLVTSR 189 (415)
Q Consensus 124 ~~lG-~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~ 189 (415)
..|| .|+.|+||.+.. .+..++||.+..... .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788899999864 477899998854221 11234567889999999998875 6777765443
Q ss_pred CCC--eEEEEEEeccc-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 190 MSC--SLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 190 ~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
... ..++|||++.+ ..+..+... ..+++.. +.+|+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 222 23599999997 455444433 2455543 578999999999999999999999999999999999999988
Q ss_pred cc
Q 014960 267 SF 268 (415)
Q Consensus 267 ~~ 268 (415)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 65
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-16 Score=133.78 Aligned_cols=133 Identities=23% Similarity=0.234 Sum_probs=108.9
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeeeeeEeecCCCeEEEEEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--PNVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~~~lv~e 199 (415)
+.+.||+|.++.||++... +..+++|.+..... ...+.+|+.+++.+.| .+++++++++.. ....+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 3568999999999999864 37899999865432 3567889999999976 588998887765 356899999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ---HVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
|+.+..+... +......++.+++.+|.+||.. +++|+||+|+||+++.++.++++|||.+...
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 9987654432 5566778899999999999985 6999999999999999999999999998653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4e-17 Score=167.82 Aligned_cols=265 Identities=22% Similarity=0.233 Sum_probs=198.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.+.+.+.+-+-+|.++.++.+.-..+|...++|+..+... .....+....+-.++-...+|.+++..--+.. ....+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~~ 880 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPLP 880 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCcc
Confidence 3567788889999999999998888887788886654322 22223333333333333345666654333222 34689
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC---
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--- 272 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~--- 272 (415)
++++|++++.+...+......+++-++.++..+..+++|||...++|+|++|.|+|+..++..++.|||......-.
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999988766666666557788888999999999999999999999999999999999999999999844322100
Q ss_pred ------------------C---------CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Q 014960 273 ------------------H---------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325 (415)
Q Consensus 273 ------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~ 325 (415)
. .......++|+.|.+||...+ ...+..+|+|+.|++++|.++|.+||...+
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 001223578999999999987 567889999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH---HHhcCC
Q 014960 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT---AALRSE 402 (415)
Q Consensus 326 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~---~~L~h~ 402 (415)
.+.+++.|.+... .|+. -....+.++.+++..+|..+|.+|..+. ++-.|+
T Consensus 1040 pq~~f~ni~~~~~-----~~p~---------------------g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1040 PQQIFENILNRDI-----PWPE---------------------GPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred hhhhhhccccCCC-----CCCC---------------------CccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence 9888877755321 1221 1124567788999999999999999988 889999
Q ss_pred CCCCCCCC
Q 014960 403 VSLYMXXX 410 (415)
Q Consensus 403 ~f~~~~~~ 410 (415)
||+.++-.
T Consensus 1094 ~~~~~~~~ 1101 (1205)
T KOG0606|consen 1094 FFQDVDWE 1101 (1205)
T ss_pred ccCCCCcc
Confidence 99987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=8e-14 Score=122.33 Aligned_cols=140 Identities=18% Similarity=0.190 Sum_probs=101.5
Q ss_pred eeeccCCceEEEEEEECC------CCceEEEEEEecCCC--------------------ChHHHHHHH----HHHHHHHh
Q 014960 124 DKIGQGTYSNVYKARDTL------TGQIVALKKVRFDNL--------------------EPESVRFMA----REILILRR 173 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~--------------------~~~~~~~~~----~E~~~l~~ 173 (415)
..||.|--+.||.|.... .+..+|||+.+.... .......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 357899998753210 012233344 79999999
Q ss_pred CCC--CceeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeccCCCCCE
Q 014960 174 LDH--PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC-HNQHVLHRDIKGSNL 250 (415)
Q Consensus 174 l~h--~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~NI 250 (415)
+.. -++++.+++ . .-+|||||++++.+.........+++.++..+..+++.+|..| |+.|||||||++.||
T Consensus 83 l~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 853 456677654 1 2679999998753221111222456667778899999999999 899999999999999
Q ss_pred EEcCCCcEEEEeeccccccC
Q 014960 251 LIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 251 Ll~~~~~vkl~DfG~a~~~~ 270 (415)
|++ ++.+.|+|||.+...+
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 4789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=135.98 Aligned_cols=143 Identities=18% Similarity=0.204 Sum_probs=94.0
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCCh--------------------------------HHH------HHHH
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP--------------------------------ESV------RFMA 165 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------------------~~~------~~~~ 165 (415)
+.||.|++|.||+|+. .+|+.||||+.+...... +.. -++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999985 478999999986432100 000 0234
Q ss_pred HHHHHHHhC----CCCceeeeeeeEeecCCCeEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 014960 166 REILILRRL----DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLS-GLEHCHNQH 239 (415)
Q Consensus 166 ~E~~~l~~l----~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~-~L~~LH~~~ 239 (415)
+|+..+.++ .+.+-+.+-.++.+. ....++||||++|..+...... ..... ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555544 232223332233221 2347899999998655443221 11122 2345555555 478899999
Q ss_pred CeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 240 ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
++|+|+||.||+++.++.++|+|||++..+++
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999977654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-14 Score=142.05 Aligned_cols=260 Identities=19% Similarity=0.183 Sum_probs=184.7
Q ss_pred cCCCCCCCCCceeeeeeccCCceEEEEEEEC-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEe
Q 014960 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVT 187 (415)
Q Consensus 110 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~ 187 (415)
..|+.....+|..+..||.|.|+.|+.+.-. .++..|++|.............+-..|+.+...+ .|.+++.+...|.
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 3444455678999999999999999988644 6788999998765543333333333566666666 4889998777665
Q ss_pred ecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-CcEEEEeeccc
Q 014960 188 SRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLA 266 (415)
Q Consensus 188 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DfG~a 266 (415)
. ....|+-.|||.+....+...-...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.+
T Consensus 337 ~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 337 Q--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred c--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccc
Confidence 5 23467999999887666555444467888999999999999999999999999999999999886 78999999988
Q ss_pred cccCCCCCCCcccccccCccC-CcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 267 SFFDPNHKQPMTSRVVTLWYR-PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
..+.-. ......+-+++ ..|++.....+..+.|++|||.-+.+.+++.+.-+..+..- .|...
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~--------- 478 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG--------- 478 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc---------
Confidence 642211 11122233444 35656556778899999999999999999876433222100 00000
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....+....++..+.+.|...|+..|+.+.++..|.=|...
T Consensus 479 --------------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 479 --------------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred --------------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 001112223556778899999999999999999988776544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=117.98 Aligned_cols=128 Identities=14% Similarity=0.141 Sum_probs=94.3
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeeeeeEeecCCCeEEEEEEec
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~lv~e~~ 201 (415)
++.|+.|.++.||+++. .+..|++|+...... ....+..|+.+++.+.+.++ ++++.+... ..++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEEEEec
Confidence 35789999999999975 477899998754321 12345679999998865444 455554322 247999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV-----LHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i-----vHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
++..+... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98654322 11123457899999999999885 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.4e-14 Score=141.95 Aligned_cols=145 Identities=18% Similarity=0.248 Sum_probs=95.2
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC---------------------------C-----hHHHHH--
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---------------------------E-----PESVRF-- 163 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------------------------~-----~~~~~~-- 163 (415)
..|+. +.||+|++|+||+|+.+.+|+.||||+++..-. . .+..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 689999999999999888899999999975410 0 011122
Q ss_pred ----HHHHHHHHHhC----CCCceeeeeeeEeecCCCeEEEEEEecccChhhhhc--CCCC----CCCHHHHHHHHHHHH
Q 014960 164 ----MAREILILRRL----DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAA--SPTI----KFTQAQVKCYMHQLL 229 (415)
Q Consensus 164 ----~~~E~~~l~~l----~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~----~~~~~~~~~i~~qi~ 229 (415)
+.+|+..+.++ .+.+.+.+-.++.+- ....+|||||+.|.-+.... ...+ .+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 23333333333 233333333333221 34578999999996654421 1111 244555555566654
Q ss_pred HHHHHHHhCCCeeccCCCCCEEEcCCC----cEEEEeeccccccCC
Q 014960 230 SGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASFFDP 271 (415)
Q Consensus 230 ~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DfG~a~~~~~ 271 (415)
..|++|+|+||.||+++.++ .++++|||++..++.
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999988 999999999987754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-12 Score=128.96 Aligned_cols=169 Identities=19% Similarity=0.295 Sum_probs=125.7
Q ss_pred EEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCC
Q 014960 136 KARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK 215 (415)
Q Consensus 136 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~ 215 (415)
.|..+.++.+|.+...+.... .......+.++-|+.++||||+++++.++. .+.+|||+|.+.--. ..+. .
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~Pl~--~~lk---~ 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRPLE--TVLK---E 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccccHH--HHHH---H
Confidence 455577888899888875543 445667788999999999999999998887 457999999886421 1111 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-hCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccC
Q 014960 216 FTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294 (415)
Q Consensus 216 ~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 294 (415)
+....+...+.||+.||.||| +.+++|++|...-|+|+..|..||++|.++........ ......---.|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 236777788999999999998 67899999999999999999999999998865432221 1111111223677775432
Q ss_pred CcCCCchhcHHHHHHHHHHHHhC
Q 014960 295 ATDYGVGVDLWSAGCILAELLAE 317 (415)
Q Consensus 295 ~~~~~~~sDvwSlG~il~ell~g 317 (415)
-.-..|.|.|||++++++.|
T Consensus 180 ---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 ---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cccchhhhhHHHHHHHHhCc
Confidence 12456999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5e-13 Score=121.94 Aligned_cols=203 Identities=18% Similarity=0.188 Sum_probs=138.1
Q ss_pred HHhCCCCceeeeeeeEeecC---CCeEEEEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhC--CCe
Q 014960 171 LRRLDHPNVVKLEGLVTSRM---SCSLYLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQ--HVL 241 (415)
Q Consensus 171 l~~l~h~~iv~l~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~--~iv 241 (415)
|-.+.|.|||+++.|+.+.. .....++.||+..+.+...+. ....+......+|+-||+.||.|||+. .|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44557999999999987632 245788899999876655543 344688888899999999999999976 599
Q ss_pred eccCCCCCEEEcCCCcEEEEeeccccccCCC----CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhC
Q 014960 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPN----HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE 317 (415)
Q Consensus 242 HrDlkp~NILl~~~~~vkl~DfG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g 317 (415)
|+++....|++..+|-+|+.---... ..+. .........+.++|.+||.-.. ...+-++|||++|.+.++|..+
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHh
Confidence 99999999999999988874211111 1000 0011112345788999996543 4567789999999999999877
Q ss_pred CCC-CCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH
Q 014960 318 KPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396 (415)
Q Consensus 318 ~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 396 (415)
.-- -.+....+.-..+.+...... ..--.++|.+||.-.|..||++.
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~le--------------------------------n~lqr~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLE--------------------------------NGLQRGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred eeccCCCcceeehhhhhhhheeecc--------------------------------CccccCcCcccccCCCCCCcchh
Confidence 532 222222222222222211110 01123478999999999999999
Q ss_pred HHhcCCCCCCC
Q 014960 397 AALRSEVSLYM 407 (415)
Q Consensus 397 ~~L~h~~f~~~ 407 (415)
++|.||.+-++
T Consensus 327 ~llfHpllfeV 337 (458)
T KOG1266|consen 327 LLLFHPLLFEV 337 (458)
T ss_pred hhhcCceeeec
Confidence 99999986543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-11 Score=103.26 Aligned_cols=144 Identities=15% Similarity=0.246 Sum_probs=101.2
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-C-----hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-E-----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.+..+-+|+-+.|+++ ...|+.+.||.-..... . .-...+..+|+.+|.++.--+|.--.=+|.+. ..-.
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQ 86 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCe
Confidence 5678999999999999 46788888886432222 1 22245677899999998644543322244442 2356
Q ss_pred EEEEeccc--ChhhhhcCCCCCCCHHH-HHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc---EEEEeecccccc
Q 014960 196 LVFKYMEH--DLAGLAASPTIKFTQAQ-VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLASFF 269 (415)
Q Consensus 196 lv~e~~~~--~l~~~~~~~~~~~~~~~-~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DfG~a~~~ 269 (415)
|+|||+++ .....+......-.+.+ ...++++|-..+.-||.++|+||||..+||++..++. +.++|||++...
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 88999988 33333333222223333 3788999999999999999999999999999987763 689999998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.6e-11 Score=103.17 Aligned_cols=133 Identities=22% Similarity=0.248 Sum_probs=95.3
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEE-ecCCCChH-----HHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKV-RFDNLEPE-----SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~-~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
..+++|+-+.+|.+.. -|..+++|.- .+....++ ...+..+|+.++.++.--.|..-+=++.+ .....|+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEE
Confidence 3578899999998843 4445667753 22222222 23466789999998865554433223333 2336799
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
|||++|.++...+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888665543 256677888888889999999999999999998766 99999999964
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=4e-11 Score=108.27 Aligned_cols=143 Identities=18% Similarity=0.228 Sum_probs=105.5
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC--ceeeeeeeEeecC-CCeEEEEEEe
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP--NVVKLEGLVTSRM-SCSLYLVFKY 200 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~~~-~~~~~lv~e~ 200 (415)
+.|+.|..+.||++... +|..|++|........ .....+..|+++++.+.+. ++++++.+..... .+..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 56899999999999753 3678999987644321 1344678899999999753 4577776654421 1356899999
Q ss_pred cccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 014960 201 MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN------------------------------------------- 237 (415)
Q Consensus 201 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~------------------------------------------- 237 (415)
++|..+...... ..+++.....++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998765544322 356777778888888888888883
Q ss_pred -------------CCCeeccCCCCCEEEcC--CCcEEEEeecccccc
Q 014960 238 -------------QHVLHRDIKGSNLLIDN--EGILTIADFGLASFF 269 (415)
Q Consensus 238 -------------~~ivHrDlkp~NILl~~--~~~vkl~DfG~a~~~ 269 (415)
..++|+|+.+.|||++. ++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 567899999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-12 Score=129.70 Aligned_cols=158 Identities=20% Similarity=0.243 Sum_probs=116.8
Q ss_pred HHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc---c-----cccccCccCCcccccCCcC
Q 014960 227 QLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM---T-----SRVVTLWYRPPELLLGATD 297 (415)
Q Consensus 227 qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~---~-----~~~gt~~y~aPE~~~~~~~ 297 (415)
+.++||.|+|. .++||++|.|++|.++..+..||+.|+++.....+..-.. . .......|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 34499999996 5899999999999999999999999999876654222111 1 1123667999999987 66
Q ss_pred CCchhcHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCC
Q 014960 298 YGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPS 376 (415)
Q Consensus 298 ~~~~sDvwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (415)
.+.++|++|+||++|.+. .|++.+...........-... +.-. ....-..+|.+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~-~~~~------------------------~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL-LNAG------------------------AFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc-cccc------------------------cccccccCcHH
Confidence 789999999999999998 677766654433222222111 1110 11111578999
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 377 SLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 377 ~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
+++=|.++|..|+..||++..++..+||.+-...
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~ 274 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK 274 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence 9999999999999999999999999999886543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.1e-10 Score=109.86 Aligned_cols=214 Identities=19% Similarity=0.229 Sum_probs=151.4
Q ss_pred CceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec--CCCeEEEEEEecccC--h
Q 014960 130 TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSLYLVFKYMEHD--L 205 (415)
Q Consensus 130 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~~~lv~e~~~~~--l 205 (415)
--.+.|+|+...+|..|++|.+..+.... ...-..-+++++++.|.|||++.++|... .+..+++|++|.++. |
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 34688999999999999999994332211 11122357889999999999999988632 245789999999873 3
Q ss_pred hhhhc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 206 AGLAA--------------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 206 ~~~~~--------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
...+. ..+...+|+.+|.|+.||..||.++|+.|+..+-|.+.+||++.+.+++|+..|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 33222 1233578999999999999999999999999999999999999999999988887766544
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
+.. |.+.+ -.+-|.-.||.+++.|.||..--+. ...++..
T Consensus 446 d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~-------------------- 486 (655)
T KOG3741|consen 446 DPT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH-------------------- 486 (655)
T ss_pred CCC---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHH--------------------
Confidence 321 11221 2468999999999999999653211 1122211
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+......++.++.++|.-+...++++ -++.++|.
T Consensus 487 ---------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 487 ---------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred ---------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 11112346667777888888888776 56666663
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-10 Score=101.98 Aligned_cols=128 Identities=23% Similarity=0.270 Sum_probs=82.7
Q ss_pred EEEEEEECCCCceEEEEEEecCCC------------------------ChHHHHHHHHHHHHHHhCCCC--ceeeeeeeE
Q 014960 133 NVYKARDTLTGQIVALKKVRFDNL------------------------EPESVRFMAREILILRRLDHP--NVVKLEGLV 186 (415)
Q Consensus 133 ~Vy~~~~~~~~~~vaiK~~~~~~~------------------------~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~ 186 (415)
.||.|.. .+|..+|+|+.+.... ..-......+|...|.++... ++++.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899975 5677999998753210 111234567899999999766 467776542
Q ss_pred eecCCCeEEEEEEecc--cChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 187 TSRMSCSLYLVFKYME--HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH-CHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 187 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~-LH~~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
. -+|||||++ |..+..+... .++......++.+++..+.. +|..|||||||.+.|||++++ .+.|+||
T Consensus 80 ~------~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 R------NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp T------TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred C------CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 1 469999999 5333322221 11234556778888885555 579999999999999999987 9999999
Q ss_pred ccccccC
Q 014960 264 GLASFFD 270 (415)
Q Consensus 264 G~a~~~~ 270 (415)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.9e-10 Score=102.08 Aligned_cols=135 Identities=15% Similarity=0.083 Sum_probs=92.0
Q ss_pred eEEEEEEECCCCceEEEEEEecCCCCh---------HHHHHHHHHHHHHHhCCCCcee--eeeeeEeecCC---CeEEEE
Q 014960 132 SNVYKARDTLTGQIVALKKVRFDNLEP---------ESVRFMAREILILRRLDHPNVV--KLEGLVTSRMS---CSLYLV 197 (415)
Q Consensus 132 g~Vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv--~l~~~~~~~~~---~~~~lv 197 (415)
..|+++. ..|+.|.||......... .....+.+|...+.+|...+|. ..+.+.+.... ...++|
T Consensus 36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3455553 456788899764322110 0111366888888888544443 34555543222 247899
Q ss_pred EEecccC-hhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-------CCcEEEEeecccc
Q 014960 198 FKYMEHD-LAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-------EGILTIADFGLAS 267 (415)
Q Consensus 198 ~e~~~~~-l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-------~~~vkl~DfG~a~ 267 (415)
||++++. .+..+... .....+.....++.+|+..+.-||..||+|+|+++.|||++. +..+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999984 34433321 234567778899999999999999999999999999999985 4579999999885
Q ss_pred c
Q 014960 268 F 268 (415)
Q Consensus 268 ~ 268 (415)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.9e-09 Score=100.95 Aligned_cols=252 Identities=14% Similarity=0.082 Sum_probs=153.1
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeee-----eEeecCCCeEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEG-----LVTSRMSCSLY 195 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~-----~~~~~~~~~~~ 195 (415)
..+.||+|+-+.+|-.- .-+.. +.|+....... ... ..+..|... .||-+-.-+. .+-.+.+...-
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~-VAKIYh~Pppa--~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQ-VAKIYHAPPPA--AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecc--hhhch-hheeecCCCch--HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 44679999999999762 22333 45887654321 111 123334443 4654432111 01111233366
Q ss_pred EEEEecccC--hhhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 196 LVFKYMEHD--LAGLA-----ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 196 lv~e~~~~~--l~~~~-----~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
+.|..+.+- ....+ .+......+..+..+++.|+.+.+.||+.|.+-+|+.++||||.+++.|.|+|=..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 777777662 11111 11223467889999999999999999999999999999999999999999998654433
Q ss_pred cCCCCCCCcccccccCccCCccccc-C---CcCCCchhcHHHHHHHHHHHHhC-CCCCCCCCh-------HHHHHHHHHh
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLL-G---ATDYGVGVDLWSAGCILAELLAE-KPIMPGRTE-------VEQLHKIFKL 336 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~sDvwSlG~il~ell~g-~~pf~~~~~-------~~~~~~i~~~ 336 (415)
... .......+|..+|.+||.-. + .-.-+..+|.|.||++++++|.| +.||.|... .|. .|...
T Consensus 167 ~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g 242 (637)
T COG4248 167 NAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHG 242 (637)
T ss_pred ccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcc
Confidence 322 23445678999999999753 1 12345679999999999999986 999987321 110 11111
Q ss_pred cCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhccc--CCCCCCCHHHH
Q 014960 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAI--DPAERQTATAA 398 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~R~t~~~~ 398 (415)
.. ........ .-...-..--+..++.++..|..+|+.. ++.-|||++..
T Consensus 243 ~f------------~ya~~~~~-g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 243 RF------------AYASDQRR-GLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred ee------------eechhccC-CCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 10 00000000 0000001122235678899999999876 46789998643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.3e-09 Score=92.36 Aligned_cols=108 Identities=18% Similarity=0.180 Sum_probs=81.7
Q ss_pred HHHHHHHHHHHhCCCCc--eeeeeeeEeecCC--CeEEEEEEecccC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014960 162 RFMAREILILRRLDHPN--VVKLEGLVTSRMS--CSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236 (415)
Q Consensus 162 ~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~--~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 236 (415)
....+|...+..|...+ ++..+++.+.+.. ...++|+|++++. .+..+.......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 35667888887775433 3455555554322 2458999999883 45555444333677788899999999999999
Q ss_pred hCCCeeccCCCCCEEEcCCC---cEEEEeecccccc
Q 014960 237 NQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFF 269 (415)
Q Consensus 237 ~~~ivHrDlkp~NILl~~~~---~vkl~DfG~a~~~ 269 (415)
+.||+|+|+++.|||++.++ .+.|+||+-+...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-08 Score=92.45 Aligned_cols=139 Identities=24% Similarity=0.233 Sum_probs=102.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCC--------------------CChHHHHHHHHHHHHHHhCCCC-
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN--------------------LEPESVRFMAREILILRRLDHP- 177 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------------~~~~~~~~~~~E~~~l~~l~h~- 177 (415)
-+.++..||-|--+.||.|.+. .|..+|||.=+... +........++|.++|++|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4566788999999999999864 68889999533211 0112234566899999999655
Q ss_pred -ceeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC
Q 014960 178 -NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (415)
Q Consensus 178 -~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 256 (415)
.+++-+++ +.-.+|||+++|-.+.... +..+.+..++..|++-+.-+-..||||+|+.+=||||++||
T Consensus 171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 171 VKVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 67777653 3357999999995543322 23445556667777777777789999999999999999999
Q ss_pred cEEEEeecccccc
Q 014960 257 ILTIADFGLASFF 269 (415)
Q Consensus 257 ~vkl~DfG~a~~~ 269 (415)
.+.++||--+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999877543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.9e-08 Score=84.82 Aligned_cols=140 Identities=14% Similarity=0.174 Sum_probs=98.4
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCC---CC-hHHHHHHHHHHHHHHhCCCCc--eeeeeeeEe---ecCCCeEEE
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDN---LE-PESVRFMAREILILRRLDHPN--VVKLEGLVT---SRMSCSLYL 196 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~-~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~---~~~~~~~~l 196 (415)
-|+||-+.|+... ..|+.|-+|.-.... .. +.....|.+|...|+.|...+ +++.+ ++. ....-.-+|
T Consensus 26 ~~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 4678888899874 344467788764110 11 334567889999999985333 44444 332 122234689
Q ss_pred EEEeccc--ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc--EEEEeeccccc
Q 014960 197 VFKYMEH--DLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--LTIADFGLASF 268 (415)
Q Consensus 197 v~e~~~~--~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DfG~a~~ 268 (415)
|+|-+++ ++...+... ..+.++.....++.+|+..+.-||+.|+.|+|+-+.|||++.++. |+++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998885 443333222 235677888899999999999999999999999999999987777 99999997654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.6e-07 Score=84.18 Aligned_cols=139 Identities=21% Similarity=0.236 Sum_probs=95.9
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHH----------------------HHHHHHHHHHHHhCC--CCce
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES----------------------VRFMAREILILRRLD--HPNV 179 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----------------------~~~~~~E~~~l~~l~--h~~i 179 (415)
..|.+|--+.||+|. ..++..+|+|+++........ ..-...|..-|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 367888889999997 356889999998643211111 011224666666663 3444
Q ss_pred eeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcE
Q 014960 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGIL 258 (415)
Q Consensus 180 v~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~v 258 (415)
++-+++.. -.|||||++..-.-.-......+...++..+..++++.+.-|-. .++||+||..-|||+. ++.+
T Consensus 133 P~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 55555432 46999999976211111122234444788888999999998877 8999999999999999 8999
Q ss_pred EEEeeccccccC
Q 014960 259 TIADFGLASFFD 270 (415)
Q Consensus 259 kl~DfG~a~~~~ 270 (415)
.+||||-|...+
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.3e-07 Score=79.92 Aligned_cols=140 Identities=16% Similarity=0.225 Sum_probs=87.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHH-HH------HHHHHHHHHHhCC---CCceeeeeeeEe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VR------FMAREILILRRLD---HPNVVKLEGLVT 187 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~------~~~~E~~~l~~l~---h~~iv~l~~~~~ 187 (415)
.+|.+.+.+-......|.+. .-+|+.|++|..+......+. .. ...+.+..+.++. ...+..++-+.+
T Consensus 31 ~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 56888888888777777766 456788999987644321111 00 1123333333332 222223222222
Q ss_pred ec---CCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 188 SR---MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 188 ~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
-. .....+++|||++|..+.... .+.+ .+...|..++.-||+.|++|+|..|.|++++.++ ++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 11 123467899999996544322 1222 2456677889999999999999999999999655 9999998
Q ss_pred cccc
Q 014960 265 LASF 268 (415)
Q Consensus 265 ~a~~ 268 (415)
....
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 6643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.6e-07 Score=80.12 Aligned_cols=134 Identities=16% Similarity=0.098 Sum_probs=80.6
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +++.+++... +....+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 57899999999984 24467889876422 2234678999999886443 4566666654 44578899999
Q ss_pred ccCh-hhhhc---------------------CC--CCCCCHHHH-HHHHHH----------HHH-HHHHHH----hCCCe
Q 014960 202 EHDL-AGLAA---------------------SP--TIKFTQAQV-KCYMHQ----------LLS-GLEHCH----NQHVL 241 (415)
Q Consensus 202 ~~~l-~~~~~---------------------~~--~~~~~~~~~-~~i~~q----------i~~-~L~~LH----~~~iv 241 (415)
.|.. ..... .. ......... ..+..+ +.. ...+|. ...++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9851 11000 00 001111110 011000 111 112222 12478
Q ss_pred eccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 242 HRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 242 HrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999988 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.3e-08 Score=101.26 Aligned_cols=246 Identities=16% Similarity=0.075 Sum_probs=161.6
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeeeeeEeecCCCeEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~~~lv 197 (415)
-|.....+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++ .+.+.+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCC--cccccchh
Confidence 3556678999999999999876655544 6665432 22345899999999999 444433333 35678999
Q ss_pred EEecccC--hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 198 FKYMEHD--LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 198 ~e~~~~~--l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
++++.++ ...........+.+-+...+.+.-+++|++||+.-=+|+| ||+..+ +..|..||+....+....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999876 1111111222345555666777788999999998778999 776655 779999999987765543
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......+++.++|||+... ..+....|+|++|.-..+|.-|.+|-..... ... ..+..+ .+
T Consensus 386 ~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~----~~g~~p----------~s-- 446 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLP----MIGNGP----------NS-- 446 (829)
T ss_pred ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCcc--ccC----CCCCCC----------Cc--
Confidence 3456678999999998875 5688899999999887788888777654110 000 000000 00
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
..+..+. ..-+..-.++...|+..-|..|+....++-|.+|..-.
T Consensus 447 -------~~L~~~~-aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 447 -------PMLTDKS-AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred -------cccchhh-hcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 0000000 00001111356778889999999999998888887543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.7e-07 Score=80.07 Aligned_cols=139 Identities=22% Similarity=0.327 Sum_probs=80.3
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC--ceeeeeeeEee-cCCCeEEEEEE
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP--NVVKLEGLVTS-RMSCSLYLVFK 199 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~-~~~~~~~lv~e 199 (415)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.+... .+++++.+... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 4678999999999997544 48899986532 4566788899998888533 35677664422 22345799999
Q ss_pred ecccChhhh--------------------h-cC--CCCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 014960 200 YMEHDLAGL--------------------A-AS--PTIKFTQAQ---------VKCY------------MHQLLS-GLEH 234 (415)
Q Consensus 200 ~~~~~l~~~--------------------~-~~--~~~~~~~~~---------~~~i------------~~qi~~-~L~~ 234 (415)
++.+..+.. + .. ....+.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998853333 0 00 111111000 0000 111222 3333
Q ss_pred HHh-------CCCeeccCCCCCEEEc-CCCcEEEEeecccc
Q 014960 235 CHN-------QHVLHRDIKGSNLLID-NEGILTIADFGLAS 267 (415)
Q Consensus 235 LH~-------~~ivHrDlkp~NILl~-~~~~vkl~DfG~a~ 267 (415)
+++ ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 332 3599999999999999 66777899999774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-06 Score=88.32 Aligned_cols=142 Identities=20% Similarity=0.256 Sum_probs=85.1
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCC---------------------------C-h----HHH------HHHH
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---------------------------E-P----ESV------RFMA 165 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------------------------~-~----~~~------~~~~ 165 (415)
+-|+.++-|+||+|+- .+|+.||||+.+..-. . . +.. -++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4589999999999985 4599999999764310 0 0 000 1233
Q ss_pred HHHHHHHhCC-----CCce--eeeeeeEeecCCCeEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 014960 166 REILILRRLD-----HPNV--VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHN 237 (415)
Q Consensus 166 ~E~~~l~~l~-----h~~i--v~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~ 237 (415)
+|+.-+.++. .++| +++ +++- .....|+|||++|--..... .....++...+.....++. +..+=.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V--~we~--t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKV--YWEY--TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEecee--ehhc--cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh
Confidence 3444444441 2222 222 1221 34578999999993222221 1112334333332222221 122224
Q ss_pred CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|++|.|..|.||+++.+|.+-+.|||+...+++.
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 89999999999999999999999999999877643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.3e-06 Score=78.64 Aligned_cols=135 Identities=16% Similarity=0.130 Sum_probs=80.1
Q ss_pred eeccCCc-eEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 125 KIGQGTY-SNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 125 ~lG~G~~-g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
.|-.|.. ..||++.. .+..+.+|...... ...+.+|+.+++.+. +--+++++++... ....++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeC
Confidence 3455555 78999953 34678888765332 234667999988883 4456677776655 345789999998
Q ss_pred cChhhhhcC---------------------C--CCCCCHH--HHHHH----HH----------------HHHHHHHHHH-
Q 014960 203 HDLAGLAAS---------------------P--TIKFTQA--QVKCY----MH----------------QLLSGLEHCH- 236 (415)
Q Consensus 203 ~~l~~~~~~---------------------~--~~~~~~~--~~~~i----~~----------------qi~~~L~~LH- 236 (415)
|..+..... . ...+... ..... +. .+...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 854332110 0 0011100 00000 00 0111122221
Q ss_pred ------hCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 237 ------NQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 237 ------~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999988889999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.4e-06 Score=88.78 Aligned_cols=147 Identities=21% Similarity=0.311 Sum_probs=91.3
Q ss_pred eeeeccCCceEEEEEEECCCC--ceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCce--eeeeeeEeecC-CCeEEE
Q 014960 123 LDKIGQGTYSNVYKARDTLTG--QIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNV--VKLEGLVTSRM-SCSLYL 196 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~l~~~~~~~~-~~~~~l 196 (415)
++.|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.+. |.++ ++++.++.+.. .+..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 567899999999998754432 46788876543221 12346889999999995 6665 77777765521 245789
Q ss_pred EEEecccChhhh------------------------hcC-C--C-------C--CCCHHHHHHHHHH-------------
Q 014960 197 VFKYMEHDLAGL------------------------AAS-P--T-------I--KFTQAQVKCYMHQ------------- 227 (415)
Q Consensus 197 v~e~~~~~l~~~------------------------~~~-~--~-------~--~~~~~~~~~i~~q------------- 227 (415)
||||+.|..+.. +.. . . . .+...++..|..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998853110 000 0 0 0 0112233222221
Q ss_pred --HHHHHHHHHh-----------CCCeeccCCCCCEEEcCC-Cc-EEEEeeccccccC
Q 014960 228 --LLSGLEHCHN-----------QHVLHRDIKGSNLLIDNE-GI-LTIADFGLASFFD 270 (415)
Q Consensus 228 --i~~~L~~LH~-----------~~ivHrDlkp~NILl~~~-~~-vkl~DfG~a~~~~ 270 (415)
+...+++|.. ..+||+|+++.|||++.+ +. +-|+||+++..-+
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2233556632 249999999999999863 33 6799999986544
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.8e-05 Score=69.49 Aligned_cols=129 Identities=25% Similarity=0.327 Sum_probs=90.6
Q ss_pred CCceeeeeeccCCc-eEEEEEEECCCCceEEEEEEec---CC-------CCh---------HHHHHHHHHHHHHHhC---
Q 014960 118 DTFEKLDKIGQGTY-SNVYKARDTLTGQIVALKKVRF---DN-------LEP---------ESVRFMAREILILRRL--- 174 (415)
Q Consensus 118 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~vaiK~~~~---~~-------~~~---------~~~~~~~~E~~~l~~l--- 174 (415)
.+++.++.||.|.- |.||+++ -.|+.||||++.. .. ... ....-|..|....-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 9999995 5678999999432 10 000 1223566677776666
Q ss_pred CCCce--eeeeeeEeec----------------CCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014960 175 DHPNV--VKLEGLVTSR----------------MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236 (415)
Q Consensus 175 ~h~~i--v~l~~~~~~~----------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 236 (415)
.+.++ |+++|+..-. ......||.||+.... .+.... +.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 45566 9999987321 1123567888776533 222223 567788888899
Q ss_pred hCCCeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 237 ~~~ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
..||+-+|+++.|.. .=||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999984 4589999965
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.4e-06 Score=90.65 Aligned_cols=206 Identities=19% Similarity=0.157 Sum_probs=138.3
Q ss_pred HHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe--EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 014960 161 VRFMAREILILRRLDHPNVVKLEGLVTSRMSCS--LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238 (415)
Q Consensus 161 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~--~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 238 (415)
......|+..+.++.|+|++.++.|-..+.... ..+..+++....+..........+...++.+..++++||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 334455777888889999999988765432221 223346677766666667777889999999999999999999999
Q ss_pred CCeeccCCCC---CEEEcCCCcEEEE--eeccccccCCCCCCCcccccccCccCCcccccCC-cCCCchhcHHHHHHHHH
Q 014960 239 HVLHRDIKGS---NLLIDNEGILTIA--DFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILA 312 (415)
Q Consensus 239 ~ivHrDlkp~---NILl~~~~~vkl~--DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ 312 (415)
...|.-|... +-.++.++.+.+. ||+........... ....-+..+.++|..... .......|+|.+|.++.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 6666555555 4444556666666 88887766443221 222335567888876531 12234479999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCC
Q 014960 313 ELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392 (415)
Q Consensus 313 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 392 (415)
.+..|..+-.. ...+.... .........+++.+|+.-|+++|
T Consensus 384 ~~~~~~~i~~~------~~~~~~~l--------------------------------~~~~~~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 384 QLSQGEDISEK------SAVPVSLL--------------------------------DVLSTSELLDALPKCLDEDSEER 425 (1351)
T ss_pred hhhhcCccccc------ccchhhhh--------------------------------ccccchhhhhhhhhhcchhhhhc
Confidence 99987653211 11111100 00111256678899999999999
Q ss_pred CCHHHHhcCCCCCC
Q 014960 393 QTATAALRSEVSLY 406 (415)
Q Consensus 393 ~t~~~~L~h~~f~~ 406 (415)
+.+.++|.|+|.+.
T Consensus 426 l~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 426 LSALELLTHPFLRF 439 (1351)
T ss_pred cchhhhhhchhccc
Confidence 99999999999653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1e-05 Score=68.88 Aligned_cols=130 Identities=22% Similarity=0.213 Sum_probs=90.7
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeeeeeEeecCCCeEEEEEE
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~lv~e 199 (415)
...+.|++|.+|.||++. ..|..+|+|+-+.+. ....++.|+++|+.+.-.++ ++++.+.. .++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech------hhhhhh
Confidence 345779999999999996 456789999876543 33457789999999976665 45554433 345699
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCC-CCCEEEcCCCcEEEEeecccccc
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIK-GSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk-p~NILl~~~~~vkl~DfG~a~~~ 269 (415)
|+.|--+....... . +.-...+++.---|-..||-|+.|. |..++|..++.+.|+||..|+.-
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 99984444332211 1 2224455566555677899999885 66677777779999999999743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=72.77 Aligned_cols=72 Identities=14% Similarity=0.171 Sum_probs=43.6
Q ss_pred eeeccCCce-EEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC---ceeeeeeeEeecCC-CeEEEEE
Q 014960 124 DKIGQGTYS-NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP---NVVKLEGLVTSRMS-CSLYLVF 198 (415)
Q Consensus 124 ~~lG~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~~~~~-~~~~lv~ 198 (415)
+.|+.|+.. .||+. +..+++|..... .....+.+|+++|..+... .++++++....... ...+++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 456766665 58976 234777865431 1234688899999888532 34555544332211 2458899
Q ss_pred EecccC
Q 014960 199 KYMEHD 204 (415)
Q Consensus 199 e~~~~~ 204 (415)
+++.|.
T Consensus 74 ~~i~G~ 79 (235)
T cd05155 74 RWLEGE 79 (235)
T ss_pred EeecCC
Confidence 998874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.14 E-value=6.2e-05 Score=66.52 Aligned_cols=133 Identities=20% Similarity=0.264 Sum_probs=89.4
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCC--------------CChHHHHHHHHHHHHHHhCC------CCceeeee
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDN--------------LEPESVRFMAREILILRRLD------HPNVVKLE 183 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~~iv~l~ 183 (415)
..||+|+.=.||.- . .....+||++.... ..........+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999954 3 34446789987665 11122445566776666555 88999999
Q ss_pred eeEeecCCCeEEEEEEecccC------hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-
Q 014960 184 GLVTSRMSCSLYLVFKYMEHD------LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG- 256 (415)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~------l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~- 256 (415)
|+.++. ...-+|+|.+... .+..+... ..+++ .. ...+-+-..||-+.+|+.+||+|.||++....
T Consensus 84 G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETN--LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecC--CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999884 4588999987642 23333322 24555 33 33444555788899999999999999996533
Q ss_pred ---cEEEEe-eccc
Q 014960 257 ---ILTIAD-FGLA 266 (415)
Q Consensus 257 ---~vkl~D-fG~a 266 (415)
.+.|+| ||..
T Consensus 157 ~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 157 GEFRLVLIDGLGEK 170 (199)
T ss_pred CceEEEEEeCCCCc
Confidence 477777 5544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=2e-05 Score=69.18 Aligned_cols=99 Identities=24% Similarity=0.263 Sum_probs=78.2
Q ss_pred HHHHHHHhCCC-CceeeeeeeEeecCCCeEEEEEEecccC-hhhh--hcCCCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 014960 166 REILILRRLDH-PNVVKLEGLVTSRMSCSLYLVFKYMEHD-LAGL--AASPTIKFTQAQVKCYMHQLLSGLEHCHN---Q 238 (415)
Q Consensus 166 ~E~~~l~~l~h-~~iv~l~~~~~~~~~~~~~lv~e~~~~~-l~~~--~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~ 238 (415)
.|.-+++.+++ +++++++|++- .++|.||++.. +... .+......++..+..|+.++++.+++|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48888898875 69999999863 46788999864 3211 11222356899999999999999999997 3
Q ss_pred CCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 239 ~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
.+.-.|++++|+-|++++.+|++|...+...+
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 47779999999999999999999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.6e-05 Score=76.61 Aligned_cols=140 Identities=16% Similarity=0.157 Sum_probs=84.5
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCC-----------------------------hHHHHH------HHHHH
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-----------------------------PESVRF------MAREI 168 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----------------------------~~~~~~------~~~E~ 168 (415)
+.||.-+.|+||+|+-+. |+.||+|+-+..-.. .+..+. |.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 469999999999998654 999999986532100 111112 22233
Q ss_pred HHHHh----CCCCc------eeeeeeeEeecCCCeEEEEEEecccC---hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 014960 169 LILRR----LDHPN------VVKLEGLVTSRMSCSLYLVFKYMEHD---LAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235 (415)
Q Consensus 169 ~~l~~----l~h~~------iv~l~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L 235 (415)
+-..+ +.|-+ |++++-.+ .....|+||||+|. .+..+... .++...+...+.++..- -|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~--qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLE--QI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHH--HH
Confidence 22222 23444 44443222 34589999999993 22222222 34444443333332221 12
Q ss_pred HhCCCeeccCCCCCEEEcC----CCcEEEEeeccccccCCC
Q 014960 236 HNQHVLHRDIKGSNLLIDN----EGILTIADFGLASFFDPN 272 (415)
Q Consensus 236 H~~~ivHrDlkp~NILl~~----~~~vkl~DfG~a~~~~~~ 272 (415)
=..|++|+|-.|.||+++. ++.+.+.|||+...+...
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2468999999999999984 568999999999877543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00012 Score=66.61 Aligned_cols=73 Identities=14% Similarity=0.170 Sum_probs=45.9
Q ss_pred eeeeccCCceEEEEEEECC-CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeeeeeEeecCCCeEEEEEEe
Q 014960 123 LDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
++.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+...+ .+++++.+. + .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence 3567888889999996433 356788997653211 1123346888888885333 455544332 1 379999
Q ss_pred cccC
Q 014960 201 MEHD 204 (415)
Q Consensus 201 ~~~~ 204 (415)
++|.
T Consensus 74 i~G~ 77 (235)
T cd05157 74 IPGR 77 (235)
T ss_pred eCCC
Confidence 9874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=2.8e-06 Score=92.20 Aligned_cols=217 Identities=11% Similarity=-0.072 Sum_probs=140.8
Q ss_pred HHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHH
Q 014960 160 SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHC 235 (415)
Q Consensus 160 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~L 235 (415)
..+....|...++...|+++.....-..+..+...|.+++++.++.+...+.. ...+.+..+.....+.+....-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 33444455556666789998877665655556678999999988766655432 22233333444444446666666
Q ss_pred HhC-----CCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHH
Q 014960 236 HNQ-----HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 310 (415)
Q Consensus 236 H~~-----~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~i 310 (415)
|+. -.+|++||+-|.+|..+.++|+.++|+.+.. .......+..++++.|+.+++.. ...++.++|+|..|+.
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLS 1429 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHH
Confidence 643 2799999999999999999999999999833 23334455667788999999764 3567788999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCC
Q 014960 311 LAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390 (415)
Q Consensus 311 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 390 (415)
+|+...|.++|. ...+.+++....... ..+...-.|.+.-.+...+|-....
T Consensus 1430 ly~rs~~n~~fi-----~flq~~Lkgiidn~t-----------------------f~sIe~l~pgdaNve~~~~Ll~K~~ 1481 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFI-----FFLQPALKGIIDNHT-----------------------FFSIEKLKPGDANVEALHRLLWKYM 1481 (2724)
T ss_pred HHHHhcccHHHH-----HHHHHHHcCcccccc-----------------------cccccccCCCcccHHHHHHHHHHhh
Confidence 999998888762 222222222111000 0011112345555566667777777
Q ss_pred CCCCHHHHhcCCCCCC
Q 014960 391 ERQTATAALRSEVSLY 406 (415)
Q Consensus 391 ~R~t~~~~L~h~~f~~ 406 (415)
.||.-...+.-+.|-.
T Consensus 1482 ~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1482 ERPGQYISLSRDHFAV 1497 (2724)
T ss_pred hcchhhhhcccccccc
Confidence 7777777776665543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00037 Score=66.00 Aligned_cols=77 Identities=14% Similarity=0.156 Sum_probs=53.5
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC---CceeeeeeeEeec-CCCeEEEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH---PNVVKLEGLVTSR-MSCSLYLV 197 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~l~~~~~~~-~~~~~~lv 197 (415)
-.+.||.|..+.||.... .++ .+.+|..+ .. .....+..|+..|+.|.- -.++++++++... ..+..++|
T Consensus 18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~-~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYD-SQG-NPMPLMAR-SF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEc-CCC-CEEEEEec-cc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 346799999999999853 223 46778743 21 122478889999998853 3678888876542 23558999
Q ss_pred EEecccC
Q 014960 198 FKYMEHD 204 (415)
Q Consensus 198 ~e~~~~~ 204 (415)
||++++.
T Consensus 92 mE~i~G~ 98 (297)
T PRK10593 92 LERLRGV 98 (297)
T ss_pred EeccCCE
Confidence 9998874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00036 Score=66.19 Aligned_cols=141 Identities=20% Similarity=0.268 Sum_probs=98.0
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCC-------------------C-ChHHHH----HHHHHHHHHHhCCCCce
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-------------------L-EPESVR----FMAREILILRRLDHPNV 179 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------------~-~~~~~~----~~~~E~~~l~~l~h~~i 179 (415)
.+|..|--+.||.|. ..+|..+|||+++-.- . ..+..+ -...|+.-|.+|+..+|
T Consensus 150 GCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 568888899999998 5678889999864210 0 001111 12347777777776665
Q ss_pred eeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCCCCCEEEcCCCcE
Q 014960 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNEGIL 258 (415)
Q Consensus 180 v~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NILl~~~~~v 258 (415)
+----.... .-.|||+|++.+-.-.-......++...+..+-.+++..+.-|- ..++||.||.-=|+|+.+ |.+
T Consensus 229 P~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 229 PCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence 433222221 25799999997544433444557788888888888888888775 579999999999998864 789
Q ss_pred EEEeeccccccC
Q 014960 259 TIADFGLASFFD 270 (415)
Q Consensus 259 kl~DfG~a~~~~ 270 (415)
.|+|.+-+...+
T Consensus 304 yiIDVSQSVE~D 315 (520)
T KOG2270|consen 304 YIIDVSQSVEHD 315 (520)
T ss_pred EEEEccccccCC
Confidence 999999886554
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00049 Score=67.36 Aligned_cols=77 Identities=19% Similarity=0.106 Sum_probs=53.0
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCC-----ChHHHHHHHHHHHHHHhCC---CCceeeeeeeEeecCCCeE
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-----EPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~ 194 (415)
.+.||.|.+..||++.+...++.|+||.-..... .+-..++...|.+.|+.+. -..+++++.+.. ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----CCC
Confidence 3679999999999998754445899998542110 0223456777888888763 346788876633 337
Q ss_pred EEEEEeccc
Q 014960 195 YLVFKYMEH 203 (415)
Q Consensus 195 ~lv~e~~~~ 203 (415)
++|||++++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00016 Score=66.89 Aligned_cols=134 Identities=19% Similarity=0.210 Sum_probs=76.5
Q ss_pred eccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeeeeeEeecCCCeEEEEEEecccC
Q 014960 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 126 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
+..|-...+|+.. .++..|++|......... . -...+|..+++.+...++ ++++.... -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCc
Confidence 5567788999885 456678888754322111 0 124678899998864333 44544321 25899999884
Q ss_pred hhhhh-------------------cC--CCCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCeeccC
Q 014960 205 LAGLA-------------------AS--PTIKFTQA-QVKCYMHQL---------LSGLEHCHN--------QHVLHRDI 245 (415)
Q Consensus 205 l~~~~-------------------~~--~~~~~~~~-~~~~i~~qi---------~~~L~~LH~--------~~ivHrDl 245 (415)
.+... .. ....+... .+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 32210 00 01111211 112222112 111222221 24899999
Q ss_pred CCCCEEEcCCCcEEEEeeccccccC
Q 014960 246 KGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 246 kp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
.|.||+++.++ +.|+||..|..-+
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcCC
Confidence 99999999877 7899999886543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00052 Score=65.66 Aligned_cols=31 Identities=26% Similarity=0.428 Sum_probs=26.7
Q ss_pred CCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
.+++|+|+.+.|||++.+..+-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999999766668999998854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00073 Score=63.88 Aligned_cols=139 Identities=15% Similarity=0.127 Sum_probs=80.9
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeeeeeEe----ecCCCeEEE
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVT----SRMSCSLYL 196 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~----~~~~~~~~l 196 (415)
.+.|..|....+|++.. .+..+++|+... . ....+..|+.+++.+.+.+ +++++.... ....+..++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 46688888889999853 345688998753 1 1234666888888774333 444433210 011345789
Q ss_pred EEEecccChhhh----------------h--cCC-CC------CCCHHHH----------HHHHHHHHHHHHHHHh----
Q 014960 197 VFKYMEHDLAGL----------------A--ASP-TI------KFTQAQV----------KCYMHQLLSGLEHCHN---- 237 (415)
Q Consensus 197 v~e~~~~~l~~~----------------~--~~~-~~------~~~~~~~----------~~i~~qi~~~L~~LH~---- 237 (415)
++++++|..... + ... .. ...+... ......+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999998743211 0 000 00 0000000 0011122334444443
Q ss_pred ---CCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 238 ---QHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 238 ---~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999987789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00097 Score=63.47 Aligned_cols=143 Identities=15% Similarity=0.138 Sum_probs=80.9
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeeeeeE----eecCCCe
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLV----TSRMSCS 193 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~----~~~~~~~ 193 (415)
...++.++.|....+|++.. .+ ..+++|+..... . ...+..|++++..|...+ +++++... .....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~-~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DV-GRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CC-CcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 33456678888889999863 33 458889875421 1 223445677777764222 34443321 1112356
Q ss_pred EEEEEEecccChhh----------------hhc-CCCC--------CCC-HHHH--H----------HHHHHHHHHHHHH
Q 014960 194 LYLVFKYMEHDLAG----------------LAA-SPTI--------KFT-QAQV--K----------CYMHQLLSGLEHC 235 (415)
Q Consensus 194 ~~lv~e~~~~~l~~----------------~~~-~~~~--------~~~-~~~~--~----------~i~~qi~~~L~~L 235 (415)
.+++++|++|.... .+. .... .+. +... . .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999873210 000 0000 000 0000 0 0112233445555
Q ss_pred Hh-------CCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 236 HN-------QHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 236 H~-------~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 42 5799999999999999988779999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00061 Score=64.65 Aligned_cols=72 Identities=24% Similarity=0.239 Sum_probs=44.8
Q ss_pred eeeccCCceEEEEEEECC------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeeeeeEeecCCCeEEE
Q 014960 124 DKIGQGTYSNVYKARDTL------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~~~l 196 (415)
+.|..|-...||++.... .++.|++|+..... .......+|+.+++.+...+ .+++++++.. .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN------GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC------Cc
Confidence 456677778899886432 25789999865432 12234567888888885333 3455555432 25
Q ss_pred EEEecccC
Q 014960 197 VFKYMEHD 204 (415)
Q Consensus 197 v~e~~~~~ 204 (415)
|+||++|.
T Consensus 75 v~e~i~G~ 82 (302)
T cd05156 75 IEEFIPSR 82 (302)
T ss_pred hhheeCCC
Confidence 78888774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.002 Score=61.00 Aligned_cols=149 Identities=21% Similarity=0.234 Sum_probs=85.2
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeeeeeEeecCCCeEEEEE
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--PNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.+.+.+-.|-.-.+|...+ +++.+++. ...............+|..+++.+.- --+...++++.+..-+..|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3444443444445555543 37788888 43223344556677889999988743 2334445555543224679999
Q ss_pred EecccChhhhhcCC------------------------------C--CCCCHHHHHHHHHHH--------------HHHH
Q 014960 199 KYMEHDLAGLAASP------------------------------T--IKFTQAQVKCYMHQL--------------LSGL 232 (415)
Q Consensus 199 e~~~~~l~~~~~~~------------------------------~--~~~~~~~~~~i~~qi--------------~~~L 232 (415)
+|+.|......... . ..+...++..+..+. ....
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99988311100000 0 001111222222211 2223
Q ss_pred HHHHhC--------CCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 233 EHCHNQ--------HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 233 ~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+.+ .+||+|+++.||+++.++.+=|+||+++..-++.
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 444432 4899999999999999999999999999776543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00015 Score=67.63 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=92.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC--------------------hHHHHHHHHHHHHHHhCCCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--------------------PESVRFMAREILILRRLDHP 177 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~ 177 (415)
.-+.+++.||-|--+.||.+-+ ..|.++++|.=++.... .-..-...+|...|+.|.-.
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3577889999999999999975 45788889854322111 00111234677888887432
Q ss_pred --ceeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC
Q 014960 178 --NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (415)
Q Consensus 178 --~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 255 (415)
-+++.+++ +.-++|||++.+--+..... ...+..+...+..-+--|-.+|+||+|+.-=||+|+++
T Consensus 171 gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 171 GFPVPKPIDH------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCCcccc------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence 24444443 33578999988744332221 11223344555556667788999999999999999999
Q ss_pred CcEEEEeecccccc
Q 014960 256 GILTIADFGLASFF 269 (415)
Q Consensus 256 ~~vkl~DfG~a~~~ 269 (415)
+.++++||--+...
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 99999999866544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0017 Score=60.73 Aligned_cols=31 Identities=23% Similarity=0.359 Sum_probs=25.9
Q ss_pred CCeeccCCCCCEEEcCCCc-EEEEeecccccc
Q 014960 239 HVLHRDIKGSNLLIDNEGI-LTIADFGLASFF 269 (415)
Q Consensus 239 ~ivHrDlkp~NILl~~~~~-vkl~DfG~a~~~ 269 (415)
.++|+|+++.|||++.++. +-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 3899999999999997565 569999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0021 Score=61.84 Aligned_cols=151 Identities=16% Similarity=0.236 Sum_probs=82.0
Q ss_pred cCCCCCCCCCceeeeeeccCCceEEEEEEECCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeeeee
Q 014960 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGL 185 (415)
Q Consensus 110 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~ 185 (415)
.+|.....+...+ +.|..|-...+|++..... +..|++|+..... +..-.-.+|..+++.+...++ ++++++
T Consensus 7 ~~w~~~~~~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~ 82 (330)
T PLN02421 7 KGWSDLDDSDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGV 82 (330)
T ss_pred CccccCCcCceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEE
Confidence 3454333334444 4455587888998864322 2378889765321 112233568888888865444 566665
Q ss_pred EeecCCCeEEEEEEecccChhhh-------------------hcCC--C-CCC-CHHHHHHHHHHH--------------
Q 014960 186 VTSRMSCSLYLVFKYMEHDLAGL-------------------AASP--T-IKF-TQAQVKCYMHQL-------------- 228 (415)
Q Consensus 186 ~~~~~~~~~~lv~e~~~~~l~~~-------------------~~~~--~-~~~-~~~~~~~i~~qi-------------- 228 (415)
+.. + +|.+|+.+..+.. +... . ..+ ....+..+..++
T Consensus 83 ~~~--G----~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~ 156 (330)
T PLN02421 83 FGN--G----MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKY 156 (330)
T ss_pred eCC--c----EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhh
Confidence 532 2 4788887642211 0000 0 001 122222222221
Q ss_pred --------HHHHHHHH----hCC----CeeccCCCCCEEEcC-CCcEEEEeeccccccC
Q 014960 229 --------LSGLEHCH----NQH----VLHRDIKGSNLLIDN-EGILTIADFGLASFFD 270 (415)
Q Consensus 229 --------~~~L~~LH----~~~----ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~ 270 (415)
..-+..+. ..+ +.|+|+-+.|||+++ ++.++++||..|..-+
T Consensus 157 ~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 157 ETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred cccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 11111111 112 799999999999975 5789999999886543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00099 Score=65.84 Aligned_cols=172 Identities=22% Similarity=0.256 Sum_probs=111.1
Q ss_pred HHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 014960 163 FMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242 (415)
Q Consensus 163 ~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 242 (415)
.+.....+++.+.|+|+...+++-.... ....+|+|+++.++......+. +-.. +++ .+++.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHYTMSLEDILKTGN--LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhhccchHHHHHhcc--cchh-------hhc-------ccccce
Confidence 3445688899999999999998877654 4589999999987766544432 1100 111 122222
Q ss_pred ccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCC
Q 014960 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP 322 (415)
Q Consensus 243 rDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~ 322 (415)
-|| ++.+| -++ |. | |- ..++++||||+|.++.++.-|...|.
T Consensus 91 -----~~~-------~~~td-~~~----------------t~-~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFL----------------TK-Y--PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----ehh-------hhccc-ccc----------------cc-C--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 122 22333 110 00 1 11 12259999999999999999999888
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCC
Q 014960 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (415)
Q Consensus 323 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~ 402 (415)
.....+....+.+....+....- -.+-.......+..+.++.++|+-..|..||...++..+.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~-----------------~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLS-----------------TAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHH-----------------HHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 88888888877776543321110 0011122335667788999999999999999999999888
Q ss_pred CCCC
Q 014960 403 VSLY 406 (415)
Q Consensus 403 ~f~~ 406 (415)
-|..
T Consensus 196 i~~e 199 (725)
T KOG1093|consen 196 SFTE 199 (725)
T ss_pred cHHH
Confidence 7754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0067 Score=58.71 Aligned_cols=140 Identities=16% Similarity=0.182 Sum_probs=79.4
Q ss_pred eeeeeccCCceEEEEEEECC----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeeeeeEeecCCCeEEE
Q 014960 122 KLDKIGQGTYSNVYKARDTL----TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~l 196 (415)
-+..|-.|-.-.+|++.... .++.|++|+..... +..-...+|..+++.+...++ +++++.+.. + .
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--g----~ 110 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFPN--G----R 110 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEECC--c----e
Confidence 34456668888999986322 24678899775432 111123568888888854444 456665532 2 4
Q ss_pred EEEecccChhhhh------------------cC---CCC--CCCHHHHHHHHHHH-----------------HHHHHHH-
Q 014960 197 VFKYMEHDLAGLA------------------AS---PTI--KFTQAQVKCYMHQL-----------------LSGLEHC- 235 (415)
Q Consensus 197 v~e~~~~~l~~~~------------------~~---~~~--~~~~~~~~~i~~qi-----------------~~~L~~L- 235 (415)
|.+|+++..+... .. ... ......+..++.++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7888876332110 00 000 11122232332221 1111122
Q ss_pred ---H----hCCCeeccCCCCCEEEcC-CCcEEEEeeccccccC
Q 014960 236 ---H----NQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFD 270 (415)
Q Consensus 236 ---H----~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~ 270 (415)
. ...++|+|+++.|||+++ ++.+.|+||..+..-.
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 1 225899999999999986 4689999999886543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0049 Score=59.30 Aligned_cols=75 Identities=19% Similarity=0.146 Sum_probs=47.1
Q ss_pred eeccCCceEEEEEEECCCCceEEEEEEecC-----CCChHHHHHHHHHHHHHHhCC--CC-ceeeeeeeEeecCCCeEEE
Q 014960 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFD-----NLEPESVRFMAREILILRRLD--HP-NVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~E~~~l~~l~--h~-~iv~l~~~~~~~~~~~~~l 196 (415)
.||.|....||++.+...++.++||.-..- ...+-...+...|...|+... -| .+++++.+-. ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~----e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT----EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc----cccee
Confidence 479999999999987544467999974311 111222344456777777653 23 5667765432 23568
Q ss_pred EEEeccc
Q 014960 197 VFKYMEH 203 (415)
Q Consensus 197 v~e~~~~ 203 (415)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.011 Score=58.04 Aligned_cols=75 Identities=16% Similarity=0.167 Sum_probs=50.0
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCC-C----hHHHHHHHHHHHHHHhCC---CCceeeeeeeEeecCCCeE
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-E----PESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~ 194 (415)
.+.||.|....||+..+ .+..|+||+-..... . +....+-..|+..|+.+. ...+++++.++.+ ..
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CC
Confidence 56799999999999975 345688997652111 0 113344445677776653 3578888877664 26
Q ss_pred EEEEEeccc
Q 014960 195 YLVFKYMEH 203 (415)
Q Consensus 195 ~lv~e~~~~ 203 (415)
+++||++.+
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999966
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0057 Score=59.56 Aligned_cols=77 Identities=18% Similarity=0.138 Sum_probs=49.4
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEec----CCCChHHHHHHHHHHHHHHhCC--CC-ceeeeeeeEeecCCCeEE
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRF----DNLEPESVRFMAREILILRRLD--HP-NVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~E~~~l~~l~--h~-~iv~l~~~~~~~~~~~~~ 195 (415)
.+.||.|.-.-||++.+...++.|+||.-.. ....+-...+...|.++|+.+. .| .+++++.+-. ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence 5679999999999998744456789997431 1111233445556778887763 23 5677765432 2366
Q ss_pred EEEEeccc
Q 014960 196 LVFKYMEH 203 (415)
Q Consensus 196 lv~e~~~~ 203 (415)
+|||++..
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88888753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0062 Score=58.01 Aligned_cols=30 Identities=27% Similarity=0.291 Sum_probs=27.8
Q ss_pred CCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 239 HVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 239 ~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998854
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.01 Score=56.62 Aligned_cols=73 Identities=26% Similarity=0.355 Sum_probs=57.4
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
..+.|++|++-++.+...- .-..+++..++++.+..++-+..+ ..-|||+.-.||||+ +|+|.|+||-+++.-
T Consensus 298 ~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 5678888888776544321 234677888888888777777754 689999999999999 999999999999854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.012 Score=55.34 Aligned_cols=75 Identities=15% Similarity=0.185 Sum_probs=46.7
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeeeeeEeecCCCeEEEE
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+-.+.++.|....+|+.. .+++.|.+|+-.. .....|..|++-|+.|. --.+++.+++.... ..-||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEE
Confidence 345679999999999985 6778899998762 23356778888888873 45577888877663 335899
Q ss_pred EEecccC
Q 014960 198 FKYMEHD 204 (415)
Q Consensus 198 ~e~~~~~ 204 (415)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998654
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0082 Score=53.71 Aligned_cols=30 Identities=30% Similarity=0.633 Sum_probs=21.3
Q ss_pred CCeeccCCCCCEEE-cCCCcEEEEeeccccc
Q 014960 239 HVLHRDIKGSNLLI-DNEGILTIADFGLASF 268 (415)
Q Consensus 239 ~ivHrDlkp~NILl-~~~~~vkl~DfG~a~~ 268 (415)
-+.|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.023 Score=55.65 Aligned_cols=91 Identities=18% Similarity=0.151 Sum_probs=49.2
Q ss_pred ccccCCCCCCCCCceeeeeeccCCceEEEEEEECCC-CceEEEEEE-ec-CCCChHHHHHHHHHHHHHHhCCCCc-eeee
Q 014960 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLT-GQIVALKKV-RF-DNLEPESVRFMAREILILRRLDHPN-VVKL 182 (415)
Q Consensus 107 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~-~~-~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l 182 (415)
+.+..|.....+.+.+ +.|..|-...+|++..... +..+.+|.+ .. -....+..-.-.+|+.+++.+...+ -+++
T Consensus 40 ~~~p~w~~~~~~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l 118 (383)
T PTZ00384 40 RHVPFWNNVNPEFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKI 118 (383)
T ss_pred HHCCccccCCcccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeE
Confidence 3444565443344444 4566688899999964332 223323321 11 0111111122346899999986544 4666
Q ss_pred eeeEeecCCCeEEEEEEecccC
Q 014960 183 EGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 183 ~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
++.+. -+++.||++|.
T Consensus 119 ~~~f~------~g~l~efIeGr 134 (383)
T PTZ00384 119 IGRFG------DFTIQEWVEGN 134 (383)
T ss_pred EEecC------CEEEEEEeccc
Confidence 66654 25889999874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.14 Score=56.74 Aligned_cols=31 Identities=32% Similarity=0.611 Sum_probs=26.6
Q ss_pred CCCeeccCCCCCEEEcCCC--cEE-EEeeccccc
Q 014960 238 QHVLHRDIKGSNLLIDNEG--ILT-IADFGLASF 268 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~--~vk-l~DfG~a~~ 268 (415)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999998854
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.094 Score=50.24 Aligned_cols=136 Identities=16% Similarity=0.204 Sum_probs=77.8
Q ss_pred eeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc------eeeeeeeEeecCCC--eEEE
Q 014960 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN------VVKLEGLVTSRMSC--SLYL 196 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~l~~~~~~~~~~--~~~l 196 (415)
.|.+ .-..||++.. .+..+++|+.... .. ...+..|+..|..|.-.+ +..+-|-....-.. +.+-
T Consensus 33 ~l~s-~eN~~f~~~~--~~g~~iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 33 GLNS-EENSNFRVQT--EDGRYILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred cccc-ccCceEEEEe--cCCCeEEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 3445 5567898863 3334589988765 32 234556777777763211 33333322222233 7888
Q ss_pred EEEecccChhhh-----------------hc-CCCC---------CCCHH----HH---------HHHHHHHHHHHHHHH
Q 014960 197 VFKYMEHDLAGL-----------------AA-SPTI---------KFTQA----QV---------KCYMHQLLSGLEHCH 236 (415)
Q Consensus 197 v~e~~~~~l~~~-----------------~~-~~~~---------~~~~~----~~---------~~i~~qi~~~L~~LH 236 (415)
+++|++|..... +. .+.. ...+. .. .....++...++.+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999998854431 00 0000 01111 00 012334445555555
Q ss_pred h--------CC--CeeccCCCCCEEEcCCCc-EEEEeecccc
Q 014960 237 N--------QH--VLHRDIKGSNLLIDNEGI-LTIADFGLAS 267 (415)
Q Consensus 237 ~--------~~--ivHrDlkp~NILl~~~~~-vkl~DfG~a~ 267 (415)
+ .+ +||+|+.|.|||++.+.. +.++||+.+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 23 999999999999999885 9999999874
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.082 Score=52.88 Aligned_cols=86 Identities=10% Similarity=0.167 Sum_probs=51.1
Q ss_pred ccCCCCCCCCCceeeeeeccCCceEEEEEEECC--------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-
Q 014960 109 ISGWTPRRADTFEKLDKIGQGTYSNVYKARDTL--------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV- 179 (415)
Q Consensus 109 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i- 179 (415)
+.+|.....++. -++.|..|-.-.+|++.... .++.|.+++.-... +..-....|..+++.+...+|
T Consensus 97 vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~~gi~ 172 (442)
T PTZ00296 97 VPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSKYRIA 172 (442)
T ss_pred CCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHHCCCC
Confidence 445653333444 56678888888999987432 14678888764321 111233458888887755444
Q ss_pred eeeeeeEeecCCCeEEEEEEecccC
Q 014960 180 VKLEGLVTSRMSCSLYLVFKYMEHD 204 (415)
Q Consensus 180 v~l~~~~~~~~~~~~~lv~e~~~~~ 204 (415)
+++++.+.. +.+.||+.+.
T Consensus 173 P~l~~~f~g------g~I~efi~g~ 191 (442)
T PTZ00296 173 PQLLNTFSG------GRIEEWLYGD 191 (442)
T ss_pred CceEEEeCC------CEEEEeeCCc
Confidence 356655431 3567888764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.31 Score=46.76 Aligned_cols=28 Identities=25% Similarity=0.201 Sum_probs=24.0
Q ss_pred CCCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 238 QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
.+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.12 Score=46.22 Aligned_cols=116 Identities=17% Similarity=0.210 Sum_probs=69.8
Q ss_pred CCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEecccChhhh
Q 014960 129 GTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL 208 (415)
Q Consensus 129 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~ 208 (415)
++.++.-.+...- | ...+|+++.-...- ....+..+..++.++. +|+++.. + ..-.+-++.|.|..--
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N---D-n~~~yGvIlE~Cy~~~--- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN---D-NNYKYGVILERCYKIK--- 140 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec---C-CCceeEEEEeeccCcc---
Confidence 4444444443222 3 34566665433321 2245567788877653 6777752 2 2445778888886311
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 209 AASPTIKFTQAQVKCYMHQLLSGLEHCHN--QHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 209 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
..... ++.-=+..|.-.|+ .+.+|||..|+||+-|..|.+||.|-+.-
T Consensus 141 ------i~~~N----~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 ------INFSN----FITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------cchhH----HHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 01111 11111456777883 46999999999999999999999997743
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.043 Score=52.14 Aligned_cols=30 Identities=20% Similarity=0.406 Sum_probs=26.1
Q ss_pred CCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999988 6789999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.024 Score=49.44 Aligned_cols=31 Identities=32% Similarity=0.417 Sum_probs=26.8
Q ss_pred CeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 240 ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
.+|+|+.|.||++++++ ++|+||+.|..-++
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp 109 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDGDI 109 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccCCCH
Confidence 69999999999998877 99999999865443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 415 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-61 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-61 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-61 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-61 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-57 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-57 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-56 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-56 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-56 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-56 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-56 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-56 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-56 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-56 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-56 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-56 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-56 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-56 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-56 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-56 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-56 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-56 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-55 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-55 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-55 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-55 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-55 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-55 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-55 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-55 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-55 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-55 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-55 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-55 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-55 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-55 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-55 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-55 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-55 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-55 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-54 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-54 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-52 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-51 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-50 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-50 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-50 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-50 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-47 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-46 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-44 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-44 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-44 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-44 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-44 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-44 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-44 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-41 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-40 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-40 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-40 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-40 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-40 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-40 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-40 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-40 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-40 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-40 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-40 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-40 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-40 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-40 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-40 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-40 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-40 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-40 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-40 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-39 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-39 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-39 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-39 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-39 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-39 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-39 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-39 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-39 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-39 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-39 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-39 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-39 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-39 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-39 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-38 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-38 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-38 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-38 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-38 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-38 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-38 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-38 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-38 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-38 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-38 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-38 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-38 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-38 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-38 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-38 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-38 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-38 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-38 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-38 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-38 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-38 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-38 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-38 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-38 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-38 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-38 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-38 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-38 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-38 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-38 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-38 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-38 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-38 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-38 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-38 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-38 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-38 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-38 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-38 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-38 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-38 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-38 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-38 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-38 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-38 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-38 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-38 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-38 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-38 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-38 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-38 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-38 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-38 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-38 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-38 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-38 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-38 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-38 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-38 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-38 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-38 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-38 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-38 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-38 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-38 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-38 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-38 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-37 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-37 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-37 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-37 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-37 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-37 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-37 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-37 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-37 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-36 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-36 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-35 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-34 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-34 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-34 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-34 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-32 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-32 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-32 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-32 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-32 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-32 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-30 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-30 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-30 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-30 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-30 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-30 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-30 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-30 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-30 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-29 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-29 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-29 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-29 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-29 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-29 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-29 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-29 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-29 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-29 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-28 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-28 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-26 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-26 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-26 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-26 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-26 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-25 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-25 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-25 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-25 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-25 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-25 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-25 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-25 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-25 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-25 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-25 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-25 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-24 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-23 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-21 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-20 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-16 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-14 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-14 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 492 bits (1269), Expect = e-175
Identities = 134/309 (43%), Positives = 178/309 (57%), Gaps = 14/309 (4%)
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA- 165
+++ +EKL KIGQGT+ V+KAR TGQ VALKKV +N E E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 166 REILILRRLDHPNVVKLEGLVTSRMS------CSLYLVFKYMEHDLAGLAASPTIKFTQA 219
REI IL+ L H NVV L + ++ S S+YLVF + EHDLAGL ++ +KFT +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK---QP 276
++K M LL+GL + H +LHRD+K +N+LI +G+L +ADFGLA F
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
T+RVVTLWYRPPELLLG DYG +DLW AGCI+AE+ PIM G TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 337 CGSPSEEYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSS--LPLIETLLAIDPAERQ 393
CGS + E W + + KR + + K + L LI+ LL +DPA+R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 394 TATAALRSE 402
+ AL +
Sbjct: 305 DSDDALNHD 313
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 446 bits (1150), Expect = e-157
Identities = 124/295 (42%), Positives = 172/295 (58%), Gaps = 11/295 (3%)
Query: 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMA-REIL 169
RA +EKLD +G+G ++ VYKARD T QIVA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
+L+ L HPN++ L + + + LVF +ME DL + ++ T + +K YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRP 288
GLE+ H +LHRD+K +NLL+D G+L +ADFGLA SF PN T +VVT WYR
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRA 180
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 347
PELL GA YGVGVD+W+ GCILAELL P +PG ++++QL +IF+ G+P+EE W
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
LP FK + F L LI+ L +P R TAT AL+ +
Sbjct: 241 CSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 391 bits (1008), Expect = e-136
Identities = 117/296 (39%), Positives = 173/296 (58%), Gaps = 9/296 (3%)
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REI 168
+ + + ++KL+K+G+GTY VYKA+D+ G+IVALK++R D E E + A REI
Sbjct: 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREI 70
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL 228
+L+ L HPN+V L ++ S L LVF++ME DL + +Q+K Y++QL
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYR 287
L G+ HCH +LHRD+K NLLI+++G L +ADFGLA F P T VVTLWYR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYR 186
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
P++L+G+ Y VD+WS GCI AE++ KP+ PG T+ +QL KIF + G+P+ W +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246
Query: 348 -SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+LP Q K+ + F + L+ +L DP +R +A A+
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 389 bits (1002), Expect = e-135
Identities = 108/299 (36%), Positives = 154/299 (51%), Gaps = 17/299 (5%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF---MAREILIL 171
+E + +IG G Y VYKARD +G VALK VR N RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 172 RRL---DHPNVVKLEGLVTSR---MSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCY 224
RRL +HPNVV+L + + + LVF++++ DL L +P +K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
M Q L GL+ H ++HRD+K N+L+ + G + +ADFGLA + +T VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTL 183
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
WYR PE+LL +T Y VD+WS GCI AE+ KP+ G +E +QL KIF L G P E+
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 345 WKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
W + LP F P+ R + + S L+ +L +P +R +A AL+
Sbjct: 243 WPRDVSLPRGA-FPPRG--PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 384 bits (990), Expect = e-134
Identities = 118/289 (40%), Positives = 169/289 (58%), Gaps = 10/289 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKH 60
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V+L ++ S L LVF++ + DL S VK ++ QLL GL CH
Sbjct: 61 KNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGA 295
+++VLHRD+K NLLI+ G L +A+FGLA F P ++ VVTLWYRPP++L GA
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGA 176
Query: 296 TDYGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHA 353
Y +D+WSAGCI AEL A +P+ PG +QL +IF+L G+P+EE W +KLP
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ P + + L++ LL +P +R +A AL+
Sbjct: 237 KPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 386 bits (993), Expect = e-134
Identities = 107/287 (37%), Positives = 156/287 (54%), Gaps = 7/287 (2%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+T+ KLDK+G+GTY+ VYK + LT +VALK++R ++ E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+V L ++ + S L LVF+Y++ DL VK ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGAT 296
Q VLHRD+K NLLI+ G L +ADFGLA P + VVTLWYRPP++LLG+T
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGST 176
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATI 355
DY +D+W GCI E+ +P+ PG T EQLH IF++ G+P+EE W
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ + + L+ LL + R +A A++
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-133
Identities = 109/288 (37%), Positives = 163/288 (56%), Gaps = 10/288 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+ + L+KIG+GTY VYKA++ G+ ALKK+R + E E + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+VKL ++ ++ L LVF++++ DL L K ++ QLL+G+ +CH
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGA 295
++ VLHRD+K NLLI+ EG L IADFGLA F P T +VTLWYR P++L+G+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS 175
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
Y +D+WS GCI AE++ P+ PG +E +QL +IF++ G+P+ + W ++LP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
K S + L+ +L +DP +R TA AL
Sbjct: 236 PNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-131
Identities = 105/299 (35%), Positives = 165/299 (55%), Gaps = 14/299 (4%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILI 170
+ D + ++ K+G+GTY VYKA DT+T + VA+K++R ++ E E V A RE+ +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSL 86
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLS 230
L+ L H N+++L+ ++ L+L+F+Y E+DL + +K +++QL++
Sbjct: 87 LKELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLIN 143
Query: 231 GLEHCHNQHVLHRDIKGSNLLID-----NEGILTIADFGLASFF-DPNHKQPMTSRVVTL 284
G+ CH++ LHRD+K NLL+ +L I DFGLA F P T ++TL
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITL 201
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
WYRPPE+LLG+ Y VD+WS CI AE+L + P+ PG +E++QL KIF++ G P +
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 345 WKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
W + LP P+ K L L+ +L +DP +R +A AL
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-130
Identities = 111/300 (37%), Positives = 164/300 (54%), Gaps = 20/300 (6%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRL 174
+ F++L+K+G GTY+ VYK + TG VALK+V+ D+ E E A REI +++ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPSTAIREISLMKEL 60
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIK-----FTQAQVKCYMHQLL 229
H N+V+L ++ + L LVF++M++DL S T+ VK + QLL
Sbjct: 61 KHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRP 288
GL CH +LHRD+K NLLI+ G L + DFGLA F P + +S VVTLWYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRA 176
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 347
P++L+G+ Y +D+WS GCILAE++ KP+ PG + EQL IF + G+P+E W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLP-----LIETLLAIDPAERQTATAALRSE 402
+KLP Q+ + + + + L + LL ++P R +A AL
Sbjct: 237 TKLPKYNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-129
Identities = 106/328 (32%), Positives = 163/328 (49%), Gaps = 39/328 (11%)
Query: 110 SGWTPRRADTFEKLD-KIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMAR 166
S R D FE K+G+GTY +VYKA+ D + ALK++ + + R
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---- 67
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL--------AASPTIKFTQ 218
EI +LR L HPNV+ L+ + S ++L+F Y EHDL + A ++ +
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHK 274
VK ++Q+L G+ + H VLHRD+K +N+L+ G + IAD G A F+ K
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 275 Q--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV----- 327
+ VVT WYR PELLLGA Y +D+W+ GCI AELL +PI R E
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 328 ----EQLHKIFKLCGSPSEEYWKK-SKLPHATIFKP---QQSYKRC-----IAETFKDFP 374
+QL +IF + G P+++ W+ K+P + + +Y C + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 375 PSSLPLIETLLAIDPAERQTATAALRSE 402
+ L++ LL +DP +R T+ A++
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDP 335
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-129
Identities = 110/301 (36%), Positives = 157/301 (52%), Gaps = 17/301 (5%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMA-REIL 169
R +E + +IG+G Y V+KARD G+ VALK+VR E + RE+
Sbjct: 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVA 63
Query: 170 ILRRL---DHPNVVKLEGLVTSRMS---CSLYLVFKYMEHDLAG-LAASPTIKFTQAQVK 222
+LR L +HPNVV+L + T + L LVF++++ DL L P +K
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
M QLL GL+ H+ V+HRD+K N+L+ + G + +ADFGLA + +TS VV
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVV 181
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
TLWYR PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P E
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 343 EYWKK-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
E W + LP + I + D L+ L +PA+R +A +AL
Sbjct: 241 EDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 402 E 402
Sbjct: 298 P 298
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 371 bits (956), Expect = e-128
Identities = 85/297 (28%), Positives = 152/297 (51%), Gaps = 9/297 (3%)
Query: 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-R 166
+ + +E L +G+G+Y V K R+ TG+IVA+KK + + + V+ +A R
Sbjct: 15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMR 73
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
EI +L++L H N+V L + + YLVF++++H + V+ Y+
Sbjct: 74 EIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLW 285
Q+++G+ CH+ +++HRDIK N+L+ G++ + DFG A + P + V T W
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRW 189
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
YR PELL+G YG VD+W+ GC++ E+ +P+ PG ++++QL+ I G+ +
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 346 KK-SKLPHATIFK-PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ +K P + P+ + + + + L + L IDP +R L
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 369 bits (950), Expect = e-127
Identities = 98/287 (34%), Positives = 150/287 (52%), Gaps = 9/287 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
+ +EK+ KIG+G+Y V+K R+ TGQIVA+KK + ++ +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PN+V L + R L+LVF+Y +H + + VK Q L + CH
Sbjct: 62 PNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
+ +HRD+K N+LI ++ + DFG A P+ V T WYR PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGD 177
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHAT 354
T YG VD+W+ GC+ AELL+ P+ PG+++V+QL+ I K G + + S + +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 355 IFK-PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
K P + F + +L L++ L +DP ER T L
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 322 bits (826), Expect = e-107
Identities = 111/343 (32%), Positives = 166/343 (48%), Gaps = 20/343 (5%)
Query: 69 GEKRRSSKPNPRLS-NPPKHVHGEQVAAGWP-SWLSAVAGEAISGWTPRRADTFEKLDKI 126
G R +S P +V+ S ++ V G + ++ I
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 127 GQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLV 186
G G++ VY+A+ +G++VA+KKV D RF RE+ I+R+LDH N+V+L
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 187 TS----RMSCSLYLVFKYMEHDLAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
S + L LV Y+ + +A + VK YM+QL L + H+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 240 VLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
+ HRDIK NLL+D + +L + DFG A +P S + + +YR PEL+ GATDY
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDY 234
Query: 299 GVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358
+D+WSAGC+LAELL +PI PG + V+QL +I K+ G+P+ E ++ P+ T FK
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFKF 293
Query: 359 QQSYKRCIAETF-KDFPPSSLPLIETLLAIDPAERQTATAALR 400
Q + F PP ++ L LL P R T A
Sbjct: 294 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 1e-99
Identities = 101/302 (33%), Positives = 154/302 (50%), Gaps = 20/302 (6%)
Query: 108 AISGWTPRRAD-TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
A G T + + + IG G++ V++A+ + + VA+KKV D RF R
Sbjct: 29 ASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNR 81
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAAS---PTIKFTQA 219
E+ I+R + HPNVV L+ S L LV +Y+ + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMT 278
+K YM+QLL L + H+ + HRDIK NLL+D G+L + DFG A +P
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNV 199
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
S + + +YR PEL+ GAT+Y +D+WS GC++AEL+ +P+ PG + ++QL +I K+ G
Sbjct: 200 SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259
Query: 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETF-KDFPPSSLPLIETLLAIDPAERQTATA 397
+PS E K+ P+ K Q ++ F PP ++ LI LL P+ R TA
Sbjct: 260 TPSREQI-KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318
Query: 398 AL 399
AL
Sbjct: 319 AL 320
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-92
Identities = 92/321 (28%), Positives = 143/321 (44%), Gaps = 25/321 (7%)
Query: 96 GWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN 155
G S +S A A + + D F+ GQGT+ V ++ TG VA+KKV D
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD- 59
Query: 156 LEPESVRFMAREILILRRL---DHPNVVKLEGLVTSRMSCS-----LYLVFKYMEHDLAG 207
RF RE+ I++ L HPN+V+L+ + L +V +Y+ L
Sbjct: 60 -----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR 114
Query: 208 LAASPTIK---FTQAQVKCYMHQLLSGLEHCHNQ--HVLHRDIKGSNLLIDNE-GILTIA 261
+ + +K ++ QL+ + H +V HRDIK N+L++ G L +
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 262 DFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIM 321
DFG A P+ +P + + + +YR PEL+ G Y VD+WS GCI AE++ +PI
Sbjct: 175 DFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
Query: 322 PGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ---QSYKRCIAETFKDFPPSSL 378
G QLH+I ++ G PS E +K H + + ++ +
Sbjct: 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292
Query: 379 PLIETLLAIDPAERQTATAAL 399
L+ LL P ER AL
Sbjct: 293 DLLSALLQYLPEERMKPYEAL 313
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 5e-90
Identities = 82/327 (25%), Positives = 143/327 (43%), Gaps = 50/327 (15%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
+ + +G G++ V + D +G+ ALKKV D R+ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 174 LDHPNVVKLEGLVTSRMSCS------------------------------------LYLV 197
LDH N++KL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 198 FKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID- 253
+Y+ L + S + Y++QL + H+ + HRDIK NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 254 NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
+ L + DFG A P+ +P + + + +YR PEL+LGAT+Y +DLWS GC+ E
Sbjct: 177 KDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373
L+ KP+ G T ++QL +I ++ G+P++E + PH T + + + +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEVRFPTLKAKDWRKILPEG 293
Query: 374 -PPSSLPLIETLLAIDPAERQTATAAL 399
P ++ L+E +L +P R A+
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAM 320
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 6e-90
Identities = 88/295 (29%), Positives = 147/295 (49%), Gaps = 23/295 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DH 176
D ++ + K+G+G YS V++A + + V +K ++ P + + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
PN++ L +V +S + LVF++ D L T ++ YM+++L L++C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 146
Query: 236 HNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H+ ++HRD+K N++ID+E L + D+GLA F+ P Q RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVD 204
Query: 295 ATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCGSPSEE-YWKKSKLPH 352
Y +D+WS GC+LA ++ K P G +QL +I K+ G+ Y K +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 353 ATIFK---PQQSYKR----CIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
F + S KR +E P +L ++ LL D R TA A+
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 6e-84
Identities = 97/297 (32%), Positives = 152/297 (51%), Gaps = 20/297 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ L +G G V+ A D + VA+KK+ + P+SV+ REI I+RRLDH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 180 VKLEGLVTSRMSCS------------LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
VK+ ++ S +Y+V +YME DLA + + + + +M+Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQ 128
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPN--HKQPMTSRVVTL 284
LL GL++ H+ +VLHRD+K +NL I+ E +L I DFGLA DP+ HK ++ +VT
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
WYR P LLL +Y +D+W+AGCI AE+L K + G E+EQ+ I + EE
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 345 WKKSKLPHATIFKPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ + + + + ++ +E +L P +R TA AL
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-82
Identities = 94/289 (32%), Positives = 149/289 (51%), Gaps = 17/289 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
+ +G G Y +V A D +G+ VA+KK+ F + + RE+L+L+ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHE 83
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T S YLV +M+ DL + F++ +++ ++Q+L GL+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLK 140
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H+ V+HRD+K NL ++ + L I DFGLA D MT VVT WYR PE++L
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVIL 196
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD+WS GCI+AE+L K + G+ ++QL +I K+ G P E+ +K A
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 354 -TIFKPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + R + F P + L+E +L +D +R TA AL
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 8e-82
Identities = 96/289 (33%), Positives = 149/289 (51%), Gaps = 12/289 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLDHPN 178
+ L IG+G Y V A D L VA+KK+ F++ + REI IL R H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 86
Query: 179 VVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
++ + ++ + +Y+V ME DL L + + + +++Q+L GL++
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYI 144
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTSRVVTLWYRPPELLL 293
H+ +VLHRD+K SNLL++ L I DFGLA DP+H +T V T WYR PE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
+ Y +D+WS GCILAE+L+ +PI PG+ ++QL+ I + GSPS+E A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 354 T--IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ K F + +L L++ +L +P +R AL
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 9e-82
Identities = 107/420 (25%), Positives = 175/420 (41%), Gaps = 89/420 (21%)
Query: 46 GPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVA 105
G +H ++ +N TV ++ + K +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSD------------ 48
Query: 106 GEAISGWT-PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVR 162
W P R +E IG G+Y +V +A D L ++VA+KK+ F++ + R
Sbjct: 49 ------WQIPDR---YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKR 98
Query: 163 FMAREILILRRLDHPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQA 219
+ REI IL RL+H +VVK+ +V + LY+V + + D L +P + T+
Sbjct: 99 -ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTEL 156
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA------------- 266
+K ++ LL G+++ H+ +LHRD+K +N L++ + + + DFGLA
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 267 -------------SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
N K+ +T VVT WYR PEL+L +Y +D+WS GCI AE
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 314 LLAE-----------KPIMPG--------------------RTEVEQLHKIFKLCGSPSE 342
LL P+ PG R +QL+ IF + G+PSE
Sbjct: 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE 336
Query: 343 EYWKKSKLPHATIFKPQQSY--KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
E + + A + +AE F ++ L++ +L +P +R T L
Sbjct: 337 EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-81
Identities = 84/296 (28%), Positives = 129/296 (43%), Gaps = 18/296 (6%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMA--------REILI 170
+ I G+Y V D+ G VA+K+V + +V REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 171 LRRLDHPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
L HPN++ L + + LYLV + M DLA + I + ++ +M+
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+L GL H V+HRD+ N+L+ + +TI DF LA + T V WYR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYR 200
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PEL++ + VD+WSAGC++AE+ K + G T QL+KI ++ G+P E
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 348 SKLPHAT--IFKPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P A + + P +L LI +L +P R + ALR
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 6e-81
Identities = 92/289 (31%), Positives = 145/289 (50%), Gaps = 16/289 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
+ L +G G Y V A D TG VA+KK+ F + + RE+ +L+ + H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHE 84
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T + YLV +M DL L K + +++ ++Q+L GL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 142
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H ++HRD+K NL ++ + L I DFGLA D MT VVT WYR PE++L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVIL 198
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD+WS GCI+AE++ K + G ++QL +I K+ G+P E+ ++ + A
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 354 TIFKPQQSY--KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ K+ A + P ++ L+E +L +D +R TA AL
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-80
Identities = 99/291 (34%), Positives = 147/291 (50%), Gaps = 16/291 (5%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLD 175
+ ++ L +G G Y +V A DT TG VA+KK+ F + + RE+ +L+ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMK 86
Query: 176 HPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
H NV+ L + T S +YLV M DL + K T V+ ++Q+L G
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRG 144
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L++ H+ ++HRD+K SNL ++ + L I DFGLA MT V T WYR PE+
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEI 200
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+L Y VD+WS GCI+AELL + + PG ++QL I +L G+P E KK
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 352 HATIFKPQQSY--KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
A + + K A F P ++ L+E +L +D +R TA AL
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 7e-79
Identities = 92/300 (30%), Positives = 146/300 (48%), Gaps = 20/300 (6%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRLD 175
+ F+ +G+G Y V A TG+IVA+KK+ FD P REI IL+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFK 67
Query: 176 HPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
H N++ + + + +Y++ + M+ DL + ++ + ++ +++Q L +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAV 125
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN---------HKQPMTSRVVT 283
+ H +V+HRD+K SNLLI++ L + DFGLA D + + M V T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343
WYR PE++L + Y +D+WS GCILAEL +PI PGR QL IF + G+P +
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 344 ---YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+S I + + F P + L++ +L DPA+R TA AL
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 5e-76
Identities = 82/304 (26%), Positives = 149/304 (49%), Gaps = 35/304 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
++ L IG G V A D + + VA+KK+ F N + RE+++++ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 84
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ L + T + S +Y+V + M+ +L + ++ ++Q+L G++
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIK 141
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H H+ ++HRD+K SN+++ ++ L I DFGLA + MT VVT +YR PE++L
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 199
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK------ 347
G Y VD+WS GCI+ E++ + PG ++Q +K+ + G+P E+ KK
Sbjct: 200 G-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 348 ---SKLPHATIFKPQQSYKR--------CIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
P S+++ +E K + L+ +L ID ++R +
Sbjct: 259 TYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 397 AALR 400
AL+
Sbjct: 315 EALQ 318
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 7e-76
Identities = 98/324 (30%), Positives = 160/324 (49%), Gaps = 45/324 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRL- 174
+E + K+G+G Y V+K+ D TG++VA+KK+ F N + REI+IL L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELS 66
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
H N+V L ++ + +YLVF YME DL + + + ++QL+ +++
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKY 124
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLA--------------------SFFDPNHK 274
H+ +LHRD+K SN+L++ E + +ADFGL+ + + +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
+T V T WYR PE+LLG+T Y G+D+WS GCIL E+L KPI PG + + QL +I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 335 KLCGSPSEEYW----------------KKSKLPHATIFKPQQSYKRCIAETF--KDFPPS 376
+ PS E +K ++ + +K + + D
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 377 SLPLIETLLAIDPAERQTATAALR 400
+L L++ LL +P +R +A AL+
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALK 328
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 2e-75
Identities = 85/304 (27%), Positives = 151/304 (49%), Gaps = 35/304 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLDHP 177
++ L IG G V A D + + VA+KK+ F N + RE+++++ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 121
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ L + T + + +YLV + M+ +L + ++ ++Q+L G++
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIK 178
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H H+ ++HRD+K SN+++ ++ L I DFGLA + MT VVT +YR PE++L
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 236
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK------ 347
G Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ KK
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295
Query: 348 ---SKLPHATIFKPQQSYKR--------CIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
P ++ + +E K + L+ +L IDPA+R +
Sbjct: 296 NYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 397 AALR 400
AL+
Sbjct: 352 DALQ 355
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 6e-74
Identities = 98/339 (28%), Positives = 153/339 (45%), Gaps = 59/339 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLD 175
D + IG+G+Y VY A D T + VA+KKV F++L + R + REI IL RL
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI-DCKR-ILREITILNRLK 83
Query: 176 HPNVVKLEGLVTSRMSCS---LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+++L L+ LY+V + + DL L +P I T+ +K ++ LL G
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGE 142
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA---------------------SFFDP 271
H ++HRD+K +N L++ + + + DFGLA +
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-----------EKPI 320
N K+ +TS VVT WYR PEL+L +Y +D+WS GCI AELL P+
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 321 MPG-----------------RTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT--IFKPQQS 361
PG ++ +QL+ IF + G+P+E+ K P I
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR 322
Query: 362 YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + + + L+E++L +P +R T AL
Sbjct: 323 KPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 5e-63
Identities = 73/313 (23%), Positives = 124/313 (39%), Gaps = 55/313 (17%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
R A FE++ +GQG + V KAR+ L + A+KK+R + ++ E+++L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 175 DHPNVVKL-----------EGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVK 222
+H VV+ + + + +L++ +Y E L L S + + +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP------ 276
Q+L L + H+Q ++HRD+K N+ ID + I DFGLA +
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 277 -------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329
+TS + T Y E+L G Y +D++S G I E++ P G V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 330 LHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
L K+ + ++ + K +I L+ DP
Sbjct: 238 LKKLRSVSIEFPPDFDDN------------------KMKVEKK-------IIRLLIDHDP 272
Query: 390 AERQTATAALRSE 402
+R A L S
Sbjct: 273 NKRPGARTLLNSG 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-58
Identities = 64/296 (21%), Positives = 117/296 (39%), Gaps = 48/296 (16%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN- 178
+ L +IG G S V++ + QI A+K V + + +++ EI L +L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 179 -VVKLEG-LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+++L +T + +Y+V + DL + K Y +L + H
Sbjct: 89 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH 144
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRVVTLWYRPPELLLGA 295
++H D+K +N LI + G+L + DFG+A+ P+ + S+V T+ Y PPE +
Sbjct: 145 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 296 ----------TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE-EY 344
+ D+WS GCIL + K P + + Q+ K+ + E E+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEF 261
Query: 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ +D ++ L DP +R + L
Sbjct: 262 PDI------------------PEKDLQDV-------LKCCLKRDPKQRISIPELLA 292
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 69/355 (19%), Positives = 118/355 (33%), Gaps = 59/355 (16%)
Query: 47 PNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAG 106
+ + + Q ++PR R S E
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPE--------------- 52
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
+F++L ++G G+Y V+K R G++ A+K+ P+
Sbjct: 53 -------SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA 105
Query: 167 EILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYM 225
E+ ++ HP V+LE LYL + L + +AQV Y+
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYL 163
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
L L H H+Q ++H D+K +N+ + G + DFGL +
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPR 221
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y PELL G YG D++S G + E+ +P E ++ +
Sbjct: 222 YMAPELLQG--SYGTAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQG--------- 267
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P+ + ++ + + +L DP R TA A L
Sbjct: 268 ---------YLPPE--FTAGLSSELRSV-------LVMMLEPDPKLRATAEALLA 304
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 31/303 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ D +GQG +NV++ R TG + A+K + M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASP--TIKFTQAQVKCYMHQLLSG 231
N+VKL + + L+ ME L + P +++ + ++ G
Sbjct: 68 NIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 232 LEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+ H ++HR+IK N++ D + + + DFG A + + + S T Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYL 182
Query: 288 PPELLLGATD-------YGVGVDLWSAGCILAELLAEKP----IMPGRTEVEQLHKIFKL 336
P++ A YG VDLWS G R E ++KI
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
S + +K++ + ++ + P++ +L D +
Sbjct: 243 KPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQV---LLTPVLANILEADQEKCWGFD 298
Query: 397 AAL 399
Sbjct: 299 QFF 301
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-56
Identities = 63/296 (21%), Positives = 114/296 (38%), Gaps = 48/296 (16%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN- 178
+ L +IG G S V++ + QI A+K V + + +++ EI L +L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 179 -VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+++L + +Y+V + DL + K Y +L + H
Sbjct: 70 KIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRVVTLWYRPPELLLG-- 294
++H D+K +N LI + G+L + DFG+A+ P+ + S+V T+ Y PPE +
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 295 --------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
+ D+WS GCIL + K P + + Q+ K+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA----------- 232
Query: 347 KSKLPHATIFKPQQSYK--RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
I P + + +D ++ L DP +R + L
Sbjct: 233 --------IIDPNHEIEFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLA 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-55
Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 45/299 (15%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
P RA+ +E L IG G+Y K R G+I+ K++ + ++ + + E+ +LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGL---AASPTIKFTQAQVKCYMH 226
L HPN+V+ + R + +LY+V ME+ DLA + + V M
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIV---MEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 227 QLLSGLEHCHNQH-----VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281
QL L+ CH + VLHRD+K +N+ +D + + + DFGLA + + + V
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFV 177
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
T +Y PE + Y D+WS GC+L EL A P ++ E KI + G
Sbjct: 178 GTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF- 233
Query: 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++P+ ++ + +I +L + R + L
Sbjct: 234 ------RRIPY------------RYSDELNE-------IITRMLNLKDYHRPSVEEILE 267
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-55
Identities = 68/304 (22%), Positives = 122/304 (40%), Gaps = 58/304 (19%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
R F++++ IG G + V+KA+ + G+ +K+V+++N E RE+ L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAE---REVKALAK 60
Query: 174 LDHPNVVKL--------------EGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFT 217
LDH N+V + + L++ ++ + L + K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277
+ Q+ G+++ H++ +++RD+K SN+ + + + I DFGL + + K
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--R 178
Query: 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLC 337
T TL Y PE + DYG VDL++ G ILAELL T E L
Sbjct: 179 TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLH-----VCDTAFETSKFFTDL- 231
Query: 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397
+ + + K L++ LL+ P +R +
Sbjct: 232 --------RDGIISD------------IFDKKEKT-------LLQKLLSKKPEDRPNTSE 264
Query: 398 ALRS 401
LR+
Sbjct: 265 ILRT 268
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 5e-55
Identities = 76/367 (20%), Positives = 131/367 (35%), Gaps = 62/367 (16%)
Query: 48 NHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGE 107
+H SS + R +P L S+ A E
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDD------------DDKASSSANE 49
Query: 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMARE 167
IS + + L +IG G S V++ + QI A+K V + + +++ E
Sbjct: 50 CIS----VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNE 104
Query: 168 ILILRRLDHPN--VVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYM 225
I L +L + +++L + +Y+V + DL + K Y
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM-TSRVVTL 284
+L + H ++H D+K +N LI + G+L + DFG+A+ P+ + S+V +
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 285 WYRPPELLLGATD----------YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
Y PPE + + D+WS GCIL + K P + + Q+ K+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLH 278
Query: 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLP-LIETLLAIDPAERQ 393
I P + F D P L +++ L DP +R
Sbjct: 279 A-------------------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRI 313
Query: 394 TATAALR 400
+ L
Sbjct: 314 SIPELLA 320
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 8e-55
Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 31/299 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ D +GQG +NV++ R TG + A+K + M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASP--TIKFTQAQVKCYMHQLLSG 231
N+VKL + + L+ ME L + P +++ + ++ G
Sbjct: 68 NIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 232 LEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+ H ++HR+IK N++ D + + + DFG A + + + S T Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYL 182
Query: 288 PPELLLGATD-------YGVGVDLWSAGCILAELLAEKP----IMPGRTEVEQLHKIFKL 336
P++ A YG VDLWS G R E ++KI
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
S + +K++ + ++ + P++ +L D +
Sbjct: 243 KPSGAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQV---LLTPVLANILEADQEKCWGF 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-53
Identities = 84/295 (28%), Positives = 136/295 (46%), Gaps = 52/295 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++++ K+G G Y V RD +T A+K +R ++ S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLLS 230
N++KL + + YLV ME G + KF + + Q+LS
Sbjct: 97 NIMKLYDFFEDKR--NYYLV---MEC-YKGGELFDEIIHRM---KFNEVDAAVIIKQVLS 147
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
G+ + H +++HRD+K NLL+++ + ++ I DFGL++ F+ + M R+ T +Y
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYI 205
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYW 345
PE+L Y D+WS G IL LLA P G+T+ E L K+ K G + W
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDSPEW 261
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
K ++E KD I+ +L D R +A AL
Sbjct: 262 KN------------------VSEGAKDL-------IKQMLQFDSQRRISAQQALE 291
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-53
Identities = 79/288 (27%), Positives = 122/288 (42%), Gaps = 34/288 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
F KIG+G +S VY+A L G VALKKV+ +L R +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLLSGL 232
PNV+K L +V + + DL+ + + V Y QL S L
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
EH H++ V+HRDIK +N+ I G++ + D GL FF + S V T +Y PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
Y D+WS GC+L E+ A + P + L+ + K K + +
Sbjct: 209 HE-NGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCK----------KIEQCDY 255
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ S + + + + DP +R T
Sbjct: 256 PPLPSDHYSEE------LRQL-------VNMCINPDPEKRPDVTYVYD 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 78/295 (26%), Positives = 137/295 (46%), Gaps = 52/295 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + + +G+G++ V K +D +T Q A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLLS 230
N++KL ++ S Y+V E G + +F++ + Q+ S
Sbjct: 82 NIMKLFEILEDSS--SFYIV---GEL-YTGGELFDEIIKRK---RFSEHDAARIIKQVFS 132
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
G+ + H +++HRD+K N+L+++ + + I DFGL++ F N M R+ T +Y
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYI 190
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYW 345
PE+L G Y D+WSAG IL LL+ P G+ E + L ++ G + W
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQW 246
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ I++ KD LI +L P+ R TAT L
Sbjct: 247 RT------------------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-52
Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 56/312 (17%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
R FE + +G+G + V++A++ + A+K++R N E + M RE+ L +L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 175 DHPNVVK----------LEGLVTSRMSCSLYLVFKYMEH-DLAGL--AASPTIKFTQAQV 221
+HP +V+ E L S LY+ + +L + ++
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD----------- 270
Q+ +E H++ ++HRD+K SN+ + ++ + DFGL + D
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330
T +V T Y PE + G Y VD++S G IL ELL P T++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL-----YPFSTQMERV 234
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390
+ + + K P F P +++ +L+ P
Sbjct: 235 RTLTDV---------RNLKFPP----------------LFTQKYPCEYVMVQDMLSPSPM 269
Query: 391 ERQTATAALRSE 402
ER A + +
Sbjct: 270 ERPEAINIIENA 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-51
Identities = 66/293 (22%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + +L KIG+G++ + T G+ +K++ + + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 178 NVVK-LEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIK------FTQAQVKCYMHQLL 229
N+V+ E + SLY+V Y E DL I F + Q+ + Q+
Sbjct: 84 NIVQYRESFEENG---SLYIVMDYCEGGDLFKR-----INAQKGVLFQEDQILDWFVQIC 135
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRP 288
L+H H++ +LHRDIK N+ + +G + + DFG+A N + + T +Y
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLS 193
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
PE+ Y D+W+ GC+L EL K + + KI GS
Sbjct: 194 PEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSF-------P 243
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
+ + + L+ L +P +R + + L
Sbjct: 244 PVSL------------HYSYDLRS-------LVSQLFKRNPRDRPSVNSILEK 277
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-51
Identities = 80/296 (27%), Positives = 137/296 (46%), Gaps = 53/296 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDH 176
D ++ +G+G++ V +D +TGQ A+K + ++ + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLL 229
PN++KL + YLV E G ++ +F++ + Q+L
Sbjct: 86 PNIMKLYEFFEDKGY--FYLV---GEV-YTGGELFDEIISRK---RFSEVDAARIIRQVL 136
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
SG+ + H ++HRD+K NLL+++ + + I DFGL++ F+ + + M ++ T +Y
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYY 194
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEY 344
PE+L G Y D+WS G IL LL+ P G E + L K+ K G +
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQ 250
Query: 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
WKK ++E+ KD I +L P+ R +A AL
Sbjct: 251 WKK------------------VSESAKDL-------IRKMLTYVPSMRISARDALD 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-51
Identities = 65/308 (21%), Positives = 107/308 (34%), Gaps = 19/308 (6%)
Query: 106 GEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA 165
G + +E +++G G + V + TG+ VA+K+ R + L P++
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC 60
Query: 166 REILILRRLDHPNVVKL----EGLVTSRMSCSLYLVFKYMEH-DLAGLAASP--TIKFTQ 218
EI I+++L+HPNVV +GL + L +Y E DL +
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNHKQ 275
++ + + S L + H ++HRD+K N+++ I I D G A D
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL- 179
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
T V TL Y PELL Y V VD WS G + E + + Q H +
Sbjct: 180 -CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
+ + ++ +L +R T
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLS-----GILAGKLERWLQCMLMWHQRQRGTD 292
Query: 396 TAALRSEV 403
Sbjct: 293 PQNPNVGC 300
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-51
Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 52/307 (16%)
Query: 106 GEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA 165
G + A+ + + +G+G++ V K +D +T Q A+K + + + + +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 166 REILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQ 218
RE+ +L++LDHPN++KL ++ S Y+V + G + +F++
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSS--SFYIVGELYT----GGELFDEIIKRK---RFSE 120
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQ 275
+ Q+ SG+ + H +++HRD+K N+L++++ + I DFGL++ F N
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T 178
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
M R+ T +Y PE+L G Y D+WSAG IL LL+ P G+ E + L ++
Sbjct: 179 KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-- 234
Query: 336 LCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
G + W+ I++ KD LI +L P+ R
Sbjct: 235 ETGKYAFDLPQWRT------------------ISDDAKD-------LIRKMLTFHPSLRI 269
Query: 394 TATAALR 400
TAT L
Sbjct: 270 TATQCLE 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 63/293 (21%), Positives = 105/293 (35%), Gaps = 45/293 (15%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HP 177
+F D +G G + R + VA+K++ PE F RE+ +LR D HP
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHP 78
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NV++ R Y+ + L + + Q SGL H H+
Sbjct: 79 NVIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 238 QHVLHRDIKGSNLLIDNEG-----ILTIADFGLASFFDPNHK--QPMTSRVVTLWYRPPE 290
+++HRD+K N+LI I+DFGL + T + PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 291 LLLGATD--YGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
+L VD++SAGC+ +++E + + + C K
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-GACSLDCLHPEKH 255
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ LIE ++A+DP +R +A L+
Sbjct: 256 ------------------EDVIARE-------LIEKMIAMDPQKRPSAKHVLK 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-50
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 55/302 (18%)
Query: 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
+ + +D ++ +++G+G +S V + TG A K + L + + RE I R
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYM 225
+L HPN+V+L + YLVF + G +A +++A +
Sbjct: 61 KLQHPNIVRLHDSIQEES--FHYLVFDLVT----GGELFEDIVARE---FYSEADASHCI 111
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVV 282
Q+L + +CH+ ++HR++K NLL+ ++ + +ADFGLA + + +
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAG 169
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSP 340
T Y PE+L Y VD+W+ G IL LL P P + +I G+
Sbjct: 170 TPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAY 224
Query: 341 S--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398
W + K LI+++L ++P +R TA A
Sbjct: 225 DYPSPEWDT------------------VTPEAKS-------LIDSMLTVNPKKRITADQA 259
Query: 399 LR 400
L+
Sbjct: 260 LK 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-50
Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 63/306 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-----------FDNLEPESVRFMAR 166
+++ K+ K+G G Y V ++ A+K ++ + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQA 219
EI +L+ LDHPN++KL + + YLV E G + KF +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKY--FYLV---TEF-YEGGELFEQIINRH---KFDEC 146
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQP 276
M Q+LSG+ + H +++HRDIK N+L++N + I DFGL+SFF +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YK 204
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
+ R+ T +Y PE+L Y D+WS G I+ LL P G+ + + + K+ K
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK- 261
Query: 337 CGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
G WK I++ K+ I+ +L D +R T
Sbjct: 262 -GKYYFDFNDWKN------------------ISDEAKEL-------IKLMLTYDYNKRCT 295
Query: 395 ATAALR 400
A AL
Sbjct: 296 AEEALN 301
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 73/283 (25%), Positives = 117/283 (41%), Gaps = 36/283 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-MAREILILR 172
PR + + +G+G ++ ++ D T ++ A K V L R M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
L H +VV G +++V + L L T+ + + Y+ Q++ G
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 127
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
++ H V+HRD+K NL ++ + + I DFGLA+ + + ++ T Y PE+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEV 186
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
L + VD+WS GCI+ LL KP E +I K EY +P
Sbjct: 187 LSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP 235
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
K P + LI+ +L DP R T
Sbjct: 236 -------------------KHINPVAASLIQKMLQTDPTARPT 259
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-49
Identities = 54/295 (18%), Positives = 105/295 (35%), Gaps = 54/295 (18%)
Query: 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
+ + K+G+G +S V G ALK++ + RE + R +HPN
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPN 87
Query: 179 VVKLEG--LVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLLSGL 232
+++L L +L+ + + L T+ Q+ + + GL
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--------TL 284
E H + HRD+K +N+L+ +EG + D G + + + + + T+
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 285 WYRPPELLLGATDYGVG--VDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342
YR PEL + + D+WS GC+L ++ +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG----------------------- 244
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLP-----LIETLLAIDPAER 392
P+ +F+ S + L+ +++ +DP +R
Sbjct: 245 --------PYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 71/295 (24%), Positives = 120/295 (40%), Gaps = 51/295 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D ++ +++G+G +S V + TG A K + L + + RE I R+L HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLLS 230
N+V+L + YLVF + G +A +++A + Q+L
Sbjct: 89 NIVRLHDSIQEES--FHYLVFDLVT----GGELFEDIVARE---FYSEADASHCIQQILE 139
Query: 231 GLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+ +CH+ ++HR++K NLL+ + +ADFGLA + + + T Y
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYL 197
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYW 345
PE+L Y VD+W+ G IL LL P + +I G+ W
Sbjct: 198 SPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEW 254
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ K LI+++L ++P +R TA AL+
Sbjct: 255 DT------------------VTPEAKS-------LIDSMLTVNPKKRITADQALK 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 45/318 (14%), Positives = 79/318 (24%), Gaps = 56/318 (17%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VRFMAREILILRR 173
+ + ++ + G S V+ RD + ALK S + + R
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 174 LDHPN------------------------VVKLEGLVTSRMSCSLYLVFKYMEHDLAGL- 208
L + +L + L+ DL L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 209 -----AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263
+ QL+ + ++ ++H NL I +G L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMP 322
+ V + Y P E L + ++ W G + + P
Sbjct: 239 SALWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P 292
Query: 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIE 382
F L + WK+ L + + K LI
Sbjct: 293 -----------FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-------LIG 334
Query: 383 TLLAIDPAERQTATAALR 400
L D R A+
Sbjct: 335 RFLNFDRRRRLLPLEAME 352
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-49
Identities = 56/214 (26%), Positives = 111/214 (51%), Gaps = 6/214 (2%)
Query: 108 AISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-MAR 166
+++ + + F+ + +G+G+++ VY+A TG VA+K + + + +
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM 225
E+ I +L HP++++L +YLV + + ++ + F++ + + +M
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
HQ+++G+ + H+ +LHRD+ SNLL+ + IADFGLA+ H++ T T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319
Y PE+ + +G+ D+WS GC+ LL +P
Sbjct: 178 YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRP 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-49
Identities = 79/318 (24%), Positives = 126/318 (39%), Gaps = 36/318 (11%)
Query: 79 PRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKAR 138
P ++P K A G P+ PR + + +G+G ++ ++
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 139 DTLTGQIVALKKVRFDNLEPESVRF-MAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197
D T ++ A K V L R M+ EI I R L H +VV G +++V
Sbjct: 62 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVV 119
Query: 198 FKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256
+ L L T+ + + Y+ Q++ G ++ H V+HRD+K NL ++ +
Sbjct: 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ I DFGLA+ + + ++ T Y PE+L + VD+WS GCI+ LL
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLV 236
Query: 317 EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPS 376
KP E +I K EY +P K P
Sbjct: 237 GKPPFETSCLKETYLRIKKN------EY----SIP-------------------KHINPV 267
Query: 377 SLPLIETLLAIDPAERQT 394
+ LI+ +L DP R T
Sbjct: 268 AASLIQKMLQTDPTARPT 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 54/302 (17%)
Query: 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
R + ++ +++G+G +S V + L GQ A + L + + RE I R
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYM 225
L HPN+V+L ++ YL+F + G +A +++A +
Sbjct: 66 LLKHPNIVRLHDSISEEG--HHYLIFDLVT----GGELFEDIVARE---YYSEADASHCI 116
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRVV 282
Q+L + HCH V+HR++K NLL+ + +ADFGLA + +Q
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAG 175
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSP 340
T Y PE+L YG VDLW+ G IL LL P P + +I G+
Sbjct: 176 TPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAY 230
Query: 341 S--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398
W + KD LI +L I+P++R TA A
Sbjct: 231 DFPSPEWDT------------------VTPEAKD-------LINKMLTINPSKRITAAEA 265
Query: 399 LR 400
L+
Sbjct: 266 LK 267
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-48
Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 56/296 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDH 176
+ + IG+G++ V A T A KK+ +E + + +EI I++ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDH 65
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLL 229
PN+++L +YLV + G + F ++ M +L
Sbjct: 66 PNIIRLYETFEDNTD--IYLVMELCT----GGELFERVVHKR---VFRESDAARIMKDVL 116
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
S + +CH +V HRD+K N L + L + DFGLA+ F P + M ++V T +Y
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYY 174
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEY 344
P++L G YG D WSAG ++ LL P T+ E + KI G+ + E+
Sbjct: 175 VSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKD 230
Query: 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
W ++ + LI LL P +R T+ AL
Sbjct: 231 WLN------------------VSPQAES-------LIRRLLTKSPKQRITSLQALE 261
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-48
Identities = 90/393 (22%), Positives = 139/393 (35%), Gaps = 73/393 (18%)
Query: 41 RNGNGGPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAG---- 96
+ KE + E R ++R + + ++ E
Sbjct: 7 HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 97 --WPSWLSAVAGEAISGWTPRRADTFEKL----DKIGQGTYSNVYKARDTLTGQIVALK- 149
+ G A F + D IG+G S V + TG A+K
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 150 ----KVRFDNLEPESVRFM-AREILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH 203
R + E VR RE ILR++ HP+++ L S ++LVF M
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS--FMFLVFDLMR- 183
Query: 204 DLAG-------LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256
++ + + M LL + H +++HRD+K N+L+D+
Sbjct: 184 ---KGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM 237
Query: 257 ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCIL 311
+ ++DFG + +P + + T Y PE+L + D YG VDLW+ G IL
Sbjct: 238 QIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 312 AELLAEKPIMP--GRTEVEQLHKIFKLCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIA 367
LLA P P R ++ L I + G W +
Sbjct: 296 FTLLAGSP--PFWHRRQILMLRMI--MEGQYQFSSPEWDD------------------RS 333
Query: 368 ETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
T KD LI LL +DP R TA AL+
Sbjct: 334 STVKD-------LISRLLQVDPEARLTAEQALQ 359
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-47
Identities = 71/304 (23%), Positives = 126/304 (41%), Gaps = 58/304 (19%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVR----FMAREILI 170
+ +E + +G+G S V + T + A+K + E V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 171 LRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKC 223
LR++ HPN+++L+ + +LVF M+ L + ++ + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMK----KGELFDYLTEK--VTLSEKETRK 128
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT 283
M LL + H +++HRD+K N+L+D++ + + DFG + DP + + T
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGT 186
Query: 284 LWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
Y PE++ + + YG VD+WS G I+ LLA P R ++ L I + G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSG 244
Query: 339 SPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
+ W ++T KD L+ L + P +R TA
Sbjct: 245 NYQFGSPEWDD------------------YSDTVKD-------LVSRFLVVQPQKRYTAE 279
Query: 397 AALR 400
AL
Sbjct: 280 EALA 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 66/291 (22%), Positives = 117/291 (40%), Gaps = 42/291 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D F K+G G + +V+ + +G +K + D + + + EI +L+ LDHP
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHP 80
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++K+ + + +Y+V + E + A + ++ V M Q+++ L
Sbjct: 81 NIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 234 HCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
+ H+QHV+H+D+K N+L + + I DFGLA F + + T+ T Y PE
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE 196
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSK 349
+ D D+WSAG ++ LL G + E K P+ +
Sbjct: 197 VFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRP-- 250
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ D ++ +L DP R +A L
Sbjct: 251 ----------------LTPQAVDL-------LKQMLTKDPERRPSAAQVLH 278
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-47
Identities = 70/334 (20%), Positives = 118/334 (35%), Gaps = 80/334 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRL 174
+ IGQG+Y V A + T I A+K K + + P+ V + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYME-------------------------------- 202
HPN+ +L + + LV +
Sbjct: 86 HHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 203 --------HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI-- 252
+ G S + + M Q+ S L + HNQ + HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 253 DNEGILTIADFGLASFFDPNHK---QPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAG 308
+ + + DFGL+ F + MT++ T ++ PE+L + YG D WSAG
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 309 CILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKKSKLPHATIFKPQQSYKRCI 366
+L LL PG + + + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNYNV------------------L 303
Query: 367 AETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ +D L+ LL + ER A AL+
Sbjct: 304 SPLARD-------LLSNLLNRNVDERFDAMRALQ 330
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 64/306 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV------RFDNLEPESVRFMAREILIL 171
D + +G G V A + T + VA++ + E + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQVKCY 224
++L+HP ++K++ + Y+V + ME +L + +A K Y
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 244
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRV 281
+Q+L +++ H ++HRD+K N+L+ + + ++ I DFG + M +
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC 302
Query: 282 VTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMP---GRTEVEQLHKIFKL 336
T Y PE+L+ Y VD WS G IL L+ P P RT+V +I
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--T 358
Query: 337 CGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
G + E W + ++E D L++ LL +DP R T
Sbjct: 359 SGKYNFIPEVWAE------------------VSEKALD-------LVKKLLVVDPKARFT 393
Query: 395 ATAALR 400
ALR
Sbjct: 394 TEEALR 399
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 64/323 (19%), Positives = 115/323 (35%), Gaps = 60/323 (18%)
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
I + + +G G+ V + G+ VA+K+ + +
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR-----MLIDFCDIALM 57
Query: 167 EILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLA------GLAASPTIKFTQA 219
EI +L D HPNV++ T+ LY+ + +L ++ +
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILT-------------IADFGLA 266
+ Q+ SG+ H H+ ++HRD+K N+L+ T I+DFGL
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 267 SFFDPNH---KQPMTSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELLAE 317
D + + + T +R PELL + + +D++S GC+ +L++
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 318 KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS 377
P + + I + G S + K + D
Sbjct: 236 G-KHPFGDKYSRESNIIR--GIFSLDEMKCLHDRS-------------LIAEATD----- 274
Query: 378 LPLIETLLAIDPAERQTATAALR 400
LI ++ DP +R TA LR
Sbjct: 275 --LISQMIDHDPLKRPTAMKVLR 295
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 66/307 (21%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKV------RFDNLEPESVRFMAREILIL 171
D + +G G V A + T + VA+K + E + + EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQVKCY 224
++L+HP ++K++ + Y+V + ME +L + +A K Y
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 119
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRV 281
+Q+L +++ H ++HRD+K N+L+ ++ ++ I DFG + M +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLC 177
Query: 282 VTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMP---GRTEVEQLHKIFKL 336
T Y PE+L+ Y VD WS G IL L+ P P RT+V +I
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--T 233
Query: 337 CGS---PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
G E W + ++E D L++ LL +DP R
Sbjct: 234 SGKYNFIP-EVWAE------------------VSEKALD-------LVKKLLVVDPKARF 267
Query: 394 TATAALR 400
T ALR
Sbjct: 268 TTEEALR 274
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-47
Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 52/299 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRL 174
D +E + IG+G +S V + + TGQ A+K +F + S + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIKFTQAQVKCYMHQLLS 230
HP++V+L +S LY+VF++M+ A +++A YM Q+L
Sbjct: 84 KHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 231 GLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
L +CH+ +++HRD+K +L+ +N + + FG+A + RV T +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFM 200
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFK--LCGSPS-- 341
PE++ YG VD+W G IL LL+ P G E ++F+ + G
Sbjct: 201 APEVVKR-EPYGKPVDVWGCGVILFILLSGCL--PFYGTKE-----RLFEGIIKGKYKMN 252
Query: 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
W I+E+ KD L+ +L +DPAER T AL
Sbjct: 253 PRQWSH------------------ISESAKD-------LVRRMLMLDPAERITVYEALN 286
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-47
Identities = 70/337 (20%), Positives = 135/337 (40%), Gaps = 46/337 (13%)
Query: 68 RGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIG 127
G K R P++++ K + + D ++ L+++G
Sbjct: 10 HGSKVRGKYDGPKINDYDKFYEDIW---------KKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 128 QGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLV 186
G + V++ + TG++ K + +V+ EI I+ +L HP ++ L
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAF 117
Query: 187 TSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDI 245
+ + L+ +++ +L A+ K ++A+V YM Q GL+H H ++H DI
Sbjct: 118 EDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 246 KGSNLLIDN--EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVD 303
K N++ + + I DFGLA+ +P+ + + T + PE++ G D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYTD 232
Query: 304 LWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYK 363
+W+ G + LL+ G ++E L + + E+ +
Sbjct: 233 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS---------------- 276
Query: 364 RCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ KDF I+ LL +P +R T AL
Sbjct: 277 --VSPEAKDF-------IKNLLQKEPRKRLTVHDALE 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-47
Identities = 58/313 (18%), Positives = 109/313 (34%), Gaps = 62/313 (19%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
R F +L+KIG G + +V+K L G I A+K+ + + RE+ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 175 -DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLL 229
H +VV+ + + +Y LA F +A++K + Q+
Sbjct: 68 GQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILT-------------------IADFGLASFFD 270
GL + H+ ++H DIK SN+ I I I D G +
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330
+ E+L + D+++ + +P +P +Q
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQW 237
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390
H+I + G +P + +++ F + ++ ++ DP
Sbjct: 238 HEIRQ--GRLPR-------IP------------QVLSQEFTEL-------LKVMIHPDPE 269
Query: 391 ERQTATAALRSEV 403
R +A A ++ V
Sbjct: 270 RRPSAMALVKHSV 282
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 8e-47
Identities = 82/301 (27%), Positives = 122/301 (40%), Gaps = 56/301 (18%)
Query: 113 TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILIL 171
T TF ++ +G G +S V+ + LTG++ ALK ++ S+ EI +L
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVL 60
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCY 224
+++ H N+V LE + S YLV + + G L +T+
Sbjct: 61 KKIKHENIVTLEDIYESTT--HYYLVMQLVS----GGELFDRILERG---VYTEKDASLV 111
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRV 281
+ Q+LS +++ H ++HRD+K NLL + + I DFGL+ M++
Sbjct: 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTAC 168
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341
T Y PE+L Y VD WS G I LL P TE + KI + G
Sbjct: 169 GTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYE 225
Query: 342 --EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+W I+E+ KDF I LL DP ER T AL
Sbjct: 226 FESPFWDD------------------ISESAKDF-------ICHLLEKDPNERYTCEKAL 260
Query: 400 R 400
Sbjct: 261 S 261
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 73/353 (20%), Positives = 129/353 (36%), Gaps = 39/353 (11%)
Query: 55 NSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTP 114
S + T V G++R+ + V++ + +++ + +
Sbjct: 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 115 RRADTFEKL----DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI 170
+ D +++G G + V++ + TG A K V + + +EI
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQT 207
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLL 229
+ L HP +V L + +++++M +L A K ++ + YM Q+
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
GL H H + +H D+K N++ L + DFGL + DP Q + T +
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFA 323
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PE+ G G D+WS G + LL+ G + E L + + + +
Sbjct: 324 APEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
I+E KDF I LL DP R T AL
Sbjct: 383 ------------------ISEDGKDF-------IRKLLLADPNTRMTIHQALE 410
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-46
Identities = 61/290 (21%), Positives = 108/290 (37%), Gaps = 49/290 (16%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
++G+G++ V++ +D TG A+KKVR + E E++ L P +
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 180 VKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
V L G R + + + +E L + + Y+ Q L GLE+
Sbjct: 113 VPLYG--AVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYL 166
Query: 236 HNQHVLHRDIKGSNLLIDNEGILT-IADFGLASFFDPNHKQPMTSRVVTL----WYRPPE 290
H + +LH D+K N+L+ ++G + DFG A P+ + + PE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
+++G VD+WS+ C++ +L P T+ + K+ P
Sbjct: 227 VVMG-KPCDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEP---------- 272
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P + A I+ L +P R +A R
Sbjct: 273 ------PPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRR 309
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 57/288 (19%), Positives = 112/288 (38%), Gaps = 40/288 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + + +G+G + V++ +T + + K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N++ L S L ++F+++ D+ + + + ++ Y+HQ+ L+ H
Sbjct: 62 NILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 237 NQHVLHRDIKGSNLLIDNE--GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+ ++ H DI+ N++ + I +FG A P Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
D+WS G ++ LL+ P T + + I + EE +K+
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAFKE----- 229
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
I+ DF ++ LL + R TA+ AL+
Sbjct: 230 -------------ISIEAMDF-------VDRLLVKERKSRMTASEALQ 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 93/336 (27%), Positives = 144/336 (42%), Gaps = 75/336 (22%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR----EILILR 172
A +E L IG+G++ V KA D Q VALK VR + + R EI IL
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILE 148
Query: 173 RL------DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT 217
L + NV+ + + +S +LY + K ++ G F+
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK--KNKFQG--------FS 198
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG--ILTIADFGLASFFDPNHKQ 275
V+ + H +L L+ H ++H D+K N+L+ +G + + DFG + + Q
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----Q 254
Query: 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
+ + + + +YR PE++LGA YG+ +D+WS GCILAELL P++PG E +QL + +
Sbjct: 255 RVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKD----------------FPPSSLP 379
L G PS++ SK + + C T D PP S
Sbjct: 314 LLGMPSQKLLDASKRAK-NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESRE 372
Query: 380 ---------------LIETLLAIDPAERQTATAALR 400
++ L DPA R T ALR
Sbjct: 373 WGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 59/307 (19%), Positives = 115/307 (37%), Gaps = 43/307 (14%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMA----------- 165
+ + + QG ++ + + ALK K + +
Sbjct: 33 YRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 166 -REILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME--------HDLAGLAASPTIKF 216
E+ I+ + + + EG++T+ +Y++++YME L + T
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 217 TQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275
+KC + +L+ + HN+ ++ HRD+K SN+L+D G + ++DFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-- 206
Query: 276 PMTSRVVTLWYRPPELLLGATDY-GVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKI 333
+ T + PPE + Y G VD+WS G L + P + VE + I
Sbjct: 207 -IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
+ + P + + + ++ L +PAER
Sbjct: 266 RT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 394 TATAALR 400
T+ AL+
Sbjct: 316 TSEDALK 322
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-46
Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 9/218 (4%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VRFMAREILILRRLDHPN 178
FE +G+G + NVY AR+ + I+ALK + LE + RE+ I L HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
+++L G +YL+ +Y + + KF + + Y+ +L + L +CH+
Sbjct: 71 ILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 127
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+ V+HRDIK NLL+ + G L IADFG + + + + TL Y PPE++ G
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEG-RM 183
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
+ VDLWS G + E L KP T E +I +
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-46
Identities = 81/375 (21%), Positives = 147/375 (39%), Gaps = 50/375 (13%)
Query: 35 AEAVEIRNGNGGPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVA 94
+ V++ N K S + ++ + ++ P S + + A
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 95 AGWPSWLSAVAGEAISGWTPRRAD-----TFEKLDKIGQGTYSNVYKARDTLTGQIVALK 149
P V T ++ T K + +G G + V+K +T TG +A K
Sbjct: 69 PPAPFDHRIV--------TAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK 120
Query: 150 KVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAG 207
++ ++ E V+ EI ++ +LDH N+++L S+ + LV +Y++ +L
Sbjct: 121 IIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFD 175
Query: 208 LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGL 265
+ T+ +M Q+ G+ H H ++LH D+K N+L N + I DFGL
Sbjct: 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325
A + P + + T + PE++ D+WS G I LL+ G
Sbjct: 236 ARRYKPR--EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292
Query: 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLL 385
+ E L+ I +E ++ I+E K+F I LL
Sbjct: 293 DAETLNNILACRWDLEDEEFQD------------------ISEEAKEF-------ISKLL 327
Query: 386 AIDPAERQTATAALR 400
+ + R +A+ AL+
Sbjct: 328 IKEKSWRISASEALK 342
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-46
Identities = 71/313 (22%), Positives = 123/313 (39%), Gaps = 64/313 (20%)
Query: 111 GWTPRRADTFEKL----DKIGQGTYSNVYKARDTLTGQIVALK-------KVRFDNLEPE 159
G P + E +++G G ++ V K R+ TG A K + + E
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 160 SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG------LAASPT 213
+ RE+ ILR++ H NV+ L + +R + L+ + + +G LA
Sbjct: 61 EIE---REVSILRQVLHHNVITLHDVYENRTD--VVLILELV----SGGELFDFLAQKE- 110
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFF 269
++ + ++ Q+L G+ + H + + H D+K N+++ + + DFGLA
Sbjct: 111 -SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEV 327
+ + T + PE++ G+ D+WS G I LL+ P G T+
Sbjct: 170 EDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQ 224
Query: 328 EQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAI 387
E L I + EE++ +E KDF I LL
Sbjct: 225 ETLANITSVSYDFDEEFFSH------------------TSELAKDF-------IRKLLVK 259
Query: 388 DPAERQTATAALR 400
+ +R T ALR
Sbjct: 260 ETRKRLTIQEALR 272
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 83/368 (22%), Positives = 136/368 (36%), Gaps = 78/368 (21%)
Query: 47 PNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAG 106
+H SS + E + S+ P P + G
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSN-------------- 47
Query: 107 EAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR 166
+D FE ++G+G S VY+ + T + ALK ++ + + VR
Sbjct: 48 ------RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVR---T 97
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQA 219
EI +L RL HPN++KL+ + + + LV + + G + +++
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVT----GGELFDRIVEKG---YYSER 148
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQP 276
+ Q+L + + H ++HRD+K NLL + L IADFGL+ +
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VL 206
Query: 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK- 335
M + T Y PE+L G YG VD+WS G I LL P E +F+
Sbjct: 207 MKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRR 262
Query: 336 -LCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
L +W + ++ KD + L+ +DP +R
Sbjct: 263 ILNCEYYFISPWWDE------------------VSLNAKDL-------VRKLIVLDPKKR 297
Query: 393 QTATAALR 400
T AL+
Sbjct: 298 LTTFQALQ 305
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 67/303 (22%), Positives = 122/303 (40%), Gaps = 62/303 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRR 173
D ++ +++G G ++ V K R+ TG A K ++ S + RE+ IL+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYM----------EHDLAGLAASPTIKFTQAQVKC 223
+ HPNV+ L + ++ + L+ + + E + T+ +
Sbjct: 71 IQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKE----------SLTEEEATE 118
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE----GILTIADFGLASFFDPNHKQPMTS 279
++ Q+L+G+ + H+ + H D+K N+++ + + I DFGLA D +
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKN 176
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLC 337
T + PE++ G+ D+WS G I LL+ P G T+ E L + +
Sbjct: 177 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVSAVN 233
Query: 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397
+EY+ + KDF I LL DP +R T
Sbjct: 234 YEFEDEYFSN------------------TSALAKDF-------IRRLLVKDPKKRMTIQD 268
Query: 398 ALR 400
+L+
Sbjct: 269 SLQ 271
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 58/301 (19%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRR 173
D +E +++G G ++ V K R TG+ A K ++ L S + RE+ ILR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTI----KFTQAQVKCYM 225
+ HPN++ L + ++ + L+ + + D + T+ + ++
Sbjct: 65 IRHPNIITLHDIFENKTD--VVLILELVSGGELFDF--------LAEKESLTEDEATQFL 114
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI----LTIADFGLASFFDPNHKQPMTSRV 281
Q+L G+ + H++ + H D+K N+++ ++ + + + DFG+A + +
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIF 172
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGS 339
T + PE++ G+ D+WS G I LL+ P G T+ E L I +
Sbjct: 173 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNISAVNYD 229
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
EEY+ +E KDF I LL DP R T +L
Sbjct: 230 FDEEYFSN------------------TSELAKDF-------IRRLLVKDPKRRMTIAQSL 264
Query: 400 R 400
Sbjct: 265 E 265
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 60/283 (21%), Positives = 107/283 (37%), Gaps = 38/283 (13%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE 183
+IG+G++ VYK DT T VA +++ L + E +L+ L HPN+V+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 184 G--LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE--HCHNQ 238
T + + LV + M L ++ + Q+L GL+ H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 239 HVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++HRD+K N+ I G + I D GLA+ + + T + PE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE--MYEEK 205
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
Y VD+++ G + E+ + P +E + +I++ S
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSG----------------V 246
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
S+ + K+ IE + + ER + L
Sbjct: 247 KPASFDKVAIPEVKEI-------IEGCIRQNKDERYSIKDLLN 282
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-45
Identities = 60/286 (20%), Positives = 108/286 (37%), Gaps = 44/286 (15%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH-PNVVKLE 183
++G+G ++ V + TGQ A K ++ + + EI +L P V+ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 184 GLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
+ + + L+ +Y L ++ V + Q+L G+ + H +
Sbjct: 96 EVYENTS--EIILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 240 VLHRDIKGSNLLIDNE---GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++H D+K N+L+ + G + I DFG++ + + T Y PE+L
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNY-D 208
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
D+W+ G I LL P G E I ++ SEE +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNISQVNVDYSEETFSS------- 259
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+++ DF I++LL +P +R TA L
Sbjct: 260 -----------VSQLATDF-------IQSLLVKNPEKRPTAEICLS 287
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-45
Identities = 75/329 (22%), Positives = 128/329 (38%), Gaps = 70/329 (21%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-------- 174
+ K+G G +S V+ A+D + VA+K VR D + E+ EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 175 ---DHPNVVKLEG-------------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ 218
+++KL +V + +L + K EH
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH----------RGIPL 130
Query: 219 AQVKCYMHQLLSGLEHCH-NQHVLHRDIKGSNLLIDNE------GILTIADFGLASFFDP 271
VK QLL GL++ H ++H DIK N+L++ + IAD G A ++D
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------ 325
++ T+ + T YR PE+LLGA +G G D+WS C++ EL+ +
Sbjct: 191 HY----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLP------ 379
+ + + +I +L G + K T F + + F
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTR-TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 380 --------LIETLLAIDPAERQTATAALR 400
+ +L +DP +R A +
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVN 333
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 46/329 (13%), Positives = 92/329 (27%), Gaps = 80/329 (24%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRR 173
R T + +GQ +A D TG+ + F P +++ M E+L LR
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 174 L-------------------------DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL 208
L ++++ S + ++ M+ +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 209 ------AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIAD 262
+S Q++ L H+ ++H ++ ++++D G + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 263 FGLASFFDPNHKQPMTSRVVTLWYRPPELL----------LGATDYGVGVDLWSAGCILA 312
F V+ + PPEL T D W+ G ++
Sbjct: 250 FEHLVRDG-----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 313 ELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKD 372
+ + + IF+ C K+
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSC---------------------------------KN 331
Query: 373 FPPSSLPLIETLLAIDPAERQTATAALRS 401
P L+E L +R A+ +
Sbjct: 332 IPQPVRALLEGFLRYPKEDRLLPLQAMET 360
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-44
Identities = 73/222 (32%), Positives = 107/222 (48%), Gaps = 17/222 (7%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV-RFMAREILILRRLDHPN 178
F+ +G+G + NVY AR+ I+ALK + LE E V + REI I L HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 179 VVKLEGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLE 233
++++ R +YL+ +E G L +F + + +M +L L
Sbjct: 76 ILRMYNYFHDRKR--IYLM---LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALH 128
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+CH + V+HRDIK NLL+ +G L IADFG S P+ ++ T TL Y PPE++
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRR-RTM-CGTLDYLPPEMIE 185
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
G + VDLW AG + E L P + E +I
Sbjct: 186 G-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 64/304 (21%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALK-------KVRFDNLEPESVRFMAREILI 170
D ++ +++G G ++ V K R+ TG A K + + E + RE+ I
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE---REVSI 68
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTI----KFTQAQVK 222
LR++ HPN++ L + +R + L+ + + D + ++ +
Sbjct: 69 LRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFD--------FLAQKESLSEEEAT 118
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMT 278
++ Q+L G+ + H + + H D+K N+++ + + DFGLA +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFK 176
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP--GRTEVEQLHKIFKL 336
+ T + PE++ G+ D+WS G I LL+ P G T+ E L I +
Sbjct: 177 NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITAV 233
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396
EE++ + +E KDF I LL + +R T
Sbjct: 234 SYDFDEEFFSQ------------------TSELAKDF-------IRKLLVKETRKRLTIQ 268
Query: 397 AALR 400
ALR
Sbjct: 269 EALR 272
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 64/293 (21%), Positives = 105/293 (35%), Gaps = 56/293 (19%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKL 182
+G G V + TGQ ALK + + R +E+ + P++V +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---QEVDHHWQASGGPHIVCI 87
Query: 183 EGLV--TSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ L ++ + ME G + FT+ + M + + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 235 CHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
H+ ++ HRD+K NLL ++ +L + DFG A N + + T +Y PE
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPE- 199
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK--LCGSPS--EEYWKK 347
+LG Y D+WS G I+ LL P T + + G W +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++E K LI LL DP ER T T +
Sbjct: 260 ------------------VSEDAKQ-------LIRLLLKTDPTERLTITQFMN 287
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-43
Identities = 66/331 (19%), Positives = 117/331 (35%), Gaps = 49/331 (14%)
Query: 107 EAISGWTPRRADTFEKLDKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFM 164
+ +S + P +E L IG+G V AR TG+ V ++++ + E V F+
Sbjct: 15 QGMSSFLPE-GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL 73
Query: 165 AREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQ 220
E+ + + +HPN+V + L++V +M DL + +
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL--ICTHFMDGMNELA 129
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG-LASFFDPNHKQ---- 275
+ + +L L++ H+ +HR +K S++LI +G + ++ S +Q
Sbjct: 130 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 276 -PMTSRVVTLWYRPPELLL-GATDYGVGVDLWSAGCILAEL---------------LAEK 318
V L + PE+L Y D++S G EL L EK
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249
Query: 319 PIMP---------GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAET 369
E + + S + S + P Y R +
Sbjct: 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309
Query: 370 FKDFPPSSLPLIETLLAIDPAERQTATAALR 400
F F +E L +P R +A+ L
Sbjct: 310 FHHF-------VEQCLQRNPDARPSASTLLN 333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 71/342 (20%), Positives = 124/342 (36%), Gaps = 80/342 (23%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR----EILILR 172
D +E IG+G++ V KA D + + VA+K ++ + + E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 173 RL------DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFT 217
+ +V L+ LV +S +LY + + + G +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR--NTNFRG--------VS 155
Query: 218 QAQVKCYMHQLLSGLEHCHNQ--HVLHRDIKGSNLLIDNEG--ILTIADFGLASFFDPNH 273
+ + Q+ + L ++H D+K N+L+ N + I DFG +
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--- 212
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
Q + + + +YR PE+LLG Y + +D+WS GCIL E+ +P+ G EV+Q++KI
Sbjct: 213 -QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
Query: 334 FKLCGSPSEEYWKKSKLPH--------------------ATIFKPQQSYKRCIAETFKDF 373
++ G P ++ P I
Sbjct: 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330
Query: 374 PPSSLP---------------LIETLLAIDPAERQTATAALR 400
P LI +L DP R AL+
Sbjct: 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-43
Identities = 70/344 (20%), Positives = 122/344 (35%), Gaps = 82/344 (23%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAR----EILILR 172
+ F + K+G GT+ V + + A+K VR +++ R E IL+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILK 86
Query: 173 RL-----DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQ 218
++ ++ N+VK G L+ + SLY + ++ G F
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIIT--RNNYNG--------FHI 136
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN-LLIDNEGILT------------------ 259
+K Y ++L L + + H D+K N LL D +
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 260 ------IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAE 313
+ DFG A+F H S + T YR PE++L + V D+WS GC+LAE
Sbjct: 197 KSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAE 251
Query: 314 LLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDF 373
L + +E L + + + ++ + + + + K E
Sbjct: 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSI 311
Query: 374 P-----PSSLP------------LIETLLAIDPAERQTATAALR 400
LP + ++L IDP R + L+
Sbjct: 312 NSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 70/362 (19%), Positives = 128/362 (35%), Gaps = 60/362 (16%)
Query: 56 SNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPR 115
SN++ ++ V P P L +PP + + +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII-- 60
Query: 116 RADTFEKLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
D ++ + +G G V + + T + ALK ++ + R RE+ + R
Sbjct: 61 --DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRA 111
Query: 175 -DHPNVVKLEGLV--TSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKCYM 225
P++V++ + L +V + ++ G + FT+ + M
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIM 167
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVV 282
+ +++ H+ ++ HRD+K NLL ++ IL + DFG A + +T+
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCY 225
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK--LCGSP 340
T +Y PE +LG Y D+WS G I+ LL P + + G
Sbjct: 226 TPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 341 S--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398
W + ++E K LI LL +P +R T T
Sbjct: 285 EFPNPEWSE------------------VSEEVKM-------LIRNLLKTEPTQRMTITEF 319
Query: 399 LR 400
+
Sbjct: 320 MN 321
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-43
Identities = 72/295 (24%), Positives = 119/295 (40%), Gaps = 58/295 (19%)
Query: 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK 181
+G+GTY VY RD +A+K++ + + + EI + + L H N+V+
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 182 LEGLVTSRMSCSLYLVFKYMEHD-LAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQ 238
G + + + + + + L+ L S +K + + Y Q+L GL++ H+
Sbjct: 84 YLG--SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 239 HVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGAT 296
++HRDIKG N+LI+ G+L I+DFG + + T TL Y PE++
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGP 199
Query: 297 D-YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
YG D+WS GC + E+ KP P + + P A +
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP--P----------------------FYELGEPQAAM 235
Query: 356 FK----------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
FK P+ ++ K F I DP +R A L
Sbjct: 236 FKVGMFKVHPEIPES-----MSAEAKAF-------ILKCFEPDPDKRACANDLLV 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-43
Identities = 78/305 (25%), Positives = 121/305 (39%), Gaps = 79/305 (25%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLD-HPNV 179
+G+G++S K + Q A+K K N + +EI L+ + HPN+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNI 68
Query: 180 VKLEGLVTSRMSCSLYLVFKYME------------HDLAGLAASPTIKFTQAQVKCYMHQ 227
VKL + ++ +LV + + H F++ + M +
Sbjct: 69 VKLHEVFHDQL--HTFLVMELLNGGELFERIKKKKH------------FSETEASYIMRK 114
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMTSRVVTL 284
L+S + H H+ V+HRD+K NLL +E + I DFG A P+ QP+ + TL
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTL 173
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELL-------AEKPIMPGRTEVEQLHKIFKLC 337
Y PE LL Y DLWS G IL +L + + + VE + KI
Sbjct: 174 HYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI--KK 230
Query: 338 GSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
G S E WK +++ KD LI+ LL +DP +R
Sbjct: 231 GDFSFEGEAWKN------------------VSQEAKD-------LIQGLLTVDPNKRLKM 265
Query: 396 TAALR 400
+
Sbjct: 266 SGLRY 270
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 75/298 (25%), Positives = 116/298 (38%), Gaps = 57/298 (19%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DH 176
D +E + IG G+YS + T A+K + +P EI IL R H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQH 75
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-------LAASPTIKFTQAQVKCYMHQLL 229
PN++ L+ + +Y+V + M+ G L F++ + + +
Sbjct: 76 PNIITLKDVYDDGK--YVYVVTELMK----GGELLDKILRQK---FFSEREASAVLFTIT 126
Query: 230 SGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
+E+ H Q V+HRD+K SN+L N + I DFG A + + T
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTAN 185
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKP---IMPGRTEVEQLHKIFKLCGSPSE 342
+ PE+L Y D+WS G +L +L P T E L +I S S
Sbjct: 186 FVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
YW +++T KD L+ +L +DP +R TA LR
Sbjct: 245 GYWNS------------------VSDTAKD-------LVSKMLHVDPHQRLTAALVLR 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALK--------KVRFDNLEPESVRFMA---------- 165
D+IG+G+Y V A + A+K + P
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 166 ------REILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQ 218
+EI IL++LDHPNVVKL ++ LY+VF+ + + + ++
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSE 136
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
Q + Y L+ G+E+ H Q ++HRDIK SNLL+ +G + IADFG+++ F +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 279 SRVVTLWYRPPELLLGAT-DY-GVGVDLWSAGCILAELLA 316
+ V T + PE L + G +D+W+ G L +
Sbjct: 197 T-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 66/318 (20%), Positives = 110/318 (34%), Gaps = 82/318 (25%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKL 182
D +G+G ++ V + +T Q A+K + S + RE+ +L + H NV++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLEL 76
Query: 183 EGLVTSRMSCSLYLVFKYME------------HDLAGLAASPTIKFTQAQVKCYMHQLLS 230
YLVF+ M H F + + + + S
Sbjct: 77 IEFFEEED--RFYLVFEKMRGGSILSHIHKRRH------------FNELEASVVVQDVAS 122
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNH------KQPMTSRV 281
L+ HN+ + HRD+K N+L ++ + I DF L S N + +
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 282 VTLWYRPPELLLG----ATDYGVGVDLWSAGCIL-----------AELLAEKPIMPGRTE 326
+ Y PE++ A+ Y DLWS G IL ++ G
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 327 VEQLHKIFK--LCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIE 382
+ +F+ G ++ W I+ KD LI
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAH------------------ISCAAKD-------LIS 277
Query: 383 TLLAIDPAERQTATAALR 400
LL D +R +A L+
Sbjct: 278 KLLVRDAKQRLSAAQVLQ 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-41
Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 58/284 (20%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+G+G Y V A + +T + VA+K R + PE+++ +EI I + L+H NVVK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 183 -EGLVTSRMSCSLYLV---------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+ YL F +E D I + + + HQL++G+
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV 118
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPEL 291
+ H + HRDIK NLL+D L I+DFGLA+ F N+++ + +++ TL Y PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 292 LLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L + VD+WS G +L +LA E P + +EY +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP--------------WDQPSDSCQEYSDWKE- 223
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
+ +K + L L+ +L +P+ R T
Sbjct: 224 --KKTYLNP----------WKKIDSAPLALLHKILVENPSARIT 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 68/340 (20%), Positives = 122/340 (35%), Gaps = 80/340 (23%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNLEPESVRFMAR----EILIL 171
+ +E +D +G+G + V + D G + VA+K V+ +V EI +L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVL 65
Query: 172 RRL------DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKF 216
L V++ +V + S Y K E+ F
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIK--ENGFLP--------F 115
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN-LLIDNEGILT---------------- 259
++ +Q+ + H+ + H D+K N L + ++
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 260 --IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE 317
+ DFG A++ D +H ++ V T YR PE++L + D+WS GCIL E
Sbjct: 176 IKVVDFGSATYDDEHH----STLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLG 230
Query: 318 KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS 377
+ P E L + ++ G + +K++ F + + + +
Sbjct: 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK--YFHHDRLDWDEHSSAGRYVSRAC 288
Query: 378 LPL-----------------IETLLAIDPAERQTATAALR 400
PL I+ +L DPA+R T AL+
Sbjct: 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+G+G+Y V + D+ T A+K K + + + +EI +LRRL H NV++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQL 71
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
++ + +Y+V +Y + + + P +F Q Y QL+ GLE+ H+Q ++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM--TSRVVTLWYRPPELLLGATDY- 298
H+DIK NLL+ G L I+ G+A P TS+ + ++PPE+ G +
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIANGLDTFS 190
Query: 299 GVGVDLWSAGCILAELLA 316
G VD+WSAG L +
Sbjct: 191 GFKVDIWSAGVTLYNITT 208
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 69/340 (20%), Positives = 119/340 (35%), Gaps = 80/340 (23%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ-IVALKKVRFDNLEPESVRFMAR----EILIL 171
+ +E + +G+GT+ V + D G+ VALK +R +V EI +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 172 RRL------DHPNVVKLEG---------LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKF 216
+++ + V + + + + + K E++ +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQP--------Y 120
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSN-LLIDNEGILT---------------- 259
V+ +QL L H + H D+K N L +++E
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 260 --IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE 317
+ADFG A+F +H T+ V T YRPPE++L + D+WS GCIL E
Sbjct: 181 IRVADFGSATFDHEHH----TTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRG 235
Query: 318 KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSS 377
+ E L + K+ G +++ F + + +
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQK--YFYKGGLVWDENSSDGRYVKENC 293
Query: 378 LPL-----------------IETLLAIDPAERQTATAALR 400
PL + +L DPA+R T AL
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-41
Identities = 67/303 (22%), Positives = 114/303 (37%), Gaps = 42/303 (13%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
D +E + IG G + V A + VA+K++ + + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 174 LDHPNVVKLEG--LVTSRMSCSLYLVFKYME----HDL----AGLAASPTIKFTQAQVKC 223
HPN+V +V L+LV K + D+ + ++ +
Sbjct: 70 CHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGL-ASFFDPNHKQPMTSR-- 280
+ ++L GLE+ H +HRD+K N+L+ +G + IADFG+ A R
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 281 -VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
V T + PE++ Y D+WS G EL P HK
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--P-------YHKY-----P 231
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIA--ETFKDFPPSSLPLIETLLAIDPAERQTATA 397
P + + ++ Q + ++F+ I L DP +R TA
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKM-------ISLCLQKDPEKRPTAAE 284
Query: 398 ALR 400
LR
Sbjct: 285 LLR 287
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 58/284 (20%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+G+G Y V A + +T + VA+K R + PE+++ +EI I + L+H NVVK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 183 -EGLVTSRMSCSLYLV---------FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+ YL F +E D I + + + HQL++G+
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV 118
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPEL 291
+ H + HRDIK NLL+D L I+DFGLA+ F N+++ + +++ TL Y PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 292 LLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L + VD+WS G +L +LA E P + +EY +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP--------------WDQPSDSCQEYSDWKE- 223
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394
+ +K + L L+ +L +P+ R T
Sbjct: 224 --KKTYLNP----------WKKIDSAPLALLHKILVENPSARIT 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)
Query: 122 KLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
+L K IG+G ++ V AR LTG+ VA+K + L P S++ + RE+ I++ L+HPN+V
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 181 KL-EGLVTSRMSCSLYLVFKY----------MEHDLAGLAASPTIKFTQAQVKCYMHQLL 229
KL E + T + LYL+ +Y + H + + + + Q++
Sbjct: 78 KLFEVIETEKT---LYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFRQIV 124
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
S +++CH + ++HRD+K NLL+D + + IADFG ++ F K + + Y P
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAP 182
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLA 316
EL G G VD+WS G IL L++
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 56/250 (22%), Positives = 98/250 (39%), Gaps = 30/250 (12%)
Query: 98 PSWLSAVAGEAISGWTPRRAD----TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRF 153
P L +G S + + + + +G ++ VY+A+D +G+ ALK++
Sbjct: 4 PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63
Query: 154 DNLEPESVRFMAREILILRRL-DHPNVVKLEG---LVTSRMSCSLYLVFKYMEHDLAGL- 208
+ E R + +E+ +++L HPN+V+ + E L
Sbjct: 64 NE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLV 121
Query: 209 ----AASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIAD 262
+ V +Q ++H H Q ++HRD+K NLL+ N+G + + D
Sbjct: 122 EFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181
Query: 263 FGLASFFDPNHKQPMTS-----------RVVTLWYRPPEL--LLGATDYGVGVDLWSAGC 309
FG A+ ++ R T YR PE+ L G D+W+ GC
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241
Query: 310 ILAELLAEKP 319
IL L +
Sbjct: 242 ILYLLCFRQH 251
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 47/292 (16%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-ESVRFMAREILILRRLD 175
F L +IG G++ VY ARD ++VA+KK+ + + E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 176 HPNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
HPN ++ G L +LV +Y + L + ++ H L GL
Sbjct: 113 HPNTIQYRGCYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR---VVTLWYRPPE 290
+ H+ +++HRD+K N+L+ G++ + DFG AS M V T ++ PE
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-------I-MAPANSFVGTPYWMAPE 220
Query: 291 LLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
++L + Y VD+WS G I LAE P + + ++ + +
Sbjct: 221 VILAMDEGQYDGKVDVWSLG-ITCIELAE--RKPPLFNMNAMSALYHI-----------A 266
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + S E F++F +++ L P +R T+ L+
Sbjct: 267 QNESPALQSGHWS------EYFRNF-------VDSCLQKIPQDRPTSEVLLK 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-40
Identities = 43/381 (11%), Positives = 94/381 (24%), Gaps = 73/381 (19%)
Query: 57 NNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRR 116
+ + + + + W + + R
Sbjct: 21 GTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGE----R 76
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-VRFMAREILILRRL- 174
T + +GQ +A D TG+ + F P + ++ M E+L LR L
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 175 ------------------------DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAA 210
++++ S + ++ M+ +L
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 211 SPTIK------FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
Q++ L H+ ++H ++ ++++D G + + F
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 265 LASFFDPNHKQPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPI 320
+ P+ +L T D W+ G + +
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 321 MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPL 380
+ IF+ C K+ P L
Sbjct: 317 NTDDAALGGSEWIFRSC---------------------------------KNIPQPVRAL 343
Query: 381 IETLLAIDPAERQTATAALRS 401
+E L +R A+ +
Sbjct: 344 LEGFLRYPKEDRLLPLQAMET 364
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 23/228 (10%)
Query: 102 SAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK-----KVRFDNL 156
AV E ++ + + + +G G + V+ A D + V +K KV D
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 157 -EPESVRFMAREILILRRLDHPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAG------L 208
E + + EI IL R++H N++K+ + LV ME +G +
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF---FQLV---MEKHGSGLDLFAFI 121
Query: 209 AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268
P + + QL+S + + + ++HRDIK N++I + + + DFG A++
Sbjct: 122 DRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
+ + T+ Y PE+L+G G +++WS G L L+
Sbjct: 180 LERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 40/291 (13%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ +E + ++G G + VYKA++ TG + A K + + E + EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 177 PNVVKLEG--LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
P +VKL G + L+++ ++ + + T+ Q++ Q+L L
Sbjct: 76 PYIVKLLGAYYHDGK----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H++ ++HRD+K N+L+ EG + +ADFG+++ Q S + T ++ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSFIGTPYWMAPEVVM 190
Query: 294 GAT----DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
T Y D+WS G I +A+ I P E+ + + K+ S
Sbjct: 191 CETMKDTPYDYKADIWSLG-ITLIEMAQ--IEPPHHELNPMRVLLKIAKSDP------PT 241
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
L + + + F+DF ++ L +P R +A L
Sbjct: 242 LLTPSKWSVE----------FRDF-------LKIALDKNPETRPSAAQLLE 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-38
Identities = 76/294 (25%), Positives = 135/294 (45%), Gaps = 54/294 (18%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ F KL+KIG+G++ V+K D T ++VA+K + + E E + + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 177 PNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSG 231
P V K G L ++ L+++ +Y+ G +A ++ + Q+ + ++L G
Sbjct: 80 PYVTKYYGSYLKDTK----LWIIMEYL----GGGSALDLLEPGPLDETQIATILREILKG 131
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
L++ H++ +HRDIK +N+L+ G + +ADFG+A + T V T ++ PE+
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEV 190
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKP----IMPGRTEVEQLHKIFKLCGSPS-EEYWK 346
+ + Y D+WS G EL +P + P + L I K P+ E +
Sbjct: 191 IKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKV----LFLIPK-NNPPTLEGNYS 244
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
K K+F +E L +P+ R TA L+
Sbjct: 245 KP---------------------LKEF-------VEACLNKEPSFRPTAKELLK 270
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALK-----KVRFDNLEPESVRFMAREILILRRL 174
+ +G+G + V+ VA+K +V + +SV E+ +L ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 175 D----HPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAG------LAASPTIKFTQAQVKC 223
HP V++L + T LV +E L + + + +C
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG---FMLV---LERPLPAQDLFDYITEKGPLGEGPS--RC 143
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQPMTSRVV 282
+ Q+++ ++HCH++ V+HRDIK N+LID G + DFG + H +P T
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDG 200
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
T Y PPE + + + +WS G +L +++
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 57/311 (18%), Positives = 102/311 (32%), Gaps = 80/311 (25%)
Query: 110 SGWTPRRADTFEKLD----KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA 165
SG ++ + +G G V + + T + ALK ++ + R
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR--- 58
Query: 166 REILILRRL-DHPNVVKLEGLV--TSRMSCSLYLVFKYMEHDLAG------LAASPTIKF 216
RE+ + R P++V++ + L +V + ++ G + F
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAF 114
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNH 273
T+ + M + +++ H+ ++ HRD+K NLL ++ IL + DFG A
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------- 167
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
E Y D+WS G I+ LL P + +
Sbjct: 168 ---------------KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 210
Query: 334 FK--LCGSPS--EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
G W + ++E K LI LL +P
Sbjct: 211 KTRIRMGQYEFPNPEWSE------------------VSEEVKM-------LIRNLLKTEP 245
Query: 390 AERQTATAALR 400
+R T T +
Sbjct: 246 TQRMTITEFMN 256
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
+D ++ + IG G + RD LT ++VA+K + E+V+ REI+ R L
Sbjct: 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSL 73
Query: 175 DHPNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQL 228
HPN+V+ E ++T L ++ ME+ G + + +F++ + + + QL
Sbjct: 74 RHPNIVRFKEVILTPTH---LAII---MEYASGGELYERICNAG--RFSEDEARFFFQQL 125
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGI--LTIADFGLASFFDPNHKQPMTSRVVTLWY 286
LSG+ +CH+ + HRD+K N L+D L I DFG + H QP ++ V T Y
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKST-VGTPAY 183
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLA 316
PE+LL G D+WS G L +L
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 43/288 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + +KIGQG VY A D TGQ VA++++ + + EIL++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 178 NVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGL 232
N+V LV L++V +Y+ G + + + + Q+ + L L
Sbjct: 78 NIVNYLDSYLVGDE----LWVVMEYLA----GGSLTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
E H+ V+HRDIK N+L+ +G + + DFG + P + T V T ++ PE++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVV 188
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
YG VD+WS G I+A + E P L ++ + + + E KL
Sbjct: 189 TR-KAYGPKVDIWSLG-IMAIEMIE--GEPPYLNENPLRALYLIATNGTPELQNPEKL-- 242
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ F+DF + L +D +R +A L+
Sbjct: 243 --------------SAIFRDF-------LNRCLEMDVEKRGSAKELLQ 269
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 46/309 (14%), Positives = 93/309 (30%), Gaps = 64/309 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
+G+G ++ VY+A D Q LK + N P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH----DLAGLAASPTIK-FTQAQVKCYMHQ 227
+K + LV + + + L + K Q V + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLI-----------DNEGILTIADFGLA---SFFDPNH 273
+L +E H+ ++H DIK N ++ D L + D G + F
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG- 239
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
T++ T ++ E+L + +D + + +L
Sbjct: 240 -TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCML------------------ 279
Query: 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
G+ + + + KP+ ++R + +L I
Sbjct: 280 ---FGTYMKVKNEGGE------CKPEGLFRR-----LPHLDMWN-EFFHVMLNIPDCHHL 324
Query: 394 TATAALRSE 402
+ LR +
Sbjct: 325 PSLDLLRQK 333
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 126 IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-MAREILILRRLDHPNVVKL-E 183
+G GT+ V LTG VA+K + + V + REI L+ HP+++KL +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 184 GLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
+ T ++V ME+ G + + + + + Q+LS +++CH
Sbjct: 79 VISTPTD---FFMV---MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH 130
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK------QPMTSRVVTLWYRPPELL 292
V+HRD+K N+L+D IADFGL++ P Y PE++
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YAAPEVI 182
Query: 293 LGATDYGVGVDLWSAGCILAELLA 316
G G VD+WS G IL LL
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLC 206
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-D 175
A FE ++ +G GTY VYK R TGQ+ A+K + ++ + + +EI +L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 176 HPNVVKLEG----LVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQ 227
H N+ G M L+LV ++ DL + + + + +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
+L GL H H V+HRDIKG N+L+ + + DFG+++ D + T + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 196
Query: 288 PPELLLGATD----YGVGVDLWSAGCILAELLAE 317
PE++ + Y DLWS G I A +AE
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLG-ITAIEMAE 229
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 45/289 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F+ L+K+G+G+Y +VYKA TGQIVA+K+V ++ + + + +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSP 84
Query: 178 NVVKLEG--LVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+VVK G + L++V +Y D+ L T+ ++ + L G
Sbjct: 85 HVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKG 137
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LE+ H +HRDIK N+L++ EG +ADFG+A + + T ++ PE+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEV 196
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+ Y D+WS G I A +AE P ++ + IF + +P + K
Sbjct: 197 IQEI-GYNCVADIWSLG-ITAIEMAE--GKPPYADIHPMRAIFMIPTNPPPTFRKPELW- 251
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ F DF ++ L P +R TAT L+
Sbjct: 252 ---------------SDNFTDF-------VKQCLVKSPEQRATATQLLQ 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 122 KLDK-IGQGTYSNVYKARDTLTGQIVALK---KVRFDNLE-PESVRFMAREILILRRLDH 176
+ + +G+G++ V A T Q VALK + + V REI L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 177 PNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P+++KL + + T + +V +Y +L + T+ + + + Q++ +E+C
Sbjct: 69 PHIIKLYDVITTPTD---IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC 124
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK------QPMTSRVVTLWYRPP 289
H ++HRD+K NLL+D+ + IADFGL++ + P Y P
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN--------YAAP 176
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLA 316
E++ G G VD+WS G +L +L
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLV 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 33/215 (15%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILRRLD 175
++ +G G + +VY VA+K V D + E+++L+++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 176 H--PNVVKL-EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTI----------KFTQAQVK 222
V++L + L+ +E P + +
Sbjct: 105 SGFSGVIRLLDWFERPDS---FVLI---LER------PEPVQDLFDFITERGALQEELAR 152
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRV 281
+ Q+L + HCHN VLHRDIK N+LID N G L + DFG + T
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 209
Query: 282 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316
T Y PPE + +G +WS G +L +++
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-36
Identities = 68/288 (23%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ KIG+G+ V AR+ +G+ VA+K + D + + + E++I+R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 178 NVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGL 232
NVV++ LV L+++ ++++ G A + + + Q+ +L L
Sbjct: 103 NVVEMYKSYLVGEE----LWVLMEFLQ----GGALTDIVSQVRLNEEQIATVCEAVLQAL 154
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ H Q V+HRDIK ++L+ +G + ++DFG + + + S V T ++ PE++
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVI 213
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
+ Y VD+WS G I+ + + P + + +L SP + K+
Sbjct: 214 SR-SLYATEVDIWSLG-IMVIEMVD--GEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV-- 267
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ +DF +E +L DP ER TA L
Sbjct: 268 --------------SPVLRDF-------LERMLVRDPQERATAQELLD 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 53/226 (23%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL 171
R +D + +G+G + K TG+++ +K+ + E+ R +E+ ++
Sbjct: 5 RIFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVM 61
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLS 230
R L+HPNV+K G++ L + +Y++ L G+ S ++ +Q + + S
Sbjct: 62 RCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP-------------M 277
G+ + H+ +++HRD+ N L+ + +ADFGLA QP
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG 323
+ V ++ PE++ G Y VD++S G +L E++ P
Sbjct: 180 YTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 60/356 (16%), Positives = 108/356 (30%), Gaps = 99/356 (27%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVA----------------------LKKVR 152
R FE + +G+G + V++A++ + A L K+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 153 FDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS------------------- 193
+ ++ + +K E S S
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 194 -------------LYLVFKYMEH-DLAGL--AASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
LY+ + +L Q+ +E H+
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLA-----------SFFDPNHKQPMTSRVVTLWY 286
+ ++HRD+K SN+ + ++ + DFGL T +V T Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PE + G +Y VD++S G IL ELL T++E++ I + +
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDV---------R 287
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
K P F P +++ +L+ P ER AT + +
Sbjct: 288 NLKFP----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 39/212 (18%), Positives = 76/212 (35%), Gaps = 22/212 (10%)
Query: 120 FEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
F++L+ K+ + ++K G + +K ++ + R E LR H
Sbjct: 9 FKQLNFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYME----HDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
PNV+ + G S + L+ +M +++ L Q+Q + + G+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGM 124
Query: 233 E--HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
H + + +++ID + I+ + F R+ + PE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE 178
Query: 291 LLLG--ATDYGVGVDLWSAGCILAELLA-EKP 319
L D+WS +L EL+ E P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 122 KLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF-MAREILILRRLDHPNV 179
L +G GT+ V + LTG VA+K + + V + REI L+ HP++
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 180 VKL-EGLVTSRMSCSLYLVFKYMEHDLAG-----LAASPTIKFTQAQVKCYMHQLLSGLE 233
+KL + + T +++V ME+ G + + + + + + Q+LSG++
Sbjct: 79 IKLYQVISTPSD---IFMV---MEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVD 130
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK------QPMTSRVVTLWYR 287
+CH V+HRD+K N+L+D IADFGL++ P Y
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YA 182
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLA 316
PE++ G G VD+WS+G IL LL
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLC 211
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 44/284 (15%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRL 174
R + F+ +G+G++S V AR+ T + A+K + + ++ V ++ RE ++ RL
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYME-----HDLAGLAASPTIKFTQAQVKCYMHQLL 229
DHP VKL T + LY Y + + F + + Y +++
Sbjct: 88 DHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIV 140
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRP 288
S LE+ H + ++HRD+K N+L++ + + I DFG A P KQ + V T Y
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
PELL DLW+ GCI+ +L+A P E KI K +
Sbjct: 201 PELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----------LEY 249
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
P + F P + L+E LL +D +R
Sbjct: 250 DFP-------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-----VRFMAREILILRRL 174
E +IG+G + V+K R +VA+K + + E E+ + RE+ I+ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+HPN+VKL GL+ + +V +++ DL + M + G+E
Sbjct: 81 NHPNIVKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 234 --HCHNQHVLHRDIKGSNLLIDNEG-----ILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
N ++HRD++ N+ + + +ADFGL+ ++ + +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSGLLGNFQW 192
Query: 287 RPPELLLGATD-YGVGVDLWSAGCILAELLAEK 318
PE + + Y D +S IL +L +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 120 FEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ L+ KIG G++ V++A G VA+K + + E V RE+ I++RL H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL--AASPTIKFTQAQVKCYMHQLLSGLE 233
PN+V G VT +L +V +Y+ L L + + + + + + G+
Sbjct: 94 PNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 234 --HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
H N ++HR++K NLL+D + + + DFGL+ S T + PE+
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEV 210
Query: 292 LLGATDYGVGVDLWSAGCILAELL 315
L D++S G IL EL
Sbjct: 211 LRD-EPSNEKSDVYSFGVILWELA 233
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 63/300 (21%), Positives = 113/300 (37%), Gaps = 39/300 (13%)
Query: 109 ISGWT-PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMARE 167
I G + E L ++G GT V+K R TG ++A+K++R E + + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMD 73
Query: 168 ILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
+ ++ + D P +V+ G + + +++ + M L + +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 227 QLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
++ L + +H V+HRD+K SN+L+D G + + DFG++ +
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAA 189
Query: 286 YRPPE----LLLGATDYGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIFKLCGSP 340
Y PE DY + D+WS G L EL + P +T+ E L K+ +
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EE 246
Query: 341 SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
LP F F+ F ++ L D +R L
Sbjct: 247 PP------LLPGHMGFSGD----------FQSF-------VKDCLTKDHRKRPKYNKLLE 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
E + +G+G + V KA + VA+K++ ++ F+ E+ L R++HPN+
Sbjct: 10 IEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKA---FI-VELRQLSRVNHPNI 63
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGL--AASPTIKFTQAQVKCYMHQLLSGLEHCH 236
VKL G + + LV +Y E L + A P +T A + Q G+ + H
Sbjct: 64 VKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 237 NQH---VLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
+ ++HRD+K NLL+ G +L I DFG A + MT+ + + PE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVF 175
Query: 293 LGATDYGVGVDLWSAGCILAELLA-EKP 319
G ++Y D++S G IL E++ KP
Sbjct: 176 EG-SNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 70/311 (22%), Positives = 126/311 (40%), Gaps = 43/311 (13%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ D FEK+ ++G G V+K +G ++A K + + +P + RE+ +L +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN 89
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAAS---PTIKFTQAQVKCYMHQLLSGL 232
P +V G S + + ++M+ G + + + ++ GL
Sbjct: 90 SPYIVGFYGAFYS--DGEISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 233 EHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
+ +H ++HRD+K SN+L+++ G + + DFG++ + S V T Y PE
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPER 201
Query: 292 LLGATDYGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L G T Y V D+WS G L E+ + PI P + +L ++ G +E +
Sbjct: 202 LQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 351 ------------PHATIFK---------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDP 389
P IF+ P + + F+DF + L +P
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF-------VNKCLIKNP 313
Query: 390 AERQTATAALR 400
AER +
Sbjct: 314 AERADLKQLMV 324
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
+IG G++ VYK G VA+K + P+ ++ E+ +LR+ H N++
Sbjct: 29 GQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
G T+ L +V ++ E L + KF ++ Q G+++ H + ++
Sbjct: 86 MGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDP-NHKQPMTSRVVTLWYRPPELLLGATD--Y 298
HRD+K +N+ + + + I DFGLA+ + ++ + PE++ Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 299 GVGVDLWSAGCILAELL 315
D+++ G +L EL+
Sbjct: 203 SFQSDVYAFGIVLYELM 219
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 21/248 (8%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
++ + L+ +G + V+KA L + VA+K F + +S + E+ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 176 HPNVVKLEGLVT--SRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQ--------AQVKCY 224
H N+++ G + + L+L+ + E L+ + + + + A+ Y
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAY 136
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-T 283
+H+ + GL+ H + HRDIK N+L+ N IADFGLA F+ T V T
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 284 LWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
Y PE+L GA D + +D+++ G +L EL + G + L ++
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256
Query: 340 PSEEYWKK 347
PS E ++
Sbjct: 257 PSLEDMQE 264
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 120 FEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
FE+L+ IG+G + VY G+ VA++ + + + ++ RE++ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
NVV G S L ++ + L + I + + +++ G+ +
Sbjct: 89 ENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASF----FDPNHKQPMTSRVVTLWYRPPEL 291
H + +LH+D+K N+ DN G + I DFGL S + + + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 292 LLGATD--------YGVGVDLWSAGCILAELLA-EKP 319
+ + + D+++ G I EL A E P
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 22/232 (9%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRL 174
+ D FE L IG+G +S V + TGQ+ A+K + + L+ V E +L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 175 DHPNVVKLEGLVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
D + +L + LYLV +Y DL L + + + Y+ +
Sbjct: 119 DRRWITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++ ++ H +HRDIK N+L+D G + +ADFG + V T Y
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 288 PPELLLG------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
PE+L YG D W+ G E+ + + E KI
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 61/297 (20%), Positives = 114/297 (38%), Gaps = 47/297 (15%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI-LRRL 174
+AD E + ++G+G Y V K R +GQI+A+K++R + + + + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTV 63
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYME---HDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
D P V G + +++ + M+ + + ++
Sbjct: 64 DCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 232 LEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPE 290
LEH H++ V+HRD+K SN+LI+ G + + DFG++ + Y PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPE 179
Query: 291 LLLGATD---YGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIFKLCGSP---SEE 343
+ + Y V D+WS G + EL + P T +QL ++ + +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPAD 237
Query: 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ F DF L + ER T ++
Sbjct: 238 KFSAE---------------------FVDF-------TSQCLKKNSKERPTYPELMQ 266
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 61/295 (20%), Positives = 121/295 (41%), Gaps = 39/295 (13%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL- 174
A+ + L +IG+G Y +V K +GQI+A+K++R ++ + + + ++ ++ R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSS 78
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYM----EHDLAGLAASPTIKFTQAQVKCYMHQLLS 230
D P +V+ G + ++ + M + + + + + +
Sbjct: 79 DCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 231 GLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
L H ++HRDIK SN+L+D G + + DFG++ + + T Y P
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAP 194
Query: 290 ELLLGATD---YGVGVDLWSAGCILAEL-LAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
E + + Y V D+WS G L EL P + +QL ++ K G P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP----- 247
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+L + ++ + + +F +F + L D ++R L+
Sbjct: 248 --PQLSN----SEEREF----SPSFINF-------VNLCLTKDESKRPKYKELLK 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A + + +IG+G Y V+ G+ VA+K E+ F EI + H
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRH 90
Query: 177 PNVVKLEGLVT--SRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ + LYL+ Y E+ L S T+ +K + +SGL
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-LKL-AYSSVSGLC 148
Query: 234 HCHNQ--------HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ---PMTSRVV 282
H H + + HRD+K N+L+ G IAD GLA F + + P +RV
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 283 TLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELL 315
T Y PPE+L + + D++S G IL E+
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 120 FEKLD---KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFM--AREILILRRL 174
F +L IG G + VY+A G VA+K R D E S +E + L
Sbjct: 6 FAELTLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
HPN++ L G+ +L LV ++ L + + I V + Q+ G+
Sbjct: 64 KHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDIL-VN-WAVQIARGMN 119
Query: 234 HCHNQH---VLHRDIKGSNLLIDNEG--------ILTIADFGLASFFDPNHKQPMTSRVV 282
+ H++ ++HRD+K SN+LI + IL I DFGLA + H+ S
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAG 176
Query: 283 TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
+ PE++ + + G D+WS G +L ELL
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELL 208
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 51/287 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
+TF + +G+G + V + TG++ A KK+ + + + E IL +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 177 PNVVKLEGLVTSRMSC-----SLYLVFKYME------HDLAGLAASPTIKFTQAQVKCYM 225
VV L +L LV M H + F +A+ Y
Sbjct: 244 RFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYA 292
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW 285
++ GLE H + +++RD+K N+L+D+ G + I+D GLA Q + RV T+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVG 350
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y PE++ Y D W+ GC+L E++A + R + + ++ +L
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------- 400
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ + + Y + + L LL DPAER
Sbjct: 401 ---------VKEVPEEYSERFSPQARS-------LCSQLLCKDPAER 431
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 20/230 (8%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRL 174
+ FE L IG+G + V + ++ A+K + ++ L+ E +L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 175 DHPNVVKLEGLVTSRMSCS------LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
D + L + LYLV Y DL L + + + + Y+ +
Sbjct: 132 DSKWITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++ ++ H H +HRDIK N+L+D G + +ADFG + + V T Y
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 288 PPELLLGATD----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
PE+L YG D WS G + E+L + + VE KI
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 77/377 (20%), Positives = 132/377 (35%), Gaps = 110/377 (29%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-- 174
+ + K+G G +S V+ + D + VA+K V+ E+ EI +L+ +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRN 92
Query: 175 ---DHPN---VVKL------EGLVTSRMSCSLYLVFKYMEHDLAGL-AASPTIKFTQAQV 221
+ PN VV+L G+ + + C +VF+ + H L S V
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHI-C---MVFEVLGHHLLKWIIKSNYQGLPLPCV 148
Query: 222 KCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNE------------------------- 255
K + Q+L GL++ H + ++H DIK N+L+
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 256 ------------------------GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
+ IAD G A + + + + +R YR E+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEV 264
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQLHKIFKLCGSPSEEYW 345
L+G+ Y D+WS C+ EL + + + + + I +L G +
Sbjct: 265 LIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 346 KKSK-----------LPHATIFKPQQSYKRCI---------AETFKDFPPSSLPLIETLL 385
K L H T KP ++ + A F DF + +L
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF-------LLPML 376
Query: 386 AIDPAERQTATAALRSE 402
+ P +R TA LR
Sbjct: 377 ELIPEKRATAAECLRHP 393
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 28/219 (12%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A L+ +G+G Y V++ + G+ VA+K + + F E+ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSW---FRETELYNTVMLRH 61
Query: 177 PNVVKLEGLVTSRMSCS--LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM-HQLLSGL 232
N++ + S L+L+ Y E L T+ + + SGL
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASGL 118
Query: 233 EHCHNQH--------VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ---PMTSRV 281
H H + + HRD+K N+L+ G IAD GLA + Q RV
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 282 VTLWYRPPELLLGATDYGVG-----VDLWSAGCILAELL 315
T Y PE+L VD+W+ G +L E+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 9/223 (4%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVR-FDNLEPESVRFMAREILILRRL 174
+A+ +E + IG+G + V R T ++ A+K + F+ ++ F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ P VV+L + LY+V +YM DL L + + + Y +++ L+
Sbjct: 127 NSPWVVQLFY--AFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALD 182
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H+ +HRD+K N+L+D G L +ADFG + + V T Y PE+L
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 294 ---GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
G YG D WS G L E+L + V KI
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 51/215 (23%), Positives = 76/215 (35%), Gaps = 28/215 (13%)
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
+ IG+G + V++ G+ VA+K F EI L H N++
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW---FREAEIYQTVMLRHENIL 99
Query: 181 KLEGLVTSRMSCS--LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM-HQLLSGLEHCH 236
L+LV Y EH L T+ + SGL H H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM---IKLALSTASGLAHLH 156
Query: 237 NQH--------VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---KQPMTSRVVTLW 285
+ + HRD+K N+L+ G IAD GLA D RV T
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 286 YRPPELLLGATDYGVG-----VDLWSAGCILAELL 315
Y PE+L + + D+++ G + E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 67/285 (23%), Positives = 115/285 (40%), Gaps = 44/285 (15%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
D F +G+G + V+ + TG++ A KK+ + + + E IL ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 177 PNVVKLEGLVTSRMSC-----SLYLVFKYMEH-DL---AGLAASPTIKFTQAQVKCYMHQ 227
+V L L LV M D+ F + + Y Q
Sbjct: 245 RFIVSLA-------YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++SGLEH H +++++RD+K N+L+D++G + I+D GLA + T +
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFM 356
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PELLLG +Y VD ++ G L E++A + R E + ++ +
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----------- 404
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ + +Y F P+S E LL DP +R
Sbjct: 405 -------VLEQAVTYPD-------KFSPASKDFCEALLQKDPEKR 435
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 63/293 (21%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
D FE L IG+G++ V + T ++ A+K + +E VR + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 177 PNVVKLEGLVTSRMSCS------LYLVFKYME------HDLAGLAASPTIKFTQAQVKCY 224
P +V L S +++V + H + F + VK +
Sbjct: 75 PFLVNLW--------YSFQDEEDMFMVVDLLLGGDLRYH------LQQNVHFKEETVKLF 120
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
+ +L+ L++ NQ ++HRD+K N+L+D G + I DF +A+ +T+ T
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTK 178
Query: 285 WYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKP---IMPGRTEVEQLHKIFKLCGS 339
Y PE+ Y VD WS G ELL + I + E +H
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---- 234
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
P + + L++ LL +P +R
Sbjct: 235 ------TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQR 262
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 37/226 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA-REILILRRLDH 176
D + L+ IG+G Y VYK +L + VA+K F ++ F+ + I + ++H
Sbjct: 13 DNLKLLELIGRGRYGAVYKG--SLDERPVAVKV--FSFANRQN--FINEKNIYRVPLMEH 66
Query: 177 PNVVKLEG---LVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM-HQLLSG 231
N+ + VT+ LV +Y + L + T + C + H + G
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS---SCRLAHSVTRG 123
Query: 232 LEHCHNQH---------VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ------- 275
L + H + + HRD+ N+L+ N+G I+DFGL+ N
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 276 PMTSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELL 315
S V T+ Y PE+L GA + VD+++ G I E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 46/215 (21%), Positives = 84/215 (39%), Gaps = 19/215 (8%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
A +E I G +Y A D + G+ V LK + M E L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAM-AERQFLAEVV 137
Query: 176 HPNVVKLEGLV---TSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
HP++V++ V Y+V +Y+ L A+ Y+ ++L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPA 194
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPE 290
L + H+ +++ D+K N+++ E + + D G S + + T ++ PE
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRIN------SFGYLYGTPGFQAPE 247
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325
++ V D+++ G LA L + P GR
Sbjct: 248 IVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESV-RFMAREILILRRLDHP 177
++ +DK+G G S VY A DT+ VA+K + + E++ RF RE+ +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRF-EREVHNSSQLSHQ 71
Query: 178 NVVKL------EGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLS 230
N+V + + YLV +Y+E L+ S + + +Q+L
Sbjct: 72 NIVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILD 122
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPP 289
G++H H+ ++HRDIK N+LID+ L I DFG+A T+ V+ T+ Y P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSP 181
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKP 319
E G D++S G +L E+L +P
Sbjct: 182 EQAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 69/286 (24%), Positives = 117/286 (40%), Gaps = 49/286 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA---REIL-ILRR 173
+ F IG+G + VY R TG++ A+K + ++ + +A R +L ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYME------HDLAGLAASPTIKFTQAQVKCYMHQ 227
D P +V + + L + M H L+ F++A ++ Y +
Sbjct: 249 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYH----LSQHG--VFSEADMRFYAAE 300
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYR 287
++ GLEH HN+ V++RD+K +N+L+D G + I+D GLA F K+ + V T Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYM 357
Query: 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWK 346
PE+L Y D +S GC+L +LL P R + H+I ++
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS--PFRQHKTKDKHEIDRM---------- 405
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ + L+E LL D R
Sbjct: 406 --------TLTMAVELPDSFSPELRS-------LLEGLLQRDVNRR 436
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESV-RFMAREILILRRLDHP 177
+E + +G G S V+ ARD + VA+K +R D +P RF RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF-RREAQNAAALNHP 72
Query: 178 NVVKL--EGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+V + G + Y+V +Y++ L + + T + + L
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNF 131
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT--SRVV-TLWYRPPEL 291
H ++HRD+K +N++I + + DFG+A + +T + V+ T Y PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQ 190
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKP 319
G + D++S GC+L E+L +P
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFD-NLEPESVRFMAREILILRRLDHPNVVK 181
+G+G +VY+A DT+ +IVALK + + +P M RE RL P+VV
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 182 L------EGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ +G LY+ + + DLA + + + Q+ S L+
Sbjct: 99 IHDFGEIDGQ--------LYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDA 149
Query: 235 CHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLL 293
H HRD+K N+L+ + + DFG+AS + K V TL+Y PE
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFS 208
Query: 294 GATDYGVGVDLWSAGCILAELLAEKP 319
+ D+++ C+L E L P
Sbjct: 209 ESH-ATYRADIYALTCVLYECLTGSP 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 37/273 (13%), Positives = 82/273 (30%), Gaps = 62/273 (22%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE------PESVRFMAREILIL 171
+ ++ +KIG+G + V++ VA+K + + + ++ + EI+I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 172 RRL---------DHPNVVKLEGLVTSRMSCSLYLVFKY---------------------- 200
+ L + L + + S L+ +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 201 -----MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH-VLHRDIKGSNLLIDN 254
E L T + A K +HQL + L HRD+ N+L+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 255 EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 314
+ + P V++ DY + + ++
Sbjct: 198 TSLKKLHYTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFCDV 242
Query: 315 LAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
++ + G + + I++L + W +
Sbjct: 243 SMDEDLFTG--DGDYQFDIYRLMKKENNNRWGE 273
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 59/287 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
D F+++ +G G++ V + +G A+K + ++ + + E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYME-----HDL--AGLAASPTIKFTQAQVKCYMHQLL 229
P +VKLE + + + +LY+V +Y+ L G +F++ + Y Q++
Sbjct: 101 PFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIV 151
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----W 285
E+ H+ +++RD+K NLLID +G + + DFG A K+ + R TL
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-------KR-VKGRTWTLCGTPE 203
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
PE++L Y VD W+ G ++ E+ A P ++ KI
Sbjct: 204 ALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---------- 252
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
K + P F L+ LL +D +R
Sbjct: 253 GKVRFP-------------------SHFSSDLKDLLRNLLQVDLTKR 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 69/294 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
+ FE L +G+GT+ V ++ TG+ A+K ++ + + + V E +L+ H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 177 PNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCYM 225
P + L+ L V +Y H S F++ + + Y
Sbjct: 208 PFLTALK-------YSFQTHDRLCFVMEYANGGELFFH------LSRERVFSEDRARFYG 254
Query: 226 HQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-- 282
+++S L++ H++ V++RD+K NL++D +G + I DFGL K+ +
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-------KEGIKDGATMK 307
Query: 283 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
T Y PE+L DYG VD W G ++ E++ + + + I
Sbjct: 308 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--- 363
Query: 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
++ + P + P + L+ LL DP +R
Sbjct: 364 -------EEIRFP-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
+++ +G+G + V R TG+ VA+K ++ ++ +EI ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRN 79
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
L H N+VK +G+ T + L+ +++ L K Q Y Q+ G+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
++ ++ +HRD+ N+L+++E + I DFGL
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 1e-23
Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 59/287 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
F+ L +G G++ V+ R G+ A+K ++ + + + V E L+L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYME-----HDL--AGLAASPTIKFTQAQVKCYMHQLL 229
P ++++ G T + + ++++ Y+E L + +F K Y ++
Sbjct: 66 PFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVC 116
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLW---- 285
LE+ H++ +++RD+K N+L+D G + I DFG A K + TL
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-------KY-VPDVTYTLCGTPD 168
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y PE++ Y +D WS G ++ E+LA ++ KI
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---------- 217
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ + P F L+ L+ D ++R
Sbjct: 218 AELRFP-------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 68/293 (23%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRLDH 176
+ F+ L +G+GT+ V R+ TG+ A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 177 PNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCYM 225
P + L+ L V +Y H S FT+ + + Y
Sbjct: 65 PFLTALK-------YAFQTHDRLCFVMEYANGGELFFH------LSRERVFTEERARFYG 111
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--- 282
+++S LE+ H++ V++RDIK NL++D +G + I DFGL K+ ++
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDGATMKT 164
Query: 283 ---TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
T Y PE+L DYG VD W G ++ E++ + + I
Sbjct: 165 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---- 219
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
++ + P + P + L+ LL DP +R
Sbjct: 220 ------EEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 41/279 (14%), Positives = 74/279 (26%), Gaps = 60/279 (21%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV--RFMAREILILRRLDHPNVV 180
L G ++A DT + VAL V + P+ V + L L R+D P V
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVA 94
Query: 181 KLEGLVTSRMSCSLYLVFKYME-HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
++ +V +R +V +++ L +A + + M L + + H
Sbjct: 95 RVLDVVHTRAGG--LVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG 149
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
V S + + +G + +A +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP--------DANPQ------------------- 182
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359
D+ G L LL + +P L +
Sbjct: 183 --DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ---------PIEPADIDR- 230
Query: 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA 398
D P + + D R +T
Sbjct: 231 ------------DIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 74/297 (24%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL-EPESVRFMAREILILRR 173
FE L +GQG++ V+ + Q+ A+K ++ L + VR E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 174 LDHPNVVKLEGLVTSRMSCS------LYLVFKY------MEHDLAGLAASPTIKFTQAQV 221
++HP +VKL + LYL+ + L+ FT+ V
Sbjct: 83 VNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR----LSKEV--MFTEEDV 128
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281
K Y+ +L L+H H+ +++RD+K N+L+D EG + + DFGL+ K+ +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KESIDHEK 181
Query: 282 V------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
T+ Y PE++ + D WS G ++ E+L G+ E + I K
Sbjct: 182 KAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
K +P + P + L+ L +PA R
Sbjct: 241 ----------AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 9e-23
Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 43/240 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL--EPESVRFMAREILILR 172
+ FE L +G+G Y V++ R TG+I A+K ++ + + E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 173 RLDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQV 221
+ HP +V L + LYL+ +Y L F +
Sbjct: 77 EVKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQ----LEREG--IFMEDTA 123
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRV 281
Y+ ++ L H H + +++RD+K N++++++G + + DFGL K+ +
Sbjct: 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-------KESIHDGT 176
Query: 282 V------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335
V T+ Y PE+L+ + + VD WS G ++ ++L P G + + KI K
Sbjct: 177 VTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
+R + +G+G + V + TG++VA+K ++ D + +EI
Sbjct: 29 HKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEID 85
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQL 228
ILR L H +++K +G + SL LV +Y+ L P AQ+ + Q+
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQI 143
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+ + H QH +HRD+ N+L+DN+ ++ I DFGLA
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
R F + ++G+G + +V R TG++VA+KK++ + E F REI
Sbjct: 8 EERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIE 63
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQL 228
IL+ L H N+VK +G+ S +L L+ +Y+ + L + ++ Y Q+
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---------KQPMTS 279
G+E+ + +HRD+ N+L++NE + I DFGL + + P+
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF- 182
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
WY PE L + + V D+WS G +L EL
Sbjct: 183 -----WY-APESLTESK-FSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREIL 169
R F + ++G+G + +V R TG++VA+KK++ + E F REI
Sbjct: 39 EERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIE 94
Query: 170 ILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQL 228
IL+ L H N+VK +G+ S +L L+ +Y+ + L + ++ Y Q+
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---------KQPMTS 279
G+E+ + +HRD+ N+L++NE + I DFGL + + P+
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF- 213
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 315
WY PE L + + V D+WS G +L EL
Sbjct: 214 -----WY-APESLTESK-FSVASDVWSFGVVLYELF 242
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 6/159 (3%)
Query: 112 WTPRRADTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREI 168
+ + IG+G + VY A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQ 227
+I++ HPNV+ L G+ R S +V YM+H DL + T T + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ G+++ ++ +HRD+ N ++D + + +ADFGLA
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 35/150 (23%), Positives = 74/150 (49%), Gaps = 4/150 (2%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++IG+G + V+ R +VA+K R +F+ +E IL++ HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHP 172
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V+L G+ T + +Y+V + ++ D + + + + +G+E+
Sbjct: 173 NIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
++ +HRD+ N L+ + +L I+DFG++
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 23/232 (9%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILI 170
+ +K +G G + V R L + VA+K ++ E + F+ E I
Sbjct: 43 DATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASI 99
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLL 229
+ + DHPN+++LEG+VT S + +V +YME+ L +FT Q+ + +
Sbjct: 100 MGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL---WY 286
SG+++ + +HRD+ N+LI++ + ++DFGL + + + T+R + W
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 287 RPPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE A Y D+WS G +L E+ E+P + + + +
Sbjct: 218 -SPE----AIAYRKFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAV 263
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-22
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
+ + ++G+G + +V R TG +VA+K+++ P+ R REI IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKA 80
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
L +VK G+ SL LV +Y+ L + +++ Y Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH---------KQPMTSRVVT 283
E+ ++ +HRD+ N+L+++E + IADFGLA + + P+
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----- 195
Query: 284 LWYRPPELLLGATDYGV---GVDLWSAGCILAELL 315
WY PE L + D+WS G +L EL
Sbjct: 196 -WY-APESLS----DNIFSRQSDVWSFGVVLYELF 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILI 170
EK IG G V R + GQ VA+K ++ E + F+ E I
Sbjct: 47 EASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASI 103
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLL 229
+ + DHPN+++LEG+VT +V +YME+ L + +FT Q+ + +
Sbjct: 104 MGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL---WY 286
+G+ + + +HRD+ N+L+D+ + ++DFGL+ + + T+ + W
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 287 RPPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE A + D+WS G ++ E+ E+P T + + +
Sbjct: 222 -APE----AIAFRTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV 267
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 1e-21
Identities = 63/298 (21%), Positives = 113/298 (37%), Gaps = 73/298 (24%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILIL 171
+ F L +G+G++ V + T ++ A+K ++ D + + E + + +L L
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLAL 397
Query: 172 RRLDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQ 220
P + +L SC LY V +Y M H +F +
Sbjct: 398 PG-KPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYH------IQQVGRFKEPH 443
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
Y ++ GL ++ +++RD+K N+++D+EG + IADFG+ K+ +
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDG 496
Query: 281 VV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
V T Y PE++ YG VD W+ G +L E+LA + G E E I
Sbjct: 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555
Query: 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ P K ++ + + L+ P +R
Sbjct: 556 E----------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 13/221 (5%)
Query: 50 RKESSNSNNEQETTTVRPRGEKRRSSKPNPRLSNPPKHVHGEQVAAGWPSWLSAVAGEAI 109
+ S + + K+ S+ H+ + P + AV I
Sbjct: 28 PRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN---PELVQAVQHVVI 84
Query: 110 SGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPESVRFMAR 166
+ + IG+G + VY A+K + E +F+
Sbjct: 85 ----GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-T 139
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM 225
E +I++ HPNV+ L G+ R S +V YM+H DL + T T + +
Sbjct: 140 EGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
Q+ G++ ++ +HRD+ N ++D + + +ADFGLA
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 69/296 (23%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRRL 174
+ F L +G+G++ V + T ++ A+K ++ D ++ + V E +L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 175 D-HPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVK 222
P + +L SC LY V +Y M H +F +
Sbjct: 78 GKPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYH------IQQVGRFKEPHAV 124
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
Y ++ GL ++ +++RD+K N+++D+EG + IADFG+ K+ + V
Sbjct: 125 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVT 177
Query: 283 ------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
T Y PE++ YG VD W+ G +L E+LA + G E E I +
Sbjct: 178 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME- 235
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
P K ++ + + L+ P +R
Sbjct: 236 ---------HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 66/296 (22%), Positives = 107/296 (36%), Gaps = 73/296 (24%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRR 173
F L IG+G++ V AR A+K ++ + E + + R +L L+
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNVL-LKN 95
Query: 174 LDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVK 222
+ HP +V L LY V Y H F + + +
Sbjct: 96 VKHPFLVGLH-------FSFQTADKLYFVLDYINGGELFYH------LQRERCFLEPRAR 142
Query: 223 CYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV 282
Y ++ S L + H+ ++++RD+K N+L+D++G + + DFGL K+ +
Sbjct: 143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-------KENIEHNST 195
Query: 283 ------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKL 336
T Y PE+L Y VD W G +L E+L P R E I
Sbjct: 196 TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN- 253
Query: 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
K +L + S+ L+E LL D +R
Sbjct: 254 ---------KPLQLK-------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 65/298 (21%), Positives = 118/298 (39%), Gaps = 73/298 (24%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILIL 171
D FE + +G+G++ V AR TG + A+K ++ D + + E + IL L
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRILSL 79
Query: 172 RRLDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQ 220
R +HP + +L C L+ V ++ M H + +F +A+
Sbjct: 80 AR-NHPFLTQLF-------CCFQTPDRLFFVMEFVNGGDLMFH------IQKSRRFDEAR 125
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
+ Y +++S L H++ +++RD+K N+L+D+EG +ADFG+ K+ + +
Sbjct: 126 ARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNG 178
Query: 281 VVTLW------YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIF 334
V T Y PE+L YG VD W+ G +L E+L E + I
Sbjct: 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
+ P + ++++ + +P R
Sbjct: 238 N----------DEVVYP-------------------TWLHEDATGILKSFMTKNPTMR 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 60/294 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRR-LD 175
F+ L IG+G+Y+ V R T +I A+K V+ + + E + ++ E + + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 176 HPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCY 224
HP +V L SC L+ V +Y M H K + + Y
Sbjct: 69 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEHARFY 115
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-- 282
++ L + H + +++RD+K N+L+D+EG + + D+G+ K+ +
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTS 168
Query: 283 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
T Y PE+L G DYG VD W+ G ++ E++A + P F + G
Sbjct: 169 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVG 214
Query: 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
S I + Q R ++ ++++ L DP ER
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS-------VLKSFLNKDPKER 261
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-21
Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR----FMAREILI 170
+K+G+G + VYK + VA+KK+ ++ + F EI +
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKG--YVNNTTVAVKKLA-AMVDITTEELKQQFDQ-EIKV 83
Query: 171 LRRLDHPNVVKLEGLVTSRMSCS----LYLVFKYM-----EHDLAGLAASPTIKFTQ--- 218
+ + H N+V+L G S L LV+ YM L+ L +P + +
Sbjct: 84 MAKCQHENLVELLGF------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 219 -----AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273
A G+ H H +HRDIK +N+L+D I+DFGLA +
Sbjct: 138 IAQGAAN----------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 274 KQPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTE 326
+ MTSR+V T Y PE L G + D++S G +L E++ + R
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILIL 171
+ + F +G+G++ V+ A T Q A+K ++ D + + E + + +L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VEKRVL-S 72
Query: 172 RRLDHPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQ 220
+HP + + +L+ V +Y M H KF ++
Sbjct: 73 LAWEHPFLTHMF-------CTFQTKENLFFVMEYLNGGDLMYH------IQSCHKFDLSR 119
Query: 221 VKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR 280
Y +++ GL+ H++ +++RD+K N+L+D +G + IADFG+ K+ M
Sbjct: 120 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-------KENMLGD 172
Query: 281 VVTLW------YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
T Y PE+LLG Y VD WS G +L E+L + G+ E E H I
Sbjct: 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 50/229 (21%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI----VALKKVRFDNLEPESVRFMAREILILRR 173
+ IG G + VYK + VA+K ++ E + V F+ E I+ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 102
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
H N+++LEG+++ + ++ +YME+ L +F+ Q+ + + +G+
Sbjct: 103 FSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL---WYRPP 289
++ N + +HRD+ N+L+++ + ++DFGL+ + + + T+ + W P
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-AP 219
Query: 290 ELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
E + Y D+WS G ++ E+ E+P + E + I
Sbjct: 220 EAIS----YRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-21
Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 8/205 (3%)
Query: 66 RPRGEKRRSSKPNPR-LSNPPKHVHGEQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLD 124
R P P +++P K + + S S +R +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342
Query: 125 KIGQGTYSNVYKAR-DTLTGQI-VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
++G G + +V + QI VA+K ++ + ++ M RE I+ +LD+P +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
G+ + +L LV + L + + V +HQ+ G+++ ++ +
Sbjct: 402 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 242 HRDIKGSNLLIDNEGILTIADFGLA 266
HR++ N+L+ N I+DFGL+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLS 483
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 60/294 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN-LEPESVRFMAREILILRR-LD 175
F+ L IG+G+Y+ V R T +I A++ V+ + + E + ++ E + + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 176 HPNVVKLEGLVTSRMSC-----SLYLVFKY------MEHDLAGLAASPTIKFTQAQVKCY 224
HP +V L SC L+ V +Y M H K + + Y
Sbjct: 112 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEHARFY 158
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-- 282
++ L + H + +++RD+K N+L+D+EG + + D+G+ K+ +
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTS 211
Query: 283 ----TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCG 338
T Y PE+L G DYG VD W+ G ++ E++A + P F + G
Sbjct: 212 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVG 257
Query: 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
S I + Q R + + ++++ L DP ER
Sbjct: 258 SSDNPDQNTEDYLFQVILEKQIRIPRSL-------SVKAASVLKSFLNKDPKER 304
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 15/225 (6%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
R T + K+G G Y VY+ VA+K ++ D +E E F+ E +++
Sbjct: 218 ERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK-EAAVMKE 272
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
+ HPN+V+L G+ T Y++ ++M + +L L + + + Q+ S
Sbjct: 273 IKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPE 290
+E+ ++ +HR++ N L+ ++ +ADFGL+ + ++ W P
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 291 LLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
L + + D+W+ G +L E+ P PG + +
Sbjct: 391 LAYNK--FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 432
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 39/191 (20%), Positives = 79/191 (41%), Gaps = 15/191 (7%)
Query: 89 HGEQVAAGWPSWLSAVAGEAISGWT-PRRADTFEKLDKIGQGTYSNVYKAR---DTLTGQ 144
H ++G S + R K +G+G + +V + + T
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSL 63
Query: 145 IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVT---SRMSCSLYLVFKYM 201
VA+K ++ DN + E ++ HPNV++L G+ S+ ++ +M
Sbjct: 64 KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 202 EH-DL-----AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255
++ DL + + +M + G+E+ N++ LHRD+ N ++ ++
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183
Query: 256 GILTIADFGLA 266
+ +ADFGL+
Sbjct: 184 MTVCVADFGLS 194
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-DTLTGQI-VALKKVRFDNLEPESVRFMAREILIL 171
R + ++G G + +V + QI VA+K ++ + ++ M RE I+
Sbjct: 7 KRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIM 64
Query: 172 RRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLS 230
+LD+P +V+L G+ + +L LV + L + + V +HQ+
Sbjct: 65 HQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 121
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+++ ++ +HRD+ N+L+ N I+DFGL+
Sbjct: 122 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILI 170
P IG+G + VY Q A+K + + F+ RE L+
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REGLL 75
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLL 229
+R L+HPNV+ L G++ +++ YM H DL SP T + + Q+
Sbjct: 76 MRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+E+ Q +HRD+ N ++D + +ADFGLA
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-20
Identities = 38/169 (22%), Positives = 73/169 (43%), Gaps = 12/169 (7%)
Query: 101 LSAVAGEAISGW-TPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE 159
++A SGW + + IG+G + +V G VA+K ++ D
Sbjct: 5 VAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA 60
Query: 160 SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFT 217
F+ E ++ +L H N+V+L G++ LY+V +YM L L +
Sbjct: 61 ---FL-AEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ + + +E+ + +HRD+ N+L+ + + ++DFGL
Sbjct: 116 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 22/228 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR---DTLTGQI-VALKKVRFDNLEPESVRFMAREILILRR 173
F+K+ +G G + VYK + +I VA+K++R + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+D+P+V +L G+ + ++ L+ + M L + + Q+ G+
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPE 290
+ ++ ++HRD+ N+L+ + I DFGLA K+ +V W E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE 189
Query: 291 LLLGATDYGV---GVDLWSAGCILAELLA--EKPIMPGRTEVEQLHKI 333
+L + + D+WS G + EL+ KP G E +
Sbjct: 190 SIL----HRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 6e-20
Identities = 59/291 (20%), Positives = 120/291 (41%), Gaps = 21/291 (7%)
Query: 57 NNEQETTTVRPRGEKRRSSKPNPRLSN-PPKHVHGEQVAAGWPSWLSAVAGEAISGWTPR 115
N ++ +RP+ E R+ P+L+N + V V+ + + E + P
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381
Query: 116 RA------DTFEKLDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPESVRFMAR 166
+ E IG+G + +V++ VA+K + + +F+ +
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-Q 440
Query: 167 EILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYM 225
E L +R+ DHP++VKL G++T ++++ + +L A + Y
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 226 HQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA-SFFDPNHKQPMTSRVVTL 284
+QL + L + ++ +HRDI N+L+ + + + DFGL+ D + + ++
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
W P + + D+W G + E+ KP G + + +I
Sbjct: 558 WMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 53/240 (22%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D F + +G+G + VYK R G +VA+K+++ + + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYM-----EHDLAGLAAS------PT---IKFTQA 219
N+++L G C LV+ YM L S P I A
Sbjct: 88 NLLRLRGF------CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--HKQPM 277
+ Y+H +HC ++HRD+K +N+L+D E + DFGLA D H +
Sbjct: 142 RGLAYLH------DHCD-PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---V 191
Query: 278 TSRVV-TLWYRPPE-----LLLGATD-YGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQ 329
T+ V T+ + PE TD +G GV +L EL+ ++ R +
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV-------MLLELITGQRAFDLARLANDD 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 34/157 (21%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 123 LDKIGQGTYSNVYKAR---DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+G+G + +V +A+ + + VA+K ++ D + + RE ++ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 180 VKLEGLVT----SRMSCSLYLVFKYMEH-DL-----AGLAASPTIKFTQAQVKCYMHQLL 229
KL G+ ++ +M+H DL A + +M +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+E+ +++ +HRD+ N ++ + + +ADFGL+
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 17/225 (7%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PR + E K+GQG + V+ T + VA+K ++ + PE F+ +E ++++
Sbjct: 182 PRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKK 235
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
L H +V+L +V+ +Y+V +YM L L Q+ Q+ SG
Sbjct: 236 LRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPE 290
+ + + +HRD++ +N+L+ + +ADFGLA D + ++ W P
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 291 LLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
L G + + D+WS G +L EL P PG E L ++
Sbjct: 353 ALYGR--FTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQV 394
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
R T + K+G G Y VY+ VA+K ++ D +E E F+ +E +++
Sbjct: 11 ERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKE 65
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
+ HPN+V+L G+ T Y++ ++M + +L L + + + Q+ S
Sbjct: 66 IKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+E+ ++ +HRD+ N L+ ++ +ADFGL+
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 54/231 (23%), Positives = 106/231 (45%), Gaps = 29/231 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
+ TF K ++G G + V + GQ VA+K ++ ++ + F+ E ++
Sbjct: 22 DPKDLTFLK--ELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSEDE--FI-EEAKVMM 74
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
L H +V+L G+ T + ++++ +YM + L +F Q+ +
Sbjct: 75 NLSHEKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYR 287
+E+ ++ LHRD+ N L++++G++ ++DFGL+ + + TS V + W
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWS- 188
Query: 288 PPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PPE+L+ Y D+W+ G ++ E+ L + P T E I
Sbjct: 189 PPEVLM----YSKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHI 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 51/231 (22%), Positives = 95/231 (41%), Gaps = 29/231 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
R T K ++G G + V GQ VA+K ++ ++ + F +E +
Sbjct: 6 KREEITLLK--ELGSGQFGVVKLG--KWKGQYDVAVKMIKEGSMSED--EFF-QEAQTMM 58
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+L HP +VK G+ + +Y+V +Y+ + L S +Q+ + + G
Sbjct: 59 KLSHPKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYR 287
+ + +HRD+ N L+D + + ++DFG+ + S V T W
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWS- 172
Query: 288 PPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE+ Y D+W+ G ++ E+ L + P T E + K+
Sbjct: 173 APEVFH----YFKYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 58/245 (23%), Positives = 104/245 (42%), Gaps = 49/245 (20%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL--EPESVRFMAREILILR 172
+ FE L +G G Y V+ R TG++ A+K ++ + + ++ E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 173 RLDH-PNVVKLEGLVTSRMSCS------LYLVFKY------MEHDLAGLAASPTIKFTQA 219
+ P +V L + L+L+ Y H L+ +FT+
Sbjct: 114 HIRQSPFLVTLH--------YAFQTETKLHLILDYINGGELFTH----LSQRE--RFTEH 159
Query: 220 QVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS 279
+V+ Y+ +++ LEH H +++RDIK N+L+D+ G + + DFGL+ K+ +
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------KEFVAD 212
Query: 280 RVVTLW-------YRPPELLLGATDYGVG--VDLWSAGCILAELLAEKPIMPGRTEVEQL 330
+ Y P+++ G D G VD WS G ++ ELL E
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRG-GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271
Query: 331 HKIFK 335
+I +
Sbjct: 272 AEISR 276
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 29/231 (12%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
TF + +IG G + V+ + VA+K +R + E F+ E ++
Sbjct: 6 DPSELTFVQ--EIGSGQFGLVHLGY--WLNKDKVAIKTIREGAMSEED--FI-EEAEVMM 58
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+L HP +V+L G+ + + LV ++MEH L+ + F + + G
Sbjct: 59 KLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WYR 287
+ + V+HRD+ N L+ ++ ++DFG+ F + TS T W
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWA- 172
Query: 288 PPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE+ + D+WS G ++ E+ + P R+ E + I
Sbjct: 173 SPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDI 218
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 35/148 (23%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
IG+G + +V++ VA+K + + +F+ +E L +R+ DHP++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHI 78
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
VKL G++T ++++ + +L A + Y +QL + L + ++
Sbjct: 79 VKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLA 266
+HRDI N+L+ + + + DFGL+
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPESVRFMAREILILRRL 174
+ +G+G + VY+ T VA+K + D +FM E +I++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNL 70
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
DHP++VKL G++ +++ + + +L + Y Q+ +
Sbjct: 71 DHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ + + +HRDI N+L+ + + + DFGL+
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 110 SGWTPRRADTFE-------KLDKIGQGTYSNVYKARDTLTGQI---VALKKVRFDNLEPE 159
+G P ++ T L+K+G G++ V + VA+K ++ D L
Sbjct: 3 AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 160 SVR--FMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKF 216
F+ RE+ + LDH N+++L G+V + + +V + L F
Sbjct: 63 EAMDDFI-REVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHF 118
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ Y Q+ G+ + ++ +HRD+ NLL+ ++ I DFGL
Sbjct: 119 LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
PR + ++G G + V+ G VA+K ++ ++ P++ F+A E +++
Sbjct: 11 PRETLKLVE--RLGAGQFGEVWMG--YYNGHTKVAVKSLKQGSMSPDA--FLA-EANLMK 63
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLS 230
+L H +V+L +VT +Y++ +YME+ L L IK T ++ Q+
Sbjct: 64 QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL----WY 286
G+ ++ +HRD++ +N+L+ + IADFGLA + N T+R W
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWT 177
Query: 287 RPPELLLGATDYGV---GVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
PE A +YG D+WS G +L E+ P PG T E + +
Sbjct: 178 -APE----AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNL 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 33/146 (22%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 125 KIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
++G G + V K + + VA+K ++ + +P + E ++++LD+P +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
G+ + S LV + E L L + + +HQ+ G+++ +
Sbjct: 84 IGICEAE---SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLA 266
+HRD+ N+L+ + I+DFGL+
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 17/225 (7%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PR + E K+GQG + V+ T + VA+K ++ + PE F+ +E ++++
Sbjct: 265 PRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKK 318
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
L H +V+L +V+ +Y+V +YM L L Q+ Q+ SG
Sbjct: 319 LRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRPPE 290
+ + + +HRD++ +N+L+ + +ADFGLA D + ++ W P
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 291 LLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
L G + + D+WS G +L EL P PG E L ++
Sbjct: 436 ALYGR--FTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQV 477
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 33/168 (19%), Positives = 72/168 (42%), Gaps = 20/168 (11%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYK--ARDTLTGQ---IVALKKVRFDNLEPESVRFMAREI 168
R T + ++GQG++ VY+ A+ + + VA+K V E + F+ E
Sbjct: 23 AREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEA 79
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------AGLAASPTIKFTQ 218
+++ + +VV+L G+V+ ++ + M DL A +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+++ ++ G+ + + +HRD+ N ++ + + I DFG+
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 9e-19
Identities = 34/154 (22%), Positives = 70/154 (45%), Gaps = 9/154 (5%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR---DTLTGQI-VALKKVRFDNLEPESVRFMAREILILRR 173
F+K+ +G G + VYK + +I VA+K++R + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+D+P+V +L G+ + ++ L+ + M L + + Q+ G+
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ ++ ++HRD+ N+L+ + I DFGLA
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 19/208 (9%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRR 173
KL +G G + V+K G+ V +K + + +L +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGS 71
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
LDH ++V+L GL SL LV +Y+ L + + Q+ G+
Sbjct: 72 LDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTS--RVVTLWYRPPE 290
+ ++HR++ N+L+ + + +ADFG+A P+ KQ + S + W E
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALE 187
Query: 291 LLLGATDYGV---GVDLWSAGCILAELL 315
+ +G D+WS G + EL+
Sbjct: 188 SIH----FGKYTHQSDVWSYGVTVWELM 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 35/146 (23%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
L IG+G + +V G VA+K ++ D F+ E ++ +L H N+V+L
Sbjct: 198 LQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA---FL-AEASVMTQLRHSNLVQL 251
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHV 240
G++ LY+V +YM L L + + + + +E+ +
Sbjct: 252 LGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 241 LHRDIKGSNLLIDNEGILTIADFGLA 266
+HRD+ N+L+ + + ++DFGL
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 26/174 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
A F + ++G+ + VYK Q VA+K ++ P F E
Sbjct: 7 SLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEA 63
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLAASP 212
++ RL HPNVV L G+VT L ++F Y H DL +
Sbjct: 64 MLRARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ Q+ +G+E+ + HV+H+D+ N+L+ ++ + I+D GL
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQI-VALKKVRFDNLEPESVRFMAREILILR 172
PR + EK K+G G + V+ A T VA+K ++ ++ E+ F+ E +++
Sbjct: 186 PRESLKLEK--KLGAGQFGEVWMA--TYNKHTKVAVKTMKPGSMSVEA--FL-AEANVMK 238
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLS 230
L H +VKL +VT +Y++ ++M L L + K ++ + Q+
Sbjct: 239 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 231 GLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
G+ ++ +HRD++ +N+L+ + IADFGLA
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 39/236 (16%), Positives = 80/236 (33%), Gaps = 32/236 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI-------VALKKVRFDNLEPESVRFMAREILI 170
+ + +GQGT++ ++K G V LK + + F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF-EAASM 65
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLL 229
+ +L H ++V G+ LV ++++ L QL
Sbjct: 66 MSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 230 SGLEHCHNQHVLHRDIKGSNLLIDNEGILT--------IADFGLASFFDPN--HKQPMTS 279
+ + ++H ++ N+L+ E ++D G++ P ++ +
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP- 182
Query: 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLHKI 333
W PPE + + + D WS G L E+ +KP + +L
Sbjct: 183 -----WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 43/222 (19%), Positives = 83/222 (37%), Gaps = 42/222 (18%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE- 183
KIG G + +Y A T + A V+ +E + + E+ +R+ + +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK---VEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 184 ----------------GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
GL + ++V + + DL ++ F ++ V +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIR 159
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLID--NEGILTIADFGLAS-FFDPNHKQPMTSRVVTL 284
+L LE+ H +H DIK +NLL+ N + +AD+GL+ + + +
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ------ 213
Query: 285 WYRPPELLLGATDY-------GVGV----DLWSAGCILAELL 315
P + G ++ GV + D+ G + L
Sbjct: 214 -ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 24/172 (13%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTG--QIVALKKVRFDNLEPESVRFMAREILIL 171
F+ IG+G + V KAR G A+K+++ + + F E+ +L
Sbjct: 23 DWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVL 79
Query: 172 RRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLAASPTI 214
+L HPN++ L G R LYL +Y H +L +A S
Sbjct: 80 CKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 215 KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ Q+ + + G+++ + +HRD+ N+L+ + IADFGL+
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 26/173 (15%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYK--ARDTLTGQ---IVALKKVRFDNLEPESVRFMAREI 168
RR + ++G+G + V+ + L Q +VA+K ++ + E F RE
Sbjct: 39 KRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REA 94
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL--------------AGLAASPT 213
+L L H ++V+ G+ T L +VF+YM H DL AG
Sbjct: 95 ELLTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
Q+ Q+ +G+ + H +HRD+ N L+ ++ I DFG++
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 27/174 (15%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
RR ++ ++G+G + V+ A T +VA+K ++ D F RE
Sbjct: 13 KRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REA 68
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLAASP 212
+L L H ++VK G+ L +VF+YM+H DL G
Sbjct: 69 ELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ +Q+ Q+ SG+ + +QH +HRD+ N L+ ++ I DFG++
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 55/254 (21%), Positives = 96/254 (37%), Gaps = 57/254 (22%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR+ T + +G G + VY+ + + + VA+K + E + + F+ E
Sbjct: 28 PRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEA 84
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQV 221
LI+ + +H N+V+ G+ + +++ + M DL S +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHKQPMT 278
+ G ++ H +HRDI N L+ G + I DFG+A
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------------ 190
Query: 279 SRVV--TLWYR------------PPELLLGATDYGV---GVDLWSAGCILAEL--LAEKP 319
R + +YR PPE + G+ D WS G +L E+ L P
Sbjct: 191 -RDIYRASYYRKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 320 IMPGRTEVEQLHKI 333
P ++ E L +
Sbjct: 246 Y-PSKSNQEVLEFV 258
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 57/230 (24%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRF--MAREILILRRL 174
F KIG G + + ++ T + VA+K LEP R + E ++L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQL 61
Query: 175 DH-PNVVKL-----EG----LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCY 224
+ ++ G +V + SL +F + F+ V
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR-----------TFSLKTVLMI 110
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLI-----DNEGILTIADFGLASFF-DPNHKQ--P 276
QL+S +E+ H++++++RD+K N LI + ++ I DF LA + DP K+ P
Sbjct: 111 AIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170
Query: 277 MTSRVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELL 315
YR + L G Y +G DL + G + L
Sbjct: 171 ---------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL 211
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 8e-17
Identities = 65/241 (26%), Positives = 94/241 (39%), Gaps = 62/241 (25%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLT-GQIVALKKVRFDNLEPESVR----FMAREILILRRL 174
F+ IG G + VYK L G VALK+ PES + F EI L
Sbjct: 41 FDHKFLIGHGVFGKVYKG--VLRDGAKVALKR-----RTPESSQGIEEFET-EIETLSFC 92
Query: 175 DHPNVVKLEGLVTSRMSCS----LYLVFKYMEHD-----LAGLAASPT---------IKF 216
HP++V L G C + L++KYME+ L G I
Sbjct: 93 RHPHLVSLIGF------CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 217 TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276
A+ GL + H + ++HRD+K N+L+D + I DFG++ +
Sbjct: 147 GAAR----------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 277 MTSRVV-TLWYRPPE-----LLLGATD-YGVGVDLWSAGCILAELL-AEKPIMPGRTEVE 328
+++ V TL Y PE L +D Y GV +L E+L A I+
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV-------VLFEVLCARSAIVQSLPREM 249
Query: 329 Q 329
Sbjct: 250 V 250
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 58/266 (21%), Positives = 101/266 (37%), Gaps = 68/266 (25%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH-PNVVKL- 182
+IG+G++ +++ + L Q VA+K + P+ + E + L + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVY 72
Query: 183 ----EG----LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
EG LV + SL + KF+ V Q+L+ ++
Sbjct: 73 YFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----------KFSVKTVAMAAKQMLARVQS 121
Query: 235 CHNQHVLHRDIKGSNLLI-----DNEGILTIADFGLASFF-DPNHKQPMTSRVVTLWYRP 288
H + +++RDIK N LI N ++ + DFG+ F+ DP KQ + YR
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-------YRE 174
Query: 289 PELLLGATDYG-----VGV------DLWSAGCILAELLAEKPIMP-----GRTEVEQLHK 332
+ L G Y +G DL + G + L + +P T ++ +
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL--RGSLPWQGLKAATNKQKYER 232
Query: 333 IFK---------LC-GSPSE--EYWK 346
I + LC G P E +Y
Sbjct: 233 IGEKKQSTPLRELCAGFPEEFYKYMH 258
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 26/175 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR K +G+G + V +A T T + VA+K ++ E M E+
Sbjct: 25 PRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SEL 81
Query: 169 LILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLAAS 211
IL + H NVV L G T + L ++ ++ + +L
Sbjct: 82 KILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 212 PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
T + CY Q+ G+E ++ +HRD+ N+L+ + ++ I DFGLA
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 37/168 (22%), Positives = 69/168 (41%), Gaps = 20/168 (11%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR+ T + +G G + VY+ + + + VA+K + E + + F+ E
Sbjct: 69 PRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEA 125
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL------AGLAASPTIKFTQAQV 221
LI+ + +H N+V+ G+ + +++ + M DL S +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 222 KCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLA 266
+ G ++ H +HRDI N L+ G + I DFG+A
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 43/182 (23%), Positives = 80/182 (43%), Gaps = 34/182 (18%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR + + IG+G + V++AR +VA+K ++ + F RE
Sbjct: 45 PRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 101
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------------- 205
++ D+PN+VKL G+ + + L+F+YM + DL
Sbjct: 102 ALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 206 -AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
A +++ + A+ C Q+ +G+ + + +HRD+ N L+ ++ IADFG
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 265 LA 266
L+
Sbjct: 220 LS 221
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 38/182 (20%), Positives = 74/182 (40%), Gaps = 34/182 (18%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR+ K +G+G + V KA VA+K ++ + E + E
Sbjct: 21 PRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEF 77
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------------- 205
+L++++HP+V+KL G + L L+ +Y ++ L
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 206 -AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
+ L T + + Q+ G+++ ++HRD+ N+L+ + I+DFG
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 265 LA 266
L+
Sbjct: 196 LS 197
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-16
Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 62/270 (22%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ + KIG G++ ++Y D G+ VA+K P+ + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 177 -PNVVKL-----EG----LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMH 226
+ + EG +V + SL +F + KF+ V
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----------KFSLKTVLLLAD 112
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFF-DPNHKQPMTSRVV 282
Q++S +E+ H+++ +HRD+K N L+ ++ I DFGLA + D Q +
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---- 168
Query: 283 TLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAEK---PIMPGRTEVE 328
YR + L G Y +G+ DL S G +L + T+ +
Sbjct: 169 ---YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225
Query: 329 QLHKIFK---------LC-GSPSE--EYWK 346
+ +I + LC G PSE Y
Sbjct: 226 KYERISEKKMSTPIEVLCKGYPSEFATYLN 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-------DTLTGQIVALKKVRFDNLEPESVRFMAR 166
PR T K +G+G + V A VA+K ++ D E + +
Sbjct: 33 PRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-S 89
Query: 167 EILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLA 209
E+ +++ + H N++ L G T LY++ +Y +L +
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
P + T + +QL G+E+ +Q +HRD+ N+L+ ++ IADFGLA
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 38/177 (21%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-------DTLTGQIVALKKVRFDNLEPESVRFMAR 166
PR K +G+G + V A VA+K ++ D E + +
Sbjct: 67 PRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-S 123
Query: 167 EILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLA 209
E+ +++ + H N++ L G T LY++ +Y +L +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+P + + + +Q+ G+E+ ++ +HRD+ N+L+ + ++ IADFGLA
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-------DTLTGQIVALKKVRFDNLEPESVRFMAR 166
PR T K +G+G + V A VA+K ++ D E + +
Sbjct: 79 PRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-S 135
Query: 167 EILILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL---------------AGLA 209
E+ +++ + H N++ L G T LY++ +Y +L +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
P + T + +QL G+E+ +Q +HRD+ N+L+ ++ IADFGLA
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 39/177 (22%), Positives = 70/177 (39%), Gaps = 29/177 (16%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR +F K +G G + V +A + VA+K ++ E M E+
Sbjct: 21 PRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SEL 77
Query: 169 LILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL-----------------AGLA 209
+L L +H N+V L G T ++ +Y + DL +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 210 ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ + + +Q+ G+ +++ +HRD+ N+L+ + I I DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 43/222 (19%), Positives = 76/222 (34%), Gaps = 39/222 (17%)
Query: 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE- 183
IGQG + +Y A + + V +EP + E+ +R P ++
Sbjct: 42 PIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 184 ----------------GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQ 227
GL +++ DL + + +F++ V +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLID--NEGILTIADFGLAS-FFDPNHKQPMTSRVVTL 284
+L LE+ H +H DIK SNLL++ N + + D+GLA + +
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA------ 214
Query: 285 WYRPPELLLGATDY-------GVGV----DLWSAGCILAELL 315
P G ++ GV DL G + + L
Sbjct: 215 -ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 25/173 (14%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKA-----RDTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR F K +G G + V +A VA+K ++ E M E+
Sbjct: 44 PRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SEL 100
Query: 169 LILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL-------------AGLAASPT 213
I+ L H N+V L G T + ++ +Y + DL A
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266
+ + + Q+ G+ +++ +HRD+ N+L+ N + I DFGLA
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/227 (25%), Positives = 87/227 (38%), Gaps = 47/227 (20%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR 173
PR + F KIG G++ +Y + T + VA+K P+ + E I R
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRI 58
Query: 174 L-DHPNVVKL-----EG----LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKC 223
L + + EG LV + SL +F + K + V
Sbjct: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-----------KLSLKTVLM 107
Query: 224 YMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFF-DPNHKQPMTS 279
Q+++ +E H++ LHRDIK N L+ + I DFGLA + D + Q +
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP- 166
Query: 280 RVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELL 315
YR + L G Y +G+ DL S G +L L
Sbjct: 167 ------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL 207
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 34/182 (18%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREI 168
PR F K +G G + V A T VA+K ++ E M E+
Sbjct: 43 PRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SEL 99
Query: 169 LILRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DL--------------------- 205
++ +L H N+V L G T +YL+F+Y + DL
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 206 -AGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
T + C+ +Q+ G+E + +HRD+ N+L+ + ++ I DFG
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 265 LA 266
LA
Sbjct: 218 LA 219
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 31/184 (16%), Positives = 55/184 (29%), Gaps = 50/184 (27%)
Query: 125 KIGQGTYSNVYKARDTLTGQI--------VALKKVRFDNLEPES------VRFMAREILI 170
+ +Y+A T T +LK L+ + F R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQNFFQRAAKP 102
Query: 171 --------LRRLDHPNVVKLEG----------LVTSRMSCSLYLVFKYMEHDLAGLAASP 212
L + G LV + SL SP
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV----------SP 152
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI--DNEGILTIADFGLASFFD 270
++ V +LL LE H +H ++ N+ + +++ +T+A +G A +
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 271 PNHK 274
P+ K
Sbjct: 213 PSGK 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 2e-08
Identities = 54/412 (13%), Positives = 127/412 (30%), Gaps = 94/412 (22%)
Query: 22 SVRVDRKVSAAAAAEAVEIRNGNGGPNHRKESSNSNNEQETTTVRPRGEKRRSSKPNPRL 81
++ +++ + +E R+ N N + Q +R + +P +
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QALLELRPAKNV 153
Query: 82 SNPPKHVHGEQVAAGWPSWLSAVAGEAISG------------W-TPRRADTFEKLDKIGQ 128
+ G + +G +W+ A + W + ++ E + ++ Q
Sbjct: 154 L-----IDG-VLGSG-KTWV---ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 129 GTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMARE-----ILILRRLDHPNVVK-L 182
+ + + +K +R +++ E R + + +L+L + +
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIK-LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF 262
Query: 183 EG----LVTSR-MSCSLYLVFKY-----MEHDLAGLAASPT----IKFTQAQVK------ 222
L+T+R + +L ++H L +K+ + +
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV 322
Query: 223 CYMHQLLSGL-------EHCHNQHVLHRDIKGSNLLIDNE-GILTIAD----FGLASFFD 270
+ + + H + +I++ +L A+ F S F
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL----LAEKPIMPGRTE 326
P+ P T + +W+ + +D V + ++ +L L EK
Sbjct: 383 PSAHIP-TILLSLIWFDVIK-----SD----VMV-----VVNKLHKYSLVEKQPKESTIS 427
Query: 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSL 378
+ ++ +L EY L H +I Y D P L
Sbjct: 428 IPSIY--LELKVKLENEY----AL-HRSIV---DHYNIPKTFDSDDLIPPYL 469
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 1e-06
Identities = 47/307 (15%), Positives = 90/307 (29%), Gaps = 71/307 (23%)
Query: 91 EQVAAGWPSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKK 150
+V P LS + E+I D ++ ++ D LT I +
Sbjct: 320 REVLTTNPRRLS-IIAESIRDG-LATWDNWKHVNC-------------DKLTTII----E 360
Query: 151 VRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL--YLVFKYMEHDLAGL 208
+ LEP R M + + P+ + + + + ++ + + L
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFP----PSA-----HIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 209 AASPTIKFTQAQVKCYMHQL-LSGLEHCHNQHVLHRDIKGS-NLL--IDNEGILTIADFG 264
++ + + + L N++ LHR I N+ D++ ++
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
Query: 265 LASFFDPNH--KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP 322
+H R+ + L D+ + I + A
Sbjct: 472 YFYSHIGHHLKNIEHPERMTLF----RMVFL---DFR-----FLEQKIRHDSTAWNASGS 519
Query: 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIE 382
++QL K +K Y I Y+R + DF LP IE
Sbjct: 520 ILNTLQQL-KFYK-------PY----------ICDNDPKYERLV-NAILDF----LPKIE 556
Query: 383 TLLAIDP 389
L
Sbjct: 557 ENLICSK 563
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 7/124 (5%)
Query: 216 FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA--SFFDPNH 273
T + CY Q+ G+E ++ +HRD+ N+L+ + ++ I DFGLA + DP++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAEKPIMPGRTEVEQLH 331
+ +R+ W PE + Y + D+WS G +L E+ L P PG E+
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFC 306
Query: 332 KIFK 335
+ K
Sbjct: 307 RRLK 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 27/103 (26%), Positives = 46/103 (44%), Gaps = 15/103 (14%)
Query: 114 PRRADTFE------KLDK-IGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESV 161
P A +E KL K +G+G + V +A T T + VA+K ++ +
Sbjct: 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEH 69
Query: 162 RFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYMEH 203
R + E+ IL + H NVV L G T + L ++ ++ +
Sbjct: 70 RALMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF 111
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 415 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.76 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.22 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.99 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.27 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.44 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.3 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.6 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 85.41 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=483.82 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=229.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|+|||||+++++|.+ ...+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 4689999999999999999999999999999999986432 23345678999999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~- 274 (415)
||||||.++.+..++...+.++|.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999977777776667899999999999999999999999999999999999999999999999999998764432
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++.+|.+....+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-------------- 253 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF-------------- 253 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------------
T ss_pred ccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 33456789999999999986 679999999999999999999999999999999999887743221
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA------ALRSEVSLYMXX 409 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~------~L~h~~f~~~~~ 409 (415)
...+++++++||.+||..||++|||++| +++||||+.++-
T Consensus 254 ---------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 254 ---------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp ---------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ---------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 1247788999999999999999999988 589999998863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-65 Score=485.06 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=226.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|+++++||+|+||.||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+ ...+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~i 148 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWV 148 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 35799999999999999999999999999999999865432 23457899999999999999999999988 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||||.++.+..++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 9999999877766654 479999999999999999999999999999999999999999999999999998775433 23
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+..+.+..|.+... +..
T Consensus 227 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~-------------- 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRL-------------- 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCC--------------
T ss_pred ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC--------------
Confidence 456789999999999876 6799999999999999999999999999999888888865321 111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....+++++++||.+||+.||++|||++|+|+||||+....
T Consensus 291 -----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 291 -----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp -----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 112357888999999999999999999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-64 Score=467.28 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=208.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... ..+....+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 5789999999999999999999999999999999987654 34456678999999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||++|+++..+.. ...+++.+++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+......
T Consensus 90 ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp EEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 9999998877766544 4589999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....+||+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+.+..+.+.....
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~--------------- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL--------------- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 33567899999999999875556789999999999999999999999998888888876642211
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
...+++++++||.+||+.||++|||++|+|+||||+
T Consensus 232 --------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 232 --------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp --------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred --------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 134778899999999999999999999999999996
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-64 Score=483.86 Aligned_cols=258 Identities=23% Similarity=0.433 Sum_probs=221.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|+++++||+|+||.||+|+++.+|+.||||++.+........+.+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999999887777778889999999999999999999999988 567999
Q ss_pred EEEecccChhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAA--SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|||||.++.+..++ .....+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999987665554 344568999999999999999999999999999999999999999999999999998764321
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|.+....+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-------------- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------------
T ss_pred ccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 12245689999999999987 679999999999999999999999999999999998887643211
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
....+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 245 --------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 245 --------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 12357888999999999999999999999999999964
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-63 Score=487.54 Aligned_cols=293 Identities=32% Similarity=0.519 Sum_probs=242.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec----CCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----~~~ 192 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.+........+.+.+|+.+|+.|+|||||++++++... ...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3689999999999999999999999999999999987665566677888999999999999999999988653 235
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|||||||++++...+ .....+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i-~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQII-HSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHH-TSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 79999999998766555 44568999999999999999999999999999999999999999999999999999876432
Q ss_pred C---CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 273 H---KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 273 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
. .......+||++|+|||++.+...|+.++||||+|||+|||++|.+||.+.+..+++..|.+..+.++...|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 1 2334567899999999999886778999999999999999999999999999999999999999999877665422
Q ss_pred CCCCCc--CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 350 LPHATI--FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 350 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
...... ...+......+....+.++++++|||.+||.+||.+|||++|+|+||||+...+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 111100 0000001112344456788899999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-63 Score=487.10 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=226.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|+++++||+|+||.||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+ ...+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEE
Confidence 36799999999999999999999999999999999876432 33567899999999999999999999988 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||||.++.+..++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 9999999877776654 369999999999999999999999999999999999999999999999999998775433 23
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+..+.+..|..... +..
T Consensus 304 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~-------------- 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRL-------------- 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCC--------------
T ss_pred ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC--------------
Confidence 466799999999999876 6799999999999999999999999999999888888765321 110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....+++++++||.+||..||++|||++|+|+||||+....
T Consensus 368 -----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 368 -----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp -----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 112457889999999999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-63 Score=470.10 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=218.0
Q ss_pred CCceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
++|++++.||+|+||.||+|++. .+++.||||++.+..........+.+|+.+|++++|||||++++++.+ ...+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 57999999999999999999874 467899999997654333334467789999999999999999999988 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|||||||.++.+..++.....+++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 180 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 180 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-
Confidence 9999999998777777666789999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+..+++.+|.+....+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------- 245 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-------------- 245 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 23456789999999999986 679999999999999999999999999999999998887643211
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
...+|+++++||.+||+.||++||| ++|+++||||+.++
T Consensus 246 ---------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 246 ---------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 1247888999999999999999998 58999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-62 Score=457.26 Aligned_cols=256 Identities=22% Similarity=0.274 Sum_probs=216.4
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec--CCCeEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSLYLV 197 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~~~lv 197 (415)
|++.++||+|+||.||+|++..++..||+|++..........+.+.+|+.+|++|+|||||+++++|.+. ....+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4677889999999999999999999999999987766677778899999999999999999999998652 24568999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEcC-CCcEEEEeeccccccCCCCC
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||.++.+..++.....+++..++.|+.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 999999888777777778999999999999999999999998 999999999999985 78999999999986543
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|||||++.+ .|+.++|||||||+||||+||.+||.+.+....+.........+ .
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~-~------------ 249 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-A------------ 249 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-G------------
T ss_pred CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-C------------
Confidence 23456789999999998865 59999999999999999999999998766554443332211111 1
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.....+++++++||.+||..||++|||++|+|+||||++
T Consensus 250 -------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 -------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 111346678999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=460.82 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=221.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|++.++||+|+||.||+|+++.+|+.||||+++++... .+|+.+|+.|+|||||++++++.+ ...+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 45799999999999999999999999999999999865432 369999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~~~ 275 (415)
|||||.++.+..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999988777776667899999999999999999999999999999999999999998 6999999999887543221
Q ss_pred ----CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 ----PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ----~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+..+.+.+|.+.. ++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~---------- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PP---------- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CG----------
T ss_pred cceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CC----------
Confidence 1233579999999999987 679999999999999999999999999988777777776532 10
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA-------------LRSEVSLYMXXXX 411 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~-------------L~h~~f~~~~~~~ 411 (415)
..+..+.+++++.+||.+||+.||.+|||+.|+ |+|||+...+++.
T Consensus 275 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 275 --------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp --------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred --------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 122345688899999999999999999999997 6799999887654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=453.33 Aligned_cols=283 Identities=26% Similarity=0.346 Sum_probs=221.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.++||+|+||.||+|+++ .+++.||+|.+.... ....+.+|+++|+.+ +|||||+++++|.+ ..
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~ 93 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--ND 93 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TT
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CC
Confidence 467999999999999999999874 467899999986542 234577899999998 69999999999988 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-CcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DfG~a~~~~~ 271 (415)
++|+||||++++.+..++. .+++.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 7999999999876666553 58999999999999999999999999999999999999877 7999999999976543
Q ss_pred CCC---------------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCC-C
Q 014960 272 NHK---------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP-G 323 (415)
Q Consensus 272 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~-~ 323 (415)
... ......+||++|+|||++.+...|+.++||||+||++|||++|++||. +
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 123446899999999999876679999999999999999999999885 5
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhCCCCCC---CcCCC----------------------cchhhhhhhhhcCCCCCChH
Q 014960 324 RTEVEQLHKIFKLCGSPSEEYWKKSKLPHA---TIFKP----------------------QQSYKRCIAETFKDFPPSSL 378 (415)
Q Consensus 324 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~----------------------~~~~~~~~~~~~~~~~~~~~ 378 (415)
.++.+++..|.+..|.+....+........ ..... .........+.+..++++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 677888999998887655443322110000 00000 00000011233456788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 379 PLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 379 ~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
|||.+||.+||++|+|++|+|+||||++++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-59 Score=440.49 Aligned_cols=262 Identities=22% Similarity=0.373 Sum_probs=198.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC-------
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------- 190 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------- 190 (415)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|++|+|||||+++++|.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 47999999999999999999999999999999998654 3445567889999999999999999999987542
Q ss_pred ---CCeEEEEEEecccChhhhhcCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 191 ---SCSLYLVFKYMEHDLAGLAASPTIK---FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 191 ---~~~~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
..++|+|||||.++.+..++..... ..+..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 2357999999998777666554433 4566789999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-----------CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014960 265 LASFFDPNHKQ-----------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333 (415)
Q Consensus 265 ~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i 333 (415)
+|+........ ..+..+||+.|||||++.+ ..|+.++|||||||+||||++ ||.+.. +....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHH
Confidence 99877543211 1234579999999999986 679999999999999999996 675432 222222
Q ss_pred HHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
...........| ...++++.+||.+||+.||.+|||+.|+|+||||++++...
T Consensus 238 ~~~~~~~~p~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 238 TDVRNLKFPPLF-------------------------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHTTCCCHHH-------------------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HHHhcCCCCCCC-------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 222111111111 11344567899999999999999999999999999987644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=429.07 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=209.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||+|+||.||+|+.. ..||||+++......+..+.|.+|+.+|++++|||||+++|++.. ..+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEE
Confidence 467999999999999999999753 359999998766667778899999999999999999999998864 34899
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC-C
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-K 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~-~ 274 (415)
|||||.++.+..++ .....+++.++..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+...... .
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999987666554 455689999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
......+||+.|||||++.+ ...|+.++|||||||+||||+||++||.+.+....+..+......++.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD---------- 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC----------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC----------
Confidence 23455689999999999864 235899999999999999999999999987776655555442211110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHH------hcCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA------LRSEVS 404 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~------L~h~~f 404 (415)
......++|+++.+||.+||+.||++|||+.|+ |+|+|-
T Consensus 259 -------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 259 -------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 122334678889999999999999999999876 567664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=464.07 Aligned_cols=263 Identities=22% Similarity=0.349 Sum_probs=231.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+ ...+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999997643 4455678899999999999999999999987 568999
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC--CcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE--GILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~--~~vkl~DfG~a~~~~~~~ 273 (415)
|||||.++.+..++ .....+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999986655444 455689999999999999999999999999999999999999864 899999999999876542
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+++..|.+....++...|
T Consensus 312 --~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 380 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF-------- 380 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG--------
T ss_pred --ceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc--------
Confidence 3456789999999999987 67999999999999999999999999999999999988776544433322
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
..+++++++||.+||..||.+|||++|+|+||||+..+...
T Consensus 381 -----------------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 381 -----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred -----------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 45788899999999999999999999999999999876654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-58 Score=433.81 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=214.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|.+.++||+|+||.||+|++. .++..||||+++.. .....+.|.+|+++|++|+|||||+++|++.+ .
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--G 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--C
Confidence 468999999999999999999864 45788999999753 35566789999999999999999999999987 4
Q ss_pred CeEEEEEEecccChhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcE
Q 014960 192 CSLYLVFKYMEHDLAGLAASP-------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGIL 258 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~-------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~v 258 (415)
..+|||||||.++.+..++.. ...+++.++..|+.||+.||+|||+++||||||||+||||+.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 569999999998776665532 3469999999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014960 259 TIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKL 336 (415)
Q Consensus 259 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 336 (415)
||+|||+|+........ ......||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+++..+.+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876543222 1233468999999999986 679999999999999999998 99999999998888888664
Q ss_pred cCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
...+ ....+|+++.+||.+||+.||++|||+++++ +|++.+...
T Consensus 247 ~~~~----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~~~ 290 (299)
T 4asz_A 247 RVLQ----------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLAKA 290 (299)
T ss_dssp CCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHHHH
T ss_pred CCCC----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHHhc
Confidence 2111 1235788899999999999999999999984 455544433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=461.69 Aligned_cols=259 Identities=25% Similarity=0.347 Sum_probs=217.6
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC----ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
..++|++++.||+|+||.||+|+++.+|+.||||++.+... ..........++.+++.++|||||+++++|.+ .
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~--~ 264 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--P 264 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--S
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE--C
Confidence 46899999999999999999999999999999999976432 12222233345677778899999999999988 5
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..+|||||||.|+.+..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 67999999999988877777777899999999999999999999999999999999999999999999999999987754
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCHHHHhhC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.. ..+.+||+.|||||++.+...|+.++||||||||||||++|.+||.+.+. .++...+.....
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~---------- 411 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---------- 411 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC----------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC----------
Confidence 32 35578999999999997546799999999999999999999999987432 233333333211
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
.....+++++++||.+||+.||.+|++ ++|+++||||+.++
T Consensus 412 -------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 412 -------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred -------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 112357888999999999999999998 79999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=426.89 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=205.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|.+.++||+|+||.||+|+.. .++..||||+++.. .....+.|.+|+.+|++|+|||||+++|++.+ .
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--G 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 357899999999999999999854 46889999999743 35566789999999999999999999999987 4
Q ss_pred CeEEEEEEecccChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASP---------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~---------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 256 (415)
..+|||||||.++.+..++.. ...+++.++..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 569999999998877665432 24689999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014960 257 ILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIF 334 (415)
Q Consensus 257 ~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (415)
.+||+|||+|+....... ...+...||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999987644322 22344678999999999986 679999999999999999999 899999999888888776
Q ss_pred HhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+....+ ....+|+++.+||.+||+.||++|||++|++++
T Consensus 275 ~g~~~~----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELE----------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCC----------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCC----------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 532111 123578889999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=421.65 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=210.5
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
..++++.++||+|+||.||+|+. ..+++.||||++.... .....+.|.+|+.++++++|||||+++|++.. .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--D 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--C
Confidence 45788999999999999999985 3467899999987543 34455779999999999999999999999987 4
Q ss_pred CeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 255 (415)
..+|||||||.++.+..++.. ...+++.++..|+.||+.||+|||+++||||||||+||||+.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 569999999998766655422 2358999999999999999999999999999999999999999
Q ss_pred CcEEEEeeccccccCCCC-CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014960 256 GILTIADFGLASFFDPNH-KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKI 333 (415)
Q Consensus 256 ~~vkl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i 333 (415)
+++||+|||+|+...... ....+...||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+++..+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999998664332 223345678999999999986 679999999999999999998 89999999988888777
Q ss_pred HHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.+....+ ...++|+++.+||.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5432111 123577889999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=409.81 Aligned_cols=288 Identities=38% Similarity=0.638 Sum_probs=242.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++++.||+|+||.||+|++..+++.||+|++............+.+|+.++++++|+||+++++++.+ ...+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998776656666788899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||++++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 9999999888887777789999999999999999999999999999999999999999999999999998765332 233
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
....||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....|...........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5567899999999998755689999999999999999986655 777888889999999999888877765332221111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
..............+.++.++++||.+||+.||++|||++|+|+||||+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 1111111223334456788899999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=412.65 Aligned_cols=289 Identities=38% Similarity=0.688 Sum_probs=238.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|+++++||+|+||.||+|++. +|+.||+|++............+.+|+.++++++||||+++++++.+ ...+|+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEE
Confidence 578999999999999999999985 58999999998665444556778899999999999999999999987 557999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 99999998888887777789999999999999999999999999999999999999999999999999998765332 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|...........
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 34557899999999988766789999999999999999999999999999999999999998887776665332110000
Q ss_pred -CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 357 -KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 357 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
..............+.+++++++||.+||+.||.+|||++|+|+||||++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 00000011133445567888999999999999999999999999999998864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=405.63 Aligned_cols=287 Identities=36% Similarity=0.617 Sum_probs=232.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++++.||+|+||.||+|++ .+|+.||+|++............+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 5799999999999999999998 678999999997654333344667889999999999999999999987 4579999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 9999998877777666789999999999999999999999999999999999999999999999999998765332 223
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....|+...........
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 44578999999999977567899999999999999999999999999999999999998888877666542211110000
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
...............+++++++||.+||..||++|||++|+|+||||++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC--
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcC
Confidence 000000112333456788899999999999999999999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=428.52 Aligned_cols=293 Identities=32% Similarity=0.530 Sum_probs=225.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC---CCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~ 193 (415)
.++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++|+|||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999999999999999999766556666788999999999999999999999985431 256
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+||||+++++...+.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 999999999877766654 4579999999999999999999999999999999999999999999999999998764322
Q ss_pred C--------------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-----------
Q 014960 274 K--------------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA----------- 316 (415)
Q Consensus 274 ~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~----------- 316 (415)
. ......+||++|+|||++.....|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 123456789999999987655779999999999999999998
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHhcCCCCHHHHhhCCCCCCC--cCCCcchhhhhhhhhcCCCC
Q 014960 317 EKPIMPGRT--------------------EVEQLHKIFKLCGSPSEEYWKKSKLPHAT--IFKPQQSYKRCIAETFKDFP 374 (415)
Q Consensus 317 g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 374 (415)
|.++|.+.+ ..+++..|++.++.+..+.|......... ...........+.+.++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 788887754 35778889999999988777653321100 00000001111344456678
Q ss_pred CChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 375 PSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 375 ~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.++++||.+||.+||.+|||++|+|+||||+.+...
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 899999999999999999999999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=416.87 Aligned_cols=292 Identities=34% Similarity=0.568 Sum_probs=231.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.+. |+||+++++++.......+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999999999999999999765555666778889999999997 99999999999875556799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC--
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-- 273 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~-- 273 (415)
+||||+++++...+.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999877666543 378999999999999999999999999999999999999999999999999998654311
Q ss_pred ------------------CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014960 274 ------------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFK 335 (415)
Q Consensus 274 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 335 (415)
.......+||++|+|||++.+...++.++|||||||++|||++|.+||.+.+..+++..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 11234468999999999998767799999999999999999999999999999999999999
Q ss_pred hcCCCCHHHHhhCCCCCCCcC-------------CCcch---hhhhhhh--hcCCCCCChHHHHHHhcccCCCCCCCHHH
Q 014960 336 LCGSPSEEYWKKSKLPHATIF-------------KPQQS---YKRCIAE--TFKDFPPSSLPLIETLLAIDPAERQTATA 397 (415)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~---~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 397 (415)
..+.|..+.+.....+..... ..... +...... ....+++++++||.+||..||.+|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 999998877765433211000 00000 0000000 11266788999999999999999999999
Q ss_pred HhcCCCCCCCCCC
Q 014960 398 ALRSEVSLYMXXX 410 (415)
Q Consensus 398 ~L~h~~f~~~~~~ 410 (415)
+|+||||+.+.+.
T Consensus 326 ~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 326 ALKHPFVSIFHNP 338 (388)
T ss_dssp HTTSTTTTTTCCG
T ss_pred HhCCHHHHHhcCC
Confidence 9999999887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=417.53 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=207.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-----CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC-CceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEPESVRFMAREILILRRLDH-PNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++... ++.||+|.+.... .....+.+.+|+.+|.+++| ||||+++|+|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 46899999999999999999987543 3679999987543 34556778899999999965 8999999998653
Q ss_pred CCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 254 (415)
+..+|||||||.++.+..++.. ...+++..+..|+.||+.||+|||+++||||||||+||||+.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 4568999999998766655421 235899999999999999999999999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014960 255 EGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (415)
Q Consensus 255 ~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 332 (415)
++.+||+|||+|+........ ..+...||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876543322 2334578999999999986 679999999999999999998 9999998664444433
Q ss_pred HHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
++.....+. ....+++++++||.+||+.||++|||+.++++|
T Consensus 300 ~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 333211110 113467789999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=406.98 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=228.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 568999999999999999999999999999999998776666777888999999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+...+.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 169 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--K 169 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--G
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--c
Confidence 99999887666666555679999999999999999999999999999999999999999999999999998765442 3
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------------- 233 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---------------- 233 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------------
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 4566899999999999875555689999999999999999999999999888888776632211
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
...++.++.+||++||..||.+|||++|+|+||||+...+
T Consensus 234 -------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 234 -------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp -------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred -------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 1236778899999999999999999999999999987554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=410.67 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=230.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.+.|++.+.||+|+||.||+|++..+|+.||+|++.+..... ...+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 467999999999999999999999999999999998764321 235678899999999999999999999987 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC----cEEEEeeccccc
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASF 268 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DfG~a~~ 268 (415)
.+|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 7999999998877777777777899999999999999999999999999999999999998877 799999999987
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+....|
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 242 (361)
T 2yab_A 169 IEDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF--- 242 (361)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH---
T ss_pred cCCCC--ccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc---
Confidence 75432 3355679999999999876 57899999999999999999999999999999999888776555555444
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
..+++++++||.+||..||.+|||++|+|+||||+.+.
T Consensus 243 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 243 ----------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred ----------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 35788899999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=406.76 Aligned_cols=293 Identities=35% Similarity=0.649 Sum_probs=223.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEE
Confidence 3579999999999999999999999999999999986542 2233567789999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 197 VFKYMEHDLAGLAASP-----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 9999998766554322 24589999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....|+.....
T Consensus 161 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred Cc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 32 22345678999999999977567899999999999999999999999999999999999999988887777653221
Q ss_pred CCCc----CCCcchhhhhhh-hhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 014960 352 HATI----FKPQQSYKRCIA-ETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXX 413 (415)
Q Consensus 352 ~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~ 413 (415)
.... ......+...+. .....++.++++||.+||..||++|||++|+|+||||++....+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence 1110 001111111111 2223678889999999999999999999999999999988776554
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=423.91 Aligned_cols=286 Identities=28% Similarity=0.493 Sum_probs=229.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999999999999999865445666778889999999999999999999986532 24
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+||||+++++...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 6899999999988776643 4899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|.+.++.+..+.|.......
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 23456789999999999987 579999999999999999999999999999999999999999999888775532100
Q ss_pred C-----CcCCCcchhhhhhhhh--------cCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 353 A-----TIFKPQQSYKRCIAET--------FKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~-----~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
. ........+....... ....+.++++||.+||..||++|||++|+|+||||+.+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0 0000000000100000 001134689999999999999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=416.75 Aligned_cols=295 Identities=31% Similarity=0.518 Sum_probs=237.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC---Ce
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS---CS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---~~ 193 (415)
.++|.+.+.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++|+||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999999999999999998665556667789999999999999999999999876421 56
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+||||+++++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 999999999876665544 4579999999999999999999999999999999999999999999999999998765432
Q ss_pred C---------------------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-----------CCCCC
Q 014960 274 K---------------------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-----------EKPIM 321 (415)
Q Consensus 274 ~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-----------g~~pf 321 (415)
. ......+||++|+|||++.....++.++|||||||+||||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 123567899999999987665779999999999999999998 56666
Q ss_pred CCCC-----------------hHHHHHHHHHhcCCCCHHHHhhCCCCCCC--cCCCcchhhhhhhhhcCCCCCChHHHHH
Q 014960 322 PGRT-----------------EVEQLHKIFKLCGSPSEEYWKKSKLPHAT--IFKPQQSYKRCIAETFKDFPPSSLPLIE 382 (415)
Q Consensus 322 ~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~ 382 (415)
.+.+ ..+++..|++.++.|..+.+......... +...............+.+++++++||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 6654 46788899999999998877653321110 0000000111133445678899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 383 TLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 383 ~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
+||..||.+|||++|+|+||||+.+.....
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~ 373 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKKKL 373 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence 999999999999999999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=394.61 Aligned_cols=291 Identities=32% Similarity=0.543 Sum_probs=234.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++++.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.++++++|+||+++++++.. ....++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEE
Confidence 67999999999999999999999999999999998766566667788899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+.++++..+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYY 159 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-ccc
Confidence 9999999888877767789999999999999999999999999999999999999999999999999998765332 223
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC--CCc
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH--ATI 355 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~ 355 (415)
....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+.+..+......+....... ...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 455789999999999876778999999999999999999999999999999998888887776544332211000 000
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
..+............+.++.++.+||.+||+.||.+|||++|+|+||||+++++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 00000011112333457888899999999999999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=407.53 Aligned_cols=290 Identities=37% Similarity=0.659 Sum_probs=232.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|.+++.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 5799999999999999999999999999999999754321 111234579999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 9999998888777666679999999999999999999999999999999999999999999999999997654332 233
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC-CcC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA-TIF 356 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~ 356 (415)
....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....|+....... ...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 4557899999999988766789999999999999999999999999999999999999999988777764211100 000
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
................+++++.+||.+||+.||.+|||++|+|+||||..+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 0000111113344557788899999999999999999999999999999887654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=403.50 Aligned_cols=289 Identities=34% Similarity=0.616 Sum_probs=225.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++.+ ...+|+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 110 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLHL 110 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEEE
Confidence 568999999999999999999999999999999998765555555677899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc-----CCCcEEEEeeccccccCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-----NEGILTIADFGLASFFDP 271 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-----~~~~vkl~DfG~a~~~~~ 271 (415)
||||+++++...+.. ...+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 111 v~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999999866665543 44699999999999999999999999999999999999995 445699999999987653
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....|......
T Consensus 190 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 190 PI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 32 22345578999999999987566899999999999999999999999999999999999999888877766542211
Q ss_pred CCCcCCCcch-hhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 352 HATIFKPQQS-YKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 352 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.......... ...........+++++++||.+||+.||.+|||++|+|+||||+.++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 1100000000 000111112236788999999999999999999999999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=402.19 Aligned_cols=259 Identities=26% Similarity=0.384 Sum_probs=223.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEE
Confidence 4689999999999999999999999999999999975421 22345678889999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... .
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence 999999998777666666689999999999999999999999999999999999999999999999999998643322 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+.......
T Consensus 161 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 224 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--------------- 224 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred cccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 3455689999999999876 678999999999999999999999999988888877776532111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
...+++++.+||.+||..||.+|| +++++++||||+.++
T Consensus 225 --------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 225 --------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred --------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 124678899999999999999999 999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=414.61 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=227.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEE
Confidence 368999999999999999999999999999999998776666667789999999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc---CCCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999877666655556899999999999999999999999999999999999998 45789999999998765433
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......++...|
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 237 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW-------- 237 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT--------
T ss_pred -ceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc--------
Confidence 23345689999999999876 57899999999999999999999999999999999888776544433332
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
..+++++++||.+||..||.+|||++|+|+||||+.
T Consensus 238 -----------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 238 -----------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred -----------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 357888999999999999999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=402.83 Aligned_cols=293 Identities=44% Similarity=0.688 Sum_probs=239.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 190 (415)
.++|++++.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++|+||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 57899999999999999999999999999999999766554444456778999999999999999999987643
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
...+|+||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 34689999999998888888777789999999999999999999999999999999999999999999999999998765
Q ss_pred CCC---CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 271 PNH---KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 271 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
... ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....|+.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 322 12234567899999999998766789999999999999999999999999999999999999998887776654
Q ss_pred CCCCCCC-----cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 348 SKLPHAT-----IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 348 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
....... ...........+.. ...++++++||.+||+.||.+|||++|+|+||||+......
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKA--YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHH--HHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred cccchhhcccccccccccCHHHHhhh--ccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 2211000 00000000000100 01356789999999999999999999999999998766544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=412.28 Aligned_cols=286 Identities=34% Similarity=0.532 Sum_probs=232.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec----CCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----~~~ 192 (415)
..+|++.+.||+|+||.||+|++..+|+.||||++..+.. ...+|+++|+.++|+|||++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4579999999999999999999999999999999975432 233699999999999999999988542 234
Q ss_pred eEEEEEEecccChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-CcEEEEeeccccc
Q 014960 193 SLYLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASF 268 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DfG~a~~ 268 (415)
++++||||+.+++...+. .....+++..++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 578999999987655433 345679999999999999999999999999999999999999965 5689999999987
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
..... .....+||+.|+|||++.+...++.++|||||||+||||++|++||.+.+..+.+.++.+..+.+..+.|...
T Consensus 207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 65432 2345678999999999987567999999999999999999999999999999999999999999998887653
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
......+..+......+.......++.++++||.+||.+||.+|||+.|+|+||||+.+.+.
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 32111111111000111112234678889999999999999999999999999999887654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=393.91 Aligned_cols=287 Identities=36% Similarity=0.616 Sum_probs=231.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhC---CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRL---DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 46899999999999999999999999999999999754321 11223455677777766 5999999999987643
Q ss_pred C---CeEEEEEEecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 191 S---CSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 191 ~---~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
. ..+++||||+++++...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 2589999999987776665443 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++.+..+.+....|+
T Consensus 168 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQM--ALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTCC--CSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCCc--ccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 8765432 3355688999999999976 568999999999999999999999999999999999999999988887776
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.........+... .........+.+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 245 RDVSLPRGAFPPR--GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp SSCSSCGGGSCCC--CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred chhhccccccCCC--CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 5332222111111 11223445567889999999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=404.82 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=227.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+ ....|+|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 106 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 106 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998876666777889999999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---cEEEEeeccccccCCCCC
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFDPNHK 274 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DfG~a~~~~~~~~ 274 (415)
|||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-- 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 184 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--
Confidence 99999877766666667899999999999999999999999999999999999998654 5999999999876543
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......++...|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 254 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW--------- 254 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG---------
T ss_pred cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc---------
Confidence 22345689999999999876 57899999999999999999999999999988888888775544433333
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
..+++++++||.+||..||.+|||++++|+||||..
T Consensus 255 ----------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 255 ----------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ----------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ----------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 347788999999999999999999999999999965
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=407.29 Aligned_cols=289 Identities=31% Similarity=0.521 Sum_probs=232.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----C 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~ 192 (415)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++|+||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999999999999999997655555666788899999999999999999999876421 3
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+||||+++++...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 5799999996665554433 36899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+..+.++.+.+.......
T Consensus 182 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 182 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 3456789999999999875679999999999999999999999999999999999999999999888776532211
Q ss_pred CCcC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
...+ ..+......+......+++++.+||.+||..||.+|||++++|+||||+.+.+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 0000 0000000112333456788899999999999999999999999999999887643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=398.50 Aligned_cols=259 Identities=20% Similarity=0.305 Sum_probs=227.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++..+++.||+|.+... ......+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEE
Confidence 46899999999999999999999999999999998743 3455678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC--CCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999866555554 3457999999999999999999999999999999999999987 7899999999998875432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+....+....|
T Consensus 159 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred --ccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh--------
Confidence 2345678999999999876 56899999999999999999999999999999999988886655554444
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
+.++.++++||.+||..||.+|||+.|+|+||||+...
T Consensus 228 -----------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred -----------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 45788899999999999999999999999999997653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=408.16 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=220.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 4789999999999999999999999999999999986422 233456678899999988 79999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 9999999988777766666689999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..|.+.....+
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------- 244 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP------------- 244 (353)
T ss_dssp -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 23345689999999999876 6789999999999999999999999999999998888876432211
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA------TAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~~~L~h~~f~~~~ 408 (415)
..++.++.+||++||+.||.+||++ +++++||||+.++
T Consensus 245 ----------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 245 ----------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred ----------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 2367789999999999999999999 8999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=400.66 Aligned_cols=293 Identities=40% Similarity=0.662 Sum_probs=237.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC---hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
..++|++.+.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.++|+||+++++++.+ ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KS 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CC
Confidence 357899999999999999999999999999999998754321 1122467789999999999999999999987 45
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|+||||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 69999999999887777766678999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+++..+.+....|+......
T Consensus 166 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 N-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp C-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred c-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 233456789999999998765668999999999999999999999999999999999999999998888777643222
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
....... ............+++++++||.+||..||.+|||++|+|+||||+.....++
T Consensus 245 ~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 245 DYVTFKS-FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp TCCCCCC-CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred ccccccc-cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 2111100 0001123344677889999999999999999999999999999998765543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=393.56 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=228.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.+.|.+.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 357999999999999999999999999999999998754321 235678899999999999999999999987 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC----cEEEEeeccccc
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASF 268 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DfG~a~~ 268 (415)
..|+||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 7999999999877777777777899999999999999999999999999999999999999887 899999999987
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...........|
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 241 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF--- 241 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH---
T ss_pred CCCCC--ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc---
Confidence 75432 2345679999999999875 57899999999999999999999999999988888888765544443333
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
..++..+.+||.+||..||.+|||++++|+||||+...
T Consensus 242 ----------------------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 242 ----------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred ----------------------ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 45778899999999999999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=397.83 Aligned_cols=256 Identities=23% Similarity=0.238 Sum_probs=189.4
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC--CeEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS--CSLY 195 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--~~~~ 195 (415)
++|.+.++||+|+||.||+|++ +|+.||||++... .......+.|+..+.+++|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999975 6899999998643 2222334456666678899999999999976432 3689
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ--------HVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
||||||.++.+..++... .+++..+..++.||+.||+|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999988777766543 689999999999999999999987 99999999999999999999999999998
Q ss_pred ccCCCCCC---CcccccccCccCCcccccCCc-----CCCchhcHHHHHHHHHHHHhCCCCCCCCCh-------------
Q 014960 268 FFDPNHKQ---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAEKPIMPGRTE------------- 326 (415)
Q Consensus 268 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~sDvwSlG~il~ell~g~~pf~~~~~------------- 326 (415)
........ .....+||+.|||||++.+.. .++.++|||||||+||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543321 223458999999999986531 467899999999999999999887754321
Q ss_pred --HHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 327 --VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 327 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.+....+......|.. +. .......+..+.+||.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~--------------------p~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNI--------------------PN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCC--------------------CG--GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCC--------------------Cc--cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111110000000 00 00001122357889999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=403.44 Aligned_cols=285 Identities=28% Similarity=0.467 Sum_probs=232.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec-------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------- 189 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 189 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++..+... ..+|+.+++.++|+||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 46899999999999999999999999999999999755322 23699999999999999999998542
Q ss_pred -----------------------------CCCeEEEEEEecccChhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 014960 190 -----------------------------MSCSLYLVFKYMEHDLAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHN 237 (415)
Q Consensus 190 -----------------------------~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 237 (415)
...++++||||+++++...+ ......+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23458999999998754433 3456689999999999999999999999
Q ss_pred CCCeeccCCCCCEEEc-CCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh
Q 014960 238 QHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~-~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~ 316 (415)
+||+||||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999998 68899999999998765443 23456789999999998876679999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH
Q 014960 317 EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT 396 (415)
Q Consensus 317 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 396 (415)
|.+||.+.+..+.+..+.+..+.+..+.+............+......+.......++.++++||.+||..||.+|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999999999999999999999998877664322221111111111122223345788899999999999999999999
Q ss_pred HHhcCCCCCCCCC
Q 014960 397 AALRSEVSLYMXX 409 (415)
Q Consensus 397 ~~L~h~~f~~~~~ 409 (415)
|+|+||||+.+++
T Consensus 318 e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 318 EAMAHPFFDHLRN 330 (383)
T ss_dssp HHHTSGGGHHHHH
T ss_pred HHhcCHHHHHHHh
Confidence 9999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=395.24 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=223.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEE
Confidence 4689999999999999999999999999999999975422 12345667889999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999998777776666668999999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+...++.+.....
T Consensus 160 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------- 222 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--------------- 222 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC---------------
T ss_pred -cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 245678999999999876 678999999999999999999999999998888888876632111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
...++.++.+||.+||..||.+|+ +++++++||||+.+.
T Consensus 223 --------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 223 --------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred --------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 124677899999999999999999 999999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=402.57 Aligned_cols=289 Identities=34% Similarity=0.532 Sum_probs=223.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec----CCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----~~~ 192 (415)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++|+||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3689999999999999999999999999999999976555556677888999999999999999999998653 125
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+|||++++++...+.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 6899999997665544433 47999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.+.......
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 3456789999999998876679999999999999999999999999999999999999999999888776532210
Q ss_pred CCcC--CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 353 ATIF--KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 353 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
...+ .........+......+++++++||.+||..||.+|||++++|+||||+.+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 0000 0000000112333456788899999999999999999999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=403.69 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=215.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.++.++ +|||||++++++.+ ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 4689999999999999999999999999999999987543 233445677899999887 89999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence 9999999998777666666689999999999999999999999999999999999999999999999999998633222
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCCHHHH
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---------EVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~ 345 (415)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.. .......+.....
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------- 279 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------- 279 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-------
T ss_pred CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-------
Confidence 23456789999999999986 678999999999999999999999996432 1222333332111
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA------TAALRSEVSLYMX 408 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~~~L~h~~f~~~~ 408 (415)
.....++.++++||++||+.||.+||++ +|+++||||+.++
T Consensus 280 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 280 ----------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred ----------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 1123467889999999999999999995 8999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=400.10 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=222.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+... .......+..|..++..+ +||||+++++++.+ ...+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~ 93 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 93 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEE
Confidence 5789999999999999999999999999999999976421 123345677899999876 99999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 172 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence 9999999987777666655689999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+.......
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 237 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY-------------- 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 22355689999999999986 578999999999999999999999999999888888776532111
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT-AALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-~~L~h~~f~~~~ 408 (415)
...++.++.+||.+||..||.+||++. ++++||||+.++
T Consensus 238 ---------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 238 ---------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp ---------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ---------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 124678899999999999999999998 999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=387.20 Aligned_cols=260 Identities=26% Similarity=0.369 Sum_probs=214.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh------------------------HHHHHHHHHHHHHH
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP------------------------ESVRFMAREILILR 172 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 172 (415)
.++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999999999999999997653211 12356889999999
Q ss_pred hCCCCceeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 173 ~l~h~~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
+++||||+++++++.+.....+|+||||+.++.+..+.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999999998765678999999999877665543 3479999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcC--CCchhcHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||++....... .......||+.|+|||++.+... ++.++|||||||++|+|++|.+||.+.+.....
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999998765432 22345678999999999876332 478899999999999999999999988777666
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
..+.......+ ....+++++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 250 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEFP---------------------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCCC---------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCCC---------------------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 66544221110 1135778899999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=387.62 Aligned_cols=261 Identities=24% Similarity=0.418 Sum_probs=222.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEE
Confidence 46899999999999999999999999999999999765432 24568899999999999999999999987 557999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 99999887776665443 689999999999999999999999999999999999999999999999999987654432 3
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+........
T Consensus 173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 236 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------------- 236 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------------
T ss_pred cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 345679999999999886 5789999999999999999999999999888777766654321110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.....++..+.+||.+||..||.+|||++++|+||||+.....
T Consensus 237 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 237 -----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL 279 (297)
T ss_dssp -----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred -----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence 0113467788999999999999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=394.25 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=217.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++++ +||||+++++++.+ ...+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEE
Confidence 5789999999999999999999999999999999987644 455667788999999988 89999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 9999999987776666555689999999999999999999999999999999999999999999999999998643222
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHHhcCCCCHHHH
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR---------TEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~ 345 (415)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||... +.......+.....
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------- 236 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------- 236 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-------
T ss_pred CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-------
Confidence 23455689999999999986 67899999999999999999999999752 22223333332110
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA------TAALRSEVSLYMX 408 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~------~~~L~h~~f~~~~ 408 (415)
.....++.++.+||.+||+.||.+||++ +++++||||+.++
T Consensus 237 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 237 ----------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred ----------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 0113467789999999999999999995 8999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=413.76 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=223.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|+++++||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++..++|+||+++++++.+ ...+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 150 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLY 150 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEE
Confidence 4689999999999999999999999999999999975321 11122347789999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 196 LVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+||||+.++.+..++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++........
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999987666555543 56899999999999999999999999999999999999999999999999999987655443
Q ss_pred CCcccccccCccCCccccc----CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 275 QPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
......+||+.|+|||++. +...++.++|||||||++|||++|.+||.+.+..+.+.+|.+......
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 301 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--------- 301 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---------
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc---------
Confidence 3344568999999999986 235689999999999999999999999999999888888865321100
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEVSLYMX 408 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~~L~h~~f~~~~ 408 (415)
.......+++++++||++||+.+|++ |++++|+++||||+.++
T Consensus 302 ---------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 302 ---------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp ---------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ---------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 11112457888999999999999888 99999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=401.22 Aligned_cols=286 Identities=33% Similarity=0.511 Sum_probs=231.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
..+|.+.+.||+|+||.||+|++..++. ||+|++...... ..+|+.+++.++|+||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999877666 888888654321 236999999999999999999986532 23
Q ss_pred eEEEEEEecccChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc-CCCcEEEEeeccccc
Q 014960 193 SLYLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASF 268 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DfG~a~~ 268 (415)
++|+||||+.++++.... .....+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||++..
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 488999999997665433 2355799999999999999999999999999999999999999 789999999999987
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
..... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.+...
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 65433 2345678999999999987667999999999999999999999999999999999999999999988776653
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.........+......+.......+++++++||.+||.+||.+|||+.++|+||||+.++...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 211111100110011111222335788999999999999999999999999999999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=391.58 Aligned_cols=288 Identities=28% Similarity=0.540 Sum_probs=234.4
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
..++|++++.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+++.++|+||+++++++.. ....|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEE
Confidence 3578999999999999999999999999999999998776666667778899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 179 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 179 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-c
Confidence 999999999888877666689999999999999999999999999999999999999999999999999997765432 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh---CCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK---SKLPH 352 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~ 352 (415)
......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......+.. .....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 234557899999999998755789999999999999999999999999999999999888877765443221 10000
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
. ...+............+.+++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 260 ~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 260 G-VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp T-CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred c-ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0 00000001111334455788899999999999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=397.67 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=222.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++++.||+|+||.||+|++..+++.||||++.+... .....+.+..|+.++..+ +||+|+++++++.+ ...+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEE
Confidence 5789999999999999999999999999999999976422 123456677899999988 79999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 9999999987776666655679999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+++..|.+.....
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-------------- 240 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-------------- 240 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 23355689999999999876 678999999999999999999999999999888888887632111
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
...++.++++||.+||..||.+||+ ++++++||||+.++
T Consensus 241 ---------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 241 ---------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred ---------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 1357788999999999999999994 69999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=397.09 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=223.6
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..++|++++.||+|+||.||+|++..+|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence 35789999999999999999999999999999999975432 12345678889999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999988777666655567999999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 195 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 257 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-------------- 257 (350)
T ss_dssp --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred --cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 245679999999999886 578999999999999999999999999999888888887632111
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
...++.++.+||.+||+.||.+||+ ++++++||||+.++
T Consensus 258 ---------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 258 ---------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ---------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ---------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 1246788999999999999999999 99999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=411.27 Aligned_cols=264 Identities=24% Similarity=0.297 Sum_probs=221.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++|||||++++++.+ ...+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 145 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY 145 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEE
Confidence 5789999999999999999999999999999999975221 11122347789999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++.. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 99999988666655543 36899999999999999999999999999999999999999999999999999877554332
Q ss_pred CcccccccCccCCcccccCCc---CCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGAT---DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~---~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.....+||+.|+|||++.+.. .++.++|||||||+||||++|.+||.+.+..+...+|.+......
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------- 293 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------- 293 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----------
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc-----------
Confidence 334668999999999987532 278999999999999999999999999999888888875321110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE--RQTATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~t~~~~L~h~~f~~~~ 408 (415)
......++.++++||.+||+.+|.+ |++++|+++||||+.++
T Consensus 294 --------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 294 --------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp --------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred --------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 0011357888999999999999988 99999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=395.17 Aligned_cols=291 Identities=33% Similarity=0.533 Sum_probs=238.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC---CCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~ 193 (415)
.++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.++++++|+||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999999999999999997533 3455577889999999999999999999986532 246
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.|+||||+++++...+.. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999999877665543 368999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 274 K--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 274 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.|......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 12345588999999999876667899999999999999999999999999999999999999999988776542210
Q ss_pred CCCc--CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 352 HATI--FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 352 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.... ..........+......++.++.+||.+||+.||.+|||++|+|+||||+...+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 0000 0000000011234445678889999999999999999999999999999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=396.20 Aligned_cols=287 Identities=33% Similarity=0.545 Sum_probs=234.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC----
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC---- 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~---- 192 (415)
.++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3689999999999999999999999999999999987655666677888999999999999999999999764321
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+||||+.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 121 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 249999999987666542 35899999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.+.......
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3455789999999998875678999999999999999999999999999999999999999998877665432110
Q ss_pred CCc--CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 353 ATI--FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 353 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
... .................+++++.+||.+||+.||.+|||++|+|+||||+.+.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 000 0000000111233445678899999999999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=387.77 Aligned_cols=263 Identities=27% Similarity=0.380 Sum_probs=215.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEE
Confidence 4789999999999999999999999999999999975532 2334567899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC-CC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-KQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~-~~ 275 (415)
||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999987777777777789999999999999999999999999999999999999999999999999998654322 12
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+...............
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 227 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 227 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---------------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---------------
Confidence 23456789999999999875545889999999999999999999998765432222221111100
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
......++.++.+||.+||..||.+|||++|+|+||||+...
T Consensus 228 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 011234778889999999999999999999999999998643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=397.36 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=214.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHH-HHhCCCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILI-LRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|..+ ++.++||||+++++++.+ ...+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEE
Confidence 5789999999999999999999999999999999987543 23334456667776 567899999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 9999999997777666666689999999999999999999999999999999999999999999999999998643222
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....|.+....
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 257 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--------------- 257 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC---------------
T ss_pred CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC---------------
Confidence 23456689999999999886 67899999999999999999999999999988888888763211
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA----TAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~----~~~L~h~~f~~~~ 408 (415)
....++.++++||.+||+.||.+|+++ +++++||||+.++
T Consensus 258 --------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 258 --------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp --------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred --------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 113577889999999999999999997 6999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=393.76 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=222.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+|+.++|+||+++++++.+ ...+|+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 468999999999999999999999999999999997543 3445678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC--CCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999998876655554 4457999999999999999999999999999999999999974 4679999999998775432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+....+..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 271 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 271 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred --ceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 2344578999999999876 67899999999999999999999999999888888877664322211
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.....++.++++||.+||..||.+|||+.++|+||||+...
T Consensus 272 --------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 272 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp --------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred --------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 12245788899999999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=398.24 Aligned_cols=293 Identities=18% Similarity=0.249 Sum_probs=219.4
Q ss_pred CCCceeeeeeccC--CceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQG--TYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++++.||+| +||.||+|++..+|+.||||++............+.+|+.+++.++|||||++++++.. ...+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEE
Confidence 5789999999999 99999999999999999999998876667777889999999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 195 YLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
|+||||+.++.+..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999998766655533 357999999999999999999999999999999999999999999999999988654221
Q ss_pred C------CCCcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH--
Q 014960 273 H------KQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE-- 343 (415)
Q Consensus 273 ~------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 343 (415)
. ........||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+..........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1 1112334789999999998763 468999999999999999999999999876665554443321110000
Q ss_pred HHhhCCCC-------------CCCc--CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 344 YWKKSKLP-------------HATI--FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 344 ~~~~~~~~-------------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
......+. .... .................+++++++||.+||+.||.+|||++|+|+||||+.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 00000000 0000 00000000001123345788899999999999999999999999999999887
Q ss_pred CCC
Q 014960 409 XXX 411 (415)
Q Consensus 409 ~~~ 411 (415)
...
T Consensus 342 ~~~ 344 (389)
T 3gni_B 342 RRA 344 (389)
T ss_dssp --C
T ss_pred hcc
Confidence 544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=407.19 Aligned_cols=266 Identities=24% Similarity=0.306 Sum_probs=221.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.++..++|+||+++++++.+ ...+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 137 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYLY 137 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEE
Confidence 4789999999999999999999999999999999975321 12233457789999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 196 LVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+||||+.++.+..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++........
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 99999987666555543 34799999999999999999999999999999999999999999999999999987765433
Q ss_pred CCcccccccCccCCcccccC------CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 275 QPMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~------~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
......+||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.+.+..+.+.+|.+......
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~------- 290 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS------- 290 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-------
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC-------
Confidence 22345689999999999862 24689999999999999999999999999999888888865311000
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER---QTATAALRSEVSLYMXX 409 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~~~L~h~~f~~~~~ 409 (415)
.......++.++++||++||+ ||.+| ++++++++||||+.++-
T Consensus 291 -----------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 291 -----------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp -----------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred -----------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 001123578899999999999 99998 59999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=395.74 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=219.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDMF 91 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 5789999999999999999999999999999999975431 22345678899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++.....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 99999998877777777778999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||..... .+....+.....
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------ 237 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV------------ 237 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC------------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc------------
Confidence 3456789999999999864 24589999999999999999999999986432 333333322111
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-ATAALRSEVSLYMX 408 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~~~L~h~~f~~~~ 408 (415)
.....++.++.+||.+||+.||.+||+ ++++++||||+.++
T Consensus 238 -----------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 238 -----------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred -----------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 112356788999999999999999999 89999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=393.65 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=216.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC---ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
+.|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 579999999999999999999999999999999974321 11235678899999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc---EEEEeecccc
Q 014960 195 YLVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLAS 267 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DfG~a~ 267 (415)
|+||||+.++.+...+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999976554332 22346899999999999999999999999999999999999987654 9999999998
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+. ..+....+.+.........|
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~-- 256 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW-- 256 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH--
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc--
Confidence 775432 22345679999999999876 56899999999999999999999999875 44556666554433333333
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
..+++++++||.+||..||.+|||+.++|+||||+..
T Consensus 257 -----------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 -----------------------SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -----------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 4578889999999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=387.74 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=211.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|++. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--G 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--C
Confidence 468999999999999999999875 6889999999986543 22344567889999999999999999999987 5
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..+|+||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 67999999999876666665556799999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.....
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----------- 240 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL----------- 240 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-----------
T ss_pred CC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 22 22345678999999999876 568999999999999999999999999998888888877642211
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
...++.++.+||.+||..||.+|| +++++++||||+.++
T Consensus 241 ------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 241 ------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp ------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred ------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 124677899999999999999999 899999999998764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=397.32 Aligned_cols=286 Identities=30% Similarity=0.461 Sum_probs=228.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC------CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL------DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~l~~~~~~~~ 190 (415)
..+|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 46799999999999999999999999999999999743 44456677889888887 57799999999987
Q ss_pred CCeEEEEEEecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc--EEEEeecccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--LTIADFGLAS 267 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DfG~a~ 267 (415)
...+++||||+.+++...+.... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||++.
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 46799999999988777665443 45999999999999999999999999999999999999999987 9999999997
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
..... ....+||+.|+|||++.+ ..++.++|||||||+||||++|.+||.+.+..+.+..+.+..+.++...+..
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCCc----ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 65432 345678999999999986 5689999999999999999999999999999999999999999998877654
Q ss_pred CCCCCCCcCC------------------------------CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHH
Q 014960 348 SKLPHATIFK------------------------------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397 (415)
Q Consensus 348 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 397 (415)
.......+.. .......+........++++++||.+||+.||++|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 3221100000 0000001111111233566899999999999999999999
Q ss_pred HhcCCCCCCCCCCCC
Q 014960 398 ALRSEVSLYMXXXXX 412 (415)
Q Consensus 398 ~L~h~~f~~~~~~~~ 412 (415)
+|+||||+......+
T Consensus 406 ~L~Hpw~~~~~~~~~ 420 (429)
T 3kvw_A 406 ALRHPWLRRRLPKPP 420 (429)
T ss_dssp HHTSTTTC-------
T ss_pred HhCChhhccCCCCCC
Confidence 999999998765444
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=378.10 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=228.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++|+||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 478999999999999999999999999999999998776666777889999999999999999999999986 567899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc---EEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999998766555555557999999999999999999999999999999999999987665 9999999997765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+..+....+.......+..
T Consensus 163 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 229 (284)
T 3kk8_A 163 --AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------- 229 (284)
T ss_dssp --BCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----------
T ss_pred --cccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch----------
Confidence 2345678999999999876 568999999999999999999999999998888888776654333221
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
....+++++.+||.+||+.||.+|||++|+|+||||++....
T Consensus 230 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 230 ---------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp ---------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred ---------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 123577889999999999999999999999999999886654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=396.92 Aligned_cols=290 Identities=35% Similarity=0.592 Sum_probs=216.7
Q ss_pred CCcee-eeeeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEK-LDKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~-~~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
+.|.+ .++||+|+||.||+|++. .+++.||||++...... ..+.+|+.+|+.++||||+++++++.......+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 45776 458999999999999965 57889999999755432 356789999999999999999999976667789
Q ss_pred EEEEEecccChhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE----cCCCcEEEEe
Q 014960 195 YLVFKYMEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIAD 262 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~D 262 (415)
|+||||+++++...+.. ....+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999999987765431 22359999999999999999999999999999999999999 6778999999
Q ss_pred eccccccCCCCC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 014960 263 FGLASFFDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---------VEQLH 331 (415)
Q Consensus 263 fG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---------~~~~~ 331 (415)
||++........ ......+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+. .+.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653221 2234567899999999998766799999999999999999999999987654 47889
Q ss_pred HHHHhcCCCCHHHHhhCCCCCCC---------cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCC
Q 014960 332 KIFKLCGSPSEEYWKKSKLPHAT---------IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (415)
Q Consensus 332 ~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~ 402 (415)
.+++..+.+....|......... ...................+.++.+||.+||..||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 99999999888777653211110 000000111112222234478899999999999999999999999999
Q ss_pred CCCCCCCCC
Q 014960 403 VSLYMXXXX 411 (415)
Q Consensus 403 ~f~~~~~~~ 411 (415)
||+.....+
T Consensus 336 ~f~~~~~~~ 344 (405)
T 3rgf_A 336 YFLEDPLPT 344 (405)
T ss_dssp GGTSSSCCC
T ss_pred hhccCCCCc
Confidence 998865543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=395.51 Aligned_cols=287 Identities=27% Similarity=0.485 Sum_probs=222.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999999999999999876555666778889999999999999999999987642 13
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..|+||||+.+++...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 789999999998776664 35899999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.|.......
T Consensus 181 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 F--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred c--ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 2345678999999999986 578999999999999999999999999999999999999988888777665421100
Q ss_pred CC-----cCCCcchhhhhhhh--------hcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 353 AT-----IFKPQQSYKRCIAE--------TFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 353 ~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.. .......+...... .....+.++++||.+||..||.+|||++|+|+||||+...+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 00 00000000000000 00111456899999999999999999999999999986544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=408.58 Aligned_cols=263 Identities=29% Similarity=0.444 Sum_probs=225.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh-----------HHHHHHHHHHHHHHhCCCCceeeeeee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP-----------ESVRFMAREILILRRLDHPNVVKLEGL 185 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~l~~~ 185 (415)
.++|.++++||+|+||.||+|++..+++.||+|++....... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999999999999999998654321 335678899999999999999999999
Q ss_pred EeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---cEEEEe
Q 014960 186 VTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIAD 262 (415)
Q Consensus 186 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~D 262 (415)
+.+ ...+|+||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 987 567999999999876655555556799999999999999999999999999999999999998876 699999
Q ss_pred eccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 263 FGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 263 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+.+....+..
T Consensus 193 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 193 FGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CTTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred CCCCEEcCCCC--ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 99998775442 3355679999999999864 5899999999999999999999999999999999988876555554
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
..| ..+++++++||.+||..||.+|||++++|+||||+.....
T Consensus 269 ~~~-------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 269 NDW-------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp HHH-------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred ccc-------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 444 4578889999999999999999999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=398.98 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=212.6
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
...++|.+.+.||+|+||.||+|++..+++.||+|++..... ..+....+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCE
Confidence 345789999999999999999999999999999999975321 11223568899999999999999999999987 457
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.|+||||++++++..+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999999987776665443 479999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+....+....+..
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~------------------ 222 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------------------ 222 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS------------------
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc------------------
Confidence 335567999999999998755458899999999999999999999976443211111000
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
........+++++.+||.+||..||.+|||++|+++||||+.
T Consensus 223 -----------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 223 -----------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -----------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -----------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 001112346788999999999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=383.12 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=226.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.+.|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 367999999999999999999999999999999998654321 235678899999999999999999999987 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC----cEEEEeeccccc
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASF 268 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DfG~a~~ 268 (415)
..|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 7999999998877766666666899999999999999999999999999999999999999888 799999999987
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...........
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 241 (321)
T 2a2a_A 169 IEDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF---- 241 (321)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH----
T ss_pred cCccc--cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh----
Confidence 65432 2345678999999999876 5789999999999999999999999999988888877766443333322
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
...++..+.+||.+||..||.+|||++++|+||||+.+.
T Consensus 242 ---------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 242 ---------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp ---------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ---------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 245778899999999999999999999999999998765
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=410.51 Aligned_cols=265 Identities=28% Similarity=0.464 Sum_probs=225.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.++++++||||+++++++.+ ...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 367999999999999999999999999999999997543323345678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc---CCCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999876665555556899999999999999999999999999999999999995 45679999999998765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+....|
T Consensus 179 --~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 246 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW-------- 246 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG--------
T ss_pred --ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc--------
Confidence 2355679999999999875 5899999999999999999999999999999998888775544433333
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
..+++++++||.+||..||.+|||+.++|+||||+......+
T Consensus 247 -----------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~ 288 (486)
T 3mwu_A 247 -----------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP 288 (486)
T ss_dssp -----------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCC
T ss_pred -----------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCc
Confidence 347888999999999999999999999999999988765543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=389.59 Aligned_cols=279 Identities=23% Similarity=0.351 Sum_probs=225.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-----CCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-----HPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~l~~~~~~~~~ 191 (415)
.++|.++++||+|+||.||+|++..+++.||||++.. .......+..|+.+++.+. |+||+++++++.. .
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--Y 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--T
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--C
Confidence 4689999999999999999999999999999999873 2445567788999999996 9999999999987 4
Q ss_pred CeEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC----------------
Q 014960 192 CSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---------------- 254 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---------------- 254 (415)
...|+||||+++++...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 679999999966666655433 346999999999999999999999999999999999999975
Q ss_pred ---------CCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Q 014960 255 ---------EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325 (415)
Q Consensus 255 ---------~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~ 325 (415)
++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 788999999999865432 245678999999999986 579999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcch-----------------hhhhhhhhcCCCCCChHHHHHHhcccC
Q 014960 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQS-----------------YKRCIAETFKDFPPSSLPLIETLLAID 388 (415)
Q Consensus 326 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~L~~d 388 (415)
..+.+..+....+.++...+................ ...+........++.+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 999999999988888776655432211100000000 000011111123456789999999999
Q ss_pred CCCCCCHHHHhcCCCCC
Q 014960 389 PAERQTATAALRSEVSL 405 (415)
Q Consensus 389 P~~R~t~~~~L~h~~f~ 405 (415)
|.+|||++|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=409.87 Aligned_cols=260 Identities=30% Similarity=0.493 Sum_probs=220.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..++..||+|++.+..........+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 357999999999999999999999999999999998765444445678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC---CcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++.......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999987666555555679999999999999999999999999999999999999764 459999999998765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+.+....+....|
T Consensus 194 --~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 261 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW-------- 261 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG--------
T ss_pred --cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc--------
Confidence 3455679999999998864 6899999999999999999999999999999999888776554443333
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
..+++++++||.+||..||.+|||+.++|+||||+..
T Consensus 262 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 262 -----------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred -----------------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 4578889999999999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=391.65 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=214.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.... ..+|++++.++ +||||+++++++.+ ...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEE
Confidence 46799999999999999999999999999999999865432 34588888887 79999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-C---cEEEEeeccccccCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-G---ILTIADFGLASFFDP 271 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~---~vkl~DfG~a~~~~~ 271 (415)
+||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||+..+ + .+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999987666666566689999999999999999999999999999999999998543 3 599999999987654
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG---RTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+ .+..+++..+...........
T Consensus 173 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~---- 246 (342)
T 2qr7_A 173 EN-GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY---- 246 (342)
T ss_dssp TT-CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT----
T ss_pred CC-CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc----
Confidence 32 23345678999999999875 5688999999999999999999999986 345566666655332222222
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
+..+++++++||.+||..||++|||++++|+||||.+...
T Consensus 247 ---------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 247 ---------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp ---------------------TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred ---------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 2457888999999999999999999999999999976543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=378.46 Aligned_cols=265 Identities=29% Similarity=0.417 Sum_probs=228.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEE
Confidence 3579999999999999999999999999999999976532 234678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE---cCCCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+.........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999887666655555679999999999999999999999999999999999999 778899999999998765443
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.+....++...|
T Consensus 164 --~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-------- 231 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--------
T ss_pred --chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--------
Confidence 2345678999999999865 4899999999999999999999999999988888888776555544433
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXXX 414 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~~ 414 (415)
..+++++.+||.+||+.||.+|||+.++|+||||+.....+++.
T Consensus 232 -----------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~ 275 (277)
T 3f3z_A 232 -----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275 (277)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCSGGG
T ss_pred -----------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccccccc
Confidence 35788899999999999999999999999999998766555543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=386.25 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=197.6
Q ss_pred CCceee---eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCe
Q 014960 118 DTFEKL---DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~---~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~ 193 (415)
++|++. +.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCE
Confidence 346654 7899999999999999999999999999743 3456778999999997 9999999999987 567
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---cEEEEeeccccccC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLASFFD 270 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DfG~a~~~~ 270 (415)
.|+||||+.++.+...+.....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999877766666667899999999999999999999999999999999999998766 79999999998765
Q ss_pred CCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCCHH
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE-------VEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~ 343 (415)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+. .+.+..+.+....+...
T Consensus 161 ~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 161 PDN-QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCC-CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 432 23345678999999999876 6789999999999999999999999987543 34444443333222222
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
.| ..+++++++||.+||..||.+|||++++|+||||+.......
T Consensus 239 ~~-------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~ 282 (325)
T 3kn6_A 239 AW-------------------------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282 (325)
T ss_dssp HH-------------------------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred cc-------------------------cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCC
Confidence 22 357888999999999999999999999999999998655443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=388.43 Aligned_cols=291 Identities=29% Similarity=0.457 Sum_probs=227.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC-----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM-----S 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~ 191 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++..+... ...+.+++..+..++|+||+++++++.... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 47899999999999999999999999999999998755322 234556888888999999999999986522 2
Q ss_pred CeEEEEEEecccChhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCeeccCCCCCEEEcC-CCcEEEEeecc
Q 014960 192 CSLYLVFKYMEHDLAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCH--NQHVLHRDIKGSNLLIDN-EGILTIADFGL 265 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NILl~~-~~~vkl~DfG~ 265 (415)
.++++||||+.+++...+ ......+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 348999999999866543 345668999999999999999999999 999999999999999997 89999999999
Q ss_pred ccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
+....... ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.|
T Consensus 179 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98765433 2345578999999999877666899999999999999999999999999999999999999999998887
Q ss_pred hhCCCCCCCc---CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 346 KKSKLPHATI---FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 346 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
.......... ......+...........++++++||.+||+.||.+|||+.|+|+||||+.+.+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 7643322211 111111222223333345678999999999999999999999999999999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=382.15 Aligned_cols=283 Identities=28% Similarity=0.492 Sum_probs=223.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++... ..+.+.+|+.+++.++ |+||+++++++........+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47899999999999999999999999999999998743 2356889999999997 99999999999876667899
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHK 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~~ 274 (415)
+||||+.++.+..+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999999877766653 489999999999999999999999999999999999999777 89999999998765443
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHHH-hhCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMP-GRTEVEQLHKIFKLCGSPSEEYW-KKSKLPH 352 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~ 352 (415)
......+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+.+..+.+....+ .......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 23456789999999998775678999999999999999999999985 45666667766666554332211 1111110
Q ss_pred CCc------CCCcchhhhh-hhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 353 ATI------FKPQQSYKRC-IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 353 ~~~------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
... ......+... .......+++++.+||.+||+.||.+|||++|+|+||||+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 000 0000000000 11112237888999999999999999999999999999998864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=405.80 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=214.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence 4689999999999999999999999999999999975421 23344567789999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
+||||+.++.+...+.....+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||++.......
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 999999998777766666689999999999999999999998 999999999999999999999999999997643322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|+|||++.+ ..++.++|||||||+||||++|.+||.+.+..+....+.......
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-------------- 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 23455789999999999876 678999999999999999999999999998888887776532211
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
...+++++.+||.+||..||.+|| |++++|+||||+.++
T Consensus 369 ---------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 369 ---------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 134678899999999999999999 999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=391.85 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=213.9
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEe
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~ 200 (415)
...+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeC
Confidence 33678999999999999999999999999998643 3456778899999999999999999999987 5679999999
Q ss_pred cccChh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE--cCCCcEEEEeeccccccCCCCCCCc
Q 014960 201 MEHDLA-GLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI--DNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 201 ~~~~l~-~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl--~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
+.++.+ ..+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....... ..
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 987654 4444444579999999999999999999999999999999999999 566789999999998875443 23
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 246 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 309 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED--------------- 309 (373)
T ss_dssp CCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS---------------
T ss_pred ccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh---------------
Confidence 44578999999999875 67899999999999999999999999999998888888775433222
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.....+++++++||.+||..||.+|||++++|+||||++.+
T Consensus 310 ----------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 310 ----------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp ----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred ----------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 22346788999999999999999999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=386.73 Aligned_cols=286 Identities=34% Similarity=0.557 Sum_probs=232.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC----Ce
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS----CS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~~ 193 (415)
++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 67999999999999999999999999999999998765556667788899999999999999999999876422 23
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+||||+.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 69999999986554432 25899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+..+.+........
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 24457899999999987656789999999999999999999999999999999999999998888776654221100
Q ss_pred C--cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 354 T--IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 354 ~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
. ...........+......++.++.+||.+||+.||.+|||++++|+||||+.+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 0 00000000011223334678889999999999999999999999999999988654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=388.07 Aligned_cols=291 Identities=29% Similarity=0.439 Sum_probs=229.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC---------hHHHHHHHHHHHHHHhCCCCceeeeeeeEe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---------PESVRFMAREILILRRLDHPNVVKLEGLVT 187 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 187 (415)
.++|.+.+.||+|+||.||+|.+.. |..||||++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4689999999999999999999754 899999998653321 233477889999999999999999999985
Q ss_pred e---cCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 188 S---RMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 188 ~---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
. .....+|+||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 5 2234789999999999988888777789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 265 LASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 265 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
++....... ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....
T Consensus 180 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 997654332 234457899999999988756789999999999999999999999999999999999999998888765
Q ss_pred HhhCCCCCCCc---CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 345 WKKSKLPHATI---FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 345 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
+.......... .................+++.+.+||.+||+.||.+|||++++|+||||+.+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 54322110000 0000000111233445677889999999999999999999999999999988543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=403.54 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=222.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|.+.+.||+|+||.||+|++..+|+.||||++..... ..+....+.+|+.+++.++||||+++++++.. ...+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDIF 92 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence 5789999999999999999999999999999999975422 12335678899999999999999999999987 46799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 999999887777777777789999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+......++.......
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------- 235 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT--------------- 235 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC---------------
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC---------------
Confidence 23456899999999999875555889999999999999999999999988888777775432111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
...++.++.+||.+||..||.+|||++++++||||+.
T Consensus 236 --------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 236 --------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp --------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred --------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 1246778999999999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=386.40 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=203.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.++++++|+||+++++++.. ....|+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 467999999999999999999999999999999997542 33567789999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---CCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999998777776666678999999999999999999999999999999999999975 889999999999876433
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+ .+..+.+.......
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~---------- 272 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS---------- 272 (349)
T ss_dssp ---------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT----------
T ss_pred -cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC----------
Confidence 22345678999999999886 568999999999999999999999998766554 44444433222111
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....++.++.+||.+||..||++|||+.++|+||||.....
T Consensus 273 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 273 ---------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp ---------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred ---------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 122457888999999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=383.49 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=207.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.++||+|+||.||+|++..+|+.||||++...............|+..+.++ +|+||+++++++.+ ...+|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 579999999999999999999999999999999876555444445555566666555 89999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+++++...+......+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++....... .
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--A 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--C
Confidence 99999988887776666679999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+.+. ...
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~--~~~--------------- 270 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQG--YLP--------------- 270 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTT--CCC---------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhcc--CCC---------------
Confidence 344568999999999875 689999999999999999999877755322 2222111 111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
......+++++.+||.+||+.||++|||++++|+||||++
T Consensus 271 ----------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 ----------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ----------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1122457888999999999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=406.06 Aligned_cols=261 Identities=29% Similarity=0.466 Sum_probs=227.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.++++++||||+++++++.+ ....|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 36799999999999999999999999999999999876542 3456778899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE---cCCCcEEEEeeccccccCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DfG~a~~~~~~ 272 (415)
+||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999987776666566689999999999999999999999999999999999999 46789999999999877644
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+.+....+....|
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------- 251 (484)
T 3nyv_A 183 K--KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW------- 251 (484)
T ss_dssp C--SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG-------
T ss_pred c--ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc-------
Confidence 2 3355679999999999875 5899999999999999999999999999999999888775544433333
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
..+++++++||.+||..||.+|||+.++|+||||+...
T Consensus 252 ------------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 252 ------------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ------------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 34788899999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=392.70 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=200.9
Q ss_pred CCCceee-eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHH-hCCCCceeeeeeeEee--cCCC
Q 014960 117 ADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILR-RLDHPNVVKLEGLVTS--RMSC 192 (415)
Q Consensus 117 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~--~~~~ 192 (415)
.++|.+. +.||+|+||.||+|++..+|+.||||++... ..+.+|+.++. ..+|+||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4678887 6899999999999999999999999998632 34667888875 4589999999998864 2245
Q ss_pred eEEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---CCcEEEEeecccc
Q 014960 193 SLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLAS 267 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DfG~a~ 267 (415)
.+|+||||+.++.+..++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 68999999988655544433 246999999999999999999999999999999999999998 7889999999998
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCCHH
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE----QLHKIFKLCGSPSEE 343 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~ 343 (415)
...... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+... ....+.......+.
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~- 288 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN- 288 (400)
T ss_dssp ECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT-
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC-
Confidence 765332 2345678999999999875 679999999999999999999999998755322 22333322111111
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
..+..++.++++||.+||..||.+|||++++|+||||....
T Consensus 289 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 289 ------------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 11245788899999999999999999999999999997644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=379.14 Aligned_cols=290 Identities=37% Similarity=0.605 Sum_probs=234.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeeeeeEee---c
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-LTGQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTS---R 189 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~---~ 189 (415)
.++|++.+.||+|+||.||+|++. .+|+.||+|++............+.+|+.+++.+ +||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468999999999999999999985 6789999999875433222223455677777666 89999999999862 1
Q ss_pred CCCeEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 190 MSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
.....++||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 24679999999998766655433 34589999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....|...
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 6432 22345678999999999876 56899999999999999999999999999999999999999888888777653
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.......+.... ...+......++..+.+||.+||..||.+|||+.++|+||||+++....
T Consensus 247 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 247 VALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp CSSCGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred cccchhhhcccC--cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 322221111110 1113344567888899999999999999999999999999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=378.06 Aligned_cols=267 Identities=24% Similarity=0.307 Sum_probs=208.7
Q ss_pred CCCCCceee-eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCC
Q 014960 115 RRADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 115 ~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 192 (415)
+..+.|++. +.||+|+||.||+|++..+++.||||++.... ......+.+|+.++.++ +||||+++++++.+ ..
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~ 84 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--ED 84 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TT
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CC
Confidence 345789985 78999999999999999999999999997653 23446788999999985 79999999999987 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc---EEEEeecccccc
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLASFF 269 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DfG~a~~~ 269 (415)
.+|+||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 79999999997766666555567999999999999999999999999999999999999998776 999999998765
Q ss_pred CCCCC------CCcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh-------------
Q 014960 270 DPNHK------QPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTE------------- 326 (415)
Q Consensus 270 ~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~------------- 326 (415)
..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11234468999999999863 13578899999999999999999999987542
Q ss_pred --HHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 327 --VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 327 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
......+.+.....+.. ....++.++++||.+||..||.+|||++|+|+||||
T Consensus 245 ~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDK-------------------------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred HHHHHHHHHhccCcccCch-------------------------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 22334443332222222 224578889999999999999999999999999999
Q ss_pred CCCCCC
Q 014960 405 LYMXXX 410 (415)
Q Consensus 405 ~~~~~~ 410 (415)
+.....
T Consensus 300 ~~~~~~ 305 (316)
T 2ac3_A 300 QGCAPE 305 (316)
T ss_dssp C-----
T ss_pred cCCCCc
Confidence 986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=391.48 Aligned_cols=260 Identities=26% Similarity=0.361 Sum_probs=200.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..+++.||||++...... .+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEE
Confidence 46899999999999999999999999999999999865432 2457789999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc--EEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--LTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++......
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 9999988776666655567999999999999999999999999999999999999987765 999999999754322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.......||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.+....... .
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~------~----- 240 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY------S----- 240 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC------C-----
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC------C-----
Confidence 22345578999999999987444445599999999999999999999875543222222221110000 0
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
......+++++++||.+||..||.+|||+.++|+||||..
T Consensus 241 ------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 241 ------------IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp ------------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred ------------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 0011246788999999999999999999999999999944
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=387.70 Aligned_cols=268 Identities=25% Similarity=0.365 Sum_probs=219.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCC---CChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN---LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 367999999999999999999999999999999997542 134456788999999999999999999999987 567
Q ss_pred EEEEEEecccChhhhhcCC----------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 014960 194 LYLVFKYMEHDLAGLAASP----------------------------------------TIKFTQAQVKCYMHQLLSGLE 233 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~----------------------------------------~~~~~~~~~~~i~~qi~~~L~ 233 (415)
.|+||||+.++.+...+.. ...+++..++.++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999988766655421 112468889999999999999
Q ss_pred HHHhCCCeeccCCCCCEEEcCCC--cEEEEeeccccccCCCC---CCCcccccccCccCCcccccCC-cCCCchhcHHHH
Q 014960 234 HCHNQHVLHRDIKGSNLLIDNEG--ILTIADFGLASFFDPNH---KQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSA 307 (415)
Q Consensus 234 ~LH~~~ivHrDlkp~NILl~~~~--~vkl~DfG~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSl 307 (415)
|||++||+||||||+|||++.++ .+||+|||++..+.... ........||+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 89999999998653321 1123456789999999998642 568899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhccc
Q 014960 308 GCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAI 387 (415)
Q Consensus 308 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 387 (415)
||++|+|++|..||.+.+..+....+.+....+.... ...+++++.+||.+||+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN-------------------------YNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG-------------------------GGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc-------------------------cccCCHHHHHHHHHHcCC
Confidence 9999999999999999998888888876543332221 234678899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 388 DPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 388 dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
||.+|||+.++|+||||+++.+..
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred ChhHCCCHHHHhcChhhccChHhh
Confidence 999999999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=384.20 Aligned_cols=259 Identities=26% Similarity=0.450 Sum_probs=221.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.+.|.+++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++++++||||+++++++.. ....|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEE
Confidence 3569999999999999999999999999999999986643 34455678899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 99999998877776655668999999999999999999999999999999999999999999999999999776432
Q ss_pred CcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+.+..+.+..+.+.....
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~------------- 272 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------------- 272 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------------
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Confidence 34578999999999852 3568999999999999999999999999888777766665432110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....+++.+.+||.+||+.||.+|||++++|+||||.....
T Consensus 273 --------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 273 --------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred --------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 011246778899999999999999999999999999976543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=416.74 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=224.6
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCe
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 193 (415)
..++|++++.||+|+||.||+|++..+++.||||++.+... .....+.+..|+.+|..+ +|++|+++++++.+ ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 35789999999999999999999999999999999985421 223345677899999987 79999999999887 567
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+||||||+.++.+..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999988777777666689999999999999999999999999999999999999999999999999998643332
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+++..|.+.....
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 561 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------- 561 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC-------------
T ss_pred -cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence 23456789999999999976 679999999999999999999999999999988888886532211
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA-----TAALRSEVSLYMX 408 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~L~h~~f~~~~ 408 (415)
...++.++++||++||+.||.+|+++ +++++||||+.++
T Consensus 562 ----------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 562 ----------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp ----------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred ----------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 13578889999999999999999997 9999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=379.10 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=221.0
Q ss_pred CCceee-eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 118 DTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 118 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
+.|.+. +.||+|+||.||+|++..+++.||+|++............+.+|+.+++.+ .||||+++++++.. ....|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~ 105 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEII 105 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeEE
Confidence 567777 889999999999999999999999999987655555567788999999999 56999999999987 56799
Q ss_pred EEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---CCcEEEEeeccccccC
Q 014960 196 LVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFD 270 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DfG~a~~~~ 270 (415)
+||||+.++.+..+... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 99999998766655533 457999999999999999999999999999999999999988 7899999999998765
Q ss_pred CCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+........
T Consensus 186 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------- 255 (327)
T 3lm5_A 186 HAC--ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE------- 255 (327)
T ss_dssp ----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------
T ss_pred Ccc--ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch-------
Confidence 432 2344678999999999876 578999999999999999999999999999888888877654433322
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
....++..+.+||.+||..||.+|||++++|+||||+.++..
T Consensus 256 ------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 256 ------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp ------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 224577889999999999999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=375.45 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=219.4
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48888899999999999999999999999999986542 334568899999999999999999999987 45799999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
||+.++.+..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 122 e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 199 (321)
T ss_dssp CCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccc
Confidence 999998777776543 799999999999999999999999999999999999999999999999999987654322 234
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
...||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 200 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 261 (321)
T 2c30_A 200 SLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL----------------- 261 (321)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-----------------
T ss_pred cccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-----------------
Confidence 5678999999999876 6789999999999999999999999999888777766654321100
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....+++++.+||.+||..||.+|||++++|+||||.....
T Consensus 262 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 262 ---------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred ---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCC
Confidence 011246778899999999999999999999999999986553
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=374.18 Aligned_cols=293 Identities=32% Similarity=0.541 Sum_probs=225.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec-------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------- 189 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 189 (415)
.++|++++.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 46899999999999999999999999999999999754 355667888999999999999999999987432
Q ss_pred -----CCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc-CCCcEEEEee
Q 014960 190 -----MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADF 263 (415)
Q Consensus 190 -----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~Df 263 (415)
.....|+||||+.+++...+. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 236789999999986665543 24789999999999999999999999999999999999997 5679999999
Q ss_pred ccccccCCCCC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 014960 264 GLASFFDPNHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS 341 (415)
Q Consensus 264 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 341 (415)
|++........ .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99987643221 2234456799999999987656789999999999999999999999999999999999988777666
Q ss_pred HHHHhhCCCCCCCcCCC-cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 014960 342 EEYWKKSKLPHATIFKP-QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXX 413 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~ 413 (415)
.+.+............. ............+.++.++++||.+||+.||.+|||++++|+||||+.+......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~ 318 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence 55544311100000000 0000011233445788999999999999999999999999999999988766543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=391.88 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=207.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL------EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 190 (415)
.++|.+.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+|++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4789999999999999999999999999999999976432 12223357889999999999999999999864
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---cEEEEeecccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTIADFGLAS 267 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DfG~a~ 267 (415)
...|+||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 34899999999887777777777899999999999999999999999999999999999997644 59999999998
Q ss_pred ccCCCCCCCcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHH
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEY 344 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 344 (415)
..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+..... ....+.........
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~-- 366 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP-- 366 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH--
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc--
Confidence 76543 22345678999999999853 3568899999999999999999999998754433 33333332222222
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....+++++.+||.+||..||.+|||++++|+||||++.
T Consensus 367 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 367 -----------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp -----------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred -----------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 2234578889999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=382.09 Aligned_cols=268 Identities=22% Similarity=0.308 Sum_probs=218.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC--Ce
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS--CS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--~~ 193 (415)
.++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4689999999999999999999999999999999987543 34556788899999999999999999999866422 24
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 59999999887666666555679999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 274 K--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 274 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......+..
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 240 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 240 (311)
T ss_dssp -----------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH---------
T ss_pred cccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc---------
Confidence 2 12234568999999999986 57899999999999999999999999998888777766654333221
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.....++.++.+||.+||+.||.+||++.++|.|+|++..+..
T Consensus 241 ----------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp ----------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred ----------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 2234688889999999999999999999999999999865543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=409.51 Aligned_cols=259 Identities=26% Similarity=0.407 Sum_probs=216.4
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..++|.+.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEE
Confidence 35789999999999999999999999999999999975422 12234567889999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 195 YLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
|+||||+.++.+..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999988766655433 234999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCHHHHhhC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE----VEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+. .++...+.....
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~---------- 406 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE---------- 406 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC----------
T ss_pred c--cccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc----------
Confidence 2 2345689999999999986 5689999999999999999999999987542 333333332110
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
.....++.++++||.+||+.||.+|| +++|+++||||+.++
T Consensus 407 -------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 407 -------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred -------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 11135788899999999999999999 899999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=380.53 Aligned_cols=292 Identities=30% Similarity=0.505 Sum_probs=230.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec---CCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR---MSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~---~~~~ 193 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++|+||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 468999999999999999999999999999999996432 345556788999999999999999999987652 1257
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.|+||||+.+++...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999999876665543 368999999999999999999999999999999999999999999999999998765322
Q ss_pred CC---------CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 274 KQ---------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 274 ~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
.. ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 122357899999999887656789999999999999999999999999999999988888877765321
Q ss_pred HhhCCCCCC---CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 345 WKKSKLPHA---TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 345 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
......... ...................++.++.+||.+||..||.+|||++++|+||||+.+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 110000000 0000000000112334457888999999999999999999999999999999887654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=371.84 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=210.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++..++..||+|++..... ....+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEE
Confidence 4679999999999999999999999999999999986542 2335678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE---cCCCcEEEEeecccccc
Q 014960 197 VFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFF 269 (415)
Q Consensus 197 v~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DfG~a~~~ 269 (415)
||||+.++.+...+. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999998865444332 23579999999999999999999999999999999999999 44578999999999776
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 245 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-------- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred CCcc--cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc--------
Confidence 5432 2345578999999998864 689999999999999999999999999887776665544221111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.....+++++.+||.+||..||.+|||++|+|+||||++
T Consensus 246 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 ------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 112346778999999999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=381.80 Aligned_cols=260 Identities=29% Similarity=0.431 Sum_probs=223.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC--C----hHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--E----PESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~----~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
++|.+.+.||+|+||.||+|++..+|+.||||++..... . ....+.+.+|+.+++++ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 579999999999999999999999999999999986542 1 12245678899999999 79999999999887
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
....|+||||+.++.+..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 56799999999987766666555679999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCCCcccccccCccCCcccccC-----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
... ......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+......+....|
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 443 2345678999999998853 235889999999999999999999999998888888777765544443333
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
..++.++.+||.+||..||.+|||++++|+||||+.
T Consensus 330 -------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 -------------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp -------------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 356788999999999999999999999999999973
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=373.73 Aligned_cols=259 Identities=30% Similarity=0.429 Sum_probs=217.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..++..||+|++..... .......+.+|+.+++.++||||+++++++.+ ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 85 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 85 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEEE
Confidence 5789999999999999999999999999999999875322 12234568899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 999999987666665555679999999999999999999999999999999999999999999999999986554322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+..+....+.......
T Consensus 164 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 226 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--------------- 226 (279)
T ss_dssp -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------------
T ss_pred -ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC---------------
Confidence 244578999999999876 668899999999999999999999999988888877776533221
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
...+++++.+||.+||..||.+|||++++|+||||+.....
T Consensus 227 --------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 227 --------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp --------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred --------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 12367778999999999999999999999999999875543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=376.13 Aligned_cols=259 Identities=23% Similarity=0.366 Sum_probs=204.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 190 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 367999999999999999999999999999999998654 3345577889999999999999999999885532
Q ss_pred -------------------------------------------------CCeEEEEEEecccChhhhhcCCCC---CCCH
Q 014960 191 -------------------------------------------------SCSLYLVFKYMEHDLAGLAASPTI---KFTQ 218 (415)
Q Consensus 191 -------------------------------------------------~~~~~lv~e~~~~~l~~~~~~~~~---~~~~ 218 (415)
..++|+||||+.++.+..++.... ...+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 124899999999876666554432 3566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-----------CCcccccccCccC
Q 014960 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-----------QPMTSRVVTLWYR 287 (415)
Q Consensus 219 ~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-----------~~~~~~~gt~~y~ 287 (415)
..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++........ .......||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 77899999999999999999999999999999999999999999999987754421 1223457899999
Q ss_pred CcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhh
Q 014960 288 PPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIA 367 (415)
Q Consensus 288 aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (415)
|||++.+ ..++.++|||||||++|+|++|..|+. +....+..........
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~------------------------ 293 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL------------------------ 293 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH------------------------
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc------------------------
Confidence 9999886 578999999999999999999877642 1111111111111111
Q ss_pred hhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 368 ETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 368 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....++++.+||.+||+.||.+|||++|+|+||||+++
T Consensus 294 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 294 -LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp -HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred -ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 111234567889999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=373.51 Aligned_cols=267 Identities=26% Similarity=0.380 Sum_probs=218.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ....|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 4689999999999999999999999999999999976543 45566789999999999999999999999887 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999998777766666668999999999999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+...+........ .
T Consensus 168 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~------------- 232 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-V------------- 232 (294)
T ss_dssp -------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC-H-------------
T ss_pred ccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC-c-------------
Confidence 3445678999999999986 568999999999999999999999999988776655544321111 0
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
.......+++.+.++|.+||..||.+||+..+.|.+.|...+...
T Consensus 233 ----------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 ----------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ----------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ----------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 122345688899999999999999999977777777776665543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=383.06 Aligned_cols=283 Identities=25% Similarity=0.411 Sum_probs=223.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CC-----ceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HP-----NVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++ |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 47899999999999999999999999999999999743 344567778999988885 44 49999999887
Q ss_pred CCeEEEEEEecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCCeeccCCCCCEEEc--CCCcEEEEeecc
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCH--NQHVLHRDIKGSNLLID--NEGILTIADFGL 265 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NILl~--~~~~vkl~DfG~ 265 (415)
....|+||||+++++...+.... ..+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 46799999999987776665443 46999999999999999999999 57999999999999995 477899999999
Q ss_pred ccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 266 ASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 266 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++...+
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc----cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876532 245678999999999986 56899999999999999999999999999999999999999988887766
Q ss_pred hhCCCC--------CCC-----------cCCCc--chhhhhhhhh-----cCCC---------CCChHHHHHHhcccCCC
Q 014960 346 KKSKLP--------HAT-----------IFKPQ--QSYKRCIAET-----FKDF---------PPSSLPLIETLLAIDPA 390 (415)
Q Consensus 346 ~~~~~~--------~~~-----------~~~~~--~~~~~~~~~~-----~~~~---------~~~~~~li~~~L~~dP~ 390 (415)
...... ... .+... ..+...+... .... .+++++||.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 542210 000 00000 0000000000 0000 02578999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCC
Q 014960 391 ERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 391 ~R~t~~~~L~h~~f~~~~~ 409 (415)
+|||++|+|+||||+...+
T Consensus 363 ~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp TSCCHHHHTTSGGGCC---
T ss_pred hCCCHHHHhcCcccccCCC
Confidence 9999999999999988654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=368.80 Aligned_cols=268 Identities=24% Similarity=0.384 Sum_probs=224.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC---C----hHHHHHHHHHHHHHHhCC-CCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---E----PESVRFMAREILILRRLD-HPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~ 188 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++..... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999986542 1 223456788999999995 9999999999977
Q ss_pred cCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
....|+||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 567999999999876666665556799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCccCCccccc-----CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLL-----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 343 (415)
..... ......||+.|+|||++. ....++.++||||||+++|+|++|..||.+.+..+....+..........
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 174 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 65432 234567899999999885 23467899999999999999999999999988888777776643332211
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXXX 413 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~~ 413 (415)
....++.++.+||.+||..||.+|||++++|+||||++......+
T Consensus 252 -------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 252 -------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp -------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred -------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence 123477889999999999999999999999999999988766544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=379.51 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=224.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..++|.+.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.+ ....
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeE
Confidence 35789999999999999999999999999999999986543 45566788899999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 9999999987766666555689999999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.+....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------- 259 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------------- 259 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------------
T ss_pred ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 22344578999999999876 56899999999999999999999999988877766665442211
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
....++.++.+||.+||..||.+|||++++|+|+||.....
T Consensus 260 --------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 260 --------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred --------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 11246677899999999999999999999999999987544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=399.98 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=217.7
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..++|.+++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 260 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDL 260 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEE
Confidence 35789999999999999999999999999999999975432 12334567889999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 195 YLVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
|+||||+.++.+..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999998766554432 3469999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCCHHHHh
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT----EVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 346 (415)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+ ..++...+......
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~------- 411 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT------- 411 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC-------
T ss_pred CCCc-ccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC-------
Confidence 4332 2344589999999999986 679999999999999999999999998753 34445444432111
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
....++.++++||.+||+.||.+||+ ++++++||||+.++
T Consensus 412 ----------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 412 ----------------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred ----------------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 11357888999999999999999996 58999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=366.59 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=216.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec--CCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~~ 194 (415)
.+.|.+.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+++.++||||+++++++... ....+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4578999999999999999999999999999999987766677788899999999999999999999988653 24568
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEc-CCCcEEEEeeccccccCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLID-NEGILTIADFGLASFFDP 271 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~-~~~~vkl~DfG~a~~~~~ 271 (415)
|+||||+.++.+..++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999998777776666567999999999999999999999999 99999999999998 788999999999976543
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..................+
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 248 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------- 248 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred c---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-----------
Confidence 2 2345578999999998864 58999999999999999999999998855544443332211111
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.......++++.+||.+||..||.+|||++++|+||||++
T Consensus 249 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ---------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0112345677899999999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=363.67 Aligned_cols=264 Identities=27% Similarity=0.380 Sum_probs=217.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++|+||+++++++.+ ....|+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 579999999999999999999999999999999975533 2345678899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-CC
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-QP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-~~ 276 (415)
|||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999877766766667899999999999999999999999999999999999999999999999999976543221 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....||+.|+|||++.+...++.++||||||+++|+|++|..||.+..... ....+.....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 226 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----------------- 226 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-----------------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-----------------
Confidence 3445789999999998764445789999999999999999999998765432 2222211100
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.......++.++.+||.+||..||.+|||++++++||||+......
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 227 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred ----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 0011234678899999999999999999999999999998765543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=368.24 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=220.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
++|++.+.||+|+||.||+|++..+++.||+|++....... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 57999999999999999999999999999999998654321 235678899999999999999999999987 567
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC----cEEEEeecccccc
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASFF 269 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DfG~a~~~ 269 (415)
.|+||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999998776666665556799999999999999999999999999999999999998877 8999999999876
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+..........
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 233 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE------ 233 (283)
T ss_dssp C----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH------
T ss_pred cCCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch------
Confidence 5432 2344578999999999875 568999999999999999999999999988888777765543333222
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
....++..+.+||.+||..||.+|||+.++|+||||+.++.
T Consensus 234 -------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 234 -------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp -------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred -------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 22457788999999999999999999999999999987643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=382.06 Aligned_cols=252 Identities=20% Similarity=0.303 Sum_probs=211.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhCCCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE------SVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++..+++.||||++........ ....+.+|+.++++++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 4689999999999999999999999999999999987643211 33456779999999999999999999987
Q ss_pred CCeEEEEEEecccC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 191 SCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 191 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
...+++||||+..+ .+..+......+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 56799999998765 66666666668999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|..||..... ... .
T Consensus 181 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~-----------~-- 239 (335)
T 3dls_A 181 ERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE-----------A-- 239 (335)
T ss_dssp CTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT-----------T--
T ss_pred CCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh-----------h--
Confidence 5442 234567899999999998755458999999999999999999999965221 000 0
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.......+++++.+||.+||..||.+|||++++|+||||+..
T Consensus 240 ----------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 240 ----------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ----------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ----------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 001122467889999999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=371.64 Aligned_cols=259 Identities=28% Similarity=0.373 Sum_probs=218.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEE
Confidence 3579999999999999999999999999999999986432 233568899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE---cCCCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999886665555445579999999999999999999999999999999999999 77889999999998764332
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+....+...
T Consensus 163 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 229 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP---------- 229 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTT----------
T ss_pred --ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc----------
Confidence 2344578999999999876 678999999999999999999999999988888887776643322211
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
....++.++.+||.+||..||.+|||++++|+||||+...
T Consensus 230 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 230 ---------------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ---------------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ---------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1245788899999999999999999999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=386.94 Aligned_cols=282 Identities=23% Similarity=0.355 Sum_probs=225.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--------CCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD--------HPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~l~~~~~~ 188 (415)
.++|++.++||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+. |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 36899999999999999999999999999999999743 455677889999999985 7889999998863
Q ss_pred c--CCCeEEEEEEecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCC--------
Q 014960 189 R--MSCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEG-------- 256 (415)
Q Consensus 189 ~--~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~-------- 256 (415)
. ....+|+||||++++++..+.... ..+++..++.|+.||+.||+|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 2 246799999999998888776543 5799999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------cEEEEeeccccccCCCCCCCcccccccCccCCcccccCC
Q 014960 257 -----------------------------------------ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295 (415)
Q Consensus 257 -----------------------------------------~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 295 (415)
.+||+|||++...... .....||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~- 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG- 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT-
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC-
Confidence 7999999999876532 345578999999999986
Q ss_pred cCCCchhcHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcc---------
Q 014960 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQ--------- 360 (415)
Q Consensus 296 ~~~~~~sDvwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 360 (415)
..++.++|||||||+||+|++|.+||.+.+ ....+..+.+..+.++...+.........+.....
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 568999999999999999999999998755 56778888888888877766543322111100000
Q ss_pred -hhhhhhhhh---cCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 361 -SYKRCIAET---FKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 361 -~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.....+... ....+.++++||.+||+.||++|||++|+|+||||+.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000000010 1122345789999999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=369.75 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=201.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+|+.||+|++............+.++...++.++||||+++++++.+ ....|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEEE
Confidence 478999999999999999999999999999999997664444445556566666888899999999999987 456999
Q ss_pred EEEecccChhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 197 VFKYMEHDLAGLA---ASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 197 v~e~~~~~l~~~~---~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
||||+++++...+ ......+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 84 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred EEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 9999998764443 33556899999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCCcccc---cCCcCCCchhcHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 273 HKQPMTSRVVTLWYRPPELL---LGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~sDvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.. .....||+.|+|||++ .....++.++|||||||++|+|++|..||.. ......+..+.......
T Consensus 164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 233 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-------- 233 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--------
T ss_pred cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--------
Confidence 22 2334789999999996 2346789999999999999999999999986 34444444443321110
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....++.++.+||.+||+.||.+|||++++|+||||+..
T Consensus 234 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 -------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0113467789999999999999999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=368.02 Aligned_cols=263 Identities=26% Similarity=0.359 Sum_probs=224.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..++|.+.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.+ ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEE
Confidence 35789999999999999999999999999999999986543 45566788899999999999999999999987 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999999877666665556899999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+.+....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 233 (294)
T 2rku_A 171 -RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------------- 233 (294)
T ss_dssp -CBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------------
T ss_pred -ccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC---------------
Confidence 2344578999999999876 56899999999999999999999999988877666555332110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
....++..+.+||.+||..||++|||++++|+||||+.....+
T Consensus 234 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 234 --------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred --------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 1124667789999999999999999999999999998765543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=366.77 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=219.9
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
..++|++.+.||+|+||.||+|++..+++.||+|++..........+.+.+|+.++++++||||+++++++........|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 45789999999999999999999999999999999988766677778899999999999999999999988665567899
Q ss_pred EEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 196 LVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQH-----VLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
+||||+.++.+..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999998754444332 2345999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...+..+....+......
T Consensus 164 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------- 234 (279)
T 2w5a_A 164 RILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR------- 234 (279)
T ss_dssp HHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------
T ss_pred eeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-------
Confidence 8765332 11233568999999999876 56899999999999999999999999998877777666553211
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....++.++.+||.+||..||.+|||++++|+|+|+..-
T Consensus 235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 ---------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1113467889999999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=382.14 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=206.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--CCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD--HPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~~~ 194 (415)
.+.|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.++ |+||+++++++.. ...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 3569999999999999999999765 899999999887666777788999999999996 5999999999887 4579
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+|||+.++++...+. ....+++.+++.|+.||+.||+|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 132 ~lv~E~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEECCSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9999966555555444 344789999999999999999999999999999999999995 58999999999987654332
Q ss_pred C-CcccccccCccCCcccccC----------CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCH
Q 014960 275 Q-PMTSRVVTLWYRPPELLLG----------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSE 342 (415)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~~~~----------~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 342 (415)
. .....+||+.|+|||++.+ ...++.++|||||||+||+|++|.+||.+.... ..+..+.......
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~-- 287 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 287 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC--
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC--
Confidence 1 2345679999999999864 136889999999999999999999999875433 3333332211000
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
......+.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 288 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 -------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -------------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 00112356789999999999999999999999999997544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=371.91 Aligned_cols=261 Identities=26% Similarity=0.381 Sum_probs=210.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL------EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 190 (415)
.++|.+.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 3679999999999999999999999999999999975432 122334578899999999999999999998753
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc---EEEEeecccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLAS 267 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DfG~a~ 267 (415)
..|+||||+.++.+...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp --SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred --ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 38999999988666666666678999999999999999999999999999999999999987664 9999999998
Q ss_pred ccCCCCCCCcccccccCccCCccccc--CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHH
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 344 (415)
..... .......||+.|+|||++. +...++.++|||||||++|+|++|.+||...... .....+.........
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 241 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP-- 241 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH--
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc--
Confidence 76432 1223456899999999873 2456889999999999999999999999875443 233333332222211
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.....++.++.+||.+||..||.+|||++++|+||||+..
T Consensus 242 -----------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 242 -----------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp -----------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred -----------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 2234578889999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=367.32 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=191.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeE
Confidence 35789999999999999999999999999999999975321 11234678899999999999999999999987 5679
Q ss_pred EEEEEecccChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|+||||+.++.+..+ ......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999987555544 4444679999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...+..+....+...
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 227 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----------------- 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-----------------
T ss_pred C-cceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-----------------
Confidence 2 2234578999999999876 56889999999999999999999999876543333221100
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.......++.++.+||.+||..||.+|||++++|+||||....
T Consensus 228 ------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 228 ------------DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ------------ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 0001124677889999999999999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=367.97 Aligned_cols=257 Identities=28% Similarity=0.407 Sum_probs=217.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..++..||+|++...... ......+.+|+.+++.++|+||+++++++.+ ....|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEE
Confidence 57899999999999999999999999999999999753211 1224578899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 999999886555555444579999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....|++.|+|||++.+ ..++.++||||||+++|+|++|.+||...+..+....+......
T Consensus 169 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 230 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK---------------- 230 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----------------
T ss_pred -cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC----------------
Confidence 244578999999999886 56899999999999999999999999988877776666442111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
....++.++.+||.+||..||.+|||++++|+||||+...
T Consensus 231 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 231 -------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 1134677889999999999999999999999999997543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=364.90 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=210.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|.+.+.||+|+||.||+|++..+|+.||+|++..... ..+..+.+.+|+.+++.++|+||+++++++.. ....|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEE
Confidence 4789999999999999999999999999999999975321 12335578899999999999999999999887 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 999999886666665555579999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......+|+.|+|||++.+....+.++||||||+++|+|++|..||...+..+....+......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 229 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY---------------- 229 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc----------------
Confidence 2344578999999999887444578999999999999999999999988777776666442211
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
....++.++.+||.+||+.||.+|||++++|+||||+..
T Consensus 230 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 230 -------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 112456778999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=371.19 Aligned_cols=283 Identities=22% Similarity=0.364 Sum_probs=226.2
Q ss_pred CCCceeeeeeccCCceEEEEEEE-CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC------ceeeeeeeEeec
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP------NVVKLEGLVTSR 189 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~l~~~~~~~ 189 (415)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|+ +|+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-
Confidence 46899999999999999999998 568899999998643 34566788999999998655 59999999987
Q ss_pred CCCeEEEEEEecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC--------------
Q 014960 190 MSCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-------------- 254 (415)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-------------- 254 (415)
....|+||||+++++...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 89 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 -HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 56799999999777776655433 46899999999999999999999999999999999999987
Q ss_pred -----CCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH
Q 014960 255 -----EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329 (415)
Q Consensus 255 -----~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~ 329 (415)
++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999875432 244578999999999886 5789999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHhhCCCCCCC-----cCCCcchhhhhhhhhc----------CCCCCChHHHHHHhcccCCCCCCC
Q 014960 330 LHKIFKLCGSPSEEYWKKSKLPHAT-----IFKPQQSYKRCIAETF----------KDFPPSSLPLIETLLAIDPAERQT 394 (415)
Q Consensus 330 ~~~i~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~li~~~L~~dP~~R~t 394 (415)
...+.+..+..+...+......... ................ ...++++.+||.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 9999888888887766553321100 0000000000011111 112356789999999999999999
Q ss_pred HHHHhcCCCCCCCCC
Q 014960 395 ATAALRSEVSLYMXX 409 (415)
Q Consensus 395 ~~~~L~h~~f~~~~~ 409 (415)
++|+|+||||+.++.
T Consensus 323 ~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 323 LREALKHPFFDLLKK 337 (339)
T ss_dssp HHHHTTSGGGGGGGC
T ss_pred HHHHhcCHHHHHHhc
Confidence 999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=362.31 Aligned_cols=254 Identities=21% Similarity=0.266 Sum_probs=207.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++............+.+|+.++..+ +||||+++++++.+ ....|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 4689999999999999999999999999999999987655555667788899999999 99999999999987 56799
Q ss_pred EEEEecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC----------------
Q 014960 196 LVFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---------------- 255 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---------------- 255 (415)
+||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999988655554433 2568999999999999999999999999999999999999854
Q ss_pred ---CcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014960 256 ---GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332 (415)
Q Consensus 256 ---~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~ 332 (415)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+++..... ...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~ 239 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE 239 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH
Confidence 47999999999876543 2345899999999998755677899999999999999999988755432 222
Q ss_pred HHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
+.+.. .......+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 240 ~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 240 IRQGR----------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHTTC----------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHcCC----------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 22110 0111235778899999999999999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=367.23 Aligned_cols=266 Identities=27% Similarity=0.386 Sum_probs=218.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|.+.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++|+||+++++++........
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4689999999999999999999999999999999975421 12345678899999999999999999999865445679
Q ss_pred EEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|+||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999986655443 34579999999999999999999999999999999999999999999999999998765332
Q ss_pred C-CCcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 274 K-QPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 274 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+.+....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------ 231 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA------------ 231 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC------------
Confidence 1 222345689999999998752 23478999999999999999999999998877777766543211
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
....++.++.+||.+||..||.+|||++++|+||||+.....+
T Consensus 232 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 232 -----------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp -----------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred -----------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 1134677889999999999999999999999999998776544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=367.62 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=221.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++............+.+|+.++++++||||+++++++.. ....|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 368999999999999999999999999999999998655444556778899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC---CcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DfG~a~~~~~~~ 273 (415)
||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999876665544444579999999999999999999999999999999999999764 469999999998765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......+|+.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+....+......+..
T Consensus 179 --~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 243 (287)
T 2wei_A 179 --KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----------- 243 (287)
T ss_dssp --SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred --ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----------
Confidence 2344568999999999875 4899999999999999999999999998888877777654322211
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....++.++.+||.+||..||.+|||++++|+||||+....
T Consensus 244 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 244 --------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp --------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred --------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 112457888999999999999999999999999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.48 Aligned_cols=283 Identities=24% Similarity=0.360 Sum_probs=227.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC-ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc------eeeeeeeEeec
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-QIVALKKVRFDNLEPESVRFMAREILILRRLDHPN------VVKLEGLVTSR 189 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~l~~~~~~~ 189 (415)
.++|++.+.||+|+||.||+|++..++ ..||+|++... ....+.+.+|+.+++.+.|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 468999999999999999999998777 68999998743 455667888999999987655 8899998887
Q ss_pred CCCeEEEEEEecccChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE----------------
Q 014960 190 MSCSLYLVFKYMEHDLAGLAASPT-IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---------------- 252 (415)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---------------- 252 (415)
....|+||||++++++..+.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred -CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 56799999999888887766543 579999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH
Q 014960 253 ---DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ 329 (415)
Q Consensus 253 ---~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~ 329 (415)
+.++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999865432 244578999999999986 5789999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHhhCCCCCCCc-----CCCcchhhhhhhhhcC----------CCCCChHHHHHHhcccCCCCCCC
Q 014960 330 LHKIFKLCGSPSEEYWKKSKLPHATI-----FKPQQSYKRCIAETFK----------DFPPSSLPLIETLLAIDPAERQT 394 (415)
Q Consensus 330 ~~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~li~~~L~~dP~~R~t 394 (415)
+..+.+..+.++...+.......... ................ ..+.++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 99999988888877665533211100 0000000000111111 11336789999999999999999
Q ss_pred HHHHhcCCCCCCCCC
Q 014960 395 ATAALRSEVSLYMXX 409 (415)
Q Consensus 395 ~~~~L~h~~f~~~~~ 409 (415)
++|+|+||||+.+..
T Consensus 328 ~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 328 LAEALLHPFFAGLTP 342 (355)
T ss_dssp HHHHTTSGGGGGCCH
T ss_pred HHHHhcChhhcCCCh
Confidence 999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=373.66 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=205.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--PNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| +||+++++++.. ...+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 84 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 84 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEE
Confidence 46899999999999999999987 468899999998877667777889999999999976 999999999887 5689
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+|||+.++++...+. ....+++.+++.|+.||+.||+|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 85 ~lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEECCCSEEHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 9999976666555544 445799999999999999999999999999999999999997 68899999999987654332
Q ss_pred C-CcccccccCccCCcccccC----------CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCH
Q 014960 275 Q-PMTSRVVTLWYRPPELLLG----------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSE 342 (415)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~~~~----------~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 342 (415)
. ......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||...... ..+..+......
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--- 239 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 239 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC---
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc---
Confidence 2 2235679999999999853 256889999999999999999999999875433 223222211000
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
.......+.++.+||.+||..||.+|||+.++|+||||+.-
T Consensus 240 ------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 240 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ------------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 00112345578999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=384.03 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=210.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNL--EPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++++.||+|+||.||+|++. .+++.||||++..... .....+.+.+|+.+++.+ +|+||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 468999999999999999999974 5889999999865321 112234566799999999 69999999999987
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
...+|+||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 56799999999987776666555679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCccCCcccccC-CcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCHHHH
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGRTE----VEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 345 (415)
..........+||+.|+|||++.+ ...++.++|||||||+||+|++|..||..... ..+...+.....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 283 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------- 283 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC-------
Confidence 433333345679999999999875 24578999999999999999999999976432 222222222110
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
.....++..+.+||.+||..||.+|| |++++++|+||+.++
T Consensus 284 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 284 ----------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ----------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 11234677789999999999999999 999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=368.88 Aligned_cols=272 Identities=24% Similarity=0.318 Sum_probs=193.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ......+.+|+.++++++||||+++++++.. ....|+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES--SSCEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEE
Confidence 4689999999999999999999988999999999875432 2345567889999999999999999999987 456999
Q ss_pred EEEecccChhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 197 VFKYMEHDLAGLAAS--------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 197 v~e~~~~~l~~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 999998765554432 345689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC----CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 269 FDPNHK----QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 269 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.......................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 653321 1123457899999999986545689999999999999999999999988776555544332211100000
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
. ........++.++.+||.+||+.||.+|||+.++|+||||+..+..
T Consensus 251 ~-------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 251 V-------------------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp -----------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred c-------------------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 0 0112234677889999999999999999999999999999987764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=363.61 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=207.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++ +|+.||+|++..........+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLSI 111 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceEE
Confidence 46899999999999999999975 68899999998776677777889999999999999999999999987 456899
Q ss_pred EEEecccChhhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 197 VFKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
||||+.++.+..++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999876666554433 3899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------- 258 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----------- 258 (309)
T ss_dssp -----------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred cc-cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 32 22345678999999999886 568999999999999999999999999988877766654322111
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEVSLY 406 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~--h~~f~~ 406 (415)
.....++.++.+||.+||..||.+|||++++++ .++++.
T Consensus 259 ----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ----------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112357778999999999999999999999987 455544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=376.50 Aligned_cols=285 Identities=22% Similarity=0.308 Sum_probs=216.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEE
Confidence 578999999999999999999999999999999998653 45566788999999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++.....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999877766666556799999999999999999999996 9999999999999999999999999999765322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC-HHHHhhCC--CCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSK--LPH 352 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~--~~~ 352 (415)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+........ ...+.... ...
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 1234578999999999886 6789999999999999999999999998776665433321111110 00000000 000
Q ss_pred CCc---CCCc----chhhhhhhhh-----cCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 353 ATI---FKPQ----QSYKRCIAET-----FKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~---~~~~----~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
... .... .......... ...++.++.+||.+||..||.+|||++++|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 000 0000 0000011111 123566799999999999999999999999999997643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=363.84 Aligned_cols=262 Identities=25% Similarity=0.375 Sum_probs=212.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence 468999999999999999999999999999999987543 3345678889999999999999999999987 457999
Q ss_pred EEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 999999876655443 34579999999999999999999999999999999999999999999999999875432110 1
Q ss_pred CcccccccCccCCccccc----CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 276 PMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
......||+.|+|||++. ....++.++|||||||++|+|++|.+||...+.......+.+......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 242 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL---------- 242 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc----------
Confidence 123346899999999884 235688999999999999999999999999887777666654321100
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....++.++.+||.+||..||.+|||++++|+||||+.+..
T Consensus 243 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 243 ----------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp ----------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred ----------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 011245777899999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=369.70 Aligned_cols=280 Identities=19% Similarity=0.266 Sum_probs=211.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.++++++||||+++++++........|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4689999999999999999999999999999999975432 223466778999999999999999999998765668999
Q ss_pred EEEecccChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE----cCCCcEEEEeecccccc
Q 014960 197 VFKYMEHDLAGLAASPT---IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFF 269 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DfG~a~~~ 269 (415)
||||+.++.+..++... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999876665554332 239999999999999999999999999999999999999 77788999999999877
Q ss_pred CCCCCCCcccccccCccCCcccccC-------CcCCCchhcHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLG-------ATDYGVGVDLWSAGCILAELLAEKPIMPGR----TEVEQLHKIFKLCG 338 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~sDvwSlG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~ 338 (415)
.... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||... ...+.+..+.....
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 5443 2345678999999998852 257899999999999999999999999753 33455555554322
Q ss_pred CCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014960 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403 (415)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~ 403 (415)
. ..|.................. ........++..+.+||.+||+.||++|||++|+|+||-
T Consensus 245 ~---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 245 S---GAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp T---TCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred c---ccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1 111110000000000000000 000011123456789999999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=359.72 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=219.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|++++.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEE
Confidence 3579999999999999999999999999999999986643 3345778899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999998766666654 479999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...........+.+....
T Consensus 176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 237 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP----------------- 237 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------------
T ss_pred cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC-----------------
Confidence 344578999999999876 56889999999999999999999999988776666555432110
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.....++..+.+||.+||..||.+|||+.++|+|+||....
T Consensus 238 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 238 -----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp -----------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred -----------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 11235677899999999999999999999999999996543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=372.57 Aligned_cols=286 Identities=26% Similarity=0.401 Sum_probs=222.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-----------CCceeeeeee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-----------HPNVVKLEGL 185 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~l~~~ 185 (415)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++++. |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 46899999999999999999999999999999999743 345567888999999886 8999999999
Q ss_pred Eeec--CCCeEEEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcC------C
Q 014960 186 VTSR--MSCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDN------E 255 (415)
Q Consensus 186 ~~~~--~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~------~ 255 (415)
+... ....+++|||++++.+...+.. ....+++..++.++.||+.||+|||++ ||+||||||+||||+. .
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 8763 2337899999997776666543 344699999999999999999999998 9999999999999953 3
Q ss_pred CcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC------hHHH
Q 014960 256 GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQ 329 (415)
Q Consensus 256 ~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~------~~~~ 329 (415)
+.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+ ..+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 47999999999876532 244578999999999986 568999999999999999999999998754 5567
Q ss_pred HHHHHHhcCCCCHHHHhhCCCCCCCc---------CCCcc-hhhhhhhh---hcCCCCCChHHHHHHhcccCCCCCCCHH
Q 014960 330 LHKIFKLCGSPSEEYWKKSKLPHATI---------FKPQQ-SYKRCIAE---TFKDFPPSSLPLIETLLAIDPAERQTAT 396 (415)
Q Consensus 330 ~~~i~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~t~~ 396 (415)
+..+.+..+.++...|.........+ ..... ........ ....++.++.+||.+||+.||.+|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 78888888888876665433210000 00000 00000111 1112346788999999999999999999
Q ss_pred HHhcCCCCCCCCCC
Q 014960 397 AALRSEVSLYMXXX 410 (415)
Q Consensus 397 ~~L~h~~f~~~~~~ 410 (415)
++|+||||+.....
T Consensus 330 ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 330 GLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHTCGGGTTCTTC
T ss_pred HHhhChhhhcccCc
Confidence 99999999987544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=380.20 Aligned_cols=267 Identities=16% Similarity=0.187 Sum_probs=194.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhC--CCCceeeee-------eeEe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRL--DHPNVVKLE-------GLVT 187 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~~iv~l~-------~~~~ 187 (415)
..|.+.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 469999999999999999999999999999999997654 345566778885555544 699988754 4443
Q ss_pred ecCC---------------CeEEEEEEecccChhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCeeccCC
Q 014960 188 SRMS---------------CSLYLVFKYMEHDLAGLAASPTIKFTQAQV------KCYMHQLLSGLEHCHNQHVLHRDIK 246 (415)
Q Consensus 188 ~~~~---------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~------~~i~~qi~~~L~~LH~~~ivHrDlk 246 (415)
.... ..+|+||||+++++...+......+.+..+ ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3211 348999999997766665543334455555 6777999999999999999999999
Q ss_pred CCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccC-CcCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Q 014960 247 GSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGRT 325 (415)
Q Consensus 247 p~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlG~il~ell~g~~pf~~~~ 325 (415)
|+||||+.++.+||+|||++...... .....+|+.|+|||++.+ ...++.++|||||||+||+|++|.+||.+..
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred HHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 99999999999999999999876432 124567799999999864 2468999999999999999999999998754
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 326 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
... ...|......... . ..........+++++.+||.+||+.||++|||++++|+||||+
T Consensus 298 ~~~-------------~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 298 PGI-------------KGSWKRPSLRVPG--T-----DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp TTC-------------TTCCCBCCTTSCC--C-----CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred ccc-------------ccchhhhhhhhcc--c-----cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 210 0001100000000 0 0001112346788999999999999999999999999999998
Q ss_pred CCC
Q 014960 406 YMX 408 (415)
Q Consensus 406 ~~~ 408 (415)
.+.
T Consensus 358 ~~~ 360 (371)
T 3q60_A 358 QLQ 360 (371)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=389.32 Aligned_cols=254 Identities=17% Similarity=0.236 Sum_probs=198.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHH---HHHhCCCCceeeee-------ee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREIL---ILRRLDHPNVVKLE-------GL 185 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~---~l~~l~h~~iv~l~-------~~ 185 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+. +++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4689999999999999999999989999999999986533 4456678889995 45555899999998 55
Q ss_pred EeecCC----------C-----eEEEEEEecccChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecc
Q 014960 186 VTSRMS----------C-----SLYLVFKYMEHDLAGLAASPT------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244 (415)
Q Consensus 186 ~~~~~~----------~-----~~~lv~e~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrD 244 (415)
+..... . ..|+||||+++++...+.... ..+++..++.|+.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 554311 0 389999999876655443221 1233488888999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCC----------cCCCchhcHHHHHHHHHHH
Q 014960 245 IKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAEL 314 (415)
Q Consensus 245 lkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~sDvwSlG~il~el 314 (415)
|||+||||+.++.+||+|||++..... ......| +.|+|||++.+. ..++.++|||||||+||||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999986432 2345567 999999999763 2689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC
Q 014960 315 LAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT 394 (415)
Q Consensus 315 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 394 (415)
++|.+||.+.+....... +......+++++.+||.+||+.||.+|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhh---------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 999999966443221111 11222467889999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 014960 395 ATAALRSEVSLYMX 408 (415)
Q Consensus 395 ~~~~L~h~~f~~~~ 408 (415)
+.++|+||||+.+.
T Consensus 354 ~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 354 PLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHTSHHHHHHH
T ss_pred HHHHhhChHHHHHH
Confidence 99999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.87 Aligned_cols=276 Identities=22% Similarity=0.358 Sum_probs=217.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh---------------HHHHHHHHHHHHHHhCCCCceee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP---------------ESVRFMAREILILRRLDHPNVVK 181 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~ 181 (415)
.++|.+.+.||+|+||.||+|++ +++.||+|++....... ...+.+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47899999999999999999987 89999999987532211 11267889999999999999999
Q ss_pred eeeeEeecCCCeEEEEEEecccChhhhh------cCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEE
Q 014960 182 LEGLVTSRMSCSLYLVFKYMEHDLAGLA------ASP--TIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLI 252 (415)
Q Consensus 182 l~~~~~~~~~~~~~lv~e~~~~~l~~~~------~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl 252 (415)
+++++.+ ....|+||||+.++.+..+ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 108 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999987 5679999999998666555 444 5679999999999999999999999 999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCc-hhcHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGV-GVDLWSAGCILAELLAEKPIMPGRTE-VEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~sDvwSlG~il~ell~g~~pf~~~~~-~~~~ 330 (415)
+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||.+.+. .+..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876433 2345678999999999987435666 99999999999999999999998776 6666
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
..+.......+.. . ...... ............++.++.+||.+||+.||.+|||++++|+||||+..+.
T Consensus 263 ~~i~~~~~~~~~~-----~---~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 263 NNIRTKNIEYPLD-----R---NHFLYP--LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHTSCCCCCCCS-----S---SSSTTT--TCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHhccCcCCccc-----h---hhhhcc--ccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 6554332111100 0 000000 0000011222467888999999999999999999999999999998763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=364.24 Aligned_cols=262 Identities=23% Similarity=0.374 Sum_probs=209.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC----C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM----S 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~----~ 191 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+|+.+++++ +|+||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 5789999999999999999999999999999999975532 335678899999999 7999999999987642 4
Q ss_pred CeEEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 192 CSLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
...|+||||+.++.+..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 579999999988555544432 347899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 345 (415)
.... .......||+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+.......+.+.....
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 253 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR----- 253 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc-----
Confidence 4322 12234578999999999862 2568899999999999999999999998887766665554321100
Q ss_pred hhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....++..+.+||.+||..||.+|||++++|+||||+....
T Consensus 254 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 254 ----------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp ----------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred ----------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 012356788999999999999999999999999999987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=370.06 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=208.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-------LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 188 (415)
.++|++.+.||+|+||.||+|++. .++..||+|++... ......+.+.+|+.+++.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 478999999999999999999864 34567999999755 3445567889999999999 89999999999987
Q ss_pred cCCCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
...+|+||||+.++.+..++.. ...+++.+++.++.||+.||+|||++||+||||||+||||
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 4569999999998666554432 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999987654322 22233456889999999886 679999999999999999999 99999988777666
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+...... .....++.++.+||.+||..||.+|||+.+++++
T Consensus 316 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555432110 1123467789999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=359.84 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=211.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ..+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 468999999999999999999999999999999998643 23467789999999999999999999987 567999
Q ss_pred EEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-A 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-S
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-c
Confidence 999999865555443 45579999999999999999999999999999999999999999999999999997764332 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......
T Consensus 181 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 244 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT--------------- 244 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------
T ss_pred ccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc---------------
Confidence 2344578999999999876 568999999999999999999999998877665554443321100
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
......++.++.+||.+||..||.+|||+.++|+||||+....
T Consensus 245 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 245 -----------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp -----------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred -----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 0011235778899999999999999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=354.39 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=205.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++..+++.||+|++.. ......+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEE
Confidence 4689999999999999999999999999999998854 346677889999999999999999999999987 567999
Q ss_pred EEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++. ....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999998866655543 3567999999999999999999999999999999999999999999999999999876443221
Q ss_pred C-------------cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 276 P-------------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 276 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------- 232 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------- 232 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------
Confidence 1 114578999999999986 678999999999999999999999986532110000
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
...............+++++.+||.+||+.||++|||++++++
T Consensus 233 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 ---------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000011123568899999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=357.67 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=201.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec-------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR------- 189 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 189 (415)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 35799999999999999999999999999999999643 45567788999999999999999999987652
Q ss_pred ----CCCeEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 190 ----MSCSLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 190 ----~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
.....|+||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 235789999999875555444 345568899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-------------CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC-ChHHHH
Q 014960 265 LASFFDPNH-------------KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQL 330 (415)
Q Consensus 265 ~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~-~~~~~~ 330 (415)
++....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||... +..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 997664321 1122345789999999999865578999999999999999998 45432 222333
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
..+.......+ .......+..+.+||.+||+.||.+|||++++|+||||+..
T Consensus 239 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 239 KKLRSVSIEFP-------------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHSTTCCCC-------------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HhccccccccC-------------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 33322111110 01112345568999999999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=352.51 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=210.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+ ....|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEE
Confidence 468999999999999999999976 5778999999865433 3568899999999999999999999987 456999
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999886555544 55567999999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+.......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 227 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------- 227 (269)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------------
T ss_pred cccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC--------------
Confidence 3344556788999999875 568999999999999999999 999999988888777765432111
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....+++++.+||.+||+.||.+|||+.+++++
T Consensus 228 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 228 --------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 112457779999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=360.14 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=209.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|.+.+.||+|+||.||+|++..++. .||||++... ......+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCc
Confidence 4689999999999999999999876554 5999999754 245566788999999999999999999999977 456
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|+||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 89999999886555544 45568999999999999999999999999999999999999999999999999999877543
Q ss_pred CCCC--cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 273 HKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 273 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 274 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--------- 274 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------
T ss_pred ccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---------
Confidence 3221 122345778999999875 568999999999999999999 999999988888777765432111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+++++.+||.+||..||.+|||+.++++
T Consensus 275 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 -------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11357788999999999999999999999885
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=363.92 Aligned_cols=263 Identities=18% Similarity=0.271 Sum_probs=194.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC-
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC- 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~- 192 (415)
.++|++.+.||+|+||.||+|++..++. .||+|++..........+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999999877765 799999987655556678899999999999999999999998763221
Q ss_pred ---eEEEEEEecccChhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 193 ---SLYLVFKYMEHDLAGLAAS------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 193 ---~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
..++||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 2399999999866555442 1226899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 014960 264 GLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPS 341 (415)
Q Consensus 264 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 341 (415)
|++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-- 258 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-- 258 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred cccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC--
Confidence 99987644322 11223456788999999876 568999999999999999999 99999998887777666543211
Q ss_pred HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCCC
Q 014960 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-------ATAALRSEVSLYMX 408 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~~~L~h~~f~~~~ 408 (415)
.....+++++.+||.+||..||.+||| .++++.|+|+....
T Consensus 259 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 259 --------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred --------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 112356788999999999999999999 88999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=359.10 Aligned_cols=252 Identities=20% Similarity=0.215 Sum_probs=205.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+ +|+||+++++++.. ....|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccE
Confidence 36899999999999999999999999999999998765322 3477899999999 99999999999887 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc-----EEEEeeccccccC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI-----LTIADFGLASFFD 270 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-----vkl~DfG~a~~~~ 270 (415)
+||||+++++...+......+++..++.|+.||+.||+|||++||+||||||+|||++.++. +||+|||++..+.
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999965665555544568999999999999999999999999999999999999999887 9999999998764
Q ss_pred CCCCC------CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCC
Q 014960 271 PNHKQ------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---EVEQLHKIFKLCGSPS 341 (415)
Q Consensus 271 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~ 341 (415)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+ ..+.+..+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 33221 1245678999999999986 678999999999999999999999998844 3344444433221111
Q ss_pred HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......+| ++.+||..||..||.+||+++++++
T Consensus 241 ------------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 ------------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 112223456 8999999999999999999988876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=358.73 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=199.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..+|+.||||++............+.++..+++.++|+||+++++++.. ....|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEE
Confidence 578999999999999999999999999999999998765444445556666667888899999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+++.+..........+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (318)
T 2dyl_A 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-- 179 (318)
T ss_dssp EECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence 999996555444444355799999999999999999999995 99999999999999999999999999997664432
Q ss_pred CcccccccCccCCccccc----CCcCCCchhcHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 276 PMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~----~~~~~~~~sDvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
......||+.|+|||++. ....++.++|||||||++|+|++|..||.. .+..+.+..+.+.....
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 249 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL---------- 249 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC----------
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC----------
Confidence 223457899999999985 235688999999999999999999999987 44555555554422110
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
......++.++.+||.+||..||.+|||++++|+||||+.++
T Consensus 250 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 250 ----------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp ----------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred ----------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 011135778899999999999999999999999999997654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=349.11 Aligned_cols=253 Identities=18% Similarity=0.206 Sum_probs=208.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+ +|+||+++++++.. ....|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeE
Confidence 4689999999999999999999999999999999875432 23467899999999 79999999999876 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc-----EEEEeeccccccC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI-----LTIADFGLASFFD 270 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-----vkl~DfG~a~~~~ 270 (415)
+||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999966666655555557999999999999999999999999999999999999988776 9999999998765
Q ss_pred CCCC------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCC
Q 014960 271 PNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR---TEVEQLHKIFKLCGSPS 341 (415)
Q Consensus 271 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~ 341 (415)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. +..+.+..+......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4322 12345578999999999876 56899999999999999999999999884 34444444443321111
Q ss_pred HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......+++++.+||.+||+.||.+|||++++++
T Consensus 242 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 22334568889999999999999999999998874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=365.65 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=207.4
Q ss_pred CCCceeeeeeccCCceEEEEEE-----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 4789999999999999999998 56677899999997543 345567789999999999 799999999998764
Q ss_pred CCeEEEEEEecccChhhhhcCCCC--------------------------------------------------------
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTI-------------------------------------------------------- 214 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~-------------------------------------------------------- 214 (415)
+..+++||||+.++.+..++....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 456899999999865555443221
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-CCccccccc
Q 014960 215 ----------KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVT 283 (415)
Q Consensus 215 ----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt 283 (415)
.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 289999999999999999999999999999999999999999999999999986643322 223345678
Q ss_pred CccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchh
Q 014960 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSY 362 (415)
Q Consensus 284 ~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (415)
+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+.........+.
T Consensus 259 ~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------- 316 (359)
T 3vhe_A 259 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--------------------- 316 (359)
T ss_dssp GGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------
T ss_pred ceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC---------------------
Confidence 99999999875 678999999999999999998 9999988765554444443221111
Q ss_pred hhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 363 KRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 363 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....+++++.+||.+||+.||.+|||++++++|
T Consensus 317 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 113467789999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=369.50 Aligned_cols=257 Identities=18% Similarity=0.272 Sum_probs=208.6
Q ss_pred CCCCceeeeeeccCCceEEEEEE-----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC
Q 014960 116 RADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 190 (415)
..++|++++.||+|+||.||+|+ +..+++.||||++... ........+.+|+.++++++|+||+++++++..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 35789999999999999999998 4567789999998643 344555678889999999999999999999877
Q ss_pred CCeEEEEEEecccChhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC---cEEE
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP-------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG---ILTI 260 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl 260 (415)
....|+||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 4568999999987555444321 24589999999999999999999999999999999999999655 5999
Q ss_pred EeeccccccCCCC-CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 014960 261 ADFGLASFFDPNH-KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCG 338 (415)
Q Consensus 261 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~ 338 (415)
+|||++....... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999997553221 122344567999999999876 579999999999999999998 9999999888887776654321
Q ss_pred CCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.. ....++.++.+||.+||+.||.+|||+++++++.++
T Consensus 305 ~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 305 MD----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 113567789999999999999999999999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=350.83 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=204.2
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. ....++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEE
Confidence 34555668999999999999999999999999997653 3445678899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-CCcEEEEeeccccccCCCC
Q 014960 198 FKYMEHDLAGLAASP---TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-EGILTIADFGLASFFDPNH 273 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DfG~a~~~~~~~ 273 (415)
|||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999987655544432 235679999999999999999999999999999999999988 8999999999998765322
Q ss_pred CCCcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHHhhCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.......||+.|+|||++.+. ..++.++||||||+++|+|++|..||........ ..........
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 244 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH------------ 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC------------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc------------
Confidence 122345789999999998642 2478999999999999999999999976443322 2111111000
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
......++.++.+||.+||..||++|||++++|+||||+......
T Consensus 245 ---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 289 (295)
T 2clq_A 245 ---------------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289 (295)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred ---------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence 011235678899999999999999999999999999999776543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=350.71 Aligned_cols=250 Identities=18% Similarity=0.290 Sum_probs=206.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEec--CCCeEE
Confidence 468999999999999999999865 6778999999865433 3457889999999999999999999976 456999
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999876555544 43567999999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||...+..+....+.+......
T Consensus 177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 242 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------- 242 (283)
T ss_dssp STTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------------
T ss_pred cccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-------------
Confidence 2334456788999999875 568999999999999999998 9999999888877777755322111
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
...+++.+.+||.+||+.||.+|||++++++|
T Consensus 243 ---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 ---------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 12356778999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=353.50 Aligned_cols=255 Identities=23% Similarity=0.293 Sum_probs=199.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 5789999999999999999999999999999999875433 34455788899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999998666665555567999999999999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+ ......
T Consensus 191 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~--------------- 253 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPR--------------- 253 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCC---------------
T ss_pred cccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCC---------------
Confidence 3445678999999999876 67899999999999999999999999886654333222 211111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-CHHHHhc
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-TATAALR 400 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-t~~~~L~ 400 (415)
.......++.++.+||.+||+.||.+|| +++++++
T Consensus 254 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1122356889999999999999999999 6766653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=348.41 Aligned_cols=250 Identities=18% Similarity=0.252 Sum_probs=207.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.++++++||||+++++++.. ....|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCceEE
Confidence 478999999999999999999865 5677999999765433 3457889999999999999999999976 556999
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999877555444 33446999999999999999999999999999999999999999999999999999876554333
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||...+..+....+.......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 225 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY-------------- 225 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred cccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC--------------
Confidence 3334456778999999875 568999999999999999999 999999888877776664432111
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....+++++.+||.+||+.||.+|||+.+++++
T Consensus 226 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 226 --------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012356778999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=362.61 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=208.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCC--CCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLD--HPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.++++++ |+||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 468999999999999999999999999999999997654321 12245667999999996 5999999999987
Q ss_pred CCeEEEEEEeccc-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc-CCCcEEEEeeccccc
Q 014960 191 SCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASF 268 (415)
Q Consensus 191 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DfG~a~~ 268 (415)
....++|||++.+ +.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 5679999999974 44444444455799999999999999999999999999999999999999 788999999999987
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+ .+....
T Consensus 200 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~----------- 259 (320)
T 3a99_A 200 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ----------- 259 (320)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC-----------
T ss_pred cccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccc-----------
Confidence 6543 23445789999999998764555789999999999999999999996532 111110
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
......+++++.+||.+||..||.+|||++++|+||||+++..
T Consensus 260 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 260 ------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp ------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 0011357788999999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=351.24 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=196.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|++.+.||+|+||.||+|++..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++.+ ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Cc
Confidence 46899999999999999999998654 456999988653 234556788899999999999999999999853 45
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|+||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 89999999985555444 34457999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.+....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~------------ 236 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------ 236 (281)
T ss_dssp ---------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------------
T ss_pred cccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC------------
Confidence 3323334456789999999875 568999999999999999996 99999988877776666432111
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....+++++.+||.+||..||.+|||+.+++++
T Consensus 237 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1123577889999999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=360.13 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=209.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 122 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 122 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--C
Confidence 478999999999999999999986 455899999997543 45566789999999999999999999999977 4
Q ss_pred CeEEEEEEecccChhhhhcCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASP------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 247 (415)
...|+||||+.++.+..++.. ...+++.+++.++.||+.||+|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 569999999998655554432 15799999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCC
Q 014960 248 SNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT 325 (415)
Q Consensus 248 ~NILl~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~ 325 (415)
+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999987643221 12234567899999999875 568999999999999999999 999999988
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 326 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+....+.+.... .....++.++.+||.+||+.||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNIL----------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCcC----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 87777666442110 1123567789999999999999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=347.05 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=197.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||+|+||.||+|++. ..||+|++..........+.+.+|+.+++.++|+||++++++... ...++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~l 96 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 96 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---CccEE
Confidence 468999999999999999999753 359999998776667777889999999999999999999997643 45899
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC-C
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH-K 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~-~ 274 (415)
||||+.++.+...+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999876555544 455679999999999999999999999999999999999999999999999999997654321 2
Q ss_pred CCcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 246 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD---------- 246 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC----------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc----------
Confidence 22344578999999999862 356888999999999999999999999987666655554443211110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......+++++.+||.+||+.||.+|||++++++
T Consensus 247 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 -------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11223457788999999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=352.71 Aligned_cols=269 Identities=22% Similarity=0.338 Sum_probs=200.1
Q ss_pred CCCceeeeeeccCCceEEEEEE----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++||||+++++++......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 5789999999999999999998 6678999999998753 355667889999999999999999999998664455
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
.+++||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 689999999876555544 3344699999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .. +..+......+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~----~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FM----RMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-HH----HHHCTTCCTHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH-HH----hhhcCccccchhHHH
Confidence 322 11223456788999999876 56899999999999999999999998653221 11 111111000000000
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
... .............+++++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIE-------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHH-------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHH-------HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 00000000112356788999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=361.82 Aligned_cols=253 Identities=20% Similarity=0.303 Sum_probs=210.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 188 (415)
.++|.+.+.||+|+||.||+|++.. .+..||+|++... ........+.+|+.+++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4689999999999999999998643 3357999999765 3455567888999999999 89999999999987
Q ss_pred cCCCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
....|+||||+.++.+..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 4569999999988665554432 2359999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987654322 22334467889999999986 678999999999999999999 99999998877777
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+.+.... .....+++++.+||.+||+.||.+|||+++++++
T Consensus 304 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666443211 1113567889999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=348.30 Aligned_cols=247 Identities=17% Similarity=0.221 Sum_probs=201.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCC-------ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEee
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTG-------QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS 188 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 188 (415)
..++|.+.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3578999999999999999999988777 469999986532 3455778899999999999999999999987
Q ss_pred cCCCeEEEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc--------EE
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI--------LT 259 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--------vk 259 (415)
....|+||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 456899999999765555443 3334999999999999999999999999999999999999998887 99
Q ss_pred EEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcC
Q 014960 260 IADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCG 338 (415)
Q Consensus 260 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~ 338 (415)
|+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+..... .+.....
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~ 235 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRH 235 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTC
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccC
Confidence 999999865532 233467899999999986567899999999999999999955 555444443333 3322111
Q ss_pred CCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......+.++.+||.+||+.||.+|||+.+++++
T Consensus 236 -----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 -----------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp -----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1113457889999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=354.77 Aligned_cols=253 Identities=19% Similarity=0.294 Sum_probs=208.7
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|.+.+.||+|+||.||+|++ ..++..||+|++... ......+.+.+|+.+++.++||||+++++++.. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--D 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--C
Confidence 46899999999999999999987 345688999998754 345566788999999999999999999999877 4
Q ss_pred CeEEEEEEecccChhhhhcCCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASPT------------------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 247 (415)
...|+||||+.++.+..++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 5699999999976655544322 2389999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCC
Q 014960 248 SNLLIDNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT 325 (415)
Q Consensus 248 ~NILl~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~ 325 (415)
+|||++.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987654322 12233456888999999876 568999999999999999999 999999887
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 326 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+....+...... .....+++++.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRM----------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCcC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76666555332110 1123577889999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=359.28 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=200.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhC----CCCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRL----DHPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~~iv~l~~~~~~ 188 (415)
.++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.++.++ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 468999999999999999999999999999999997654321 2233456799999998 89999999999877
Q ss_pred cCCCeEEEEEEe-cccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc-CCCcEEEEeeccc
Q 014960 189 RMSCSLYLVFKY-MEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID-NEGILTIADFGLA 266 (415)
Q Consensus 189 ~~~~~~~lv~e~-~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DfG~a 266 (415)
....++|||+ +.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 110 --~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 --QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred --CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 4568999998 66655555555455799999999999999999999999999999999999999 7899999999999
Q ss_pred cccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.... .+.....
T Consensus 188 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~-------- 250 (312)
T 2iwi_A 188 ALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL-------- 250 (312)
T ss_dssp EECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCC--------
T ss_pred hhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhcc--------
Confidence 876543 23456789999999998764444568999999999999999999996531 1111100
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
.....++.++.+||.+||..||++|||++++|+||||+...+..+
T Consensus 251 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~ 295 (312)
T 2iwi_A 251 ---------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP 295 (312)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC------
T ss_pred ---------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccc
Confidence 011346778899999999999999999999999999998766443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=350.48 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=210.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 86 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 86 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCEEE
Confidence 46899999999999999999999999999999999754 3345678899999999999999999999877 456999
Q ss_pred EEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 999999755544443 345699999999999999999999999999999999999999999999999999987765443
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+.......+.+....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 231 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------- 231 (288)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--------------
T ss_pred ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC--------------
Confidence 33344566889999999875 568999999999999999999 99999987776666555432111
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+++++.+||.+||..||.+|||++++++
T Consensus 232 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 232 --------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 112356788999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=342.98 Aligned_cols=249 Identities=18% Similarity=0.224 Sum_probs=209.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++. ++.||+|++..........+.+.+|+.++++++||||+++++++.+......++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 468999999999999999999864 889999999887666777788999999999999999999999998765577999
Q ss_pred EEEecccChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 197 VFKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
||||+.++.+..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999865555554332 5899999999999999999999999 99999999999999999999999998765322
Q ss_pred CCCCcccccccCccCCcccccCCc--CCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 231 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--------- 231 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC---------
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC---------
Confidence 3457799999999987632 233489999999999999999999999888777666654322211
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.+||.+||+.||.+|||++++++
T Consensus 232 ------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 ------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12357788999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=360.23 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=180.0
Q ss_pred CCCceeee-eeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec--CCCe
Q 014960 117 ADTFEKLD-KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCS 193 (415)
Q Consensus 117 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~ 193 (415)
.++|.+.+ .||+|+||.||+|++..+|+.||||++... .. ...+....++.++|+||+++++++... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 46799965 599999999999999999999999998743 11 222233446677999999999998652 2345
Q ss_pred EEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---CCcEEEEeeccccc
Q 014960 194 LYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASF 268 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DfG~a~~ 268 (415)
+|+||||+.++.+..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 8999999988555444433 246999999999999999999999999999999999999976 44599999999986
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+.+...... +
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~--- 250 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ---Y--- 250 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc---c---
Confidence 6532 2345578999999999865 5688999999999999999999999987665443222211110000 0
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
. ........++.++.+||.+||..||.+|||++++|+||||+...
T Consensus 251 ~---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 251 G---------------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp C---------------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred c---------------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0 01112245788899999999999999999999999999998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=342.75 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=203.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHH-----HHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESV-----RFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.......... +.+.+|+.++++++|+||+++++++.+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 478999999999999999999999999999999987654322211 6788999999999999999999998653
Q ss_pred CeEEEEEEecccC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEcCCCc-----EEEEee
Q 014960 192 CSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGI-----LTIADF 263 (415)
Q Consensus 192 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~-----vkl~Df 263 (415)
.++||||+.++ +...+......+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+||
T Consensus 96 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 --PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp --TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred --CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 37999999865 44555566668999999999999999999999999 999999999999988776 999999
Q ss_pred ccccccCCCCCCCcccccccCccCCcccccC-CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCC
Q 014960 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ--LHKIFKLCGSP 340 (415)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~ 340 (415)
|++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.... ...+......+
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 99975432 2345678999999999842 34578999999999999999999999987554332 22222211110
Q ss_pred CHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 341 SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+++++.+||.+||+.||.+|||++++++
T Consensus 250 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 ---------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 112356788999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.99 Aligned_cols=272 Identities=22% Similarity=0.235 Sum_probs=200.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC--CCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM--SCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~~ 194 (415)
.++|++.+.||+|+||.||+|++. ++.||||++... ........+|+.++++++||||+++++++.... ...+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 468999999999999999999764 789999999643 233445667999999999999999999987743 3457
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ----------HVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----------~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
|+||||+.++.+..++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999987666655443 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-CCcccccccCccCCcccccCC----cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014960 265 LASFFDPNHK-QPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 265 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
++........ .......||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+................
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987654332 223345789999999998752 35667899999999999999999999875432221111111222
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+....+............ ..... .....++++.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPV----LRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCHHHHHHHHTTSCCCCC----CCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhhhhhhhhcccCCCC----ccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222221110000000000 00000 00011234889999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=356.73 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=188.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHH-HHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREIL-ILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ......+..|+. +++.++||||+++++++.. ....|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceE
Confidence 4789999999999999999999999999999999986543 333344555555 6777899999999999987 46799
Q ss_pred EEEEecccChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 196 LVFKYMEHDLAGLAA----SPTIKFTQAQVKCYMHQLLSGLEHCHNQ-HVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 196 lv~e~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
+||||+.+++...+. .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 999999987655443 2345789999999999999999999999 99999999999999999999999999997764
Q ss_pred CCCCCCcccccccCccCCccccc---CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHh
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLL---GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 346 (415)
... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... +.+..+.. +.+.
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~----- 248 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP----- 248 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SCCC-----
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CCCC-----
Confidence 432 223347899999999983 2356889999999999999999999999764321 11111000 0000
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.........++.++.+||.+||..||.+|||+.++|+||||....
T Consensus 249 -----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 249 -----------------QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp -----------------CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred -----------------CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 001111235778899999999999999999999999999997544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=350.49 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=203.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC--CCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD--HPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++++.||+|+||.||+|++. +++.||+|++............+.+|+.++++++ |+||+++++++.. ....
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEE
Confidence 467999999999999999999975 5889999999877666777788999999999997 5999999999887 5679
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+|||+.++++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 104 ~lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEECCCSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEEEecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 9999966665555544 345789999999999999999999999999999999999996 48999999999987654322
Q ss_pred C-CcccccccCccCCcccccC----------CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCH
Q 014960 275 Q-PMTSRVVTLWYRPPELLLG----------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV-EQLHKIFKLCGSPSE 342 (415)
Q Consensus 275 ~-~~~~~~gt~~y~aPE~~~~----------~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 342 (415)
. ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... ..+..+......
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--- 258 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 258 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC---
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc---
Confidence 1 2234578999999999864 136888999999999999999999999875433 222222211000
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.......+.++.+||.+||..||.+|||++++|+||||+....
T Consensus 259 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 259 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred ------------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 0011234667899999999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=342.33 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=196.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC--hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE--PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.++|++.+.||+|+||.||+|++ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 81 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNL 81 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCce
Confidence 46899999999999999999986 4889999998764332 2345678899999999999999999999987 4568
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CeeccCCCCCEEEcC--------CCcEEEEee
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH---VLHRDIKGSNLLIDN--------EGILTIADF 263 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NILl~~--------~~~vkl~Df 263 (415)
|+||||+.++.+..+... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999988777766654 47999999999999999999999999 899999999999986 678999999
Q ss_pred ccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 014960 264 GLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 343 (415)
|++....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+......+
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 233 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL--- 233 (271)
T ss_dssp CC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC---
T ss_pred Cccccccccc---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC---
Confidence 9998765432 234578999999999876 568999999999999999999999999888776665554321111
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....+++++.+||.+||+.||.+|||+.+++++
T Consensus 234 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 234 ------------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1113567789999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=364.90 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=207.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++..+++.||||++... ...+....+.+|+.+|++++||||+++++++.. ....|+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEE
Confidence 46899999999999999999999989999999998744 344555678899999999999999999999976 456999
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++ .....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999876554443 33446899999999999999999999999999999999999999999999999999765432111
Q ss_pred C-cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 276 P-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 276 ~-~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
. .....+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.+....+
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP------------- 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC-------------
T ss_pred ecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 1 112235778999999875 568999999999999999998 999999988777666554321111
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+++++.+||.+||+.||.+|||++++++
T Consensus 336 ---------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 336 ---------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11246778999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=349.71 Aligned_cols=256 Identities=18% Similarity=0.258 Sum_probs=201.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC--
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS-- 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-- 191 (415)
.++|.+.+.||+|+||.||+|++.. ++..||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998754 55689999998776666777889999999999999999999999876432
Q ss_pred -CeEEEEEEecccChhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 192 -CSLYLVFKYMEHDLAGLAA------SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 192 -~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
...|+||||+.++.+..++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 2469999999986665544 344579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 014960 265 LASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSE 342 (415)
Q Consensus 265 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 342 (415)
++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--- 268 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--- 268 (313)
T ss_dssp CC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---
T ss_pred cceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC---
Confidence 9987644321 11223456889999999876 678999999999999999999 99999988877766665442211
Q ss_pred HHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 343 EYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....+++++.+||.+||..||.+|||+.+++++
T Consensus 269 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 -------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123577789999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=354.01 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=203.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCce----EEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQI----VALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.+.||+|+||.||+|++..+++. ||+|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---C
Confidence 46899999999999999999999888876 6667664332 12223456679999999999999999998864 4
Q ss_pred eEEEEEEecccChhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++||||+.++.+.. +......+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 5899999998755444 444456799999999999999999999999999999999999999999999999999988755
Q ss_pred CCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL---------- 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC----------
T ss_pred ccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC----------
Confidence 4332 2344567889999999875 568999999999999999999 99999988776666655432111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++.++.+||.+||..||.+|||+.+++++
T Consensus 237 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 237 ------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112467789999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=343.67 Aligned_cols=254 Identities=19% Similarity=0.229 Sum_probs=205.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..+.++... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 47899999999999999999999999999999998765432 3477899999999998877777666443 567899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE---cCCCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999666666555455679999999999999999999999999999999999999 478899999999998765433
Q ss_pred CC------CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCHHH
Q 014960 274 KQ------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT---EVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 274 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~ 344 (415)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..+.+..+.+.....+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 21 1245578999999999886 568999999999999999999999998743 2233333333211111
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......+++++.+||.+||+.||.+|||++++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 12223567889999999999999999999998875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.08 Aligned_cols=263 Identities=19% Similarity=0.172 Sum_probs=198.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-----CceEEEEEEecCCCCh-HH--------HHHHHHHHHHHHhCCCCceeee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-----GQIVALKKVRFDNLEP-ES--------VRFMAREILILRRLDHPNVVKL 182 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~-~~--------~~~~~~E~~~l~~l~h~~iv~l 182 (415)
.++|++.+.||+|+||.||+|++..+ ++.||||++....... .. ...+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 46899999999999999999998664 5889999987653110 00 0122335556677789999999
Q ss_pred eeeEeecC--CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc--CCCcE
Q 014960 183 EGLVTSRM--SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID--NEGIL 258 (415)
Q Consensus 183 ~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~v 258 (415)
++++.... ..+.|+||||+++++...+......+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 99986632 256899999996566655555556899999999999999999999999999999999999999 88999
Q ss_pred EEEeeccccccCCCCC------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014960 259 TIADFGLASFFDPNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332 (415)
Q Consensus 259 kl~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~ 332 (415)
||+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||+||||++|..||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999977643321 11234468999999999986 5689999999999999999999999986433322222
Q ss_pred HHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhh--cCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAET--FKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
............ .+... ...++.++.+||..||..||.+||++.++++
T Consensus 273 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIAS--------------------LMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHH--------------------HHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHH--------------------HHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 221110001000 01111 1467889999999999999999999988874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.34 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=206.0
Q ss_pred CCCceeee-eeccCCceEEEEEE--ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLD-KIGQGTYSNVYKAR--DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~-~lG~G~~g~Vy~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|.+.+ .||+|+||.||+|. +..+++.||+|++..........+.+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CCC
Confidence 36799988 99999999999995 4567789999999866555556778999999999999999999999984 345
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
.|+||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999987666666556679999999999999999999999999999999999999999999999999998765433
Q ss_pred CC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 274 KQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 274 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
.. ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+....+......
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 239 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----------- 239 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----------
T ss_pred CcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 21 1122345788999999875 568899999999999999999 99999998877766655432100
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.+||.+||+.||.+|||+.++++
T Consensus 240 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111357788999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=359.18 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=196.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEC---CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT---LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|.+.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCc
Confidence 468999999999999999999876 467789999987543 45556788999999999999999999999977 456
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|+||||+.++.+..++ .....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999876555544 44557999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcc--cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 273 HKQPMT--SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 273 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
...... ...+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~--------- 270 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP--------- 270 (373)
T ss_dssp -------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC---------
T ss_pred CccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 222111 2234778999999875 578999999999999999998 999999988877776664432111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.+||.+||..||.+||++.++++
T Consensus 271 -------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 -------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11246777899999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=343.15 Aligned_cols=254 Identities=19% Similarity=0.230 Sum_probs=201.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..++++... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 46899999999999999999999999999999987654322 2467899999999988888777766443 567899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE---cCCCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999666666655455679999999999999999999999999999999999999 788999999999998765432
Q ss_pred C------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCHHH
Q 014960 274 K------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV---EQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 274 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 344 (415)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.. ..+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence 2 12234578999999999886 56899999999999999999999999874432 22222222211111
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......+++++.+||..||+.||++|||++++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 22233567889999999999999999999999886
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=341.96 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=207.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEE
Confidence 368999999999999999999975 6778999999865432 3568899999999999999999999977 456999
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999876555444 44457899999999999999999999999999999999999999999999999999876433222
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+++.|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+.......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------- 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------- 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------------
T ss_pred ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC--------------
Confidence 2234456788999999875 568999999999999999999 899999988877777665431110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....++..+.+||.+||+.||.+|||+.+++++
T Consensus 226 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 --------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112456778999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=348.52 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=207.4
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|.+.+.||+|+||.||+|++ ..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 46899999999999999999984 4677899999997553 344567889999999999 99999999999987
Q ss_pred CCeEEEEEEecccChhhhhcCC-C-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP-T-----------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~-~-----------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
....++||||+.++.+..++.. . ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 4568999999988555444322 1 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999876544322 1233456889999999875 578999999999999999998 99999887665555
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+......+ .....++.++.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4444322111 0113467789999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=353.73 Aligned_cols=260 Identities=17% Similarity=0.132 Sum_probs=197.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECC---CCceEEEEEEecCCCChH---------HHHHHHHHHHHHHhCCCCceeeeee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPE---------SVRFMAREILILRRLDHPNVVKLEG 184 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~l~~ 184 (415)
.++|.+.+.||+|+||.||+|++.. ++..||+|++........ ....+.+|+.+++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999887 788999999986532110 1123557888999999999999999
Q ss_pred eEeec--CCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC--cEEE
Q 014960 185 LVTSR--MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG--ILTI 260 (415)
Q Consensus 185 ~~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~--~vkl 260 (415)
++... .....|+||||+ ++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 98762 246799999999 555555555545899999999999999999999999999999999999999887 9999
Q ss_pred EeeccccccCCCCC------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC--CChHHHHHH
Q 014960 261 ADFGLASFFDPNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG--RTEVEQLHK 332 (415)
Q Consensus 261 ~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~--~~~~~~~~~ 332 (415)
+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+ .+.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999987643221 11244578999999999886 5789999999999999999999999965 233333322
Q ss_pred HHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcC--CCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFK--DFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
........+.. +..... .+++++.+||..||..||.+|||++++++
T Consensus 274 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQS----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHH----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHH----------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 22222222111 111122 68889999999999999999999998875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=350.81 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=207.6
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-------CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-------LTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 188 (415)
.++|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 478999999999999999999875 456789999987543 455567888999999999 89999999999977
Q ss_pred cCCCeEEEEEEecccChhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAASPT----------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
...+|+||||+.++.+..++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 45799999999886655554332 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987654321 11233456888999999875 568999999999999999999 99999998887777
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+.+.... .....++.++.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 666543211 1113567789999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=344.73 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=204.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECC---CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|.+.+.||+|+||.||+|++.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CC
Confidence 4689999999999999999998643 34569999987653 44566788999999999999999999999865 34
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|+||||+.++.+..++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 68999999976655544 33456999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~----------- 234 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP----------- 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-----------
T ss_pred cccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-----------
Confidence 3333344556889999999875 568999999999999999998 999998877766666554432111
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....+++.+.+||.+||..||.+|||+.+++++
T Consensus 235 -----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 -----------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 112467789999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.81 Aligned_cols=253 Identities=24% Similarity=0.302 Sum_probs=203.9
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceE--EEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCC
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIV--ALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 191 (415)
...++|++.+.||+|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee--C
Confidence 34578999999999999999999998888865 999887432 334456788999999999 89999999999987 5
Q ss_pred CeEEEEEEecccChhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASPT----------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE 255 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 255 (415)
...|+||||+.++.+..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 6799999999876555544332 379999999999999999999999999999999999999999
Q ss_pred CcEEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014960 256 GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIF 334 (415)
Q Consensus 256 ~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (415)
+.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CeEEEcccCcCccccccc--cccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 999999999997543221 1233456889999999875 568999999999999999998 999999988777665553
Q ss_pred HhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..... .....+++++.+||.+||..||.+|||+++++++
T Consensus 256 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32100 1113467789999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.57 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=203.4
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|.+.+.||+|+||.||+|++ ..++..||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 46899999999999999999986 3456789999997543 233456788999999999 89999999999987
Q ss_pred CCeEEEEEEecccChhhhhcCC-C----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP-T----------------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~-~----------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 247 (415)
....|+||||+.++.+..++.. . ..+++..++.++.||+.||+|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 4569999999987655544432 2 2379999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCC
Q 014960 248 SNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT 325 (415)
Q Consensus 248 ~NILl~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~ 325 (415)
+|||++.++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999866443221 1233456889999999875 568999999999999999998 999998877
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 326 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....+..+......+ .....+++++.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 280 VDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 655555444422111 0113467789999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=345.68 Aligned_cols=269 Identities=21% Similarity=0.350 Sum_probs=201.6
Q ss_pred CCCceeeeeeccCCceEEEEEE----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.+.|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3579999999999999999998 67789999999997553 233456788999999999999999999999876556
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
.+|+||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 799999999886555554 4455799999999999999999999999999999999999999999999999999987765
Q ss_pred CCC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..|+.... .. ..+............ .
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~~~~~~~~~-~ 251 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM--AL---FLKMIGPTHGQMTVT-R 251 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HH---HHHHHCSCCGGGHHH-H
T ss_pred CCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh--hH---HhhccCCcccccCHH-H
Confidence 432 22334567888999999876 568899999999999999999998864321 11 111111111000000 0
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
... .............+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVN-------TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHH-------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHH-------HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 000 00000001112357788999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.61 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=198.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceE----EEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIV----ALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.+.||+|+||.||+|++..+++.+ |+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 468999999999999999999988887765 677665332 234456788999999999999999999999863
Q ss_pred eEEEEEEecccChhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++|+||+.++.+.. +......+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 3788899988765544 444456799999999999999999999999999999999999999999999999999987754
Q ss_pred CCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------- 239 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--------- 239 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred CcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---------
Confidence 4322 2223456889999999886 678999999999999999999 999999887766655554322111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....++.++.+||.+||..||.+|||+.+++++
T Consensus 240 -------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 -------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 113456778999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=371.98 Aligned_cols=250 Identities=20% Similarity=0.332 Sum_probs=208.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..++..||||++..... ..+.+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEEE
Confidence 4679999999999999999999998899999999975432 34678899999999999999999999987 456999
Q ss_pred EEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++. ....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++........
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 999999765555443 345689999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......+++.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+....+.+....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 438 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------- 438 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--------------
T ss_pred eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22333456788999999875 568999999999999999999 99999988776666555332110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 439 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 --------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 112357788999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=355.07 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=203.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 112 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMIL 112 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCCEE
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 46899999999999999999985 468899999887543 3445678899999999999999999999877 456999
Q ss_pred EEEecccChhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 197 VFKYMEHDLAGLAASPT----IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
||||+.++.+..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999987666655432 35899999999999999999999999999999999999999999999999999865432
Q ss_pred CC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 273 HK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 273 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+... ........+.
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 266 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNNGQLE 266 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHHTTTCCC
T ss_pred cccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhccccccHH
Confidence 22 22234568999999999875 56899999999999999999999999875432211111000 0000000000
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.. .... .........+..+.++|.+||+.||++|||+.+++++
T Consensus 267 ~~--~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 267 QI--VDPN-----LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SS--SSSS-----CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hh--cChh-----hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0000 0000111234567899999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=348.72 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=205.8
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++ ..+++.||+|++.... .......+.+|+.++.++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 46899999999999999999984 4577899999997553 345566788999999999 799999999998764
Q ss_pred CCeEEEEEEecccChhhhhcCCCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIK----------------FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~----------------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 254 (415)
+..+|+||||+.++.+..++..... +++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4568999999998655554433222 899999999999999999999999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014960 255 EGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHK 332 (415)
Q Consensus 255 ~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~ 332 (415)
++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 999999999999876543221 2234567889999999875 568999999999999999998 9999988664443333
Q ss_pred HHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.......+ .....++.++.++|.+||+.||.+|||+.++++|
T Consensus 263 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33221111 0112467789999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=364.51 Aligned_cols=277 Identities=20% Similarity=0.290 Sum_probs=207.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.++++++||||+++++++........|+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4689999999999999999999999999999999975432 223456778999999999999999999998765567899
Q ss_pred EEEecccChhhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE----cCCCcEEEEeecccccc
Q 014960 197 VFKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI----DNEGILTIADFGLASFF 269 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DfG~a~~~ 269 (415)
||||+.++.+..++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999998866666554422 39999999999999999999999999999999999999 77778999999999876
Q ss_pred CCCCCCCcccccccCccCCcccccCC-------cCCCchhcHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHHHhcC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGA-------TDYGVGVDLWSAGCILAELLAEKPIMPG----RTEVEQLHKIFKLCG 338 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~sDvwSlG~il~ell~g~~pf~~----~~~~~~~~~i~~~~~ 338 (415)
.... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. ....+.+..+....
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~- 243 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK- 243 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC-
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC-
Confidence 5432 23456789999999988531 4578899999999999999999999975 33445555554432
Q ss_pred CCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+ ...|............-...+. ........++..+.++|.+||..||++|||+.++++
T Consensus 244 -p-~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 244 -P-SGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp -C-TTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred -C-cccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 1 1111110000000000000000 000001123446789999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.50 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=208.2
Q ss_pred CCCceeee-eeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLD-KIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CC
Confidence 35677776 9999999999999853 467889999997652 45567788999999999999999999999843 45
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|+||||+.++.+..++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 89999999986555544 44567999999999999999999999999999999999999999999999999999877543
Q ss_pred CC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 273 HK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 273 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.+....
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---------- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC----------
T ss_pred cceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC----------
Confidence 22 11233456889999999875 568999999999999999998 99999998887777666442110
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....+++++.+||.+||..||.+||++.+++++
T Consensus 233 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 233 ------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp ------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123577889999999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=340.61 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=206.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++. ++..||+|++..... ..+.+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEE
Confidence 468999999999999999999864 567899999975532 24568899999999999999999998864 34899
Q ss_pred EEEecccChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999998877666665432 689999999999999999999999999999999999999999999999999987754433
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......+++.|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+.+....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC--------------
Confidence 33334456888999999875 568999999999999999999 99999998887776666432110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+++++.+||.+||..||++|||++++++
T Consensus 230 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 230 --------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011356788999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=351.97 Aligned_cols=253 Identities=16% Similarity=0.237 Sum_probs=208.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|++. .+++.||+|.+.... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--C
Confidence 468999999999999999999876 457889999987543 34455678899999999999999999999977 4
Q ss_pred CeEEEEEEecccChhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEE
Q 014960 192 CSLYLVFKYMEHDLAGLAASP----------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 261 (415)
...|+||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 568999999988655544322 2467999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 014960 262 DFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 262 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.+....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 9999976543221 11223456889999999875 568999999999999999999 89999988877776665442110
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++.++.+||.+||..||.+|||+.+++++
T Consensus 260 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 ----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1123577789999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=350.53 Aligned_cols=257 Identities=18% Similarity=0.271 Sum_probs=203.8
Q ss_pred CCCCceeeeeeccCCceEEEEEE-----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC
Q 014960 116 RADTFEKLDKIGQGTYSNVYKAR-----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM 190 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 190 (415)
..++|++.+.||+|+||.||+|+ +..++..||+|++... ........+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 35789999999999999999998 5567889999998644 244556678899999999999999999999887
Q ss_pred CCeEEEEEEecccChhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC---CcEEE
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPT-------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE---GILTI 260 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl 260 (415)
....|+||||+.++.+..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 45689999999775554443221 358999999999999999999999999999999999999854 46999
Q ss_pred EeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 014960 261 ADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCG 338 (415)
Q Consensus 261 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~ 338 (415)
+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999976533221 22234567899999999875 568999999999999999998 9999998887777666644221
Q ss_pred CCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
. .....++..+.+||.+||..||.+|||+.+++++.|+
T Consensus 264 ~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 264 M----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1 0113567789999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=350.45 Aligned_cols=267 Identities=22% Similarity=0.309 Sum_probs=206.2
Q ss_pred CCCceeeeeeccCCceEEEEEE----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++|+||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4789999999999999999998 5778999999998754 355667789999999999999999999998765567
Q ss_pred eEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..|+||||+.++.+..++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 89999999987666555433 44699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC-HHHHhhC
Q 014960 272 NHKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPS-EEYWKKS 348 (415)
Q Consensus 272 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 348 (415)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.............. ...+. .......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-RDVPALSRLLELL 257 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc-cccccHHHHHHHh
Confidence 3321 2233467888999999876 5689999999999999999999999875433211100000 00000 0000000
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
...........+++++.+||.+||..||.+|||+.++++
T Consensus 258 -------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 258 -------------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp -------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000001112457788999999999999999999999964
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=348.90 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=186.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEee------cC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTS------RM 190 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~------~~ 190 (415)
.+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++++. |+||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 5799999999999999999999999999999998654 3455667889999999995 9999999998842 22
Q ss_pred CCeEEEEEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 191 SCSLYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
...+++||||+.+++...+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 456899999999877665543 3457999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCC-----------cccccccCccCCccccc--CCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014960 267 SFFDPNHKQP-----------MTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333 (415)
Q Consensus 267 ~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~--~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i 333 (415)
.......... .....||+.|+|||++. ....++.++|||||||++|+|++|..||............
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 265 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence 8765432211 11346899999999883 2356889999999999999999999999765443222111
Q ss_pred HHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.. .......+..+.+||.+||+.||.+|||+++++++
T Consensus 266 ~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 266 YS-------------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp CC-------------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cc-------------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 00113456678999999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.62 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=195.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++|+||+++++++.. ....+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEE
Confidence 4689999999999999999999999999999999986433 45667788999999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 196 LVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
+||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999865554442 355789999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT--EVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.. .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.. .......+.. ...+.
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-------- 257 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP-------- 257 (310)
T ss_dssp -----------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCC--------
T ss_pred CC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCC--------
Confidence 32 22234578999999999876 578999999999999999999999997643 2223322221 11100
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 258 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 258 ------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001356778999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=362.96 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=194.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+|.+.+.||+|+||.||. ....+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+ ....|+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEE
Confidence 4699999999999999663 3357889999999875432 2345799999999 79999999999887 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---C--CcEEEEeeccccccCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---E--GILTIADFGLASFFDP 271 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~--~~vkl~DfG~a~~~~~ 271 (415)
||||+++++...+......+.+..++.++.||+.||+|||++||+||||||+||||+. + ..+||+|||++.....
T Consensus 96 v~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9999999888877776666777778899999999999999999999999999999953 2 3588999999987654
Q ss_pred CCC--CCcccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 272 NHK--QPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 272 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
... .......||+.|+|||++.+ ...++.++|||||||++|+|++ |.+||.......... +. .......+
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~---~~~~~~~~- 250 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LL---GACSLDCL- 250 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HT---TCCCCTTS-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-Hh---ccCCcccc-
Confidence 321 22344678999999999874 2457789999999999999999 899996654433221 11 11100000
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
......+..+.+||.+||+.||.+|||++++|+||||..+
T Consensus 251 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 251 ---------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ---------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ---------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 0001122346789999999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=365.35 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=206.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+|++++||||+++++++.. ..+|+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~l 259 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 259 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---CccEE
Confidence 468999999999999999999875 46789999997643 235678899999999999999999999863 45899
Q ss_pred EEEecccChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++........
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999886665555432 3689999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......+++.|+|||++.. ..++.++|||||||+||||++ |.+||.+.+..+....+.+....+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 405 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------------- 405 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------------
T ss_pred eccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 22233445788999999875 568999999999999999999 999999988888887776532211
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+++++.+||.+||..||.+|||++++++
T Consensus 406 ---------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ---------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11356788999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=349.14 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=198.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceE----EEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIV----ALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++++.||+|+||.||+|++..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence 478999999999999999999998888766 556554332 334456788999999999999999999999863
Q ss_pred eEEEEEEecccChhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++|+|++.++.+.. +......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 3788889888765544 444456799999999999999999999999999999999999999999999999999987644
Q ss_pred CCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 239 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--------- 239 (327)
T ss_dssp ----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred ccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 322 12233456888999999986 678999999999999999999 999999887776665554322111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.+||.+||..||.+|||+.++++
T Consensus 240 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 -------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11346677999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.17 Aligned_cols=253 Identities=19% Similarity=0.320 Sum_probs=201.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
..+|.+.+.||+|+||.||+|++..++ ..||+|++.... .......+.+|+.+++.++|+||+++++++.. ..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--CC
Confidence 468999999999999999999876543 459999997543 44556678899999999999999999999876 55
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..|+||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 799999999885555444 4456799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC--cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 272 NHKQP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 272 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.+....+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~-------- 270 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-------- 270 (333)
T ss_dssp -----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------
T ss_pred ccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC--------
Confidence 32211 122345788999999875 578999999999999999998 999999888877776664421111
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....++.++.+||.+||..||.+||++.+++++
T Consensus 271 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 --------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp --------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112467788999999999999999999998763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=362.78 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=191.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+ ..+.+.+|+.+++++ +|||||++++++.+ ...+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEE
Confidence 3567778899999999998753 567999999998743 235577899999876 89999999999876 56799
Q ss_pred EEEEecccChhhhhcCCCCC------CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-------------C
Q 014960 196 LVFKYMEHDLAGLAASPTIK------FTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-------------G 256 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-------------~ 256 (415)
+||||+++++...+...... .++..++.++.||+.||+|||++||+||||||+||||+.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999988666555443211 1334567899999999999999999999999999999754 4
Q ss_pred cEEEEeeccccccCCCCCC---CcccccccCccCCcccccC------CcCCCchhcHHHHHHHHHHHHh-CCCCCCCCCh
Q 014960 257 ILTIADFGLASFFDPNHKQ---PMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-EKPIMPGRTE 326 (415)
Q Consensus 257 ~vkl~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~ 326 (415)
.+||+|||++......... ......||+.|+|||++.+ ...++.++|||||||++|||++ |.+||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 7999999999887644321 1234578999999999864 2468999999999999999999 9999977654
Q ss_pred HHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 327 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.+ ..+.+........ .. . ....++.++.+||.+||+.||.+|||+.++|+||||..
T Consensus 246 ~~--~~i~~~~~~~~~~----------~~----------~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEM----------KC----------L--HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCCCCC----------TT----------C--CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCcccc----------cc----------c--ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 43 2333322111000 00 0 00123456889999999999999999999999999964
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=374.20 Aligned_cols=245 Identities=19% Similarity=0.260 Sum_probs=203.3
Q ss_pred eeeccCCceEEEEEEE--CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARD--TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
++||+|+||.||+|.+ ..+++.||||++..........+.+.+|+.+|++++|+|||++++++.. ..+++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 4799999999999954 5667899999998665555567789999999999999999999999864 3489999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--CCccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK--QPMTS 279 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~--~~~~~ 279 (415)
.++.+..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+..... .....
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9877777666666899999999999999999999999999999999999999999999999999987754332 12233
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
..+|+.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+.+....+
T Consensus 532 ~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------------ 592 (635)
T 4fl3_A 532 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------ 592 (635)
T ss_dssp ---CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------
T ss_pred CCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 456788999999975 679999999999999999998 999999998888777765432111
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+++++.+||..||..||++|||++++++
T Consensus 593 ----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 ----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 12357788999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=360.82 Aligned_cols=244 Identities=20% Similarity=0.341 Sum_probs=201.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+ .|+.||||++.... ..+.+.+|+.+|++++||||+++++++... ...+|+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEE
Confidence 57899999999999999999976 47899999997543 345688999999999999999999998763 346999
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999988655554433 2247999999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+.+....
T Consensus 344 ---~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------- 405 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------- 405 (450)
T ss_dssp ------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC--------------
T ss_pred ---cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22356889999999976 679999999999999999998 99999987777666665432110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+++++.+||.+||..||.+|||+.++++
T Consensus 406 --------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 --------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112357788999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=347.78 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=205.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc-----eEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ-----IVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 4689999999999999999999876664 79999987543 345567888999999999 89999999999977
Q ss_pred CCeEEEEEEecccChhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP--------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG 256 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 256 (415)
....|+||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 4569999999987554443321 34689999999999999999999999999999999999999999
Q ss_pred cEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014960 257 ILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIF 334 (415)
Q Consensus 257 ~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 334 (415)
.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999865433221 1233456889999999875 568999999999999999998 999998876655555554
Q ss_pred HhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 335 KLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+. .....+.++.+||.+||..||.+|||+.++++
T Consensus 281 ~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 281 KDGYQMA---------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCC---------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 4321110 11235677899999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=337.52 Aligned_cols=253 Identities=25% Similarity=0.293 Sum_probs=202.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.-.|.+.+.||+|+||.||+|++..++. .||+|.+... ......+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 97 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGL 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCC
Confidence 3467788999999999999998655544 7999998753 3445667888999999999999999999999764 344
Q ss_pred EEEEEEecccChhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.++||||+.++.+. .+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 58999999765544 44454667999999999999999999999999999999999999999999999999999765432
Q ss_pred C---CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 273 H---KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 273 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP-------- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC--------
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC--------
Confidence 1 112234567889999999876 678999999999999999999 556666666655555544322111
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+++++.+||.+||..||.+|||+.++++
T Consensus 249 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 249 --------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11346778999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=339.19 Aligned_cols=253 Identities=20% Similarity=0.238 Sum_probs=202.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
..+|++.+.||+|+||.||+|++..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++... ...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CCc
Confidence 457999999999999999999865433 45899988753 3455667888999999999999999999986543 456
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|+||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 89999999986555544 44567899999999999999999999999999999999999999999999999999866432
Q ss_pred CC---CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 273 HK---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 273 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.+.....
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-------- 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC--------
T ss_pred chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC--------
Confidence 21 11233456889999999875 568999999999999999999 778887777666665554422111
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+++++.++|.+||..||.+|||+.++++
T Consensus 253 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 253 --------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11246777999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=344.80 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=201.6
Q ss_pred CceeeeeeccCCceEEEEEE----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 119 TFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
.|++++.||+|+||.||++. +..+++.||||++... ......+.+.+|+.++++++||||+++++++.+.....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 34999999999999998874 4457899999999865 345566788999999999999999999999988656789
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999987766666544 589999999999999999999999999999999999999999999999999987754432
Q ss_pred --CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH-----------HHHHHHhcCCCC
Q 014960 275 --QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-----------LHKIFKLCGSPS 341 (415)
Q Consensus 275 --~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~-----------~~~i~~~~~~~~ 341 (415)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+.+..
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 264 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL---- 264 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH----
T ss_pred ccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH----
Confidence 11233457888999999876 5688999999999999999999999975322110 00011000
Q ss_pred HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
... ........++.++.+||.+||..||.+|||+.++++
T Consensus 265 ----~~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ----ERG----------------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp ----HTT----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----hcc----------------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 001112357788999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=351.70 Aligned_cols=255 Identities=17% Similarity=0.164 Sum_probs=198.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECC--------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceee-------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL--------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVK------- 181 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~------- 181 (415)
.++|++.+.||+|+||.||+|++.. .++.||+|++... ..+.+|+.++++++|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4789999999999999999999887 4889999999754 34678999999999999987
Q ss_pred --------eeeeEeecCCCeEEEEEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 182 --------LEGLVTSRMSCSLYLVFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 182 --------l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
+++++... ....|+||||+++++...+... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 55666542 5679999999955555444432 3579999999999999999999999999999999999999
Q ss_pred cCCC--cEEEEeeccccccCCCCC------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC
Q 014960 253 DNEG--ILTIADFGLASFFDPNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR 324 (415)
Q Consensus 253 ~~~~--~vkl~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~ 324 (415)
+.++ .+||+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 899999999987653221 12234578999999999886 57899999999999999999999999875
Q ss_pred C--hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 325 T--EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 325 ~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
. .......+......+.... . .......++.++.+||.+||..||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~--~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFV--G------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEE--C------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhh--h------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 3 3333333322211111000 0 00112357888999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=340.52 Aligned_cols=255 Identities=25% Similarity=0.309 Sum_probs=194.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--CCCCceeeeeeeEeec--CCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR--LDHPNVVKLEGLVTSR--MSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~--~~~ 192 (415)
.++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 46899999999999999999976 6899999998642 33455567777776 7999999999986542 235
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH--------NQHVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
..|+||||+.++.+..++.. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 68999999998777666644 47999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCC---CcccccccCccCCcccccCCc-----CCCchhcHHHHHHHHHHHHhC----------CCCCCCCC-
Q 014960 265 LASFFDPNHKQ---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAE----------KPIMPGRT- 325 (415)
Q Consensus 265 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~sDvwSlG~il~ell~g----------~~pf~~~~- 325 (415)
++......... ......||+.|+|||++.+.. .++.++|||||||++|||++| .+||....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99766443221 123347899999999987632 345799999999999999999 88886532
Q ss_pred ---hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 326 ---EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 326 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+..+......... .+ ........+.++.+||.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~--------------~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPN--------------IP-------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCC--------------CC-------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCC--------------CC-------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22222222211110000 00 00001123456889999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=352.42 Aligned_cols=276 Identities=20% Similarity=0.264 Sum_probs=201.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|.+.+.||+|+||.||+|++ .+|+.||+|++...... .....+.+|+.+++.++|+||+++++++.. ....++
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 104 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 104 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCCEE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec--CCceEE
Confidence 46899999999999999999974 46889999998765322 222357889999999999999999999987 456899
Q ss_pred EEEecccChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 197 VFKYMEHDLAGLAASP----TIKFTQAQVKCYMHQLLSGLEHCHNQ---HVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
||||+.++.+..++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 9999998666555432 23499999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ........|....
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~ 255 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAN--------DDDVMLLDWVKGL 255 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT--------TSCSBHHHHHTTT
T ss_pred CcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCccccccccc--------ccchhHHHHHHHH
Confidence 6544444455568999999999875 568999999999999999999999995210000 0000001111100
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
........... ...........+..+.+||..||+.||.+|||+.++++|-.-..+
T Consensus 256 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVD--VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSC--TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcC--hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 00000000000 000000011123568899999999999999999999987544333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.87 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=204.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|++++||||+++++++.. ...|+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEE
Confidence 4689999999999999999998764 467999999765432 3568899999999999999999999865 45899
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999998766655542 34689999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......+++.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+....+.+....+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 401 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 401 (452)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 22334456788999999875 578999999999999999999 999999988888777665432111
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc--CCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEVSLYM 407 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~--h~~f~~~ 407 (415)
....+++++.+||.+||..||++|||++++++ ..+|...
T Consensus 402 ---------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 402 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 11356778999999999999999999999986 3555543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=366.13 Aligned_cols=254 Identities=17% Similarity=0.199 Sum_probs=196.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCC-Cceee-------------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH-PNVVK------------- 181 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~------------- 181 (415)
...|.+.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.+.| .|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4568899999999999999999999999999999874432 33345678899999999977 22111
Q ss_pred --------eeeeEeec---CCCeEEEEEEecccChhhhh------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecc
Q 014960 182 --------LEGLVTSR---MSCSLYLVFKYMEHDLAGLA------ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRD 244 (415)
Q Consensus 182 --------l~~~~~~~---~~~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrD 244 (415)
+..++... ....++++|+++.+++...+ ......+++..++.++.||+.||+|||++||+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111111 12347888998888776655 23344678889999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccccCccCCccccc---------CCcCCCchhcHHHHHHHHHHHH
Q 014960 245 IKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL---------GATDYGVGVDLWSAGCILAELL 315 (415)
Q Consensus 245 lkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~sDvwSlG~il~ell 315 (415)
|||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999998765432 344567 9999999983 3356888999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCH
Q 014960 316 AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395 (415)
Q Consensus 316 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 395 (415)
+|+.||.+.+..+.... +......+|+++.+||.+||+.||.+|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHH---------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999976543221111 112224678899999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 014960 396 TAALRSEVSLYMX 408 (415)
Q Consensus 396 ~~~L~h~~f~~~~ 408 (415)
.++|+||||+.+.
T Consensus 359 ~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 359 LQAMETPEYEQLR 371 (413)
T ss_dssp HHHTTSHHHHHHH
T ss_pred HHHHhCHHHHHHH
Confidence 9999999998653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.98 Aligned_cols=253 Identities=21% Similarity=0.241 Sum_probs=203.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~~~ 195 (415)
.++|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.|.|.+ |+.+..++.. ....|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEE
Confidence 57899999999999999999999999999999998765432 23668999999998755 4444444444 56789
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE---cCCCcEEEEeeccccccCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DfG~a~~~~~~ 272 (415)
|||||+++.+...+......+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||++..+...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999766666665556689999999999999999999999999999999999999 68899999999999876543
Q ss_pred CCC------CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCHH
Q 014960 273 HKQ------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 273 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 343 (415)
... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||.+... .+.+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~--- 235 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT--- 235 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS---
T ss_pred ccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc---
Confidence 321 1225678999999999986 6789999999999999999999999987543 33343333321111
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.+......++.++.+||..||..||.+||+++++++
T Consensus 236 ---------------------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 ---------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ---------------------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ---------------------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 123334578899999999999999999999987764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=344.57 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=199.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec--CCCeE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSL 194 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~~ 194 (415)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46899999999999999999999999999999998754 355667888999999999999999999998632 24578
Q ss_pred EEEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 195 YLVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
|+||||+.++.+...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999865544332 35679999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC--------CcccccccCccCCcccccCCc--CCCchhcHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcC
Q 014960 271 PNHKQ--------PMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAEKPIMPGRTE--VEQLHKIFKLCG 338 (415)
Q Consensus 271 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~--~~~~~sDvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~ 338 (415)
..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||..... ......+ ....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~ 264 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-QNQL 264 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-HCC-
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-hccC
Confidence 21110 012235699999999986532 368899999999999999999999953110 0011111 1000
Q ss_pred CCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 339 SPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.......++.++.+||.+||+.||.+|||+++++++
T Consensus 265 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 ---------------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 000113567789999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=336.19 Aligned_cols=246 Identities=25% Similarity=0.413 Sum_probs=201.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEee--------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS-------- 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-------- 188 (415)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 357999999999999999999999999999999998543 245689999999999999999998754
Q ss_pred ------cCCCeEEEEEEecccChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEE
Q 014960 189 ------RMSCSLYLVFKYMEHDLAGLAAS--PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTI 260 (415)
Q Consensus 189 ------~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl 260 (415)
.....+|+||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 11345899999999866655543 2357999999999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 014960 261 ADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSP 340 (415)
Q Consensus 261 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 340 (415)
+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||... ......+...
T Consensus 164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~---- 234 (284)
T 2a19_B 164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG---- 234 (284)
T ss_dssp CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT----
T ss_pred Ccchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc----
Confidence 9999998765432 2344578999999999876 56899999999999999999999887421 1111111100
Q ss_pred CHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 341 SEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....++.++.+||.+||..||.+|||+.+++++.+.
T Consensus 235 ---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 235 ---------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0112467778999999999999999999999998664
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=350.88 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=195.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
...|.+.+.||+|+||.||+|++..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++... ...
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCC
Confidence 346889999999999999999865432 46899988653 2345667888999999999999999999987543 356
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|+||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 89999999986555444 44557899999999999999999999999999999999999999999999999999866432
Q ss_pred CCC---CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 273 HKQ---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 273 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.+.....
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-------- 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-------- 316 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC--------
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 211 1233456788999999875 678999999999999999999 788998876666555543321100
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....++.++.++|.+||..||.+|||+.+++++
T Consensus 317 --------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 --------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 113467789999999999999999999998863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=365.69 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=201.6
Q ss_pred CCceeee-eeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 118 DTFEKLD-KIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 118 ~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
+++.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|++++|+|||++++++.. ..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCe
Confidence 4566666 8999999999999765 456679999997653 33456778899999999999999999999875 349
Q ss_pred EEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 195 YLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
|+||||+.++.+..++ .....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999987666554 445579999999999999999999999999999999999999999999999999998765432
Q ss_pred CC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 274 KQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 274 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
.. ......+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..++...+.+....
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----------- 558 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----------- 558 (613)
T ss_dssp -----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-----------
T ss_pred ceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 21 1122345688999999875 579999999999999999998 99999998888877776543211
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHh
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L 399 (415)
.....+++++.+||..||..||.+||++.+++
T Consensus 559 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 559 -----------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp -----------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred -----------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 11235788899999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=336.65 Aligned_cols=244 Identities=20% Similarity=0.335 Sum_probs=193.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++|+||+++++++... ....|+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEE
Confidence 46899999999999999999976 48899999987542 345688999999999999999999987553 346899
Q ss_pred EEEecccChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTI--KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 999998855544443322 38999999999999999999999999999999999999999999999999997654321
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
....+++.|+|||++.+ ..++.++||||||+++|+|++ |.+||...+..+....+.+...
T Consensus 172 ---~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 232 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------- 232 (278)
T ss_dssp -------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---------------
T ss_pred ---cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 23456889999999875 578999999999999999998 9999988776665554432110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
......+++++.++|.+||..||.+|||+.++++
T Consensus 233 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 233 -------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0112356788999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=338.08 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=197.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECC-CCc--eEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL-TGQ--IVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++.+.||+|+||.||+|++.. ++. .||+|++..... .....+.+.+|+.++++++|+||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4689999999999999999998543 333 689999876543 345667889999999999999999999998763
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
..++||||+.++.+...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 388999999875544433 3345689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 272 NHKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 272 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+.+....+.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 245 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------- 245 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-------
T ss_pred cccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC-------
Confidence 3321 1223456888999999875 568899999999999999999 9999999888777766654321111
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.++|.+||..||.+|||+.++++
T Consensus 246 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 --------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11357788999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=341.06 Aligned_cols=251 Identities=20% Similarity=0.253 Sum_probs=201.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++.. .||+|++..........+.+.+|+.++++++|+||+++++++.. ....++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~i 106 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLAI 106 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceEE
Confidence 4689999999999999999998753 49999997654444444567789999999999999999999987 456999
Q ss_pred EEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC---
Q 014960 197 VFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN--- 272 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~--- 272 (415)
||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 9999987666655544 44799999999999999999999999999999999999998 689999999998765321
Q ss_pred -CCCCcccccccCccCCcccccC--------CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Q 014960 273 -HKQPMTSRVVTLWYRPPELLLG--------ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343 (415)
Q Consensus 273 -~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 343 (415)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 262 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--- 262 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC---
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC---
Confidence 1122334568999999999864 2357899999999999999999999999888777766654321110
Q ss_pred HHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....++.++.+||.+||..||.+|||+.++++
T Consensus 263 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 ------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011257889999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.34 Aligned_cols=241 Identities=25% Similarity=0.371 Sum_probs=190.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++ .++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEE
Confidence 46899999999999999999976 4788999998632 345678899999999999999999998764 3789
Q ss_pred EEEecccChhhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCeeccCCCCCEEEcCCCc-EEEEeecccccc
Q 014960 197 VFKYMEHDLAGLAASPTI---KFTQAQVKCYMHQLLSGLEHCHN---QHVLHRDIKGSNLLIDNEGI-LTIADFGLASFF 269 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NILl~~~~~-vkl~DfG~a~~~ 269 (415)
||||+.++.+..++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999998866665554332 47899999999999999999999 89999999999999998886 799999999765
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHHhh
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 347 (415)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+....
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------- 221 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---------- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC----------
T ss_pred ccc----cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC----------
Confidence 432 234468999999999876 57899999999999999999999999764322 2222221110
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.......++..+.+||.+||..||.+|||++++++
T Consensus 222 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 ------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00112357788999999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=365.92 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=208.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||+|+||.||+|++.. +..||||++...... .+.+.+|+.+|++++|+||+++++++.. ..+||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceE
Confidence 3678999999999999999998764 467999999865432 3568899999999999999999999865 45899
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++.. ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++........
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999988666555542 34689999999999999999999999999999999999999999999999999987643221
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......++..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+++..+.+....+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 484 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 484 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 12233456788999999875 578999999999999999999 999999988888777765432111
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC--CCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS--EVSLYM 407 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h--~~f~~~ 407 (415)
....+++++.+||.+||..||++|||++++++. .+|...
T Consensus 485 ---------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 485 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 113567789999999999999999999999864 555443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=376.31 Aligned_cols=283 Identities=23% Similarity=0.271 Sum_probs=207.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEee----cCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS----RMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~ 192 (415)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ......+.+.+|+.++++++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 46899999999999999999999999999999998754 345666788999999999999999999998754 1245
Q ss_pred eEEEEEEecccChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc---EEEEeeccc
Q 014960 193 SLYLVFKYMEHDLAGLAASPT---IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI---LTIADFGLA 266 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DfG~a 266 (415)
..|+||||+.++.+..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 689999999876665554332 26899999999999999999999999999999999999997765 999999999
Q ss_pred cccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............ ........
T Consensus 172 ~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~---~~~~~~~~ 245 (676)
T 3qa8_A 172 KELDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNEHIV 245 (676)
T ss_dssp CBTTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---------CC
T ss_pred ccccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh---cccchhhh
Confidence 8775443 2345678999999999876 6789999999999999999999999987543322111000 00000000
Q ss_pred h-CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 347 K-SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 347 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
. ........+....+. .......+++.+.+||.+||..||.+|||++++|+||||+.+.+
T Consensus 246 ~~~~l~g~~~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp SCCCCSSSCCCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhhccccccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0 000000000000000 01112235567899999999999999999999999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=337.27 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=187.7
Q ss_pred CCCceee-eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHH-HhCCCCceeeeeeeEee--cCCC
Q 014960 117 ADTFEKL-DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILIL-RRLDHPNVVKLEGLVTS--RMSC 192 (415)
Q Consensus 117 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~--~~~~ 192 (415)
.++|.+. +.||+|+||.||+|++..+++.||+|++... ..+.+|+.++ +.++|+||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4678887 7799999999999999999999999998632 3466788888 56699999999999865 2245
Q ss_pred eEEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---CCcEEEEeecccc
Q 014960 193 SLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLAS 267 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DfG~a~ 267 (415)
.+|+||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 68999999988555444432 346999999999999999999999999999999999999998 7889999999986
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
... ...++.++|||||||++|+|++|.+||.+.........+.....
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~--------- 215 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--------- 215 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC---------
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh---------
Confidence 432 13477899999999999999999999977554332211100000
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
... ..........++.++.+||.+||+.||.+|||++++|+||||+.....
T Consensus 216 ---------~~~---~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 216 ---------MGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp ---------TTC---CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred ---------hcc---ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 000 000112235678899999999999999999999999999999876543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=336.03 Aligned_cols=262 Identities=24% Similarity=0.273 Sum_probs=200.8
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCC--CChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDN--LEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
..|...+.||+|+||.||+|++ +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+ ....|
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 106 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLC 106 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceE
Confidence 3456668999999999999974 68899999987543 234456788999999999999999999999977 45699
Q ss_pred EEEEecccChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 196 LVFKYMEHDLAGLAAS---PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
+||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 9999998765554432 2346899999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--CCHHHHhhCC
Q 014960 273 HKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS--PSEEYWKKSK 349 (415)
Q Consensus 273 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~ 349 (415)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+.+.... .....|....
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 221 1233578999999998865 4789999999999999999999999876544333333222111 1111111000
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+.......+..+.++|.+||..||.+|||+.+++++
T Consensus 265 ----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 ----------------MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ----------------CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000111234567889999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=337.79 Aligned_cols=269 Identities=22% Similarity=0.340 Sum_probs=201.2
Q ss_pred CCCceeeeeeccCCceEEEEEE----ECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKAR----DTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++|+||+++++++......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4679999999999999999998 4678999999998754 345567889999999999999999999998765455
Q ss_pred eEEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCC
Q 014960 193 SLYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDP 271 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~ 271 (415)
.+++||||+.++.+..++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 789999999875555444 3445699999999999999999999999999999999999999999999999999987754
Q ss_pred CCCC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 272 NHKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 272 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||..... +. .+..+......+....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~-~~----~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-EF----MRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-HH----HHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-HH----HHhhccccchhhhHHH
Confidence 3321 1223456778999999876 5688999999999999999999998864211 11 1111111100000000
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+... ............++.++.+||.+||..||.+|||+.++++
T Consensus 272 ~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIEL-------LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHH-------HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHH-------hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 0000000112357788999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=347.48 Aligned_cols=245 Identities=17% Similarity=0.163 Sum_probs=191.7
Q ss_pred CCCceeeeeeccCCceEEEEE-----EECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKA-----RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~ 188 (415)
.++|.+.+.||+|+||.||+| .+..+++.||+|++... ....+.+|+.+++.+. |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 468999999999999999999 46778999999998743 2345677888888886 9999999999887
Q ss_pred cCCCeEEEEEEecccChhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---------
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAAS-----PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--------- 254 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--------- 254 (415)
....|+||||+.++.+..++. ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 456899999999876655543 3557999999999999999999999999999999999999998
Q ss_pred --CCcEEEEeeccccccCC-CCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014960 255 --EGILTIADFGLASFFDP-NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLH 331 (415)
Q Consensus 255 --~~~vkl~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~ 331 (415)
++.+||+|||+|..... .........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~---- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG---- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC----
Confidence 89999999999975432 11223455679999999999987 56899999999999999999999999643220
Q ss_pred HHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCC
Q 014960 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402 (415)
Q Consensus 332 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~ 402 (415)
.|.... . ... ...++.+.+++..||+.+|.+|++..+.|++.
T Consensus 292 ------------~~~~~~-----------~----~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 292 ------------ECKPEG-----------L----FRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ------------EEEECS-----------C----CTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ------------ceeech-----------h----ccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000000 0 000 01234567799999999999998766666544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=335.82 Aligned_cols=255 Identities=25% Similarity=0.303 Sum_probs=188.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC--CCCceeeeeeeEeecCC--C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL--DHPNVVKLEGLVTSRMS--C 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~~--~ 192 (415)
.++|++.+.||+|+||.||+|++. ++.||||++... ....+.+|.+++..+ +|+||+++++++..... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 368999999999999999999764 899999998643 223444566666554 89999999999876422 6
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeccCCCCCEEEcCCCcEEEEeec
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ--------HVLHRDIKGSNLLIDNEGILTIADFG 264 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DfG 264 (415)
..|+||||+.++.+..++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 799999999886666555433 689999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCC---CcccccccCccCCcccccCCcCCCc------hhcHHHHHHHHHHHHhC----------CCCCCCCC
Q 014960 265 LASFFDPNHKQ---PMTSRVVTLWYRPPELLLGATDYGV------GVDLWSAGCILAELLAE----------KPIMPGRT 325 (415)
Q Consensus 265 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~------~sDvwSlG~il~ell~g----------~~pf~~~~ 325 (415)
++..+...... ......||+.|+|||++.+. .+.. ++|||||||++|||++| ..||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99776543321 12345789999999998763 3333 49999999999999999 66665422
Q ss_pred ----hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 326 ----EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 326 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.......+......... +. .......+++++.+||.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~-------------------~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPS-------------------FP--NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCC-------------------CC--GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCcc-------------------cc--ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11222222111100000 00 000012344568899999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=363.33 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=205.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC---CceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|++.+.||+|+||.||+|++..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++.+ ..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 46899999999999999999987543 467999988653 234556788899999999999999999999854 45
Q ss_pred EEEEEEecccChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAAS-PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.|+||||+.++.+..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 899999999766555443 4457999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+......+
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 612 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----------- 612 (656)
T ss_dssp ---------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC-----------
T ss_pred cceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 3333334456789999999875 578999999999999999997 999999988888877775532111
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.+||.+||..||.+|||+.++++
T Consensus 613 -----------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 -----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11356788999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.09 Aligned_cols=276 Identities=25% Similarity=0.266 Sum_probs=189.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHH--HHhCCCCceeeeeeeEee---cCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI--LRRLDHPNVVKLEGLVTS---RMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~l~~~~~~---~~~ 191 (415)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.++ +..++|+||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 57899999999999999999965 68999999997432 2333344444 445899999999986533 223
Q ss_pred CeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeeccCCCCCEEEcCCCcEEEEe
Q 014960 192 CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ---------HVLHRDIKGSNLLIDNEGILTIAD 262 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---------~ivHrDlkp~NILl~~~~~vkl~D 262 (415)
..+|+||||+.++.+..++... .+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 4679999999886666555433 458999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCC-------CCCcccccccCccCCcccccCC------cCCCchhcHHHHHHHHHHHHhCCCCCC-CCChHH
Q 014960 263 FGLASFFDPNH-------KQPMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLAEKPIMP-GRTEVE 328 (415)
Q Consensus 263 fG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~sDvwSlG~il~ell~g~~pf~-~~~~~~ 328 (415)
||++..+.... ........||+.|+|||++.+. ..++.++|||||||++|||++|..||. +....+
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99998764321 1122345789999999998752 346678999999999999999965553 322111
Q ss_pred HHHHHHHhcC-CCCHHHHhhCCCCCCCcCCCcchhhhhhhhh---cCCCCCChHHHHHHhcccCCCCCCCHHHH------
Q 014960 329 QLHKIFKLCG-SPSEEYWKKSKLPHATIFKPQQSYKRCIAET---FKDFPPSSLPLIETLLAIDPAERQTATAA------ 398 (415)
Q Consensus 329 ~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~t~~~~------ 398 (415)
....+....+ .+....+......... .+ . +... ...++.++.+||.+||..||.+|||++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQ--RP--K----FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCC--CC--C----CCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhccccc--CC--C----CCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 1111111111 1111111100000000 00 0 0000 00122358999999999999999999999
Q ss_pred hcCCCCCCCC
Q 014960 399 LRSEVSLYMX 408 (415)
Q Consensus 399 L~h~~f~~~~ 408 (415)
|.++|-++-+
T Consensus 316 ll~~~~~~~~ 325 (336)
T 3g2f_A 316 LMMIWERNKS 325 (336)
T ss_dssp HHHCCCC---
T ss_pred HHHHHHhccc
Confidence 5678876644
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=341.75 Aligned_cols=250 Identities=17% Similarity=0.195 Sum_probs=190.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC------ChHHHHHHHHHHHHHHhCC---------CCceee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL------EPESVRFMAREILILRRLD---------HPNVVK 181 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~~iv~ 181 (415)
.++|++++.||+|+||.||+|++ +|+.||||++..... .....+.+.+|+.+++.++ |+|||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36799999999999999999987 789999999987642 2233467888999999885 666666
Q ss_pred eeeeEe-----------------ec-----------CCCeEEEEEEecccC-hhhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 014960 182 LEGLVT-----------------SR-----------MSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMHQLLSGL 232 (415)
Q Consensus 182 l~~~~~-----------------~~-----------~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~i~~qi~~~L 232 (415)
+.+++. .. ....+|+||||+.++ ++..+.. ..+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 665532 10 146799999999876 5555433 4689999999999999999
Q ss_pred HHHH-hCCCeeccCCCCCEEEcCCC--------------------cEEEEeeccccccCCCCCCCcccccccCccCCccc
Q 014960 233 EHCH-NQHVLHRDIKGSNLLIDNEG--------------------ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291 (415)
Q Consensus 233 ~~LH-~~~ivHrDlkp~NILl~~~~--------------------~vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~ 291 (415)
+||| ++||+||||||+||||+.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999987 899999999987653 23478999999999
Q ss_pred ccCCcCCCchhcHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhh
Q 014960 292 LLGATDYGVGVDLWSAGCI-LAELLAEKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAET 369 (415)
Q Consensus 292 ~~~~~~~~~~sDvwSlG~i-l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (415)
+.+. .+.++|||||+++ .+++++|..||.+... ......+.+....... . ....
T Consensus 249 ~~g~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~-------~~~~ 304 (336)
T 2vuw_A 249 FTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK---------------C-------NTPA 304 (336)
T ss_dssp GCCC--SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC---------------C-------CSHH
T ss_pred hcCC--CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc---------------c-------chhh
Confidence 9863 3889999998777 7788899999844221 1122233321111000 0 0111
Q ss_pred cCCCCCChHHHHHHhcccCCCCCCCHHHHh-cCCCCC
Q 014960 370 FKDFPPSSLPLIETLLAIDPAERQTATAAL-RSEVSL 405 (415)
Q Consensus 370 ~~~~~~~~~~li~~~L~~dP~~R~t~~~~L-~h~~f~ 405 (415)
...+++++++||.+||++| |++|+| +||||+
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 2235677899999999987 999999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=333.64 Aligned_cols=253 Identities=23% Similarity=0.267 Sum_probs=194.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh--CCCCceeeeeeeEeecCC--Ce
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR--LDHPNVVKLEGLVTSRMS--CS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~~--~~ 193 (415)
++|.+.+.||+|+||.||+|++ +|+.||||++.. .....+.+|++++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 5799999999999999999986 589999999863 234567789999987 789999999999877432 27
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeccCCCCCEEEcCCCcEEEEeecc
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH--------NQHVLHRDIKGSNLLIDNEGILTIADFGL 265 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~ivHrDlkp~NILl~~~~~vkl~DfG~ 265 (415)
.|+||||+.++.+..++.. ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999998666655543 36899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---CcccccccCccCCcccccCCc-----CCCchhcHHHHHHHHHHHHhC----------CCCCCCCCh-
Q 014960 266 ASFFDPNHKQ---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAE----------KPIMPGRTE- 326 (415)
Q Consensus 266 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~sDvwSlG~il~ell~g----------~~pf~~~~~- 326 (415)
+......... ......||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9876543321 224457899999999987632 233789999999999999999 678865421
Q ss_pred ----HHHHHHHHHhcCCCC-HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 327 ----VEQLHKIFKLCGSPS-EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 327 ----~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
......+......+. ...| .....++.+.+||.+||+.||.+|||+++++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRW-----------------------QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGG-----------------------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCcccc-----------------------cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 122222211100000 0000 001233467899999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=322.78 Aligned_cols=227 Identities=19% Similarity=0.132 Sum_probs=184.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++..++|+||+++++++.. ....|+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence 679999999999999999999999999999999987654 35566788899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||+.++.+..++... ....++..|+.||+.||+|||++||+||||||+||||+.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 99999987666666543 4667789999999999999999999999999999999999999997443
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
|++ .++.++|||||||++|+|++|..||.+.+..+.+....+. .
T Consensus 175 ---------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-------------------~ 218 (286)
T 3uqc_A 175 ---------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-------------------T 218 (286)
T ss_dssp ---------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-------------------T
T ss_pred ---------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-------------------h
Confidence 333 3678999999999999999999999875542211000000 0
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
... ..........+++++.+||.+||+.||.+| |+.++++
T Consensus 219 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 219 AGQ---PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp TSC---BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ccC---CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 000 001233445788899999999999999999 9999886
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=360.06 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=198.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECC-CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC---C
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL-TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS---C 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---~ 192 (415)
.++|++.+.||+|+||.||+|++.. +|+.||||++... ........+.+|+.++++++|||||++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3789999999999999999999876 7899999988653 345566778899999999999999999999977422 1
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
..||||||+.++.+...... .+++.+++.|+.||+.||+|||++|||||||||+||||+.+ .+||+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 26999999998777655444 79999999999999999999999999999999999999885 8999999999876532
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
....||+.|+|||++.+ .++.++|||||||+||+|++|.+||.+.... ..+..
T Consensus 235 -----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~---------- 287 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPED---------- 287 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTT----------
T ss_pred -----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccc----------
Confidence 44578999999999865 3589999999999999999999988652110 00000
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.. ....++.+.+||.+||..||.+||+..++|.|+|+..
T Consensus 288 -------~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 -------DP--------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -------CH--------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------cc--------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0013456789999999999999999999999888653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=305.78 Aligned_cols=187 Identities=16% Similarity=0.070 Sum_probs=135.9
Q ss_pred eeccCCceEEEEEEECCCCceEEEEEEecCCC----C----hHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCeEE
Q 014960 125 KIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----E----PESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 125 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~----~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++.|++|.+..++....|+.||+|++.++.. . ....+.|.+|+++|+++ .|+||+++++++++ +...|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEE
Confidence 46788888888888888999999999987632 1 23345789999999999 69999999999988 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||||++|+.+..++.....+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...... .
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 999999999888888887788775 478999999999999999999999999999999999999999998765433 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKP 319 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~ 319 (415)
...+.+||+.|+|||++.+ .+..++|+||+|+++++|+++..
T Consensus 395 ~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred cccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence 3456789999999999976 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-29 Score=251.38 Aligned_cols=187 Identities=17% Similarity=0.144 Sum_probs=140.7
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChH------HHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeE
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE------SVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~ 194 (415)
...+.||+|+||.||+| ...+..+++|.......... ..+.+.+|+.++++++|+||+++..++.. ....
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNK 414 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCcc
Confidence 34568999999999999 45678899998765433211 23457899999999999999955444444 3347
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|+||||+.++.+..++.. +..|+.||+.+|+|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999987666666554 5689999999999999999999999999999999 999999999988754321
Q ss_pred CC------cccccccCccCCcccccC-CcCCCchhcHHHHHHHHHHHHhCCCCC
Q 014960 275 QP------MTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAEKPIM 321 (415)
Q Consensus 275 ~~------~~~~~gt~~y~aPE~~~~-~~~~~~~sDvwSlG~il~ell~g~~pf 321 (415)
.. .....||+.|+|||++.. ...|+..+|+|+..+-.++.+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 135678999999999864 135788899999999988888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=212.84 Aligned_cols=148 Identities=14% Similarity=0.084 Sum_probs=117.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh----------------HHHHHHHHHHHHHHhCCCCcee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----------------ESVRFMAREILILRRLDHPNVV 180 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~~iv 180 (415)
...|.+.+.||+|+||.||+|++ .+|+.||||+++...... .....+.+|+.++++++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34577789999999999999998 889999999996532211 24567889999999999 5 6
Q ss_pred eeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEE
Q 014960 181 KLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTI 260 (415)
Q Consensus 181 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl 260 (415)
++.+++.. ...|+||||+.++.+..+ .. ..+..++.||+.||.|||++||+||||||+||||+ ++.+||
T Consensus 165 ~v~~~~~~---~~~~lvmE~~~g~~L~~l-~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 165 AVPKVYAW---EGNAVLMELIDAKELYRV-RV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp SSCCEEEE---ETTEEEEECCCCEEGGGC-CC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred CcCeEEec---cceEEEEEecCCCcHHHc-ch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence 77666654 346999999988665552 11 23457999999999999999999999999999999 999999
Q ss_pred EeeccccccCCCCCCCcccccccCccCCccccc
Q 014960 261 ADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293 (415)
Q Consensus 261 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 293 (415)
+|||+|.. +..|.|||++.
T Consensus 234 ~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE--------------TTSTTHHHHHH
T ss_pred EECCCCeE--------------CCCCCHHHHHH
Confidence 99999864 33478899764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=185.34 Aligned_cols=140 Identities=16% Similarity=0.222 Sum_probs=107.7
Q ss_pred CceeeeeeccCCceEEEEEEECCCCce--EEEEEEecCCCCh----------------------HHHHHHHHHHHHHHhC
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEP----------------------ESVRFMAREILILRRL 174 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 174 (415)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999998778988 9999976432110 1123678899999999
Q ss_pred CCCce--eeeeeeEeecCCCeEEEEEEeccc-C----hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCC
Q 014960 175 DHPNV--VKLEGLVTSRMSCSLYLVFKYMEH-D----LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH-NQHVLHRDIK 246 (415)
Q Consensus 175 ~h~~i--v~l~~~~~~~~~~~~~lv~e~~~~-~----l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlk 246 (415)
.|+++ +.++++ ...++||||+++ + .+..... ..++..+..++.||+.+|.||| ++||+|||||
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 88764 344332 236899999953 2 3333221 1235577899999999999999 9999999999
Q ss_pred CCCEEEcCCCcEEEEeecccccc
Q 014960 247 GSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 247 p~NILl~~~~~vkl~DfG~a~~~ 269 (415)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=167.21 Aligned_cols=142 Identities=19% Similarity=0.214 Sum_probs=100.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC---------------hHH-----HHHHHHHHHHHHhCCCC
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE---------------PES-----VRFMAREILILRRLDHP 177 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------------~~~-----~~~~~~E~~~l~~l~h~ 177 (415)
--|.+.++||+|+||.||+|.+ .+|+.||||+++..... ... .-...+|...|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 4599999999999999999997 46899999987642110 000 00123466666666544
Q ss_pred ceeeeeeeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-
Q 014960 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG- 256 (415)
Q Consensus 178 ~iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~- 256 (415)
++....-+... ..+|||||+++..+..+.. ...+..++.||+.+|.+||+.|||||||||.||||++++
T Consensus 174 gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 174 GFPVPEPIAQS----RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TCSCCCEEEEE----TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCCeeeecc----CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 44222111111 1379999999866654332 123467889999999999999999999999999998876
Q ss_pred ---------cEEEEeeccccccC
Q 014960 257 ---------ILTIADFGLASFFD 270 (415)
Q Consensus 257 ---------~vkl~DfG~a~~~~ 270 (415)
.+.|+||+-+...+
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=3.6e-13 Score=123.76 Aligned_cols=139 Identities=14% Similarity=0.118 Sum_probs=107.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~l 196 (415)
+.|.+...++.|+.+.||++.. .+..+++|+...... .....+.+|+.+++.+. +..++++++++.. .+..|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence 4688888999999999999963 367899999874211 11235788999999884 6778899988876 567899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------------------------------------- 237 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 237 (415)
|||+++|..+..... +......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999976665432 122334678899999999998
Q ss_pred --------------------CCCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 238 --------------------QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 238 --------------------~~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876667799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.8e-12 Score=116.36 Aligned_cols=134 Identities=13% Similarity=0.116 Sum_probs=97.0
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeeeeeEeecCCCeEEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~~~l 196 (415)
.|.+....+.|..+.||++. ..+|..|++|+.... ....+.+|+.+++.+.+.+ +++++++... .+..|+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~ 92 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWL 92 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEE
Confidence 45554444566679999996 356778999987643 1234678999999885444 5668877665 456899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH------------------------------------- 239 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------------------------------------- 239 (415)
||||++|..+. .. ... ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999986653 11 112 2356778888888888753
Q ss_pred ---------------------CeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 240 ---------------------VLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 240 ---------------------ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998743
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.8e-11 Score=117.77 Aligned_cols=143 Identities=15% Similarity=0.229 Sum_probs=104.7
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEe--cCCCChHHHHHHHHHHHHHHhCC--CCceeeeeeeEeecCC-CeEEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVR--FDNLEPESVRFMAREILILRRLD--HPNVVKLEGLVTSRMS-CSLYL 196 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~-~~~~l 196 (415)
.++.|+.|.++.||++.. .+..+++|+.. .... ......+.+|+.+++.|. +..+++++.++.+... +..|+
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 457899999999999964 34678889765 3221 122346788999999996 4557888887765321 45899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------------------------------------- 237 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 237 (415)
||||++|..+... ....+++.+...++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998654321 12246788889999999999999997
Q ss_pred -------------------CCCeeccCCCCCEEEcCCCc--EEEEeecccccc
Q 014960 238 -------------------QHVLHRDIKGSNLLIDNEGI--LTIADFGLASFF 269 (415)
Q Consensus 238 -------------------~~ivHrDlkp~NILl~~~~~--vkl~DfG~a~~~ 269 (415)
..++|||+++.|||++.++. +.|+||+.+..-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999998763 699999998654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.6e-11 Score=115.44 Aligned_cols=184 Identities=16% Similarity=0.145 Sum_probs=120.6
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCc--eeeeeeeEeecC-CCeEEEEEE
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPN--VVKLEGLVTSRM-SCSLYLVFK 199 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~--iv~l~~~~~~~~-~~~~~lv~e 199 (415)
+.++.|....||++. ..+++|+... ......+.+|+.+|+.+ .+.. +++++....... ....|+||+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 458999999999873 4588998542 24456788999999887 3333 445544433211 124588999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN------------------------------------------ 237 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~------------------------------------------ 237 (415)
+++|..+..... ..++..+...++.+++..|..||+
T Consensus 97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999865432111 246778888889999999998886
Q ss_pred ----------------CCCeeccCCCCCEEEcC--CCcEEEEeeccccccCCCCCCCcccc----cc---------cCcc
Q 014960 238 ----------------QHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNHKQPMTSR----VV---------TLWY 286 (415)
Q Consensus 238 ----------------~~ivHrDlkp~NILl~~--~~~vkl~DfG~a~~~~~~~~~~~~~~----~g---------t~~y 286 (415)
..++|+|++|.||+++. ++.+.|+||+.+...++......... .+ ...+
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 13699999999999998 45689999999876543211000000 00 0011
Q ss_pred CC-cccccCCcCCCchhcHHHHHHHHHHHHhCCCCC
Q 014960 287 RP-PELLLGATDYGVGVDLWSAGCILAELLAEKPIM 321 (415)
Q Consensus 287 ~a-PE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf 321 (415)
.. |+.... ...-.+.|+++.++|.+.+|.++|
T Consensus 255 ~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 222111 122368999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=8.5e-08 Score=89.98 Aligned_cols=137 Identities=15% Similarity=0.186 Sum_probs=96.5
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC---ceeeeeeeEeecCCCeEEEEEE
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP---NVVKLEGLVTSRMSCSLYLVFK 199 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~~~~~~~~~lv~e 199 (415)
++.++.|....||+. |..+++|+.. .......+.+|+.+|+.|.+. .+++.+.+... ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEe
Confidence 356788988999988 4668899842 234567889999999999642 35666666643 2456789999
Q ss_pred ecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 014960 200 YMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ----------------------------------------- 238 (415)
Q Consensus 200 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----------------------------------------- 238 (415)
+++|..+..... ..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999865543211 1235555666666666666666642
Q ss_pred -------------------CCeeccCCCCCEEEcC---CCc-EEEEeeccccccCC
Q 014960 239 -------------------HVLHRDIKGSNLLIDN---EGI-LTIADFGLASFFDP 271 (415)
Q Consensus 239 -------------------~ivHrDlkp~NILl~~---~~~-vkl~DfG~a~~~~~ 271 (415)
.++|+|+++.|||++. ++. +.|+||+.+...++
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 3599999999999987 455 58999998876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=6.8e-08 Score=88.68 Aligned_cols=133 Identities=15% Similarity=0.158 Sum_probs=91.3
Q ss_pred eeccCCce-EEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEEEEEecc
Q 014960 125 KIGQGTYS-NVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYLVFKYME 202 (415)
Q Consensus 125 ~lG~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~lv~e~~~ 202 (415)
.+..|..| .||+......+..+++|+-. ......+.+|+.+|+.+. +-.++++++++.+ ....|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~-----~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGK-----GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEE-----THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECC-----CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeC
Confidence 34445544 69998877777889999865 234567889999999884 3346788888776 456899999999
Q ss_pred cChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 014960 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------------------------------------------- 237 (415)
Q Consensus 203 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------------- 237 (415)
|..+...... .......+..++...|..||.
T Consensus 104 G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8544332211 111223344555555555552
Q ss_pred ------C-------CCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 238 ------Q-------HVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 238 ------~-------~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
. .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1 279999999999999877778999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=7.5e-07 Score=86.57 Aligned_cols=77 Identities=18% Similarity=0.154 Sum_probs=48.4
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCC-C----hHHHHHHHHHHHHHHhCCC--C-ceeeeeeeEeecCCCeE
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-E----PESVRFMAREILILRRLDH--P-NVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~~E~~~l~~l~h--~-~iv~l~~~~~~~~~~~~ 194 (415)
.+.||.|.++.||++....+++.|++|....... . ......+..|+.+|+.+.. + .+++++.+ +. ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC--Ccc
Confidence 5679999999999997655678899998653211 0 0122345678888887732 3 45566543 21 235
Q ss_pred EEEEEeccc
Q 014960 195 YLVFKYMEH 203 (415)
Q Consensus 195 ~lv~e~~~~ 203 (415)
++|||++.+
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 799999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=9e-07 Score=84.59 Aligned_cols=85 Identities=9% Similarity=0.047 Sum_probs=53.4
Q ss_pred eeeeee-ccCCceEEEEEEEC--C----CCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCC-C--CceeeeeeeEeec
Q 014960 121 EKLDKI-GQGTYSNVYKARDT--L----TGQIVALKKVRFDNL-EPESVRFMAREILILRRLD-H--PNVVKLEGLVTSR 189 (415)
Q Consensus 121 ~~~~~l-G~G~~g~Vy~~~~~--~----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~ 189 (415)
...+.| +.|....+|++... . ++..+++|+...... .......+.+|+.+++.|. + -.+++++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88989999988642 0 256788997643210 0000134667888888874 2 3567787766542
Q ss_pred C-CCeEEEEEEecccCh
Q 014960 190 M-SCSLYLVFKYMEHDL 205 (415)
Q Consensus 190 ~-~~~~~lv~e~~~~~l 205 (415)
. .+..|+|||+++|..
T Consensus 103 ~~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVV 119 (357)
T ss_dssp TTTSSCEEEEECCCCBC
T ss_pred CccCCceEEEEecCCCC
Confidence 1 135689999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.22 E-value=9e-06 Score=76.81 Aligned_cols=31 Identities=23% Similarity=0.387 Sum_probs=28.0
Q ss_pred CCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.99 E-value=6.7e-05 Score=70.21 Aligned_cols=74 Identities=19% Similarity=0.181 Sum_probs=57.0
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC---CCceeeeeeeEeecCCCeEEEEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD---HPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
-.+.|+.|....+|+... ++..|++|+.... ....+.+|+..|+.|. ...+++.+.+... .+..|+||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEE
Confidence 356799999999999963 4677889987632 3567888999998883 3567888877665 45789999
Q ss_pred EecccC
Q 014960 199 KYMEHD 204 (415)
Q Consensus 199 e~~~~~ 204 (415)
|++++.
T Consensus 111 e~l~G~ 116 (312)
T 3jr1_A 111 EALNKS 116 (312)
T ss_dssp ECCCCC
T ss_pred EeccCC
Confidence 999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.87 E-value=2.6e-05 Score=76.32 Aligned_cols=79 Identities=8% Similarity=0.023 Sum_probs=47.5
Q ss_pred HhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcccccc--cCccCCcccccCCc--CCCchhcHHHHHHHH
Q 014960 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGAT--DYGVGVDLWSAGCIL 311 (415)
Q Consensus 236 H~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~--~~~~~sDvwSlG~il 311 (415)
+...++|||+++.|||++.++ ++|+||+.+..-++.... ..... ...|++|+...... ......++..+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 356799999999999999877 999999998764322110 01110 23356665442100 111234555777777
Q ss_pred HHHHhC
Q 014960 312 AELLAE 317 (415)
Q Consensus 312 ~ell~g 317 (415)
++.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00024 Score=65.96 Aligned_cols=68 Identities=15% Similarity=0.050 Sum_probs=42.1
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeeeeeEeecCCCeEEEEEEec
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~lv~e~~ 201 (415)
++.|+.|....+|++ ..|++|+...... ......+|+.+++.+...++ ++++++..+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVDPA----TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT----TCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEECC----CCEEEEeec
Confidence 678999999999998 4588998754211 11123457777777642222 566554322 246899999
Q ss_pred -cc
Q 014960 202 -EH 203 (415)
Q Consensus 202 -~~ 203 (415)
++
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=5.6e-05 Score=70.85 Aligned_cols=142 Identities=11% Similarity=0.080 Sum_probs=76.9
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc--eeeeeeeEe----ecCCCeE
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN--VVKLEGLVT----SRMSCSL 194 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~----~~~~~~~ 194 (415)
.-++.|+.|....+|++... +| .|++|+..... ....+..|+.+++.|...+ +++++.... ....+..
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34567888988999999643 33 68899886421 1123456777777663222 344432110 0013457
Q ss_pred EEEEEecccChhh----------------hh--cCC-CCC----CC---HHHHHH------------HHHHHHHHHHHHH
Q 014960 195 YLVFKYMEHDLAG----------------LA--ASP-TIK----FT---QAQVKC------------YMHQLLSGLEHCH 236 (415)
Q Consensus 195 ~lv~e~~~~~l~~----------------~~--~~~-~~~----~~---~~~~~~------------i~~qi~~~L~~LH 236 (415)
+++|++++|.... .+ ... ... .. +..... +...+...++.|+
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999873210 00 000 000 01 111000 0012344555555
Q ss_pred h-------CCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 237 N-------QHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 237 ~-------~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
. .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 2 3689999999999999876668999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00019 Score=69.01 Aligned_cols=141 Identities=16% Similarity=0.165 Sum_probs=82.9
Q ss_pred CCceeeeeeccCCceEEEEEEECC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeec
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSR 189 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~ 189 (415)
+.+.+ +.|..|-...+|++.... +++.|++|+.-.. ......+.+|..+++.|. +.-.+++++++.+
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 34443 567778889999997532 3467899985321 122345668999988874 3233667666542
Q ss_pred CCCeEEEEEEecccChhhh------------------hcCC----CCCC--CHHHHHHHHHHHHH---------------
Q 014960 190 MSCSLYLVFKYMEHDLAGL------------------AASP----TIKF--TQAQVKCYMHQLLS--------------- 230 (415)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~------------------~~~~----~~~~--~~~~~~~i~~qi~~--------------- 230 (415)
.+||||++|..+.. +-.. .... -+.++..|..++..
T Consensus 126 -----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 126 -----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp -----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred -----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 28999998732210 0000 1111 24556666654422
Q ss_pred ----HHHHHH----h----CCCeeccCCCCCEEEcCC----CcEEEEeeccccc
Q 014960 231 ----GLEHCH----N----QHVLHRDIKGSNLLIDNE----GILTIADFGLASF 268 (415)
Q Consensus 231 ----~L~~LH----~----~~ivHrDlkp~NILl~~~----~~vkl~DfG~a~~ 268 (415)
.++.|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233333 2 248999999999999887 7899999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00059 Score=62.81 Aligned_cols=76 Identities=16% Similarity=0.218 Sum_probs=52.9
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC---CceeeeeeeEeecCCCeEE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH---PNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~l~~~~~~~~~~~~~ 195 (415)
...-++.+|.|..+.||+++ ..+|+.|.+|+...... .....+.+|+..|+.|.- -.+++++++ + . -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~--~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D--RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T--TE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C--ce
Confidence 45566889999999999997 45788999998654322 223457889999998842 234555543 2 1 47
Q ss_pred EEEEeccc
Q 014960 196 LVFKYMEH 203 (415)
Q Consensus 196 lv~e~~~~ 203 (415)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 89999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00075 Score=58.86 Aligned_cols=96 Identities=15% Similarity=0.036 Sum_probs=62.7
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCccccccc
Q 014960 205 LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVT 283 (415)
Q Consensus 205 l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~~~~gt 283 (415)
|...+...+.+++|+++|.++.|.+..|.-+-. ..-..+=+.|..|++..+|.|.+.+ ..+. ...
T Consensus 35 L~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~ 100 (229)
T 2yle_A 35 LEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGE 100 (229)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------------
T ss_pred HHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------ccc
Confidence 445555567799999999999999999877621 1112333457899999999998653 1110 012
Q ss_pred CccCCcccccCCcCCCchhcHHHHHHHHHHHHh
Q 014960 284 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA 316 (415)
Q Consensus 284 ~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~ 316 (415)
..+.+||... ...+.+.=|||||+++|..|-
T Consensus 101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 2367888653 346788999999999999985
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00038 Score=68.17 Aligned_cols=71 Identities=17% Similarity=0.181 Sum_probs=47.5
Q ss_pred eeeeccCCceEEEEEEECC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeeeeeEeecCCCeE
Q 014960 123 LDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCSL 194 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~~ 194 (415)
++.|+.|....||++.... .+..|++|+..... . ...+.+|+.+++.|...+ .+++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~------ 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T--ESHLVAESVIFTLLSERHLGPKLYGIFSG------ 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C--HHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC------
Confidence 4678889999999997542 25778999874211 1 134457998888884333 3677765532
Q ss_pred EEEEEeccc
Q 014960 195 YLVFKYMEH 203 (415)
Q Consensus 195 ~lv~e~~~~ 203 (415)
.+|+||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 278999976
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0014 Score=61.94 Aligned_cols=33 Identities=27% Similarity=0.383 Sum_probs=28.9
Q ss_pred CCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
..++|+|+.+.||+++.++.+.|+||+.+...+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 358999999999999988899999999886644
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=62.16 Aligned_cols=138 Identities=13% Similarity=0.072 Sum_probs=77.6
Q ss_pred eeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCC--ceeeeeeeEee----cCCCeEEEE
Q 014960 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP--NVVKLEGLVTS----RMSCSLYLV 197 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~----~~~~~~~lv 197 (415)
..|+ |....||++.. .+|+.+++|........ ...+..|..+++.|... .+++++.. .. ...+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence 4566 77889998853 35667999998643222 23556688887777422 24445443 11 013467889
Q ss_pred EEecccChhh----------------h--hcCC-----CCCCCHHHH----------------------HHHHHHHHHHH
Q 014960 198 FKYMEHDLAG----------------L--AASP-----TIKFTQAQV----------------------KCYMHQLLSGL 232 (415)
Q Consensus 198 ~e~~~~~l~~----------------~--~~~~-----~~~~~~~~~----------------------~~i~~qi~~~L 232 (415)
|++++|.... . .... ...+..... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999873110 0 0000 011111110 11112222222
Q ss_pred HHH----HhCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 233 EHC----HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 233 ~~L----H~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
+-+ ....++|||+++.|||++ + .+.|+||+.+..-
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 222 123589999999999999 4 8999999987553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00035 Score=66.86 Aligned_cols=72 Identities=7% Similarity=0.019 Sum_probs=42.0
Q ss_pred eeeeccCCceEEEEEEECC--------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCc-eeeeeeeEeecCCCe
Q 014960 123 LDKIGQGTYSNVYKARDTL--------TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN-VVKLEGLVTSRMSCS 193 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~ 193 (415)
.+.|+.|....+|++.... .+..|++|+.... .........|..+++.+...+ ++++++.+.
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~------ 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTFN------ 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEecC------
Confidence 4568888889999997542 1257888876432 111112356888888774333 456665431
Q ss_pred EEEEEEeccc
Q 014960 194 LYLVFKYMEH 203 (415)
Q Consensus 194 ~~lv~e~~~~ 203 (415)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 2579999987
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00042 Score=65.19 Aligned_cols=33 Identities=30% Similarity=0.333 Sum_probs=28.4
Q ss_pred CCCeeccCCCCCEEEcCC----CcEEEEeeccccccC
Q 014960 238 QHVLHRDIKGSNLLIDNE----GILTIADFGLASFFD 270 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~----~~vkl~DfG~a~~~~ 270 (415)
..++|||+.+.|||++.+ +.+.|+||+.+..-.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 469999999999999875 679999999987644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0024 Score=62.91 Aligned_cols=73 Identities=18% Similarity=0.112 Sum_probs=46.7
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCce-eeeeeeEeecCCCeEEEEEEe
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV-VKLEGLVTSRMSCSLYLVFKY 200 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~lv~e~ 200 (415)
-++.|+.|-...+|++.....+..|++|+....... .-...+|..+++.|...++ +++++++. + .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT---N---GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEe
Confidence 356788899999999976544578899987432111 1112478999998864444 67777663 2 249999
Q ss_pred ccc
Q 014960 201 MEH 203 (415)
Q Consensus 201 ~~~ 203 (415)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 986
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0049 Score=59.99 Aligned_cols=74 Identities=7% Similarity=-0.008 Sum_probs=46.3
Q ss_pred eeeeeccCCceEEEEEEECCC-------CceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCe
Q 014960 122 KLDKIGQGTYSNVYKARDTLT-------GQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~ 193 (415)
-++.|..|-...+|++..... +..|++|+..... +..-...+|..+++.+. +.-.+++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~------ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP------ 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC------
Confidence 345677888899999975421 5778999854321 11112346888888774 323456665332
Q ss_pred EEEEEEecccC
Q 014960 194 LYLVFKYMEHD 204 (415)
Q Consensus 194 ~~lv~e~~~~~ 204 (415)
-++||||++|.
T Consensus 145 ~~~I~efI~G~ 155 (424)
T 3mes_A 145 EGRIEEFIDGE 155 (424)
T ss_dssp TEEEEECCCSE
T ss_pred CCEEEEEeCCc
Confidence 26889999873
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.30 E-value=0.11 Score=50.02 Aligned_cols=29 Identities=28% Similarity=0.543 Sum_probs=24.7
Q ss_pred CeeccCCCCCEEE------cCCCcEEEEeeccccc
Q 014960 240 VLHRDIKGSNLLI------DNEGILTIADFGLASF 268 (415)
Q Consensus 240 ivHrDlkp~NILl------~~~~~vkl~DfG~a~~ 268 (415)
++|+|+.+.|||+ +.+..++|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3456799999998854
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.60 E-value=0.028 Score=55.37 Aligned_cols=65 Identities=11% Similarity=0.167 Sum_probs=18.7
Q ss_pred eeeeeeccCCceEEEEEEECCCCceEEE------EEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEee
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTGQIVAL------KKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTS 188 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 188 (415)
.+.+.|| ||.||++........||+ |.........+....+.+|+.+++.++|+|+++.++|...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3445676 999999987655567888 7665433444555667789999999999999999887643
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=85.41 E-value=12 Score=34.58 Aligned_cols=138 Identities=14% Similarity=0.191 Sum_probs=76.8
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeee-------------
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGL------------- 185 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~------------- 185 (415)
.+..++..-.|..|.++... ++..|+||-. ..-..+.+..++...-.+.-|+..-+.-.
T Consensus 70 ~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s-----~~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~ 141 (342)
T 1cja_A 70 QFKGIERSEKGTEGLFFVET---ESGVFIVKRS-----TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAA 141 (342)
T ss_dssp GEEEEEECCSTTSCEEEEEE---SSCEEEEECC-----TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHH
T ss_pred CeeEEEeccCCCCCeEEEEe---CCCEEEEeCc-----HHHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHH
Confidence 46677777778766555444 4667889943 12344555555555555666664222100
Q ss_pred -------EeecCCCeEEEEEEecccChhhhhcCC--CCCCCHHHHHHHHHHH--HHHHHHHHhCC----Cee-ccCCCCC
Q 014960 186 -------VTSRMSCSLYLVFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQL--LSGLEHCHNQH----VLH-RDIKGSN 249 (415)
Q Consensus 186 -------~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi--~~~L~~LH~~~----ivH-rDlkp~N 249 (415)
.........+++|+|+.|..+...... ...+.++. +.++ +-+++.+..++ .+. .--.++|
T Consensus 142 ~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~----~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~N 217 (342)
T 1cja_A 142 IDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKST----MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDN 217 (342)
T ss_dssp HCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHH----HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGG
T ss_pred hhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHH----HHhhchhheehhhhcCCccCcccccCCCChhh
Confidence 001112357799999987443322211 01123232 3333 44566666553 222 2257899
Q ss_pred EEEcCCCc-EEEEeeccccc
Q 014960 250 LLIDNEGI-LTIADFGLASF 268 (415)
Q Consensus 250 ILl~~~~~-vkl~DfG~a~~ 268 (415)
||++.++. +.++|-+++..
T Consensus 218 IL~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 218 IMLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp EEEESBTTCEEECSCCCCCC
T ss_pred eEEeCCCCeEEEEcCCcccc
Confidence 99987655 99999998854
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 415 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-78 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-73 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-72 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-70 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-70 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-68 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-68 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-67 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-65 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-65 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-63 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-63 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-61 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-61 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-57 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-51 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-44 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-29 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (622), Expect = 1e-78
Identities = 132/300 (44%), Positives = 175/300 (58%), Gaps = 12/300 (4%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
+EKL KIGQGT+ V+KAR TGQ VALKKV +N + REI IL+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 175 DHPNVVKLEGLVTSRMS------CSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL 228
H NVV L + ++ S S+YLVF + EHDLAGL ++ +KFT +++K M L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN---HKQPMTSRVVTLW 285
L+GL + H +LHRD+K +N+LI +G+L +ADFGLA F T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
YRPPELLLG DYG +DLW AGCI+AE+ PIM G TE QL I +LCGS + E W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 346 KK-SKLPHATIFKPQQSYKRCIAETFKDF--PPSSLPLIETLLAIDPAERQTATAALRSE 402
+ + KR + + K + P +L LI+ LL +DPA+R + AL +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 1e-73
Identities = 119/286 (41%), Positives = 167/286 (58%), Gaps = 9/286 (3%)
Query: 121 EKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL---EPESVRFMAREILILRRLDHP 177
EKLD +G+G ++ VYKARD T QIVA+KK++ + + R REI +L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N++ L + ++ LVF +ME DL + ++ T + +K YM L GLE+ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+LHRD+K +NLL+D G+L +ADFGLA F ++ T +VVT WYR PELL GA
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARM 177
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPHATIF 356
YGVGVD+W+ GCILAELL P +PG ++++QL +IF+ G+P+EE W LP F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
K + F L LI+ L +P R TAT AL+ +
Sbjct: 238 KSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 2e-72
Identities = 114/284 (40%), Positives = 163/284 (57%), Gaps = 4/284 (1%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ F+K++KIG+GTY VYKAR+ LTG++VALKK+R D REI +L+ L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+VKL ++ + LYLVF+++ DL + AS +K Y+ QLL GL CH
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ VLHRD+K NLLI+ EG + +ADFGLA F + T VVTLWYR PE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCK 178
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y VD+WS GCI AE++ + + PG +E++QL +IF+ G+P E W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ ++ ++ L+ +L DP +R +A AAL
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 3e-70
Identities = 102/312 (32%), Positives = 152/312 (48%), Gaps = 16/312 (5%)
Query: 99 SWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP 158
S ++ V G + ++ IG G++ VY+A+ +G++VA+KKV D
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--- 57
Query: 159 ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLA---AS 211
RF RE+ I+R+LDH N+V+L S L LV Y+ + +A +
Sbjct: 58 ---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 212 PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFD 270
VK YM+QL L + H+ + HRDIK NLL+D + +L + DFG A
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQL 330
+P S + + +YR PEL+ GATDY +D+WSAGC+LAELL +PI PG + V+QL
Sbjct: 175 RG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPA 390
+I K+ G+P+ E ++ + PQ PP ++ L LL P
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 391 ERQTATAALRSE 402
R T A
Sbjct: 293 ARLTPLEACAHS 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 220 bits (562), Expect = 4e-70
Identities = 103/283 (36%), Positives = 157/283 (55%), Gaps = 4/283 (1%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + L+KIG+GTY VYKA++ G+ ALKK+R + + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+VKL ++ ++ L LVF++++ DL L K ++ QLL+G+ +CH+
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
+ VLHRD+K NLLI+ EG L IADFGLA F ++ +VTLWYR P++L+G+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
Y +D+WS GCI AE++ P+ PG +E +QL +IF++ G+P+ + W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
K S + L+ +L +DP +R TA AL
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 1e-68
Identities = 96/291 (32%), Positives = 149/291 (51%), Gaps = 10/291 (3%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
+ L IG+G Y V A D + VA+KK+ + R + REI IL R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 177 PNVVKLEGLV---TSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
N++ + ++ T +YLV M DL L + + + +++Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP--MTSRVVTLWYRPPEL 291
+ H+ +VLHRD+K SNLL++ L I DFGLA DP+H +T V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+L + Y +D+WS GCILAE+L+ +PI PG+ ++QL+ I + GSPS+E
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 352 HATIFKPQQSYKRCI--AETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
A + +K + F + +L L++ +L +P +R AL
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-68
Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 30/286 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++ + +G+G Y V A + +T + VA+K V +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHE 63
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
NVVK G R YL +Y P I + + + HQL++G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGAT 296
+ HRDIK NLL+D L I+DFGLA+ F N+++ + +++ TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
+ VD+WS G +L +LA + ++ Q + +K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------- 228
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+K + L L+ +L +P+ R T +
Sbjct: 229 -------------WKKIDSAPLALLHKILVENPSARITIPDIKKDR 261
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (552), Expect = 1e-68
Identities = 110/284 (38%), Positives = 160/284 (56%), Gaps = 4/284 (1%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+V+L ++ S LVF++ + DL S VK ++ QLL GL CH+
Sbjct: 62 NIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++VLHRD+K NLLI+ G L +A+FGLA F + ++ VVTLWYRPP++L GA
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKL 178
Query: 298 YGVGVDLWSAGCILAELL-AEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y +D+WSAGCI AEL A +P+ PG +QL +IF+L G+P+EE W
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P + + L++ LL +P +R +A AL+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 5e-67
Identities = 66/301 (21%), Positives = 121/301 (40%), Gaps = 23/301 (7%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
+ D FEK+ ++G G V+K +G ++A K + + + + RE+ +L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHECN 62
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
P +V G S + + ++M+ + + + ++ GL +
Sbjct: 63 SPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 236 HNQH-VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+H ++HRD+K SN+L+++ G + + DFG++ + S V T Y PE L G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCG----SPSEEYWKKSK 349
T Y V D+WS G L E+ + PI P + +L ++ G +P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLP----------LIETLLAIDPAERQTATAAL 399
L + + + + PP LP + L +PAER +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 400 R 400
Sbjct: 297 V 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-65
Identities = 101/291 (34%), Positives = 147/291 (50%), Gaps = 12/291 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ ++ L +G G Y +V A DT TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 178 NVVKLEGLVTSRMSC----SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T S +YLV M DL + K T V+ ++Q+L GL+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H+ ++HRD+K SNL ++ + L I DFGLA D MT V T WYR PE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIML 191
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLP 351
Y VD+WS GCI+AELL + + PG ++QL I +L G+P E KK S+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
I Q K A F P ++ L+E +L +D +R TA AL
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 6e-65
Identities = 91/289 (31%), Positives = 144/289 (49%), Gaps = 12/289 (4%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ L +G G Y V A D TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 178 NVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
NV+ L + T + YLV +M DL L K + +++ ++Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ H ++HRD+K NL ++ + L I DFGLA D MT VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVIL 191
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD+WS GCI+AE++ K + G ++QL +I K+ G+P E+ ++ + A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 354 TIFKPQ--QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + K+ A + P ++ L+E +L +D +R TA AL
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 7e-65
Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 39/294 (13%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD 175
RA+ +E L IG G+Y K R G+I+ K++ + ++ + + E+ +LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL---AASPTIKFTQAQVKCYMHQLLSG 231
HPN+V+ + R + +LY+V +Y E DLA + + V M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 232 LEHCHNQH-----VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
L+ CH + VLHRD+K +N+ +D + + + DFGLA + + + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYY 180
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PE + Y D+WS GC+L EL A P ++ E KI + K
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------GK 230
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++P+ + +I +L + R + L
Sbjct: 231 FRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 208 bits (530), Expect = 2e-64
Identities = 64/286 (22%), Positives = 120/286 (41%), Gaps = 35/286 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D ++ L+++G G + V++ + TG++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHP 86
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
++ L + + L+ +++ +L A+ K ++A+V YM Q GL+H H
Sbjct: 87 KLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 237 NQHVLHRDIKGSNLLID--NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
++H DIK N++ + + I DFGLA+ +P+ +T T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR 202
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
G D+W+ G + LL+ G ++E L + + E+ +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS------- 254
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P + I+ LL +P +R T AL
Sbjct: 255 ------------------VSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 2e-64
Identities = 108/294 (36%), Positives = 155/294 (52%), Gaps = 13/294 (4%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLT-GQIVALKKVRFDNLEPESVRFMAREILILRR 173
R +E + +IG+G Y V+KARD G+ VALK+VR E RE+ +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 174 L---DHPNVVKLEGLVT---SRMSCSLYLVFKYMEHD-LAGLAASPTIKFTQAQVKCYMH 226
L +HPNVV+L + T + L LVF++++ D L P +K M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 227 QLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWY 286
QLL GL+ H+ V+HRD+K N+L+ + G + +ADFGLA + +TS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWY 181
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
R PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P EE W
Sbjct: 182 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ F + + I + D L+ L +PA+R +A +AL
Sbjct: 241 RDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-63
Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 36/288 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D +E + ++G G + VYKA++ T + A K + + E + EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+VKL + L+++ ++ + + T++Q++ Q L L + H
Sbjct: 70 NIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ ++HRD+K N+L +G + +ADFG+++ Q S + T ++ PE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCET 186
Query: 297 D----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
Y D+WS G L E+ +P + L KI K P+ +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSR----- 240
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ FKD ++ L + R T + L+
Sbjct: 241 -------------WSSNFKD-------FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 204 bits (521), Expect = 4e-63
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 35/286 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D ++ +++G G + V++ + TG A K V + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 83
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+V L + +++++M +L A K ++ + YM Q+ GL H H
Sbjct: 84 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 237 NQHVLHRDIKGSNLLIDNE--GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+ +H D+K N++ + L + DFGL + DP +T+ T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEG 199
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
G D+WS G + LL+ G + E L + + + +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG------- 251
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
I+E KD I LL DP R T AL
Sbjct: 252 -----------ISEDGKD-------FIRKLLLADPNTRMTIHQALE 279
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-63
Identities = 79/284 (27%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVR-FMAREILILRRLDH 176
+ FE +G+G + NVY AR+ + I+ALK + LE V + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PN+++L G + +YL+ +Y KF + + Y+ +L + L +CH
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ V+HRDIK NLL+ + G L IADFG + + T+ TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRM 180
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
+ VDLWS G + E L KP T E +I ++ + +
Sbjct: 181 -HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ LI LL +P++R L
Sbjct: 226 ---------------FVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 5e-63
Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 34/290 (11%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRR 173
+R + F+ +G+G++S V AR+ T + A+K + ++ + V ++ RE ++ R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
LDHP VKL LY Y ++ F + + Y +++S LE
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELL 292
+ H + ++HRD+K N+L++ + + I DFG A P KQ + V T Y PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
+ DLW+ GCI+ +L+A P E KI KL E+++ K
Sbjct: 183 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----- 236
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+D L+E LL +D +R
Sbjct: 237 -----------------ARD-------LVEKLLVLDATKRLGCEEMEGYG 262
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 5e-63
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDH 176
F L +IG G++ VY ARD ++VA+KK+ + + E + + +E+ L++L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
PN ++ G + +LV +Y + L + ++ H L GL + H
Sbjct: 75 PNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
+ +++HRD+K N+L+ G++ + DFG AS P S V T ++ PE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMD 187
Query: 297 D--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
+ Y VD+WS G EL KP + + L+ I + SP+ +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQ----------- 235
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ +++ L P +R T+ L+
Sbjct: 236 ---------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 199 bits (507), Expect = 2e-61
Identities = 85/295 (28%), Positives = 149/295 (50%), Gaps = 23/295 (7%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DH 176
D ++ + K+G+G YS V++A + + V +K ++ P + + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
PN++ L +V +S + LVF+++ + D L T ++ YM+++L L++C
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 145
Query: 236 HNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
H+ ++HRD+K N++ID+E L + D+GLA F+ P Q RV + +++ PELL+
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVD 203
Query: 295 ATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSKLPH 352
Y +D+WS GC+LA ++ K P G +QL +I K+ G+ +Y K +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 353 ATIFK-------PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
F ++ + +E P +L ++ LL D R TA A+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-61
Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 33/283 (11%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + +KIGQG VY A D TGQ VA++++ + EIL++R +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNI 79
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
V L++V +Y+ + Q+ + L LE H+
Sbjct: 80 VNYLDSYLV--GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYG 299
V+HRDIK N+L+ +G + + DFG + P + ++ V T ++ PE++ YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR-KAYG 194
Query: 300 VGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359
VD+WS G + E++ +P + L+ I G+P + +K
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK------------ 241
Query: 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
++ F+D + L +D +R +A L+ +
Sbjct: 242 ------LSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQ 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 8e-61
Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 36/287 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
D ++ D +G G +S V A D T ++VA+K + LE + EI +L ++ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N+V L+ + S LYL+ + + +L +T+ + Q+L +++ H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 237 NQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ ++HRD+K NLL D + + I+DFGL+ DP +++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD WS G I LL P + + +I K YW
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
D S+ I L+ DP +R T AL+
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 193 bits (491), Expect = 1e-59
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 44/297 (14%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPES-------VRFMAREILI 170
+ +E + +G+G S V + T + A+K + S +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 171 LRRL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQL 228
LR++ HPN+++L+ + +LVF M+ +L ++ + + M L
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRAL 119
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
L + H +++HRD+K N+L+D++ + + DFG + DP K + T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 289 PELLLGATD-----YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEE 343
PE++ + + YG VD+WS G I+ LLA P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 344 YWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
W D+ + L+ L + P +R TA AL
Sbjct: 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-59
Identities = 52/286 (18%), Positives = 108/286 (37%), Gaps = 36/286 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ + + +G+G + V++ +T + + K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N++ L S L ++F+++ D+ + + + ++ Y+HQ+ L+ H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 237 NQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLG 294
+ ++ H DI+ N++ + I +FG A Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQH 177
Query: 295 ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
D+WS G ++ LL+ T + + I + EE +
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
K+ ++ ++ LL + R TA+ AL+
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-58
Identities = 62/291 (21%), Positives = 122/291 (41%), Gaps = 38/291 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPE----SVRFMAREILILRR 173
D ++ +++G G ++ V K R+ TG A K ++ + S + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ HPNV+ L + ++ + L+ + + + T+ + ++ Q+L+G+
Sbjct: 70 IQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGI----LTIADFGLASFFDPNHKQPMTSRVVTLWYRPP 289
+ H+ + H D+K N+++ + + + I DFGLA D ++ + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349
E++ G+ D+WS G I LL+ G T+ E L + + +EY+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + I LL DP +R T +L+
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 8e-58
Identities = 53/288 (18%), Positives = 109/288 (37%), Gaps = 33/288 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+IG G++ VYK + VA+K + P+ ++ E+ +LR+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
N++ G T+ L +V ++ E L KF ++ Q G+++ H
Sbjct: 65 NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPELLLGA 295
+ ++HRD+K +N+ + + + I DFGLA+ ++ ++ + PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 296 TD--YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y D+++ G +L EL+ + +Q+ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------------------ 223
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
+ +++ + P + L+ L ER L S
Sbjct: 224 -----RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 187 bits (476), Expect = 2e-57
Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 32/296 (10%)
Query: 113 TPRR-ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILI 170
TP +D +E + +G G S V+ ARD + VA+K +R D +P RE
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 171 LRRLDHPNVVKLEGLVTSR--MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL 228
L+HP +V + + Y+V +Y++ T + +
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTLWY 286
L H ++HRD+K +N++I + + DFG+A N + + T Y
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 287 RPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346
PE G + D++S GC+L E+L +P G + V ++ + P
Sbjct: 181 LSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH- 238
Query: 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSE 402
+ ++ LA +P R A +R++
Sbjct: 239 ------------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-57
Identities = 84/309 (27%), Positives = 151/309 (48%), Gaps = 23/309 (7%)
Query: 109 ISGWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREI 168
+ T ++ L IG G V A D + + VA+KK+ + RE+
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCS----LYLVFKYMEHDLAGLAASPTIKFTQAQVKCY 224
++++ ++H N++ L + T + + +YLV + M+ L ++ ++
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYL 124
Query: 225 MHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTL 284
++Q+L G++H H+ ++HRD+K SN+++ ++ L I DFGLA + MT VVT
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTR 182
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
+YR PE++LG Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+
Sbjct: 183 YYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 345 WKKSKLPHATIFKPQQSYKR-------------CIAETFKDFPPSSLPLIETLLAIDPAE 391
KK + + + Y +E K + L+ +L IDPA+
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 392 RQTATAALR 400
R + AL+
Sbjct: 302 RISVDDALQ 310
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-55
Identities = 59/287 (20%), Positives = 107/287 (37%), Gaps = 37/287 (12%)
Query: 120 FEKLD-KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPN 178
F K D +IG+G++ VYK DT T VA +++ L + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 179 VVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+V+ T + + LV + M ++ + Q+L GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 237 --NQHVLHRDIKGSNLLIDNE-GILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
++HRD+K N+ I G + I D GLA+ + + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y VD+++ G + E+ + Q+++ P+
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----------- 233
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + K+ +IE + + ER + L
Sbjct: 234 --------FDKVAIPEVKE-------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 179 bits (456), Expect = 2e-53
Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 35/290 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMA----REILILRR 173
+ F IG+G + VY R TG++ A+K + ++ + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
D P +V + + L + M S F++A ++ Y +++ GLE
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
H HN+ V++RD+K +N+L+D G + I+D GLA F + V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQ 178
Query: 294 GATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353
Y D +S GC+L +LL ++ H+I ++ + + E
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP-------- 229
Query: 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403
F P L+E LL D R EV
Sbjct: 230 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-53
Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 35/286 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLD 175
+ F +G+G++ V+ A T Q A+K ++ D + + + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 176 HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
HP + + ++ + L+ V +Y+ KF ++ Y +++ GL+
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
H++ +++RD+K N+L+D +G + IADFG+ + + T Y PE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQ 178
Query: 296 TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
Y VD WS G +L E+L + G+ E E H I
Sbjct: 179 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----------------------I 215
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
Y R + + KD L+ L +P +R +R
Sbjct: 216 RMDNPFYPRWLEKEAKD-------LLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-52
Identities = 57/286 (19%), Positives = 115/286 (40%), Gaps = 39/286 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+T + ++++G G + V+ VA+K ++ ++ P++ E ++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQ 68
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAG--LAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+V+L +VT +Y++ +YME+ L IK T ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
++ +HRD++ +N+L+ + IADFGLA + N + + PE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 296 TDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
T + + D+WS G +L E++ + PG T E + + + + P
Sbjct: 186 T-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---------GYRMVRP--- 232
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ P L+ P +R T
Sbjct: 233 ----------------DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (438), Expect = 3e-51
Identities = 57/287 (19%), Positives = 111/287 (38%), Gaps = 37/287 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
F+ L +G G++ V+ R G+ A+K ++ + + + V E L+L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
P ++++ G ++++ Y+E + +F K Y ++ LE+ H
Sbjct: 64 PFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ +++RD+K N+L+D G + I DFG A + + T Y PE++
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKP 177
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
Y +D WS G ++ E+LA ++ KI + + P
Sbjct: 178 -YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------AELRFP----- 221
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403
F L+ L+ D ++R +V
Sbjct: 222 --------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 9e-51
Identities = 68/287 (23%), Positives = 118/287 (41%), Gaps = 34/287 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDH 176
+ F+ L +G+GT+ V R+ TG+ A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 177 PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
P + L+ + L V +Y S FT+ + + Y +++S LE+ H
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
++ V++RDIK NL++D +G + I DFGL + M + T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED-N 180
Query: 297 DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356
DYG VD W G ++ E++ + + I ++ + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------EEIRFP----- 225
Query: 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403
+ P + L+ LL DP +R + EV
Sbjct: 226 --------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-50
Identities = 62/288 (21%), Positives = 101/288 (35%), Gaps = 46/288 (15%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL----EPESVRFMAREILILRRLD 175
++ +G G + +VY VA+K V D + E + + E+++L+++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 176 --HPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
V++L S L L DL + + + Q+L +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVR 124
Query: 234 HCHNQHVLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELL 292
HCHN VLHRDIK N+LID N G L + DFG + T T Y PPE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 293 LGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
+G +WS G +L +++ E+ + F+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------------- 224
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ LI LA+ P++R T
Sbjct: 225 ------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 7e-50
Identities = 59/289 (20%), Positives = 101/289 (34%), Gaps = 37/289 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKAR---DTLTGQIVALKKVRFDNL-EPESVRFMAREILILRR 173
L+K+G G++ V + + VA+K ++ D L +PE++ RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
LDH N+++L G+V + + +V + L F + Y Q+ G+
Sbjct: 68 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPEL 291
+ ++ +HRD+ NLL+ ++ I DFGL N M +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 292 LLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
L + D W G L E+ + G + LHKI K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP------- 237
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
+D P ++ A P +R T A
Sbjct: 238 --------------------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (425), Expect = 1e-49
Identities = 50/295 (16%), Positives = 99/295 (33%), Gaps = 36/295 (12%)
Query: 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL 174
R + + KIG G++ ++Y D G+ VA+K P+ + E I + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEH 234
+ + +V + + L L + KF+ V Q++S +E+
Sbjct: 60 QGGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 235 CHNQHVLHRDIKGSNLLI---DNEGILTIADFGLASFFDPN------HKQPMTSRVVTLW 285
H+++ +HRD+K N L+ ++ I DFGLA + + + T
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 286 YRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYW 345
Y LG + DL S G +L G + K ++
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-------- 229
Query: 346 KKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ I K +P + ++ ++ + +
Sbjct: 230 -------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-49
Identities = 57/292 (19%), Positives = 108/292 (36%), Gaps = 40/292 (13%)
Query: 118 DTFEKLDK-IGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-D 175
D ++ + +G G V + + T + ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 176 HPNVVKLEGLVTSRMSC--SLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQLLSG 231
P++V++ + + + L +V + ++ +L + FT+ + M +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 232 LEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
+++ H+ ++ HRD+K NLL IL + DFG A ++ +T+ T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVA 181
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
PE+L Y D+WS G I+ LL P + + E+
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ + LI LL +P +R T T +
Sbjct: 241 ---------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-49
Identities = 56/285 (19%), Positives = 105/285 (36%), Gaps = 37/285 (12%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
+ +IG G + V+ L VA+K +R + E E ++ +L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCH 236
+V+L G+ + LVF++MEH L+ + F + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 237 NQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGAT 296
V+HRD+ N L+ ++ ++DFG+ F + T + + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S 177
Query: 297 DYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
Y D+WS G ++ E+ +E K R+ E + I +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----------------STGFRL 221
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+KP + ++ P +R + LR
Sbjct: 222 YKP------------RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (424), Expect = 6e-49
Identities = 53/294 (18%), Positives = 111/294 (37%), Gaps = 23/294 (7%)
Query: 99 SWLSAVAGEAISGWTPRRADT-----FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRF 153
+L+ + + W +T F+++ +G G++ V + +G A+K +
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 154 DNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASP 212
+ + + + E IL+ ++ P +VKLE + + + + + L
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136
Query: 213 TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272
+F++ + Y Q++ E+ H+ +++RD+K NLLID +G + + DFG A
Sbjct: 137 --RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR---- 190
Query: 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHK 332
K + T PE++L Y VD W+ G ++ E+ A P ++ K
Sbjct: 191 VKGRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLA 386
I + K + + + + +
Sbjct: 250 IVSGKVRFPSHFSSDLK----------DLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-48
Identities = 59/286 (20%), Positives = 110/286 (38%), Gaps = 39/286 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
++ K+GQG + V+ T + VA+K ++ + PE+ +E ++++L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLA--ASPTIKFTQAQVKCYMHQLLSGLEHC 235
+V+L +V+ +Y+V +YM Q+ Q+ SG+ +
Sbjct: 73 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 236 HNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGA 295
+ +HRD++ +N+L+ + +ADFGLA + N + + PE L
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 296 TDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354
+ + D+WS G +L EL + + PG E L ++ + P
Sbjct: 190 R-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP----------- 237
Query: 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ P S L+ +P ER T
Sbjct: 238 -----------------ECPESLHDLMCQCWRKEPEERPTFEYLQA 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 3e-48
Identities = 65/293 (22%), Positives = 119/293 (40%), Gaps = 34/293 (11%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL---TGQIVALKKVRFDNL--EPESVRFMAREILILR 172
+ FE L +G G Y V+ R TG++ A+K ++ + + ++ E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 173 RLDH-PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSG 231
+ P +V L + L+L+ Y+ S +FT+ +V+ Y+ +++
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 232 LEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPEL 291
LEH H +++RDIK N+L+D+ G + + DFGL+ F + + T+ Y P++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 292 LLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
+ G + + VD WS G ++ ELL E +I + Y
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----- 256
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEV 403
++ + LI+ LL DP +R E+
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-48
Identities = 54/288 (18%), Positives = 113/288 (39%), Gaps = 38/288 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLT---GQIVALKKVRFDNLEPESVRFMAREILILRRL 174
+ E IG+G + +V++ VA+K + + +F+ +E L +R+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 65
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
DHP++VKL G++T ++++ + +L A + Y +QL + L
Sbjct: 66 DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLL 293
+ ++ +HRDI N+L+ + + + DFGL+ + + + + + + + PE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 294 GATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352
+ D+W G + E+L G + + +I ++ +P
Sbjct: 183 F-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------GERLPMP- 231
Query: 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ PP+ L+ A DP+ R T
Sbjct: 232 ------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-48
Identities = 49/283 (17%), Positives = 107/283 (37%), Gaps = 37/283 (13%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
L ++G G + V + VA+K ++ ++ + E ++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKL 61
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQ 238
V+L G+ T + ++++ +YM + L +F Q+ + +E+ ++
Sbjct: 62 VQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 239 HVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDY 298
LHRD+ N L++++G++ ++DFGL+ + + + + PPE+L+ + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 299 GVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
D+W+ G ++ E+ + K T E I + + PH
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---------GLRLYRPH----- 224
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ + ER T L
Sbjct: 225 --------------LASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 9e-48
Identities = 53/282 (18%), Positives = 107/282 (37%), Gaps = 39/282 (13%)
Query: 125 KIGQGTYSNVYKA--RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
++G G + +V + R VA+K ++ + ++ M RE I+ +LD+P +V+L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 74
Query: 183 EGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVL 241
G+ + +L LV + L + + V +HQ+ G+++ ++ +
Sbjct: 75 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 242 HRDIKGSNLLIDNEGILTIADFGLASFFDPN--HKQPMTSRVVTLWYRPPELLLGATDYG 299
HRD+ N+L+ N I+DFGL+ + + ++ L + PE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190
Query: 300 VGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358
D+WS G + E L+ + E + I + K+ + P
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------GKRMECP------- 234
Query: 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ PP L+ +R +
Sbjct: 235 ------------PECPPELYALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 9e-48
Identities = 53/293 (18%), Positives = 107/293 (36%), Gaps = 44/293 (15%)
Query: 111 GWTPRRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILI 170
GW + + L IG+G + +V G VA+K ++ + + E +
Sbjct: 1 GWALNMKE-LKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK----NDATAQAFLAEASV 53
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAG-LAASPTIKFTQAQVKCYMHQL 228
+ +L H N+V+L G++ LY+V +YM L L + + + +
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 229 LSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRP 288
+E+ + +HRD+ N+L+ + + ++DFGL + + + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTA 168
Query: 289 PELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347
PE L + D+WS G +L E+ + + P + + ++ K K
Sbjct: 169 PEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------GYK 218
Query: 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P PP+ +++ +D A R +
Sbjct: 219 MDAP-------------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-47
Identities = 47/281 (16%), Positives = 97/281 (34%), Gaps = 37/281 (13%)
Query: 125 KIGQGTYSNVYKA--RDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKL 182
++G G + V K + + VA+K ++ + +P + E ++++LD+P +V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 183 EGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLH 242
G+ + S LV + E + +HQ+ G+++ + +H
Sbjct: 74 IGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 243 RDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV--TLWYRPPELLLGATDYGV 300
RD+ N+L+ + I+DFGL+ + + + PE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSS 189
Query: 301 GVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQ 359
D+WS G ++ E + + G E + K ++ P
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------GERMGCP-------- 232
Query: 360 QSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
P L+ D R A
Sbjct: 233 -----------AGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 1e-47
Identities = 51/283 (18%), Positives = 105/283 (37%), Gaps = 31/283 (10%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHP 177
K+G G Y VY+ VA+K ++ D +E E +E +++ + HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 178 NVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN 237
N+V+L G+ T + F + L L + + + Q+ S +E+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATD 297
++ +HRD+ N L+ ++ +ADFGL+ + + + PE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 298 YGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357
+ + D+W+ G +L E+ ++ Q++++ +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------------- 230
Query: 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
K E + P L+ +P++R + +
Sbjct: 231 -----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 2e-47
Identities = 48/288 (16%), Positives = 90/288 (31%), Gaps = 40/288 (13%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
++ +IG+G++ +++ + L Q VA+K + P+ + E + L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 59
Query: 177 -PNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHC 235
+ + LV + L L KF+ V Q+L+ ++
Sbjct: 60 CTGIPNVYYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 236 HNQHVLHRDIKGSNLLIDN-----EGILTIADFGLASFFDPN------HKQPMTSRVVTL 284
H + +++RDIK N LI ++ + DFG+ F+ + + T
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 285 WYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344
Y LG + DL + G + L G K ++
Sbjct: 178 RYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG------- 229
Query: 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAER 392
KK P + E FP + +
Sbjct: 230 EKKQSTP--------------LRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 6e-47
Identities = 57/293 (19%), Positives = 118/293 (40%), Gaps = 41/293 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRL 174
+ IG G + V L G+ VA+K ++ E + F+ E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
DHPNV+ LEG+VT S + ++ ++ME+ L +FT Q+ + + +G++
Sbjct: 85 DHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV----TLWYRPP 289
+ + + +HRD+ N+L+++ + ++DFGL+ F + + P + + + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 290 ELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348
E + + D+WS G ++ E+++ + T + ++ I + P
Sbjct: 203 EAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM----- 256
Query: 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401
D P + L+ D R + +
Sbjct: 257 -----------------------DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-45
Identities = 66/301 (21%), Positives = 103/301 (34%), Gaps = 29/301 (9%)
Query: 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH 176
A T + IG+G + V++ + G+ VA+K + E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRH 56
Query: 177 PNVVKLEGLVTSRMSC--SLYLVFKYMEH-DLA------GLAASPTIKFTQAQVKCYMHQ 227
N++ L+LV Y EH L + IK + H
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 228 LLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ---PMTSRVVTL 284
+ + + HRD+K N+L+ G IAD GLA D RV T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 285 WYRPPELLLGA-----TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339
Y PE+L + + D+++ G + E+ I G E QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSD 235
Query: 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399
PS E +K +P + E + ++ + A R TA
Sbjct: 236 PSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTALRIK 289
Query: 400 R 400
+
Sbjct: 290 K 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (391), Expect = 1e-44
Identities = 60/318 (18%), Positives = 120/318 (37%), Gaps = 65/318 (20%)
Query: 114 PRRADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREI 168
PR + E + IG+G + V++AR +VA+K ++ + F RE
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 67
Query: 169 LILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGL------------------- 208
++ D+PN+VKL G + + L+F+YM + DL
Sbjct: 68 ALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 209 ----AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFG 264
++ + A+ C Q+ +G+ + + +HRD+ N L+ ++ IADFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 265 LASFFDP-NHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMP 322
L+ ++ + + + + + PPE + Y D+W+ G +L E+ +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 244
Query: 323 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIE 382
G E ++ + + + ++ P L+
Sbjct: 245 GMAHEEVIYYV------------RDGNIL----------------ACPENCPLELYNLMR 276
Query: 383 TLLAIDPAERQTATAALR 400
+ PA+R + + R
Sbjct: 277 LCWSKLPADRPSFCSIHR 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-44
Identities = 64/314 (20%), Positives = 111/314 (35%), Gaps = 62/314 (19%)
Query: 118 DTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
+ E +G G + V A T VA+K ++ E M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 173 RL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKF-------------- 216
+L H N+V L G T S +YL+F+Y + DL S KF
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 217 --------TQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268
T + C+ +Q+ G+E + +HRD+ N+L+ + ++ I DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 269 FDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTE 326
+ + + + + PE L Y + D+WS G +L E+ + PG
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 327 VEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLA 386
+K+ + FK Q ++++ A
Sbjct: 273 DANFYKLIQ------------------NGFKMDQP---------FYATEEIYIIMQSCWA 305
Query: 387 IDPAERQTATAALR 400
D +R +
Sbjct: 306 FDSRKRPSFPNLTS 319
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-44
Identities = 48/289 (16%), Positives = 96/289 (33%), Gaps = 34/289 (11%)
Query: 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALK---KVRFDNLEPESVRFMAREILILR 172
+ F+K+ +G G + VYK G+ V + K + P++ + + E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGL 232
+D+P+V +L G+ + + L + + Q+ G+
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSRVV-TLWYRPPEL 291
+ ++ ++HRD+ N+L+ + I DFGLA K+ + + E
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 292 LLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351
+L Y D+WS G + EL+ ++ I + K +LP
Sbjct: 185 ILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------KGERLP 233
Query: 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
++ ID R +
Sbjct: 234 Q-----------------PPICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (391), Expect = 5e-44
Identities = 73/322 (22%), Positives = 130/322 (40%), Gaps = 50/322 (15%)
Query: 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNV 179
+ + K+G G +S V+ A+D + VA+K VR D + E+ EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 180 VKLEGLVTSRMSCSLYLVFKYMEHD---------------LAGLAASPTIKFTQAQVKCY 224
K + + + + L F + + LA + VK
Sbjct: 72 TKEDSMGANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 225 MHQLLSGLEHCHNQH-VLHRDIKGSNLLIDNEGI------LTIADFGLASFFDPNHKQPM 277
QLL GL++ H + ++H DIK N+L++ + IAD G A ++D ++ +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQLH 331
+R YR PE+LLGA +G G D+WS C++ EL+ + + + +
Sbjct: 191 QTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 332 KIFKLCGSPSEEYWKKSKLPHATI-------------FKPQQSYKRCIAETFKDFPPSSL 378
+I +L G + K F P + + KD
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 379 PLIETLLAIDPAERQTATAALR 400
+ +L +DP +R A +
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVN 327
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-41
Identities = 54/309 (17%), Positives = 103/309 (33%), Gaps = 57/309 (18%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILR 172
+ +G G + V +A VA+K ++ E M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 173 RL-DHPNVVKLEGLVTSRMSCSLYLVFKYMEH------------------DLAGLAASPT 213
L +H N+V L G T ++ +Y + +
Sbjct: 82 YLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 214 IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273
+ + + +Q+ G+ +++ +HRD+ N+L+ + I I DFGLA +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 274 KQPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLH 331
+ + + PE + Y D+WS G L EL + PG + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 332 KIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAE 391
K+ K + ++ E P +++T DP +
Sbjct: 259 KMIK------------------------EGFRMLSPE---HAPAEMYDIMKTCWDADPLK 291
Query: 392 RQTATAALR 400
R T ++
Sbjct: 292 RPTFKQIVQ 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-41
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 39/285 (13%)
Query: 124 DKIGQGTYSNVYKARD---TLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV 180
+ IG+G + VY A+K + E +F+ E +I++ HPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 181 KLEGLVTSRMSCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH 239
L G + R S +V YM+H DL + T T + + Q+ G++ ++
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 240 VLHRDIKGSNLLIDNEGILTIADFGLASFFDPN---HKQPMTSRVVTLWYRPPELLLGAT 296
+HRD+ N ++D + + +ADFGLA T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209
Query: 297 DYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355
+ D+WS G +L EL+ P P + + + ++ P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------GRRLLQP---- 256
Query: 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
+ P ++ R + + +
Sbjct: 257 ---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-40
Identities = 51/290 (17%), Positives = 108/290 (37%), Gaps = 38/290 (13%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRR 173
+ IG G + VYK + VA+K ++ E + V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 174 LDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGL 232
H N+++LEG+++ + ++ +YME+ +F+ Q+ + + +G+
Sbjct: 66 FSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 233 EHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF--DPNHKQPMTSRVVTLWYRPPE 290
++ N + +HRD+ N+L+++ + ++DFGL+ DP + + + + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 291 LLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350
+ D+WS G ++ E++ ++ K
Sbjct: 184 AISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------------- 227
Query: 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400
T D P + L+ + A R +
Sbjct: 228 ------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-39
Identities = 56/305 (18%), Positives = 102/305 (33%), Gaps = 50/305 (16%)
Query: 118 DTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILR 172
D + +G+G + V +A T T + VA+K ++ E M+ +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 173 RLDHPNVVKLEGLVTSRMSCSLYLVFKYMEHDLAGL---------------AASPTIKFT 217
H NVV L G T + +V +L+ T
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 218 QAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277
+ CY Q+ G+E ++ +HRD+ N+L+ + ++ I DFGLA +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 278 TSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFK 335
L + PE + Y + D+WS G +L E+ + PG E+ + K
Sbjct: 193 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 336 LCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTA 395
+ P + +P++R T
Sbjct: 252 ---------------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284
Query: 396 TAALR 400
+ +
Sbjct: 285 SELVE 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-39
Identities = 62/304 (20%), Positives = 110/304 (36%), Gaps = 54/304 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRL- 174
+ + D IG+G + V KAR G A+K+++ + + F E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 175 DHPNVVKLEGLVTSRMSCSLYLVFKYMEH----------------DLAGLAASPTIKFTQ 218
HPN++ L G LYL +Y H +A S +
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 219 AQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278
Q+ + + G+++ + +HRD+ N+L+ + IADFGL+ + K T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLC 337
+ + + E L + Y D+WS G +L E+++ G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 338 GSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA 397
+ + P + L+ P ER +
Sbjct: 242 -------GYRLEKP-------------------LNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 398 ALRS 401
L S
Sbjct: 276 ILVS 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-38
Identities = 49/321 (15%), Positives = 110/321 (34%), Gaps = 50/321 (15%)
Query: 98 PSWLSAVAGEAISGWTPRRADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVR 152
P + SA W R + ++GQG++ VY+ VA+K V
Sbjct: 1 PEYFSAADVYVPDEWEVAR-EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 59
Query: 153 FDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYME---------- 202
E + F+ E +++ + +VV+L G+V+ ++ + M
Sbjct: 60 EAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRS 116
Query: 203 HDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIAD 262
A + +++ ++ G+ + + +HRD+ N ++ + + I D
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176
Query: 263 FGLASFF-DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPI 320
FG+ + ++ + ++ + + PE L + D+WS G +L E+ +
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 235
Query: 321 MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPL 380
G + + L + + + + + P L
Sbjct: 236 YQGLSNEQVLRFVM----------------------------EGGLLDKPDNCPDMLFEL 267
Query: 381 IETLLAIDPAERQTATAALRS 401
+ +P R + + S
Sbjct: 268 MRMCWQYNPKMRPSFLEIISS 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-37
Identities = 53/307 (17%), Positives = 103/307 (33%), Gaps = 54/307 (17%)
Query: 118 DTFEKLDKIGQGTYSNVYKARDTLT-------GQIVALKKVRFDNLEPESVRFMAREILI 170
D +G+G + V A VA+K ++ D E + ++ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 171 LRRLDHPNVVKLEGLVTSRMSCSLYLVFKYMEH----------------DLAGLAASPTI 214
H N++ L G T LY++ +Y + +P
Sbjct: 73 KMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 215 KFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274
+ + + +Q+ G+E+ ++ +HRD+ N+L+ + ++ IADFGLA
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 275 QPMT-SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKI 333
T + + + + PE L Y D+WS G +L E+ VE+L K+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 334 FKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ 393
K + + ++ P++R
Sbjct: 250 LKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 394 TATAALR 400
T +
Sbjct: 283 TFKQLVE 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 110 bits (276), Expect = 3e-29
Identities = 26/203 (12%), Positives = 66/203 (32%), Gaps = 30/203 (14%)
Query: 124 DKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFM--------AREILILRRLD 175
+G+G S V+ +K + + + V+ + + R +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 176 HPNVVKLEG--LVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLE 233
+ KL+G + ++ + ++ + + +L +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVA 117
Query: 234 HCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMTSR---VVTLWYRPPE 290
+++ ++H D+ N+L+ EGI I DF + + + R + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173
Query: 291 LLLGATDYGVGVDLWSAGCILAE 313
Y D+ SA + +
Sbjct: 174 -----RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 415 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.08 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.3 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 83.83 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-62 Score=452.66 Aligned_cols=261 Identities=28% Similarity=0.388 Sum_probs=217.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .+..+.+.+|+.+|++++|||||++++++.+ ...+|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEE
Confidence 4689999999999999999999999999999999986543 2334568899999999999999999999988 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-C
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-Q 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-~ 275 (415)
||||+.++.+..++.....+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999877777777777899999999999999999999999999999999999999999999999999987643322 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....+||+.|+|||++.+...++.++|||||||+||||++|.+||.+.+...............
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence 34557899999999999875555788999999999999999999998765544333333221111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
......+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 226 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0112357788999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-62 Score=449.88 Aligned_cols=254 Identities=30% Similarity=0.442 Sum_probs=222.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|+++.+++.||+|++.+... .....+.+.+|+.++++++|||||++++++.+ ...+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEE
Confidence 5689999999999999999999999999999999975432 12335678899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+|||||.++.+...+.....+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999999877777666668999999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+.+.....
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------- 223 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--------------- 223 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC---------------
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 2345689999999999987 678999999999999999999999999999888888776532111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
.+.+++++++||.+||+.||++|||++|+|+||||.
T Consensus 224 --------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 224 --------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred --------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 124778899999999999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-61 Score=451.66 Aligned_cols=292 Identities=39% Similarity=0.684 Sum_probs=243.4
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 68999999999999999999999999999999997665444445678899999999999999999999988 5679999
Q ss_pred EEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++++.... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~ 158 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT 158 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BC
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-cc
Confidence 9999988766554 445679999999999999999999999999999999999999999999999999998775433 33
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
.....||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+.+.++.+..+.+....|...........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 45568999999999987766678999999999999999999999999999999999999988888777665322222111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
................++.++++||.+||..||++|||++|+|+||||++++...|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 11111112233445577888999999999999999999999999999999998766
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-61 Score=453.72 Aligned_cols=287 Identities=40% Similarity=0.659 Sum_probs=238.7
Q ss_pred eeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh---HHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEE
Q 014960 122 KLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP---ESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVF 198 (415)
Q Consensus 122 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~ 198 (415)
.+++||+|+||+||+|+++.+|+.||||+++...... ...+.+.+|+.+|++++|||||++++++.. ...+|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehh
Confidence 4689999999999999999999999999997654321 123467899999999999999999999987 45699999
Q ss_pred EecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCcc
Q 014960 199 KYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPMT 278 (415)
Q Consensus 199 e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~~ 278 (415)
||+.++++..+......+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|........ ...
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9999999888888888899999999999999999999999999999999999999999999999999987654432 334
Q ss_pred cccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 279 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 279 ~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
..+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++.+|.+..+.+..+.|.............
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 56899999999998776678999999999999999999999999999999999999999999887776533222211110
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
. ............+++++++||.+||..||++|||++|+|+||||++.....|
T Consensus 239 ~-~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 239 S-FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp C-CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred c-CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 0 0011133445677889999999999999999999999999999998876554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-61 Score=449.85 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=223.5
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|+++++||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEE
Confidence 5799999999999999999999999999999999865432 34678899999999999999999999988 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||||.++.+..+... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+.... ...
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 999999877766544 379999999999999999999999999999999999999999999999999998875443 234
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+....... .
T Consensus 174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~--------------- 236 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-L--------------- 236 (293)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-C---------------
T ss_pred cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-C---------------
Confidence 56689999999999986 678999999999999999999999999988888777776542111 0
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
.....+++++++||.+||..||.+|||++|+|+||||+...
T Consensus 237 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 237 ----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp ----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 11234788899999999999999999999999999997544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-61 Score=446.82 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=213.1
Q ss_pred CCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 116 RADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 116 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
+.++|++++.||+|+||.||+|+++.+|+.||+|++..........+.+.+|+++|++++|||||++++++.+.....+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 35789999999999999999999999999999999988776777778899999999999999999999998765566799
Q ss_pred EEEEecccChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeeccCCCCCEEEcCCCcEEEEeeccc
Q 014960 196 LVFKYMEHDLAGLAAS----PTIKFTQAQVKCYMHQLLSGLEHCHNQH-----VLHRDIKGSNLLIDNEGILTIADFGLA 266 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NILl~~~~~vkl~DfG~a 266 (415)
+|||||.++.+..++. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999876655442 3457999999999999999999999876 999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 014960 267 SFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 346 (415)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 346 (415)
+.+.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..++..++.+....
T Consensus 162 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~------- 232 (269)
T d2java1 162 RILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR------- 232 (269)
T ss_dssp HHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------
T ss_pred eecccCC-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 8875433 22345689999999999876 67999999999999999999999999999888888877653211
Q ss_pred hCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014960 347 KSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVS 404 (415)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f 404 (415)
.....+++++.+||.+||+.||.+|||++|+|+|||+
T Consensus 233 ---------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 ---------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 1123578889999999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-61 Score=450.12 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=222.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+++|++++|||||++++++.+ ...+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 3679999999999999999999999999999999975432 23345678899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~- 274 (415)
+||||+.++.+..+......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999877766666666899999999999999999999999999999999999999999999999999988754332
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+++.+|.+.....
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 229 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-------------- 229 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--------------
T ss_pred cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 23345689999999999986 678999999999999999999999999999888888876532111
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATA------ALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~------~L~h~~f~~~~ 408 (415)
...+++++++||.+||+.||++|||++| +++||||+.++
T Consensus 230 ---------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 230 ---------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp ---------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ---------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 1247788999999999999999999987 58999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-59 Score=450.95 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=228.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+ ...+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999997543 4456778899999999999999999999988 567999
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC--CCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN--EGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~~vkl~DfG~a~~~~~~~ 273 (415)
|||||.++.+...+ .....+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|..+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999987665544 55667999999999999999999999999999999999999964 5789999999998876442
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+....+....
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 248 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA--------- 248 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG---------
T ss_pred --ccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc---------
Confidence 3355789999999999986 6789999999999999999999999999999999998877554433222
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
...+++++++||.+||+.||++|||++|+|+||||+..+..
T Consensus 249 ----------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 249 ----------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ----------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 23578889999999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-60 Score=447.25 Aligned_cols=260 Identities=28% Similarity=0.394 Sum_probs=208.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.+.|++.+.||+|+||.||+|+++.+|+.||||++.+..... ....+.+|+.+|++++|||||++++++.+ +..+|+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 356999999999999999999999999999999998765432 34567899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc---CCCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID---NEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DfG~a~~~~~~~ 273 (415)
|||||.++.+..++.....+++.+++.|+.||+.||+|||++||+||||||+|||+. .++.+||+|||+|.......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999877766666667899999999999999999999999999999999999995 47899999999998765442
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+....+.+....+..
T Consensus 165 --~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 230 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS----------- 230 (307)
T ss_dssp ----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT-----------
T ss_pred --eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC-----------
Confidence 2355689999999999986 67899999999999999999999999999988888888764333221
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
...+.+|+++++||.+||..||++|||++|+|+||||+.-
T Consensus 231 --------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 --------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1224678889999999999999999999999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-60 Score=450.24 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=228.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... ..+..+.+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccccc
Confidence 4689999999999999999999999999999999986432 23345678899999999999999999999988 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+|||||.++.+..++.....+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... .
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence 999999998887777777789999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+.+..+......+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~--------------- 224 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--------------- 224 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred ccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC---------------
Confidence 3456789999999999986 678999999999999999999999999999988888876643221
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
...+++++++||.+||++||.+|++ ++|+++||||+.++
T Consensus 225 --------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 225 --------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred --------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 1357888999999999999999994 99999999998763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-60 Score=446.55 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=224.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
+.|++++.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+ ...+|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEE
Confidence 3599999999999999999999999999999999876543 4456678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||||.++++..+......+++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 999999988877666667899999999999999999999999999999999999999999999999999987543
Q ss_pred cccccccCccCCcccccC--CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCC
Q 014960 277 MTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHAT 354 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~--~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 354 (415)
.....||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.+.+..+.+..+.+....+.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------- 234 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------- 234 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 244679999999999864 24589999999999999999999999999888888777765321110
Q ss_pred cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 355 IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
....+++++++||.+||+.||.+|||++|+|+||||+.-.
T Consensus 235 --------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 235 --------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp --------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred --------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 1134678899999999999999999999999999997543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=441.54 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=227.7
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC----hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
++|++++.||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+.+|++++|||||++++++.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 5799999999999999999999999999999999865432 2245778899999999999999999999987 567
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC----cEEEEeecccccc
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG----ILTIADFGLASFF 269 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DfG~a~~~ 269 (415)
+|||||||.++.+..++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999887777666666899999999999999999999999999999999999998876 4999999999887
Q ss_pred CCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.... ......||+.|+|||++.+ ..++.++|||||||+||||++|.+||.+.+..+.+..+.+....+....+
T Consensus 168 ~~~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---- 240 (293)
T d1jksa_ 168 DFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240 (293)
T ss_dssp TTSC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH----
T ss_pred CCCc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc----
Confidence 5443 2345678999999999986 67899999999999999999999999999999998888775544443322
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
+.+|.++++||++||+.||++|||++|+|+||||+..+.
T Consensus 241 ---------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp ---------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred ---------------------CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 457888999999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=435.26 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=215.1
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec--CCCeEEEE
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR--MSCSLYLV 197 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~~~lv 197 (415)
|++.++||+|+||+||+|++..++..||+|++..........+.+.+|+++|++++|||||++++++... ....+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4677889999999999999999999999999987766666778899999999999999999999998652 24568999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCEEEc-CCCcEEEEeeccccccCCCCC
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQH--VLHRDIKGSNLLID-NEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~-~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|||+.++.+..++.....+++..++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 999999888777766678999999999999999999999998 99999999999996 4789999999999865432
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+...... ...+... ..+.
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~--~~~~----------- 232 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPA----------- 232 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCG-----------
T ss_pred -ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC--CCCc-----------
Confidence 2356789999999999865 599999999999999999999999987655444 3333221 1111
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
......++++.+||.+||+.||++|||++|+|+||||+
T Consensus 233 --------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 --------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11234677899999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-59 Score=448.82 Aligned_cols=259 Identities=24% Similarity=0.409 Sum_probs=226.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|++++|||||+++++|.+ ...+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 357999999999999999999999999999999998653 3445678899999999999999999999987 567999
Q ss_pred EEEecccChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEc--CCCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLID--NEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~vkl~DfG~a~~~~~~~ 273 (415)
|||||.++.+... ......+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|..+....
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999998766544 44555799999999999999999999999999999999999998 57899999999998876542
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+.+....++..
T Consensus 184 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 250 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED---------- 250 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS----------
T ss_pred --ceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 3455688999999999886 679999999999999999999999999999999998887755443322
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
....+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 251 ---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 ---------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ---------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 224578889999999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-59 Score=439.20 Aligned_cols=285 Identities=36% Similarity=0.630 Sum_probs=239.2
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|+++++||+|+||+||+|+++ +|+.||||++..........+.+.+|+.+|++++|||||++++++.+ ....|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEE
Confidence 68999999999999999999985 78999999998765444445778899999999999999999999987 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
||++.++++..+......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 99999999999888888999999999999999999999999999999999999999999999999999988754332 23
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFK 357 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 357 (415)
....+++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++.+..+.+....|............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 44578999999999987777899999999999999999999999999999999999999998887777653322221111
Q ss_pred CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 358 PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
...............++++++|||++||..||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111112234445667888999999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-60 Score=443.65 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=220.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
+.|++++.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+++|++++|||||++++++.+ ...+|+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEE
Confidence 57999999999999999999999999999999998653 3445678899999999999999999999988 5679999
Q ss_pred EEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
||||.++.+..++ .....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|....... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 9999987766554 345579999999999999999999999999999999999999999999999999997653211 12
Q ss_pred cccccccCccCCcccccC----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 277 MTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.....||+.|+|||++.. ...|+.++|||||||+||||++|.+||.+.+..+.+.++.+......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~----------- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL----------- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 235679999999999842 35688999999999999999999999999988888887766421110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
.....+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 236 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 ---------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ---------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ---------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 111347888999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-59 Score=445.17 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=227.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 4689999999999999999999999999999999975432 22345678899999999999999999999987 56899
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999988888877778999999999999999999999999999999999999999999999999999876532
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.++.+.....
T Consensus 158 -~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------------- 220 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--------------- 220 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC---------------
T ss_pred -cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC---------------
Confidence 345689999999999876 678999999999999999999999999999999888887642211
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
...++++++++|.+||..||.+|+ |++++|+||||+.++
T Consensus 221 --------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 221 --------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred --------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 134778899999999999999996 999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-60 Score=451.59 Aligned_cols=285 Identities=22% Similarity=0.312 Sum_probs=215.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|+++++||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|++++|||||+++++|.+ ...+|+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999998653 34445678899999999999999999999987 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
||||+.++.+..++.....+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|......
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 99999987777776666689999999999999999999997 59999999999999999999999999999876432
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHH----HhhCCC
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQ-LHKIFKLCGSPSEEY----WKKSKL 350 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~----~~~~~~ 350 (415)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+. ...+....+.+.... +.....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 2345689999999999987 6799999999999999999999999988664432 221222222111110 000000
Q ss_pred C-CCCcCCCcchhh----hhhhhhc-----CCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 351 P-HATIFKPQQSYK----RCIAETF-----KDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 351 ~-~~~~~~~~~~~~----~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
. ......+..... ....... ..++.++++||.+||..||.+|||++|+|+||||+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0 000000000000 0011111 12466789999999999999999999999999997543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=436.80 Aligned_cols=288 Identities=37% Similarity=0.621 Sum_probs=235.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCC-CceEEEEEEecCCCChHHHHHHHHHHHHHHhC---CCCceeeeeeeEeec---
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLT-GQIVALKKVRFDNLEPESVRFMAREILILRRL---DHPNVVKLEGLVTSR--- 189 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~--- 189 (415)
.++|+++++||+|+||+||+|++..+ ++.||||++............+.+|+.+|+.| +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999665 67799999976543333333455677777665 899999999998542
Q ss_pred CCCeEEEEEEecccChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 190 MSCSLYLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
....+|++|||+.++++... ......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 24578999999999876543 44556799999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.... .......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++.++.+..+.+....|+..
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5433 23456789999999999986 67999999999999999999999999999999999999999999988877654
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.......+.... ..........+++++++||.+||.+||++|||++|+|+||||+++.-
T Consensus 243 ~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 243 VALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CSSCGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccchhhhhcccc--ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 333222211111 11133344567888999999999999999999999999999998853
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-58 Score=428.32 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=226.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC-------hHHHHHHHHHHHHHHhCC-CCceeeeeeeEeec
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE-------PESVRFMAREILILRRLD-HPNVVKLEGLVTSR 189 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~ 189 (415)
++|++.+.||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.++++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 6899999999999999999999999999999999876532 123446788999999997 9999999999987
Q ss_pred CCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeecccccc
Q 014960 190 MSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFF 269 (415)
Q Consensus 190 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~ 269 (415)
+..+||||||+.++.+..++.....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 5689999999998766666666668999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCcccccccCccCCcccccC-----CcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Q 014960 270 DPNHKQPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEY 344 (415)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 344 (415)
.... .....+||+.|+|||++.+ ...++.++||||+||+||+|++|.+||.+.+..+....+.+....+...
T Consensus 161 ~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~- 237 (277)
T d1phka_ 161 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP- 237 (277)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred cCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc-
Confidence 6543 2355689999999999853 3457889999999999999999999999999988888887754332221
Q ss_pred HhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 345 WKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
....+|+++++||.+||+.||++|||++|+|+||||+..
T Consensus 238 ------------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 ------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp ------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ------------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 223588899999999999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-59 Score=446.82 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=226.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccccc
Confidence 4789999999999999999999999999999999975432 22345678899999999999999999999987 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
+||||+.++.+...+.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 99999999887777766668999999999999999999999999999999999999999999999999999887532
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+....+.++.+....+
T Consensus 195 -~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------------- 257 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--------------- 257 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred -cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC---------------
Confidence 345689999999999986 678999999999999999999999999999888888887643221
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
...+++++.+||++||..||.+|+ |++++|+||||+.++
T Consensus 258 --------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 258 --------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp --------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred --------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 135788899999999999999995 999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-58 Score=437.08 Aligned_cols=257 Identities=20% Similarity=0.312 Sum_probs=226.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+++|+.++|||||+++++|.+ ...+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 368999999999999999999999999999999997643 344568899999999999999999999988 567999
Q ss_pred EEEecccChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC--CcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE--GILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~--~~vkl~DfG~a~~~~~~~ 273 (415)
|||||.++.+...+.. ...+++.+++.|+.||+.||+|||++||+||||||+|||++.+ ..+||+|||++.......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999998766665544 4479999999999999999999999999999999999999854 489999999998765432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......+|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|.+....++...|
T Consensus 159 --~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred --cccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc--------
Confidence 2345678999999999876 67899999999999999999999999999999999999887666655544
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLY 406 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~ 406 (415)
+.+++++++||.+||..||.+|||++|+|+||||+.
T Consensus 228 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -----------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 357888999999999999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-58 Score=439.57 Aligned_cols=285 Identities=34% Similarity=0.523 Sum_probs=236.4
Q ss_pred CceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec----CCCeE
Q 014960 119 TFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSCSL 194 (415)
Q Consensus 119 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----~~~~~ 194 (415)
+|+.+++||+|+||+||+|++..+|+.||||++..+... ..+|+.+|++++|+|||+++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999999999999999999865422 23699999999999999999998542 34568
Q ss_pred EEEEEecccChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccC
Q 014960 195 YLVFKYMEHDLAGLAA---SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFD 270 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~ 270 (415)
||||||+++++...+. .....+++.+++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987655443 4556799999999999999999999999999999999999999875 89999999998775
Q ss_pred CCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
... .....+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+..+.+..+.+..+.|.....
T Consensus 175 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 432 335568999999999988767899999999999999999999999999999999999999999999888876443
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
....................+.+++++++||.+||..||++|||+.|+|+||||+++.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 2222111111111122233456788899999999999999999999999999999886543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=432.31 Aligned_cols=291 Identities=45% Similarity=0.696 Sum_probs=233.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC------
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM------ 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 190 (415)
.++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|++++|+||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57899999999999999999999999999999999776555555567889999999999999999999875521
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
....|+||||+.++++.........+++..++.+++||+.||+|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999999998888888899999999999999999999999999999999999999999999999999997765
Q ss_pred CCCC---CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 271 PNHK---QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 271 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
.... ......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+.+..+.+..+.|..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 3321 2234457899999999998767899999999999999999999999999999999999999998887766554
Q ss_pred CCCCCCC-cCCCcchhhhhhhhh--cCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014960 348 SKLPHAT-IFKPQQSYKRCIAET--FKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYM 407 (415)
Q Consensus 348 ~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~ 407 (415)
....... ............... ....+++++|||.+||..||++|||++|+|+||||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 2211110 000000000001111 11235678899999999999999999999999999964
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4e-58 Score=443.25 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=215.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC----hHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----PESVRFMAREILILRRLDHPNVVKLEGLVTSRMSC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 192 (415)
.++|++++.||+|+||.||+|++..+|+.||||++.+.... ........+++.+++.++|||||++++++.+ ..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CC
Confidence 47899999999999999999999999999999999754321 1112223345777788899999999999987 56
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+||||+.++.+..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 79999999998887777766678999999999999999999999999999999999999999999999999999877543
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
. .....||+.|+|||++.+...|+.++|||||||+||||++|.+||.+.+..+......... ...
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~----------- 225 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMA----------- 225 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-SCC-----------
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCC-----------
Confidence 2 3456899999999999765678999999999999999999999998765443332222211 111
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQT-----ATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~~~L~h~~f~~~~ 408 (415)
......+++++++||.+||..||.+||| ++|+|+||||++++
T Consensus 226 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 226 --------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp --------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred --------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 0112357888999999999999999999 79999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-58 Score=434.09 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=222.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHH-hCCCCceeeeeeeEeecCCCeEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILR-RLDHPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~~~~~~~~ 195 (415)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ..+..+.+.+|+.++. .++|||||++++++.+ ...+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 689999999999999999999999999999999975432 1233445566777665 6899999999999988 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ 275 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~ 275 (415)
|||||+.++.+..++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++...... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 999999998888777777789999999999999999999999999999999999999999999999999998765433 3
Q ss_pred CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 276 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 276 ~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+++.++......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------------- 221 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF---------------- 221 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 3455689999999999986 67999999999999999999999999999998888887653211
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT-AALRSEVSLYMX 408 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-~~L~h~~f~~~~ 408 (415)
..+.+++++++||.+||+.||.+|||+. ++++||||++++
T Consensus 222 -------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 222 -------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 1134788899999999999999999995 899999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-57 Score=422.40 Aligned_cols=289 Identities=38% Similarity=0.636 Sum_probs=242.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++|+||+++++++.+ ....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 58999999999999999999999999999999998776666677889999999999999999999999988 5679999
Q ss_pred EEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCCc
Q 014960 198 FKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQPM 277 (415)
Q Consensus 198 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~~ 277 (415)
++++.++.+..+......+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.+....... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccc
Confidence 9999999888888888899999999999999999999999999999999999999999999999999998765433 233
Q ss_pred ccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcC
Q 014960 278 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIF 356 (415)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 356 (415)
....+++.|+|||++.+...++.++|||||||++|||++|..| |.+.+..+.+.++....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4456788999999988766689999999999999999998876 566777888888888888877666654222111111
Q ss_pred CCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 357 KPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
................+++++++||++||+.||.+|||++|+|+||||+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 11111122233444567788999999999999999999999999999998754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=436.63 Aligned_cols=288 Identities=32% Similarity=0.517 Sum_probs=233.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC----CC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM----SC 192 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~ 192 (415)
.++|+++++||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|+.++|||||+++++|.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999999999999999999876666666778899999999999999999999987642 23
Q ss_pred eEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 193 SLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.+|+||||++..+..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 97 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 589999999765554433 347999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++.+.|.......
T Consensus 175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 3566889999999999876678999999999999999999999999999999999999999999888776533211
Q ss_pred CCcCC--CcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014960 353 ATIFK--PQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXX 410 (415)
Q Consensus 353 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~ 410 (415)
..... ........+......+++++++||.+||..||.+|||++|+|+||||+.+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 10000 00000011233345678889999999999999999999999999999988754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-57 Score=418.18 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=210.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCCh----HHHHHHHHHHHHHHhCC--CCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEP----ESVRFMAREILILRRLD--HPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++.+..... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 357999999999999999999999999999999998653321 11234567999999986 8999999999987
Q ss_pred CCeEEEEEEeccc-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCC-CcEEEEeeccccc
Q 014960 191 SCSLYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNE-GILTIADFGLASF 268 (415)
Q Consensus 191 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DfG~a~~ 268 (415)
....|+||||+.+ +++.........+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|..
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 5679999999975 4555555555689999999999999999999999999999999999999854 7999999999987
Q ss_pred cCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhC
Q 014960 269 FDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 348 (415)
Q Consensus 269 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 348 (415)
.... ..+...||+.|+|||++.+...++.++|||||||+||||++|.+||.+.+ .+.+...
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~---------- 221 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV---------- 221 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC----------
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhccc----------
Confidence 5432 34567899999999999875556788999999999999999999997532 2222110
Q ss_pred CCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014960 349 KLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXX 409 (415)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~ 409 (415)
.....+|+++++||.+||..||++|||++|+|+||||+++..
T Consensus 222 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 222 -------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp -------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred -------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 112357889999999999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-56 Score=411.36 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=207.6
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|+.. ..||||+++.........+.|.+|+.+|++++|||||++++++.. ..+|+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEE
Confidence 468999999999999999999743 359999998776666777889999999999999999999998754 35899
Q ss_pred EEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC-
Q 014960 197 VFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK- 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~- 274 (415)
||||+.++.+..++ .....+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|........
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999976555544 5556799999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccCccCCcccccCC--cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......||+.|+|||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..+......++.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD---------- 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC----------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc----------
Confidence 233456789999999998642 35899999999999999999999999987776655554443211110
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.......+|+++.+||.+||+.||++|||+++++++
T Consensus 231 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 -------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 222334678899999999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-55 Score=419.67 Aligned_cols=282 Identities=28% Similarity=0.487 Sum_probs=225.9
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|+++++||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+.+|+.+. ||||++++++|.......+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 47899999999999999999999999999999998743 2456788999999995 99999999999876667899
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCC-cEEEEeeccccccCCCCC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEG-ILTIADFGLASFFDPNHK 274 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DfG~a~~~~~~~~ 274 (415)
+||||+.++.+.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|.......
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999998776553 3699999999999999999999999999999999999998765 69999999998776543
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCHHHHhh-CCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKK-SKLPH 352 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~-~~~~~ 352 (415)
.....++|+.|+|||++.+...++.++|||||||++|+|++|..||... +..++...+.+..+.+....|.. .....
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 2355678999999999987677899999999999999999999999764 45566777777766554333322 11111
Q ss_pred CCcC------CCcchhhh-hhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 353 ATIF------KPQQSYKR-CIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 353 ~~~~------~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
...+ ........ ........++++++|||++||.+||++|||++|+|+||||+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 1000 00000011 11122234678899999999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=427.01 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=207.4
Q ss_pred CCCceeee-eeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHh-CCCCceeeeeeeEee--cCCC
Q 014960 117 ADTFEKLD-KIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRR-LDHPNVVKLEGLVTS--RMSC 192 (415)
Q Consensus 117 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~--~~~~ 192 (415)
.++|.++. .||+|+||.||+|++..+++.||||++... ..+.+|+.++.+ ++|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46899875 599999999999999999999999998642 356789998765 589999999999865 2346
Q ss_pred eEEEEEEecccChhhhhc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---CCcEEEEeecccc
Q 014960 193 SLYLVFKYMEHDLAGLAA-SP-TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLAS 267 (415)
Q Consensus 193 ~~~lv~e~~~~~l~~~~~-~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DfG~a~ 267 (415)
.+|+|||||.++.+..++ .. ...+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 799999999876555544 33 347999999999999999999999999999999999999986 4579999999998
Q ss_pred ccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 268 FFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
...... .....+||+.|+|||++.+ ..|+.++|||||||+||+|+||.+||.+.+..+....+..........
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~---- 235 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE---- 235 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS----
T ss_pred eccCCC--ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC----
Confidence 776543 3355689999999999876 679999999999999999999999998877666555544322111000
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
+ .......+++++++||.+||+.||++|||+.|+|+||||+.-.
T Consensus 236 --------~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 236 --------F---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp --------C---------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred --------C---------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 0 0011224788899999999999999999999999999996543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=420.63 Aligned_cols=291 Identities=32% Similarity=0.533 Sum_probs=229.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC---CCeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRM---SCSL 194 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~~ 194 (415)
++|++++.||+|+||+||+|++..+|+.||||++.+.. .....+.+.+|+.+|++++||||+++++++.... ...+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999997654 3455667889999999999999999999986532 2346
Q ss_pred EEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 195 YLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 195 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
|++++++++++...+.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++........
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 77776666666555432 3699999999999999999999999999999999999999999999999999987644322
Q ss_pred --CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 --QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 --~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
......+||+.|+|||++.....++.++||||+||++|+|++|.+||.+.+..++...+......+............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 223456789999999998766778999999999999999999999999999999999988888887765443321110
Q ss_pred CC--cCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014960 353 AT--IFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXX 411 (415)
Q Consensus 353 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~ 411 (415)
.. ..................++.++++||.+||+.||.+|||++|+|+||||+...+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 00 000000001112334556778899999999999999999999999999999776654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.5e-56 Score=413.51 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=216.4
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecC--CCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRM--SCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~ 193 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++.++.. .......+.+|+.+|+.++|||||++++++.... ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3679999999999999999999999999999999987654 4556678999999999999999999999987643 245
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+||||+.++.+.........+++.+++.|+.||+.||+|||++||+||||||+||||+.++.++|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999988777666666789999999999999999999999999999999999999999999999999987654322
Q ss_pred C--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 274 K--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 274 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|+||.+||.+.+..+.+.++.+....++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 234 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------- 234 (277)
T ss_dssp -------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG----------
T ss_pred ccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC----------
Confidence 1 23345689999999999876 6789999999999999999999999999998888887776433322
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSL 405 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~ 405 (415)
....+.+|+++.+||.+||+.||.+||+..+.|.|+|.+
T Consensus 235 ---------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 ---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 122356889999999999999999999655666677654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=423.13 Aligned_cols=289 Identities=33% Similarity=0.496 Sum_probs=231.1
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec----CCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----~~~~ 193 (415)
++|+++++||+|+||+||+|++..+|+.||||++.+........+.+.+|+.+|++++|+|||++++++... ....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 579999999999999999999999999999999987766666677888999999999999999999998642 1233
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|++ +++.++.+..+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~-~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 98 VYLV-THLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CEEE-EECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EEEE-EeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 4555 45555545555443 3799999999999999999999999999999999999999999999999999976542
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+.+..+.+..+.+........
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 234567899999999988766789999999999999999999999999999999999999998888766544221110
Q ss_pred Cc--CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014960 354 TI--FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMXXXXX 412 (415)
Q Consensus 354 ~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~~~~~ 412 (415)
.. ..........+......+++++++||.+||..||.+|||++|+|+||||+.+.+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 00 000000011123334567888999999999999999999999999999998876553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-55 Score=419.81 Aligned_cols=285 Identities=29% Similarity=0.498 Sum_probs=226.0
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeec----CCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSR----MSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----~~~~ 193 (415)
++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||+++++|... ...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999987766667777899999999999999999999998653 2468
Q ss_pred EEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 014960 194 LYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNH 273 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~ 273 (415)
+|+||||+.++++.... ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||++.......
T Consensus 97 ~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 99999999999887764 368999999999999999999999999999999999999999999999999987665432
Q ss_pred CCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 274 KQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
......+|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+......++....+.+..+.|........
T Consensus 174 --~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 174 --MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred --ccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 3355678999999999987 6799999999999999999999999999999999999999999888887764221100
Q ss_pred -----CcCCCcchhhhh--------hhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014960 354 -----TIFKPQQSYKRC--------IAETFKDFPPSSLPLIETLLAIDPAERQTATAALRSEVSLYMX 408 (415)
Q Consensus 354 -----~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h~~f~~~~ 408 (415)
............ .......++.++++||++||..||++|||++|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000000000000 0111112355689999999999999999999999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-55 Score=409.42 Aligned_cols=250 Identities=20% Similarity=0.327 Sum_probs=207.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.++||+|+||.||+|++..+|+.||||++..+.. ..+.+.+|+.+|++++|||||++++++.+ ...+|+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEee--CCeeEE
Confidence 3579999999999999999999999999999999876543 34568899999999999999999999987 456899
Q ss_pred EEEecccChhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAA--SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++ .....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999987665544 3456799999999999999999999999999999999999999999999999999987765444
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIM-PGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......||+.|+|||++.+ ..|+.++|||||||++|||++|..|| .+.+..++...+.+.. .+
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-~~------------- 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RM------------- 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CC-------------
T ss_pred eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-CC-------------
Confidence 33444567999999999876 67999999999999999999966554 4555544444332211 11
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.....+++++++||.+||+.||++|||++++++
T Consensus 236 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 --------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112357888999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=400.48 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=199.9
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++++.||+|+||.||+|++. +++.||||++...... .+.+.+|++++++++|||||+++|++.. ...+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceecc--CCceEEE
Confidence 57999999999999999999875 5678999999765433 3568899999999999999999999987 4569999
Q ss_pred EEecccChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++.+..+ ......+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+++.........
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999998766554 4555678999999999999999999999999999999999999999999999999998776544444
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||...+..++...+.+....+
T Consensus 159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--------------- 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY--------------- 222 (263)
T ss_dssp ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---------------
T ss_pred ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---------------
Confidence 445678999999999886 679999999999999999999 678888888877777776532111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++++.+||.+||+.||++|||++|+|+|
T Consensus 223 -------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 -------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 112456788999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=405.71 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=211.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|+++ ++..||||++...... .+.+.+|+.+|++++|||||+++|++.+ ..+|+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEE
Confidence 368999999999999999999865 5788999999765433 3568899999999999999999998764 34799
Q ss_pred EEEecccChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASPT--IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+....... ..+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999998776654432 3589999999999999999999999999999999999999999999999999988765544
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......||+.|+|||++.+ ..++.++|||||||+||||+| |.+||...+..+.+..+.+....+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~------------- 230 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV------------- 230 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------------
Confidence 44455678999999999875 578999999999999999999 566777777777776664422111
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEVSL 405 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~--h~~f~ 405 (415)
....+++++.+||.+||+.||++|||++++++ ++||.
T Consensus 231 ---------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 ---------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11357788999999999999999999999998 77764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=406.70 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=206.1
Q ss_pred eeeccCCceEEEEEEEC--CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEEEEec
Q 014960 124 DKIGQGTYSNVYKARDT--LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 124 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
++||+|+||.||+|.+. .+++.||||++..........+.+.+|+.+|++++|||||++++++.. ...||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 46999999999999754 456789999997665556667789999999999999999999999865 2478999999
Q ss_pred ccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCC--Cccc
Q 014960 202 EHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQ--PMTS 279 (415)
Q Consensus 202 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~--~~~~ 279 (415)
.++.+..++.....+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++........ ....
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 99877777766678999999999999999999999999999999999999999999999999999876543321 1233
Q ss_pred ccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCC
Q 014960 280 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKP 358 (415)
Q Consensus 280 ~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (415)
..||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..++...+.+....
T Consensus 170 ~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------------- 229 (277)
T d1xbba_ 170 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------- 229 (277)
T ss_dssp -CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred cCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 568999999999876 678999999999999999998 89999998888777766542110
Q ss_pred cchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHH---hcCCCCCC
Q 014960 359 QQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA---LRSEVSLY 406 (415)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~---L~h~~f~~ 406 (415)
.....+|+++.+||.+||+.||++|||++++ |+|+|++.
T Consensus 230 ---------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 230 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 1113578889999999999999999999998 56766543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-54 Score=404.96 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=200.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc---eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ---IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|++.+.||+|+||.||+|+++.+++ .||||.+.... .....+.+.+|+.+|++++|||||+++|++.. ...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCE
Confidence 4679999999999999999999877665 58888876543 45556778999999999999999999999977 456
Q ss_pred EEEEEEecccChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
+|+|||||.++.+..+ ......+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999998766654 444567999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC----cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 273 HKQP----MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 273 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
.... .....||+.|+|||++.+ ..++.++|||||||+||||+| |.+||.+.+..+++..+.+....+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------- 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------- 253 (299)
T ss_dssp --------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------
T ss_pred CCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 2211 122457899999999876 679999999999999999998 899999999888887775532111
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....+++++.+||.+||+.||++|||+.|++++
T Consensus 254 ---------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ---------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 113577889999999999999999999988764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=395.57 Aligned_cols=249 Identities=18% Similarity=0.297 Sum_probs=213.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
++|++.++||+|+||.||+|+++ +++.||||++++.... .+.+.+|+.++++++|||||+++|++.+ ...+|+|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEE
Confidence 57999999999999999999974 7788999999876543 3468899999999999999999999987 4569999
Q ss_pred EEecccChhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCCCC
Q 014960 198 FKYMEHDLAG-LAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHKQP 276 (415)
Q Consensus 198 ~e~~~~~l~~-~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~~~ 276 (415)
|||+.++.+. ........+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999876544 445566689999999999999999999999999999999999999999999999999998766554444
Q ss_pred cccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCCCc
Q 014960 277 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHATI 355 (415)
Q Consensus 277 ~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 355 (415)
.....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..++..++.+....+
T Consensus 158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------- 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------------
T ss_pred ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 455678999999999886 678999999999999999998 899999999888887776532111
Q ss_pred CCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 356 FKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.....++++.+||.+||+.||++|||++++|+|
T Consensus 222 -------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 -------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 112466789999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=402.24 Aligned_cols=255 Identities=21% Similarity=0.275 Sum_probs=211.9
Q ss_pred CCCceeeee-eccCCceEEEEEEECC--CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDK-IGQGTYSNVYKARDTL--TGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~-lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|.+.+. ||+|+||.||+|.++. ++..||||++... ......+.+.+|+++|++++|||||+++|++.. ..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---Ce
Confidence 357888884 9999999999997654 4557999999754 345566788999999999999999999999865 34
Q ss_pred EEEEEEecccChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLA-ASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
+|+||||++++.+..+ ......+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 8999999998766655 455668999999999999999999999999999999999999999999999999999877543
Q ss_pred CC--CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 273 HK--QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 273 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+++..+.+....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---------- 231 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------- 231 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC----------
T ss_pred ccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 32 22234567999999999875 578999999999999999998 99999998888877776542211
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHH---hcCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAA---LRSEVS 404 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~---L~h~~f 404 (415)
+..+.+|+++.+||.+||+.||++|||+.++ |+|.|+
T Consensus 232 ------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 232 ------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1124578889999999999999999999888 567775
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=408.58 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=206.1
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCc-----eEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQ-----IVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.+.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|.++ +|||||++++++.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 3689999999999999999999865543 68999886543 233445688899999998 89999999999987
Q ss_pred CCeEEEEEEecccChhhhhcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPT-----------------------IKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~-----------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 247 (415)
...+|+|||||.++.+..++... ..+++..++.|+.||+.||+|||+++||||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 45699999999987666554322 2489999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCC
Q 014960 248 SNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRT 325 (415)
Q Consensus 248 ~NILl~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~ 325 (415)
+|||++.++.+||+|||+|+........ ......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876543322 2234567999999999875 679999999999999999997 899999877
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 326 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
..+.+.++.+....++ ....+|+++++||.+||+.||++|||++|+++|
T Consensus 272 ~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCC---------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7666666655322111 123567889999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=412.61 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=219.0
Q ss_pred CCCceeeeeeccCCceEEEEEEE---CCCCceEEEEEEecCCC--ChHHHHHHHHHHHHHHhCCC-CceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD---TLTGQIVALKKVRFDNL--EPESVRFMAREILILRRLDH-PNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~ 190 (415)
.++|++++.||+|+||+||+|++ ..+|+.||||++.+... .....+.+.+|+++|++++| |||+++++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 47899999999999999999987 44789999999865432 12234567789999999976 899999999988
Q ss_pred CCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFD 270 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~ 270 (415)
...+|++|||+.++.+...+.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 45799999999998887777777788999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCCcccccccCccCCcccccCC-cCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 271 PNHKQPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
...........|++.|+|||.+.+. ..++.++|||||||+||+|++|..||.+.+..+....+.+....+.
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-------- 252 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------- 252 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--------
Confidence 5444444566889999999998753 3578899999999999999999999988766655555554321110
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQ-----TATAALRSEVSLYMX 408 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~L~h~~f~~~~ 408 (415)
......+++++.+||++||.+||.+|| |++|+|+||||+.++
T Consensus 253 -----------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 253 -----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -----------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 011235788899999999999999999 589999999999876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=395.21 Aligned_cols=252 Identities=20% Similarity=0.306 Sum_probs=199.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|++.+.||+|+||.||+|++..++ ..||||.+... ......+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---Ce
Confidence 368999999999999999999876543 46888887543 345556788999999999999999999999864 45
Q ss_pred EEEEEEecccChhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
+|+||||+.++.+.. .......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 899999999765554 3455567999999999999999999999999999999999999999999999999999877654
Q ss_pred CCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCC
Q 014960 273 HKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 351 (415)
Q Consensus 273 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 351 (415)
.........||+.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..++..++.+....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------------ 228 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------ 228 (273)
T ss_dssp ---------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------------
T ss_pred cceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 4434455678999999999875 679999999999999999998 89999999888888777543211
Q ss_pred CCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 352 HATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
...+.+|+++.+||.+||+.||++|||++|++++
T Consensus 229 ----------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1124578889999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=393.98 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=206.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+ ..||||++...... .+.|.+|+.++++++|+|||+++|++.+ ...|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEE
Confidence 36899999999999999999998655 56999999765433 3568899999999999999999999854 34799
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+...... ...+++.++..|+.||+.||+|||++||+||||||+||||+.++++||+|||+++.......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999998866555432 34699999999999999999999999999999999999999999999999999987755444
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.......||+.|+|||++.. ..++.++|||||||+||||++| .+||.+....+++..+.+....+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~------------- 234 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 234 (285)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred eeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------------
Confidence 44455678999999999975 6789999999999999999995 66677777777777765432111
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc--CCCCCCCCC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR--SEVSLYMXX 409 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~--h~~f~~~~~ 409 (415)
....+++++++||.+||+.||++|||+++++. ++||.....
T Consensus 235 ---------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 235 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 12357788999999999999999999999988 889877643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=388.54 Aligned_cols=251 Identities=19% Similarity=0.322 Sum_probs=198.4
Q ss_pred CCceeeeeeccCCceEEEEEEECCCC----ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTG----QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
+.|++.+.||+|+||.||+|+.+.++ ..||||++.... .......+.+|+.+|++++|||||+++|++.+ ...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CCc
Confidence 57999999999999999999876554 469999997543 44555678899999999999999999999987 456
Q ss_pred EEEEEEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.++||||+.++.+.... .....+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999987665543 45567999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 273 HKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 273 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
... ......||+.|+|||++.+ ..++.++|||||||+||||++| .+||.+.+..+++..+......+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--------- 233 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP--------- 233 (283)
T ss_dssp ----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---------
T ss_pred CccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC---------
Confidence 322 1233467999999999876 6799999999999999999995 56666677766666554322111
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....++.++.+||.+||+.||++|||+.++++
T Consensus 234 -------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 -------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 11346778999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=397.78 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=202.3
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCc----eEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQ----IVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
++|++++.||+|+||.||+|++..+|+ .||+|.+.... .....+.+.+|+.++++++|||||+++|++.+. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 579999999999999999999888876 47788776432 334456788999999999999999999999763 3
Q ss_pred EEEEEEeccc-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEH-DLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.++++|++.+ +++..+......+++..++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|......
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 6677777765 555666666678999999999999999999999999999999999999999999999999999887554
Q ss_pred CCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCC
Q 014960 273 HKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 350 (415)
Q Consensus 273 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 350 (415)
... ......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..++...+.+....+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---------- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---------- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC----------
T ss_pred cccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 332 2233468999999999886 579999999999999999998 899999888777776665432111
Q ss_pred CCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 351 PHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
....+++++.+||.+||..||.+|||+.|++.|
T Consensus 234 ------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 234 ------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 113467789999999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=388.33 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=208.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|+.+ .+++.||||++.... ..+....+.+|+.+|++++||||+++++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc--C
Confidence 467999999999999999999864 356789999987543 45556788999999999999999999999987 4
Q ss_pred CeEEEEEEecccChhhhhcCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 014960 192 CSLYLVFKYMEHDLAGLAASP------------------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKG 247 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~~------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 247 (415)
...+++|||+.++.+..++.. ...+++..+..|+.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 569999999998765554321 22489999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhC-CCCCCCCC
Q 014960 248 SNLLIDNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRT 325 (415)
Q Consensus 248 ~NILl~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g-~~pf~~~~ 325 (415)
+||||+.++.+||+|||+|+........ ..+...||+.|+|||++.+ ..|+.++|||||||+||||++| .+||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999876543322 2234568899999999986 6799999999999999999998 47899999
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 326 EVEQLHKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 326 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
..++...+.+.... .....++.++++||.+||+.||++|||+.|+++
T Consensus 248 ~~e~~~~v~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNIL----------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888777543211 112357788999999999999999999999965
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=387.73 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=196.2
Q ss_pred CCCceeeeeeccCCceEEEEEEECC-----CCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTL-----TGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.++||+|+||.||+|++.. +++.||||++.... .....+.+.+|+.++.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 3689999999999999999998643 45789999987543 344455667788777776 689999999987654
Q ss_pred CCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC
Q 014960 191 SCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN 254 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 254 (415)
+..+++|||||.++.+..++.. ...+++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 4568999999998766655421 235899999999999999999999999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Q 014960 255 EGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHK 332 (415)
Q Consensus 255 ~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g-~~pf~~~~~~~~~~~ 332 (415)
++++||+|||+|+........ ......||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+.+..+.+..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876543322 2345678999999999986 6799999999999999999986 578887665555444
Q ss_pred HHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 333 IFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 333 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+.+....+ .....+++++++||.+||+.||++|||++|+++|
T Consensus 249 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44322111 1113467789999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=383.95 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=199.3
Q ss_pred CCceeeeeeccCCceEEEEEEEC-CCC--ceEEEEEEecCCC-ChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCe
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDT-LTG--QIVALKKVRFDNL-EPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 193 (415)
++|++.+.||+|+||.||+|+.. .++ ..||||++.+... ..+..+.+.+|+.+|++++|||||+++|++.+ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence 57999999999999999999754 333 3689999876544 34556788999999999999999999999975 24
Q ss_pred EEEEEEecccChhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCC
Q 014960 194 LYLVFKYMEHDLAGL-AASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPN 272 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~ 272 (415)
.++||||+.++.+.. .......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 789999998765543 4444557999999999999999999999999999999999999999999999999999987544
Q ss_pred CCC--CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCC
Q 014960 273 HKQ--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 349 (415)
Q Consensus 273 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 349 (415)
... ......|+..|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+.++.+....++
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 235 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP-------- 235 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--------
T ss_pred CCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--------
Confidence 322 1223456889999999986 678999999999999999998 8999999999998888765422211
Q ss_pred CCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 350 LPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
....+|.++.+||.+||+.||++|||++++++
T Consensus 236 -------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 -------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12457788999999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=377.18 Aligned_cols=245 Identities=20% Similarity=0.334 Sum_probs=197.5
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|+++++||+|+||.||+|++ +|..||||+++.+. ..+.+.+|++++++++|||||+++|++.+. ...+|+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEE
Confidence 46799999999999999999986 57889999997543 335688999999999999999999988553 345899
Q ss_pred EEEecccChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 014960 197 VFKYMEHDLAGLAASP--TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK 274 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~ 274 (415)
||||+.++.+..++.. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999998766655533 235899999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhCCCCCC
Q 014960 275 QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPHA 353 (415)
Q Consensus 275 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 353 (415)
.....+|+.|+|||++.+ ..++.++|||||||++|||+| |++||...+..++...+.+....
T Consensus 157 --~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~-------------- 219 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------- 219 (262)
T ss_dssp -------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC--------------
T ss_pred --CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 233467899999999876 579999999999999999998 79999888877777766432110
Q ss_pred CcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 354 TIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
+....+++++.+||.+||..||.+|||+.+++++
T Consensus 220 --------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 --------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1123567789999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=380.06 Aligned_cols=252 Identities=20% Similarity=0.304 Sum_probs=203.8
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCC-------ceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEee
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTG-------QIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTS 188 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 188 (415)
.++|++++.||+|+||.||+|++..++ ..||||++..+. .......+.+|+..+.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 368999999999999999999875544 479999997654 344556788899988888 89999999999987
Q ss_pred cCCCeEEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 189 RMSCSLYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 189 ~~~~~~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
+...|+||||+.++.+..++.. ...+++.++..++.||+.||+|||+++||||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 4579999999998776665532 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||++......... ......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..++.
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999876543322 2344578999999999876 679999999999999999998 79999888877766
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
..+.... .+ .....+++++++||.+||+.||.+|||+.|+|+
T Consensus 248 ~~i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGH-RM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTC-CC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCC-CC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 6554321 11 112357788999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=381.35 Aligned_cols=263 Identities=15% Similarity=0.203 Sum_probs=217.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEC-----CCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDT-----LTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS 191 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 191 (415)
.++|++.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.++++++|||||++++++.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--C
Confidence 378999999999999999999874 245789999997543 44556678899999999999999999999976 4
Q ss_pred CeEEEEEEecccChhhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEE
Q 014960 192 CSLYLVFKYMEHDLAGLAAS----------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIA 261 (415)
Q Consensus 192 ~~~~lv~e~~~~~l~~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 261 (415)
...++||||+.++.+..++. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 56999999999876654432 22357999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCC-CcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCC
Q 014960 262 DFGLASFFDPNHKQ-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAE-KPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 262 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
|||+|+........ ......||+.|+|||.+.+ ..++.++|||||||++|||+|| .+||.+.+..+.+..+.+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999866433221 1233468999999999876 6789999999999999999998 5889888888888777543211
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc------CCCCCCCCCCC
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR------SEVSLYMXXXX 411 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~------h~~f~~~~~~~ 411 (415)
.....+++.+.+||.+||+.||++|||+.++++ +|+|+.++..-
T Consensus 255 ----------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~~~ 304 (308)
T d1p4oa_ 255 ----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 304 (308)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTT
T ss_pred ----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCCCC
Confidence 112356788999999999999999999999998 88887666543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=383.05 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=204.7
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCce--EEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecCCCe
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQI--VALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRMSCS 193 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 193 (415)
.++|++.++||+|+||.||+|+++.+|.. ||||.+.... ..+..+.+.+|+.+|+++ +|||||++++++.+ ...
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCe
Confidence 46899999999999999999999888874 6777775432 234456788999999999 79999999999987 567
Q ss_pred EEEEEEecccChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCc
Q 014960 194 LYLVFKYMEHDLAGLAASP----------------TIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGI 257 (415)
Q Consensus 194 ~~lv~e~~~~~l~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 257 (415)
+|+||||++++.+..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999998776665532 357999999999999999999999999999999999999999999
Q ss_pred EEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHh
Q 014960 258 LTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEK-PIMPGRTEVEQLHKIFKL 336 (415)
Q Consensus 258 vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~ 336 (415)
+||+|||+++....... .....||..|+|||.+.+ ..++.++|||||||++|||++|. +||.+.+..+....+.+.
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999976543322 234468999999999976 67899999999999999999964 678888887777666432
Q ss_pred cCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 337 CGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
.. + .....+++++++||.+||+.||++|||++++|++
T Consensus 243 ~~-~---------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YR-L---------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CC-C---------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-C---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 0 1123567889999999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-50 Score=376.40 Aligned_cols=261 Identities=19% Similarity=0.224 Sum_probs=205.3
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~l 196 (415)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+++++.++|+|++.+++.+... ....++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEE
Confidence 36799999999999999999999999999999998865432 2467899999999877766555444332 567999
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC---CCcEEEEeeccccccCCCC
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN---EGILTIADFGLASFFDPNH 273 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DfG~a~~~~~~~ 273 (415)
||||+++++..........+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+....
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999999888887777778999999999999999999999999999999999999864 4579999999998875432
Q ss_pred C------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Q 014960 274 K------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 347 (415)
Q Consensus 274 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 347 (415)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||...........+.+.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~------- 232 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------- 232 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-------
T ss_pred cccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-------
Confidence 2 12244579999999999986 669999999999999999999999998866555444433221000
Q ss_pred CCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHH---HHhcCCCC
Q 014960 348 SKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTAT---AALRSEVS 404 (415)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~---~~L~h~~f 404 (415)
.........+.+|+++.+||..||+.||++||++. ++|+|+|.
T Consensus 233 --------------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 233 --------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp --------------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred --------------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00002233457889999999999999999999986 55677664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=378.76 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=209.0
Q ss_pred CCCceeeeeeccCCceEEEEEEE-----CCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhC-CCCceeeeeeeEeecC
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARD-----TLTGQIVALKKVRFDNLEPESVRFMAREILILRRL-DHPNVVKLEGLVTSRM 190 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 190 (415)
.++|++.++||+|+||.||+|+. ..+++.||||++.... .......+.+|+.+++++ +|||||++++++.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 36899999999999999999975 3566789999998654 345556788999999999 69999999999987
Q ss_pred CCeEEEEEEecccChhhhhcC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEE
Q 014960 191 SCSLYLVFKYMEHDLAGLAAS------------------PTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLI 252 (415)
Q Consensus 191 ~~~~~lv~e~~~~~l~~~~~~------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 252 (415)
...+|+|||||.++.+..++. ....+++..+..|+.||+.||+|||+++||||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 456999999999876655442 12358999999999999999999999999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCC-CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014960 253 DNEGILTIADFGLASFFDPNHK-QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-EKPIMPGRTEVEQL 330 (415)
Q Consensus 253 ~~~~~vkl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~-g~~pf~~~~~~~~~ 330 (415)
+.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987754432 22234578999999999875 678999999999999999998 77888887776766
Q ss_pred HHHHHhcCCCCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
.++.+....+. ....+++++.+||.+||+.||++|||++++|+
T Consensus 258 ~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66655322211 11346788999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=369.98 Aligned_cols=250 Identities=19% Similarity=0.218 Sum_probs=198.2
Q ss_pred eeeeeeccCCceEEEEEEECCCC---ceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCCCeEEEE
Q 014960 121 EKLDKIGQGTYSNVYKARDTLTG---QIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLV 197 (415)
Q Consensus 121 ~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~lv 197 (415)
...++||+|+||+||+|++..++ ..||||.+... ......+.+.+|+++|++++|||||+++|++... ...+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEE
Confidence 33678999999999999876543 36899998743 3466678899999999999999999999998653 4579999
Q ss_pred EEecccChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEeeccccccCCCCC--
Q 014960 198 FKYMEHDLAGLAA-SPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADFGLASFFDPNHK-- 274 (415)
Q Consensus 198 ~e~~~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~~~~~~~-- 274 (415)
||||+++.+..+. .....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999987776544 4555788999999999999999999999999999999999999999999999999987654322
Q ss_pred -CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCHHHHhhCCCCC
Q 014960 275 -QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPG-RTEVEQLHKIFKLCGSPSEEYWKKSKLPH 352 (415)
Q Consensus 275 -~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 352 (415)
.......||+.|+|||++.+ ..++.++||||||++||||+||..||.. .+..+....+.+.. .+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~~------------ 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RL------------ 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-CC------------
T ss_pred ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CC------------
Confidence 12233568999999999875 6799999999999999999997666654 33434444443221 10
Q ss_pred CCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhcC
Q 014960 353 ATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALRS 401 (415)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~h 401 (415)
...+.+++++.+||.+||..||++|||+.|+++|
T Consensus 254 ---------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 ---------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0113467789999999999999999999999988
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-48 Score=363.19 Aligned_cols=252 Identities=18% Similarity=0.209 Sum_probs=206.0
Q ss_pred CCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC-CceeeeeeeEeecCCCeEE
Q 014960 117 ADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH-PNVVKLEGLVTSRMSCSLY 195 (415)
Q Consensus 117 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~~~ 195 (415)
.++|+++++||+|+||.||+|++..+|+.||||++...... ..+.+|+++++.+.| +|++.+++++.. ....|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccE
Confidence 35899999999999999999999999999999998754322 246678999999965 899999999877 56799
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcC-----CCcEEEEeeccccccC
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDN-----EGILTIADFGLASFFD 270 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-----~~~vkl~DfG~a~~~~ 270 (415)
+||||+++++...+......+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999988887777666678999999999999999999999999999999999999974 5789999999998764
Q ss_pred CCCC------CCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Q 014960 271 PNHK------QPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRTE---VEQLHKIFKLCGSPS 341 (415)
Q Consensus 271 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~ 341 (415)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+... .+....+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3221 12345679999999999986 6799999999999999999999999986543 333333332211111
Q ss_pred HHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHh
Q 014960 342 EEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAAL 399 (415)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L 399 (415)
..+..+.+|+++.+++..|+..+|++||+.+.+.
T Consensus 237 ------------------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 237 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ------------------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 2334467889999999999999999999876654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-48 Score=373.08 Aligned_cols=285 Identities=25% Similarity=0.377 Sum_probs=218.4
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-----------CCceeeeeeeE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-----------HPNVVKLEGLV 186 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~l~~~~ 186 (415)
++|+++++||+|+||+||+|++..+|+.||||+++++ ....+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999999999999999999754 334466788999988875 57899999998
Q ss_pred eecCCCeEEEEEEecccC---hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCEEEcCCCc-----
Q 014960 187 TSRMSCSLYLVFKYMEHD---LAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN-QHVLHRDIKGSNLLIDNEGI----- 257 (415)
Q Consensus 187 ~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~----- 257 (415)
........+++++++... ...........+++..++.++.||+.||+|||+ .||+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 775566777777776553 222334455689999999999999999999998 89999999999999987654
Q ss_pred -EEEEeeccccccCCCCCCCcccccccCccCCcccccCCcCCCchhcHHHHHHHHHHHHhCCCCCCCCC------hHHHH
Q 014960 258 -LTIADFGLASFFDPNHKQPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAEKPIMPGRT------EVEQL 330 (415)
Q Consensus 258 -vkl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDvwSlG~il~ell~g~~pf~~~~------~~~~~ 330 (415)
+|++|||.+..... .....+||+.|+|||++.+ ..++.++||||+||++++|++|++||.... ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 99999999976543 2345678999999999986 678999999999999999999999997543 44567
Q ss_pred HHHHHhcCCCCHHHHhhCCCCC----------CCcCCCcchhhhhhhhhc---CCCCCChHHHHHHhcccCCCCCCCHHH
Q 014960 331 HKIFKLCGSPSEEYWKKSKLPH----------ATIFKPQQSYKRCIAETF---KDFPPSSLPLIETLLAIDPAERQTATA 397 (415)
Q Consensus 331 ~~i~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~t~~~ 397 (415)
..+++.++.++.+.+....... .................. ...+++++|||.+||.+||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 7778888888777665433211 000111111111111111 223567899999999999999999999
Q ss_pred HhcCCCCCCCCCC
Q 014960 398 ALRSEVSLYMXXX 410 (415)
Q Consensus 398 ~L~h~~f~~~~~~ 410 (415)
+|+||||++.-..
T Consensus 325 ~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 325 LVNHPWLKDTLGM 337 (362)
T ss_dssp HHTCGGGTTCTTC
T ss_pred HhcCcccCCCCCc
Confidence 9999999966443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=365.90 Aligned_cols=270 Identities=23% Similarity=0.230 Sum_probs=188.3
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeeeeeEeecCC--CeEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLEGLVTSRMS--CSLY 195 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--~~~~ 195 (415)
++|.+.+.||+|+||.||+|+. +|+.||||++..+ .......+.|+..+..++|||||++++++.+... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5799999999999999999974 6899999998643 2222233345555567899999999999876432 3689
Q ss_pred EEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 196 LVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------QHVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 196 lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------~~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
+||||+.++.+..++... .+++..++.++.|++.||+|||+ +|||||||||+||||+.++++||+|||++.
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999987777666543 68999999999999999999996 699999999999999999999999999998
Q ss_pred ccCCCCC---CCcccccccCccCCcccccCCc-----CCCchhcHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014960 268 FFDPNHK---QPMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAEKPIMPGRTEVEQLHKIFKLCGS 339 (415)
Q Consensus 268 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-----~~~~~sDvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 339 (415)
....... .......||+.|+|||++.+.. .++.++|||||||+||||+||.+||......+..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~ 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSD 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSS
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-ccccc
Confidence 7754332 1234567999999999986521 3677899999999999999999887542211000000 00000
Q ss_pred CCHHHHhhCCCCCCCcCCCcchhhhhhhhhcCCCCCChHHHHHHhcccCCCCCCCHHHHhc
Q 014960 340 PSEEYWKKSKLPHATIFKPQQSYKRCIAETFKDFPPSSLPLIETLLAIDPAERQTATAALR 400 (415)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~L~ 400 (415)
+............ ..++. +.. .......+..+.+||.+||..||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~--~~~p~--~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKVVCEQ--KLRPN--IPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTS--CCCCC--CCG--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhcc--ccCCC--CCc--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0000000000000 00000 000 0000112234788999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=6.3e-27 Score=204.12 Aligned_cols=166 Identities=14% Similarity=0.091 Sum_probs=122.4
Q ss_pred ceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCC----------------hHHHHHHHHHHHHHHhCCCCceeeee
Q 014960 120 FEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLE----------------PESVRFMAREILILRRLDHPNVVKLE 183 (415)
Q Consensus 120 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~~iv~l~ 183 (415)
+.+.++||+|+||.||+|++. +|+.||||+++..... ........+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999874 6899999987532110 11223455688899999999999887
Q ss_pred eeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCEEEcCCCcEEEEee
Q 014960 184 GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHNQHVLHRDIKGSNLLIDNEGILTIADF 263 (415)
Q Consensus 184 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~Df 263 (415)
++.. .+++|||+++..... +++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~------~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET------TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC------CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 6521 369999999865432 3445567899999999999999999999999999999965 4899999
Q ss_pred ccccccCCCCCCCcccccccCccCC------cccccCCcCCCchhcHHHHHHHH
Q 014960 264 GLASFFDPNHKQPMTSRVVTLWYRP------PELLLGATDYGVGVDLWSAGCIL 311 (415)
Q Consensus 264 G~a~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~sDvwSlG~il 311 (415)
|+|......... .|.. .+.+. ..|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 999765432211 1111 12222 4688999999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=3.1e-07 Score=81.50 Aligned_cols=139 Identities=14% Similarity=0.109 Sum_probs=88.6
Q ss_pred CCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeecCCCeEEE
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSRMSCSLYL 196 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~l 196 (415)
+.|++.+..+.++.+.||+.. .++..+.+|....... .....+.+|+.+++.+. +--+++++.+..+ ++..|+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEE
Confidence 456766665555667999884 4566778898764322 11234667888888773 4446777777665 467899
Q ss_pred EEEecccChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 014960 197 VFKYMEHDLAGLAASPTIKFTQAQVKCYMHQLLSGLEHCHN--------------------------------------- 237 (415)
Q Consensus 197 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 237 (415)
||++++|..+........ . ...++.++...|..||+
T Consensus 88 v~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEecccccccccccccc--c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 999999865543322111 1 11123333333333331
Q ss_pred --------------C------CCeeccCCCCCEEEcCCCcEEEEeecccc
Q 014960 238 --------------Q------HVLHRDIKGSNLLIDNEGILTIADFGLAS 267 (415)
Q Consensus 238 --------------~------~ivHrDlkp~NILl~~~~~vkl~DfG~a~ 267 (415)
. .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 27999999999999987667799999774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.21 E-value=3.3e-06 Score=74.20 Aligned_cols=72 Identities=13% Similarity=0.089 Sum_probs=47.8
Q ss_pred eeccCC-ceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCC--CceeeeeeeEeecCCCeEEEEEEec
Q 014960 125 KIGQGT-YSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDH--PNVVKLEGLVTSRMSCSLYLVFKYM 201 (415)
Q Consensus 125 ~lG~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~~~lv~e~~ 201 (415)
.+..|. .+.||+... ..+..+++|...... ...+..|+..++.+.. -.+++++.+..+ .+..|+||+++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 344454 368999863 456678889765432 2246678888877742 335677776665 45689999999
Q ss_pred ccC
Q 014960 202 EHD 204 (415)
Q Consensus 202 ~~~ 204 (415)
+|.
T Consensus 89 ~G~ 91 (255)
T d1nd4a_ 89 PGQ 91 (255)
T ss_dssp SSE
T ss_pred ecc
Confidence 874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.08 E-value=2.7e-06 Score=80.22 Aligned_cols=77 Identities=19% Similarity=0.130 Sum_probs=47.3
Q ss_pred eeeeccCCceEEEEEEECCCCceEEEEEEecC----C-CChHHHHHHHHHHHHHHhCC-C--CceeeeeeeEeecCCCeE
Q 014960 123 LDKIGQGTYSNVYKARDTLTGQIVALKKVRFD----N-LEPESVRFMAREILILRRLD-H--PNVVKLEGLVTSRMSCSL 194 (415)
Q Consensus 123 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~-~~~~~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~~~~~~ 194 (415)
.+.||.|....||++.+..+++.|++|.-... . .......+...|+.+|+.+. + ..+++++.+.. ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~----~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT----EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET----TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC----CCC
Confidence 45789999999999988777888999975421 0 00112234456888877662 2 34667765432 235
Q ss_pred EEEEEeccc
Q 014960 195 YLVFKYMEH 203 (415)
Q Consensus 195 ~lv~e~~~~ 203 (415)
++|||++.+
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 789999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00059 Score=61.87 Aligned_cols=67 Identities=18% Similarity=0.191 Sum_probs=42.3
Q ss_pred ceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCcee-----eeee--eEeecCCCeEEEEEEeccc
Q 014960 131 YSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVV-----KLEG--LVTSRMSCSLYLVFKYMEH 203 (415)
Q Consensus 131 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-----~l~~--~~~~~~~~~~~lv~e~~~~ 203 (415)
--.||+++. .+|..|++|+.+..... .+.+..|...+..|...+|. ..-+ .+.. ....+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~--~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee--eeEEEEEEeecCC
Confidence 358999963 67888999998755433 34466788888777422221 1111 1122 4568889999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.25 E-value=0.00042 Score=64.67 Aligned_cols=75 Identities=16% Similarity=0.165 Sum_probs=49.1
Q ss_pred CCceeeeeeccCCceEEEEEEECC-------CCceEEEEEEecCCCChHHHHHHHHHHHHHHhCC-CCceeeeeeeEeec
Q 014960 118 DTFEKLDKIGQGTYSNVYKARDTL-------TGQIVALKKVRFDNLEPESVRFMAREILILRRLD-HPNVVKLEGLVTSR 189 (415)
Q Consensus 118 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~ 189 (415)
+.+++ +.|+.|-.-.+|++.... ..+.|.+++.- ... ......+|..+++.+. +.-.+++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34444 578889999999997543 23557777654 211 1234567999988884 4334678777642
Q ss_pred CCCeEEEEEEeccc
Q 014960 190 MSCSLYLVFKYMEH 203 (415)
Q Consensus 190 ~~~~~~lv~e~~~~ 203 (415)
++|+||+.|
T Consensus 117 -----g~I~efi~g 125 (395)
T d1nw1a_ 117 -----GRLEEYIPS 125 (395)
T ss_dssp -----EEEECCCCE
T ss_pred -----ceEEEEecc
Confidence 578899887
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.30 E-value=0.0041 Score=55.60 Aligned_cols=31 Identities=23% Similarity=0.338 Sum_probs=27.5
Q ss_pred CCCeeccCCCCCEEEcCCCcEEEEeeccccc
Q 014960 238 QHVLHRDIKGSNLLIDNEGILTIADFGLASF 268 (415)
Q Consensus 238 ~~ivHrDlkp~NILl~~~~~vkl~DfG~a~~ 268 (415)
.|+||+|+.+.||+++.+..+-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999888788999998853
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=83.83 E-value=5.8 Score=34.07 Aligned_cols=142 Identities=14% Similarity=0.195 Sum_probs=77.8
Q ss_pred CCCCCceeeeeeccCCceEEEEEEECCCCceEEEEEEecCCCChHHHHHHHHHHHHHHhCCCCceeeee-----------
Q 014960 115 RRADTFEKLDKIGQGTYSNVYKARDTLTGQIVALKKVRFDNLEPESVRFMAREILILRRLDHPNVVKLE----------- 183 (415)
Q Consensus 115 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~----------- 183 (415)
...+.++.++.=-.|+-|..|.- . ++..++||.-. .-..+.+-.++...-.++-|...-+.
T Consensus 66 ~~l~~~K~i~~s~~Gs~Gv~FV~--~-e~gaiVlK~s~-----tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~ 137 (342)
T d1cjaa_ 66 KNLQQFKGIERSEKGTEGLFFVE--T-ESGVFIVKRST-----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLE 137 (342)
T ss_dssp TCGGGEEEEEECCSTTSCEEEEE--E-SSCEEEEECCT-----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHH
T ss_pred hhHHhhhceEEeecCCceEEEEE--c-CCceEEEecCC-----chHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHHH
Confidence 34566776666666777766653 2 34457788522 34456666676666667777765442
Q ss_pred ---------eeEeecCCCeEEEEEEecccChhhhhcCCCCCCCHHHHHHHHHHH--HHHHH-HHHhC---CCeecc-CCC
Q 014960 184 ---------GLVTSRMSCSLYLVFKYMEHDLAGLAASPTIKFTQAQVKCYMHQL--LSGLE-HCHNQ---HVLHRD-IKG 247 (415)
Q Consensus 184 ---------~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~qi--~~~L~-~LH~~---~ivHrD-lkp 247 (415)
++.........+++|||++|..+..... ...++......+.++ +-+++ ++++. .+.+|+ =.+
T Consensus 138 ~~l~~~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~--~~a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~ 215 (342)
T d1cjaa_ 138 CLAAIDKSFRVITTLANQANILLMELVRGITLNKLTT--TSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNL 215 (342)
T ss_dssp HHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCS--SSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCG
T ss_pred HHhcCCChhHHHHHHHhcccceeeeccCCcccccccc--ccchhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCc
Confidence 0111112245789999998855433221 111222222233333 22233 34432 356663 289
Q ss_pred CCEEEcCCC-cEEEEeeccc
Q 014960 248 SNLLIDNEG-ILTIADFGLA 266 (415)
Q Consensus 248 ~NILl~~~~-~vkl~DfG~a 266 (415)
.||++..++ .+..+|=|..
T Consensus 216 ~Niml~~n~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 216 DNIMLSERGATVVPIDSKII 235 (342)
T ss_dssp GGEEEESBTTCEEECSCCCC
T ss_pred cceEEecCCcEEEEecCCcc
Confidence 999998877 6777774443
|